10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2011

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 1-32258

Reynolds American Inc.

(Exact name of registrant as specified in its charter)

North Carolina	20-0546644
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

401 North Main Street

Winston-Salem, NC 27101

(Address of principal executive offices) (Zip Code)

(336) 741-2000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each exchange on which registered	Title of each class	Name of each exchange on which registered
Common stock, par value $.0001 per share	New York	Rights to Purchase Series A Junior Participating Preferred Stock	New York

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  þ    No  ¨

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.    Yes  ¨    No  þ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  þ    No  ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  þ

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  þ	Accelerated filer  ¨	Non-accelerated filer  ¨	Smaller reporting company  ¨
		(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  þ

The aggregate market value of common stock held by non-affiliates of Reynolds American Inc. on June 30, 2011, was approximately $12.5 billion, based on the closing price of $37.05. Directors, executive officers and a significant shareholder of Reynolds American Inc. are considered affiliates for purposes of this calculation, but should not necessarily be deemed affiliates for any other purpose.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: January 27, 2012: 576,142,238 shares of common stock, par value $.0001 per share.

Documents Incorporated by Reference:

Portions of the Definitive Proxy Statement of Reynolds American Inc. to be filed with the Securities and Exchange Commission pursuant to Regulation 14A of the Securities Exchange Act of 1934 on or about March 23, 2012, are incorporated by reference into Part III of this report.

INDEX

PART I
Item 1.	Business	2
Item 1A.	Risk Factors	14
Item 1B.	Unresolved Staff Comments	24
Item 2.	Properties	24
Item 3.	Legal Proceedings	24
Item 4.	Reserved	24
PART II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	25
Item 6.	Selected Financial Data	27
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	64
Item 8.	Financial Statements and Supplementary Data	66
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	181
Item 9A.	Controls and Procedures	181
Item 9B.	Other Information	181
PART III
Item 10.	Directors, Executive Officers and Corporate Governance	182
Item 11.	Executive Compensation	182
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	182
Item 13.	Certain Relationships and Related Transactions, and Director Independence	182
Item 14.	Principal Accountant Fees and Services	182
PART IV
Item 15.	Exhibits and Financial Statement Schedules	183
Signatures		191

1

PART I

Item 1. Business

Reynolds American Inc., referred to as RAI, is a holding company whose operating subsidiaries include the second largest cigarette manufacturer in the United States, R. J. Reynolds Tobacco Company; the second largest smokeless tobacco products manufacturer in the United States, American Snuff Company, LLC, referred to as American Snuff Co.; the manufacturer of the fastest growing super-premium cigarette brand, Santa Fe Natural Tobacco Company, Inc. referred to as SFNTC; and Niconovum AB. RAI was incorporated in the state of North Carolina on January 2, 2004, and its common stock is listed on the NYSE under the symbol “RAI.” RAI’s headquarters are located in Winston-Salem, North Carolina. On July 30, 2004, the U.S. assets, liabilities and operations of Brown & Williamson Tobacco Corporation, now known as Brown & Williamson Holdings, Inc., referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c., referred to as BAT, were combined with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of R.J. Reynolds Tobacco Holdings, Inc., a wholly owned subsidiary of RAI, referred to as RJR. These July 30, 2004, transactions generally are referred to as the B&W business combination. As a result of the B&W business combination, B&W owns approximately 42% of RAI’s outstanding common stock.

References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a New Jersey corporation. References to RJR Tobacco on and subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W and R. J. Reynolds Tobacco Company. Concurrent with the completion of the B&W business combination, RJR Tobacco became a North Carolina corporation.

In 2006, RAI, through a subsidiary, completed its acquisition of American Snuff Co. and Rosswil, LLC.

RAI’s Internet Web site address is www.reynoldsamerican.com. RAI’s annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, insider trading reports on Forms 3, 4 and 5 and all amendments to those reports are available free of charge through RAI’s Web site, as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. RAI’s Internet Web site and the information contained therein or connected thereto are not intended to be incorporated into this Annual Report on Form 10-K. RAI’s Web site is the primary source of publicly disclosed news about RAI and its operating companies.

RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane, Limited, referred to as Lane. During the fourth quarter of 2011, RAI elected to begin reporting the Santa Fe segment, which includes the primary operations of SFNTC. RAI has retrospectively revised segment disclosures for all periods presented. Although the operations and results of Santa Fe currently do not meet the quantitative criteria to be required to be reported, RAI management believes that reporting this segment is important to the financial statement user for additional understanding and transparency with respect to the aggregate operations and results of RAI’s subsidiaries that produce and market cigarettes in the U.S. Niconovum AB, among other RAI subsidiaries, is included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI. For net sales and operating income attributable to each segment, see Item 8, note 17 to consolidated financial statements.

As a result of the B&W business combination, Lane became a wholly owned subsidiary of RAI. On February 28, 2011, RAI completed the sale of all of the capital stock of Lane and certain other assets related to the Lane operations, to an affiliate of Scandinavian Tobacco Group A/S, referred to as STG, for net proceeds of

2

$202 million in cash. The assets and liabilities of the disposal group were classified as held for sale as of December 31, 2010, and its results of operations were included through February 28, 2011, in income from continuing operations in the American Snuff segment.

RAI Strategy

RAI’s strategy is focused on transforming tobacco in anticipation of shifts in consumer preferences to deliver sustainable earnings growth, strong cash flow and enhanced long-term shareholder value. This transformation strategy includes growing the core cigarette and moist-snuff businesses, focusing on innovation, including modern smoke-free tobacco, such as CAMEL Dissolvables, exploring nicotine replacement treatments and other opportunities for adult tobacco consumers while maintaining efficient and effective operations. RAI remains committed to maintaining high standards of corporate governance and business conduct in a high performing culture.

RJR Tobacco

Overview

RAI’s largest reportable operating segment, RJR Tobacco, is the second largest cigarette manufacturer in the United States. RJR Tobacco’s brands include many of the best-selling cigarettes in the United States: CAMEL, PALL MALL, WINSTON, KOOL, DORAL and SALEM. Those brands, and its other brands, including MISTY and CAPRI, are manufactured in a variety of styles and marketed in the United States. RJR Tobacco also manages contract manufacturing of cigarettes and tobacco products through arrangements with BAT affiliates, and manages the export of tobacco products to certain U.S. territories, U.S. duty-free shops and U.S. overseas military bases. On January 1, 2012, the management of super premium cigarette brands, DUNHILL and STATE EXPRESS 555, was transferred to RJR Tobacco from Santa Fe.

RJR Tobacco primarily conducts its business in the highly competitive U.S. cigarette market. The international rights to substantially all of RJR Tobacco’s brands were sold in 1999 to Japan Tobacco Inc., referred to as JTI, and no international rights were acquired in connection with the B&W business combination. The U.S. cigarette market, which has a few large manufacturers and many smaller participants, is a mature market in which overall consumer demand has declined since 1981, and is expected to continue to decline. Management Science Associates, Inc., referred to as MSAi, reported that U.S. cigarette shipments declined 3.5% in 2011, to 293.1 billion cigarettes, 3.8% in 2010 and 8.6% in 2009. From year to year, shipments are impacted by various factors including price increases, excise tax increases and wholesale inventory adjustments.

Profitability of the U.S. cigarette industry and RJR Tobacco continues to be adversely impacted by the decreases in consumption, increases in federal and state excise taxes and governmental regulations and restrictions, such as marketing limitations, product standards, smoking bans and ingredients legislation.

RJR Tobacco offers two types of modern smoke-free tobacco, CAMEL Snus and CAMEL Dissolvables. CAMEL Snus is pasteurized tobacco in a small pouch that provides convenient tobacco consumption. CAMEL Dissolvables consist of CAMEL Orbs, Sticks and Strips, all of which are made of finely milled tobacco and dissolve completely in the mouth.

Competition

RJR Tobacco’s primary competitors include Philip Morris USA Inc., Lorillard Tobacco Company, Liggett Group and Commonwealth Brands, Inc., as well as manufacturers of deep-discount brands. Deep-discount brands are brands manufactured by companies that are not original participants in the Master Settlement Agreement,

3

referred to as the MSA, and other state settlement agreements with the states of Mississippi, Florida, Texas and Minnesota, together with the MSA collectively referred to as the State Settlement Agreements, and accordingly, do not have cost structures burdened with payments related to State Settlement Agreements to the same extent as the original participating manufacturers. For further discussion of the State Settlement Agreements, see “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements” in Item 8, note 13 to consolidated financial statements.

Based on data collected by Information Resources Inc., referred to as IRI/Capstone, during 2011 and 2010, RJR Tobacco had an overall retail share of the U.S. cigarette market of 27.4% and 28.1%, respectively. During these same years, Philip Morris USA Inc. had an overall retail share of the U.S. cigarette market of 48.2% and 49.1%, respectively.

Domestic shipment volume and retail share of market data that appear in this document have been obtained from MSAi and IRI/Capstone, respectively. These two organizations are the primary sources of volume and market share data relating to the cigarette and tobacco industry. This information is included in this document because it is used by RJR Tobacco primarily as an indicator of the relative performance of industry participants. However, you should not rely on the market share data reported by IRI/Capstone as being precise measurements of actual market share because IRI/Capstone uses a sample and projection methodology that is not able to effectively track all volume. Moreover, you should be aware that in a product market experiencing overall declining consumption, a particular product can experience increasing market share relative to competing products, yet still be subject to declining consumption volumes. RJR Tobacco believes that deep-discount brands made by small manufacturers have combined shipments of approximately 15% of total U.S. industry shipments. Accordingly, the retail share of market of RJR Tobacco and its brands as reported by IRI/Capstone may overstate their actual market share.

Competition is based primarily on brand positioning, including price, product attributes and packaging, consumer loyalty, promotions, advertising and retail presence. Cigarette brands produced by the major manufacturers generally require competitive pricing, substantial marketing support, retail programs and other incentives to maintain or improve market position or to introduce a new brand or brand style. Competition among the major cigarette manufacturers has begun shifting to product innovation and expansion into smoke-free tobacco categories, such as snus, as well as finding efficient and effective means of balancing market share and profit growth.

Marketing

RJR Tobacco is committed to building and maintaining a portfolio of profitable brands. RJR Tobacco’s marketing programs are designed to strengthen brand image, build brand awareness and loyalty, and switch adult smokers of competing brands to RJR Tobacco brands. In addition to building strong brand equity, RJR Tobacco’s marketing approach utilizes a retail pricing strategy, including discounting at retail, to defend certain brands’ shares of market against competitive pricing pressure. RJR Tobacco’s competitive pricing methods may include list price changes, discounting programs, such as retail and wholesale buydowns, periodic price reductions, off-invoice price reductions, dollar-off promotions and consumer coupons. Retail buydowns refer to payments made to the retailer to reduce the price that consumers pay at retail. Consumer coupons generally are distributed by a variety of methods including in, or on, the pack and by direct mail.

RJR Tobacco provides trade incentives through trade terms, wholesale partner programs and retail incentives. Trade discounts are provided to wholesalers based on compliance with certain terms. The wholesale partner programs provide incentives to RJR Tobacco’s direct buying customers based on performance levels. Retail incentives are paid to the retailer based on compliance with RJR Tobacco’s contract terms.

RJR Tobacco’s cigarette brand portfolio strategy is based upon three brand categories: growth, support and non-support. The growth brands consist of a premium brand, CAMEL, and a value brand, PALL MALL.

4

Although both of these brands are managed for long-term market share and profit growth, CAMEL will continue to receive the most significant equity support. The support brands include four premium brands, WINSTON, KOOL, SALEM and CAPRI, and two value brands, DORAL and MISTY, all of which receive limited marketing support. The non-support brands, consisting of all other brands, are managed to maximize near-term profitability. The key objectives of the portfolio strategy are to ensure the long-term market share growth of the growth brands while managing the support brands for long-term sustainability and profitability. Consistent with that strategy, RJR Tobacco has discontinued many of its non-core cigarette styles as well as private-label cigarette brands. RJR Tobacco’s modern smoke-free products, snus and dissolvable tobacco products, are marketed under the CAMEL brand and focus on long-term growth.

Anti-tobacco groups have attempted to restrict cigarette sales, cigarette advertising, and the testing and introduction of new tobacco products as well as encourage smoking bans. The MSA and federal, state and local laws and regulations, including the FDA Tobacco Act, discussed below, and related regulations, restrict or prohibit utilization of television, radio or billboard advertising or certain other marketing and promotional tools for cigarettes and smoke-free tobacco products. RJR Tobacco continues to use direct mailings and other means to market its brands and enhance their appeal among age-verified adults who use tobacco products. RJR Tobacco continues to advertise and promote at retail locations and in adult venues where permitted and also uses print advertising in newspapers and consumer magazines in the United States.

Manufacturing and Distribution

RJR Tobacco owns its manufacturing facilities, located in the Winston-Salem, North Carolina area, known as the Tobaccoville manufacturing facility and the Whitaker Park complex, which includes a cigarette manufacturing facility. During 2010, RJR Tobacco announced plans to close the Whitaker Park cigarette manufacturing facility by mid-2011, which date, due to additional demand, has been extended to early 2012. Production from this facility will be transferred to the Tobaccoville facility. RJR Tobacco has a total production capacity of approximately 110 billion cigarettes per year.

RJR Tobacco distributes its cigarettes primarily through a combination of direct wholesale deliveries from a local distribution center and public warehouses located throughout the United States.

RJR Tobacco has entered into various transactions with affiliates of BAT. RJR Tobacco sells contract-manufactured cigarettes and processed strip leaf to BAT affiliates. Net sales, primarily of cigarettes, to BAT affiliates represented approximately 6%, 4% and 5% of RAI’s total net sales in 2011, 2010 and 2009, respectively.

Raw Materials

In its production of tobacco products, RJR Tobacco uses U.S. and foreign, grown primarily in Brazil, burley and flue-cured leaf tobaccos, as well as Oriental tobaccos grown primarily in Turkey, Macedonia and Bulgaria. RJR Tobacco believes there is a sufficient supply of leaf in the worldwide tobacco market to satisfy its current and anticipated production requirements.

RJR Tobacco purchases the majority of its U.S. flue-cured and burley leaf directly through contracts with tobacco growers. These short-term contracts are frequently renegotiated. RJR Tobacco believes the relationship with its leaf suppliers is good.

Under the modified terms of settlement agreements with flue-cured and burley tobacco growers, and quota holders, RJR Tobacco is required, among other things, to purchase a minimum amount, in pounds and subject to adjustment based on its annual total requirements, annually of U.S. green leaf flue-cured and burley tobacco combined, through the 2015 crop year.

5

RJR Tobacco also uses other raw materials such as filter tow, filter rods and fire standards compliant paper, which are sourced from either one supplier or a few suppliers. RJR Tobacco believes it has reasonable measures in place designed to mitigate the risk posed by the limited number of suppliers of certain raw materials.

American Snuff

Overview

RAI’s reportable operating segment, American Snuff, is the second largest smokeless tobacco products manufacturer in the United States. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane. On February 28, 2011, RAI completed the sale of all of the capital stock of Lane and certain other assets related to the Lane operations to STG. Moist snuff has been the key driver of American Snuff’s overall growth and profitability within the U.S. smokeless tobacco market. The moist snuff category is divided into premium and price-value brands. American Snuff’s primary products include its largest selling moist snuff brands, GRIZZLY, in the price-value category, and KODIAK, in the premium category.

In contrast to the declining U.S. cigarette market, U.S. moist snuff volumes grew nearly 5% in 2011. Profit margins on moist snuff products are generally higher than on cigarette products. Moist snuff’s growth is partially attributable to cigarette smokers switching from cigarettes to smokeless tobacco products or using both. In 2011, moist snuff industry volume growth returned to historic levels after a higher-than-expected level in 2010, as the growth in 2010 was positively impacted by competitive promotional strategies.

Moist snuff accounted for approximately 83%, 74% and 71% of American Snuff’s revenue in 2011, 2010 and 2009, respectively. The increase in 2011 was impacted by the sale of Lane during 2011. American Snuff’s retail share of market of U.S. moist snuff, according to data processed by A.C. Nielsen, was 31.5% and 30.3% in 2011 and 2010, respectively. GRIZZLY moist snuff had a market share of 27.7% and 26.1% in 2011 and 2010, respectively.

Competition

American Snuff is dependent on the U.S. smokeless tobacco market, where competition is significant. Similar to the cigarette market, competition is based primarily on brand positioning and price, as well as product attributes and packaging, consumer loyalty, promotions, advertising and retail presence. Moist snuff has developed many of the characteristics of the larger, cigarette market, including multiple pricing tiers with intense competition, focused marketing programs and product innovation.

American Snuff’s largest competitor is U.S. Smokeless Tobacco Company LLC, referred to as USSTC, which had approximately 55.8% and 55.7% of the U.S. moist snuff market share in 2011 and 2010, respectively. American Snuff also competes in the U.S. smokeless tobacco market with other domestic and international companies.

Marketing

American Snuff is committed to building and maintaining a portfolio of profitable brands. American Snuff’s marketing programs are designed to strengthen brand image, build brand awareness and loyalty, and switch adult smokeless consumers of competing brands to American Snuff brands.

American Snuff’s brand portfolio strategy consists of investment brands, KODIAK and GRIZZLY, and selective and non-support brands that include all other brands. American Snuff offers GRIZZLY pouches, which provide pre-measured portions that are more convenient than traditional, loose moist snuff. Pouches represented

6

approximately 9% of the total U.S. moist snuff market as of December 31, 2011, and demand continues to grow. In 2011, American Snuff’s performance was enhanced by new retail contracts and the support of the expanded RJR Tobacco field trade-marketing organization.

Manufacturing and Distribution

American Snuff’s manufacturing facilities are located in Memphis, Tennessee; Clarksville, Tennessee; Winston-Salem, North Carolina; and Bowling Green, Kentucky. American Snuff owns all of its facilities. American Snuff began capacity upgrade and expansion projects during 2009 at newly acquired sites in Memphis, Tennessee and Clarksville, Tennessee. The new Memphis facility will replace the current Memphis facility with production expected to begin in 2012, while the new Clarksville facility provides for capacity expansion with initial processing that began in 2011. American Snuff distributes its products primarily through a combination of direct wholesale deliveries from a distribution center in North Carolina and public warehouses located throughout the United States.

Raw Materials

In its production of moist snuff, American Snuff uses U.S. fire-cured and air-cured tobaccos as well as foreign, primarily Brazilian, burley and air-cured leaf tobaccos. American Snuff purchases the majority of its U.S. fire-cured and air-cured leaf directly through contracts with tobacco growers. These short-term contracts are frequently renegotiated. American Snuff believes the relationship with its leaf suppliers is good.

American Snuff believes there is a sufficient supply of leaf in the worldwide tobacco market to satisfy its current and anticipated production requirements.

Santa Fe

Overview

RAI’s operating segment, Santa Fe, manufactures and markets cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand. Santa Fe managed RJR Tobacco’s super premium cigarette brands, DUNHILL and STATE EXPRESS 555, which are licensed from BAT, until January 1, 2012, at which time such management was transferred to RJR Tobacco.

Competition

Santa Fe competes primarily in the U.S. cigarette market, which features several large competitors such as Philip Morris USA, Inc., Lorillard Tobacco Company, Liggett Group and Commonwealth Brands, Inc., and to a much lesser extent, many smaller manufacturers of deep-discount brands. As a super premium brand, Santa Fe’s cigarette brand, NATURAL AMERICAN SPIRIT, is priced at a premium compared with most other competitive brands, and is differentiated from key competitors through its use of all natural, additive-free tobacco. Competition in the cigarette category is based primarily on brand positioning, including price, product attributes and packaging, consumer loyalty, promotions, advertising and retail presence.

Based upon data collected by IRI/Capstone, Santa Fe had an overall retail share of 1.0% in 2011, as compared to 0.8% in 2010.

Marketing

Santa Fe has a commitment to its natural tobacco products, the environment and its consumers. Anti-tobacco groups have attempted to restrict cigarette sales, cigarette advertising, and the testing and introduction of

7

new tobacco products as well as encourage smoking bans. Santa Fe is a voluntary signatory to the MSA. The MSA and federal, state and local laws and regulations, including the FDA Tobacco Act and related regulations, restrict or prohibit utilization of television, radio or billboard advertising or certain other marketing and promotional tools for cigarettes and smoke-free tobacco products. Santa Fe uses direct mailings and other means to market its brands and enhance their appeal among age-verified adults who use tobacco products. Santa Fe advertises and promotes at retail locations and in adult venues where permitted and also uses print advertising in newspapers and consumer magazines in the United States.

Manufacturing and Distribution

Santa Fe’s facilities include manufacturing located in Oxford, North Carolina and a leased distribution center in Reno, Nevada.

Raw Materials

Santa Fe’s support for sustainable agriculture is part of its commitment to the environment and natural resources. Santa Fe contracts directly with independent farmers and advocates earth-friendly practices to grow its premium natural tobacco. Santa Fe’s Purity Residue Clean, referred to as PRC, tobacco program utilizes environmentally friendly cultivation practices. PRC tobacco is grown using only certain fertilizers and pesticides which break down quickly. After the tobacco cures, sample testing is done to ensure that there are no detectable residues of the fertilizers or pesticides.

In its production of tobacco products, Santa Fe relies on sustainable resources, such as purchasing electricity generated from renewable sources, including wind power.

Consolidated RAI

Customers

The largest customer of RAI’s operating companies is McLane Company, Inc. Sales to McLane, a distributor, comprised approximately 27% of RAI’s consolidated revenue in each of 2011, 2010 and 2009. No other customer accounted for 10% or more of RAI’s consolidated revenue during those periods. Sales of RJR Tobacco, American Snuff and Santa Fe to McLane are not governed by any written supply contract and each believe that its relationship with McLane is good. No significant backlog of orders existed at RJR Tobacco, American Snuff or Santa Fe as of December 31, 2011 or 2010.

Sales to Foreign Countries

RAI’s operating subsidiaries’ sales to foreign countries, primarily to BAT affiliates, for the years ended December 31, 2011, 2010 and 2009 were $610 million, $525 million and $548 million, respectively. The increase during 2011 was attributable to higher sales to BAT, a related party.

Raw Materials

In 2004, legislation was passed eliminating the U.S. government’s tobacco production controls and price support program. The buyout is funded by a direct quarterly assessment on every tobacco product manufacturer and importer, on a market-share basis measured on volume to which federal excise tax is applied. The aggregate cost of the buyout to the tobacco industry is approximately $9.9 billion, including approximately $9.6 billion payable to quota tobacco holders and growers through industry assessments over ten years and approximately $290 million for the liquidation of quota tobacco stock. RAI’s operating subsidiaries estimate that their overall share will approximate $2.3 billion to $2.8 billion prior to the deduction of permitted offsets under the MSA.

8

Research and Development

The primary research and development activities of RAI’s operating subsidiaries are currently conducted at one of RJR Tobacco’s Winston-Salem locations. Scientists and engineers continue to explore and develop innovative products, packaging and processes, as well as harm reduction technologies, modified risk tobacco products and analytical methodologies. Another key activity for research and development is to ensure RAI’s operating companies remain compliant with regulations of the U.S. Food and Drug Administration, referred to as the FDA, and to adhere to future FDA guidelines and approval processes. As part of RJR Tobacco’s efforts to optimize its facilities footprint, its research and development may be relocated during 2013.

RAI’s operating subsidiaries’ research and development expense for the years ended December 31, 2011, 2010 and 2009, was $69 million, $71 million and $68 million, respectively.

Intellectual Property

RAI’s operating subsidiaries own or have the right to use numerous trademarks, including the brand names of their tobacco products and the distinctive elements of their packaging and displays. RAI’s operating subsidiaries’ material trademarks are registered with the U.S. Patent and Trademark Office. Rights in these trademarks in the United States will last as long as RAI’s subsidiaries continue to use the trademarks. The operating subsidiaries consider the distinctive blends and recipes used to make each of their brands to be trade secrets. These trade secrets are not patented, but RAI’s operating subsidiaries take appropriate measures to protect the unauthorized disclosure of such information.

In 1999, RJR Tobacco sold most of its trademarks and patents outside the United States in connection with the sale of the international tobacco business to JTI. The sale agreement granted JTI the right to use certain of RJR Tobacco’s trade secrets outside the United States, but details of the ingredients or formulas for flavors and the blends of tobacco may not be provided to any sub-licensees or sub-contractors. The agreement also generally prohibits JTI and its licensees and sub-licensees from the sale or distribution of tobacco products of any description employing the purchased trademarks and other intellectual property rights in the United States. In 2005, the U.S. duty-free and U.S. overseas military businesses relating to certain brands were acquired from JTI. These rights had been sold to JTI in 1999 as a part of the sale of RJR Tobacco’s international tobacco business.

In addition to intellectual property rights it directly owns, RJR Tobacco has certain rights with respect to BAT intellectual property that were available for use by B&W prior to the completion of the B&W business combination.

Legislation and Other Matters Affecting the Tobacco Industry

The marketing, sale, taxation and use of tobacco products have been subject to substantial regulation by government and health officials for many years. In 2012, it is likely that the U.S. Congress will address the issue of roll-your-own, referred to as RYO, machines and the designation of retail entities using such machines as “tobacco manufacturers.” Such RYO-sourced tobacco products currently benefit from lower excise taxes, facilitating lower pricing and increased competition for non-RYO manufacturers. In addition, various state governments have adopted or are considering, among other things, legislation and regulations that would:

• significantly increase their taxes on tobacco products;

• restrict displays, advertising and sampling of tobacco products;

9

• raise the minimum age to possess or purchase tobacco products;

• restrict or ban the use of menthol in cigarettes or prohibit mint or wintergreen as a flavor in smokeless tobacco products;

• require the disclosure of ingredients used in the manufacture of tobacco products;

• require the disclosure of nicotine yield information for cigarettes;

• impose restrictions on smoking in public and private areas; and

• restrict the sale of tobacco products directly to consumers or other unlicensed recipients, including over the Internet.

Together with manufacturers’ price increases in recent years and substantial increases in state and federal taxes on tobacco products, and the granting to the FDA of broad authority over the manufacture, sale, marketing and packaging of tobacco products, these developments have had and will likely continue to have an adverse effect on the sale of tobacco products. For further discussion of the regulatory and legislative environment applicable to the tobacco industry and FDA-related matters, see Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Governmental Activity.”

Litigation and Settlements

Various legal proceedings or claims, including litigation claiming that lung cancer and other diseases, as well as addiction, have resulted from the use of, or exposure to, RAI’s operating subsidiaries’ products, and seeking damages in amounts ranging into the hundreds of millions or even billions of dollars, are pending or may be instituted against RJR Tobacco, American Snuff Co. or their affiliates, including RAI or RJR, or indemnitees, including B&W. Unfavorable judgments have been returned in a number of tobacco-related cases and state enforcement actions. As of December 31, 2011, RJR Tobacco had paid approximately $18 million since January 1, 2009, related to unfavorable smoking and health litigation judgments. During 2011, RJR Tobacco paid $139 million related to an unfavorable medical monitoring and smoking cessation case.

In particular, in Engle v. R. J. Reynolds Tobacco Co., the Florida Supreme Court issued a ruling that, while determining that the case could not proceed further as a class action, permitted members of the Engle class to file individual claims, including claims for punitive damages, through January 11, 2008. RJR Tobacco refers to these cases as the Engle Progeny cases. RJR Tobacco has been served as of December 31, 2011 in 6,561 of these cases on behalf of approximately 7,852 plaintiffs. The Engle Progeny cases have resulted and will continue to result in increased litigation and trial activity and increased expenses. For a more complete description of the Engle Progeny cases, see “— Litigation Affecting the Cigarette Industry — Overview” and “— Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements.

Also, the consolidated action, In re: Tobacco Litigation Individual Personal Injury Cases, is pending in West Virginia, against both RJR Tobacco and B&W. This case consists of 577 plaintiffs and will be tried in a single proceeding. On February 3, 2010 and June 8, 2010, mistrials were granted due to the inability to seat a jury. Trial began again in October 2011, but the court declared a mistrial on November 8, 2011. For a more complete description of this case, see “— Litigation Affecting the Cigarette Industry — West Virginia IPIC” in Item 8, note 13 to consolidated financial statements.

Finally, in Scott v. American Tobacco Co., a Louisiana state court class action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, a state court of appeals entered an amended judgment in 2010, holding the defendants jointly and severally liable for funding the cost of a court-supervised

10

smoking cessation program and ordered the defendants to deposit roughly $242 million plus interest into a trust to fund the program. The defendants’ petition for writ of certiorari in the U.S. Supreme Court was denied on June 27, 2011. RJR Tobacco accrued $139 million, the portion of the judgment and interest allocated to RJR Tobacco and B&W, in the second quarter of 2011. RJR Tobacco paid the judgment in August 2011. For more information on the Scott case, see “— Litigation Affecting the Cigarette Industry — Class-Action Suits — Medical Monitoring and Smoking Cessation Case” in Item 8, note 13 to consolidated financial statements.

RAI’s management continues to conclude that the loss of any particular smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular claim concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual basis, is not probable or estimable, except for four Engle Progeny cases described in “— Litigation Affecting the Cigarette Industry — Overview” and “— Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements. RAI and its subsidiaries believe that they have valid bases for appeal of adverse verdicts against them and have valid defenses to all actions and intend to defend all actions vigorously. Nonetheless, the possibility of material losses related to tobacco litigation is more than remote. Litigation is subject to many uncertainties, and generally it is not possible to predict the outcome of the litigation pending against RJR Tobacco, American Snuff Co. or their affiliates or indemnitees, or to reasonably estimate the amount or range of any possible loss. Moreover, notwithstanding the quality of defenses available to it and its affiliates in tobacco-related litigation matters, it is possible that RAI’s consolidated results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending or future litigation matters or difficulties in obtaining the bonds required to stay execution of judgments on appeal. For further discussion of the litigation and legal proceedings pending against RAI or its affiliates or indemnitees, see Item 8, note 13 to consolidated financial statements.

In 1998, RJR Tobacco, B&W and the other major U.S. cigarette manufacturers entered into the MSA with attorneys general representing most U.S. states, territories and possessions. As described in Item 8, note 13 to consolidated financial statements, the State Settlement Agreements impose a perpetual stream of future payment obligations on RJR Tobacco and the other major U.S. cigarette manufacturers, and place significant restrictions on their ability to market and sell tobacco products in the future. For more information related to historical and expected settlement expenses and payments under the State Settlement Agreements, see “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements” in Item 8, note 13 to consolidated financial statements. The State Settlement Agreements have materially adversely affected RJR Tobacco’s shipment volumes. RAI believes that these settlement obligations may materially adversely affect the results of operations, cash flows or financial position of RAI and RJR Tobacco in future periods.

RJR Tobacco and certain of the other participating manufacturers under the MSA are currently involved in litigation with the settling states with respect to the availability for certain market years of a downward adjustment to the annual MSA settlement payment obligation, known as the NPM Adjustment. RJR Tobacco has disputed a total of $3.9 billion for the years 2003 through 2010. For more information related to this litigation, see “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements — Enforcement and Validity” in Item 8, note 13 to consolidated financial statements.

Employees

At December 31, 2011, RAI and its subsidiaries had approximately 5,400 full-time employees and approximately 50 part-time employees. The 5,400 full-time employees include approximately 3,900 RJR Tobacco employees, 500 American Snuff employees and 400 Santa Fe employees. No employees of RAI or its subsidiaries are unionized.

11

Executive Officers and Certain Significant Employees of the Registrant

The executive officers of RAI are set forth below:

Daniel (Daan) M. Delen. Mr. Delen, 46, has been President and Chief Executive Officer of RAI since March 1, 2011. He served as the President and Chief Executive Officer-Elect of RAI from January 1, 2011 to February 28, 2011. Mr. Delen also has served as the President of RAI Services Company since January 2011. Mr. Delen served as Chairman of the Board of RJR Tobacco, from May 2008 to December 2010. From January 2007 to December 2010, he also served as the President and Chief Executive Officer of RJR Tobacco. Prior to joining RJR Tobacco, Mr. Delen was President of BAT Ltd. — Japan from August 2004 to December 2006, and prior to that time, held various other positions with BAT after joining BAT in 1989. Mr. Delen commenced serving on the Board of RAI as of January 1, 2011. He also is a member of the boards of directors of the United Way of Forsyth County and the Winston-Salem Alliance.

Thomas R. Adams. Mr. Adams, 61, has been Executive Vice President and Chief Financial Officer of RAI since January 2008 and Executive Vice President, Chief Financial Officer and Chief Information Officer of RAI Services Company since January 2011. He served as Executive Vice President and Chief Financial Officer of RAI Services Company from January 2010 to December 2010. In addition, he has served on the board of directors for RAI Services Company since January 2010. Mr. Adams previously served as Senior Vice President and Chief Accounting Officer of RAI from March 2007 to December 2007. He served as Senior Vice President-Business Processes of RAI from September 2006 to March 2007 and of RJR Tobacco from May 2005 to November 2006. Mr. Adams also served as Senior Vice President and Chief Accounting Officer of both RAI and RJR Tobacco from July 2004 to April 2005. From June 1999 to July 2004, he served as Senior Vice President and Controller of both RJR Tobacco and RJR. Mr. Adams is a member of the boards of directors of Allegacy Federal Credit Union, the Old Hickory Council of the Boy Scouts of America and ABC of NC Child Development Center and the board of commissioners of the Housing Authority of Winston-Salem.

Lisa J. Caldwell. Ms. Caldwell, 51, has been Executive Vice President and Chief Human Resources Officer of RAI since May 2009 and RAI Services Company since January 2010. Ms. Caldwell has served on the board of directors of RAI Services Company since January 2010. She was previously Executive Vice President and Chief Human Resources Officer for RJR Tobacco from May 2009 to January 2010. Ms. Caldwell served as Executive Vice President — Human Resources of RAI and RJR Tobacco from June 2008 to May 2009. She served as Senior Vice President — Human Resources of RAI from November 2006 to June 2008, after having served as Vice President — Human Resources of RAI from September 2004 to November 2006. She also served as Senior Vice President — Human Resources of RJR Tobacco from July 2007 to June 2008, after having served as Vice President — Human Resources of RJR Tobacco from January 2002 to November 2006. Prior to 2002, Ms. Caldwell held numerous human resources positions with RJR Tobacco since joining RJR Tobacco in 1991. Ms. Caldwell serves on the University of North Carolina and Wake Forest University School of Business boards of visitors and also serves on the board of directors for Winston-Salem Industries for the Blind.

Walton T. Carpenter. Mr. Carpenter, 59, has been Senior Vice President — Strategy and Planning of RJR Tobacco since November 2006. Mr. Carpenter has served on the board of directors for RJR Tobacco since January 2011. Mr. Carpenter previously served as Senior Vice President — Strategy and Planning for RAI from January 2006 to November 2006, after having served as Vice President — Strategy and Planning for RAI from July 2004 to January 2006. Prior to joining RAI in 2004, Mr. Carpenter held various positions with B&W and its parent company, BAT. Mr. Carpenter serves on the board of directors of the Arts Council of Winston-Salem and Forsyth County and also serves on the Forsyth Technical Community College Foundation Board.

Robert H. Dunham. Mr. Dunham, 45, has been Executive Vice President — Public Affairs for RAI, RJR Tobacco and RAI Services Company since August 2011. Mr. Dunham served as Senior Vice President — Public Affairs for RAI, RAI Services Company and RJR Tobacco from January 2010 to July 2011, after having served as Senior Vice President Marketing of RJR Tobacco from October 2008 to December 2009. Mr. Dunham served

12

as Vice President of Marketing of RJR Tobacco from July 2004 to October 2008. Prior to joining RJR Tobacco in 2004, Mr. Dunham held various positions with B&W and its parent company, BAT.

Daniel A. Fawley. Mr. Fawley, 54, has served as Senior Vice President and Treasurer of RAI, RJR Tobacco and RJR since September 2004 and Senior Vice President and Treasurer of RAI Services Company since January 2010. Since joining RJR in 1999, he was Vice President and Assistant Treasurer of RJR until July 2004. Mr. Fawley is a member of the board of directors of the Reynolds American Foundation, the Board of Trustees of the Arts Council Endowment Fund, Inc. and the Finance Advisory Board for the Finance Academy.

McDara P. Folan, III. Mr. Folan, 53, has been Senior Vice President, Deputy General Counsel and Secretary of RAI since July 2004 and Senior Vice President, Deputy General Counsel and Secretary of RAI Services Company since January 2010. He also serves as Assistant Secretary of RJR Tobacco. Prior to 2004, Mr. Folan served in various positions with RJR and RJR Tobacco since joining RJR in 1999. Mr. Folan serves on the advisory board for Brenner Children’s Hospital, the board of trustees of Reynolda House Museum of American Art and the board of directors of Downtown Winston-Salem Partnership Inc. He also is chairman of the board of trustees of the Arts Council Endowment Fund, Inc.

Jeffery S. Gentry, PhD. Dr. Gentry, 54, became Executive Vice President — Operations and Chief Scientific Officer of RJR Tobacco on January 1, 2010, after having served as RAI Group Executive Vice President since April 1, 2008. Dr. Gentry has served on the board of directors of RJR Tobacco since January 2010. He was previously Executive Vice President — Research and Development of RJR Tobacco from December 2004. Dr. Gentry has served in various other positions with RJR Tobacco since joining RJR Tobacco in 1986 as a research and development chemist. He is the co-founder of No Limits II, a non-profit organization providing social opportunities for disabled adults in the Winston-Salem area.

Andrew D. Gilchrist. Mr. Gilchrist, 39, has served as President and Chief Commercial Officer of RJR Tobacco since January 1, 2011, after having served as Executive Vice President and Chief Financial Officer of RJR Tobacco and Executive Vice President and Chief Information Officer of RAI Services Company from January 2010 to December 2010. He previously served as Executive Vice President, Chief Financial Officer and Chief Information Officer of RJR Tobacco from July 2008 until January 2010. Mr. Gilchrist has served on the board of directors of RJR Tobacco since May 2008. He also served as Senior Vice President and Chief Financial Officer of RJR Tobacco from November 2006 to July 2008, after having served as Vice President — Integrated Business Management of RJR Tobacco from January 2006 to November 2006. Prior to 2006, Mr. Gilchrist served as Senior Director — Business Development since joining RAI in 2004. Prior to July 2004, Mr. Gilchrist held various positions with B&W and its parent company, BAT. Mr. Gilchrist is chairman of the finance committee and a member of the board of trustees of the Arts Council of Winston-Salem and Forsyth County and a member of the board for the Piedmont Triad Partnership.

Martin L. Holton III. Mr. Holton, 54, became Executive Vice President, General Counsel and Assistant Secretary of RAI and RAI Services Company and Executive Vice President and General Counsel of RJR Tobacco on January 1, 2011. Mr. Holton previously served as Senior Vice President and Deputy General Counsel of RAI Services Company since January 2010 and Senior Vice President, General Counsel and Secretary of RJR Tobacco from November 2006 through December 2010. In addition, Mr. Holton has served on the board of directors of RAI Services Company since January 2011. Previously, Mr. Holton served as Senior Vice President, Deputy General Counsel and Secretary of RJR Tobacco from February 2005 to November 2006 and Vice President and Assistant General Counsel – Litigation from July 2004 to February 2005. Mr. Holton serves on the board of managers for YMCA Camp Hanes.

J. Brice O’Brien. Mr. O’Brien, 43, was named Executive Vice President — Consumer Marketing of RJR Tobacco on January 1, 2010, after having served as President of Reynolds Innovations Inc. since January 2009. He served as Senior Vice President — Consumer Marketing of RJR Tobacco from January 2006 until January

13

2009, after serving as Vice President — Marketing since October 2004. Prior to 2004, he held various positions with RJR Tobacco after joining RJR Tobacco in 1995. Mr. O’Brien serves on the board of directors for the Juvenile Diabetes Research Foundation.

Frederick W. Smothers. Mr. Smothers, 48, has served as Senior Vice President and Chief Accounting Officer of RAI since January 2008 and RAI Services Company since January 2010. Mr. Smothers served as Vice President and Corporate Controller of RAI from October 2007 to December 2007. Prior to joining RAI, Mr. Smothers was an independent management consultant from 2002 until 2007, serving as Chief Executive Officer of ATRS Consulting from 2005 until October 2007, providing general management consulting to consumer products and manufacturing clients, including RAI. Prior to 2002, Mr. Smothers was employed by the accounting firm of Deloitte & Touche LLP, including four years as partner.

Robert D. Stowe. Mr. Stowe, 54, was named Executive Vice President — Trade Marketing of RJR Tobacco on January 1, 2010, after having served as Senior Vice President — Trade Marketing of RJR Tobacco from January 2006 to January 2010. He also served as an Area Vice President of RJR Tobacco from July 2004 to January 2006. Prior to July 2004, Mr. Stowe held various positions with B&W. Mr. Stowe serves on the board of directors of the Second Harvest Food Bank of Northwest North Carolina.

E. Kenan Whitehurst. Mr. Whitehurst, 55, has been Senior Vice President — Strategy and Business Development of RAI since November 2006. He was previously Vice President — Investor Relations of RAI from July 2004 until November 2006. Prior to 2004, he held various positions with RJR Tobacco after joining RJR Tobacco in 1988. Mr. Whitehurst serves on the executive committee and the board of directors of The First Tee of the Triad, an organization that provides educational programs to promote character development among youth.

The chief executive officers of RAI’s other principal operating subsidiaries are set forth below:

Mike Little. Mr. Little, 52, became President of SFNTC on December 1, 2011. Previously he served as Senior Vice President, Manufacturing from January 2002 until November 2011. Prior to 2002, Mr. Little held various positions with SFNTC after joining SFNTC in 1995.

Tommy J. Payne. Mr. Payne, 54, was named President of Niconovum USA, Inc. on January 1, 2010, after having served as Executive Vice President — Public Affairs of RAI from November 2006 to January 2010 and RJR Tobacco from May 2008 to January 2010. Mr. Payne previously served as Executive Vice President — External Relations of RAI from July 2004 to November 2006, and RJR Tobacco from September 1999 to November 2006. Prior to that time, he held various positions after joining RJR in 1988. Mr. Payne serves on the board of directors of the North Carolina Community Colleges Foundation, Inc.

Randall M. (Mick) Spach. Mr. Spach, 53, became President of American Snuff Co. on January 1, 2010. Previously he served as Vice President — Operations of American Snuff Co. from February 2009 until December 2010. Mr. Spach served as Vice President — Manufacturing/R&D of American Snuff Co. from March 2007 to February 2009. He served as Assistant Vice President — Manufacturing at American Snuff Co. from 2001 to March 2007. Between 1997 and 2001, Mr. Spach held various positions with American Snuff Co.

Item 1A. Risk Factors

RAI and its subsidiaries operate with certain known risks and uncertainties that could have a material adverse effect on their results of operations, cash flows and financial position. The risks below are not the only ones RAI and its subsidiaries face. Additional risks not currently known or currently considered immaterial also could affect RAI’s business. You should carefully consider the following risk factors in connection with other information included in this Annual Report on Form 10-K.

14

Adverse litigation outcomes could have a negative impact on RAI’s ability to continue to operate due to their impact on cash flows. Additionally, RAI’s operating subsidiaries could be subject to substantial liabilities and bonding difficulties from litigation related to cigarette products or smokeless tobacco products, thereby reducing operating margins and cash flows from operations.

RJR Tobacco, American Snuff Co. and their affiliates, including RAI, and indemnitees, including B&W, have been named in a large number of tobacco-related legal actions, proceedings or claims. The claimants seek recovery on a variety of legal theories, including negligence, strict liability in tort, design defect, fraud, misrepresentation, unfair trade practices and violations of state and federal antitrust laws. Various forms of relief are sought, including compensatory and, where available, punitive damages in amounts ranging in some cases into the hundreds of millions or even billions of dollars.

The tobacco-related legal actions range from individual lawsuits to class-actions and other aggregate claim lawsuits. In particular, class-action suits have been filed in a number of states against individual cigarette manufacturers, including RJR Tobacco, and their parents, including RAI, alleging that the use of the terms “lights” and “ultra-lights” constitutes unfair and deceptive trade practices. In 2008, the U.S. Supreme Court ruled that neither the Federal Cigarette Labeling and Advertising Act nor the Federal Trade Commission’s regulation of “tar” and nicotine disclosures preempts (or bars) such claims. This ruling limits certain defenses available to RJR Tobacco and other cigarette manufacturers and has led to the filing of additional lawsuits. In the event RJR Tobacco and its affiliates and indemnitees lose one or more of the pending “lights” class-action suits, RJR Tobacco, depending upon the amount of any damages ordered, could face difficulties in obtaining the bond required to stay execution of the judgment.

In Engle v. R. J. Reynolds Tobacco Co., the Florida Supreme Court issued a ruling that, while determining that the case could not proceed further as a class action, permitted members of the Engle class to file individual claims, including claims for punitive damages, through January 11, 2008. RJR Tobacco has been served as of December 31, 2011 in 6,561 cases on behalf of approximately 7,852 plaintiffs. The Engle Progeny cases have resulted in increased litigation and trial activity, including an increased number of adverse verdicts, and increased expenses. RJR Tobacco may be required to pay various judgments as the litigation proceeds. For a more complete description of this litigation, see “— Litigation affecting the Cigarette Industry — Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements.

Also, the consolidated action, In re: Tobacco Litigation Individual Personal Injury Cases, is pending in West Virginia, against both RJR Tobacco and B&W. The case consists of 577 plaintiffs and will be tried in a single proceeding. On February 3, 2010 and June 8, 2010, mistrials were granted due to the inability to seat a jury. The court moved the case to Ohio County (Wheeling) with the Phase I trial having commenced on October 19, 2011. The court declared a mistrial on November 8, 2011.

It is likely that similar legal actions, proceedings and claims arising out of the sale, distribution, manufacture, development, advertising, marketing and claimed health effects of cigarettes and smokeless tobacco products will continue to be filed against RJR Tobacco, American Snuff Co., or their affiliates and indemnitees and other tobacco companies for the foreseeable future.

Victories by plaintiffs in highly publicized cases against RJR Tobacco and other tobacco companies regarding the health effects of smoking may stimulate further claims. A material increase in the number of pending claims could significantly increase defense costs. In addition, adverse outcomes in pending cases could have adverse effects on the ability of RJR Tobacco and its indemnitees, including B&W, to prevail in other smoking and health litigation.

For a more complete description of the above cases and other significant litigation involving RAI and its operating subsidiaries, including RJR Tobacco and American Snuff Co., see “— Litigation Affecting the Cigarette Industry” and “— Smokeless Tobacco Litigation” in Item 8, note 13 to consolidated financial statements.

15

The verdict and order in the case brought by the U.S. Department of Justice, while not final, could subject RJR Tobacco to additional, substantial marketing restrictions as well as significant financial burdens, which would negatively impact the results of operations, cash flows and the financial position of RJR Tobacco and, consequently, of RAI.

In 1999, the U.S. Department of Justice brought an action against RJR Tobacco, B&W and other tobacco companies. The government sought, in addition to other remedies, pursuant to the civil provisions of the federal Racketeer Influenced and Corrupt Organizations Act, referred to as RICO, disgorgement of profits in an amount of approximately $280 billion, the government contends have been earned as a consequence of a RICO racketeering “enterprise.” In 2006, the court found certain defendants, including RJR Tobacco, liable for the RICO claims, but did not impose any direct financial penalties. Instead, the court, among other things, enjoined the defendants from committing future racketeering acts, participating in certain trade organizations, making misrepresentations concerning smoking and health and youth marketing, and using certain brand descriptors such as “low tar,” “light,” “ultra light,” “mild” and “natural,” and ordered the defendants to issue “corrective communications” on five subjects, including smoking and health, and addiction.

Both sides appealed. In 2009, the Court of Appeals affirmed in part the trial court’s order and remanded for further proceedings. Both sides’ petitions for writ of certiorari from the U.S. Supreme Court were denied in June 2010, including the DOJ’s request for review of the district court’s denial of the government’s request for disgorgement of profits and certain other remedies. Further proceedings are pending before the trial court to determine the extent to which the original order will be implemented and the scope thereof. RJR Tobacco believes that certain provisions of the order would have adverse business effects on the marketing of RJR Tobacco’s current product portfolio and that such effects could be material. Also, RJR Tobacco will likely incur costs in connection with complying with the order, such as the costs of corrective communications.

For a more complete description of this case, see “— Health-Care Cost Recovery Cases — Department of Justice Case” in Item 8, note 13 to consolidated financial statements.

RJR Tobacco’s overall retail market share of cigarettes has declined in recent years and may continue to decline; if RJR Tobacco is not able to continue to grow market share of its growth brands, or develop, produce or market new alternative tobacco products profitably, results of operations, cash flows and financial position of RJR Tobacco and, consequently, of RAI could be adversely impacted.

RJR Tobacco’s U.S. retail market share of cigarettes has been declining for a number of years, and may continue to decline. According to data from IRI/Capstone, RJR Tobacco’s share of the U.S. cigarette retail market declined slightly to 27.4% in 2011 from 28.1% in 2010, continuing a trend in effect for several years. If RJR Tobacco’s growth brands do not continue to grow combined market share, results of operations, cash flows and financial position could be adversely affected. In addition, consumer health concerns, changes in adult consumer preferences and changes in regulations have prompted RJR Tobacco to introduce new alternative tobacco products. Consumer acceptance of these new products, such as CAMEL Snus or CAMEL Dissolvables, may fall below expectations. Furthermore, RJR Tobacco may not find vendors willing to produce alternative tobacco products resulting in additional capital expenditures for RJR Tobacco.

RJR Tobacco is dependent on the U.S. cigarette market, which it expects to continue to decline, negatively impacting revenue.

The international rights to substantially all of RJR Tobacco’s brands were sold in 1999 to JTI, and no international rights were acquired in connection with the B&W business combination. Therefore, RJR Tobacco is dependent on the U.S. cigarette market. Price increases, restrictions on advertising and promotions, funding of smoking prevention campaigns, increases in regulation and excise taxes, health concerns, a decline in the social acceptability of smoking, increased pressure from anti-tobacco groups and other factors have reduced U.S. cigarette consumption. U.S. cigarette consumption is expected to continue to decline. In addition, RJR

16

Tobacco believes its consumers are more price-sensitive than consumers of competing brands, which may result in some consumers switching to a lower priced brand.

RJR Tobacco is RAI’s largest operating segment. As such, it is the primary source of RAI’s revenue, operating income and cash flows.

RJR Tobacco’s contract manufacturing agreements with BAT may end in 2014.

RJR Tobacco’s contract manufacturing for BAT accounted for 6% of total RAI sales and approximately 25% of total RJR Tobacco cigarette production in 2011. These contract manufacturing agreements may expire at the end of 2014. If BAT’s contracts are not renewed or extended or if sales under these contracts decline, RJR Tobacco’s revenue, operating income and cash flows will be unfavorably impacted.

In the U.S., tobacco products are subject to substantial and increasing regulation and taxation, which has a negative effect on revenue and profitability.

Tobacco products are subject to substantial federal and state excise taxes in the United States. Certain city and county governments also impose substantial excise taxes on tobacco products sold. Increased excise taxes are likely to result in declines in overall sales volume and shifts by consumers to less expensive brands.

A wide variety of federal, state and local laws limit the advertising, sale and use of cigarettes, and these laws have proliferated in recent years. For example, many local laws prohibit smoking in restaurants and other public places. Private businesses also have adopted regulations that prohibit or restrict, or are intended to discourage, smoking. Such laws and regulations also are likely to result in a decline in the overall sales volume of cigarettes. For additional information on the issues described above, see “— Governmental Activity” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7.

RAI’s operating subsidiaries are subject to significant limitations on advertising and marketing of tobacco products, which could harm the value of their existing brands or their ability to launch new brands, thus negatively impacting revenue.

In the United States, television and radio advertisements of cigarettes have been prohibited since 1971, and television and radio advertisements of smokeless tobacco products have been prohibited since 1986. Under the MSA, RAI’s operating subsidiaries, RJR Tobacco and SFNTC, cannot use billboard advertising, cartoon characters, sponsorship of certain events, non-tobacco merchandise bearing their brand names and various other advertising and marketing techniques. The MSA also prohibits targeting of youth in advertising, promotion or marketing of tobacco products, including the smokeless tobacco products of RJR Tobacco. American Snuff Co. is not a participant in the MSA. Although these restrictions were intended to ensure that tobacco advertising was not aimed at young people, some of the restrictions also may limit the ability of RAI’s operating subsidiaries to communicate with adult tobacco users. In addition, pursuant to the FDA Tobacco Act, the FDA has reissued regulations addressing advertising and marketing restrictions that were originally promulgated in 1996. Additional restrictions under the FDA regulations, or otherwise, may be imposed or agreed to in the future.

The regulation of tobacco products by the FDA may adversely affect RAI’s sales and operating profit.

The FDA Tobacco Act grants the FDA broad authority over the manufacture, sale, marketing and packaging of tobacco products. It is likely that the FDA Tobacco Act could result in a decrease in cigarette and smokeless tobacco sales in the United States, including sales of RJR Tobacco’s, American Snuff’s and Santa Fe’s brands, and an increase in costs to RJR Tobacco, American Snuff and Santa Fe, resulting in a material adverse effect on RAI’s financial condition, results of operations and cash flows. RAI believes that such regulation may adversely affect the ability of its operating subsidiaries to compete against their larger competitor, Altria Group Inc., which may be able to more quickly and cost-effectively comply with these new rules and regulations. The FDA has yet

17

to issue guidance with respect to many provisions of the FDA Tobacco Act, which may result in less efficient compliance efforts. Finally, the ability of RAI’s operating companies to gain efficient market clearance for new tobacco products could be affected by FDA rules and regulations.

For a detailed description of the FDA Tobacco Act, see “— Governmental Activity” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7.

RJR Tobacco’s, American Snuff’s and Santa Fe’s volumes, market share and profitability may be adversely affected by competitive actions and pricing pressures in the marketplace.

The tobacco industry is highly competitive. Among the major manufacturers, brands primarily compete on product quality, price, brand recognition, brand imagery and packaging. Substantial marketing support, merchandising display, discounting, promotions and other financial incentives generally are required to maintain or improve a brand’s market position or introduce a new brand.

In addition, substantial payment obligations under the State Settlement Agreements adversely affect RJR Tobacco’s ability to compete with manufacturers of deep-discount cigarettes that are not subject to such substantial obligations. For a more complete description of the State Settlement Agreements, see “— Health-Care Cost Recovery Cases — State Settlement Agreements” in Item 8, note 13 to consolidated financial statements.

Increases in commodity prices will increase costs and may reduce profitability.

Increases in the cost of tobacco leaf, other raw materials and other commodities used in RAI’s operating subsidiaries’ products could cause profits to decline.

Certain of RAI’s operating subsidiaries may be required to write down intangible assets, including goodwill, due to impairment, thus reducing operating profit.

Intangible assets include goodwill, trademarks and other intangibles. The determination of fair value involves considerable estimates and judgment. For goodwill, the determination of fair value of a reporting unit involves, among other things, RAI’s market capitalization, and application of the income approach, which includes developing forecasts of future cash flows and determining an appropriate discount rate. If goodwill impairment is implied, the fair values of individual assets and liabilities, including unrecorded intangibles, must be determined. RAI believes it has based its goodwill impairment testing on reasonable estimates and assumptions, and during the annual testing in the fourth quarter of 2011, the estimated fair value of each of RAI’s reporting units was substantially in excess of its respective carrying value.

Trademarks and other intangible assets with indefinite lives also are tested for impairment annually, in the fourth quarter. The aggregate fair value of RAI’s operating units’ trademarks and other intangible assets was substantially in excess of their aggregate carrying value. However, the individual fair values of four indefinite-lived trademarks were less than 15% in excess of their respective carrying values. The aggregate carrying value of these four trademarks was $236 million at December 31, 2011.

The methodology used to determine the fair value of trademarks includes assumptions with inherent uncertainty, including projected sales volumes and related projected revenues, long-term growth rates, royalty rates that a market participant might assume and judgments regarding the factors to develop an applied discount rate.

The carrying value of intangible assets are at risk of impairment if future projected revenues or long-term growth rates are lower than those currently projected, or if factors used in the development of a discount rate result in the application of a higher discount rate.

18

Goodwill, all trademarks and other intangible assets are tested more frequently if events and circumstances indicate that the asset might be impaired. The carrying value of these intangible assets could be impaired if a significant adverse change in the use, life, or brand strategy of the asset is determined, or if a significant adverse change in the legal and regulatory environment, business or competitive climate occurs that would adversely impact the asset. See Item 8, note 3 to consolidated financial statements for a discussion of the impairment charges, including a goodwill impairment charge in connection with the classification of the Lane operations as held for sale in the fourth quarter of 2010.

Changes in financial market conditions could result in higher costs and decreased profitability.

Changes in financial market conditions could negatively impact RAI’s interest rate risk, foreign currency exchange rate risk and the return on corporate cash, thus increasing costs and reducing profitability. Due to the adverse conditions in the financial markets, RAI continues to invest excess cash in either low interest funds or near zero interest funds, thereby lowering interest income.

Adverse changes in liquidity in the financial markets could result in additional realized or unrealized losses on investments.

Adverse changes in the liquidity in the financial markets could result in additional realized or unrealized losses associated with the value of RAI’s investments, which would negatively impact RAI’s consolidated results of operations, cash flows and financial position. As of December 31, 2011, $47 million of unrealized losses remain in other comprehensive loss. For more information on investment losses, see Item 8, note 2 to consolidated financial statements.

Increases in pension expense or pension funding may reduce RAI’s profitability and cash flow.

RAI’s profitability is affected by the costs of pension benefits available to employees generally hired prior to 2004. Adverse changes in investment returns earned on pension assets and discount rates used to calculate pension and related liabilities or changes in required pension funding levels may have an unfavorable impact on pension expense and cash flows. During 2011, RAI contributed $220 million to its pension plans and expects to contribute $309 million to its pension plans in 2012. RAI actively seeks to control increases in pension expense, but there can be no assurance that profitability will not be adversely affected. In addition, changes to pension legislation or changes in pension accounting may adversely affect profitability and cash flow.

RJR Tobacco, American Snuff and Santa Fe rely on outside suppliers to manage certain non-core business processes. Any interruption in these services could negatively affect the operations of RJR Tobacco, American Snuff and Santa Fe and harm their reputation and consequently the operations and reputation of RAI.

In an effort to gain cost efficiencies, RJR Tobacco, American Snuff and Santa Fe have substantially completed the outsourcing of many of their non-core business processes. Non-core business processes include, but are not limited to, certain processes relating to information technology, human resources, trucking and facilities. If any of the suppliers fail to perform their obligations in a timely manner or at a satisfactory quality level, RJR Tobacco, American Snuff and Santa Fe may fail to operate effectively and fail to meet shipment demand.

RAI’s operating subsidiaries rely on a limited number of suppliers for direct materials. An interruption in service from any of these suppliers could adversely affect the results of operations, cash flows and financial position of RAI.

RAI’s operating subsidiaries rely on a limited number of suppliers for direct materials. If a supplier fails to meet any of RAI’s operating subsidiary’s demand for direct materials, the operating subsidiary may fail to operate effectively and may fail to meet shipment demand, adversely impacting RAI’s results of operations.

19

Certain of RAI’s operating subsidiaries face a customer concentration risk. The loss of this customer would result in a decline in revenue and have an adverse effect on cash flows.

Revenues from McLane Company, Inc., a distributor, comprised approximately 27% of RAI’s consolidated revenues in 2011. The loss of this customer, or a significant decline in its purchases, could have a material adverse effect on revenue of RAI.

Fire, violent weather conditions and other disasters may adversely affect the operations of RAI’s operating subsidiaries.

A major fire, violent weather conditions or other disasters that affect manufacturing and other facilities of RAI’s operating subsidiaries, or of their suppliers and vendors, could have a material adverse effect on the operations of RAI’s operating subsidiaries. Despite RAI’s insurance coverage for some of these events, a prolonged interruption in the manufacturing operations of RAI’s operating subsidiaries could have a material adverse effect on the ability of its operating subsidiaries to effectively operate their businesses.

The agreement relating to RAI’s credit facility contains restrictive covenants that limit the flexibility of RAI and its subsidiaries. Breach of those covenants could result in a default under the agreement relating to the facility.

Restrictions in the agreement relating to RAI’s credit facility limit the ability of RAI and its subsidiaries to obtain future financing, and could impact the ability to withstand a future downturn in their businesses or the economy in general, conduct operations or otherwise take advantage of business opportunities that may arise. In addition, if RAI does not comply with these covenants, any indebtedness outstanding under the credit facility could become immediately due and payable. The lenders under RAI’s credit facility could refuse to lend funds if RAI is not in compliance with the covenants or could terminate the credit facility. If RAI were unable to repay accelerated amounts, the lenders under RAI’s credit facility could initiate a bankruptcy proceeding or liquidation proceeding.

For more information on the restrictive covenants in RAI’s credit facility, see Item 8, note 11 to consolidated financial statements.

RAI has substantial long-term debt, which could adversely affect its financial position and its ability to obtain financing in the future and react to changes in its business.

Because RAI and RJR have principal outstanding notes of $3.5 billion:

• RAI’s ability to obtain additional financing for working capital, capital expenditures, acquisitions, debt service requirements or general corporate purposes, and its ability to satisfy its obligations with respect to its indebtedness, may be impaired in the future;

• a substantial portion of RAI’s cash flow from operations must be dedicated to the payment of principal and interest on its indebtedness, thereby reducing the funds available to it for other purposes;

• RAI may be at a disadvantage compared to its competitors with less debt or comparable debt at more favorable interest rates; and

• RAI’s flexibility to adjust to changing market conditions and ability to withstand competitive pressures could be limited, and it may be more vulnerable to a downturn in general economic conditions or its business, or be unable to carry out capital spending that is necessary or important to its growth strategy and its efforts to improve operating margins.

20

It is likely that RAI will refinance, or attempt to refinance, a significant portion of its indebtedness prior to maturity through the incurrence of new indebtedness. There can be no assurance that RAI’s available cash or access to financing on acceptable terms will be sufficient to satisfy such indebtedness.

The ability of RAI to access the debt capital markets could be impaired if the credit rating of its debt securities falls below investment grade.

The outstanding notes issued by RAI and RJR are rated investment grade. If RAI’s credit rating falls below investment grade, RAI may not be able to sell additional debt securities or borrow money in such amounts, at the times, at the lower interest rates or upon the more favorable terms and conditions that might be available if its debt was rated investment grade. In addition, future debt security issuances or other borrowings may be subject to further negative terms, including provisions for collateral or limitations on indebtedness or more restrictive covenants.

RAI’s credit ratings are influenced by some important factors not entirely within the control of RAI or its affiliates, such as tobacco litigation, the regulatory environment and the performance of suppliers to RAI’s operating subsidiaries. Moreover, because the kinds of events and contingencies that may impair RAI’s credit ratings and the ability of RAI and its affiliates to access the debt capital markets are often the same kinds of events and contingencies that could cause RAI and its affiliates to seek to raise additional capital on an urgent basis, RAI and its affiliates may not be able to issue debt securities or borrow money with acceptable terms, or at all, at the times at which they may most need additional capital.

For more complete information on RAI’s borrowing arrangements, see Item 8, notes 11 and 12 to consolidated financial statements.

B&W’s significant equity interest in RAI could be determinative in matters submitted to a vote by RAI shareholders, resulting in RAI taking actions that RAI’s other shareholders do not support. B&W also has influence over RAI by virtue of the governance agreement, which requires B&W’s approval before RAI takes certain actions.

B&W owns approximately 42% of the outstanding shares of RAI common stock. Only one other shareholder owns more than 10% of the outstanding shares of RAI common stock. Unless substantially all of RAI’s public shareholders vote together on matters presented to RAI shareholders, B&W would have the power to determine the outcome of matters submitted to a shareholder vote, subject to the governance agreement.

Moreover, in connection with the B&W business combination, RAI, B&W and BAT entered into an agreement, referred to as the governance agreement, relating to various aspects of RAI’s corporate governance. Under the governance agreement, the approval of B&W, as a RAI shareholder, is required in connection with, among other things, the following matters:

• the sale or transfer of certain RAI intellectual property associated with B&W brands having an international presence, other than in connection with a sale of RAI; and

• RAI’s adoption of any takeover defense measures that would apply to the acquisition of equity securities of RAI by B&W or its affiliates, other than the re-adoption of the RAI rights plan in its present form.

Such influence could result in RAI taking actions that RAI’s other shareholders do not support.

Under the governance agreement, B&W is entitled to nominate certain persons to RAI’s Board, and the approvals of the majority of such persons is required before certain actions may be taken, even though such persons represent less than a majority of the entire Board. In addition, certain provisions of RAI’s articles of incorporation may create conflicts of interest between RAI and certain of these persons.

21

Under the governance agreement, B&W, based upon its current equity stake in RAI, is entitled to nominate five directors to RAI’s Board, at least three of whom are required to be independent directors and two of whom may be executive officers of BAT or any of its subsidiaries. RAI’s Board currently is composed of 13 persons, including five designees of B&W. Matters requiring the approval of RAI’s Board generally require the affirmative vote of a majority of the directors present at a meeting. Under the governance agreement, however, the approval of a majority of B&W’s designees on RAI’s Board is required in connection with the following matters:

• any issuance of RAI securities in excess of 5% of its outstanding voting stock, unless at such time B&W’s ownership interest in RAI is less than 32%; and

• any repurchase of RAI common stock, subject to a number of exceptions, unless at such time B&W’s ownership interest in RAI is less than 25%.

As a result, B&W’s designees on RAI’s Board may prevent the foregoing transactions from being effected, notwithstanding a majority of the entire Board may have voted to approve such transactions.

Under RAI’s amended and restated articles of incorporation, as amended, referred to as its articles of incorporation, a B&W designated director who is affiliated with, or employed by, BAT or its subsidiaries and affiliates is not required to present a transaction, relationship, arrangement or other opportunity, all of which are collectively referred to as a business opportunity, to RAI if that business opportunity does not relate primarily to the United States.

B&W’s significant ownership interest in RAI, and RAI’s shareholder rights plan, classified board of directors and other anti-takeover defenses could deter acquisition proposals and make it difficult for a third party to acquire control of RAI without the cooperation of B&W. This could have a negative effect on the price of RAI common stock.

As RAI’s largest shareholder, B&W could vote its shares of RAI common stock against any takeover proposal submitted for shareholder approval or refuse to accept any tender offer for shares of RAI common stock. This right would make it very difficult for a third party to acquire RAI without B&W consent. In addition, RAI has a shareholder rights plan, a classified board of directors and other takeover defenses in its articles of incorporation and bylaws. B&W’s ownership interest in RAI and these defenses could discourage potential acquisition proposals and could delay or prevent a change in control of RAI. These deterrents could adversely affect the price of RAI common stock and make it very difficult to remove or replace members of the board of directors or management of RAI without cooperation of B&W.

RAI shareholders may be adversely affected by the July 30, 2014 expiration, or earlier termination, of the “standstill” provisions in the governance agreement. These events would enable B&W to, among other things, acquire some or all of the shares of RAI common stock not held by B&W or otherwise seek to influence or gain control of RAI, subject to governance agreement limitations on changes in the composition of RAI’s Board.

The standstill provisions contained in the governance agreement generally restrict B&W from acquiring additional shares of RAI common stock, seeking to remove RAI directors not designated by B&W, or taking other specified actions to influence or gain control of RAI. These restrictions will expire upon the earlier of July 30, 2014, or the date on which a significant transaction (as defined in the governance agreement) is consummated. A significant transaction is generally defined as the acquisition by a third party or group of 30% or more of the share voting power or consolidated total assets of RAI.

After the expiration (or earlier termination) of the standstill period, B&W will be permitted to increase its ownership interest in RAI without limitation, subject to the RAI shareholder rights plan described below. The

22

RAI shareholder rights plan also expires on July 30, 2014, but the RAI Board is permitted under the governance agreement to readopt the existing RAI shareholder rights plan in its present form. However, the existing RAI shareholder rights plan generally exempts B&W from its application. B&W’s ownership will only be restricted by the RAI shareholder rights plan if all or part of the governance agreement is terminated as described in the following risk factor. See the following risk factors for a summary description of the rights plan.

The governance agreement limits B&W representation on the RAI Board to five directors (out of an entire Board of 13 directors), of whom three must be independent of both RAI and BAT. If B&W’s voting percentage of RAI drops below 32%, B&W’s board representation will be reduced to a level approximately proportionate to its level of all RAI equity ownership. The governance agreement also requires B&W to vote for the RAI board-proposed slate of director nominees (unless an unaffiliated third party makes a material effort to solicit proxies voting against that slate). These provisions will remain in effect indefinitely after July 30, 2014, unless all or part of the governance agreement is terminated as described below.

The governance agreement and RAI shareholder rights plan are Exhibits 10.4 and 4.1 to this Annual Report on Form 10-K.

RAI shareholders may be adversely affected if all or part of the governance agreement were to be terminated because in some circumstances the standstill, board composition and share transfer restrictions on B&W would no longer apply. These developments could enable B&W to, among other things, acquire some or all of the shares of RAI common stock not held by B&W, seek additional representation on the RAI Board, replace existing RAI directors, solicit proxies, otherwise influence or gain control of RAI or transfer all or a significant percentage of its shares of RAI common stock to a third party.

The governance agreement provides that it will terminate automatically in its entirety if B&W owns less than 15%, referred to as a 15% termination, or if any third party or group controls more than 50%, referred to as a third party termination, of the voting power of all RAI shares. In addition, B&W may terminate the governance agreement in its entirety if B&W nominees proposed in accordance with the governance agreement are not elected to serve on the RAI Board or its committees, referred to as an election termination, or if RAI has deprived B&W nominees of such representation for “fiduciary” reasons, referred to as a fiduciary termination, or has willfully deprived B&W or its board nominees of any veto rights, referred to as a veto termination.

B&W also may terminate the standstill, the obligation to vote its shares of RAI common stock for Board-proposed director nominees, the restriction on Board representation in excess of proportionate representation and the RAI share transfer restrictions of the governance agreement if RAI willfully and deliberately breaches the provisions regarding B&W’s Board and Board committee representation, referred to as a willful termination.

See the preceding and following risk factors regarding the possible consequences of the termination of the standstill provision as it limits B&W’s ability to acquire additional shares of RAI common stock, to seek to remove RAI directors, or to otherwise increase its influence over RAI.

If the share transfer restrictions in the governance agreement are terminated, there will be no contractual restrictions on B&W’s ability to sell or transfer its shares of RAI common stock on the open market, in privately negotiated transactions or otherwise. These sales or transfers could create a substantial decline in the price of shares of RAI common stock or, if these sales or transfers were made to a single buyer or group of buyers that own shares of RAI common stock, could result in a third party acquiring control of or influence over RAI. However, any existing RAI shareholder rights plan could effectively restrict such third party’s acquisition of shares of RAI common stock as described in the following risk factor.

23

The RAI shareholder rights plan described above may effectively restrict the acquisition of beneficial ownership of 15% or more of the shares of RAI common stock. However, absent a termination of all or certain provisions of the governance agreement, B&W is generally exempt from the application of the rights plan.

In general terms, the RAI rights plan imposes a substantial penalty upon any person or group that acquires beneficial ownership of 15% or more of the outstanding shares of RAI common stock without the approval of the RAI Board.

Termination of some or all of the provisions of the governance agreement would have differing effects on the applicability of the rights plan to B&W. If a “15% termination” occurred, the rights plan would fully apply to B&W. If a “third party termination” occurred, the rights plan would not apply to B&W. If an “election termination,” a “fiduciary termination,” or a “veto termination” occurred, the rights plan would apply if B&W sought to increase its RAI share ownership above approximately 43% (or higher if the termination occurred after the July 30, 2014 expiration of the standstill provisions and B&W had acquired ownership of RAI above 43%). If a “willful termination” occurred, the rights plan would not apply to B&W.

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

The executive offices of RAI and its material subsidiaries are located in Winston-Salem, North Carolina. RJR Tobacco’s manufacturing facilities are located in the Winston-Salem, North Carolina area, and American Snuff’s manufacturing facilities are located in Memphis, Tennessee; Clarksville, Tennessee; Winston-Salem, North Carolina; and Bowling Green, Kentucky. During 2009, American Snuff began capacity upgrade and expansion projects at newly acquired sites in Memphis, Tennessee and Clarksville, Tennessee. The new Memphis facility will replace the current Memphis facility with full production by mid-2012, while the new Clarksville facility provides for capacity expansion with initial processing that began in 2011. Santa Fe’s manufacturing facility is located in Oxford, North Carolina. All of RAI’s operating subsidiaries’ executive offices and manufacturing facilities are owned.

Item 3. Legal Proceedings

See Item 8, note 13 to consolidated financial statements for disclosure of legal proceedings involving RAI and its operating subsidiaries.

Item 4. Reserved

24

PART II

Item  5.   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

RAI common stock, par value $.0001 per share, is listed on the NYSE under the trading symbol “RAI.” On January 27, 2012, there were approximately 15,134 holders of record of RAI common stock. Shareholders whose shares are held of record by a broker or clearing agency are not included in this amount; however, each of those brokers or clearing agencies is included as one holder of record. The closing price of RAI common stock on January 27, 2012, was $39.42 per share.

The cash dividends declared, and high and low sales prices per share for RAI common stock on the NYSE Composite Tape, as reported by the NYSE, were as follows:

					Cash Dividends Declared per
	Price Per Share
	High		Low		Share
2011:
First Quarter	$	36.11	$	31.54	$	0.53
Second Quarter		39.87		35.58		0.53
Third Quarter		38.64		31.82		0.53
Fourth Quarter		42.18		36.69		0.56
2010:
First Quarter	$	27.58	$	25.38	$	0.45
Second Quarter		28.12		18.18		0.45
Third Quarter		30.22		25.74		0.45
Fourth Quarter		33.41		29.05		0.49

On February 2, 2012, the board of directors of RAI declared a quarterly cash dividend of $0.56, or $2.24 on an annualized basis, per common share. The dividends will be paid on April 2, 2012, to shareholders of record as of March 9, 2012. The current dividend reflects RAI’s policy of paying dividends to the holders of RAI common stock in an aggregate amount that is approximately 80% of RAI’s annual consolidated net income.

On November 14, 2011, the board of directors of RAI authorized the repurchase, from time to time on or before mid-2014, of up to $2.5 billion of outstanding shares of RAI common stock in open-market or privately negotiated transactions. The repurchases are subject to prevailing market and business conditions, and the program may be terminated or suspended at any time. In connection with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI’s common stock. RAI, B&W and BAT also entered into Amendment No. 3 to the governance agreement, pursuant to which RAI has agreed that, so long as B&W’s ownership interest has not dropped below 25%, if RAI issues shares of its common stock or any other RAI equity security to certain designated persons, including its directors, officers or employees, then RAI will repurchase a number of shares of outstanding RAI common stock so that the number of outstanding shares of RAI common stock are not increased, and B&W’s ownership interest is not decreased, by such issuance after taking into account such repurchase. In addition, RAI repurchases shares of its common stock forfeited with respect to the tax liability associated with certain stock option exercises and vesting of restricted stock grants under the RAI Long-Term Incentive Plan, referred to as the LTIP.

Due to RAI’s incorporation in North Carolina, which does not recognize treasury shares, the shares repurchased are cancelled at the time of repurchase. As of December 31, 2011, RAI had repurchased and cancelled 6,776,637 shares of RAI common stock for $276 million under the above share repurchase program.

25

Additionally, during 2011, at a cost of $6 million, RAI purchased 162,257 shares that were forfeited with respect to tax liabilities associated with restricted stock vesting under its LTIP.

The following table summarizes RAI’s purchases of its common stock during the fourth quarter of 2011:

	Total Number of  Shares Purchased		Average Price Paid Per  Share		Total Number of Shares  purchased as Part of Publicly Announced Plans or Programs		Approximate Dollar Value  that May Yet Be Purchased Under the Plans or Programs
November 1, 2011 to November 30, 2011		4,377,935	$	40.30		4,377,935	$	2,324
December 1, 2011 to December 31, 2011		2,398,702		41.37		2,398,702		2,224
Fourth Quarter Total		6,776,637		40.68		6,776,637		2,224

For equity-based benefit plan information, see Item 8, note 15 to consolidated financial statements.

Performance Graph

Set forth below is a line graph comparing, for the period which commenced on December 31, 2006, and ended on December 31, 2011, the cumulative shareholder return of $100 invested in RAI common stock with the cumulative return of $100 invested in the Standard & Poor’s 500 Index and the Standard & Poor’s Tobacco Index.

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN⁽¹⁾

Among Reynolds American Inc., The S&P 500 Index

and The S&P Tobacco Index

	12/31/06		12/31/07		12/31/08		12/31/09		12/31/10		12/31/11
Reynolds American Inc.	$	100.00	$	105.90	$	69.15	$	98.78	$	129.83	$	174.50
S&P 500		100.00		105.49		66.46		84.05		96.71		98.75
S&P Tobacco(2)		100.00		119.85		97.98		123.07		157.15		214.38

⁽¹⁾ Assumes that $100 was invested in RAI common stock on December 31, 2006, and that in each case all dividends were reinvested.

⁽²⁾ The S&P Tobacco Index includes as of December 31, 2011, the following companies: Altria Group, Inc.; Lorillard, Inc.; Philip Morris International Inc.; and Reynolds American Inc.

26

Item 6. Selected Financial Data

The selected historical consolidated financial data as of December 31, 2011 and 2010, and for each of the years in the three-year period ended December 31, 2011, are derived from the consolidated financial statements and accompanying notes, which have been audited by RAI’s independent registered public accounting firm. The selected historical consolidated financial data as of December 31, 2009, 2008 and 2007, and for the years ended December 31, 2008 and 2007, are derived from audited consolidated financial statements not presented or incorporated by reference. For further information, including the impact of new accounting developments, restructuring and impairment charges, you should read this table in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 and the consolidated financial statements.

	For the Years Ended December 31,
	2011			2010(1)			2009(1)			2008(1)			2007(1)
	(Dollars in Millions, Except Per Share Amounts)
Results of Operations:
Net sales(2)	$	8,541		$	8,551		$	8,419		$	8,845		$	9,023
Income from continuing operations before extraordinary item(2)(3)(4)(5)		1,406			1,337			955			444			1,386
Losses from discontinued operations		—			(216	)		—			—			—
Extraordinary item — gain on acquisition		—			—			—			—			1
Net income		1,406			1,121			955			444			1,387
Per Share Data:
Basic income from continuing operations		2.41			2.29			1.64			0.76			2.35
Diluted income from continuing operations		2.40			2.29			1.64			0.76			2.35
Basic losses from discontinued operations		—			(0.37	)		—			—			—
Diluted losses from discontinued operations		—			(0.37	)		—			—			—
Basic net income		2.41			1.92			1.64			0.76			2.35
Diluted net income		2.40			1.92			1.64			0.76			2.35
Basic weighted average shares, in thousands		582,320			582,996			582,761			586,802			590,326
Diluted weighted average shares, in thousands		585,383			584,854			583,652			587,201			590,818
Cash dividends declared per share of common stock	$	2.15		$	1.84		$	1.73		$	1.70		$	1.60
Balance Sheet Data (at end of periods):
Total assets		16,254			17,078			18,009			18,154			18,629
Long-term debt (less current maturities)		3,206			3,701			4,136			4,486			4,515
Shareholders’ equity		6,251			6,510			6,498			6,237			7,466
Cash Flow Data:
Net cash from operating activities		1,420			1,265			1,454			1,315			1,331
Net cash from (used in) investing activities		60			(126	)		(123	)		278			763
Net cash used in financing activities		(1,714	)		(1,349	)		(1,192	)		(1,206	)		(1,312	)
Net cash related to discontinued operations, net of tax benefit		—			(307	)		—			—			—
Other Data:
Ratio of earnings to fixed charges(6)		10.6			10.2			6.9			8.5			7.0

⁽¹⁾ Financial data for 2007 through 2010 has been adjusted to reflect RAI’s elective change in accounting for pension and postretirement benefits. See Item 8, note 1 to consolidated financial statements.

⁽²⁾ Net sales and cost of products sold exclude excise taxes of $4,107 million, $4,340 million, $3,927 million, $1,890 million and $2,026 million for the years ended December 31, 2011, 2010, 2009, 2008 and 2007, respectively.

⁽³⁾ Includes gain on termination of joint venture of $328 million in 2008.

27

⁽⁴⁾ Includes restructuring and/or asset impairment charges of $38 million, $56 million and $90 million for the years ended December 31, 2010, 2009 and 2008, respectively.

⁽⁵⁾ Includes trademark and/or goodwill impairment charges of $48 million, $32 million, $567 million, $318 million and $65 million for the years ended December 31, 2011, 2010, 2009, 2008 and 2007, respectively.

⁽⁶⁾ Earnings consist of income from continuing operations before equity earnings, income taxes and fixed charges. Fixed charges consist of interest on indebtedness, amortization of debt issuance costs and the interest portion of rental expense.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following is a discussion and analysis of RAI’s business, initiatives, critical accounting estimates and its consolidated results of operations and financial position. Following the overview and discussion of business initiatives, the critical accounting estimates disclose certain accounting estimates that are material to RAI’s results of operations and financial position for the periods presented in this report. The discussion and analysis of RAI’s results of operations is presented in two comparative sections, 2011 compared with 2010, and 2010 compared with 2009. Disclosures related to liquidity and financial position complete management’s discussion and analysis. You should read this discussion and analysis of RAI’s consolidated financial position and results of operations in conjunction with the consolidated financial statements and the related notes as of December 31, 2011 and 2010, and for each of the years in the three-year period ended December 31, 2011.

Overview and Business Initiatives

RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane. During the fourth quarter of 2011, RAI elected to begin reporting the Santa Fe segment, which includes the primary operations of SFNTC. RAI has retrospectively revised segment disclosures for all periods presented. Although the operations and results of Santa Fe currently do not meet the quantitative criteria to be required to be reported, RAI management believes that reporting this segment is important to the financial statement user for additional understanding and transparency with respect to the aggregate operations and results of RAI’s subsidiaries that produce and market cigarettes in the U.S. Niconovum AB, among other RAI subsidiaries, is included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI. For net sales and operating income attributable to each segment, see Item 8, note 17 to consolidated financial statements.

RAI’s largest reportable operating segment, RJR Tobacco, is the second largest cigarette manufacturer in the United States. RJR Tobacco’s brands include many of the best-selling cigarettes in the United States: CAMEL, PALL MALL, WINSTON, KOOL, DORAL and SALEM. Those brands, and its other brands, including MISTY and CAPRI, are manufactured in a variety of styles and marketed in the United States. As part of its total tobacco strategy, RJR Tobacco also offers two types of smoke-free tobacco products, CAMEL Snus, and in certain lead markets, CAMEL Dissolvables. RJR Tobacco also manages contract manufacturing of cigarette and tobacco products through arrangements with BAT affiliates, and manages the export of tobacco products to certain U.S. territories, U.S. duty-free shops and U.S. overseas military bases. On January 1, 2012, the management of super premium cigarette brands, DUNHILL and STATE EXPRESS 555, was transferred to RJR Tobacco from Santa Fe.

28

American Snuff is the second largest smokeless tobacco products manufacturer in the United States. American Snuff’s primary brands include its largest selling moist snuff brands, GRIZZLY and KODIAK.

Santa Fe manufactures and markets cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand. Santa Fe managed RJR Tobacco’s super premium cigarette brands, DUNHILL and STATE EXPRESS 555, which are licensed from BAT, until January 1, 2012, at which time management was transferred to RJR Tobacco.

RJR Tobacco

RJR Tobacco primarily conducts business in the highly competitive U.S. cigarette market, which has a few large manufacturers and many smaller participants. The U.S. cigarette market is a mature market in which overall consumer demand has declined since 1981 and is expected to continue to decline. Profitability of the U.S. cigarette industry and RJR Tobacco continues to be adversely impacted by decreases in consumption, increases in state excise taxes and governmental regulations and restrictions, such as marketing limitations, product standards and ingredients legislation.

The international rights to substantially all of RJR Tobacco’s brands were sold in 1999 to JTI, and no international rights were acquired in connection with the B&W business combination.

RJR Tobacco offers two types of modern smoke-free tobacco, CAMEL Snus and CAMEL Dissolvables. CAMEL Snus is pasteurized tobacco in a small pouch that provides convenient tobacco consumption. CAMEL Dissolvables consist of CAMEL Orbs, Sticks and Strips, all of which are made of finely milled tobacco and dissolve completely in the mouth.

RJR Tobacco’s cigarette brand portfolio strategy is based upon three brand categories: growth, support and non-support. The growth brands consist of a premium brand, CAMEL, and a value brand, PALL MALL. Although both of these brands are managed for long-term market share and profit growth, CAMEL will continue to receive the most significant equity support. The support brands include four premium brands, WINSTON, KOOL, SALEM and CAPRI, and two value brands, DORAL and MISTY, all of which receive limited marketing support. The non-support brands, consisting of all other brands, are managed to maximize near-term profitability. The key objectives of the portfolio strategy are designed to focus on the long-term market share growth of the growth brands while managing the support brands for long-term sustainability and profitability. Consistent with that strategy, RJR Tobacco has discontinued many of its non-core cigarette styles as well as private-label cigarette brands. RJR Tobacco’s modern smoke-free products are marketed under the CAMEL brand and focus on long-term growth.

Competition is based primarily on brand positioning, including price, product attributes and packaging, consumer loyalty, promotions, advertising and retail presence. Cigarette brands produced by the major manufacturers generally require competitive pricing, substantial marketing support, retail programs and other incentives to maintain or improve market position or to introduce a new brand or brand style.

RJR Tobacco is committed to building and maintaining a portfolio of profitable brands. RJR Tobacco’s marketing programs are designed to strengthen brand image, build brand awareness and loyalty, and switch adult smokers of competing brands to RJR Tobacco brands. In addition to building strong brand equity, RJR Tobacco’s marketing approach utilizes a retail pricing strategy, including discounting at retail, to defend certain brands’ shares of market against competitive pricing pressure. RJR Tobacco’s competitive pricing methods may include list price changes, discounting programs, such as retail and wholesale buydowns, periodic price reductions, off-invoice price reductions, dollar-off promotions and consumer coupons. Retail buydowns refer to payments made to the retailer to reduce the price that consumers pay at retail. Consumer coupons generally are distributed by a variety of methods, including in, or on, the pack and by direct mail.

29

American Snuff

American Snuff offers a range of differentiated smokeless and other tobacco products to adult consumers. The moist snuff category is divided into premium and price-value brands. The moist snuff category has developed many of the characteristics of the larger, cigarette market, including multiple pricing tiers with intense competition, focused marketing programs and significant product innovation.

In contrast to the declining U.S. cigarette market, U.S. moist snuff volumes grew nearly 5% in 2011. Profit margins on moist snuff products are generally higher than on cigarette products. Moist snuff’s growth is partially attributable to cigarette smokers switching from cigarettes to smokeless tobacco products or using both. In 2011, moist snuff industry volume growth returned to historic levels after a higher-than-expected level in 2010, as the growth in 2010 was positively impacted by competitive promotional strategies.

American Snuff faces significant competition in the smokeless tobacco categories. Similar to the cigarette market, competition is based primarily on brand positioning and price, as well as product attributes and packaging, consumer loyalty, promotions, advertising and retail presence.

Santa Fe

Santa Fe competes primarily in the U.S. cigarette market, which features several large competitors such as Philip Morris USA, Inc., Lorillard Tobacco Company, Liggett Group and Commonwealth Brands, Inc., and to a much lesser extent, many smaller manufacturers of deep-discount brands. Santa Fe’s cigarette brand, NATURAL AMERICAN SPIRIT, is priced at a premium compared with most other competitive brands, and is differentiated from key competitors through its use of all natural, additive-free tobacco. Competition in the cigarette category is based primarily on brand positioning, including price, product attributes and packaging, consumer loyalty, promotions, advertising and retail presence.

Critical Accounting Estimates

Accounting principles generally accepted in the United States, referred to as GAAP, require estimates and assumptions to be made that affect the reported amounts in RAI’s consolidated financial statements and accompanying notes. Some of these estimates require difficult, subjective and/or complex judgments about matters that are inherently uncertain, and as a result, actual results could differ from those estimates. Due to the estimation processes involved, the following summarized accounting policies and their application are considered to be critical to understanding the business operations, financial position and results of operations of RAI and its subsidiaries. For information related to these and other significant accounting policies, see Item 8, note 1 to consolidated financial statements.

Litigation

RAI discloses information concerning litigation for which an unfavorable outcome is more than remote. RAI and its subsidiaries record their legal expenses and other litigation costs and related administrative costs as selling, general and administrative expenses as those costs are incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. When the reasonable estimate is a range, the recorded loss will be the best estimate within the range. If no amount in the range is a better estimate than any other amount, the minimum amount of the range will be recorded.

As discussed in Item 8, note 13 to consolidated financial statements, RJR Tobacco, American Snuff Co. and their affiliates, including RAI, and indemnitees, have been named in a number of tobacco-related legal actions,

30

proceedings or claims seeking damages in amounts ranging into the hundreds of millions or even billions of dollars. Unfavorable judgments have been returned in a number of tobacco-related cases and state enforcement actions. As of December 31, 2011, RJR Tobacco had paid approximately $18 million since January 1, 2009, related to unfavorable smoking and health litigation judgments. During 2011, RJR Tobacco paid $139 million related to an unfavorable medical monitoring and smoking cessation case.

RAI and its subsidiaries believe that they have valid bases for appeal of adverse verdicts against them and believe they have valid defenses to all actions, and they intend to defend all actions vigorously. RAI’s management continues to conclude that the loss of any particular smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, including B&W, or the loss of any particular claim concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual basis, is not probable or estimable, except for four Engle Progeny cases described in “— Litigation Affecting the Cigarette Industry — Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements.

Litigation is subject to many uncertainties, and it is possible that some of the tobacco-related legal actions, proceedings or claims could ultimately be decided against RJR Tobacco, American Snuff Co. or their affiliates, including RAI, and indemnitees. Any unfavorable outcome of such actions could have a material adverse effect on the consolidated results of operations, cash flows or financial position of RAI or its subsidiaries. For further discussion of the litigation and legal proceedings pending against RAI or its affiliates or indemnitees, see Item 8, note 13 to consolidated financial statements.

State Settlement Agreements

RJR Tobacco and Santa Fe are participants in the MSA, and RJR Tobacco is a participant in the other State Settlement Agreements. Their obligations and the related expense charges under the State Settlement Agreements are subject to adjustments based upon, among other things, the volume of cigarettes sold by the operating subsidiaries, their relative market share and inflation. Since relative market share is based on cigarette shipments, the best estimate of the allocation of charges to RJR Tobacco under these agreements is recorded in cost of products sold as the products are shipped. Adjustments to these estimates are recorded in the period that the change becomes probable and the amount can be reasonably estimated. American Snuff Co. is not a participant in the State Settlement Agreements. For more information related to historical and expected settlement expenses and payments under the State Settlement Agreements, see “— Litigation Affecting the Cigarette Industry —Health-Care Cost Recovery Cases — State Settlement Agreements” and “— State Settlement Agreements — Enforcement and Validity; Adjustments” in Item 8, note 13 to consolidated financial statements.

Pension and Postretirement Benefits

RAI and certain of its subsidiaries sponsor a number of non-contributory defined benefit pension plans covering most of their employees, and also provide certain health and life insurance benefits for most of their retired employees and their dependents. These benefits are generally no longer provided to employees hired on or after January 1, 2004. For additional information relating to pension and postretirement benefits, see Item 8, note 16 to consolidated financial statements.

Because pension and other postretirement obligations ultimately will be settled in future periods, the determination of annual expense and liabilities is subject to estimates and assumptions. RAI reviews these assumptions annually based on historic experience and expected future trends or coincidental with a major event and modifies them as needed. Demographic assumptions such as termination of employment, mortality or retirement are reviewed periodically as expectations change.

In November 2011, RAI elected to change its method of accounting for pension and postretirement benefits. Historically, RAI has recognized actuarial gains and losses in accumulated other comprehensive loss in its

31

consolidated balance sheets on an annual basis, amortizing them into operating results over the average future service period of active employees in these plans, to the extent such gains and losses were in excess of 10 percent of the greater of the market-related value of plan assets or the plan’s projected benefit obligation, referred to as the corridor. RAI has elected to immediately recognize actuarial gains and losses in its operating results in the year in which they occur, to the extent they exceed the corridor. Actuarial gains and losses outside the corridor are generally recognized annually as of December 31, and are recorded as a mark-to-market, referred to as MTM, adjustment. Additionally, for purposes of calculating the expected return on plan assets, RAI will no longer use an averaging technique permitted under GAAP for the market-related value of plan assets, but instead will use the actual fair value of plan assets. These changes are intended to improve the transparency of RAI’s operating results by more quickly recognizing the effects of current economic and interest rate trends on plan investments and assumptions. See Item 8, note 1 to consolidated financial statements for a presentation of RAI’s operating results before and after the application of this accounting change.

Gains or losses are annual changes in the amount of either the benefit obligation or the market-related value of plan assets resulting from experience different from that assumed or from changes in assumptions. Prior service costs of pension expense, which are changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over the average remaining service period for active employees, or average remaining life expectancies for inactive employees if most of the plan obligations are due to inactive employees.

Prior service costs of postretirement benefits, which are changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over the service to expected full eligibility age for active employees, or average remaining life expectancies for inactive employees if most of the plan obligations are due to inactive employees.

Differences between actual results and actuarial assumptions are accumulated and recognized in the year in which they occur as an MTM adjustment, to the extent they exceed the corridor. In recent years, actual results have varied significantly from actuarial assumptions. In particular, pension and postretirement obligations have increased due to significant decreases in discount rates. These changes have resulted in an increase in charges to other comprehensive loss and increased pension and postretirement expense. The Pension Protection Act may require additional cash funding of the increased pension obligations in the future.

The most critical assumptions and their sensitivity to change are presented below:

Assumed asset return and discount rates have a significant effect on the amounts reported for the benefit plans. A one-percentage-point change in assumed discount rate for the pension plans and other postretirement plans would have had the following effects, excluding any potential MTM adjustment:

	1-Percentage Point Increase						1-Percentage Point Decrease
	Pension Plans			Postretirement Plans			Pension Plans			Postretirement Plans
Effect on 2011 net periodic benefit cost	$	14		$	5		$	(18	)	$	(6	)
Effect on December 31, 2011, projected benefit obligation and accumulated postretirement benefit obligation		(559	)		(128	)		681			152

A one-percentage point change in assumed asset return would have had the following effects:

	1-Percentage Point Increase						1-Percentage Point Decrease
	Pension Plans			Postretirement Plans			Pension Plans		Postretirement Plans
Effect on 2011 net periodic benefit cost	$	(48	)	$	(3	)	$	48	$	3

32

Intangible Assets

Intangible assets include goodwill, trademarks and other intangibles. The determination of fair value involves considerable estimates and judgment. For goodwill, the determination of fair value of a reporting unit involves, among other things, RAI’s market capitalization, and application of the income approach, which includes developing forecasts of future cash flows and determining an appropriate discount rate. If goodwill impairment is implied, the fair values of individual assets and liabilities, including unrecorded intangibles, must be determined. RAI believes it has based its goodwill impairment testing on reasonable estimates and assumptions, and during the annual testing in the fourth quarter of 2011, the estimated fair value of each of RAI’s reporting units was substantially in excess of its respective carrying value.

Trademarks and other intangible assets with indefinite lives also are tested for impairment annually, in the fourth quarter. The aggregate fair value of RAI’s operating units’ trademarks and other intangible assets was substantially in excess of their aggregate carrying value. However, the individual fair values of four indefinite-lived trademarks were less than 15% in excess of their respective carrying values. The aggregate carrying value of these four trademarks was $236 million at December 31, 2011.

The methodology used to determine the fair value of trademarks includes assumptions with inherent uncertainty, including projected sales volumes and related projected revenues, long-term growth rates, royalty rates that a market participant might assume and judgments regarding the factors to develop an applied discount rate.

The carrying value of intangible assets are at risk of impairment if future projected revenues or long-term growth rates are lower than those currently projected, or if factors used in the development of a discount rate result in the application of a higher discount rate.

Goodwill, all trademarks and other intangible assets are tested more frequently if events and circumstances indicate that the asset might be impaired. The carrying value of these intangible assets could be impaired if a significant adverse change in the use, life, or brand strategy of the asset is determined, or if a significant adverse change in the legal and regulatory environment, business or competitive climate occurs that would adversely impact the asset. See Item 8, note 3 to consolidated financial statements for a discussion of the impairment charges.

Fair Value Measurement

RAI determines fair value of certain of its assets and liabilities using a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. The levels of the fair value hierarchy are:

Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2: inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability.

33

Level 3: inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

See Item 8, note 2 to consolidated financial statements for information on assets and liabilities recorded at fair value.

Income Taxes

Tax law requires certain items to be excluded or included in taxable income at different times than is required for book reporting purposes. These differences may be permanent or temporary in nature.

RAI determines its annual effective income tax rate based on forecasted pre-tax book income and forecasted permanent book and tax differences. The rate is established at the beginning of the year and is evaluated on a quarterly basis. Any changes to the forecasted information may cause the effective rate to be adjusted. Additional tax, interest and penalties associated with uncertain tax positions are recognized in tax expense on a quarterly basis.

To the extent that any book and tax differences are temporary in nature, that is, the book realization will occur in a different period than the tax realization, a deferred tax asset or liability is established. To the extent that a deferred tax asset is created, management evaluates RAI’s ability to realize this asset. RAI maintains a valuation allowance to reduce certain deferred tax assets to amounts that are more likely than not to be realized. This allowance is attributable to deferred tax assets established for capital loss carryforwards.

The financial statements reflect management’s best estimate of RAI’s current and deferred tax liabilities and assets. Future events, including but not limited to, additional resolutions with taxing authorities could have an impact on RAI’s current estimate of tax liabilities, realization of tax assets and effective income tax rate. See Item 8, note 10 to consolidated financial statements for additional information on income taxes.

Recently Adopted Accounting Pronouncements

For information relating to recently adopted accounting guidance, see Item 8, note 1 to consolidated financial statements.

34

Results of Operations

	For the Twelve Months Ended December 31,
	2011			2010(1)			% Change			2009(1)			% Change
Net sales:(2)
RJR Tobacco	$	7,297		$	7,350			(0.7	)%	$	7,334			0.2	%
American Snuff		648			719			(9.9	)%		673			6.8	%
Santa Fe		436			356			22.5	%		289			23.2	%
All other		160			126			27.0	%		123			2.4	%
Net sales		8,541			8,551			(0.1	)%		8,419			1.6	%
Cost of products sold(2)(3)		4,464			4,544			(1.8	)%		4,488			1.2	%
Selling, general and administrative expenses		1,606			1,480			8.5	%		1,517			(2.4	)%
Amortization expense		24			25			(4.0	)%		28			(10.7	)%
Asset impairment and exit charges		—			38			NM	(4)		—			NM	(4)
Restructuring charge		—			—			NM	(4)		56			NM	(4)
Trademark impairment charges		48			6			NM	(4)		567			NM	(4)
Goodwill impairment charge		—			26			NM	(4)		—			NM	(4)
Operating income:
RJR Tobacco		1,945			2,084			(6.7	)%		1,481			40.7	%
American Snuff		331			320			3.4	%		276			15.9	%
Santa Fe		198			135			46.7	%		98			37.8	%
All other		18			(14	)		NM	(4)		14			NM	(4)
Corporate expense		(93	)		(93	)		—			(106	)		(12.3	)%
	$	2,399		$	2,432			(1.4	)%	$	1,763			37.9	%

⁽¹⁾ Revised for the change in accounting for pension and postretirement benefits. See Item 8, note 1 to consolidated financial statements.

⁽²⁾ Excludes excise taxes of:

	2011		2010		2009
RJR Tobacco	$	3,667	$	3,898	$	3,532
American Snuff		57		106		124
Santa Fe		159		144		110
All other		224		192		161
	$	4,107	$	4,340	$	3,927

⁽³⁾ See below for further information related to State Settlement Agreements, federal tobacco buyout and FDA expense included in cost of products sold.

⁽⁴⁾ Percentage change not meaningful.

35

2011 Compared with 2010

RJR Tobacco

Net Sales

Domestic cigarette shipment volume, in billions of units for RJR Tobacco and the industry, were as follows⁽¹⁾:

	For the Twelve Months Ended December 31,
	2011			2010			% Change
Growth brands:
CAMEL excluding non-filter		21.2			21.6			(1.8	)%
PALL MALL		21.7			20.1			8.0	%
		42.9			41.7			2.9	%
Support brands		26.9			31.3			(14.1	)%
Non-support brands		3.1			4.6			(31.7	)%
Total domestic		72.9			77.5			(6.0	)%
Total premium		41.5			44.5			(6.9	)%
Total value		31.4			33.0			(4.7	)%
Premium/Total mix		56.9	%		57.5	%
Industry(2):
Premium		206.6			213.3			(3.1	)%
Value		86.5			90.4			(4.4	)%
Total domestic		293.1			303.7			(3.5	)%
Premium/Total mix		70.5	%		70.2	%

⁽¹⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. Percentages are calculated on unrounded numbers.

⁽²⁾ Based on information from MSAi.

RJR Tobacco’s net sales are dependent upon its cigarette shipment volume in a declining market, premium versus value-brand mix and list pricing, offset by promotional spending, trade incentives and federal excise taxes. RJR Tobacco also believes its consumers are more price-sensitive than consumers of competing brands and, therefore, are more negatively affected by an increase in the federal excise tax and by the current adverse economic environment.

RJR Tobacco’s net sales for the year ended December 31, 2011, decreased from the year ended December 31, 2010, due to $529 million attributable to lower cigarette volume and an unfavorable premium-to-value brand mix, partially offset by higher pricing of $398 million and higher related party sales of $107 million. Related party sales are expected to return to historical levels in 2012.

36

The shares of RJR Tobacco’s brands as a percentage of total share of U.S. retail cigarette sales according to data⁽¹⁾ from IRI/Capstone, were as follows⁽²⁾:

	For the Twelve Months Ended December 31,
	2011			2010			Share Point Change
Growth brands:
CAMEL excluding non-filter		7.8	%		7.7	%		0.1
PALL MALL		8.5	%		7.4	%		1.1
Total growth brands		16.4	%		15.1	%		1.3
Support brands		9.9	%		11.2	%		(1.3	)
Non-support brands		1.1	%		1.7	%		(0.6	)
Total domestic		27.4	%		28.1	%		(0.7	)

⁽¹⁾ Retail share of U.S. cigarette sales data is included in this document because it is used by RJR Tobacco primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data reported by IRI/Capstone as being a precise measurement of actual market share because IRI/Capstone is not able to effectively track all volume. Moreover, you should be aware that in a product market experiencing overall declining consumption, a particular product can experience increasing market share relative to competing products, yet still be subject to declining consumption volumes.

⁽²⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis.

The retail share of market of CAMEL’s filtered styles at 7.8 share points, increased slightly in 2011 compared with 2010. In addition to a significant level of competitive line extensions and promotional support, the market continues to be challenging for premium-priced products.

CAMEL’s cigarette market share was favorably impacted by its menthol styles, which feature the same innovative capsule technology used in CAMEL Crush, allowing adult smokers to choose the level of menthol flavor on demand. CAMEL Crush, featuring the menthol capsule, allows adult smokers the choice between regular or menthol. CAMEL’s menthol market share at December 31, 2011, including CAMEL Crush, increased 0.4 percentage points to 2.3 percent. CAMEL Crush Bold was introduced in the third quarter of 2011. This is RJR Tobacco’s first cigarette line extension since this innovative style was expanded nationally in 2008. CAMEL Crush Bold has a more full-bodied, richer tobacco taste than CAMEL Crush.

CAMEL Snus, a smoke-free tobacco product, was expanded into select outlets nationally in 2009, and continues to bring awareness to this new smoke-free category. CAMEL Snus continued to show steady growth in 2011 as interest built in this convenient option for adult tobacco consumers.

CAMEL’s refined and improved line of dissolvable tobacco products continues to generate new consumer insights after being introduced in two new lead markets in the first quarter of 2011.

PALL MALL continued to perform well with both volume and share gains. PALL MALL’s growth is believed to be the result of the brand’s position as a product that offers a high quality, longer-lasting cigarette at a value price. Despite significant competitive activity and many offerings below PALL MALL’s price point, the brand’s 2011 market share rose 1.1 percentage points from the prior-year, to 8.5%.

The combined share of market of RJR Tobacco’s growth brands during 2011 showed improvement over 2010. RJR Tobacco’s total cigarette market share declined slightly from the prior year as RJR Tobacco has

37

discontinued many of its non-core cigarette styles and de-emphasized private-label cigarette brands. These actions are consistent with RJR Tobacco’s strategy of focusing on growth brands.

Operating Income

RJR Tobacco’s operating income for the year ended December 31, 2011, decreased from the year ended December 31, 2010, due to lower cigarette volume on support and non-support brands and trademark impairment for 2011, partially offset by growth brand volume gains, higher cigarette pricing and productivity improvements. Also, during 2011, RJR Tobacco recorded charges of $64 million related to four Engle Progeny cases in Florida and $139 million related to the Scott lawsuit in Louisiana. For additional information, see “— Litigation Affecting the Cigarette Industry — Overview,” “— Engle and Engle Progeny Cases” and “— Class-Action Suits — Medical Monitoring and Smoking Cessation Case — Scott v. American Tobacco Co.” in Item 8, note 13 to consolidated financial statements. Additionally, unfavorable premium-to-value mix and asset impairment charges of $24 million related to a plant closing impacted the operating income in 2010.

RJR Tobacco’s expense under the State Settlement Agreements, federal tobacco quota buyout and FDA user fees, included in cost of products sold, were as follows:

	For the Twelve Months Ended December 31,
	2011		2010
State Settlement Agreements	$	2,355	$	2,432
Federal tobacco quota buyout		217		232
FDA user fees		114		71

Expenses under the State Settlement Agreements are expected to be approximately $2.4 billion in 2012, subject to adjustment for changes in volume and other factors, and expense for the federal tobacco quota buyout is expected to be approximately $210 million to $220 million in 2012. Expenses for FDA user fees are expected to be approximately $115 million to $125 million in 2012. For additional information, see “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements” in Item 8, note 13 to consolidated financial statements.

Selling, general and administrative expenses include the costs of litigating and administering product liability claims, as well as other legal expenses. For the years ended December 31, 2011 and 2010, RJR Tobacco’s product liability defense costs were $160 million and $153 million, respectively. The increase in product liability defense costs in 2011 compared with 2010 is due primarily to the increase in the number of Engle Progeny cases in or scheduled for trial. For more information, see “— Litigation Affecting the Cigarette Industry — Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements.

“Product liability” cases generally include the following types of smoking and health related cases:

• Individual Smoking and Health;

• West Virginia IPIC;

• Engle Progeny;

• Broin II;

• Class Actions; and

38

• Health-Care Cost Recovery Claims.

“Product liability defense costs” include the following items:

• direct and indirect compensation, fees and related costs and expenses for internal legal and related administrative staff administering product liability claims;

• fees and cost reimbursements paid to outside attorneys;

• direct and indirect payments to third party vendors for litigation support activities;

• expert witness costs and fees; and

• payments to fund legal defense costs for the now dissolved Council for Tobacco Research — U.S.A.

Numerous factors affect product liability defense costs. The most important factors are the number of cases pending and the number of cases in trial or in preparation for trial, that is, with active discovery and motions practice. See “— Litigation Affecting the Cigarette Industry — Overview — Introduction” in Item 8, note 13 to consolidated financial statements for detailed information regarding the number and type of cases pending, and “— Litigation Affecting the Cigarette Industry — Overview — Scheduled Trials” in Item 8, note 13 to consolidated financial statements for detailed information regarding the number and nature of cases in trial and scheduled for trial through December 31, 2012.

RJR Tobacco expects that the factors described above will continue to have the primary impact on its product liability defense costs in the future. Given the increased level of activity in RJR Tobacco’s pending cases and possible new cases, including the increased number of cases in trial and scheduled for trial, particularly with respect to the Engle Progeny cases, RJR Tobacco’s product liability defense costs continue to increase. See “— Litigation Affecting the Cigarette Industry — Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements for additional information. In addition, it is possible that adverse developments in the factors discussed above, as well as other circumstances beyond the control of RJR Tobacco, could have a material adverse effect on the consolidated results of operations, cash flows or financial position of RAI or its subsidiaries. Those other circumstances beyond the control of RJR Tobacco include the results of present and future trials and appeals, and the development of possible new theories of liability by plaintiffs and their counsel.

American Snuff

Net Sales

The moist snuff shipment volume, in millions of cans, for American Snuff was as follows⁽¹⁾:

	For the Twelve Months Ended December 31,
	2011		2010		% Change
KODIAK		45.7		47.5		(3.8	)%
GRIZZLY		355.8		325.3		9.4	%
Other		3.2		4.5		(29.3	)%
Total moist snuff		404.7		377.3		7.3	%

⁽¹⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. Percentages are calculated on unrounded numbers.

39

American Snuff’s net sales for the year ended December 31, 2011, were unfavorably impacted by higher levels of competitive promotional activity and by the lack of sales from Lane subsequent to its sale on February 28, 2011, partially offset by higher volumes. Shipments of GRIZZLY, American Snuff’s leading price-value brand, increased in 2011 with gains on core styles. Shipments of KODIAK, American Snuff’s leading premium brand, declined slightly in 2011 due to high levels of competitive promotional activity.

The American Snuff retail share of market of U.S. moist snuff, according to data⁽¹⁾ processed by A.C. Nielsen, were as follows⁽²⁾:

	For the Twelve Months Ended December 31,
	2011			2010			Share Point Change
KODIAK		3.6	%		3.9	%		(0.3	)
GRIZZLY		27.7	%		26.1	%		1.6
Other		0.2	%		0.3	%		(0.1	)
Total moist snuff		31.5	%		30.3	%		1.2

⁽¹⁾ Retail share of market of U.S. moist snuff is included in this document because it is used by American Snuff primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data processed by A.C. Nielsen as being a precise measurement of actual market share because this data set is not able to effectively track all volume.

⁽²⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. Prior year shares have been restated to reflect current methodology.

Moist snuff has been the key driver to American Snuff’s overall growth and profitability within the U.S. smokeless tobacco market. Moist snuff accounted for approximately 83% of American Snuff’s revenue in 2011 and approximately 74% in 2010 reflecting the impact from the sale of Lane in 2011. Moist snuff industry volume grew nearly 5% in 2011 compared with 2010. In 2011, moist snuff industry volume growth returned to historic levels after a higher-than-expected level in 2010, as the growth in 2010 was positively impacted by competitive promotional strategies.

GRIZZLY’s market share of moist snuff shipments in 2011 increased compared with 2010 despite competitive promotional activity. In the industry, the moist pouch segment grew approximately 11.4% in 2011, and now accounts for over 9% of all moist snuff volume. GRIZZLY’s pouch styles accounted for over 27% of moist pouch industry volume at December 31, 2011.

The retail share of market of KODIAK in 2011 was down compared with 2010, continuing to be impacted by pricing pressures as a premium brand.

Operating Income

American Snuff’s operating income for the year ended December 31, 2011, increased due to higher moist snuff pricing and sales volumes, partially offset by high levels of promotional activity and by the lack of earnings from Lane subsequent to its sale on February 28, 2011. In addition, as a result of fourth quarter testing, trademark impairment charges of $5 million and $6 million were recorded in 2011 and 2010, respectively, on several loose leaf brands.

During the fourth quarter of 2010, in order to facilitate its strategic focus on key brands in the cigarette, moist-snuff and modern smoke-free categories of the tobacco business, RAI determined that it was probable that it would dispose of the operations of Lane. In connection with this determination, the goodwill of American

40

Snuff was allocated between the disposal group and the retained operations based on relative fair values. The resulting goodwill was tested for impairment comparing its fair value with its carrying value. Because the fair value, less estimated cost of disposal, of the disposal group was less than its carrying value, a goodwill impairment loss of $26 million was recorded in the fourth quarter of 2010.

Santa Fe

Net Sales

Domestic cigarette shipment volume, in billions of units for Santa Fe, was as follows:

	For the Twelve Months Ended December 31,
	2011		2010		% Change
NATURAL AMERICAN SPIRIT		2.8		2.5		13.5	%

Santa Fe’s net sales for the year ended December 31, 2011, increased over 2010 and were favorably impacted by higher volume and pricing.

The cigarette shipment volume growth of 13.5% reflects strong consumer demand, supported by expanded domestic distribution and style presence at retail.

The share of Santa Fe’s NATURAL AMERICAN SPIRIT as a percentage of total share of U.S. retail cigarette sales according to data⁽¹⁾ from IRI/Capstone, were as follows:

	For the Twelve Months Ended December 31,
	2011			2010			Share Point Change
NATURAL AMERICAN SPIRIT		1.0	%		0.8	%		0.2

⁽¹⁾ Retail share of U.S. cigarette sales data is included in this document because it is used by Santa Fe primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data reported by IRI/Capstone as being a precise measurement of actual market share because IRI/Capstone is not able to effectively track all volume. Moreover, you should be aware that in a product market experiencing overall declining consumption, a particular product can experience increasing market share relative to competing products, yet still be subject to declining consumption volumes.

Operating Income

Santa Fe’s operating income for the year ended December 31, 2011, increased as compared with the year ended December 31, 2010, as a result of higher cigarette volumes and pricing, partially offset by higher MSA costs.

Santa Fe’s expense under the MSA, federal tobacco quota buyout and FDA user fees, included in cost of products sold, were as follows:

	For the Twelve Months Ended December 31,
	2011		2010
MSA	$	75	$	60
Federal tobacco quota buyout		9		8
FDA user fees		4		3

41

Expenses under the MSA are expected to be approximately $90 million in 2012, subject to adjustment for changes in volume and other factors, and expense for the federal tobacco quota buyout is expected to be approximately $10 million in 2012. Expenses for FDA user fees are expected to be approximately $5 million in 2012. For additional information, see “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements” in Item 8, note 13 to consolidated financial statements.

RAI Consolidated

Interest and debt expense for the year ended December 31, 2011, was $221 million, a decrease of $11 million from the comparable prior year, primarily due to lower debt balances during 2011.

Provision for income taxes of $780 million reflected an effective rate of 35.7%, for the year ended December 31, 2011, compared with $868 million for an effective rate of 39.4%, for the year ended December 31, 2010. The effective tax rate for 2011 was favorably impacted by a $22 million decrease in tax attributable to the reversal of tax reserves and interest on a state statute expiration. The effective tax rate for 2010 was unfavorably impacted by a $27 million increase in tax attributable to the Patient Protection and Affordable Care Act of 2010 and the Health Care and Education Reconciliation Act of 2010. The effective tax rates exceeded the federal statutory rate of 35% primarily due to the impact of state taxes and certain non-deductible items, offset by the domestic production activities deduction of the American Jobs Creation Act of 2004.

RAI expects its effective tax rate to be between 37% and 38% in 2012.

2010 Compared with 2009

RJR Tobacco

Net Sales

Domestic cigarette shipment volume, in billions of units for RJR Tobacco and the industry, were as follows⁽¹⁾:

	For the Twelve Months Ended December 31,
	2010			2009			% Change
Growth brands:
CAMEL excluding non-filter		21.6			21.2			1.9	%
PALL MALL		20.1			14.6			37.7	%
		41.7			35.8			16.5	%
Support brands		31.3			37.9			(17.5	)%
Non-support brands		4.6			8.0			(42.9	)%
Total domestic		77.5			81.7			(5.1	)%
Total premium		44.5			48.1			(7.5	)%
Total value		33.0			33.5			(1.6	)%
Premium/Total mix		57.5	%		59.0	%
Industry(2):
Premium		213.3			222.6			(4.2	)%
Value		90.4			93.1			(2.9	)%
Total domestic		303.7			315.7			(3.8	)%
Premium/Total mix		70.2	%		70.5	%

⁽¹⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. Percentages are calculated on unrounded numbers.

⁽²⁾ Based on information from MSAi.

42

RJR Tobacco’s net sales for the year ended December 31, 2010, increased from the year ended December 31, 2009, driven by higher pricing of $551 million, partially offset by $459 million attributable to lower cigarette volume and an unfavorable premium-to-value brand mix.

The shares of RJR Tobacco’s brands as a percentage of total share of U.S. retail cigarette sales according to data⁽¹⁾ from IRI/Capstone, were as follows⁽²⁾:

	For the Twelve Months Ended December 31,
	2010			2009			Share Point Change
Growth brands:
CAMEL excluding non-filter		7.7	%		7.5	%		0.2
PALL MALL		7.4	%		4.8	%		2.7
Total growth brands		15.1	%		12.3	%		2.8
Support brands		11.2	%		13.1	%		(1.9	)
Non-support brands		1.7	%		2.9	%		(1.2	)
Total domestic		28.1	%		28.3	%		(0.2	)

⁽¹⁾ Retail share of U.S. cigarette sales data is included in this document because it is used by RJR Tobacco primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data reported by IRI/Capstone as being a precise measurement of actual market share because IRI/Capstone is not able to effectively track all volume. Moreover, you should be aware that in a product market experiencing overall declining consumption, a particular product can experience increasing market share relative to competing products, yet still be subject to declining consumption volumes.

⁽²⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis.

The retail share of market of CAMEL’s filtered styles increased in 2010 compared with 2009, favorably impacted by product upgrades in two core menthol styles in late 2009. CAMEL Crush had captured 0.8 share points as of December 31, 2010, as the success of this style continued to be a key driver in the growing menthol category.

PALL MALL increased market share in 2010 compared with 2009, due, in management’s belief, to adult consumers switching brands seeking greater value. PALL MALL, positioned as a product that offers a longer-lasting cigarette at a value price, has retained a high percentage of adult smokers who try the brand.

Operating Income

RJR Tobacco’s operating income for the year ended December 31, 2010, increased from the year ended December 31, 2009, due to higher cigarette pricing and continued productivity gains. In addition to streamlining product offerings, RJR Tobacco also eliminated non-essential activities and outsourced non-core functions. Partially offsetting these gains were lower cigarette volume, the payment of a legal judgment and higher FDA user fees. Additionally, unfavorable premium-to-value mix and asset impairment charges of $24 million related to a plant closing impacted the operating income in 2010.

Trademark impairment charges of $491 million were recorded in 2009 as the result of impairment testing to reflect the forecasted sales impact due to the increase in the federal excise tax and as the result of annual impairment testing of brand trademarks.

43

RJR Tobacco’s expense under the State Settlement Agreements, federal tobacco quota buyout and FDA user fees, included in cost of products sold, were as follows:

	For the Twelve Months Ended December 31,
	2010		2009
State Settlement Agreements	$	2,432	$	2,490
Federal tobacco quota buyout		232		231
FDA user fees		71		21

Selling, general and administrative expenses include the costs of litigating and administering product liability claims, as well as other legal expenses. For the years ended December 31, 2010 and 2009, RJR Tobacco’s product liability defense costs were $153 million and $123 million, respectively. The increase in product liability defense costs in 2010 compared with 2009 was due primarily to the increase in the number of Engle Progeny cases in or scheduled for trial.

American Snuff

Net Sales

The moist snuff shipment volume, in millions of cans, for American Snuff was as follows⁽¹⁾:

	For the Twelve Months Ended December 31,
	2010		2009		% Change
KODIAK		47.5		47.8		(0.6	)%
GRIZZLY		325.3		304.6		6.8	%
Other		4.5		4.1		11.2	%
Total moist snuff		377.3		356.5		5.8	%

⁽¹⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. Percentages are calculated on unrounded numbers.

American Snuff’s net sales for the year ended December 31, 2010, were favorably impacted by higher moist snuff volume and pricing. Shipments of GRIZZLY increased in 2010 with gains on core styles. Shipments of KODIAK declined slightly in 2010 due to competitive promotional activity.

The American Snuff shares of the moist snuff category as a percentage of total share of U.S. shipments of moist snuff, according to distributor reported data⁽¹⁾ processed by MSAi, were as follows⁽²⁾:

	For the Twelve Months Ended December 31,
	2010			2009			Share Point Change
KODIAK		3.6	%		3.8	%		(0.2	)
GRIZZLY		25.3	%		25.3	%		—
Other		0.3	%		0.3	%		—
Total moist snuff		29.2	%		29.4	%		(0.2	)

⁽¹⁾ Distributor shipments-to-retail share of U.S. moist snuff is included in this document because it is used by American Snuff primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data reported by distributors and processed by MSAi as being a precise measurement of actual market share because this distributor data set is not able to effectively track all volume.

44

⁽²⁾ Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis.

Moist snuff accounted for approximately 74% of American Snuff’s revenue in 2010 and approximately 71% in 2009. Moist snuff industry volume grew 8% in 2010 compared with 2009, due to competitive promotional strategies in 2010 and a change in competitive shipments reporting, which excludes product returns.

GRIZZLY’s market share of moist snuff shipments in 2010 was stable compared to 2009 despite competitive promotional activity and line extensions. In the first quarter of 2010, embossed metal lids were launched across the entire brand. In the industry, pouch styles grew nearly 21% in 2010, and accounted for nearly 9% of moist snuff sales. GRIZZLY’s pouch styles accounted for over 24% of the pouch segment at December 31, 2010.

The shipment share of KODIAK in 2010 was down slightly compared with 2009, due to competitive promotional activity. KODIAK upgraded to embossed metal lids in 2010 to further enhance the brand’s premium image.

Operating Income

American Snuff’s operating income for the year ended December 31, 2010, increased due to higher volume and pricing. In addition, as a result of fourth quarter testing, a trademark impairment charge of $6 million was recorded in 2010 compared with a trademark impairment charge of $76 million in 2009, which was due to the forecasted sales impact of the increase in federal excise tax.

Santa Fe

Net Sales

Domestic cigarette shipment volume, in billions of units for Santa Fe, was as follows:

	For the Twelve Months Ended December 31,
	2010		2009		% Change
NATURAL AMERICAN SPIRIT		2.5		2.1		19.9	%

Santa Fe’s net sales for the year ended December 31, 2010, as compared with the year ended December 31, 2009, were favorably impacted by higher volume of $51 million and $19 million attributable to pricing.

The share of Santa Fe’s NATURAL AMERICAN SPIRIT as a percentage of total share of U.S. retail cigarette sales according to data⁽¹⁾ from IRI/Capstone, were as follows:

	For the Twelve Months Ended December 31,
	2010			2009			Share Point Change
NATURAL AMERICAN SPIRIT		0.8	%		0.7	%		0.1

⁽¹⁾ Retail share of U.S. cigarette sales data is included in this document because it is used by Santa Fe primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data reported by IRI/Capstone as being a precise measurement of actual market share because IRI/Capstone is not able to effectively track all volume. Moreover, you should be aware that in a product market experiencing overall declining consumption, a particular product can experience increasing market share relative to competing products, yet still be subject to declining consumption volumes.

45

Operating Income

Santa Fe’s operating income for the year ended December 31, 2010, increased from the year ended December 31, 2009, due to higher cigarette volume and pricing. Partially offsetting these gains were higher MSA charges and an increase in expenses related to the expansion of the sales force.

Santa Fe’s expense under the MSA, federal tobacco quota buyout and FDA user fees, included in cost of products sold, were as follows:

	For the Twelve Months Ended December 31,
	2010		2009
MSA	$	60	$	48
Federal tobacco quota buyout		8		6
FDA user fees		3		1

RAI Consolidated

Interest and debt expense for the year ended December 31, 2010, was $232 million, a decrease of $19 million from the comparable prior year, primarily due to lower debt balances during 2010.

Interest income was $12 million for the year ended December 31, 2010, a $7 million decrease compared with the year ended December 31, 2009, as a result of lower available cash to invest in 2010.

Provision for income taxes of $868 million reflected an effective rate of 39.4%, for the year ended December 31, 2010, compared with $567 million for an effective rate of 37.3%, for the year ended December 31, 2009. The effective tax rate for 2010 was unfavorably impacted by a $27 million increase in tax attributable to the Patient Protection and Affordable Care Act of 2010 and the Health Care and Education Reconciliation Act of 2010. The effective tax rate for 2009 was unfavorably impacted by increases in unrecognized income tax benefits and increases in tax attributable to accumulated and undistributed foreign earnings. The effective tax rates exceeded the federal statutory rate of 35% primarily due to the impact of state taxes and certain non-deductible items, offset by the domestic production activities deduction of the American Jobs Creation Act of 2004.

Liquidity and Financial Condition

Liquidity

At present, the principal sources of liquidity for RAI’s operating subsidiaries’ businesses and operating needs are internally generated funds from their operations and intercompany loans and advances, mainly from RAI and RJR. The principal sources of liquidity for RAI and RJR, in turn, are proceeds from issuances of debt securities by RAI and RJR and the Credit Agreement described below under “— Borrowing Arrangements —Credit Agreement”. It is expected that the Term Loan described under “— Borrowing Arrangements — Term Loan,” if and when it is consummated, will also serve as a source of liquidity for RAI. Cash flows from operating activities are believed to be sufficient for the foreseeable future to enable the operating subsidiaries to meet their obligations under the State Settlement Agreements, to fund their capital expenditures and to make payments to RAI and RJR that, when combined with RAI’s and RJR’s cash balances and other liquidity sources, will enable RAI and RJR to make their required debt-service payments, and enable RAI to pay dividends to its shareholders and purchase shares under its share repurchase program.

The negative impact, if any, on the sources of liquidity that could result from a decrease in demand for products due to short-term inventory adjustments by wholesale and retail distributors, changes in competitive

46

pricing, accelerated declines in consumption, particularly from increases in regulation or excise taxes, or adverse impacts from financial markets, cannot be predicted. RAI cannot predict its cash requirements or those of its subsidiaries related to any future settlements or judgments, including cash required to be held in escrow or to bond any appeals, if necessary, and RAI makes no assurance that it or its subsidiaries will be able to meet all of those requirements.

RAI’s operating companies monitored the liquidity of key suppliers and customers throughout 2011, and where liquidity concerns were identified, appropriate contingency plans were developed. To date, no business interruptions have occurred caused by key supplier liquidity, and no liquidity issues were identified involving significant customers.

RAI’s excess cash may be invested in money market funds, commercial paper, U.S. treasuries, U.S. government agencies and time deposits in major institutions to minimize risk. At present, RAI primarily invests cash in U.S. treasuries.

As of December 31, 2011, R.J. Reynolds Tobacco C.V., referred to as RJRTCV, and an indirect wholly owned subsidiary of RAI, held approximately 122 million euros in a euro government liquidity fund, included in cash and cash equivalents in RAI’s consolidated balance sheet. Nearly two-thirds of the fund is comprised of repurchase agreements with financial institutions that are collateralized by sovereign debt of approved countries. The fund has investments in sovereign debt of Finland, France, Germany and the Netherlands. The average maturity of the fund was 17 days as of December 31, 2011. RAI’s management believes that this cash equivalent is not reasonably likely to have a material impact on its liquidity or results of operations. RAI has no hedge in place with respect to this exposure.

As of December 31, 2011, RAI held investments in auction rate securities, a mortgage-backed security and a marketable equity security. Adverse changes in financial markets caused the auction rate securities and the mortgage-backed security to revalue lower than carrying value and become less liquid. The auction rate securities and mortgage-backed security will not become liquid until a successful auction occurs or a buyer is found. RAI intends, and has the ability, to hold these auction rate securities and the mortgage-backed security for a period of time sufficient to allow for sale, redemption or anticipated recovery in fair value.

On February 28, 2011, RAI completed the sale of all of the capital stock of Lane and certain other assets related to the Lane operations to STG for net proceeds of $202 million in cash. The assets and liabilities of the disposal group were classified as held for sale as of December 31, 2010, and its results of operations were included through February 28, 2011, in income from continuing operations in the American Snuff segment.

Contractual obligations as of December 31, 2011 were as follows:

	Payments Due by Period
	Total		Less than  1 Year-2012		1-3  Years 2013-2014		4-5  Years 2015-2016		Thereafter
Long-term notes, exclusive of interest(1)	$	3,510	$	450	$	685	$	975	$	1,400
Interest payments related to long-term notes(1)		1,637		240		374		302		721
Operating leases(2)		66		20		33		13		—
Non-qualified pension obligations(3)		87		9		16		16		46
Postretirement benefit obligations(3)		704		70		145		145		344
Qualified pension funding(3)		300		300
Purchase obligations(4)		424		180		176		68		—
Other noncurrent liabilities(5)		51		N/A		19		5		27
State Settlement Agreements’ obligations(6)		12,500		2,500		5,000		5,000
Gross unrecognized tax benefit(7)		128
Federal tobacco buyout obligations(8)		641		228		413		—		—
FDA user fee		735		127		283		325
Total cash obligations	$	20,783	$	4,124	$	7,144	$	6,849	$	2,538

⁽¹⁾ For more information about RAI’s and RJR’s long-term notes, see Item 8, note 12 to consolidated financial statements.

47

⁽²⁾ Operating lease obligations represent estimated lease payments primarily related to office space, automobiles, warehouse space and computer equipment. See Item 8, note 13 to consolidated financial statements for additional information.

⁽³⁾ For more information about RAI’s pension plans and postretirement benefits, see Item 8, note 16 to consolidated financial statements. Non-qualified pension and postretirement benefit obligations captioned under “Thereafter” include obligations during the next five years only. These obligations are not reasonably estimable beyond ten years. Qualified pension plan funding is based on the Pension Protection Act and tax deductibility and is not reasonably estimable beyond one year.

⁽⁴⁾ Purchase obligations primarily include commitments to acquire tobacco leaf. Purchase orders for the purchase of other raw materials and other goods and services are not included in the table. RAI’s operating subsidiaries are not able to determine the aggregate amount of such purchase orders that represent contractual obligations, as purchase orders typically represent authorizations to purchase rather than binding agreements. For purposes of this table, contractual obligations for the purchase of goods or services are defined by RAI’s operating subsidiaries as agreements that are enforceable and legally binding that specify all significant terms, including fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction. Purchase orders of RAI’s operating subsidiaries are based on current demand expectations and are fulfilled by vendors within short time horizons. RAI’s operating subsidiaries do not have significant non-cancelable agreements for the purchase of raw materials or other goods or services specifying minimum quantities or set prices that exceed their expected requirements. RAI’s operating subsidiaries also enter into contracts for outsourced services; however, the obligations under these contracts were generally not significant and the contracts generally contain clauses allowing for the cancellation without significant penalty.

⁽⁵⁾ Other noncurrent liabilities include primarily restructuring and bonus compensation. Certain other noncurrent liabilities are excluded from the table above, for which timing of payments are not estimable.

⁽⁶⁾ State Settlement Agreements’ obligation amounts in the aggregate beyond five years are not presented as these are obligations into perpetuity. For more information about the State Settlement Agreements, see Item 8, note 13 to consolidated financial statements.

⁽⁷⁾ For more information on gross unrecognized tax benefits, see Item 8, note 10 to consolidated financial statements. Due to inherent uncertainties regarding the timing of payment of these amounts, RAI cannot reasonably estimate the payment period.

⁽⁸⁾ For more information about the tobacco buyout legislation, see “— Governmental Activity” below and Item 8, note 13 to consolidated financial statements.

Commitments as of December 31, 2011 were as follows:

	Commitment Expiration Period
	Total		Less than 1  Year
Standby letters of credit backed by revolving credit facility	$	7	$	7

Cash Flows

2011 Compared with 2010

Net cash flows from operating activities were $1,420 million and increased $155 million in 2011, compared with 2010. This change was driven by lower pension contributions in 2011, partially offset by higher income tax payments and litigation bonds in 2011.

48

Net cash flows from investing activities were $60 million and increased $186 million in 2011, compared with 2010 primarily due to proceeds from the sale of the Lane business during 2011, partially offset by higher capital expenditures for American Snuff’s facility expansion projects.

Net cash flows used in financing activities were $1,714 million and increased $365 million in 2011, compared with the prior-year period. This increase was the result of an increase in the comparable quarterly common stock dividend, a higher debt payment in 2011, and stock repurchases, partially offset by the receipt of cash from the termination of interest rate swaps.

2010 Compared with 2009

Net cash flows from operating activities were $1,265 million and decreased $189 million in 2010, compared with 2009. This change was driven primarily by higher pension contributions and the payment of the full MSA obligation, partially offset by higher pricing, reduced inventories in 2010, lower excise tax payments on deployed inventory and lower income tax payments.

Net cash flows used in investing activities were $126 million and increased $3 million in 2010, compared with 2009 due to higher capital expenditures for American Snuff facility expansion projects and fewer proceeds from short-term investments and the sale of fixed assets in 2010, partially offset by higher proceeds on long-term investments in 2010 and the acquisition of Niconovum AB in 2009.

Net cash flows used in financing activities were $1,349 million and increased $157 million in 2010, compared with the prior-year period. This increase was the result of a higher debt payment in 2010 as well as higher dividends paid on common stock in 2010 as a result of the increase in the dividend per share amount.

Net cash flows related to discontinued operations, net of tax benefit, include payments made in 2010, of $324 million, offset by tax benefits of $91 million, realized in 2010, and of $74 million to certain Canadian governments, resulting from the terms of a Comprehensive Agreement and plea agreement, respectively, associated with the former international businesses that were sold to JTI in 1999. See Item 8, notes 6 and 13 to consolidated financial statements for additional details of these payments.

Borrowing Arrangements

RAI and RJR Notes

As of December 31, 2011, RAI’s total consolidated debt consisted of RAI notes in the aggregate principal amount of $3.4 billion, with maturity dates ranging from 2012 to 2037, and RJR notes in the aggregate principal amount of $118 million, with maturity dates ranging from 2012 to 2015. See Item 8, note 12 to consolidated financial statements for more information on these notes.

At their option, RAI and RJR, as applicable, may redeem any or all of their outstanding fixed-rate notes, except RJR’s 9.25% notes due in 2013, $60 million in principal amount of which was outstanding as of December 31, 2011, in whole or in part at any time, subject to the payment of a make-whole premium. At maturity on June 15, 2011, RAI repaid $400 million of floating rate notes from existing cash.

Interest Rate Swaps

From time to time, RAI and RJR use interest rate swaps to manage interest rate risk on a portion of their debt obligations. In 2008, interest rate swaps existed on $1.6 billion of fixed-rate notes. When entered into, these swaps were designated as hedges of underlying exposures. In 2009, RAI and RJR entered into offsetting floating

49

to fixed interest rate swap agreements in the notional amount of $1.5 billion with maturity dates ranging from June 1, 2012 to June 15, 2017, with the same financial institution that held a notional amount of $1.5 billion of fixed to floating interest rate swaps and had a legal right of offset. The future cash flows, established as a result of entering into the 2009 swaps, total $321 million, and will be amortized and effectively reduce net interest costs over the remaining life of the notes. Concurrent with entering the swap agreements on January 6, 2009, RAI de-designated the current swaps as fair value hedges.

On January 7, 2009, RAI and RJR terminated an interest rate swap agreement in the notional amount of $100 million with a maturity date of June 1, 2012. The resulting gain of approximately $12 million will be amortized to effectively reduce interest expense over the remaining life of the notes.

As a result of these actions, RAI and RJR effectively converted $1.6 billion of fixed-rate notes swapped to a variable rate of interest, to a fixed rate of interest of approximately 4.0%.

During September 2011, RAI and RJR terminated the original and offsetting interest rate swap agreements, each with notional amounts of $1.5 billion and maturity dates ranging from June 1, 2012 to June 15, 2017. RAI and RJR received a total of $186 million cash in exchange for foregoing the future cash inflows associated with these swaps. These actions did not change the effective fixed rate of interest associated with the underlying debt. As of December 31, 2011, RAI and RJR had no outstanding interest rate swaps.

Credit Agreement

On July 29, 2011, RAI entered into a Credit Agreement with a syndicate of lenders, providing for a four-year $750 million senior unsecured revolving credit facility, which may be increased to $1 billion at the discretion of the lenders upon the request of RAI. This agreement replaces RAI’s Fifth Amended and Restated Credit Agreement, dated as of June 28, 2007, as amended.

The Credit Agreement contains restrictive covenants that (a) limit the ability of RAI and its subsidiaries to (i) pay dividends and repurchase stock, (ii) engage in transactions with affiliates, (iii) create liens, and (iv) engage in sale-leaseback transactions involving a Principal Property, as defined in the Credit Agreement, and (b) limit the ability of RAI and its Material Subsidiaries, as such term is defined in the Credit Agreement, to sell or dispose of all or substantially all of their assets and engage in specified mergers or consolidations. The Credit Agreement also contains a restrictive covenant that limits the amount of debt that may be incurred by non-guarantor subsidiaries, together with certain financial covenants. The restrictive covenants in the Credit Agreement are subject to a number of qualifications and exceptions. The financial covenant levels in the Credit Agreement are 3.00 to 1.00 for the consolidated leverage ratio and 4.00 to 1.00 for the consolidated interest coverage ratio. In addition, the maturity date of the Credit Agreement is July 29, 2015, which date may be extended, with the agreement of the requisite lenders, in two separate one-year increments. The Credit Agreement contains customary events of default, including upon a change in control, as defined therein, that could result in the acceleration of all amounts and cancellation of all commitments outstanding under the Credit Agreement.

RAI is able to use the revolving credit facility under the Credit Agreement for borrowings and issuances of letters of credit at its option, subject to a $200 million sublimit on the aggregate amount of letters of credit. Issuances of letters of credit reduce availability under such revolving credit facility. As of December 31, 2011, there were no borrowings, and $7 million of letters of credit outstanding, under the Credit Agreement.

Under the terms of the Credit Agreement, RAI is required to pay a facility fee of between 0.20% and 0.40% per annum, based on the facility’s credit ratings, on the lender commitments in respect of the revolving credit facility thereunder.

50

Borrowings under the Credit Agreement bear interest, at the option of RAI, at a rate equal to an applicable margin, based upon the credit ratings assigned to the Credit Agreement, plus:

• the alternate base rate, which is the higher of (1) the federal funds effective rate from time to time plus 0.5%, (2) the prime rate and (3) the reserve adjusted eurodollar rate for a one month interest period plus 1%; or

• the eurodollar rate, which is the reserve adjusted rate at which eurodollar deposits for one, two, three or six months are offered in the interbank eurodollar market.

Overdue principal and, to the extent permitted by law, overdue interest, outstanding under the revolving credit facility under the Credit Agreement bear interest at a rate equal to the rate then in effect with respect to such borrowings, plus 2.0% per annum.

The obligations of RAI under the Credit Agreement are unsecured. Certain of RAI’s subsidiaries, including its Material Subsidiaries, have guaranteed, on an unsecured basis, RAI’s obligations under the Credit Agreement.

Lenders and their respective commitments in the Credit Agreement, which are several, not joint, commitments, are listed below:

Lender	Commitment
JP Morgan Chase Bank, N.A.	$	67.00
Citibank N.A.		67.00
Goldman Sachs Bank USA		67.00
Mizuho Corporate Bank, Ltd.		67.00
Morgan Stanley Bank		67.00
The Bank of Nova Scotia		67.00
AG First Farm Credit Bank		47.00
Royal Bank of Canada		47.00
The Bank of New York Mellon		47.00
Wells Fargo Bank, National Association		47.00
Farm Credit Bank of Texas		40.00
Credit Suisse AG Cayman Islands Branch		35.00
Fifth Third Bank		35.00
Northern Trust Company		25.00
United FCS, PCA dba FCS Commercial Finance Group		25.00
	$	750.00

Concerns about, or lowering of, RAI’s ratings by S&P or Moody’s could have an adverse impact on RAI’s ability to access the debt markets and could increase borrowing costs. However, given the cash balances and operating performance of RAI and its subsidiaries, RAI’s management believes that such concerns about, or lowering of, such ratings would not have a material adverse impact on RAI’s cash flows.

RAI, RJR and their affiliates were in compliance with all covenants and restrictions imposed by their indebtedness at December 31, 2011. See Item 8, note 11 to consolidated financial statements for additional information on the Credit Agreement.

Term Loan

On January 23, 2012, RAI entered into a commitment letter with certain financial institutions, pursuant to which it is expected that RAI will enter into an unsecured delay draw term loan facility, referred to as the Term

51

Loan, with the agents and lenders party thereto, with an anticipated maximum aggregate borrowing amount of up to $750 million. It is anticipated that the Term Loan will mature on December 28, 2012, and that the same RAI subsidiaries that guarantee the Credit Agreement will guarantee RAI’s obligations, on an unsecured basis, under the Term Loan. The completion of the Term Loan is subject to, among other customary conditions, securing sufficient loan commitments from lenders and the negotiation, execution and delivery of mutually satisfactory final credit documentation. It is currently anticipated that the parties will enter into the Term Loan during the first quarter of 2012, although there can be no assurance that the conditions to completing the Term Loan will be satisfied or waived by that time, or at all.

It is expected that the Term Loan will contain representations and warranties, covenants and events of default substantially similar to those contained in the Credit Agreement. It is further anticipated that borrowed amounts will bear interest in a manner similar to the Credit Agreement, as described above, except that the applicable margin is expected to be based upon RAI’s senior unsecured long-term debt credit rating. Pending any borrowings, which are expected to be made in a single drawing, and only before a commitment termination date expected to be no later than April 17, 2012, RAI will incur an unused facility commitment fee.

RAI anticipates using the proceeds of the Term Loan for general corporate purposes, including to help pay at maturity the RAI and RJR notes maturing in 2012, to make payments under the MSA and to purchase shares under its share repurchase program.

Dividends

On February 2, 2012, RAI’s board of directors declared a quarterly cash dividend of $0.56 per common share. The dividend will be paid on April 2, 2012, to shareholders of record as of March 9, 2012. On an annualized basis, the dividend rate is $2.24 per common share. The current dividend reflects RAI’s policy of paying dividends to the holders of RAI common stock in an aggregate amount that is approximately 80% of RAI’s annual consolidated net income.

Stock Repurchases

On November 14, 2011, the board of directors of RAI authorized the repurchase, from time to time on or before mid-2014, of up to $2.5 billion of outstanding shares of RAI common stock in open-market or privately negotiated transactions. The repurchases are subject to prevailing market and business conditions, and the program may be terminated or suspended at any time. In connection with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI’s common stock. RAI, B&W and BAT also entered into Amendment No. 3 to the governance agreement, pursuant to which RAI has agreed that, so long as B&W’s ownership interest has not dropped below 25%, if RAI issues shares of its common stock or any other RAI equity security to certain designated persons, including its directors, officers or employees, then RAI will repurchase a number of shares of outstanding RAI common stock so that the number of outstanding shares of RAI common stock are not increased, and B&W’s ownership interest is not decreased, by such issuance after taking into account such repurchase. In addition, RAI repurchases shares of its common stock forfeited with respect to the tax liability associated with certain stock option exercises and vesting of restricted stock grants under the LTIP.

Due to RAI’s incorporation in North Carolina, which does not recognize treasury shares, the shares repurchased are cancelled at the time of repurchase. As of December 31, 2011, RAI had repurchased and cancelled 6,776,637 shares of RAI common stock for $276 million under the above share repurchase program.

Additionally, during 2011, at a cost of $6 million, RAI purchased 162,257 shares that were forfeited with respect to tax liabilities associated with restricted stock vesting under its LTIP.

52

Capital Expenditures

RAI’s operating subsidiaries’ recorded cash capital expenditures of $190 million, $174 million and $141 million in 2011, 2010 and 2009, respectively. Of the 2011 amount, $55 million related to RJR Tobacco, $106 million related to American Snuff and $7 million related to Santa Fe. RJR Tobacco plans to spend $65 million to $75 million for capital expenditures during 2012, primarily on non-discretionary business requirements, and American Snuff plans to spend $20 million to $30 million in 2012, primarily on non-discretionary capacity projects for the Memphis, Tennessee and Clarksville, Tennessee facilities. Santa Fe plans to spend $7 million to $12 million in 2012, primarily on non-discretionary business requirements for manufacturing and storage facilities. Capital expenditures are funded primarily by cash flows from operations. RAI’s operating subsidiaries’ capital expenditure programs are expected to continue at a level sufficient to support their strategic and operating needs. There were no material long-term commitments for capital expenditures as of December 31, 2011.

Retirement Benefits

RAI assessed the asset allocation and investment strategy of its pension plans and is phasing in appropriate changes to balance funded status, interest rate risk and asset returns. These changes will reduce the pension fund’s exposure to equities and increase exposure to fixed income. As a result of changes to the asset allocation and investment strategy, RAI lowered the expected long-term return on pension assets, referred to as the ELTRA, to 7.75% in 2011, from 8.25% in 2010 and will further lower it to 7.00% in 2012. The ELTRA, asset allocation, current asset performance and the discount rate may impact the funded status of RAI’s pension plans. As a result, to improve the funded status, RAI contributed $220 million to the pension assets in 2011.

In 2012, RAI plans to contribute $309 million to the pension plans, and the pension income is expected to be $43 million.

RAI’s fixed income exposure includes debt securities issued by European countries whose S&P credit rating is AA+ or below and also debt securities issued by other entities domiciled in those same countries. The countries include France, Belgium, Spain, Ireland, Italy, Russia and Greece. RAI’s net exposure to this group of countries is 3.3%, which is comprised of 2.6% in cash bonds and 0.7% in credit default swap contracts. The total includes both sovereign and non-sovereign exposure. France is RAI’s single largest net exposure at 1.7%.

Income Taxes

At December 31, 2011, RAI had a net deferred tax asset of $434 million. RAI has determined that a valuation allowance of $33 million is required to fully offset a deferred tax asset related to the federal capital loss carryforward resulting from the sale of Lane. RAI believes it is unlikely that this deferred tax asset will be realized though the expected generation of future net capital gains. No valuation allowance has been provided on other deferred tax assets as RAI believes it is more likely than not that all of such deferred tax assets will be realized through the expected generation of future taxable income.

Litigation and Settlements

As discussed in Item 8, note 13 to consolidated financial statements, various legal proceedings or claims, including litigation claiming that lung cancer and other diseases, as well as addiction, have resulted from the use of, or exposure to, RAI’s operating subsidiaries’ products, and seeking damages in amounts ranging into the hundreds of millions or even billions of dollars, are pending or may be instituted against RJR Tobacco, American Snuff Co. or their affiliates, including RAI or RJR, or indemnitees, including B&W. Unfavorable judgments have been returned in a number of tobacco-related cases and state enforcement actions. As of December 31, 2011, RJR Tobacco had paid approximately $18 million since January 1, 2009, related to unfavorable smoking and health litigation judgments. During 2011, RJR Tobacco paid $139 million related to an unfavorable medical monitoring and smoking cessation case.

53

In particular, in Engle v. R. J. Reynolds Tobacco Co., the Florida Supreme Court issued a ruling that, while determining that the case could not proceed further as a class action, permitted members of the Engle class to file individual claims, including claims for punitive damages, through January 11, 2008. RJR Tobacco refers to these cases as the Engle Progeny cases. RJR Tobacco has been served as of December 31, 2011 in 6,561 of these cases on behalf of approximately 7,852 plaintiffs. The Engle Progeny cases have resulted and will continue to result in increased litigation and trial activity and increased expenses. For a more complete description of the Engle Progeny cases, see “— Litigation Affecting the Cigarette Industry — Overview” and “— Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements.

Also, the consolidated action, In re: Tobacco Litigation Individual Personal Injury Cases, is pending in West Virginia, against both RJR Tobacco and B&W. This case consists of 577 plaintiffs and will be tried in a single proceeding. On February 3, 2010 and June 8, 2010, mistrials were granted due to the inability to seat a jury. Trial began again in October 2011, but the court declared a mistrial on November 8, 2011. For a more complete description of this case, see “— Litigation Affecting the Cigarette Industry — West Virginia IPIC” in Item 8, note 13 to consolidated financial statements.

Finally, in Scott v. American Tobacco Co., a Louisiana state court class action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, a state court of appeals entered an amended judgment in 2010, holding the defendants jointly and severally liable for funding the cost of a court-supervised smoking cessation program and ordered the defendants to deposit roughly $242 million plus interest into a trust to fund the program. The defendants’ petition for writ of certiorari in the U.S. Supreme Court was denied on June 27, 2011. RJR Tobacco accrued $139 million, the portion of the judgment and interest allocated to RJR Tobacco and B&W, in the second quarter of 2011. RJR Tobacco paid the judgment in August 2011. For more information on the Scott case, see “— Litigation Affecting the Cigarette Industry — Class-Action Suits — Medical Monitoring and Smoking Cessation Case” in Item 8, note 13 to consolidated financial statements.

RAI’s management continues to conclude that the loss of any particular smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular claim concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual case-by-case basis, is not probable or estimable, except for four Engle Progeny cases described in “— Litigation Affecting the Cigarette Industry — Engle and Engle Progeny Cases” in Item 8, note 13 to consolidated financial statements. RAI and its subsidiaries believe that they have valid bases for appeal of adverse verdicts against them and have valid defenses to all actions and intend to defend all actions vigorously. Nonetheless, the possibility of material losses related to tobacco litigation is more than remote. Litigation is subject to many uncertainties, and generally it is not possible to predict the outcome of the litigation pending against RJR Tobacco, American Snuff Co. or their affiliates or indemnitees, or to reasonably estimate the amount or range of any possible loss. Moreover, notwithstanding the quality of defenses available to it and its affiliates in tobacco-related litigation matters, it is possible that RAI’s consolidated results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending or future litigation matters or difficulties in obtaining the bonds required to stay execution of judgments on appeal.

In 1998, RJR Tobacco, B&W and the other major U.S. cigarette manufacturers entered into the MSA with attorneys general representing most U.S. states, territories and possessions. As described in Item 8, note 13 to consolidated financial statements, the State Settlement Agreements impose a perpetual stream of future payment obligations on RJR Tobacco and the other major U.S. cigarette manufacturers and place significant restrictions on their ability to market and sell cigarettes in the future. For more information related to historical and expected settlement expenses and payments under the State Settlement Agreements, see “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements” in Item 8, note 13 to consolidated financial statements. The State Settlement Agreements have materially adversely affected RJR Tobacco’s shipment volumes. RAI believes that these settlement obligations may materially adversely affect the results of operations, cash flows or financial position of RAI and RJR Tobacco in future periods. The degree of the adverse impact will depend, among other things, on the rate of decline in U.S. cigarette sales in the premium

54

and value categories, RJR Tobacco’s share of the domestic premium and value cigarette categories, and the effect of any resulting cost advantage of manufacturers not subject to the State Settlement Agreements.

RJR Tobacco and certain of the other participating manufacturers under the MSA are currently involved in litigation with the settling states with respect to the availability for certain market years of a downward adjustment to the annual MSA settlement payment obligation, known as the NPM Adjustment. RJR Tobacco has disputed a total of $3.9 billion for the years 2003 through 2010. For more information related to this litigation, see “— Litigation Affecting the Cigarette Industry — State Settlement Agreements — Enforcement and Validity; Adjustments” Item 8, note 13 to consolidated financial statements.

Governmental Activity

The marketing, sale, taxation and use of tobacco products have been subject to substantial regulation by government and health officials for many years. In 2012, it is likely that the U.S. Congress will address the issue of RYO machines and the designation of retail entities using such machines as “tobacco manufacturers.” Such RYO-sourced tobacco products currently benefit from lower excise taxes, facilitating lower pricing and increased competition for non-RYO manufacturers. In addition, various state governments have adopted or are considering, among other things, legislation and regulations that would:

• significantly increase their taxes on tobacco products;

• restrict displays, advertising and sampling of tobacco products;

• raise the minimum age to possess or purchase tobacco products;

• restrict or ban the use of menthol in cigarettes or prohibit mint or wintergreen as a flavor in smokeless tobacco products;

• require the disclosure of ingredients used in the manufacture of tobacco products;

• require the disclosure of nicotine yield information for cigarettes;

• impose restrictions on smoking in public and private areas; and

• restrict the sale of tobacco products directly to consumers or other unlicensed recipients, including over the Internet.

Together with manufacturers’ price increases in recent years and substantial increases in state and federal taxes on tobacco products, these developments have had and will likely continue to have an adverse effect on the sale of tobacco products.

Cigarettes and other tobacco products are subject to substantial taxes in the United States. On February 4, 2009, President Obama signed into law, effective April 1, 2009, an increase of $0.62 in the excise tax per pack of cigarettes, and significant tax increases on other tobacco products, to fund expansion of the State Children’s Health Insurance Program. Under these federal tax increases:

• the federal excise tax per pack of 20 cigarettes increased to $1.01; and

• the federal excise tax rate for chewing tobacco increased $0.3083 per pound to $0.5033 per pound, and for snuff increased $0.925 per pound to $1.51 per pound.

55

All states and the District of Columbia currently impose cigarette excise taxes at levels ranging from $0.17 per pack in Missouri to $4.35 per pack in New York. As of December 31, 2011, the weighted average state cigarette excise tax per pack, calculated on a 12-month rolling average basis, was approximately $1.22, compared with the 12-month rolling average of $1.24 as of December 31, 2010. During 2011, two states and the District of Columbia passed cigarette excise tax increases, and a number of other states are considering an increase in their cigarette excise taxes for 2012. In addition, during 2011, one state passed a cigarette excise tax decrease. Certain city and county governments, such as New York and Chicago, also impose substantial excise taxes on cigarettes sold in those jurisdictions.

Forty-nine states and the District of Columbia also subject smokeless tobacco to excise taxes, and the Commonwealth of Pennsylvania, the singular exception, may consider such a tax during its 2012 legislative session. As of December 31, 2011,

• 29 states taxed moist snuff on an ad valorem basis, at rates ranging from 5% in South Carolina to 100% in Wisconsin;

• 18 states had weight-based taxes on moist snuff, ranging from $0.02 for cans weighing between ⁵/₈ of an ounce and 1⁵/₈ ounces in Alabama to $2.02 per ounce in Maine; and

• two states imposed a unit tax on moist snuff: Kentucky with a tax of $0.19 per unit, and Washington, with a tax of $2.526 per unit for units weighing 1.2 ounces or less and a proportionate amount above that weight.

Legislation to convert from an ad valorem to a weight-based tax on moist snuff was introduced in several states in 2011 and one state, Indiana, adopted such a change effective January 1, 2012. During 2011, one state adopted legislation increasing its taxes on smokeless tobacco products, and other states may adopt such increases during their 2012 legislative sessions. In addition, during 2011, one state passed legislation reducing the tax rate on smokeless tobacco.

On March 31, 2010, President Obama signed into law the Prevent All Cigarette Trafficking Act. This legislation, among other things, restricts the sale of tobacco products directly to consumers or unlicensed recipients, including over the Internet, through expanded reporting requirements, requirements for delivery, sales and penalties. It is not anticipated that this legislation will have a material adverse effect on the sale of tobacco products by RAI’s operating companies.

In 1964, the Report of the Advisory Committee to the Surgeon General of the U.S. Public Health Service concluded that cigarette smoking was a health hazard of sufficient importance to warrant appropriate remedial action. Since 1966, federal law has required a warning statement on cigarette packaging, and cigarette advertising in other media also is required to contain a warning statement. Since 1971, television and radio advertising of cigarettes has been prohibited in the United States.

The warnings currently required on cigarette packages and advertisements are:

• “SURGEON GENERAL’S WARNING: Smoking Causes Lung Cancer, Heart Disease, Emphysema, And May Complicate Pregnancy;”

• “SURGEON GENERAL’S WARNING: Quitting Smoking Now Greatly Reduces Serious Risks to Your Health;”

• “SURGEON GENERAL’S WARNING: Smoking By Pregnant Women May Result in Fetal Injury, Premature Birth, And Low Birth Weight;” and

• “SURGEON GENERAL’S WARNING: Cigarette Smoke Contains Carbon Monoxide.”

56

As noted below, the FDA has proposed regulations that would revise the foregoing warnings.

Since the initial report in 1964, the Secretary of Health, Education and Welfare, now the Secretary of Health and Human Services, and the Surgeon General have issued a number of other reports which purport to find the nicotine in cigarettes addictive and to link cigarette smoking and exposure to cigarette smoke with certain health hazards, including various types of cancer, coronary heart disease and chronic obstructive lung disease. These reports have recommended various governmental measures to reduce the incidence of smoking. In 1992, the federal Alcohol, Drug Abuse and Mental Health Act was signed into law. This act required states to adopt a minimum age of 18 for purchase of tobacco products and to establish a system to monitor, report and reduce the illegal sale of tobacco products to minors in order to continue receiving federal funding for mental health and drug abuse programs. In 1996, the U.S. Department of Health and Human Services announced regulations implementing this legislation. And in 2006, the Surgeon General released a report entitled “The Health Consequences of Involuntary Exposure to Tobacco Smoke.” Among its conclusions, the report found the following: exposure of adults to secondhand smoke causes coronary heart disease and lung cancer, exposure of children to secondhand smoke results in an increased risk of sudden infant death syndrome, acute respiratory infections, ear problems and more severe asthma; and that there is no risk-free level of exposure to secondhand smoke.

In 1986, Congress enacted the Comprehensive Smokeless Tobacco Health Education Act of 1986, which, among other things, required health warning notices on smokeless tobacco packages and advertising and prohibited the advertising of smokeless tobacco products on any medium of electronic communications subject to the jurisdiction of the Federal Communications Commission. In 2009, the FDA Tobacco Act (discussed below) amended the Comprehensive Smokeless Tobacco Health Education Act to require the following warnings on smokeless tobacco packaging and advertising, displayed randomly and as equally as possible in each 12-month period:

• “WARNING: THIS PRODUCT CAN CAUSE MOUTH CANCER;”

• “WARNING: THIS PRODUCT CAN CAUSE GUM DISEASE AND TOOTH LOSS;”

• “WARNING: THIS PRODUCT IS NOT A SAFE ALTERNATIVE TO CIGARETTES;” and

• “WARNING: SMOKELESS TOBACCO IS ADDICTIVE.”

On June 22, 2009, President Obama signed into law the Family Smoking Prevention and Tobacco Control Act, referred to as the FDA Tobacco Act, which grants the FDA broad authority over the manufacture, sale, marketing and packaging of tobacco products.

The following provisions of the FDA Tobacco Act took effect upon passage:

• no charitable distribution of tobacco products;

• prohibitions on statements that would lead consumers to believe that a tobacco product is approved, endorsed, or deemed safe by the FDA;

• pre-market approval by the FDA for claims made with respect to reduced risk or reduced exposure products; and

• prohibition on the marketing of tobacco products in conjunction with any other class of product regulated by the FDA.

57

In addition, pursuant to the FDA Tobacco Act:

• as of September 20, 2009, tobacco manufacturers were banned from selling cigarettes with characterizing flavors (other than menthol, which under the FDA Tobacco Act is specifically exempt as a characterizing flavor, but the impact of which on public health will be studied as discussed below);

• on February 28, 2010, all manufacturers registered with the FDA their domestic manufacturing facilities as well as all cigarette and smokeless tobacco products sold in the United States;

• on March 18, 2010, the FDA reissued regulations addressing advertising and marketing restrictions that were originally promulgated in 1996;

• as of April 30, 2010, manufacturers were required to produce health-related documents generated from and after June 22, 2009 through December 31, 2009 (the FDA has interpreted the FDA Tobacco Act as establishing an ongoing requirement to submit health-related documents; however, the FDA has not yet established a timetable for further production);

• as of June 22, 2010, manufacturers were required to make by-brand ingredient submissions, place different and larger warnings on packaging and advertising for smokeless tobacco products and eliminate the use of descriptors on tobacco products, such as “low-tar” and “lights”;

• as of March 22, 2011, manufacturers were required to submit documentation to obtain FDA clearance for cigarettes and smokeless tobacco products commercially launched after February 15, 2007;

• on June 22, 2011, the FDA issued a final regulation for the imposition of larger, graphic health warnings on cigarette packaging and advertising, which will take effect September 22, 2012;

• on July 5, 2011, the FDA issued a final regulation setting forth a process by which manufacturers may seek an exemption to the substantial equivalence review process for tobacco additive changes;

• on August 16, 2011, the FDA announced that it would inspect every domestic establishment that manufactured cigarettes, cigarette tobacco, roll-your-own tobacco or smokeless tobacco products once in a two-year cycle beginning on October 1, 2011; and

• on December 14, 2011, the Institute of Medicine, as required under the FDA Tobacco Act, issued a report entitled “Scientific Standards for Studies on Modified Risk Tobacco Products” for consideration by the FDA as it develops regulation and or guidance regarding the scientific studies and surveillance relevant to an assessment of modified risk tobacco product submissions.

On a going forward basis, various provisions under the FDA Tobacco Act and regulations to be issued under the FDA Tobacco Act will become effective and will:

• require manufacturers to report harmful constituents;

• require manufacturers to test ingredients and constituents identified by the FDA and disclose this information to the public;

• prohibit use of tobacco containing a pesticide chemical residue at a level greater than allowed under Federal law;

• establish “good manufacturing practices” to be followed at tobacco manufacturing facilities;

58

• authorize the FDA to place more severe restrictions on the advertising, marketing and sale of tobacco products;

• permit inconsistent state regulation of labeling and advertising and eliminate the existing federal preemption of such regulation;

• authorize the FDA to require the reduction of nicotine and the reduction or elimination of other constituents; and

• grant the FDA the regulatory authority to impose broad additional restrictions.

The U.S. Congress did limit the FDA’s authority in two areas, prohibiting it from:

• banning all tobacco products; and

• requiring the reduction of nicotine yields of a tobacco product to zero.

A “Center for Tobacco Products” has been established within the FDA, funded through quarterly user fees that will be assessed against tobacco product manufacturers and importers based on market share. The total amount of user fees to be collected over the first ten years will be approximately $5.4 billion. The expense related to the FDA user fees of RAI’s operating companies for 2011 was $120 million.

Within the Center, a Tobacco Products Scientific Advisory Committee, referred to as the TPSAC, was established on March 22, 2010, to provide advice, information and recommendations with respect to the safety, dependence or health issues related to tobacco products. The TPSAC is scheduled to meet quarterly to address matters brought to it by the Center as well as those required of it by the Act, including:

• a recommendation on modified risk applications;

• a recommendation as to whether there is a threshold level below which nicotine yields do not produce dependence;

• a report on the impact of the use of menthol in cigarettes on the public health; and

• a report on the impact of dissolvable tobacco products on the public health.

The TPSAC held meetings on three occasions in the first quarter of 2011 to discuss the impact on the use of menthol in cigarettes on the public health. At a meeting held on March 18, 2011, the TPSAC presented its final report on the use of menthol, which concluded that removal of menthol cigarettes from the marketplace would benefit public health in the United States. At a meeting on July 21, 2011, the TPSAC met to discuss and formally adopt editorial changes to the menthol report proposed by the committee members. The FDA is not required to follow the TPSAC’s recommendations, and the agency has not yet taken any action with respect to menthol use. The FDA issued a status report on the issue on June 27, 2011, indicating that the agency will prepare an independent, peer-reviewed analysis of the available science on menthol and make a report available for public comment in the Federal Register.

At its July 21 and 22, 2011 meetings, the TPSAC convened its discussion of the nature and impact of the use of dissolvable tobacco products on public health. The TPSAC will issue its report and recommendations with respect to dissolvable tobacco products in March 2012.

A subcommittee of the TPSAC also met in June and July, 2010, to discuss recommendations for the development of a list of harmful and potentially harmful tobacco constituents. At a meeting held in August 2010,

59

the subcommittee provided to the full TPSAC its recommendations and a draft initial list of harmful and potentially harmful tobacco constituents, which the TPSAC adopted. The FDA has not yet taken action on these recommendations.

On February 25, 2011, RJR Tobacco, Lorillard, Inc. and Lorillard Tobacco Company jointly filed in the U.S. District Court for the District of Columbia a lawsuit, Lorillard, Inc. v. U.S. Food and Drug Administration, challenging the composition of the TPSAC. For additional information concerning this case, see “— Litigation Affecting the Cigarette Industry — Other Cases” in Item 8, note 13 to consolidated financial statements.

In February 2010, RJR Tobacco received a letter from the Center for Tobacco Products (which letter is available on the FDA’s web site) requesting, in connection with the TPSAC’s study of dissolvable tobacco products, certain information regarding the perception and use of CAMEL Dissolvables. RJR Tobacco, which markets its tobacco products only to adult tobacco users, responded to the FDA’s information request on April 1, 2010. In June 2011, the Center sent letters to all registered tobacco manufacturers, including RJR Tobacco, SFNTC and American Snuff Co., requesting documents and information concerning dissolvable tobacco products, particularly health-related documents and information on marketing research and practices. The letters indicate that this information also will be used to support the TPSAC’s study of dissolvable tobacco products. SFNTC and American Snuff Co. responded to the FDA’s information request on August 1, 2011, and RJR Tobacco completed submission to the FDA on September 13, 2011.

In May 2010, the Center for Tobacco Products sent letters to various tobacco manufacturers, including RJR Tobacco, SFNTC, American Snuff Co. and Lane, containing a document request for certain information concerning the use of menthol in cigarettes. Each of these companies responded to the FDA’s information request on August 26, 2010.

On August 31, 2009, RJR Tobacco and American Snuff Co. joined other tobacco manufacturers and a tobacco retailer in filing a lawsuit, Commonwealth Brands, Inc. v. United States of America, in the U.S. District Court for the Western District of Kentucky, challenging certain provisions of the FDA Tobacco Act that severely restrict the few remaining channels available to communicate with adult tobacco consumers. RAI believes these provisions cannot be justified on any basis consistent with the demands of the First Amendment. The suit does not challenge the U.S. Congress’s decision to give the FDA regulatory authority over tobacco products, nor does it challenge the vast majority of the provisions of the new law. For further information regarding this case, see “—Litigation Affecting the Cigarette Industry — Other Cases” in Item 8, note 13 to consolidated financial statements.

On August 16, 2011, RJR Tobacco and SFNTC joined other tobacco manufacturers in filing a lawsuit, R.J. Reynolds Tobacco Company v. U.S. Food and Drug Administration, in the U.S. District Court for the District of Columbia, challenging the final regulation specifying nine new graphic “warnings” pursuant to the FDA Tobacco Act that violates the plaintiffs’ rights under the First Amendment to the U.S. Constitution and the Administrative Procedure Act, referred to as the APA. For additional information concerning this case, see “— Litigation Affecting the Cigarette Industry — Other Cases” in Item 8, note 13 to consolidated financial statements.

It is likely that the FDA Tobacco Act could result in a decrease in cigarette and smokeless tobacco sales in the United States, including sales of RJR Tobacco’s, American Snuff Co.’s and SFNTC’s brands, and an increase in costs to RJR Tobacco, American Snuff Co. and SFNTC that could have a material adverse effect on RAI’s financial condition, results of operations and cash flows. RAI believes that such regulation may adversely affect the ability of its operating subsidiaries to compete against their larger competitor, which may be able to more quickly and cost-effectively comply with these new rules and regulations. The FDA has yet to issue guidance with respect to many provisions of the FDA Tobacco Act, which may result in less efficient compliance efforts. Finally, the ability of RAI’s operating companies to gain efficient market clearance for new tobacco products could be affected by FDA rules and regulations.

60

Legislation imposing various restrictions on public smoking also has been enacted by 49 states and many local jurisdictions, and many employers have initiated programs restricting or eliminating smoking in the workplace. A number of states have enacted legislation designating a portion of increased cigarette excise taxes to fund either anti-smoking programs, health-care programs or cancer research. In addition, educational and research programs addressing health-care issues related to smoking are being funded from industry payments made or to be made under settlements with state attorneys general. Federal law prohibits smoking in scheduled passenger aircraft, and the U.S. Interstate Commerce Commission has banned smoking on buses transporting passengers interstate. Certain common carriers have imposed additional restrictions on passenger smoking.

All states and Washington, D.C. have enacted fire standards compliance legislation, adopting the same testing standard first adopted by New York in 2003, a standard requiring cigarettes to achieve specified test results when placed on ten layers of filter paper in controlled laboratory conditions. The cigarettes that RAI’s operating companies sell in these jurisdictions comply with this standard, with RJR Tobacco, in recognition of legislative trends and in an effort to increase productivity and reduce complexity, having voluntarily converted all of its brands to fire standard compliant paper by the end of 2009.

In July 2007, the State of Maine became the first state to enact a statute that prohibits the sale of cigarettes and cigars that have a characterizing flavor. The legislation defines characterizing flavor as “a distinguishable taste or aroma that is imparted to tobacco or tobacco smoke either prior to or during consumption, other than a taste or aroma from tobacco, menthol, clove, coffee, nuts or peppers.” In October 2008, the State of New Jersey passed a similar ban on flavored cigarettes with a similar definition of characterizing flavor but excluding only tobacco, menthol or clove. Additionally, New Jersey extended the ban not only to whether the product itself has a characterizing flavor as part of the aroma of the product or smoke, but also if the product was marketed or advertised as producing such a flavor, taste or aroma. During 2009, New York City passed legislation that bans characterizing flavors in tobacco products other than cigarettes beginning on February 25, 2010. An exemption applies if the characterizing flavor is tobacco, menthol, mint or wintergreen. The New York City rule is the subject of a pending federal court challenge by certain industry participants, on the basis that the local law is preempted by the FDA Tobacco Act and violates the Commerce Clause of the U.S. Constitution. Similar bills banning characterizing flavors in tobacco products are pending in other states.

A price differential exists between cigarettes manufactured for sale abroad and cigarettes manufactured for sale in the United States. Consequently, a domestic gray market has developed in cigarettes manufactured for sale abroad, but instead diverted for domestic sales that compete with cigarettes that RJR Tobacco manufactures for domestic sale. The U.S. federal government and all states, except Massachusetts, have enacted legislation prohibiting the sale and distribution of gray market cigarettes. In addition, RJR Tobacco has taken legal action against distributors and retailers who engage in such practices.

RJR Tobacco expects to benefit from certain state legislative activity aimed at leveling the playing field between “original participating manufacturers” under the MSA and “nonparticipating manufacturers” under the MSA, referred to as NPMs. Forty-six states have passed legislation to ensure NPMs are making required escrow payments. Under this legislation, a state would only permit distribution of brands by manufacturers who are deemed by the states to be MSA-compliant. Failure to make escrow payments could result in the loss of an NPM’s ability to sell tobacco products in a respective state.

Additionally, 45 states have enacted legislation that closes a loophole in the MSA. The loophole allows NPMs that concentrate their sales in a single state, or a limited number of states, to recover most of the funds from their escrow accounts. To obtain the refunds, the manufacturers must establish that their escrow deposit was greater than the amount the state would have received had the manufacturer been a “subsequent participating manufacturer” under the MSA, that is, the state’s “allocable share.” The National Association of Attorneys General, referred to as NAAG, has endorsed adoption of the allocable share legislation needed to eliminate this loophole.

61

Finally, four states, Alaska, Michigan, Minnesota and Utah, have enacted “equity assessments” on NPMs’ products. This legislative initiative has not been endorsed by NAAG.

Forty-two states by statute or court rule have limited, and several additional states are considering limiting, the amount of the bonds required to file an appeal of an adverse judgment in state court. The limitation on the amount of such bonds generally ranges from $1 million to $150 million. Bonding statutes in 37 states allow defendants that are subject to large adverse judgments, such as cigarette manufacturers, to reasonably bond such judgments and pursue the appellate process. In five other states and Puerto Rico, the filing of a notice of appeal automatically stays the judgment of the trial court.

In 2003, the World Health Organization adopted a broad tobacco-control treaty. The treaty recommends and requires enactment of legislation establishing specific actions to prevent youth smoking, restrict and gradually eliminate tobacco products marketing, provide greater regulation and disclosure of ingredients, increase the size and scope of package warning labels to cover at least 30% of each package and include graphic pictures on packages. The treaty entered into force on February 27, 2005 — 90 days after ratification by the 40th country. In February 2006, the first session of the Conference of the Parties, referred to as the COP, occurred. Since then, the COP has met several times and adopted guidelines with respect to various provisions of the tobacco control treaty. Although the U.S. delegate to the World Health Organization voted for the treaty in May 2003, and the Secretary for Health and Human Services signed the document in May 2004, the Bush Administration did not send the treaty to the U.S. Senate for ratification. Ratification by the United States could lead to broader regulation of the industry.

It is not possible to determine what additional federal, state or local legislation or regulations relating to smoking or cigarettes will be enacted or to predict the effect of new legislation or regulations on RJR Tobacco or the cigarette industry in general, but any new legislation or regulations could have an adverse effect on RJR Tobacco or the cigarette industry in general. Similarly, it is not possible to determine what additional federal, state or local legislation or regulations relating to smokeless tobacco products will be enacted or to predict the effect of new regulation on American Snuff Co. or smokeless tobacco products in general, but any new legislation or regulations could have an adverse effect on American Snuff Co. or smokeless tobacco products in general.

Tobacco Buyout Legislation

For information relating to tobacco buyout legislation, see “— Tobacco Buyout Legislation and Related Litigation” in Item 8, note 13 to consolidated financial statements.

Other Contingencies

For information relating to other contingencies of RAI, RJR, RJR Tobacco, American Snuff Co. and SFNTC, see “— Other Contingencies” in Item 8, note 13 to consolidated financial statements.

Off-Balance Sheet Arrangements

RAI has no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on its financial position, results of operations, liquidity, capital expenditures or capital resources.

Cautionary Information Regarding Forward-Looking Statements

Statements included in this report that are not historical in nature are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements

62

regarding future events or the future performance or results of RAI and its subsidiaries inherently are subject to a variety of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include:

• the substantial and increasing taxation and regulation of tobacco products, including the regulation of tobacco products by the FDA;

• the possibility that the FDA will issue a regulation prohibiting menthol as a flavor in cigarettes or prohibit mint or wintergreen as a flavor in smokeless tobacco products;

• decreased sales resulting from the future issuance of “corrective communications,” required by the order in the U.S. Department of Justice case, on five subjects, including smoking and health, and addiction;

• various legal actions, proceedings and claims relating to the sale, distribution, manufacture, development, advertising, marketing and claimed health effects of tobacco products that are pending or may be instituted against RAI or its subsidiaries;

• the potential difficulty of obtaining bonds as a result of litigation outcomes and the challenges to the Florida bond statute applicable to the Engle Progeny cases;

• the possibility of being required to pay various adverse judgments in the Engle Progeny and/or other litigation;

• the substantial payment obligations with respect to cigarette sales, and the substantial limitations on the advertising and marketing of cigarettes (and RJR Tobacco’s smoke-free tobacco products) under the State Settlement Agreements;

• the continuing decline in volume in the U.S. cigarette industry and RAI’s dependence on the U.S. cigarette industry;

• concentration of a material amount of sales with a single customer or distributor;

• competition from other manufacturers, including industry consolidations or any new entrants in the marketplace;

• increased promotional activities by competitors, including manufacturers of deep-discount cigarette brands;

• the success or failure of new product innovations and acquisitions;

• the responsiveness of both the trade and consumers to new products, marketing strategies and promotional programs;

• the ability to achieve efficiencies in the businesses of RAI’s operating companies without negatively affecting financial or operating results;

• the reliance on a limited number of suppliers for certain raw materials;

• the cost of tobacco leaf, and other raw materials and other commodities used in products;

• the effect of market conditions on interest rate risk, foreign currency exchange rate risk and the return on corporate cash;

63

• changes in the financial position or strength of lenders participating in RAI’s credit facility;

• the impairment of goodwill and other intangible assets, including trademarks;

• the effect of market conditions on the performance of pension assets or any adverse effects of any new legislation or regulations changing pension expense accounting or required pension funding levels;

• the substantial amount of RAI debt;

• the credit rating of RAI and its securities;

• any restrictive covenants imposed under RAI’s debt agreements;

• the possibility of natural or man-made disasters or other disruptions that may adversely affect manufacturing or other operations and other facilities;

• the significant ownership interest of B&W, RAI’s largest shareholder, in RAI and the rights of B&W under the governance agreement between the companies;

• the expiration of the standstill provisions of the governance agreement on July 30, 2014;

• a termination of the governance agreement or certain provisions of it in accordance with its terms, including the limitations on B&W’s representation on RAI’s Board and its Board committees; and

• RAI’s shareholder rights plan not applying to BAT except in limited circumstances.

For a further discussion of these and other risks and uncertainties, see Part I, Item 1A. Risk Factors.

Due to these uncertainties and risks, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as provided by federal securities laws, RAI is not required to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Item  7A.   Quantitative and Qualitative Disclosures about Market Risk

Market risk represents the risk of loss that may impact the consolidated results of operations, cash flows and financial position due to adverse changes in financial market prices and rates. RAI and its subsidiaries are exposed to interest rate risk directly related to their normal investing and funding activities. In addition, RAI and its subsidiaries have immaterial exposure to foreign currency exchange rate risk related primarily to purchases and foreign operations denominated in euros, British pounds, Swiss francs, Swedish krona, Chinese renminbi and Japanese yen. RAI and its subsidiaries have established policies and procedures to manage their exposure to market risks.

64

The table below provides information, as of December 31, 2011, about RAI’s financial instruments that are sensitive to changes in interest rates. The table presents notional amounts and weighted average interest rates by contractual maturity dates for the years ending December 31:

	2012			2013			2014		2015			2016			Thereafter			Total			Fair Value(1)
Investments:
Variable Rate	$	1,485		$	—		$	—	$	—		$	—		$	56		$	1,541		$	1,541
Average Interest Rate		0.1	%		—			—		—			—			2.4	%		0.2	%		—
Fixed-Rate		—			—			—		—			—		$	7		$	7		$	7
Average Interest Rate(2)		—			—			—		—			—			4.7	%		4.7	%		—
Debt:
Fixed-Rate	$	450		$	685		$	—	$	200		$	775		$	1,400		$	3,510		$	3,978
Average Interest Rate(2)		7.3	%		7.4	%		—		7.3	%		7.6	%		7.1	%		7.3	%		—

⁽¹⁾ Fair values are based on current market rates available or on rates available for instruments with similar terms and maturities and quoted fair values.

⁽²⁾ Based upon coupon interest rates for fixed-rate indebtedness.

RAI’s exposure to foreign currency transactions was not material to results of operations for the year ended December 31, 2011, but may become material in future periods in relation to activity associated with RAI’s international operations. RAI currently has no hedges for its exposure to foreign currency.

65

Item 8. Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders

Reynolds American Inc.:

We have audited the accompanying consolidated balance sheets of Reynolds American Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, shareholders’ equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Reynolds American Inc. and subsidiaries as of December 31, 2011 and 2010, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2011, in conformity with U.S. generally accepted accounting principles.

As discussed in Note 1 to the consolidated financial statements, the Company has elected to change its method of accounting for pension and postretirement benefits in 2011.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Reynolds American Inc.’s internal control over financial reporting as of December 31, 2011, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 15, 2012, expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

/s/    KPMG, LLP

Greensboro, North Carolina

February 15, 2012

66

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Securities Exchange Act of 1934. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles and includes those policies and procedures that:

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of RAI,

(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of RAI are being made only in accordance with authorizations of management and directors of RAI, and

(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of RAI’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective, can only provide reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

Management conducted an evaluation of the effectiveness of RAI’s internal control over financial reporting based on the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that RAI’s system of internal control over financial reporting was effective as of December 31, 2011.

KPMG LLP, independent registered public accounting firm, has audited RAI’s consolidated financial statements and issued an attestation report on RAI’s internal control over financial reporting as of December 31, 2011.

Dated: February 15, 2012

67

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders

Reynolds American Inc.:

We have audited Reynolds American Inc. and subsidiaries’ internal control over financial reporting as of December 31, 2011, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Reynolds American Inc.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Reynolds American Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2011, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Reynolds American Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, shareholders’ equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011, and our report dated February 15, 2012, expressed an unqualified opinion on those consolidated financial statements.

/s/    KPMG LLP

Greensboro, North Carolina

February 15, 2012

68

REYNOLDS AMERICAN INC.

CONSOLIDATED STATEMENTS OF INCOME

(Dollars in Millions, Except Per Share Amounts)

	For the Years Ended December 31,
	2011			2010			2009
Net sales(1)	$	8,062		$	8,170		$	8,015
Net sales, related party		479			381			404
Net sales		8,541			8,551			8,419
Costs and expenses:
Cost of products sold(1)		4,464			4,544			4,488
Selling, general and administrative expenses		1,606			1,480			1,517
Amortization expense		24			25			28
Asset impairment and exit charges		—			38			—
Trademark impairment charges		48			6			567
Goodwill impairment charge		—			26			—
Restructuring charge		—			—			56
Operating income		2,399			2,432			1,763
Interest and debt expense		221			232			251
Interest income		(11	)		(12	)		(19	)
Other expense, net		3			7			9
Income from continuing operations before income taxes		2,186			2,205			1,522
Provision for income taxes		780			868			567
Income from continuing operations		1,406			1,337			955
Losses from discontinued operations, net of tax		—			(216	)		—
Net income	$	1,406		$	1,121		$	955
Basic income per share:
Income from continuing operations	$	2.41		$	2.29		$	1.64
Losses from discontinued operations		—			(0.37	)		—
Net income	$	2.41		$	1.92		$	1.64
Diluted income per share:
Income from continuing operations	$	2.40		$	2.29		$	1.64
Losses from discontinued operations		—			(0.37	)		—
Net income	$	2.40		$	1.92		$	1.64
Dividends declared per share	$	2.15		$	1.84		$	1.73

⁽¹⁾ Excludes excise taxes of $4,107 million, $4,340 million and $3,927 million for the years ended December 31, 2011, 2010 and 2009, respectively.

See Notes to Consolidated Financial Statements

69

REYNOLDS AMERICAN INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Millions)

	For the Years Ended December 31,
	2011			2010			2009
Cash flows from (used in) operating activities:
Net income	$	1,406		$	1,121		$	955
Losses from discontinued operations, net of tax		—			216			—
Adjustments to reconcile to net cash flows from (used in) continuing operating activities:
Depreciation and amortization		138			151			144
Asset impairment and exit charges, net of cash payments		—			37			—
Restructuring charge, net of cash payments		(35	)		(51	)		7
Trademark impairment charges		48			6			567
Goodwill impairment charge		—			26			—
Deferred income tax expense (benefit)		100			187			(159	)
Other changes that provided (used) cash:
Accounts and other receivables		12			(3	)		—
Inventories		88			164			(49	)
Related party, net		(32	)		45			2
Accounts payable		(66	)		(17	)		(10	)
Accrued liabilities, including income taxes and other working capital		10			(64	)		(191	)
Litigation bonds		(35	)		(21	)		(23	)
Tobacco settlement		(58	)		(22	)		291
Pension and postretirement		(165	)		(715	)		(169	)
Other, net		9			205			89
Net cash flows from operating activities		1,420			1,265			1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		—			4			19
Proceeds from settlement of long-term investments		2			13			6
Capital expenditures		(190	)		(174	)		(141	)
Acquisition, net of cash acquired		—			—			(43	)
Net proceeds from sale of business		202			—			—
Proceeds from termination of joint venture		32			28			24
Other, net		14			3			12
Net cash flows from (used in) investing activities		60			(126	)		(123	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,212	)		(1,049	)		(991	)
Repurchase of common stock		(282	)		(5	)		(5	)
Repayments of long-term debt		(400	)		(300	)		(200	)
Proceeds from termination of interest rate swaps		186			—			—
Other, net		(6	)		5			4
Net cash flows used in financing activities		(1,714	)		(1,349	)		(1,192	)
Effect of exchange rate changes on cash and cash equivalents		(5	)		(11	)		6
Net cash flow related to discontinued operations, net of tax benefit		—			(307	)		—
Net change in cash and cash equivalents		(239	)		(528	)		145
Cash and cash equivalents at beginning of year		2,195			2,723			2,578
Cash and cash equivalents at end of year	$	1,956		$	2,195		$	2,723
Income taxes paid, net of refunds	$	694		$	573		$	709
Interest paid, net of capitalized interest (2011 — $3; 2010 — $3; 2009 — $1)	$	232		$	231		$	245

See Notes to Consolidated Financial Statements

70

REYNOLDS AMERICAN INC.

CONSOLIDATED BALANCE SHEETS

(Dollars in Millions)

	December 31,
	2011			2010
Assets
Current assets:
Cash and cash equivalents	$	1,956		$	2,195
Accounts receivable		101			118
Accounts receivable, related party		67			48
Other receivables		46			44
Inventories		967			1,055
Deferred income taxes, net		945			946
Prepaid expenses and other		225			195
Assets held for sale		—			201
Total current assets		4,307			4,802
Property, plant and equipment, at cost:
Land and land improvements		91			89
Buildings and leasehold improvements		748			656
Machinery and equipment		1,756			1,700
Construction-in-process		90			157
Total property, plant and equipment		2,685			2,602
Less accumulated depreciation		1,615			1,600
Property, plant and equipment, net		1,070			1,002
Trademarks and other intangible assets, net of accumulated amortization (2011 — $696; 2010 — $672)		2,602			2,675
Goodwill		8,010			8,010
Other assets and deferred charges		265			589
	$	16,254		$	17,078
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable	$	113		$	179
Tobacco settlement accruals		2,530			2,589
Due to related party		2			4
Deferred revenue, related party		42			53
Current maturities of long-term debt		457			400
Other current liabilities		1,132			1,147
Total current liabilities		4,276			4,372
Long-term debt (less current maturities)		3,206			3,701
Deferred income taxes, net		511			518
Long-term retirement benefits (less current portion)		1,759			1,668
Other noncurrent liabilities		251			309
Commitments and contingencies:
Shareholders’ equity:
Common stock (shares issued: 2011 — 576,135,199; 2010 — 583,043,872)		—			—
Paid-in capital		8,293			8,535
Accumulated deficit		(1,660	)		(1,807	)
Accumulated other comprehensive loss — (Defined benefit pension and post-retirement plans: 2011 — $(330) and 2010 — $(186), net of tax)		(382	)		(218	)
Total shareholders’ equity		6,251			6,510
	$	16,254		$	17,078

See Notes to Consolidated Financial Statements

71

REYNOLDS AMERICAN INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

AND COMPREHENSIVE INCOME

(Dollars in Millions, Except Per Share Amounts)

	Common Stock		Paid-In Capital			Accumulated Deficit			Accumulated Other Comprehensive Loss			Total Shareholders’ Equity			Comprehensive Income
Balance at December 31, 2008	$	—	$	8,463		$	(1,792	)	$	(434	)	$	6,237
Net income		—		—			955			—			955		$	955
Retirement benefits, net of $182 tax expense		—		—			—			274			274			274
Unrealized gain on investments, net of $2 tax expense		—		—			—			4			4			4
Cumulative translation adjustment and other, net of $7 tax expense		—		—			—			3			3			3
Total comprehensive income															$	1,236
Dividends — $1.73 per share		—		—			(1,010	)		—			(1,010	)
Equity incentive award plan and stock-based compensation		—		38			—			—			38
Common stock repurchased		—		(5	)		—			—			(5	)
Excess tax benefit on stock-based compensation plans		—		2			—			—			2
Balance at December 31, 2009		—		8,498			(1,847	)		(153	)		6,498
Net income		—		—			1,121			—			1,121		$	1,121
Retirement benefits, net of $102 tax benefit		—		—			—			(78	)		(78	)		(78	)
Unrealized gain on investments, net of $13 tax expense		—		—			—			21			21			21
Cumulative translation adjustment and other, net of $10 tax benefit		—		—			—			(8	)		(8	)		(8	)
Total comprehensive income															$	1,056
Dividends — $1.84 per share		—		—			(1,081	)		—			(1,081	)
Equity incentive award plan and stock-based compensation		—		40			—			—			40
Common stock repurchased		—		(5	)		—			—			(5	)
Excess tax benefit on stock-based compensation plans		—		2			—			—			2
Balance at December 31, 2010		—		8,535			(1,807	)		(218	)		6,510
Net income		—		—			1,406			—			1,406		$	1,406
Retirement benefits, net of $95 tax benefit		—		—			—			(144	)		(144	)		(144	)
Unrealized loss on investments, net of $6 tax benefit		—		—			—			(12	)		(12	)		(12	)
Cumulative translation adjustment and other, net of $4 tax benefit		—		—			—			(8	)		(8	)		(8	)
Total comprehensive income															$	1,242
Dividends — $2.15 per share		—		—			(1,259	)		—			(1,259	)
Equity incentive award plan and stock-based compensation		—		39			—			—			39
Common stock repurchased		—		(282	)		—			—			(282	)
Excess tax benefit on stock-based compensation plans		—		1			—			—			1
Balance at December 31, 2011	$	—	$	8,293		$	(1,660	)	$	(382	)	$	6,251

See Notes to Consolidated Financial Statements

72

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Business and Summary of Significant Accounting Policies

Overview

The consolidated financial statements include the accounts of Reynolds American Inc., referred to as RAI, and its wholly owned subsidiaries. RAI’s wholly owned operating subsidiaries include R. J. Reynolds Tobacco Company; American Snuff Company, LLC, referred to as American Snuff Co.; Santa Fe Natural Tobacco Company, Inc., referred to as SFNTC; and Niconovum AB.

RAI was incorporated as a holding company in the state of North Carolina on January 5, 2004, and its common stock is listed on the NYSE under the symbol “RAI.” On July 30, 2004, the U.S. assets, liabilities and operations of Brown & Williamson Tobacco Corporation, now known as Brown & Williamson Holdings, Inc., referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c., referred to as BAT, were combined with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR. These July 30, 2004, transactions generally are referred to as the B&W business combination.

References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a New Jersey corporation and a wholly owned subsidiary of RJR. References to RJR Tobacco on and subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W and R. J. Reynolds Tobacco Company, a North Carolina corporation.

RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane, Limited, referred to as Lane. During the fourth quarter of 2011, RAI elected to begin reporting the Santa Fe segment, which includes the primary operations of SFNTC. RAI has retrospectively revised segment disclosures for all periods presented. Although the operations and results of Santa Fe currently do not meet the quantitative criteria to be required to be reported, RAI management believes that reporting this segment is important to the financial statement user for additional understanding and transparency with respect to the aggregate operations and results of RAI’s subsidiaries that produce and market cigarettes in the U.S. Niconovum AB, among other RAI subsidiaries, is included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI.

As a result of the B&W business combination, Lane became a wholly owned subsidiary of RAI. On February 28, 2011, RAI completed the sale of all of the capital stock of Lane and certain other assets related to the Lane operations, to an affiliate of Scandinavian Tobacco Group A/S, referred to as STG, for net proceeds of $202 million in cash. The assets and liabilities of the disposal group were classified as held for sale as of December 31, 2010, and its results of operations were included through February 28, 2011, in income from continuing operations in the American Snuff segment.

RAI’s operating subsidiaries primarily conduct their business in the United States.

Basis of Presentation

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, referred to as GAAP, requires estimates and assumptions to be made that affect the reported amounts in the consolidated financial statements and accompanying notes. Volatile credit

73

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

and equity markets, changes to regulatory and legal environments, and consumer spending may affect the uncertainty inherent in such estimates and assumptions. Actual results could differ from those estimates. Certain reclassifications were made to conform prior years’ financial statements to the current presentation.

All dollar amounts, other than per share amounts, are presented in millions, except for amounts set forth in note 13 and as otherwise noted.

Cash and Cash Equivalents

Cash balances are recorded net of book overdrafts when a bank right-of-offset exists. All other book overdrafts are recorded in accounts payable. Cash equivalents may include money market funds, commercial paper and time deposits in major institutions to minimize investment risk. As short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase, cash equivalents have carrying values that approximate fair values.

Fair Value Measurement

RAI determines fair value of assets and liabilities using a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.

The levels of the fair value hierarchy are:

Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2: inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3: inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

Investments

Marketable securities are classified as available-for-sale and are carried at fair value. RAI reviews these investments on a quarterly basis to determine if it is probable that RAI will realize some portion of the unrealized loss and to determine the classification of the impairment as temporary or other-than-temporary. For those securities that RAI does not intend to sell and it is more likely than not that RAI will not be required to sell the securities prior to recovery, RAI recognizes the credit loss component of an other-than-temporary impairment in earnings, and recognizes the noncredit component in other comprehensive loss. All losses deemed to be other than temporarily impaired are recorded in earnings.

74

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Inventories

Inventories are stated at the lower of cost or market. The cost of tobacco inventories is determined principally under the last-in, first-out, or LIFO, method and is calculated at the end of each year. The cost of work in process and finished goods includes materials, direct labor, variable costs and overhead and full absorption of fixed manufacturing overhead. Stocks of tobacco, which have an operating cycle that exceeds 12 months due to aging requirements, are classified as current assets, consistent with recognized industry practice.

Long-lived Assets

Long-lived assets, such as property, plant and equipment, trademarks and other intangible assets with finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the book value of the asset may not be recoverable. Impairment of the carrying value of long-lived assets would be indicated if the best estimate of future undiscounted cash flows expected to be generated by the asset grouping is less than its carrying value. If an impairment is indicated, any loss is measured as the difference between estimated fair value and carrying value and is recognized in operating income.

Property, Plant and Equipment

Property, plant and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Useful lives range from 20 to 50 years for buildings and improvements, and from 3 to 30 years for machinery and equipment. The cost and related accumulated depreciation of assets sold or retired are removed from the accounts and the gain or loss on disposition is recognized in operating income.

Intangible Assets

Intangible assets include goodwill, trademarks and other intangible assets and are capitalized when acquired. The determination of fair value involves considerable estimates and judgment. In particular, the fair value of a reporting unit involves, among other things, developing forecasts of future cash flows, determining an appropriate discount rate, and when goodwill impairment is implied, determining the fair value of individual assets and liabilities, including unrecorded intangibles. Although RAI believes it has based its impairment testing and impairment charges on reasonable estimates and assumptions, the use of different estimates and assumptions could result in materially different results. Generally, if the current competitive or regulatory environment worsens or RAI’s operating companies’ strategic initiatives adversely affect their financial performance, the fair value of goodwill, trademarks and other intangible assets could be impaired in future periods. Trademarks and other intangible assets with indefinite lives are not amortized, but are tested for impairment annually, in the fourth quarter, and more frequently if events and circumstances indicate that the asset might be impaired.

Accounting for Derivative Instruments and Hedging Activities

RAI measures any derivative instruments, including certain derivative instruments embedded in other contracts, at fair value and records them in the balance sheet as either an asset or liability. Changes in fair value of derivatives are recorded in earnings unless hedge accounting criteria are met. For derivatives designated as fair value hedges, the changes in fair value of both the derivative instrument and the hedged item are recorded in earnings. For derivatives designated as cash flow hedges, the effective portions of changes in the fair value of the derivative are reported in accumulated other comprehensive loss. The ineffective portions of hedges are recognized in earnings in the current period.

75

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

RAI formally assesses at inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item, and formally designates as a hedge those derivatives that qualify for hedge accounting. If it is determined that a derivative is not highly effective as a hedge or if a derivative ceases to be a highly effective hedge, RAI will discontinue hedge accounting prospectively. Any unrecognized gain or loss will be deferred and recognized into income as the formerly hedged item is recognized in earnings. At December 31, 2010, RAI had no derivative instruments classified as hedges, and at December 31, 2011, had no derivative instruments.

Software Costs

Computer software and software development costs incurred in connection with developing or obtaining computer software for internal use that has an extended useful life are capitalized. These costs are amortized over their estimated useful life, which is typically five years or less. During 2011 and 2010, costs of $24 million and $22 million, respectively, were capitalized or included in construction-in-process. At each of December 31, 2011 and 2010, the unamortized balance was $64 million. Software amortization expense was $24 million, $30 million and $26 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Revenue Recognition

Revenue from product sales is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the seller’s price to the buyer is fixed or determinable, and collectibility is reasonably assured. These criteria are generally met when title and risk of loss pass to the customer. Payments received in advance of shipments are deferred and recorded in other accrued liabilities until shipment occurs. Certain sales of leaf to a related party, considered as bill-and-hold for accounting purposes, are recorded as deferred revenue when all of the above revenue recognition criteria are met except delivery, postponed at the customer’s request. Revenue is subsequently recognized upon delivery. The revenues recorded are presented net of excise tax collected on behalf of government authorities.

Shipping and handling costs are classified as cost of products sold. Net sales include certain sales incentives, including retail discounting, promotional allowances and coupons.

Cost of Products Sold

Cost of products sold includes the expenses for the Master Settlement Agreement, referred to as the MSA, and other settlement agreements with the states of Mississippi, Florida, Texas and Minnesota, which together with the MSA are collectively referred to as the State Settlement Agreements; the federal tobacco quota buyout; and the user fees charged by the U.S. Food and Drug Administration, referred to as the FDA, were as follows for the years ended December 31:

	2011		2010		2009
State Settlement Agreements	$	2,435	$	2,496	$	2,540
Federal tobacco quota buyout		229		243		240
FDA user fees		120		75		22

Advertising

Advertising costs, which are expensed as incurred, were $65 million, $72 million and $69 million for the years ended December 31, 2011, 2010 and 2009, respectively.

76

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Research and Development

Research and development costs, which are expensed as incurred, were $69 million, $71 million and $68 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Interest and penalties related to uncertain tax positions are accounted for as tax expense. Federal income taxes for RAI and its subsidiaries are calculated on a consolidated basis. State income taxes for RAI and its subsidiaries are primarily calculated on a separate return basis.

RAI accounts for uncertain tax positions which require that a position taken or expected to be taken in a tax return be recognized in the financial statements when it is more likely than not (a likelihood of more than 50 percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement.

Stock-Based Compensation

Stock-based compensation expense is recognized for all forms of share-based payment awards, including shares issued to employees under stock options and restricted stock units.

Litigation Contingencies

RAI discloses information concerning litigation for which an unfavorable outcome is more than remote. RAI and its subsidiaries record their legal expenses and other litigation costs and related administrative costs as selling, general and administrative expenses as those costs are incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated. When the reasonable estimate is a range, the recorded loss will be the best estimate within the range. If no amount in the range is a better estimate than any other amount, the minimum amount of the range will be recorded.

Pension and Postretirement

Pension and postretirement benefits require balance sheet recognition of the net asset or liability for the overfunded or underfunded status of defined benefit pension and other postretirement benefit plans, on a plan-by-plan basis, and recognition of changes in the funded status in the year in which the changes occur.

Changes in benefit obligations due to plan amendments, referred to as prior service costs, are amortized on a straight-line basis over the average remaining service period for active employees. These changes are reported in accumulated other comprehensive loss, as a separate component of shareholders’ equity. Changes in the amount of either the benefit obligation or the value of plan assets resulting from experience different from that assumed or from changes in assumptions are referred to as actuarial gains and losses.

77

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In November 2011, RAI elected to change its method of accounting for pension and postretirement benefits. Historically, RAI has recognized actuarial gains and losses in accumulated other comprehensive loss in its consolidated balance sheets on an annual basis, amortizing them into operating results over the average future service period of active employees in these plans, to the extent such gains and losses were in excess of 10 percent of the greater of the market-related value of plan assets or the plan’s projected benefit obligation, referred to as the corridor. RAI has elected to immediately recognize actuarial gains and losses in its operating results in the year in which they occur, to the extent they exceed the corridor. Actuarial gains and losses outside the corridor are generally recognized annually as of December 31, and are recorded as a mark-to-market, referred to as MTM, adjustment. Additionally, for purposes of calculating the expected return on plan assets, RAI will no longer use an averaging technique permitted under GAAP for the market-related value of plan assets, but instead will use the actual fair value of plan assets. These changes are intended to improve the transparency of RAI’s operating results by more quickly recognizing the effects of current economic and interest rate trends on plan investments and assumptions.

These changes have been reported through retrospective application of the new policy to all periods presented. The impacts of all revisions made to the financial statements are summarized below:

Consolidated statements of income:

	For the Year Ended December 31, 2010							For the Year Ended December 31, 2009
	Previously Reported		Revised		Effect Of Change			Previously Reported		Revised		Effect Of Change
Cost of products sold	$	4,544	$	4,544	$	—		$	4,485	$	4,488	$	3
Selling, general and administrative expenses		1,493		1,480		(13	)		1,508		1,517		9
Operating income		2,419		2,432		13			1,775		1,763		(12	)
Income from continuing operations before income taxes		2,192		2,205		13			1,534		1,522		(12	)
Provision for income taxes		863		868		5			572		567		(5	)
Income from continuing operations		1,329		1,337		8			962		955		(7	)
Net income		1,113		1,121		8			962		955		(7	)
Earnings per share — basic		1.91		1.92		0.01			1.65		1.64		(0.01	)
Earnings per share — diluted		1.90		1.92		0.02			1.65		1.64		(0.01	)

Consolidated balance sheet:

	December 31, 2010
	Previously Reported			Revised			Effect Of Change
Accumulated deficit	$	(547	)	$	(1,807	)	$	(1,260	)
Accumulated other comprehensive loss		(1,478	)		(218	)		1,260

Consolidated statements of cash flows:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Cash flows from operating activities:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Deferred income tax expense (benefit)		182			187			5			(154	)		(159	)		(5	)
Pension and postretirement		(702	)		(715	)		(13	)		(181	)		(169	)		12

78

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Consolidated statements of shareholders’ equity and comprehensive income:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Accumulated deficit:
Beginning balance	$	(579	)	$	(1,847	)	$	(1,268	)	$	(531	)	$	(1,792	)	$	(1,261	)
Net income		1,113			1,121			8			962			955			(7	)
Ending balance		(547	)		(1,807	)		(1,260	)		(579	)		(1,847	)		(1,268	)
Accumulated other comprehensive income (loss):
Beginning balance	$	(1,421	)	$	(153	)	$	1,268		$	(1,695	)	$	(434	)	$	1,261
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7
Ending balance		(1,478	)		(218	)		1,260			(1,421	)		(153	)		1,268
Comprehensive income:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7

Recently Issued Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board, referred to as FASB, amended certain accounting and disclosure requirements related to fair value measurements. For fair value measurements categorized as Level 1 and Level 2, requirements have been expanded to include disclosures of transfers between these levels. For fair value measurements categorized as Level 3, a reporting entity should disclose quantitative information of the unobservable inputs and assumptions, a description of the valuation processes and a qualitative discussion about the sensitivity of the fair value measurement to changes in unobservable inputs. The guidance is effective for RAI for interim and annual reporting periods beginning January 1, 2012, and is not expected to have a material impact on RAI’s results of operations, cash flows or financial position.

In June 2011, the FASB issued amended guidance which requires comprehensive income to be reported in either a single statement or in two consecutive statements reporting net income and other comprehensive income. The amendment eliminates the option to report other comprehensive income and its components in the statement of changes in shareholders’ equity. The guidance is effective for fiscal years, and interim periods within those years, beginning January 1, 2012. In December 2011, the FASB deferred the changes related to the presentation of reclassification adjustments. The adoption of the amendment will have no impact on RAI’s results of operations, cash flows or financial position.

In September 2011, the FASB issued amended guidance that permits an entity to make a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount before applying the current two-step goodwill impairment test. If an entity concludes that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, it would not be required to perform

79

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

the two-step impairment test for that reporting unit. The guidance is effective for RAI for interim and annual reporting periods beginning January 1, 2012, and will not have a material impact on RAI’s results of operations, cash flows or financial position.

Note 2 — Fair Value Measurement

Fair Value of Financial Assets and Liabilities

Financial assets carried at fair value as of December 31, 2011, were as follows:

	Level 1		Level 2		Level 3		Total
Cash and cash equivalents:
Cash equivalents	$	1,473	$	—	$	—	$	1,473
Other assets and deferred charges:
Auction rate securities		—		—		63		63
Mortgage-backed security		—		—		12		12
Marketable equity security		5		—		—		5
Assets held in grantor trusts		1		—		—		1

Financial assets (liabilities) carried at fair value as of December 31, 2010, were as follows:

	Level 1		Level 2			Level 3		Total
Cash and cash equivalents:
Cash equivalents	$	2,136	$	—		$	—	$	2,136
Other assets and deferred charges:
Auction rate securities		—		—			61		61
Mortgage-backed security		—		—			14		14
Marketable equity security		24		—			—		24
Assets held in grantor trusts		12		—			—		12
Interest rate swaps — fixed to floating rate		—		227			—		227
Other noncurrent liabilities:
Interest rate swaps — floating to fixed rate		—		(22	)		—		(22	)

There were no changes among the levels during the years ended December 31, 2011 and 2010.

RAI has investments in auction rate securities linked to corporate credit risk, investments in auction rate securities related to financial insurance companies, an investment in a mortgage-backed security and an investment in a marketable equity security. The unrealized gains and losses, net of tax, were included in other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2011 and 2010. The realized losses were recorded in other expense, net in RAI’s consolidated statement of income for the years ended December 31, 2011, 2010 and 2009. The funds associated with the auction rate securities will not be accessible until a successful auction occurs or a buyer is found.

RAI reviews these investments on a quarterly basis to determine if it is probable that RAI will realize some portion of the unrealized loss and to determine the classification of the impairment as temporary or other-than-temporary. RAI recognizes the credit loss component of an other-than-temporary impairment of its debt securities in earnings and the noncredit component in other comprehensive loss for those securities in which RAI does not intend to sell and it is more likely than not that RAI will not be required to sell the securities prior to recovery.

In determining if the difference between amortized cost and estimated fair value of the auction rate securities or the mortgage-backed security was deemed either temporary or other-than-temporary impairment,

80

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

RAI evaluated each type of long-term investment using a set of criteria, including decline in value, duration of the decline, period until anticipated recovery, nature of investment, probability of recovery, financial condition and near-term prospects of the issuer, RAI’s intent and ability to retain the investment, attributes of the decline in value, status with rating agencies, status of principal and interest payments and any other issues related to the underlying securities. To assess credit losses, RAI uses historical default rates, debt ratings, credit default swap spreads and recovery rates. RAI has the intent and ability to hold these investments for a period of time sufficient to allow for the recovery in market value.

The fair value of the auction rate securities, composed of securities of certain financial insurance companies or linked to the longer-term credit risk of a diverse range of corporations, including, but not limited to, manufacturing, financial and insurance sectors, classified as Level 3, utilized an income approach model and was based upon the weighted average present value of future cash payments, given the probability of certain events occurring within the market. RAI considers the market for its auction rate securities to be inactive. The income approach model utilized observable inputs, including LIBOR-based interest rate curves, corporate credit spreads and corporate ratings/market valuations. Additionally, unobservable factors incorporated into the model included default probability assumptions, recovery potential and how these factors changed as ratings on the underlying collateral migrated from one level to another. Maturity dates for the auction rate securities begin in 2017.

The fair value for the mortgage-backed security, classified as Level 3, utilized a market approach and was based upon the calculation of an overall weighted average valuation, derived from the actual, or modeled, market pricing of the specific collateral. The market approach utilized actual pricing inputs when observable and modeled pricing when unobservable. RAI has deemed the market for its mortgage-backed security to be inactive. The maturity of the mortgage-backed security has been extended to March 2012, with the annual option to extend an additional year. Given the underlying collateral and RAI’s intent to continue to extend this security, it is classified as a noncurrent asset.

RAI determined the change in the fair value of the investment in a marketable equity security using quoted market prices as of December 31.

Financial assets classified as Level 3 investments were as follows:

	December 31, 2011							December 31, 2010
	Cost		Gross Unrealized Loss(1)			Estimated Fair  Value		Cost		Gross Unrealized Loss(1)			Estimated Fair  Value
Auction rate securities	$	99	$	(36	)	$	63	$	99	$	(38	)	$	61
Mortgage-backed security		25		(13	)		12		27		(13	)		14
	$	124	$	(49	)	$	75	$	126	$	(51	)	$	75

⁽¹⁾  Unrealized losses, net of tax, are reported in accumulated other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2011 and 2010.

The changes in the Level 3 investments as of December 31, 2011, were as follows:

	Auction Rate Securities
	Cost		Gross (Loss)  Gain			Estimated Fair  Value
Balance as of January 1, 2011	$	99	$	(38	)	$	61
Unrealized gains		—		2			2
Balance as of December 31, 2011	$	99	$	(36	)	$	63

81

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

	Mortgage-Backed Security
	Cost			Gross Loss			Estimated Fair  Value
Balance as of January 1, 2011	$	27		$	(13	)	$	14
Redemptions		(2	)		—			(2	)
Balance as of December 31, 2011	$	25		$	(13	)	$	12

During 2010, the fair value of the interest rate swaps, classified as Level 2, utilized a market approach model using the notional amount of the interest rate swap multiplied by the observable inputs of time to maturity, interest rates and credit spreads.

Fair Value of Nonfinancial Assets

The fair value of the trademarks measured on a nonrecurring basis, classified as Level 3, represent certain trademarks, for which impairment during the fourth quarter of 2011 reduced their book value to fair value. The fair value determinations utilized an income approach model and were based on a discounted cash flow valuation model under a relief from royalty methodology. This approach utilized unobservable factors, such as royalty rate, projected revenues and a discount rate, applied to the estimated cash flows. The determination of the discount rate was based on a cost of equity model, using a risk-free rate, adjusted by a stock beta-adjusted risk premium and a size premium.

Nonfinancial assets measured at fair value on a nonrecurring basis were as follows:

	Level 1		Level 2		Level 3		Total		Total Loss
Trademarks, November 30, 2011	$	—	$	—	$	81	$	81	$	(48	)

Fair Value of Debt

The estimated fair value of RAI’s and RJR’s outstanding long-term notes in the aggregate, was $4.0 billion and $4.3 billion with an effective average annual interest rate of approximately 5.9% and 5.4%, as of December 31, 2011 and 2010, respectively. The fair values are based on available market quotes, credit spreads and discounted cash flows.

Interest Rate Management

From time to time, RAI and RJR use interest rate swaps to manage interest rate risk on a portion of their respective debt obligations. Historically, the interest rate swap agreements were derivative instruments that qualified for hedge accounting. RAI and RJR assess at the inception of the hedge whether the hedging derivatives are highly effective in offsetting changes in fair value of the hedged item. Ineffectiveness results when changes in the market value of the hedged debt are not completely offset by changes in the market value of the interest rate swap. As detailed below, at December 31, 2010, RAI and RJR had no derivative instruments designated as hedges, and at December 31, 2011, had no derivative instruments.

On January 6, 2009, the fair value of RAI’s and RJR’s fixed to floating interest rate swaps, designated as hedges, was $258 million. RAI and RJR locked in the value of these swaps by entering into offsetting floating to fixed interest rate swap agreements in the notional amount of $1.5 billion with maturity dates ranging from June 1, 2012 to June 15, 2017. The floating to fixed interest rate swaps were entered into with the same financial institution that holds a notional amount of $1.5 billion of fixed to floating interest rate swaps and have a legal

82

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

right of offset. The future cash flows, established as a result of entering into the January 6, 2009, floating to fixed interest rate swaps, total $321 million, and are being amortized and effectively reduce net interest costs over the remaining life of the notes. Concurrent with entering the floating to fixed interest rate swap agreements on January 6, 2009, which were not designated as hedging instruments, RAI and RJR removed the designation of fair value hedge from the fixed to floating interest rate swaps.

On January 7, 2009, RAI and RJR terminated an interest rate swap agreement in the notional amount of $100 million with a maturity date of June 1, 2012. The resulting gain of approximately $12 million is being amortized to effectively reduce interest expense over the remaining life of the notes. The unamortized portion of this gain as well as the locked in value of the interest rate swaps on January 6, 2009, totaling $159 million and $198 million as of December 31, 2011 and 2010, respectively, were included in long-term debt (less current maturities) in the consolidated balance sheets.

As a result of these actions, RAI and RJR have economically decreased the fixed rate on $1.6 billion of debt to a fixed rate of interest of approximately 4.0%.

During September 2011, RAI and RJR terminated the original and offsetting interest rate swap agreements, each with a notional amount of $1.5 billion and maturity dates ranging from June 1, 2012 to June 15, 2017. RAI and RJR received a total of $186 million cash in exchange for foregoing the future cash inflows associated with these swaps. These actions did not change the effective fixed rate of interest associated with the underlying debt. As of December 31, 2011, RAI and RJR had no outstanding interest rate swaps.

Interest rate swaps impacted the consolidated statements of income for the years ended December 31 as follows:

	2011			2010			2009
Interest and debt expense (income)	$	(47	)	$	(48	)	$	(47	)
Other expense (income), net		4			(3	)		(9	)

Note 3 — Intangible Assets

The changes in the carrying amounts of goodwill by segment were as follows:

	RJR Tobacco			American Snuff			Santa Fe		All Other		Consolidated
Balance as of December 31, 2008
Goodwill	$	9,065		$	2,650		$	197	$	27	$	11,939
Less: Accumulated impairment charges		(3,763	)		(2	)		—		—		(3,765	)
Net goodwill balance as of December 31, 2008		5,302			2,648			197		27		8,174
2009 Activity
Acquisition of Niconovum AB		—			—			—		11		11
Balance as of December 31, 2009
Goodwill		9,065			2,650			197		38		11,950
Less: Accumulated impairment charges		(3,763	)		(2	)		—		—		(3,765	)
Net goodwill balance as of December 31, 2009		5,302			2,648			197		38		8,185

83

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

	RJR Tobacco			American Snuff			Santa Fe		All Other		Consolidated
2010 Activity
Reclassified as held for sale	$	—		$	(149	)	$	—	$	—	$	(149	)
Impairment charge		—			(26	)		—		—		(26	)
		—			(175	)		—		—		(175	)
Balance as of December 31, 2010 and 2011
Goodwill		9,065			2,501			197		38		11,801
Less: Accumulated impairment charges		(3,763	)		(28	)		—		—		(3,791	)
Net goodwill balance as of December 31, 2010 and 2011	$	5,302		$	2,473		$	197	$	38	$	8,010

The changes in the carrying amounts of indefinite-lived intangible assets by segment not subject to amortization were as follows:

	RJR Tobacco					American Snuff			Santa Fe		All Other			Consolidated
	Trademarks			Other		Trademarks			Trademarks		Other			Trademarks			Other
Balance as of December 31, 2008	$	1,653		$	55	$	1,222		$	155	$	48		$	3,030		$	103
Impairment charge		(490	)		—		(70	)		—		—			(560	)		—
Intersegment transfer		—			44		—			—		(44	)		—			—
Acquisition of Niconovum AB		—			—		—			—		43			—			43
Balance as of December 31, 2009	$	1,163		$	99	$	1,152		$	155	$	47		$	2,470		$	146
Impairment charge		—			—		(6	)		—		—			(6	)		—
Foreign currency translation		—			—		—			—		3			—			3
Reclassified as held for sale		(11	)		—		(3	)		—		—			(14	)		—
Reclassified to finite-lived		—			—		(7	)		—		—			(7	)		—
Balance as of December 31, 2010	$	1,152		$	99	$	1,136		$	155	$	50		$	2,443		$	149
Impairment charge		(43	)		—		—			—		—			(43	)		—
Foreign currency translation		—			—		—			—		(1	)		—			(1	)
Balance as of December 31, 2011	$	1,109		$	99	$	1,136		$	155	$	49		$	2,400		$	148

84

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The changes in the carrying amounts of finite-lived intangible assets by segment subject to amortization were as follows:

	RJR Tobacco						American Snuff			Consolidated
	Trademarks			Other			Trademarks			Trademarks			Other
Balance as of December 31, 2008	$	33		$	84		$	20		$	53		$	84
Amortization		(12	)		(15	)		(1	)		(13	)		(15	)
Impairment charge		(1	)		—			(6	)		(7	)		—
Balance as of December 31, 2009		20			69			13			33			69
Amortization		(9	)		(15	)		(1	)		(10	)		(15	)
Reclassified as held for sale		—			—			(1	)		(1	)		—
Reclassified from indefinite-lived		—			—			7			7			—
Balance as of December 31, 2010		11			54			18			29			54
Amortization		(7	)		(15	)		(2	)		(9	)		(15	)
Impairment charge		—			—			(5	)		(5	)		—
Balance as of December 31, 2011	$	4		$	39		$	11		$	15		$	39

Details of intangible assets as of December 31, 2011, were as follows:

	Gross		Accumulated Amortization		Net
Finite-lived:
Contract manufacturing agreements	$	151	$	112	$	39
Trademarks		96		81		15
Indefinite-lived		3,051		503		2,548
	$	3,298	$	696	$	2,602

The estimated remaining amortization associated with finite-lived intangible assets is expected to be expensed as follows:

Year	Amount
2012	$	21
2013		16
2014		10
2015		1
2016		1
Thereafter		5
	$	54

The impairment testing of trademarks in the fourth quarters of 2011 and 2010 assumed an increased rate of decline in projected net sales of certain brands, compared with that assumed in the prior year strategic plan. As a result, during 2011, impairment was indicated primarily on RJR Tobacco’s DORAL brand and several loose leaf brands at American Snuff. During 2010, American Snuff recorded a trademark impairment charge on one loose leaf brand, and reclassified the trademark as finite-lived.

85

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The annual impairment testing of trademarks in 2009 included modification to the previously anticipated level of support among certain brands, and an increased rate of decline in projected net sales of certain brands, compared with that assumed in the prior year strategic plan. Also, in 2009, an increase of $0.62 in the federal excise tax per pack of cigarettes, as well as significant tax increases on other tobacco products, were expected to adversely impact the net sales of RAI’s operating subsidiaries. The federal excise tax increase was considered a triggering event requiring the testing for impairment of the carrying value of trademarks and goodwill during the first quarter of 2009.

The analysis of the fair value of trademarks was based on estimates of fair value on an income approach using a discounted cash flow valuation model under a relief from royalty methodology. The relief from royalty model includes the estimates of the royalty rate that a market participant might assume, projected revenues and judgment regarding the 10.50% discount rate applied to those estimated cash flows. The determination of the discount rate was based on a cost of equity model, using a risk-free rate, adjusted by a stock beta-adjusted risk premium and a size premium.

As a result of these analyses, RJR Tobacco and American Snuff recorded trademark impairment charges based on the excess of certain brands’ carrying values over their estimated fair values. These trademark impairment charges are reflected as decreases in the carrying value of the trademarks in the consolidated balance sheets as of December 31, 2011 and 2010, as trademark impairment charges in the consolidated statements of income for the years ended December 31, 2011, 2010 and 2009, and had no impact on cash flows. In addition, certain brands indicated that a finite life was probable. As a result, these brands are being amortized over their remaining lives, which range from 1 to 17 years, consistent with the pattern of economic benefits estimated to be received.

For the annual impairment testing of the goodwill of RAI’s reporting units, each reporting unit’s estimated fair value was compared with its carrying value. A reporting unit is an operating segment or one level below an operating segment. The determination of estimated fair value of each reporting unit was calculated primarily utilizing an income approach model, based on the present value of the estimated future cash flows of the reporting unit assuming a discount rate of 10.25% for each of RJR Tobacco and American Snuff and 11% for Santa Fe. The determination of the discount rate was based on a weighted average cost of capital. Additionally, the aggregate estimated fair value of the reporting units, determined with the use of the income approach model, was compared with RAI’s market capitalization. The estimated fair value of each reporting unit was substantially greater than its respective carrying value.

In connection with management’s decision, in the fourth quarter of 2011, to report the domestic operations and results of Santa Fe, the goodwill of Santa Fe was allocated based on a relative fair value between domestic and international operations, and reported under Santa Fe and All Other, respectively.

During 2010, RAI determined that it was probable that it would dispose of the operations of Lane, which were included in the American Snuff segment. In accordance with accounting guidance, the assets of the disposal group were reclassified as assets held for sale, and liabilities held for sale were included in other current liabilities, in the consolidated balance sheet at December 31, 2010.

In connection with this determination, the goodwill of American Snuff was allocated between the disposal group and the retained operations based on relative fair values, and the resulting goodwill was tested for impairment in the same manner as annual testing described above. Because the fair value of the disposal group was less than its carrying value, an associated goodwill impairment charge was recorded by American Snuff in 2010. This charge was reflected as a decrease in the carrying value of goodwill in the consolidated balance sheet as of December 31, 2010, as goodwill impairment charge in the consolidated statement of income for the year ended December 31, 2010 and had no impact on cash flows.

86

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 4 — Asset Impairment and Exit Charges

On May 28, 2010, RAI announced that its operating companies were taking steps to optimize cigarette-manufacturing efficiencies, while complying with new regulatory requirements. During 2010, RJR Tobacco announced plans to close the Whitaker Park cigarette manufacturing facility by mid-2011 which, due to additional demand, has been extended to early 2012, and a factory in Yabucoa, Puerto Rico has closed. Production from those facilities will be transferred to RJR Tobacco’s facility in Tobaccoville, North Carolina. As a result of these actions, approximately 60 manufacturing positions in Puerto Rico were eliminated, and affected employees received severance benefits. In connection with these actions, during 2010, RJR Tobacco recorded an asset impairment of $24 million, and $14 million was recorded in the All Other segment, primarily for asset impairment, and to a lesser extent, severance that was substantially paid during 2010.

Note 5 — Restructuring Charges

2009 Restructuring Charge

In 2009, RJR Tobacco announced the elimination of approximately 400 full-time production positions substantially completed by December 31, 2010. The cash benefits were substantially paid by December 31, 2011.

2008 Restructuring Charge

In 2008, RAI and RJR Tobacco announced changes in their organizational structures to streamline non-core business processes and programs in order to allocate additional resources to strategic growth initiatives. The reorganizations resulted in the elimination of approximately 600 full-time jobs. The cash benefits were substantially paid by December 31, 2011.

The activity in the restructuring accruals, comprised of employee severance and related benefits, was as follows:

	2009 Restructuring Charge			2008 Restructuring Charge
Original accrual	$	—		$	91
Utilized in 2008		—			(12	)
Adjusted in 2008		—			(1	)
Balance as of December 31, 2008		—			78
Original accrual		56			—
Utilized in 2009		(8	)		(38	)
Balance as of December 31, 2009		48			40
Utilized in 2010		(22	)		(27	)
Balance as of December 31, 2010		26			13
Utilized in 2011		(24	)		(10	)
Balance as of December 31, 2011	$	2		$	3

The restructuring accruals were included in the consolidated balance sheet as of December 31, 2011 in other current liabilities.

87

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 6 — Discontinued Operations

In 1999, RJR and RJR Tobacco sold the international tobacco business to an affiliate of Japan Tobacco Inc., referred to as JTI. Northern Brands International, Inc., referred to as Northern Brands, was part of the international business of R.J. Reynolds International B.V., a former Netherlands subsidiary of RJR Tobacco, which was managed by RJR-Macdonald, Inc., referred to as RJR-MI. Northern Brands ceased being an operating company in 1997 and has been an inactive subsidiary of RJR since that time.

Effective April 13, 2010, RJR Tobacco entered into a comprehensive agreement with the Canadian federal, provincial and territorial governments, referred to as the Comprehensive Agreement, resolving a variety of civil claims related to cigarette smuggling in Canada during the period from 1985 through 1999. The Comprehensive Agreement covers all civil claims related to the movement of contraband tobacco products in Canada during the period 1985 through 1999 that the governments have asserted or could assert against RJR Tobacco and its affiliates. On April 13, 2010, RJR Tobacco paid the governments a total of CAD $325 million to bring this complex, lengthy and costly litigation to an end.

Separately, on April 13, 2010, Northern Brands entered into a plea agreement with the Ministry of the Attorney General of Ontario. Under the terms of this agreement, Northern Brands pled guilty to a one count violation of the Canadian Criminal Code for conspiring to aid other persons to sell and be in possession of tobacco products that were not packaged and stamped in conformity with the Canadian Excise Act during the period February 18, 1993 through December 31, 1996. The Judge of the Ontario Court of Justice accepted the plea by Northern Brands and required it to pay a fine of CAD $75 million, which was paid on April 13, 2010. By this plea, the criminal charges that were originally commenced against Northern Brands and certain of its affiliates in 2003 and any other charges that could be commenced against Northern Brands and its affiliates by the Canadian governments relating to contraband tobacco activities have now come to an end.

In addition to the $91 million liability previously accrued by RJR, an adjustment to reflect the impact of the separate RJR Tobacco settlement to resolve civil claims and the separate Northern Brands plea agreement, in the aggregate of $307 million, or $216 million after tax, was recorded during the first quarter of 2010.

This accrual adjustment was included in losses from discontinued operations in the consolidated statement of income for the year ended December 31, 2010. Of the aggregate accrual adjustments of $307 million, $303 million, or $213 million after tax, is classified as a loss on discontinued operations, and $4 million, or $3 million after tax, is classified as a loss on the sale of discontinued operations. The payments by RJR Tobacco of $324 million, offset by a realized tax benefit of $91 million, and by Northern Brands of $74 million have been included as net cash flows related to discontinued operations, net of tax benefit, in the consolidated statement of cash flows for the year ended December 31, 2010.

Note 7 — Income Per Share

The components of the calculation of income per share were as follows:

	For the Years Ended December 31,
	2011		2010			2009
Income from continuing operations	$	1,406	$	1,337		$	955
Losses from discontinued operations		—		(216	)		—
Net income	$	1,406	$	1,121		$	955
Basic weighted average shares, in thousands		582,320		582,996			582,761
Effect of dilutive potential shares:
Stock units		3,063		1,858			891
Diluted weighted average shares, in thousands		585,383		584,854			583,652

88

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 8 — Inventories

The major components of inventories at December 31 were as follows:

	2011		2010
Leaf tobacco	$	885	$	997
Other raw materials		44		44
Work in process		60		64
Finished products		139		122
Other		24		25
Total		1,152		1,252
Less LIFO allowance		185		197
	$	967	$	1,055

Inventories valued under the LIFO method were $466 million and $600 million at December 31, 2011 and 2010, respectively, net of the LIFO allowance. The LIFO allowance reflects the excess of the current cost of LIFO inventories at December 31, 2011 and 2010, over the amount at which these inventories were carried on the consolidated balance sheets. RAI recorded income of $12 million from LIFO inventory changes during 2011 and recorded expense of $7 million and $78 million from LIFO inventory changes during 2010 and 2009, respectively.

Note 9 — Other Current Liabilities

Other current liabilities at December 31 included the following:

	2011		2010
Payroll and employee benefits	$	134	$	188
Pension and other postretirement benefits		83		96
Marketing and advertising		100		133
Declared dividends		323		285
Excise, franchise and property tax		158		160
Restructuring		5		36
Tobacco quota buyout		86		57
Individual Engle Progeny cases accrual		64		—
Other		179		192
	$	1,132	$	1,147

89

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 10 — Income Taxes

The components of the provision for income taxes from continuing operations for the years ended December 31 were as follows:

	2011		2010		2009
Current:
Federal	$	572	$	545	$	592
State and other		108		136		134
		680		681		726
Deferred:
Federal		80		160		(154	)
State and other		20		27		(5	)
		100		187		(159	)
	$	780	$	868	$	567

Significant components of deferred tax assets and liabilities for the years ended December 31 included the following:

	2011			2010
Deferred tax assets:
Pension and other postretirement liabilities	$	707		$	714
Tobacco settlement accruals		1,006			1,031
Other accrued liabilities		81			70
Other noncurrent liabilities		154			141
Subtotal		1,948			1,956
Less: valuation allowance		(33	)		—
		1,915			1,956
Deferred tax liabilities:
LIFO inventories		(162	)		(200	)
Property and equipment		(239	)		(218	)
Trademarks and other intangibles		(950	)		(978	)
Other		(130	)		(132	)
		(1,481	)		(1,528	)
Net deferred tax asset	$	434		$	428

The current and noncurrent components of deferred tax assets and liabilities for the years ended December 31 were as follows:

	2011			2010
Current deferred tax assets	$	945		$	946
Noncurrent deferred tax liabilities		(511	)		(518	)
	$	434		$	428

90

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

At December 31, 2011, RAI had a $95 million federal capital loss carryforward resulting from the February 28, 2011, sale of Lane. The federal capital loss carryforward expires in 2016 and can be utilized only to the extent net capital gains are generated during the carryforward period.

In 2011, a $33 million valuation allowance was established to fully offset a deferred tax asset related to the federal capital loss carryforward. RAI believes it is unlikely that this deferred tax asset will be realized through the expected generation of future net capital gains. No valuation allowance was established on other deferred tax assets as of the year ended December 31, 2011 or 2010, as RAI believes it is more likely than not that all of such deferred tax assets will be realized through the expected generation of future taxable income.

Pre-tax income for domestic and foreign operations for the years ended December 31 consisted of the following:

	2011		2010		2009
Domestic (includes U.S. exports)	$	2,157	$	2,204	$	1,495
Foreign		29		1		27
	$	2,186	$	2,205	$	1,522

The differences between the provision for income taxes from continuing operations and income taxes computed at statutory U.S. federal income tax rates for the years ended December 31 were as follows:

	2011			2010			2009
Income taxes computed at statutory U.S. federal income tax rates	$	765		$	771		$	533
State and local income taxes, net of federal tax benefits		96			101			80
Domestic manufacturing deduction		(60	)		(54	)		(41	)
Other items, net		(21	)		50			(5	)
Provision for income taxes from continuing operations	$	780		$	868		$	567
Effective tax rate		35.7	%		39.4	%		37.3	%

The effective tax rate for 2011 was favorably impacted by a $22 million decrease in tax attributable to the reversal of tax reserves and interest on a state statute expiration. The effective tax rate for 2010 was unfavorably impacted by a $27 million increase in tax attributable to the Patient Protection and Affordable Care Act of 2010 and the Health Care and Education Reconciliation Act of 2010. The effective tax rate for 2009 was unfavorably impacted by increases in unrecognized income tax benefits and increases in tax attributable to accumulated and undistributed foreign earnings.

At December 31, 2011, there were $445 million of accumulated and undistributed foreign earnings. Of this amount, RAI has invested $68 million and has plans to invest $15 million overseas. RAI has recorded deferred income taxes of $129 million on the $362 million of accumulated earnings in excess of its historical and planned overseas investments.

The deferred tax benefits included in accumulated other comprehensive loss were $268 million for retirement benefits and $19 million for unrealized losses on long-term investments as of December 31, 2011, and were $173 million for retirement benefits and $13 million for unrealized losses on long-term investments as of December 31, 2010.

91

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The gross accruals for unrecognized income tax benefits, including interest and penalties, reflected in other noncurrent liabilities were $165 million and $193 million at December 31, 2011 and 2010, respectively. RAI accrues interest and penalties related to accruals for income taxes and reflects these amounts in income tax expense. The gross amount of interest accrued at December 31, 2011 and 2010, was $28 million and $57 million, respectively. The gross amount of penalties accrued at December 31, 2011 and 2010 was $10 million and $9 million, respectively.

A reconciliation of the unrecognized gross tax benefits is as follows:

	2011			2010			2009
Balance at beginning of year	$	127		$	94		$	97
Gross increases related to current period tax positions		6			37			6
Gross increases related to tax positions in prior periods		1			4			3
Gross decreases related to tax positions in prior periods		(1	)		(1	)		(4	)
Gross increases (decreases) related to audit settlements		1			(4	)		(3	)
Gross decreases related to lapse of applicable statute of limitations		(6	)		(3	)		(5	)
Balance at end of year	$	128		$	127		$	94

At December 31, 2011, $110 million of unrecognized tax benefits including interest and penalties, if recognized, would decrease RAI’s effective tax rate.

RAI and its subsidiaries are subject to income taxes in the United States, certain foreign jurisdictions and multiple state jurisdictions. A number of years may elapse before a particular matter, for which RAI has established an accrual, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. RAI’s major taxing jurisdictions and related open tax audits are discussed below.

RAI filed a federal consolidated income tax return for the years through 2010. The statute of limitations remains open for the years 2007 through 2010. There are no IRS examinations scheduled at this time for these open years.

In 2007, the State of North Carolina completed its examination of RJR Tobacco for years 2000 through 2002 and issued a total assessment of $37 million. The state concluded that the returns filed by RJR Tobacco did not reflect the company’s true net earnings as defined by North Carolina statutes. RJR Tobacco filed a protest in January 2008. RJR Tobacco will continue to work with North Carolina to resolve issues identified and assessed for years 2000 through 2002. In the event a complete resolution of this audit is reached during the next 12 months, RJR Tobacco could recognize additional expense of up to $12 million, inclusive of tax, interest, net of federal benefit, and penalties.

Note 11 — Borrowing Arrangements

On July 29, 2011, RAI entered into a credit agreement, referred to as the Credit Agreement, with a syndicate of lenders, providing for a four-year $750 million senior unsecured revolving credit facility, which may be increased to $1 billion at the discretion of the lenders upon the request of RAI. This agreement replaces RAI’s Fifth Amended and Restated Credit Agreement, dated as of June 28, 2007, as amended.

The Credit Agreement contains restrictive covenants that (a) limit the ability of RAI and its subsidiaries to (i) pay dividends and repurchase stock, (ii) engage in transactions with affiliates, (iii) create liens, and (iv) engage in sale-leaseback transactions involving a Principal Property, as defined in the Credit Agreement, and

92

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(b) limit the ability of RAI and its Material Subsidiaries, as such term is defined in the Credit Agreement, to sell or dispose of all or substantially all of their assets and engage in specified mergers or consolidations. The Credit Agreement also contains a restrictive covenant that limits the amount of debt that may be incurred by non-guarantor subsidiaries, together with certain financial covenants. The restrictive covenants in the Credit Agreement are subject to a number of qualifications and exceptions. The financial covenant levels in the Credit Agreement are 3.00 to 1.00 for the consolidated leverage ratio and 4.00 to 1.00 for the consolidated interest coverage ratio. In addition, the maturity date of the Credit Agreement is July 29, 2015, which date may be extended, with the agreement of the requisite lenders, in two separate one-year increments. The Credit Agreement contains customary events of default, including upon a change in control, as defined therein, that could result in the acceleration of all amounts and cancellation of all commitments outstanding under the Credit Agreement.

RAI is able to use the revolving credit facility under the Credit Agreement for borrowings and issuances of letters of credit at its option, subject to a $200 million sublimit on the aggregate amount of letters of credit. Issuances of letters of credit reduce availability under such revolving credit facility. As of December 31, 2011, there were no borrowings, and $7 million of letters of credit outstanding, under the Credit Agreement.

Under the terms of the Credit Agreement, RAI is required to pay a facility fee of between 0.20% and 0.40% per annum, based on the facility’s credit ratings, on the lender commitments in respect of the revolving credit facility thereunder.

Borrowings under the Credit Agreement bear interest, at the option of RAI, at a rate equal to an applicable margin, based upon the credit ratings assigned to the Credit Agreement, plus:

• the alternate base rate, which is the higher of (1) the federal funds effective rate from time to time plus 0.5%, (2) the prime rate and (3) the reserve adjusted eurodollar rate for a one month interest period plus 1%; or

• the eurodollar rate, which is the reserve adjusted rate at which eurodollar deposits for one, two, three or six months are offered in the interbank eurodollar market.

Overdue principal and, to the extent permitted by law, overdue interest, outstanding under the revolving credit facility under the Credit Agreement bear interest at a rate equal to the rate then in effect with respect to such borrowings, plus 2.0% per annum.

The obligations of RAI under the Credit Agreement are unsecured. Certain of RAI’s subsidiaries, including its Material Subsidiaries, have guaranteed, on an unsecured basis, RAI’s obligations under the Credit Agreement.

93

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 12 — Long-Term Debt

Long-term debt, net of discounts and including adjustments associated with interest rate swaps, as of December 31 consisted of the following:

	2011		2010
RJR debt:
9.25%, notes due 2013	$	60	$	60
7.25% guaranteed, notes due 2012		—		61
Total RJR debt		60		121
RAI debt:
6.75% guaranteed, notes due 2017		797		811
7.25% guaranteed, notes due 2012		—		412
7.25% guaranteed, notes due 2013		624		623
7.25% guaranteed, notes due 2037		448		448
7.3% guaranteed, notes due 2015		199		199
7.625% guaranteed, notes due 2016		829		838
7.75% guaranteed, notes due 2018		249		249
Total RAI debt		3,146		3,580
Total long-term debt (less current maturities)		3,206		3,701
Current maturities of long-term debt		457		400
	$	3,663	$	4,101

As of December 31, 2011, the maturities of RAI’s and RJR’s notes, net of discounts, were as follows:

Year	RAI		RJR		Total
2012	$	393	$	58	$	451
2013		624		60		684
2015		199		—		199
2016		773		—		773
2017 and thereafter		1,397		—		1,397
	$	3,386	$	118	$	3,504

In conjunction with their obligations under the Credit Agreement, RAI’s Material Subsidiaries, including RJR, RJR Tobacco, American Snuff Co. and SFNTC, among others, guarantee the RAI Notes.

At their option, RAI and RJR, as applicable, may redeem any or all of their outstanding fixed-rate notes, except RJR’s 9.25% notes due in 2013, $60 million in principal amount of which was outstanding as of December 31, 2011, in whole or in part at any time, subject to the payment of a make-whole premium. On June 15, 2011, RAI repaid $400 million of matured floating rate notes from existing cash.

94

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 13 — Commitments and Contingencies

Tobacco Litigation — General

Introduction

Various legal proceedings or claims, including litigation claiming that cancer and other diseases, as well as addiction, have resulted from the use of, or exposure to, RAI’s operating subsidiaries’ products, are pending or may be instituted against RJR Tobacco, American Snuff Co. or their affiliates, including RAI and RJR, or indemnitees, including B&W. These pending legal proceedings include claims relating to cigarette products manufactured by RJR Tobacco or certain of its affiliates and indemnitees, as well as claims relating to smokeless tobacco products manufactured by American Snuff Co. A discussion of the legal proceedings relating to cigarette products is set forth below under the heading “— Litigation Affecting the Cigarette Industry.” All of the references under that heading to tobacco-related litigation, smoking and health litigation and other similar references are references to legal proceedings relating to cigarette products and are not references to legal proceedings involving smokeless tobacco products, and case numbers under that heading include only cases involving cigarette products. The legal proceedings relating to the smokeless tobacco products manufactured by American Snuff Co. are discussed separately under the heading “— Smokeless Tobacco Litigation” below.

In connection with the B&W business combination, RJR Tobacco has agreed to indemnify B&W and its affiliates, including its indirect parent, BAT, against certain liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. As a result of this indemnity, RJR Tobacco has assumed the defense of pending B&W-specific tobacco-related litigation, has paid the judgments and costs related to certain pre-business combination tobacco-related litigation of B&W, and has posted bonds on behalf of B&W, where necessary, in connection with cases decided since the B&W business combination. In addition, pursuant to this indemnity, RJR Tobacco expensed less than $1 million during each of 2011, 2010 and 2009 for funds to be reimbursed to BAT for costs and expenses incurred arising out of certain tobacco-related litigation.

Certain Terms and Phrases

Certain terms and phrases used in this disclosure may require some explanation. The term “judgment” or “final judgment” refers to the final decision of the court resolving the dispute and determining the rights and obligations of the parties. At the trial court level, for example, a final judgment generally is entered by the court after a jury verdict and after post-verdict motions have been decided. In most cases, the losing party can appeal a verdict only after a final judgment has been entered by the trial court.

The term “damages” refers to the amount of money sought by a plaintiff in a complaint, or awarded to a party by a jury or, in some cases, by a judge. “Compensatory damages” are awarded to compensate the prevailing party for actual losses suffered, if liability is proved. In cases in which there is a finding that a defendant has acted willfully, maliciously or fraudulently, generally based on a higher burden of proof than is required for a finding of liability for compensatory damages, a plaintiff also may be awarded “punitive damages.” Although damages may be awarded at the trial court stage, a losing party generally may be protected from paying any damages until all appellate avenues have been exhausted by posting a supersedeas bond. The amount of such a bond is governed by the law of the relevant jurisdiction and generally is set at the amount of damages plus some measure of statutory interest, modified at the discretion of the appropriate court or subject to limits set by court or statute.

The term “settlement” refers to certain types of cases in which cigarette manufacturers, including RJR Tobacco and B&W, have agreed to resolve disputes with certain plaintiffs without resolving the case through

95

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

trial. The principal terms of certain settlements entered into by RJR Tobacco and B&W are explained below under “— Accounting for Tobacco-Related Litigation Contingencies.”

Theories of Recovery

The plaintiffs seek recovery on a variety of legal theories, including negligence, strict liability in tort, design defect, special duty, voluntary undertaking, breach of warranty, failure to warn, fraud, misrepresentation, unfair trade practices, conspiracy, unjust enrichment, medical monitoring, public nuisance and violations of state and federal antitrust laws. In certain of these cases, the plaintiffs claim that cigarette smoking exacerbated injuries caused by exposure to asbestos.

The plaintiffs seek various forms of relief, including compensatory and punitive damages, treble or multiple damages and statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and other equitable relief. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.

Defenses

The defenses raised by RJR Tobacco, American Snuff Co. and their affiliates and indemnitees include, where applicable and otherwise appropriate, preemption by the Federal Cigarette Labeling and Advertising Act of some or all claims arising after 1969, or by the Comprehensive Smokeless Tobacco Health Education Act for claims arising after 1986, the lack of any defect in the product, assumption of the risk, contributory or comparative fault, lack of proximate cause, remoteness, lack of standing and statutes of limitations or repose. RAI and RJR have asserted additional defenses, including jurisdictional defenses, in many of the cases in which they are named.

Accounting for Tobacco-Related Litigation Contingencies

In accordance with GAAP, RAI and its subsidiaries, including RJR Tobacco, American Snuff Co. and SFNTC, as applicable, record any loss concerning litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. For the reasons set forth below, RAI’s management continues to conclude that the loss of any particular pending smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular claim concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual basis, is not probable, except for four Engle Progeny cases described below.

RJR Tobacco and its affiliates believe that they have valid defenses to the smoking and health tobacco litigation claims against them, as well as valid bases for appeal of adverse verdicts against them. RAI, RJR Tobacco and their affiliates and indemnitees have, through their counsel, filed pleadings and memoranda in pending smoking and health tobacco litigation that set forth and discuss a number of grounds and defenses that they and their counsel believe have a valid basis in law and fact. With the exception of Engle Progeny cases, described below, RJR Tobacco and its affiliates and indemnitees continue to win the majority of smoking and health tobacco litigation claims that reach trial, and a very high percentage of the tobacco-related litigation claims brought against them continue to be dismissed at or before trial. Based on their experience in the smoking and health tobacco litigation against them and the strength of the defenses available to them in such litigation, RJR Tobacco and its affiliates believe that their successful defense of smoking and health tobacco litigation in the past will continue in the future.

96

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

An accrual of $64 million has been recorded in RAI’s consolidated balance sheet as of December 31, 2011 for the four Engle Progeny cases, described below, that have proceeded through the appellate process in the state of Florida. RJR Tobacco is seeking further review of these four cases by the U.S. Supreme Court. This amount includes $53 million for compensatory and punitive damages and $11 million for attorneys’ fees and statutory interest through December 31, 2011. No other liabilities for pending smoking and health litigation have been recorded as of December 31, 2011.

Generally, RJR Tobacco and its affiliates and indemnitees have not settled, and currently RJR Tobacco and its affiliates do not intend to settle, any smoking and health tobacco litigation claims. It is the policy of RJR Tobacco and its affiliates to vigorously defend all tobacco-related litigation claims.

The only material settlements of smoking and health tobacco litigation claims reached by RJR Tobacco and B&W involved:

• the State Settlement Agreements and the funding by various tobacco companies of a $5.2 billion trust fund contemplated by the MSA to benefit tobacco growers; and

• the original Broin flight attendant case discussed below under “— Litigation Affecting the Cigarette Industry — Broin II Cases.”

The circumstances surrounding the State Settlement Agreements and the funding of a trust fund to benefit the tobacco growers are readily distinguishable from the current categories of smoking and health cases involving RJR Tobacco or its affiliates and indemnitees. The claims underlying the State Settlement Agreements were brought on behalf of the states to recover funds paid for health care and medical and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. The State Settlement Agreements settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and contain releases of various additional present and future claims. In accordance with the MSA, various tobacco companies agreed to fund a $5.2 billion trust fund to be used to address the possible adverse economic impact of the MSA on tobacco growers. A discussion of the State Settlement Agreements, and a table depicting the related payment schedule, is set forth below under “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements.”

The states were a unique set of plaintiffs and are not involved in any of the smoking and health cases remaining against RJR Tobacco or its affiliates and indemnitees. Although RJR Tobacco and certain of its affiliates and indemnitees continue to be defendants in health-care cost recovery cases similar in theory to the state cases but involving other plaintiffs, such as Native American tribes and foreign governments, the vast majority of such cases have been dismissed on legal grounds. RJR Tobacco and its affiliates, including RAI, believe that the same legal principles that have resulted in dismissal of health-care cost recovery cases either at the trial court level or on appeal should compel dismissal of the similar pending cases.

As with claims that were resolved by the State Settlement Agreements, the other cases settled by RJR Tobacco can be distinguished from existing cases pending against RJR Tobacco and its affiliates and indemnitees. The original Broin case, discussed below under “— Litigation Affecting the Cigarette Industry — Broin II Cases,” was settled in the middle of trial during negotiations concerning a possible nation-wide settlement of claims similar to those underlying the State Settlement Agreements.

RJR Tobacco’s Comprehensive Agreement with the Canadian federal, provincial and territorial governments resolved all civil claims related to the movement of contraband tobacco products in Canada during the period 1985 through 1999 that the Canadian governments could assert against RJR Tobacco and its affiliates. These claims were separate from any smoking and health tobacco litigation. A discussion of the Canadian matters and the related settlement are set forth in note 6.

97

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Likewise, RJR Tobacco and B&W separately settled the antitrust case DeLoach v. Philip Morris Cos., Inc., which was brought by a unique class of plaintiffs: a class of all tobacco growers and tobacco allotment holders. The plaintiffs asserted that the defendants conspired to fix the price of tobacco leaf and to destroy the federal government’s tobacco quota and price support program. Despite legal defenses they believed to be valid, RJR Tobacco and B&W separately settled this case to avoid a long and contentious trial with the tobacco growers. The DeLoach case and the antitrust case currently pending against RJR Tobacco and B&W involve different types of plaintiffs and different theories of recovery under the antitrust laws than the smoking and health cases pending against RJR Tobacco and its affiliates and indemnitees.

Finally, as discussed under “— Litigation Affecting the Cigarette Industry — State Settlement Agreements — Enforcement and Validity; Adjustments,” RJR Tobacco and B&W each has settled certain cases brought by states concerning the enforcement of State Settlement Agreements. Despite legal defenses believed to be valid, these cases were settled to avoid further contentious litigation with the states involved. These enforcement actions involve alleged breaches of State Settlement Agreements based on specific actions taken by particular defendants. Accordingly, any future enforcement actions involving State Settlement Agreements will be reviewed by RJR Tobacco on the merits and should not be affected by the settlement of prior enforcement cases.

American Snuff Co. also believes that it has valid defenses to the smokeless tobacco litigation against it. American Snuff Co. asserted and will continue to assert some or all of these defenses in each case at the time and in the manner deemed appropriate by American Snuff Co. and its counsel. No verdict or judgment has been returned or entered against American Snuff Co. on any claim for personal injuries allegedly resulting from the use of smokeless tobacco. American Snuff Co. intends to defend vigorously all smokeless tobacco litigation claims asserted against it. No liability for pending smokeless tobacco litigation was recorded in RAI’s consolidated balance sheet as of December 31, 2011.

Cautionary Statement

Even though RAI’s management continues to conclude that the loss of any particular pending smoking and health tobacco litigation claim (except for the four Engle Progeny cases described below) against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular case concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual case-by-case basis, is not probable, the possibility of material losses related to such litigation is more than remote. Litigation is subject to many uncertainties, and generally, it is not possible to predict the outcome of any particular litigation pending against RJR Tobacco, American Snuff Co. or their affiliates or indemnitees, or to reasonably estimate the amount or range of any possible loss.

Although RJR Tobacco believes that it has valid bases for appeals of adverse verdicts in its pending cases, and RJR Tobacco and RAI believe they have valid defenses to all actions, and intend to defend all actions vigorously, it is possible that there could be further adverse developments in pending cases, and that additional cases could be decided unfavorably against RAI, RJR Tobacco or their affiliates or indemnitees. Determinations of liability or adverse rulings in such cases or in similar cases involving other cigarette manufacturers as defendants, even if such judgments are not final, could have a material adverse effect on the litigation against RJR Tobacco or its affiliates or indemnitees and could encourage the commencement of additional tobacco-related litigation. In addition, a number of political, legislative, regulatory and other developments relating to the tobacco industry and cigarette smoking have received wide media attention. These developments may negatively affect the outcomes of tobacco-related legal actions and encourage the commencement of additional similar litigation.

Although it is impossible to predict the outcome of such events on pending litigation and the rate new lawsuits are filed against RJR Tobacco or its affiliates or indemnitees, a significant increase in litigation or in

98

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

adverse outcomes for tobacco defendants, or difficulties in obtaining the bonding required to stay execution of judgments on appeal, could have a material adverse effect on any or all of these entities. Moreover, notwithstanding the quality of defenses available to RJR Tobacco and its affiliates and indemnitees in litigation matters, it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against RJR Tobacco or its affiliates or indemnitees.

Similarly, smokeless tobacco litigation is subject to many uncertainties. Notwithstanding the quality of defenses available to American Snuff Co., it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against American Snuff Co.

Litigation Affecting the Cigarette Industry

Overview

Introduction.    In connection with the B&W business combination, RJR Tobacco agreed to indemnify B&W and its affiliates against, among other things, certain litigation liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. Accordingly, the cases discussed below include cases brought solely against RJR Tobacco and its affiliates, including RAI and RJR; cases brought against both RJR Tobacco, its affiliates and B&W; and cases brought solely against B&W and assumed by RJR Tobacco in the B&W business combination.

During the fourth quarter of 2011, 19 tobacco-related cases, including nine Engle Progeny cases, were served against RJR Tobacco or its affiliates or indemnitees. On December 31, 2011, there were 170 cases pending against RJR Tobacco or its affiliates or indemnitees: 159 in the United States; 10 in Canada and one in Israel, as compared with 198 total cases on December 31, 2010. The U.S. case number does not include the 577 individual smoker cases pending in West Virginia state court as a consolidated action, 6,561 Engle Progeny cases (as hereinafter defined), involving approximately 7,852 individual plaintiffs, and 2,586 Broin II cases (as hereinafter defined), pending in the United States against RJR Tobacco or its affiliates or indemnitees. Of the U.S. cases pending on December 31, 2011, 18 are pending in federal court, 140 in state court, primarily in the following states: Florida (29 cases); Missouri (19 cases); New York (17 cases); Maryland (13 cases); Louisiana (12 cases); and California (11 cases).

The following table lists the categories of the U.S. tobacco-related cases pending against RJR Tobacco or its affiliates or indemnitees as of December 31, 2011, compared with the number of cases pending against RJR Tobacco, its affiliates or indemnitees as of September 30, 2011, as reported in RAI’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2011, filed with the SEC on October 28, 2011, and a cross-reference to the discussion of each case type.

99

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Case Type	RJR Tobacco’s Case  Numbers as of December 31, 2011			Change in Number of Cases Since September 30, 2011 Increase/(Decrease)			Page Reference
Individual Smoking and Health		97			4			112
West Virginia IPIC (Number of Plaintiffs)*		1(577	)		(– 11	)		114
Engle Progeny (Number of Plaintiffs)**		6,561 (7,852	)		– 32 (– 47	)		115
Broin II		2,586			No Change			125
Class-Action		13			– 2			125
Health-Care Cost Recovery		3			No Change			131
State Settlement Agreements-Enforcement and Validity; Adjustments		32			– 1			138
Antitrust		1			No Change			143
Other Litigation and Developments		12			– 3			144

* Includes as one case the 577 cases pending as a consolidated action In Re: Tobacco Litigation Individual Personal Injury Cases, sometimes referred to as West Virginia IPIC cases, described below. The West Virginia IPIC cases have been separated from the Individual Smoking and Health cases for reporting purposes.

** The Engle Progeny cases have been separated from the Individual Smoking and Health cases for reporting purposes. The number of cases may decrease as the result of many of the multiple plaintiff federal court cases either being dismissed or consolidated.

The following cases against RJR Tobacco and B&W have attracted significant attention: the Florida state court class-action case, Engle v. R. J. Reynolds Tobacco Co. and the related Engle Progeny cases, the Louisiana state court class-action case, Scott v. American Tobacco Co., and the case brought by the U.S. Department of Justice under the federal Racketeer Influenced and Corrupt Organizations Act, referred to as RICO.

In 2000, a jury in Engle rendered a punitive damages verdict in favor of the “Florida class” of approximately $145 billion against all defendants. In July 2006, the Florida Supreme Court, among other things, affirmed an appellate court’s reversal of the punitive damages award, decertified the class going forward, preserved several class-wide findings from the trial, including that nicotine is addictive and cigarettes are defectively designed, and authorized class members to avail themselves of these findings in individual lawsuits under certain conditions. After subsequent motions were resolved, the Florida Supreme Court issued its mandate on January 11, 2007, thus beginning a one-year period in which former class members were permitted to file individual lawsuits. In October 2007, the U.S. Supreme Court denied the defendants’ petition for writ of certiorari.

Individual Engle Progeny cases are pending in both federal and state court in Florida. As of December 31, 2011, 3,246 cases were pending in federal court, and 3,315 cases were pending in state court. These cases include approximately 7,852 plaintiffs. The number of cases will likely change due to individual plaintiffs being severed from multi-plaintiff cases and multi-plaintiff federal cases being dismissed or consolidated. In addition, as of December 31, 2011, RJR Tobacco was aware of 46 additional cases that had been filed but not served (with 319 plaintiffs). Fifty-seven trials have occurred in Florida state court since 2009, and numerous state court trials are scheduled for 2012.

As Engle Progeny litigation has progressed, the federal and state court systems have adopted different rules to govern those cases, and both have courts issuing conflicting opinions. For example, in Bernice Brown v. R. J. Reynolds Tobacco Co., the U.S. Court of Appeals for the Eleventh Circuit, referred to as the Eleventh Circuit, held that the preserved Engle findings establish only those issues “actually adjudicated” in the Engle class trial. In other words, based on the decision in Bernice Brown, the Engle findings would not prevent RJR Tobacco and

100

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

other defendants from raising issues and defenses that were not, or may not have been, resolved against them in Engle. The court further held that an Engle Progeny plaintiff bears the burden of showing, to a “reasonable degree of certainty,” that any issue the plaintiff seeks to treat as established in his favor was, in fact, actually raised and resolved in Engle. The court held that these standards were required by Florida preclusion law, and it reserved judgment on the question of whether the same standards were also required by the Due Process Clause of the U.S. Constitution. Prior to the Eleventh Circuit decision in Bernice Brown, three federal district court judges (including the judge in Bernice Brown) concluded that any broader use of the preserved Engle findings would violate both Florida preclusion law and federal due process.

The state courts in Florida, however, have taken two entirely different approaches since Bernice Brown. In Martin v. R. J. Reynolds Tobacco Co., the First District Court of Appeal, referred to as the First DCA, held that the Engle findings establish not only facts that were “actually adjudicated” in favor of the class in Engle, but also all facts that could have been decided in favor of the class. The court in Martin thus held that, “no matter the wording of the findings” in Engle, individual Engle Progeny plaintiffs need not “demonstrate the relevance of the findings to their lawsuits” in order to prevent litigation on otherwise contested issues of misconduct. The court in Martin expressly disagreed with the Eleventh Circuit decision in Bernice Brown on this point.

In Jimmie Lee Brown v. R. J. Reynolds Tobacco Co., the Fourth District Court of Appeal, referred to as the Fourth DCA, expressly disagreed with both Bernice Brown and Martin on the proper use of the Engle findings. Like Martin, but unlike Bernice Brown, the court in Jimmie Lee Brown held that the Engle findings establish certain issues of misconduct in every Engle Progeny case. Unlike Martin, however, the court in Jimmie Lee Brown held that class membership was not sufficient to establish claims for strict liability and negligence. The court held that, in addition to proving that addiction caused an injury to the smoker, the plaintiff also was required to prove that a product defect or negligence caused that injury. RJR Tobacco has sought further review of Jimmie Lee Brown in the Florida Supreme Court.

Finally, and most recently, in Waggoner v. R. J. Reynolds Tobacco Co., a district judge of the U.S. District Court for the Middle District of Florida adopted the preclusion standards set forth in Jimmie Lee Brown for Engle Progeny cases pending in federal court. The judge in Waggoner concluded that Martin and Jimmie Lee Brown effectively overruled Bernice Brown on questions of Florida law. The judge further held that the rule adopted in Martin and Jimmie Lee Brown, giving preclusive effect to any facts that the Engle jury could have decided against the defendants, does not violate due process. The Waggoner decision thus conflicts with the decisions of the other federal district judges who previously addressed the due process question. RJR Tobacco has sought interlocutory review of Waggoner in the Eleventh Circuit.

The Florida Supreme Court, the First DCA, and the Fourth DCA thus far have failed to address the due process argument. The First DCA in Martin did not mention due process, despite it being one of RJR Tobacco’s central contentions on appeal. Moreover, in five subsequent individual Engle Progeny appeals, the First DCA refused to issue any opinion; instead, it affirmed the plaintiffs’ verdicts by per curiam orders citing Martin with no explanation. The First DCA and the Fourth DCA have both refused to certify the question of the proper use of the Engle findings as one of exceptional importance warranting review by the Florida Supreme Court, even though that question affects every Engle Progeny case and notwithstanding the explicit disagreement between the state and federal courts on this issue. Moreover, on July 19, 2011, the Florida Supreme Court refused to exercise its discretionary jurisdiction to review Martin and issued summary denial of petitions in Campbell, Gray and Hall, which are discussed specifically below in “— Engle and Engle Progeny Cases.”

The Fourth DCA in Jimmie Lee Brown recognized RJR Tobacco’s due process argument as an important issue, but held that until the Florida Supreme Court addresses the issue, it is bound to follow the Florida Supreme Court’s opinion in Engle. To date, no other Florida District Court of Appeal has addressed the issues on which the Bernice Brown, Martin and Jimmie Lee Brown courts were divided, but RJR Tobacco has pending appeals

101

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

presenting these issues in the Second, Third and Fifth Florida District Courts of Appeal. RJR Tobacco is seeking review of its due process claims in the U.S. Supreme Court, sometimes referred to as the USSC, in Martin, as well as in Campbell, Gray and Hall.

In 2011, based on its evaluation of the Martin, Campbell, Gray and Hall cases, RJR Tobacco reflected an accrual for loss of $64 million on these cases ($53 million for compensatory and punitive damages and $11 million for attorneys’ fees and statutory interest through December 31, 2011). The following chart reflects the details related to these verdicts:

Plaintiff Case Name	RJR Tobacco Allocation of Fault			Compensatory Damages (as adjusted)*		Punitive Damages		Appeal Status
Martin		66	%	$	3,300,000	$	25,000,000	USSC petition filed
Campbell		39	%		3,040,000		—	USSC petition filed
Gray		60	%		4,200,000		2,000,000	USSC petition filed
Hall		65	%		3,250,000		12,500,000	USSC petition filed
Totals				$	13,790,000	$	39,500,000

* Compensatory damages are adjusted to reflect the reduction required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments should they ever have to be paid.

The following chart reflects the verdicts in the individual Engle Progeny cases that have been tried and remain pending as of December 31, 2011, in which a verdict has been returned in favor of the plaintiffs and against RJR Tobacco or B&W, or both, for which RJR Tobacco has reflected no liability as of December 31, 2011. It does not include the mistrials or verdicts returned in favor of RJR Tobacco or B&W, or both.

Plaintiff Case Name	RJR Tobacco Allocation of Fault			Compensatory Damages (as adjusted)*		Punitive Damages		Appeal Status
Sherman		50	%	$	775,000	$	—	Pending — Fourth DCA
Brown		50	%		600,000		—	Notice to invoke discretionary jurisdiction of Florida Supreme Court pending
Douglas		5	%		250,000		—	Pending — Second DCA
Cohen		33.3	%		3,300,000		10,000,000	Pending — Fourth DCA
Clay		60	%		2,100,000		17,000,000	Affirmed by First DCA per curiam; seeking further review
Townsend		51	%		5,500,000		40,800,000	Pending — First DCA
Putney		30	%		4,500,000		2,500,000	Pending — Fourth DCA
Grossman		25	%		484,000		—	Pending — Fourth DCA
Buonomo		77.5	%		4,060,000		15,700,000	Pending — Fourth DCA
Alexander		51	%		1,275,000		2,500,000	Affirmed by First DCA per curiam; seeking further review
Piendle		27.5	%		1,100,000		180,000	Pending — Fourth DCA
Koballa		30	%		300,000		—	Pending — Fifth DCA***
Webb		90	%		7,200,000		72,000,000	Pending — First DCA
Kirkland		10	%		10,000		250,000	Pending — Second DCA
Huish		25	%		188,000		1,500,000	Pending — First DCA
Mack		51	%		510,000		—	Pending — First DCA

102

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Plaintiff Case Name	RJR Tobacco Allocation of Fault			Compensatory Damages (as adjusted)*		Punitive Damages		Appeal Status
Andy Allen		45	%	$	2,700,000	$	8,100,000	Pending — First DCA
Jewett		20	%		219,000		—	Pending — First DCA
Reese		30	%		1,100,000		—	Pending — Third DCA
Soffer		40	%		2,000,000		—	Pending — First DCA
Ciccone		30	%		1,000,000		50,000	Pending — Fourth DCA
Weingart		3	%		4,500		—	Pending — Fourth DCA
Bowman		30	%		450,000		—	Pending — First DCA
Sury		20	%		200,000		—	Post-trial motions pending**
Hallgren		25	%		500,000		750,000	Post-trial motions pending**
Ward		30	%		300,000		1,700,000	Post-trial motion pending**
Totals				$	40,625,500	$	173,030,000

* Compensatory damages are adjusted to reflect the reduction required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments should they ever have to be paid.

** Should the pending post-trial motions be denied, RJR Tobacco will file a notice of appeal with the DCA in which the cases are pending.

*** The court in Koballa found RJR Tobacco not liable for the plaintiff’s injuries, but awarded damages. For a detailed description of the case, see “— Engle and Engle Progeny Cases” below.

As of December 31, 2011, jury verdicts in favor of the Engle Progeny plaintiffs had been entered against RJR Tobacco in the total amount of $54,415,500 in compensatory damages (as adjusted) and $212,530,000 in punitive damages, for a total of $266,945,500. All of these verdicts are at various stages in the appellate process, including Martin, Campbell, Gray and Hall, which RJR Tobacco is seeking review by the USSC. Except for those four cases, no liability for pending smoking and health litigation related to Engle Progeny cases was recorded in RAI’s consolidated balance sheet as of December 31, 2011. RJR Tobacco continues to believe that it has valid defenses in these cases, including the state preclusion law and federal due process issues that impact all Engle Progeny cases. RJR Tobacco has petitioned the USSC to review its due process claims in the Martin, Campbell, Gray and Hall cases and will do so in other cases as necessary and appropriate. Should RJR Tobacco not prevail in any particular individual Engle Progeny case or determine that in any individual Engle Progeny case an unfavorable outcome has become probable and the amount can be reasonably estimated, a loss would be recognized, which could have a material adverse effect on earnings and cash flows of RAI in a particular fiscal quarter or fiscal year.

This recognition of Engle Progeny cases as of December 31, 2011, is consistent with RAI’s and RJR Tobacco’s historic recognition related to such smoking and health litigation claims. It is the policy of RJR Tobacco and its affiliates to vigorously defend all such claims, including Engle Progeny cases. It is also the policy of RJR Tobacco to record any loss concerning litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. Accordingly, although RJR Tobacco has petitioned the USSC for review in the Martin, Campbell, Gray and Hall cases, RJR Tobacco recognized a liability for each of these cases as of December 31, 2011.

In 2004, a jury in Scott returned a verdict in favor of the “Louisiana class” for $591 million to establish a state-wide smoking cessation program. In 2007, the Louisiana Court of Appeal upheld class certification, significantly reduced the scope of recovery, and remanded the case for further proceedings. The Louisiana and

103

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

U.S. Supreme Courts denied the defendants’ applications for writ of certiorari. In July 2008, the trial court entered an amended judgment in favor of the class for approximately $263 million plus interest from June 30, 2004. In April 2010, the Louisiana Fourth Circuit Court of Appeal amended the final judgment, and as amended, affirmed the judgment. Pursuant to the judgment, the defendants were required to deposit with the court $242 million with judicial interest from July 21, 2008, until paid. In September 2010, the defendants’ application for writ of certiorari with the Louisiana Supreme Court and emergency motion to stay execution of judgment in the Supreme Court of Louisiana were denied. The U.S. Supreme Court also granted the application to stay the judgment pending applicants’ timely filing, and the Court’s disposition, of a petition for writ of certiorari. The defendants’ petition for writ of certiorari in the U.S. Supreme Court was denied on June 27, 2011. RJR Tobacco accrued $139 million, the portion of the judgment allocated to RJR Tobacco and B&W, in the second quarter of 2011. RJR Tobacco paid the judgment in August 2011. In December 2011, the plaintiffs filed a motion for assessment of attorneys’ fees and costs for the prosecution of the case.

In the U.S. Department of Justice case, brought in 1999 in the U.S. District Court for the District of Columbia, the government sought, among other forms of relief, the disgorgement of profits pursuant to the civil provisions of RICO. The U.S. Court of Appeals for the District of Columbia ruled in 2005 that disgorgement is not an available remedy in the case. The bench trial ended in June 2005, and the court, in August 2006, issued its ruling, among other things, finding certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, imposing no direct financial penalties on the defendants, but ordering the defendants to make certain “corrective communications” in a variety of media and enjoining the defendants from using certain brand descriptors. Both sides appealed to the U.S. Court of Appeals for the District of Columbia. In May 2009, the U.S. Court of Appeals largely affirmed the findings against the tobacco company defendants and remanded to the trial court for further proceedings. The U.S. Supreme Court denied the parties’ petitions for writ of certiorari in June 2010. Post-remand proceedings are underway.

For a detailed description of these cases, see “— Engle and Engle Progeny Cases,” “— Class-Action Suits — Medical Monitoring and Smoking Cessation Case” and “— Health-Care Cost Recovery Cases — Department of Justice Case” below.

In November 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the MSA with 46 U.S. states, Washington, D.C. and certain U.S. territories and possessions. These cigarette manufacturers previously settled four other cases, brought on behalf of Mississippi, Florida, Texas and Minnesota, by separate agreements with each state. These State Settlement Agreements:

• settled all health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions;

• released the major U.S. cigarette manufacturers from various additional present and potential future claims;

• imposed future payment obligations in perpetuity on RJR Tobacco, B&W and other major U.S. cigarette manufacturers; and

• placed significant restrictions on their ability to market and sell cigarettes and smokeless tobacco products.

Payments under the State Settlement Agreements are subject to various adjustments for, among other things, the volume of cigarettes sold, relevant market share and inflation. See “— Health-Care Cost Recovery Cases — State Settlement Agreements” below for a detailed discussion of the State Settlement Agreements, including RAI’s operating subsidiaries’ monetary obligations under these agreements. RJR Tobacco records the allocation of settlement charges as products are shipped.

104

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Scheduled Trials.    Trial schedules are subject to change, and many cases are dismissed before trial. It is likely, however, that RJR Tobacco and other cigarette manufacturers will continue to face an increased number of tobacco-related trials when compared to recent years. There are seven cases, exclusive of Engle Progeny cases, scheduled for trial as of December 31, 2011 through December 31, 2012, for RJR Tobacco or its affiliates and indemnitees: three other non-smoking and health cases, two individual smoking and health cases, one antitrust case and one class action. There are 62 Engle Progeny cases against RJR Tobacco and/or B&W set for trial through December 31, 2012, but it is not known how many of these cases will actually be tried.

Trial Results.    From January 1, 2009 through December 31, 2011, 64 smoking and health and health-care cost recovery cases in which RJR Tobacco or B&W were defendants were tried, including 9 trials for cases where mistrials were declared in the original proceedings. Verdicts in favor of RJR Tobacco, B&W and, in some cases, RJR Tobacco, B&W and other defendants, were returned in 35 cases, including 17 mistrials, tried in Florida (30), Missouri (2) and West Virginia (3). Verdicts in favor of the plaintiffs were returned in 27 cases tried in Florida and one in Connecticut. One case in Florida was dismissed during trial.

In the fourth quarter of 2011, four Engle Progeny cases in which RJR Tobacco was a defendant were tried:

• In Junious v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants on October 20, 2011.

• In Szymanski v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants on October 20, 2011.

• In Sury v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, William Sury, 60% at fault, RJR Tobacco 20% at fault, and the other defendant 20% at fault, and awarded $1 million in compensatory damages and no punitive damages.

• In Cox v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco on December 16, 2011.

For a detailed description of the above-described cases, see “— Engle and Engle Progeny Cases” below.

In addition, since the end of the fourth quarter of 2011, jurors returned verdicts in the following Engle Progeny cases:

• In Hallgren v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Claire Hallgren, 50% at fault, RJR Tobacco to be 25% at fault, and the other defendant 25% at fault, and awarded $2 million in compensatory damages and $750,000 in punitive damages against each defendant.

• In Ward v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Mattie Ward, 50% at fault, RJR Tobacco to be 30% at fault, and the remaining defendants collectively to be 20% at fault, and awarded $1 million in compensatory damages and $1.7 million in punitive damages against RJR Tobacco only.

• In Larkin v. R. J. Reynolds Tobacco Co., the court declared a mistrial after the jury informed the court that they were unable to reach a verdict.

105

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

For a detailed description of the above-described cases, see “— Engle and Engle Progeny Cases” below.

In the fourth quarter of 2011, no non-Engle Progeny individual smoking and health cases in which RJR Tobacco was a defendant were tried.

The following chart reflects the verdicts in the smoking and health cases or health-care cost recovery cases that have been tried and remain pending as of December 31, 2011, in which verdicts have been returned in favor of the plaintiffs and against RJR Tobacco or B&W, or both.

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
December 18, 2003	Frankson v. Brown & Williamson Tobacco Corp. [Individual]	Supreme Court, Kings County (Brooklyn, NY)	$350,000 in compensatory damages; 50% fault assigned to B&W; $20 million in punitive damages, of which $6 million was assigned to B&W, and $2 million to a predecessor company.	See “— Individual Smoking and Health Cases” below.
February 2, 2005	Smith v. Brown & Williamson Tobacco Corp. [Individual]	Circuit Court, Jackson County (Independence, MO)	$2 million in compensatory damages; 25% of fault assigned to B&W, which reduced the award to $500,000; $20 million in punitive damages. In August 2009, a new trial on punitive damages was conducted and the jury awarded $1.5 million.	See “— Individual Smoking and Health Cases” below.

106

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
August 17, 2006	United States v. Philip Morris USA, Inc. [Governmental Health-Care Cost Recovery]	U.S. District Court, District of Columbia (Washington, DC)	RJR Tobacco and B&W were found liable for civil RICO claims; were enjoined from using certain brand descriptors and from making certain misrepresentations; and were ordered to make corrective communications on five subjects, including smoking and health and addiction, to reimburse the U.S. Department of Justice appropriate costs associated with the lawsuit, and to maintain document web sites.	See “— Health-Care Cost Recovery Cases - Department of Justice Case” below.
May 5, 2009	Sherman v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$1.55 million in compensatory damages; 50% of fault assigned to RJR Tobacco, which reduced the award to $775,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 22, 2009	Brown v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$1.2 million in compensatory damages; 50% of fault assigned to RJR Tobacco, which reduced the award to $600,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 29, 2009	Martin v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$5 million in compensatory damages; 66% of fault assigned to RJR Tobacco, which reduced the award to $3.3 million; $25 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.

107

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
August 19, 2009	Campbell v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$7.8 million in compensatory damages; 39% of fault assigned to RJR Tobacco, which reduced the award to $3.04 million. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
February 8, 2010	Gray v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$7 million in compensatory damages; 60% of fault assigned to RJR Tobacco, which reduced the award to $4.2 million; $2 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
March 10, 2010	Douglas v. Philip Morris USA, Inc. [Engle Progeny]	Circuit Court, Hillsborough County, (Tampa, FL)	$5 million in compensatory damages; 5% of fault assigned to RJR Tobacco, which reduced the award to $250,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
March 11, 2010	Hall v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$5 million in compensatory damages; 65% of fault assigned to RJR Tobacco, which reduced the award to $3.25 million; $12.5 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
March 10, 2010	Cohen v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$10 million in compensatory damages; 33.3% of fault assigned to RJR Tobacco, which reduced the award to $3.3 million; $20 million in punitive damages, of which $10 million was assigned to RJR Tobacco.	See “— Engle and Engle Progeny Cases” below.

108

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
April 13, 2010	Clay v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$3.5 million in compensatory damages; 60% of fault assigned to RJR Tobacco, which reduced the award to $2.1 million; $18 million in punitive damages, of which $17 million was assigned to RJR Tobacco.	See “— Engle and Engle Progeny Cases” below.
April 21, 2010	Townsend v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$10.8 million in compensatory damages and $80 million punitive damages; 51% of fault assigned to RJR Tobacco, which reduced the award to $5.5 million in compensatory damages; $40.8 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
April 26, 2010	Putney v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$15.1 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $4.5 million; $5 million in punitive damages, of which $2.5 million was assigned to RJR Tobacco.	See “— Engle and Engle Progeny Cases” below.
April 29, 2010	Grossman v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$1.9 million in compensatory damages; 25% of fault assigned to RJR Tobacco, which reduced the award to $484,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 20, 2010	Buonomo v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$5.2 million in compensatory damages; 77.5% of fault assigned to RJR Tobacco, which reduced the award to $4.06 million; $25 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.

109

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
May 26, 2010	Izzarelli v. R. J. Reynolds Tobacco Co. [Individual S&H]	U.S. District Court, District of Connecticut, (Bridgeport, CT)	$13.9 million in compensatory damages; 58% of fault assigned to RJR Tobacco, which reduced the award to $8.08 million against RJR Tobacco; $3.97 million in punitive damages.	See “— Individual Smoking and Health Cases” below.
June 18, 2010	Alexander v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$2.5 million in compensatory damages; 51% of fault assigned to RJR Tobacco, which reduced the award to $1.275 million; $2.5 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
August 5, 2010	Piendle v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Palm Beach County, (West Palm Beach, FL)	$4 million in compensatory damages; 27.5% of fault assigned to RJR Tobacco, which reduced the award to $1.1 million; $180,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.
November 15, 2010	Webb v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Levy County, (Bronson, FL)	$8 million in compensatory damages; 90% of fault assigned to RJR Tobacco, which reduced the award to $7.2 million; $72 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
February 10, 2011	Kirkland v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Hillsborough County, (Tampa, FL)	$100,000 in compensatory damages; 10% of fault assigned to RJR Tobacco, which reduced the award to $10,000; $250,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.
February 22, 2011	Huish v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$750,000 in compensatory damages; 25% of fault assigned to RJR Tobacco, which reduced the award to $187,500; $1.5 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.

110

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
March 18, 2011	Mack v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$1 million in compensatory damages; 51% of fault assigned to RJR Tobacco, which reduced the award to $510,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
April 26, 2011	Andy Allen v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$6 million in compensatory damages; 45% of fault assigned to RJR Tobacco, which reduced the award to $2.7 million; $17 million in punitive damages against each defendant awarded.	See “— Engle and Engle Progeny Cases” below.
May 20, 2011	Jewett v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$1.1 million in compensatory damages; 20% of fault assigned to RJR Tobacco, which reduced the award to $218,600. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 20, 2011	Reese v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Miami-Dade County, (Miami, FL)	$3.6 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $1.1 million. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
June 16, 2011	Soffer v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$5 million in compensatory damages; 40% of fault assigned to RJR Tobacco, which reduced the award to $2 million. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
July 15, 2011	Ciccone v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$3.2 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $1 million; $50,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.

111

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
July 19, 2011	Weingart v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Palm Beach County, (West Palm Beach, FL)	Jury did not award damages; however, the plaintiff was awarded $150,000 on September 16, 2011.	See “— Engle and Engle Progeny Cases” below.
September 23, 2011	Bowman v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$1.5 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $450,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
November 28, 2011	Sury v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$1 million in compensatory damages; 20% of fault assigned to RJR Tobacco, which reduced the award to $200,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
January 24, 2012	Hallgren v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Highlands County, (Sebring, FL)	$2 million in compensatory damages; 25% of fault assigned to RJR Tobacco, which reduced the award to $500,000; $750,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.
January 25, 2012	Ward v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$1 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $300,000; $1.7 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.

Individual Smoking and Health Cases

As of December 31, 2011, 97 individual cases were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both. This category of cases includes smoking and health cases alleging personal injury brought by or on behalf of individual plaintiffs, but does not include the Broin II, Engle Progeny or West Virginia IPIC cases discussed below. A total of 94 of the individual cases are brought by or on behalf of individual smokers or their survivors, while the remaining three cases are brought by or on behalf of individuals or their survivors alleging personal injury as a result of exposure to environmental tobacco smoke, referred to as ETS.

112

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Below is a description of the individual smoking and health cases against RJR Tobacco or B&W, or both, which went to trial or were decided during the period from January 1, 2011 to December 31, 2011, or remained on appeal as of December 31, 2011.

On August 15, 2003, the jury returned a verdict in favor of B&W in Eiser v. Brown & Williamson Tobacco Corp., a case filed in March 1999 in the Court of Common Pleas, Philadelphia County, Pennsylvania. The plaintiff, Lois Eiser, sought compensatory and punitive damages in an amount in excess of $50,000, together with interest, costs and attorneys’ fees in this wrongful death action against B&W. In January 2006, the Superior Court of Pennsylvania affirmed the verdict. The Pennsylvania Supreme Court granted the plaintiff’s petition to appeal, and on December 28, 2007, remanded the case to the Superior Court for further review of certain issues. In August 2010, the Superior Court of Pennsylvania entered a memorandum affirming the final judgment. In December 2011, the plaintiff’s petition for permission to appeal to the Pennsylvania Supreme Court was denied. The deadline for the plaintiff to file a petition for writ of certiorari with the U.S. Supreme Court is March 5, 2012.

On December 18, 2003, the jury returned a verdict in favor of the plaintiff in Frankson v. Brown & Williamson Tobacco Corp., a case filed in August 2000 in Supreme Court, Kings County, New York, awarded $350,000 in compensatory damages and eventually returned a verdict of $20 million in punitive damages against the defendants in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco, who was dismissed prior to trial, and B&W. Other manufacturers were dismissed before trial. The plaintiff, Gladys Frankson, alleged that Mr. Frankson became addicted to nicotine, was unable to cease smoking, developed lung cancer and died as a result. The defendants as a group and the deceased smoker were each found to be 50% at fault. On January 9, 2004, the jury awarded $20 million in punitive damages, assigning $6 million to B&W and $2 million to American Tobacco, a predecessor company to B&W. In June 2004, the parties’ post-trial motions were denied by the trial judge, except that the trial judge granted a new trial unless the parties consented to an increase in compensatory damages to $500,000 and a decrease in punitive damages to $5 million, of which $4 million would be assigned to B&W. The plaintiff stipulated to the reduction in punitive damages in January 2005. Defendants filed a notice of appeal of the orders on post-trial motions in January 2005. In July 2006, the Appellate Division, New York Supreme Court, Second Department, directed that the plaintiffs’ claims for design defect be dismissed, but otherwise affirmed the orders denying defendants’ post-trial motions. Following remand from this appellate decision, the plaintiff withdrew her request for additur of the compensatory damages, and in December 2006, the trial judge granted this request, and reinstated the original $350,000 compensatory damages jury verdict.

On June 26, 2007, final judgment was entered against the defendants in the amount of approximately $6.8 million, including interest through the date the judgment was entered and costs. The defendants filed a notice of appeal to the Appellate Division, New York Supreme Court, Second Department. Pursuant to its agreement to indemnify B&W, RJR Tobacco posted a supersedeas bond in the amount of $8.018 million. In September 2009, the New York Supreme Court, Appellate Division, affirmed the compensatory damages award, set aside the punitive damages award and remanded the case to the Kings County Supreme Court for a new trial on punitive damages. No date has been set for the punitive damages retrial.

On February 1, 2005, the jury returned a split verdict in Smith v. Brown & Williamson Tobacco Corp., a case filed in May 2003 in Circuit Court, Jackson County, Missouri, finding in favor of B&W on two counts, fraudulent concealment and conspiracy, and finding in favor of the plaintiffs on negligence, which incorporates failure to warn and product defect claims. The plaintiff, Lincoln Smith, claimed that the defendant’s tobacco products caused Mrs. Smith’s death from lung cancer. The plaintiffs were awarded $2 million in compensatory damages and $20 million in punitive damages; however, the jury found the plaintiff to be 75% at fault and B&W 25% at fault, and thus the compensatory award was reduced to $500,000. B&W appealed to the Missouri Court of Appeals, and in July 2007, the court affirmed the compensatory damages and ordered a new trial on punitive

113

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

damages. In December 2008, the Missouri Court of Appeals issued an opinion that affirmed in part, reversed in part, and remanded the case for further proceedings on the issue of punitive damages. Trial on the issue of punitive damages began in July 2009. On July 29, 2009, RJR Tobacco, on behalf of B&W, paid the compensatory damages verdict, plus interest, in the amount of approximately $700,000. In August 2009, the jury returned a verdict for the plaintiffs, finding B&W liable for damages for aggravating circumstances, and on August 20, 2009, awarded the plaintiffs $1.5 million in punitive damages. The court denied the plaintiffs’ and the defendant’s post-trial motions. B&W and the plaintiffs filed notices of appeal in December 2009. Oral argument occurred on September 28, 2011. A decision is pending.

On May 26, 2010, a jury returned a verdict in favor of the plaintiff in Izzarelli v. R. J. Reynolds Tobacco Co., a case filed in December 1999 in the U.S. District Court for the District of Connecticut. The plaintiff sought to recover damages for personal injuries that the plaintiff alleges she sustained as a result of unsafe and unreasonably dangerous cigarette products and for economic losses she sustained as a result of unfair trade practices of the defendant. The jury found RJR Tobacco to be 58% at fault and the plaintiff to be 42% at fault, awarded $13.9 million in compensatory damages and found the plaintiff to be entitled to punitive damages. In December 2010, the court awarded the plaintiff $3.97 million in punitive damages. Final judgment was entered on December 30, 2010, in the amount of $11.95 million. The court granted the plaintiff’s motion for offer of judgment interest, and awarded the plaintiff $15.8 million for the period of December 6, 1999 up to and including December 5, 2010, and approximately $4,000 per day thereafter until an amended judgment was entered. The amended judgment was entered in the amount of approximately $28.1 million on March 4, 2011. The court denied RJR Tobacco’s motion for a new trial in August 2011, and RJR Tobacco filed a notice of appeal in September 2011. Briefing is underway.

On May 19, 2011, a jury returned a verdict in favor of RJR Tobacco in Hargroves v. R. J. Reynolds Tobacco Co., a case filed in December 2005 in the Circuit Court, Hillsborough County, Florida. The plaintiff alleged that as a result of using the defendant’s products, the decedent, Debra Hargroves, suffered from lung cancer, emphysema, heart disease and other smoking-related diseases and/or conditions. Final judgment was entered, and the plaintiff filed a motion for a new trial. At a hearing in June 2011, the court denied the plaintiff’s motion. The plaintiff filed a notice of appeal, and RJR Tobacco filed a notice of cross appeal in August 2011. Briefing is underway.

West Virginia IPIC

In West Virginia, as of December 31, 2011, 577 individual claims remain pending in a consolidated action, In re: Tobacco Litigation Individual Personal Injury Cases. The defendants are Philip Morris, Lorillard and RJR Tobacco (including claims concerning The American Tobacco Company and B&W). The Case Management Order currently calls for these cases to be resolved in a two phase procedure — a common issue trial in Phase I, and, if plaintiffs prevail on one or more issues, a Phase II, consisting of individual trials of liability, medical causation, compensatory damages and punitive damages for each of the individual plaintiffs. The Phase I trial will focus on whether defendants manufactured defective products, whether their conduct was tortious and whether their conduct meets the standard for a potential award of punitive damages under West Virginia law. There will be no lump sum award of punitive damages and the Phase I jury will not be asked to set a punitive multiplier. Instead, if the jury finds that a defendant’s conduct meets the punitive standard, then plaintiffs in their individual trials in Phase II will have the chance to ask Phase II juries to consider awarding punitive damages to each plaintiff on a case-by-case basis. Phase I trials were initiated twice in 2010 in Kanawha County (Charleston), resulting in mistrials in February and June 2010, due to an inability to find a sufficient number of impartial jurors from which to select a jury. The court moved the case to Ohio County (Wheeling), and the Phase I trial commenced again on October 19, 2011. The court declared a mistrial on November 8, 2011. A new trial date has not been scheduled.

114

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Engle and Engle Progeny Cases

Trial began in July 1998 in Engle v. R. J. Reynolds Tobacco Co., a case filed in May 1994, in Circuit Court, Miami-Dade County, Florida, in which a class consisting of Florida residents, or their survivors, alleged diseases or medical conditions caused by their alleged “addiction” to cigarettes. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking actual damages and punitive damages in excess of $100 billion each and the creation of a medical fund to compensate individuals for future health-care costs. In July 1999, the jury found against RJR Tobacco, B&W and the other cigarette-manufacturer defendants in the initial phase, which included common issues related to certain elements of liability, general causation and a potential award of, or entitlement to, punitive damages.

On July 14, 2000, in the second phase of the trial, the jury returned a punitive damages verdict in favor of the “Florida class” of approximately $145 billion against all the defendants, with approximately $36.3 billion and $17.6 billion being assigned to RJR Tobacco and B&W, respectively.

In November 2000, the trial judge denied all post-trial motions and entered judgment. The Florida Third District Court of Appeal, referred to as Third DCA, reversed the trial court’s final judgment and remanded the case to the Miami-Dade County Circuit Court with instructions to decertify the class. The class appealed, and the Florida Supreme Court accepted the case in May 2004.

In July 2006, the court affirmed the dismissal of the punitive damages award and decertified the class, on a going-forward basis. The court preserved a number of class-wide findings from Phase I of the trial, including that cigarettes can cause certain diseases, that nicotine is addictive and that defendants placed defective and unreasonably dangerous cigarettes on the market, and authorized former class members to avail themselves of those findings under certain conditions in individual lawsuits, provided they commence those lawsuits within one year of the date the court’s decision became final. The court specified that the eligible plaintiffs are confined to those Florida citizen residents who suffered or died from smoking-related illnesses that “manifested” themselves on or before November 21, 1996, and that were caused by an addiction to cigarettes that contain nicotine.

In August 2006, RJR Tobacco and the other defendants filed a rehearing motion arguing, among other things, that the findings from the Engle trial were not sufficiently specific to serve as the basis for further proceedings and that the Florida Supreme Court’s decision denied the defendants due process. The plaintiffs also filed a rehearing motion arguing that some smokers who became sick after November 21, 1996, and who were therefore not class members, should nevertheless have the statute of limitations tolled since they may have refrained from filing suit earlier in the mistaken belief that they were Engle class members. In December 2006, the Florida Supreme Court withdrew its July 2006, decision and issued a revised opinion, in which it set aside the jury’s findings of a conspiracy to misrepresent and clarified that the Engle jury’s finding on express warranty were preserved for use by eligible plaintiffs. The court also denied the plaintiffs’ motion and confirmed that the eligible plaintiffs were limited to those individuals who developed alleged smoking-related illnesses that manifested themselves on or before November 21, 1996.

In the fourth quarter of 2007, the defendants’ petition for writ of certiorari and petition for rehearing with the U.S. Supreme Court were both denied.

Pursuant to the Florida Supreme Court’s July 2006, ruling in Engle v. R. J. Reynolds Tobacco Co., which decertified the class, eligible plaintiffs had one year from January 11, 2007, in which to file individual lawsuits. In addition, some individuals who filed suit prior to January 11, 2007, and who claimed they meet the conditions in Engle, also attempted to avail themselves of the Engle ruling. Lawsuits by individuals requesting the benefit of the Engle ruling, whether filed before or after the January 11, 2007, mandate, are referred to as the Engle Progeny cases. As of December 31, 2011, RJR Tobacco had been served in 6,561 Engle Progeny cases in both

115

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

state and federal courts in Florida. These cases include approximately 7,852 plaintiffs. The number of cases will likely change due to individual plaintiffs being severed from multi-plaintiff cases. Many of these cases are in active discovery or nearing trial.

Three federal district courts ruled that the findings in the first phase of the Engle proceedings cannot be used to satisfy elements of plaintiffs’ claims, and two of those rulings, in Bernice Brown v. R. J. Reynolds Tobacco Co. and Burr v. Philip Morris USA, Inc., were certified by the trial court for interlocutory review. In July 2010, the Eleventh Circuit held, as a matter of Florida law, that the findings from the first phase of the Engle proceedings cannot be given greater effect than what the Engle jury found. Because it rejected plaintiffs’ approach on state-law grounds, the court did not find it necessary to consider whether that approach would violate the Due Process Clause of the U.S. Constitution.

On December 14, 2010, the First DCA rejected the Eleventh Circuit’s holding and concluded, in the Martin v. R. J. Reynolds Tobacco Co. case, that the Engle findings “establish the conduct of elements” of plaintiffs’ claims. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s request to review the decision of the intermediate state appellate court. On September 21, 2011, the Fourth DCA in Jimmie Lee Brown disagreed on state-law grounds with the First DCA’s decision in Martin as well as the Eleventh Circuit and in Bernice Brown. RJR Tobacco has sought review of Jimmie Lee Brown with the Florida Supreme Court. The defendants also asked the federal district court in Jacksonville to rule on their constitutional due process objection to the use of the Engle findings to satisfy elements of plaintiffs’ claims. The court ruled that application of the Engle findings would not violate the defendants’ due process rights. The defendants have moved to certify the issue for appeal to the Eleventh Circuit. A decision is pending.

In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applied to all Engle Progeny cases in the aggregate. In May, 2011, Florida removed the provision that allowed it to expire on December 31, 2012. The bond cap for any given individual Engle Progeny case varies depending on the number of judgments in effect at a given time, but never exceeds $5 million per case. The legislation, which became effective in June 2009 and 2011, applies to judgments entered after the original 2009 effective date. The plaintiffs have challenged the constitutionality of the bond cap in four of the cases discussed below. The Alachua County court upheld the bond cap in three of those cases, and the Escambia County court upheld the bond cap in the fourth case. The First DCA affirmed the trial court’s decision in all four cases. The First DCA issued a written opinion in Hall v. R. J. Reynolds Tobacco Co., on July 12, 2011, explaining why the statute is constitutional. The court also stated that the issues are likely to continue until they are definitively resolved by the Florida Supreme Court. As a result, the court certified to the Florida Supreme Court the question of whether the bond cap violates the Florida Constitution by limiting the amount of the bond necessary to obtain an automatic stay of the judgment against a signatory to the tobacco settlement agreement with the State of Florida. On January 23, 2012, the Florida Supreme Court decided to accept jurisdiction over the issue. Briefing is underway.

Below is a description of the Engle Progeny cases against RJR Tobacco or B&W, or both, which went to trial or were decided during the period from January 1, 2011 to December 31, 2011, or remained on appeal as of December 31, 2011.

On May 5, 2009, in Sherman v. R. J. Reynolds Tobacco Co., a case filed in September 2007 in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff. The plaintiff, Melba Sherman, alleged that as a result of using the defendant’s products, the decedent, John Sherman, developed lung cancer and died. The plaintiff sought compensatory damages and an unspecified amount of punitive damages. On May 8, 2009, the jury awarded compensatory damages of $1.55 million and found the decedent to be 50% at fault. No punitive damages were awarded. The court entered final judgment in the amount of $775,000 in June 2009. RJR Tobacco filed a notice of appeal to the Fourth DCA, and posted a supersedeas bond in the amount of

116

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

approximately $900,000. The plaintiff filed a notice of cross appeal of the final judgment in July 2009. Oral argument occurred on May 10, 2011. A decision is pending.

On May 20, 2009, in Jimmie Lee Brown v. R. J. Reynolds Tobacco Co., a case filed in March 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff. The plaintiff alleged that the decedent, Roger Brown, developed smoking related diseases, which resulted in his death. The plaintiff sought compensatory damages and an unspecified amount of punitive damages. The jury later returned a verdict that the decedent was 50% at fault for his injuries and awarded compensatory damages of $1.2 million. No punitive damages were awarded. In June 2009, RJR Tobacco’s post-trial motions were denied, and the court entered final judgment in the amount of $600,000. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of approximately $700,000 in July 2009. In September 2011, the Fourth DCA affirmed the trial court’s judgment. RJR Tobacco filed a motion for certification to the Florida Supreme Court, which was denied on October 21, 2011. RJR Tobacco filed a notice to invoke discretionary jurisdiction of the Florida Supreme Court. A decision is pending.

On May 29, 2009, in Martin v. R. J. Reynolds Tobacco Co., a case filed in October 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 66% at fault for the decedent’s injuries, and awarded $5 million in compensatory damages. The plaintiff alleged that as a result of Benny Martin’s use of the defendant’s tobacco products, he developed lung cancer and other medical conditions and died. The plaintiff, Mathilde Martin, sought an unspecified amount of compensatory and punitive damages. On June 1, 2009, the jury returned a punitive damages award of $25 million. In September 2009, the court entered final judgment, awarding the plaintiff the sum of $3.3 million in compensatory damages and $25 million in punitive damages, and RJR Tobacco filed a notice of appeal to the First DCA. In October 2009, RJR Tobacco posted a supersedeas bond in the amount of approximately $5 million, and the plaintiff filed a notice of cross appeal of the final judgment. The First DCA affirmed the final judgment in December 2010. RJR Tobacco asked the Florida Supreme Court to accept jurisdiction and review the decision of the First DCA. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s request to review the decision. RJR Tobacco posted a supersedeas bond in the amount of $15 million in July 2011. The bond will replace the original bond that was posted and stay execution of the judgment to allow RJR Tobacco to seek review with the U.S. Supreme Court. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

On August 19, 2009, in Campbell v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Betty Campbell, to be 57% at fault, RJR Tobacco to be 39% at fault and the remaining defendants to be 4% at fault, and awarded $7.8 million in compensatory damages. No punitive damages were awarded. The plaintiff alleged that as a result of Mrs. Campbell’s addiction to cigarettes, she suffered and died from various smoking related diseases, including chronic obstructive pulmonary disease. The plaintiff sought judgment against each defendant for an amount in excess of $15,000, taxable costs, punitive damages and interest. In September 2009, the court entered final judgment against RJR Tobacco in the amount of $3.04 million. RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of approximately $3 million in January 2010. In March 2011, the Florida First DCA affirmed per curian the trial court’s decision based on its prior ruling in Martin. RJR Tobacco moved the First DCA to certify the case as one of great public importance, which is the first step in seeking review by the Florida Supreme Court, but the court denied the motion. The defendants filed a notice to invoke discretionary jurisdiction of the Florida Supreme Court. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s petition to review the decision. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

On February 5, 2010, in Gray v. R. J. Reynolds Tobacco Co., a case filed in November 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, Carolyn Gray. The jury found

117

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

the decedent, Charles Gray, to be 40% at fault and RJR Tobacco to be 60% at fault for Mr. Gray’s injuries, and awarded $7 million in compensatory damages. On February 8, 2010, the jury awarded $2 million in punitive damages. Mrs. Gray alleged that as a result of her husband’s addiction and use of RJR Tobacco’s products, he died from lung cancer. Mrs. Gray sought an unspecified amount of compensatory and punitive damages. In March 2010, the court entered final judgment against RJR Tobacco in the amount of $4.2 million in compensatory damages and $2 million in punitive damages. In July 2010, RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of $5 million. In June 2011, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. The defendants filed a notice to invoke discretionary jurisdiction of the Florida Supreme Court. On July 20, 2011, the Florida Supreme Court denied RJR Tobacco’s petition to review the decision. RJR Tobacco posted a supersedeas bond in the amount of $6.2 million in July 2011. The bond will replace the original bond that was posted and stay execution of the judgment to allow RJR Tobacco to seek review with the U.S. Supreme Court. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

On February 25, 2010, in Grossman v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Broward County, Florida, the court declared a mistrial due to the jury’s inability to reach a decision. The plaintiff alleged that as a result of the addiction of the decedent, Laura Grossman, to cigarettes, she developed lung cancer and died. The plaintiff sought damages in excess of $15,000 and all taxable costs and interest. Retrial began in March 2010. On April 21, 2010, the jury returned a verdict in favor of the plaintiff in Phase I, finding that the decedent was addicted to cigarettes containing nicotine and the addiction was the legal cause of her death by lung cancer. On April 29, 2010, the jury awarded $1.9 million in compensatory damages and no punitive damages. The jury also found RJR Tobacco to be 25% at fault, the decedent to be 70% at fault and the decedent’s spouse to be 5% at fault. Final judgment was entered in June 2010, in the amount of $483,682. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of approximately $484,000 in July 2010. The plaintiff filed a notice of cross appeal. Briefing is complete. Oral argument has not been scheduled.

On March 10, 2010, in Douglas v. Philip Morris USA, Inc., a case filed in October 2007 in Circuit Court, Hillsborough County, Florida, a jury returned a verdict for the plaintiff, found the decedent, Charlotte Douglas, to be 50% at fault, RJR Tobacco to be 5% at fault and the remaining defendants to be 45% at fault, and awarded $5 million in compensatory damages. No punitive damages were awarded. The plaintiff alleged that as a result of the decedent’s addiction to smoking the defendants’ cigarettes, she suffered bodily injury and died. In March 2010, the court entered final judgment against RJR Tobacco in the amount of $250,000. RJR Tobacco filed a notice of appeal to the Second District Court of Appeal, referred to as the Second DCA, and posted a supersedeas bond in the amount of $250,000. Oral argument occurred on October 4, 2011. A decision is pending.

In Hall v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Alachua County, Florida, the jury returned a verdict in favor of the plaintiff on March 11, 2010. The jury also found the decedent, Arthur Hall, to be 35% at fault and RJR Tobacco to be 65% at fault, and awarded $5 million in compensatory damages. On March 12, 2010, the jury returned a $12.5 million punitive damages award. The plaintiff alleged that as a result of the decedent’s use of the defendant’s products he suffered from lung cancer and died. In March 2010, the court entered final judgment in the amount of $3.25 million in compensatory damages and $12.5 million in punitive damages. RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of $5 million in May 2010. The plaintiff filed a notice of cross appeal. In May 2011, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. RJR Tobacco filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s petition to review the decision. RJR Tobacco posted a supersedeas bond in the amount of $15 million in July 2011. The bond will replace the original bond that was posted and stay execution of the judgment to allow RJR Tobacco to seek review with the U.S. Supreme Court. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

118

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

On March 10, 2010, in Cohen v. R. J. Reynolds Tobacco Co., a case filed in May 2007 in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff. The plaintiff alleged that the decedent, Nathan Cohen, developed lung cancer as a result of using the defendants’ products, and sought in excess of $15,000 compensatory damages and unspecified punitive damages. On March 24, 2010, the jury awarded the plaintiff $10 million in compensatory damages, and found the decedent to be 33.3% at fault, RJR Tobacco to be 33.3% at fault and the remaining defendant to be 33.3% at fault. The jury also awarded $20 million in punitive damages, of which $10 million was assigned to RJR Tobacco. In July 2010, the court entered final judgment against RJR Tobacco in the amount of $3.33 million in compensatory damages and $10 million in punitive damages and the plaintiff filed a motion to amend or alter the final judgment. The court entered an amended judgment in September 2010 to include interest from the date of the verdict. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $2.5 million in October 2010. Briefing is complete. Oral argument has not been scheduled.

On April 13, 2010, in Clay v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Janie Mae Clay, to be 30% at fault, RJR Tobacco to be 60% at fault and the remaining defendant to be 10% at fault, and awarded $3.5 million in compensatory damages. The plaintiff alleged that the decedent developed addiction, chronic obstructive pulmonary disease and other conditions and diseases as a result of using the defendants’ products. On April 14, 2010, the jury awarded $18 million in punitive damages, of which $17 million was assigned to RJR Tobacco. The court entered final judgment against RJR Tobacco in the amount of $2.1 million in compensatory damages and $17 million in punitive damages in September 2010. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of approximately $4.7 million. The plaintiff filed a notice of cross appeal. Oral argument occurred on January 17, 2012. On January 25, 2012, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. RJR Tobacco intends to seek further review of the decision.

On April 26, 2010, in Putney v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Broward County, Florida, the jury returned a verdict in favor of the plaintiff, finding the decedent, Margot Putney, to be 35% at fault, RJR Tobacco to be 30% at fault and the remaining defendants to be 35% at fault, and awarded $15.1 million in compensatory damages and $2.5 million in punitive damages each against RJR Tobacco and the remaining defendants. The plaintiff alleged that the decedent, Margot Putney, suffered from nicotine addiction and lung cancer as a result of using the defendants’ products. In August 2010, final judgment was entered against RJR Tobacco in the amount of $4.5 million in compensatory damages, and $2.5 million in punitive damages. RJR Tobacco filed a notice of appeal and the plaintiff filed a notice of cross appeal. In December 2010, the court entered an amended final judgment to provide that interest would run from April 26, 2010. The defendants filed a joint notice of appeal to the Fourth DCA of the amended final judgment, and RJR Tobacco posted a supersedeas bond in the amount of approximately $2.4 million. Briefing is underway.

On April 21, 2010, in Townsend v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Alachua County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 51% at fault and the decedent, Frank Townsend, to be 49% at fault, and awarded $10.8 million in compensatory damages and $80 million in punitive damages. The plaintiff alleged that the decedent suffered from lung cancer and other conditions and diseases as a result of smoking the defendant’s products. Final judgment was entered on April 29, 2010, in the amount of $5.5 million in compensatory damages and $40.8 million in punitive damages, which represents 51% of the original damages awards. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $5 million. Oral argument occurred on October 19, 2011. A decision is pending.

On May 20, 2010, in Buonomo v. R. J. Reynolds Tobacco Co., a case filed in October 2007 in the Circuit Court, Broward County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be

119

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

77.5% at fault and the decedent, Matthew Buonomo, to be 22.5% at fault, and awarded $5.2 million in compensatory damages and $25 million in punitive damages. The plaintiff alleged that the decedent was addicted to cigarettes and as a result developed one or more smoking related medical conditions and/or diseases. Post-trial motions were denied, but the court, in accordance with the Florida statutory limitation on punitive damage awards, ordered the punitive damage award of $25 million be reduced to $15.7 million — three times the compensatory damages award of $5.2 million. In August 2010, the court entered final judgment in the amount of $4.06 million in compensatory damages and $15.7 million in punitive damages. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $5 million. The plaintiff also filed a notice of appeal. Briefing is complete. Oral argument has not been scheduled.

In Frazier v. Philip Morris USA Inc., a case filed in December 2007 in the Circuit Court, Miami-Dade County, Florida, the court declared a mistrial on May 14, 2010, due to the inability to seat a jury. The plaintiff alleged that as a result of smoking defendants’, including RJR Tobacco’s, products she developed chronic obstructive pulmonary disease. Retrial began on September 20, 2010. In October 2010, the jury returned a verdict in favor of the defendants. The plaintiff’s post-trial motions were denied and final judgment was entered in February 2011. The plaintiff filed a notice of appeal to the Third DCA, and the defendants filed a cross appeal. Oral argument occurred on February 14, 2012. A decision is pending.

On June 18, 2010, in Alexander v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Alachua County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 51% at fault and the defendant to be 49% at fault, and awarded $2.5 million in compensatory damages and $2.5 million in punitive damages. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent suffered from chronic obstructive pulmonary disease, lung cancer and emphysema. In July 2010, the court entered final judgment in the amount of $1.275 million in compensatory damages and $2.5 million in punitive damages. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of approximately $3.8 million in September 2010. The plaintiff filed a notice of cross appeal. Oral argument occurred on January 17, 2012. On January 25, 2012, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. RJR Tobacco intends to seek further review of the decision.

On August 5, 2010, in Piendle v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Palm Beach County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 27.5% at fault, the defendant to be 45% at fault and the remaining defendants to be 27.5% at fault, and awarded $4 million in compensatory damages. On August 19, 2010, the jury returned a punitive damages verdict in the amount of $180,000 against RJR Tobacco. The plaintiff’s motion for new trial as to the amount of the punitive damages was denied. In September 2010, the court entered final judgment against RJR Tobacco in the amount of $1.1 million in compensatory damages and $180,000 in punitive damages. The defendants have filed a notice of appeal to the Fourth DCA. In February 2011, RJR Tobacco posted a supersedeas bond in the amount of $1.28 million. Briefing is complete. Oral argument has not been scheduled.

On August 26, 2010, in Budnick v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco. The case was filed in December 2007, in the Circuit Court, Broward County, Florida. The plaintiff alleged that the decedent, Leonard Budnick, was addicted to cigarettes manufactured by the defendants, and as a result, developed one or more smoking related medical conditions and/or diseases. In September 2010, the court denied the motion for a new trial and entered final judgment pursuant to the jury’s verdict. The plaintiff filed a notice of appeal to the Fourth DCA. Briefing is underway.

On October 29, 2010, in Koballa v. Philip Morris USA Inc., the court declared a mistrial after the jury informed the court that they were unable to reach a verdict. The case was filed in December 2007, in the Circuit Court, Volusia County, Florida against tobacco industry defendants, including RJR Tobacco. The plaintiff alleges that as a result of the use of the defendants’ defective and unreasonably dangerous tobacco products, she suffers

120

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

from, or has suffered from, nicotine addiction, lung cancer and other smoking related medical conditions and/or diseases. Retrial began on March 21, 2011, and on March 31, 2011, the jury returned an inconsistent verdict. The jury found that RJR Tobacco was not liable for the plaintiff’s injuries, but found that her past injuries were worth $1 million with the plaintiff being 70% at fault and RJR Tobacco 30% at fault. Post-trial motions were filed, and RJR Tobacco included a request to enter judgment in favor of RJR Tobacco. In August 2011, the court denied RJR Tobacco’s post-trial motions and entered final judgment. RJR Tobacco filed a notice of appeal to the Fifth DCA and posted a supersedeas bond in the amount of $300,000. Briefing is underway.

On November 4, 2010, in Vasko v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco. The jury found that the plaintiff’s claim was barred by the statute of limitations. The case was filed in January 2008, in the Circuit Court, Broward County, Florida. The plaintiff alleged that the decedent, John Vasko, was addicted to cigarettes manufactured by the defendants, and as a result, developed one or more smoking related medical conditions and/or diseases, including lung cancer. Final judgment was entered, and the plaintiff filed a notice of appeal to the Fourth DCA. Briefing is underway.

On November 15, 2010, in Webb v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 90% at fault and the decedent, James Horner, to be 10% at fault, and awarded $8 million in compensatory damages and $72 million in punitive damages. The case was filed in December 2007, in the Circuit Court, Levy County, Florida. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent developed one or more smoking related medical conditions and/or diseases. The court entered final judgment in November 2010. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $5 million. The plaintiff filed a notice of cross appeal. Oral argument occurred on October 12, 2011. A decision is pending.

On January 5, 2011, in Smith v. R. J. Reynolds Tobacco Co., the court declared a mistrial due to the inability to seat a jury. The case was filed in January 2008 in the Circuit Court, Jackson County, Florida. The plaintiff alleged that he was addicted to cigarettes manufactured by the defendants, and as a result, developed lung cancer. Retrial was scheduled to begin on November 28, 2011; however, the court continued the trial date until March 5, 2012.

On February 10, 2011, in Kirkland v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 10% at fault and the plaintiff to be 90% at fault, and awarded $100,000 in compensatory damages. The jury also awarded the plaintiff $250,000 in punitive damages. The case was filed in January 2008, in the Circuit Court, Hillsborough County, Florida. The plaintiff alleged that he was addicted to cigarettes, and as a result, developed larynx cancer and other smoking related medical conditions and/or diseases. The plaintiff’s post-trial motions were denied, and final judgment was entered in March 2011. The plaintiff filed a notice of appeal to the Second DCA on April 12, 2011. RJR Tobacco filed a motion to dismiss the appeal as premature due to the trial court not ruling on RJR Tobacco’s post-trial motions. The motion to dismiss the appeal was denied, however, the appellate court relinquished jurisdiction for 45 days to allow the trial court to address the outstanding post-trial motions. RJR Tobacco’s post-trial motions were denied in July 2011. RJR Tobacco filed a notice of cross appeal and posted a supersedeas bond in the amount of $260,000. Briefing is underway. In January 2012, the plaintiff voluntarily dismissed his appeal. RJR Tobacco’s appeal remains pending.

On February 22, 2011, in Huish v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 25% at fault, the decedent, John Huish, to be 50% at fault and the remaining defendant to be 25% at fault, and awarded $750,000 in compensatory damages and $3 million in punitive damages, $1.5 million to each defendant. The case was filed in January 2008, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent suffered from lung cancer and other smoking related medical conditions and/or diseases. Final judgment was entered in the amount of $1.69 million against each defendant. Post-trial motions were denied, and the defendants filed a

121

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

notice of appeal to the First DCA and posted a supersedeas bond in the amount of $1.69 million. Briefing is complete. Oral argument is scheduled for March 21, 2012.

On March 18, 2011, in Mack v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 51% at fault and the decedent, Peter Mack, Sr., to be 49% at fault, and awarded $1 million in compensatory damages. No punitive damages were awarded. The case was filed in June 2008, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that due to the decedent’s addiction to cigarettes, he developed bronchitis and lung cancer. Post-trial motions were denied, and final judgment was entered in April 2011. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $510,000 in May 2011. Briefing is complete. Oral argument has not been scheduled.

On March 28, 2011, in Oliva v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the defendants, including RJR Tobacco. The case was filed in November 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that as a result of smoking the defendants’ cigarettes, he developed chronic obstructive pulmonary disease and other smoking related diseases. Final judgment was entered, and the plaintiff’s motion for a new trial was denied. The plaintiff filed a notice of appeal to the First DCA, and the defendants filed a notice of cross appeal in June 2011. Briefing is underway.

On April 13, 2011, in Tullo v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco and the plaintiff, but against the remaining defendants. The jury awarded $4.5 million in compensatory damages and no punitive damages. The jury found the decedent, Dominick Tullo, to be 45% at fault and the remaining defendants cumulatively to be 55% at fault. The case was filed in December 2007, in the Circuit Court, Palm Beach County, Florida. The plaintiff alleged that the decedent was addicted to cigarettes manufactured by the defendants, and as a result, developed chronic obstructive pulmonary disease and other smoking related illnesses and/or diseases. The plaintiff sought in excess of $15,000 against each defendant, taxable costs and interest. The court denied the plaintiff’s motion for a new trial against RJR Tobacco and denied the remaining defendants’ post-trial motions in June 2011. The remaining defendants have filed an appeal to the Fourth DCA, and the plaintiff filed a cross appeal. The plaintiff also filed a notice of appeal of the order denying the plaintiff’s motion for new trial against RJR Tobacco. RJR Tobacco filed a cross appeal of the same order. Briefing is underway.

On April 26, 2011, in Andy Allen v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 45% at fault, the decedent, Patricia Allen, to be 40% at fault and the remaining defendant to be 15% at fault, and awarded $6 million in compensatory damages and $17 million in punitive damages against each defendant. The case was filed in September 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent developed chronic obstructive pulmonary disease. Final judgment was entered against RJR Tobacco in the amount of $19.7 million in May 2011. On October 17, 2011, the court entered a remittance of the punitive damages to $8.1 million and denied all other post-trial motions. The defendants filed a joint notice of appeal, and the plaintiff filed a notice of cross appeal in November 2011. Briefing will begin in March 2012.

On May 20, 2011, in Reese v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 30% at fault, and awarded $3.6 million in compensatory damages and no punitive damages. The case was filed in September 2007, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that as a result of smoking the defendant’s products, she became addicted and developed laryngeal cancer, peripheral vascular disease and chronic obstructive pulmonary disease. The court entered final judgment on May 25, 2011. In September 2011, the court denied RJR Tobacco’s post-trial motions. RJR Tobacco filed a notice of appeal to the Third DCA and posted a supersedeas bond in the amount of $1.07 million. Briefing will begin in March 2012.

122

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

On May 20, 2011, in Jewett v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 20% at fault, the decedent, Barbara Jewett, to be 70% at fault and the remaining defendant to be 10% at fault, and awarded $1.1 million in compensatory damages and no punitive damages. The case was filed in December 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that the decedent, Barbara Jewett, was addicted to cigarettes and as a result of her addiction, developed chronic obstructive pulmonary disease, emphysema and respiratory failure. The defendants’ post-trial motions were denied in May 2011 and July 2011. Final judgment was entered in June 2011. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $218,600. Briefing is underway.

On June 16, 2011, in Soffer v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 40% at fault, the decedent, Maurice Soffer, to be 60% at fault, and awarded $5 million in compensatory damages and no punitive damages. The case was filed in December 2007, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that the decedent was addicted to cigarettes and, as a result, developed lung cancer and other smoking-related conditions and/or diseases. Post-trial motions were denied. Final judgment was entered against RJR Tobacco in the amount of $2 million. The plaintiff filed a notice of appeal to the First DCA in July 2011. RJR Tobacco filed a notice of cross appeal and posted a supersedeas bond in the amount of $2 million. Briefing is underway.

On July 15, 2011, in Ciccone v. R. J. Reynolds Tobacco Co., the jury returned a verdict finding the plaintiff is a member of the Engle class. The case was filed in August 2004, in the Circuit Court, Broward County, Florida. The plaintiff alleged that as a result of the use of the defendant’s tobacco products, the decedent, George Ciccone, suffered from nicotine addiction and one or more smoking related diseases and/or medical conditions. On July 21, 2011, the jury awarded approximately $3.2 million in compensatory damages and $50,000 in punitive damages. The jury found the plaintiff to be 70% at fault and RJR Tobacco to be 30% at fault. In August 2011, the court denied RJR Tobacco’s post-trial motions. Final judgment was entered, and RJR Tobacco filed a notice of appeal. RJR Tobacco posted a supersedeas bond in the amount of approximately $1 million on October 17, 2011. Briefing is underway.

On July 19, 2011, in Weingart v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff; however, they refused to award compensatory or punitive damages and found the plaintiff to be 91% at fault. The case was filed in November 2007, in the Circuit Court, Palm Beach County, Florida. The plaintiff alleged that as a result of using the defendants’ tobacco products, the decedent, Claire Weingart, developed lung cancer and other smoking related diseases and/or medical conditions. In September 2011, the court granted the plaintiff’s motion for additur or new trial. The plaintiff was awarded $150,000 as an additur for pain and suffering damages. Final judgment was entered in the amount of $4,500, against each defendant and the defendants filed a joint notice of appeal to the Fourth DCA in November 2011. RJR Tobacco posted a supersedeas bond in the amount of $4,500. Briefing is underway.

On September 15, 2011, in Ojeda v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco. The case was filed in October 2007, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent, Juan Ojeda, suffered from one or more smoking-related medical conditions and or diseases. The plaintiff filed a motion for a new trial, and a hearing is scheduled for March 7, 2012. Final judgment was entered September 26, 2011. The plaintiff filed a conditional notice of appeal in October 2011. The conditional status is based on the pending motion for new trial. RJR Tobacco filed a conditional notice of cross appeal in November 2011. A hearing on the motion for new trial has not been scheduled.

On September 23, 2011, in Bowman v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent to be 70% at fault and RJR Tobacco to be 30% at fault, and awarded $1.5 million in compensatory damages and no punitive damages. The case was filed in November 2007, in the Circuit

123

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Court, Duval County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent, Michael Bowman, suffered from esophageal cancer. The court denied the defendant’s post-trial motions and entered final judgment in October 2011. RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of $450,000. Briefing is underway.

On October 20, 2011, in Junious v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants. The case was filed in July 2007, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that as a result of the use of the defendants’ products, the decedent, Annie Ingraham, suffered from chronic obstructive pulmonary disease. Final judgment was entered in November 2011. The plaintiff’s motion for a new trial was denied on December 16, 2011. The plaintiff filed a notice of appeal in January 2012. Briefing has not yet begun.

On October 20, 2011, in Szymanski v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants. The case was filed in November 2007, in the Circuit Court, Lee County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the plaintiff suffers from various smoking-related conditions and diseases. The plaintiff filed a motion for a new trial. Final judgment was entered in November 2011. On December 5, 2011, the parties stipulated to a dismissal with prejudice. The court granted the motion on December 7, 2011.

On November 28, 2011, in Sury v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, William Sury, to be 60% at fault, RJR Tobacco to be 20% at fault, and the remaining defendant to be 20% at fault, and awarded $1 million in compensatory damages and no punitive damages. The case was filed in November 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that as a result of the use of the defendants’ products, the decedent, William Sury, suffered from lung cancer. Post-trial motions were filed in December 2011. Decisions are pending.

On December 16, 2011, in Cox v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants. The case was filed in January 2008, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent, Roland Cox, suffered from lung cancer. Final judgment was entered, the plaintiff filed a notice of appeal and RJR Tobacco filed a notice of cross appeal in January 2012.

On January 24, 2012, in Hallgren v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Claire Hallgren, to be 50% at fault, RJR Tobacco to be 25% at fault, and the remaining defendant to be 25% at fault, and awarded $2 million in compensatory damages and $750,000 in punitive damages. The case was filed in April 2007, in the Circuit Court, Highlands County, Florida. The plaintiff alleged that the decedent was addicted to the defendants’ products, and as a result, suffered from lung cancer. Post-trial motions are pending.

On January 25, 2012, in Ward v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Mattie Ward, to be 50% at fault, RJR Tobacco to be 30% at fault, and the remaining defendants to collectively be 20% at fault, and awarded $1 million in compensatory damages and $1.7 million in punitive damages. The case was filed in December 2007, in the Circuit Court, Escambia County, Florida. The plaintiff alleged that the decedent was addicted to the defendants’ products, and as a result, suffered from chronic obstructive pulmonary disease and other smoking related conditions and/or diseases. Post-trial motions are pending.

On February 2, 2012, in Larkin v. R. J. Reynolds Tobacco Co., the court declared a mistrial after the jury informed the court that they could not reach a verdict. The case was filed in January 2002, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that the decedent, Carole Larkin, was addicted to the defendant’s products, and as a result, suffered from oral cancer. A new trial date has not been scheduled.

124

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Broin II Cases

RJR Tobacco, B&W and other cigarette manufacturer defendants settled Broin v. Philip Morris, Inc. in October 1997. This case had been brought in Florida state court on behalf of flight attendants alleged to have suffered from diseases or ailments caused by exposure to ETS in airplane cabins. The settlement agreement required the participating tobacco companies to pay a total of $300 million in three annual $100 million installments, allocated among the companies by market share, to fund research on the early detection and cure of diseases associated with tobacco smoke. It also required those companies to pay a total of $49 million for the plaintiffs’ counsel’s fees and expenses. RJR Tobacco’s portion of these payments was approximately $86 million; B&W’s portion of these payments was approximately $57 million. The settlement agreement bars class members from bringing aggregate claims or obtaining punitive damages and also bars individual claims to the extent that they are based on fraud, misrepresentation, conspiracy to commit fraud or misrepresentation, RICO, suppression, concealment or any other alleged intentional or willful conduct. The defendants agreed that, in any individual case brought by a class member, the defendant will bear the burden of proof with respect to whether ETS can cause certain specifically enumerated diseases, referred to as “general causation.” With respect to all other issues relating to liability, including whether an individual plaintiff’s disease was caused by his or her exposure to ETS in airplane cabins, referred to as “specific causation,” the individual plaintiff will have the burden of proof. On September 7, 1999, the Florida Supreme Court approved the settlement. The Broin II cases arose out of the settlement of this case.

On October 5, 2000, the Broin court entered an order applicable to all Broin II cases that the terms of the Broin settlement agreement do not require the individual Broin II plaintiffs to prove the elements of strict liability, breach of warranty or negligence. Under this order, there is a rebuttable presumption in the plaintiffs’ favor on those elements, and the plaintiffs bear the burden of proving that their alleged adverse health effects actually were caused by exposure to ETS in airplane cabins, that is, specific causation.

As of December 31, 2011, there were 2,586 Broin II lawsuits pending in Florida. There have been no Broin II trials since 2007.

Class-Action Suits

Overview. As of December 31, 2011, 13 class-action cases, exclusive of one antitrust class action, were pending in the United States against RJR Tobacco or its affiliates or indemnitees. In 1996, the Fifth Circuit Court of Appeals in Castano v. American Tobacco Co. overturned the certification of a nation-wide class of persons whose claims related to alleged addiction to tobacco products. Since this ruling by the Fifth Circuit, most class-action suits have sought certification of state-wide, rather than nation-wide, classes. Class-action suits based on claims similar to those asserted in Castano or claims that class members are at a greater risk of injury or injured by the use of tobacco or exposure to ETS are pending against RJR Tobacco and its affiliates and indemnitees in state or federal courts in California, Illinois, Louisiana, Minnesota, Missouri, West Virginia and Arizona. All pending class-action cases are discussed below.

The pending class actions against RJR Tobacco or its affiliates or indemnitees include eight cases alleging that the use of the term “lights” constitutes unfair and deceptive trade practices under state law or violates the federal RICO statute. Such suits are pending in state or federal courts in Illinois, Minnesota, Missouri, California and Arizona and are discussed below under “— ‘Lights’ Cases.”

Finally, certain third-party payers have filed health-care cost recovery actions in the form of class actions. These cases are discussed below under “— Health-Care Cost Recovery Cases.”

125

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Few smoker class-action complaints have been certified or, if certified, have survived on appeal. Eighteen federal courts, including two courts of appeals, and most state courts that have considered the issue have rejected class certification in such cases. Apart from the Castano case discussed above, only two smoker class actions have been certified by a federal court — In re Simon (II) Litigation, and Schwab [McLaughlin] v. Philip Morris USA, Inc., discussed below under “— ‘Lights’ Cases,” both of which were filed in the U.S. District Court for the Eastern District of New York and ultimately decertified.

Medical Monitoring and Smoking Cessation Case. On November 5, 1998, in Scott v. American Tobacco Co., a case filed in District Court, Orleans Parish, Louisiana, the trial court certified a medical monitoring or smoking cessation class of Louisiana residents who were smokers on or before May 24, 1996. The case was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover an unspecified amount of damages to pay for medical monitoring and smoking cessation programs. In July 2003, the jury returned a verdict in favor of the defendants on the plaintiffs’ claim for medical monitoring and found that cigarettes were not defectively designed. However, the jury also made certain findings against the defendants on claims relating to fraud, conspiracy, marketing to minors and smoking cessation. Notwithstanding these findings, this portion of the trial did not determine liability as to any class member or class representative. What primarily remained in the case was a class-wide claim that the defendants pay for a program to help people stop smoking.

In May 2004, the jury returned a verdict in the amount of $591 million on the class’s claim for a smoking cessation program. In September 2004, the defendants posted a $50 million bond, pursuant to legislation that limits the amount of the bond to $50 million collectively for MSA signatories, and noticed their appeal. RJR Tobacco posted $25 million (the portions for RJR Tobacco and B&W) towards the bond. In February 2007, the Louisiana Court of Appeals upheld the class certification and found the defendants responsible for funding smoking cessation for eligible class members. The appellate court also ruled, however, that the defendants were not liable for any post-1988 claims, rejected the award of prejudgment interest, struck eight of the 12 components of the smoking cessation program and remanded the case for further proceedings. In particular, the appellate court ruled that no class member, who began smoking after September 1, 1988, could receive any relief, and that only those smokers, whose claims accrued on or before September 1, 1988, would be eligible for the smoking cessation program. The plaintiffs had previously expressly represented to the trial court that none of their claims accrued before 1988 and that the class claims did not accrue until around 1996, when the case was filed. The defendants’ application for writ of certiorari with the Louisiana Supreme Court was denied in January 2008. The defendants’ petition for writ of certiorari with the U.S. Supreme Court was denied in June 2008. In July 2008, the trial court entered an amended judgment in the case, finding that the defendants are jointly and severally liable for funding the cost of a court-supervised smoking cessation program and ordered the defendants to deposit approximately $263 million together with interest from June 30, 2004, into a trust for the funding of the program. The court also stated that it would favorably consider a motion to return to defendants a portion of unused funds at the close of each program year in the event the monies allocated for the preceding program year were not fully expended because of a reduction in class size or underutilization by the remaining plaintiffs.

In December 2008, the trial court judge signed an order granting the defendants an appeal from the amended judgment. In April 2010, the court of appeals amended but largely affirmed the trial court’s July 2008 judgment and ordered the defendants to deposit with the court $242 million with judicial interest from July 21, 2008, until paid. The defendants’ motion for rehearing was denied. In September 2010, the defendants’ application for writ of certiorari or review and their emergency motion to stay execution of judgment with the Louisiana Supreme Court were denied. In September 2010, the U.S. Supreme Court granted the defendant’s motion to stay the judgment pending applicants’ timely filing, and the Court’s disposition, of a petition for writ of certiorari. The defendants filed a petition for writ of certiorari in the U.S. Supreme Court in December 2010. The court denied the petition on June 27, 2011. RJR Tobacco accrued $139 million, the portions of the judgment allocated to RJR Tobacco and B&W, in the second quarter of 2011. RJR Tobacco paid the judgment in August 2011.

126

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In December 2011, the plaintiffs filed a motion for assessment of attorneys’ fees and costs for the prosecution of the case. Briefing is underway. On January 6, 2012, the defendants filed exceptions and motion to strike. A hearing on the defendants’ exceptions and a motion to strike occurred on February 3, 2012. A hearing on the plaintiffs’ motion for fees and costs is scheduled for June 18, 2012.

California Business and Professions Code Cases.    On April 11, 2001, in Brown v. American Tobacco Co., Inc., a case filed in June 1997 in Superior Court, San Diego County, California, the court granted in part the plaintiffs’ motion for certification of a class composed of residents of California who smoked at least one of the defendants’ cigarettes from June 10, 1993 through April 23, 2001, and who were exposed to the defendants’ marketing and advertising activities in California. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover restitution, disgorgement of profits and other equitable relief under California Business and Professions Code § 17200 et seq. and § 17500 et seq. However, the underlying substantive claims have been reduced to include primarily allegations regarding the use of the descriptor “lights” and statements made during the class period about the health risks of cigarettes. Certification was granted as to the plaintiffs’ claims that the defendants violated § 17200 of the California Business and Professions Code pertaining to unfair competition. The court, however, refused to certify the class under the California Legal Remedies Act and on the plaintiffs’ common law claims. In March 2005, the court granted the defendants’ motion to decertify the class, and in September 2006, the California Court of Appeal affirmed the order decertifying the class. In November 2006, the plaintiffs’ petition for review with the California Supreme Court was granted, and in May 2009, the court reversed the decision of the trial court, and the California Court of Appeal that decertified the class and remanded the case to the trial court for further proceedings. In March 2010, the trial court found that the plaintiffs’ “lights” claims were not preempted by the Federal Cigarette Labeling and Advertising Act and denied the defendants’ second motion for summary judgment. The plaintiffs filed a tenth amended complaint in September 2010. RJR Tobacco and B&W filed their answers to the complaint. Subsequently, on February 24, 2011, the court found that the named class representatives were not adequate, were not typical, and lacked standing. The plaintiffs’ motion for reconsideration was denied. The court granted the plaintiffs’ motion to amend the complaint by adding new class representatives and denied the defendants’ motion to dismiss. The plaintiffs filed an eleventh amended complaint adding new class representatives in July 2011. Trial is scheduled for October 5, 2012. The defendants have filed motions challenging the standing of the newly named class representatives and to decertify the case. A hearing is scheduled for March 21, 2012.

In Sateriale v. R. J. Reynolds Tobacco Co., a class action filed in November 2009 in the U.S. District Court for the Central District of California, the plaintiffs brought the case on behalf of all persons who tried unsuccessfully to redeem Camel Cash certificates from 1991 through March 31, 2007, or who held Camel Cash certificates as of March 31, 2007. The plaintiffs allege that in response to the defendants’ action to discontinue redemption of Camel Cash as of March 31, 2007, customers, like the plaintiffs, attempted to exchange their Camel Cash for merchandise and that the defendants, however, did not have any merchandise to exchange for Camel Cash. The plaintiffs allege unfair business practices, deceptive practices, breach of contract and promissory estoppel. The plaintiffs seek injunctive relief, actual damages, costs and expenses. In January 2010, the defendants filed a motion to dismiss, which prompted the plaintiffs to file an amended complaint in February 2010. The class definition changed to a class consisting of all persons who reside in the U.S. and tried unsuccessfully to redeem Camel Cash certificates, from October 1, 2006 (six months before the defendant ended the Camel Cash program) or who held Camel Cash certificates as of March 31, 2007. The plaintiffs also brought the class on behalf of a proposed California subclass, consisting of all California residents meeting the same criteria. In May 2010, RJR Tobacco’s motion to dismiss the amended complaint for lack of jurisdiction over subject matter and, alternatively, for failure to state a claim was granted with leave to amend. The plaintiffs filed a second amended complaint. In July 2010, RJR Tobacco’s motion to dismiss the second amended complaint was granted with leave to amend. The plaintiffs filed a third amended complaint, and RJR Tobacco filed a motion to dismiss it in September 2010. In December 2010, the court granted RJR Tobacco’s motion to dismiss with

127

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

prejudice. Final judgment was entered by the court and the plaintiffs filed a notice of appeal in January 2011. Briefing is complete. Oral argument has not been scheduled.

“Lights” Cases. As noted above, “lights” class-action cases are pending against RJR Tobacco or B&W in Illinois (2), Missouri (2), Minnesota (2), California (1) and Arizona (1). The classes in these cases generally seek to recover $50,000 to $75,000 per class member for compensatory and punitive damages, injunctive and other forms of relief, and attorneys’ fees and costs from RJR Tobacco and/or B&W. In general, the plaintiffs allege that RJR Tobacco or B&W made false and misleading claims that “lights” cigarettes were lower in tar and nicotine and/or were less hazardous or less mutagenic than other cigarettes. The cases typically are filed pursuant to state consumer protection and related statutes.

Many of these “lights” cases were stayed pending review of the Good v. Altria Group, Inc. case by the U.S. Supreme Court. In that “lights” class-action case pending against Altria Group, Inc. and Philip Morris USA, the U.S. Supreme Court decided that these claims are not preempted by the Federal Cigarette Labeling and Advertising Act or by the Federal Trade Commission’s, referred to as FTC, historic regulation of the industry. Since this decision in December 2008, a number of the stayed cases have become active again.

The seminal “lights” class-action case involves RJR Tobacco’s competitor, Philip Morris, Inc. Trial began in Price v. Philip Morris, Inc. in January 2003. In March 2003, the trial judge entered judgment against Philip Morris in the amount of $7.1 billion in compensatory damages and $3 billion in punitive damages to the State of Illinois. Based on Illinois law, the bond required to stay execution of the judgment was set initially at $12 billion. Philip Morris pursued various avenues of relief from the $12 billion bond requirement. On December 15, 2005, the Illinois Supreme Court reversed the lower court’s decision and sent the case back to the trial court with instructions to dismiss the case. On December 5, 2006, the trial court granted the defendant’s motion to dismiss and for entry of final judgment. The case was dismissed with prejudice the same day. In December 2008, the plaintiffs filed a petition for relief from judgment, stating that the U.S. Supreme Court’s decision in Good v. Altria Group, Inc. rejected the basis for the reversal. The trial court granted the defendant’s motion to dismiss the plaintiffs’ petition for relief from judgment in February 2009. In March 2009, the plaintiffs filed a notice of appeal to the Illinois Appellate Court, Fifth Judicial District, requesting a reversal of the February 2009 order and remand to the circuit court. On February 24, 2011, the appellate court entered an order, concluding that the two-year time limit for filing a petition for relief from a final judgment began to run when the trial court dismissed the plaintiffs’ lawsuit on December 18, 2006. The appellate court therefore found that the petition was timely, reversed the order of the trial court, and remanded the case for further proceedings. Philip Morris filed a petition for leave to appeal to the Illinois Supreme Court. On September 28, 2011, the Illinois Supreme Court denied Philip Morris’ petition for leave to appeal and returned the case to the trial court for further proceedings.

In Turner v. R. J. Reynolds Tobacco Co., a case filed in February 2000 in Circuit Court, Madison County, Illinois, a judge certified a class in November 2001. In June 2003, RJR Tobacco filed a motion to stay the case pending Philip Morris’s appeal of the Price v. Philip Morris Inc. case mentioned above, which the judge denied in July 2003. In October 2003, the Illinois Fifth District Court of Appeals denied RJR Tobacco’s emergency stay/supremacy order request. In November 2003, the Illinois Supreme Court granted RJR Tobacco’s motion for a stay pending the court’s final appeal decision in Price. On October 11, 2007, the Illinois Fifth District Court of Appeals dismissed RJR Tobacco’s appeal of the court’s denial of its emergency stay/supremacy order request and remanded the case to the circuit court. There is currently no activity in the case.

In Howard v. Brown & Williamson Tobacco Corp., another case filed in February 2000 in Circuit Court, Madison County, Illinois, a judge certified a class in December 2001. In June 2003, the trial judge issued an order staying all proceedings pending resolution of the Price v. Philip Morris, Inc. case mentioned above. The plaintiffs appealed this stay order to the Illinois Fifth District Court of Appeals, which affirmed the Circuit Court’s stay order in August 2005. There is currently no activity in the case.

128

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

A “lights” class-action case is pending against each of RJR Tobacco and B&W in Missouri. In Collora v. R. J. Reynolds Tobacco Co., a case filed in May 2000 in Circuit Court, St. Louis County, Missouri, a judge in St. Louis certified a class in December 2003. In April 2007, the court granted the plaintiffs’ motion to reassign Collora and the following cases to a single general division: Craft v. Philip Morris Companies, Inc. and Black v. Brown & Williamson Tobacco Corp., discussed below. In April 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc. A nominal trial date of January 10, 2011 was scheduled, but it did not proceed at that time. There is currently no activity in the case.

In Black v. Brown & Williamson Tobacco Corp., a case filed in November 2000 in Circuit Court, City of St. Louis, Missouri, B&W removed the case to the U.S. District Court for the Eastern District of Missouri. The plaintiffs filed a motion to remand, which was granted in March 2006. In April 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc. A nominal trial date of January 10, 2011, was scheduled, but it did not proceed at that time. There is currently no activity in the case.

In Dahl v. R. J. Reynolds Tobacco Co., a case filed in April 2003, and pending in District Court, Hennepin County, Minnesota, a judge dismissed the case in May 2005, ruling the “lights” claims are preempted by the Federal Cigarette Labeling and Advertising Act. In July 2005, the plaintiffs appealed to the Minnesota Court of Appeals for the Fourth Judicial District. During the pendency of the appeal, RJR Tobacco removed the case to the U.S. District Court for the District of Minnesota. In February 2007, the Eighth Circuit remanded the case to the Minnesota Court of Appeals, which in December 2007, reversed the judgment and remanded the case to the District Court. In January 2009, the Minnesota Supreme Court issued an order vacating the February 2008 order that granted RJR Tobacco’s petition for review. In July 2009, the plaintiffs in this case and in Thompson v. R. J. Reynolds Tobacco Co., discussed below, filed a motion to consolidate for discovery and trial. In October 2009, the court companioned the two cases and reserved its ruling on the motion to consolidate, which it said will be reevaluated as discovery progresses. In February 2010, a stipulation and order was entered to stay proceedings in this case and in Thompson until completion of all appellate review in Curtis v. Altria Group, Inc. There is currently no activity in the case.

In Thompson v. R. J. Reynolds Tobacco Co., a case filed in February 2005 in District Court, Hennepin County, Minnesota, RJR Tobacco removed the case to the U.S. District Court for the District of Minnesota. In October 2007, the U.S. District Court remanded the case to state district court. In May 2009, the court entered an agreed scheduling order that bifurcates merits and class certification discovery. The parties are engaged in class certification discovery. In July 2009, the plaintiffs in this case and in Dahl v. R. J. Reynolds Tobacco Co. filed a motion to consolidate for discovery and trial. In October 2009, the court companioned the two cases and reserved its ruling on the motion to consolidate, which it said will be reevaluated as discovery progresses. In February 2010, a stipulation and order was entered to stay proceedings in this case and in Dahl until completion of all appellate review in Curtis v. Altria Group, Inc. There is currently no activity in the case.

In Cleary v. Philip Morris, Inc., a case filed in June 1998, and pending in Circuit Court, Cook County, Illinois, the plaintiffs filed their motion for class certification in December 2001, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W. The case was brought on behalf of persons who have allegedly been injured by (1) the defendants’ purported conspiracy pursuant to which defendants concealed material facts regarding the addictive nature of nicotine, (2) the defendants’ alleged acts of targeting their advertising and marketing to minors, and (3) the defendants’ claimed breach of the public right to defendants’ compliance with the laws prohibiting the distribution of cigarettes to minors. The plaintiffs requested that the defendants be required to disgorge all profits unjustly received through their sale of cigarettes to plaintiffs and the class, which in no event will be greater than $75,000 per each class member, inclusive of punitive damages, interest and costs. In March 2006, the court dismissed count V, public nuisance, and count VI, unjust enrichment. The plaintiffs filed an amended complaint in March 2009, to add a claim of unjust enrichment and, to include in the class, individuals who smoked “light” cigarettes. RJR Tobacco and B&W answered the

129

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

amended complaint in March 2009. In July 2009, the plaintiffs filed an additional motion for class certification. In September 2009, the court granted the defendants’ motion for summary judgment on the pleadings concerning the “lights” claims as to all defendants other than Philip Morris. In February 2010, the court denied the plaintiffs’ motion for class certification of all three putative classes. However, the court ruled that the plaintiffs may reinstate the class dealing with the conspiracy to conceal the addictive nature of nicotine if they identify a new class representative. In April 2010, the court granted the plaintiffs’ motion to file a fourth amended complaint and withdraw the motion to reinstate count I by identifying a new plaintiff. The defendants filed a motion to dismiss the plaintiffs’ fourth amended complaint, which was granted in June 2010. The court denied the plaintiffs’ motion to reconsider, and in August 2010, the plaintiffs filed a notice of appeal in the U.S. Court of Appeals for the Seventh Circuit. In August 2011, the Seventh Circuit affirmed the trial court’s judgment. The plaintiffs’ petition for rehearing with a suggestion for rehearing en banc was denied on November 15, 2011. The deadline to file a petition for writ of certiorari with the U.S. Supreme Court is February 13, 2012.

In Shaffer v. R. J. Reynolds Tobacco Co., a case filed in October 2009 in the Superior Court of Pima County, Arizona against RJR Tobacco, RAI and other defendants, the plaintiffs brought the case on behalf of all persons residing in Arizona who purchased, not for resale, defendants’ cigarettes labeled as “light” or “ultra-light” from the date of the defendants’ first sales of such cigarettes in Arizona to the date of judgment. The plaintiffs allege consumer fraud, concealment, non-disclosure, negligent misrepresentation and unjust enrichment. The plaintiffs seek a variety of damages, including compensatory, restitutionary and punitive damages. In November 2009, the defendants removed the case to the U.S. District Court for the District of Arizona, and RJR Tobacco and RAI filed their answers to the complaint. Discovery is underway. The plaintiffs filed a motion for partial summary judgment on the grounds of the purported collateral estoppel effect of certain findings in United States v. Philip Morris USA, Inc.

Finally, also see the above discussion of Brown v. American Tobacco Co., Inc., under “— California Business and Professions Code Cases.”

As referred to in the “Cautionary Statements,” in the event RJR Tobacco and its affiliates or indemnitees lose one or more of the pending “lights” class-action suits, RJR Tobacco could face bonding difficulties depending upon the amount of damages ordered, if any, which could have a material adverse effect on RJR Tobacco’s, and consequently RAI’s, results of operations, cash flows or financial position.

Other Class Actions.    In Young v. American Tobacco Co., Inc., a case filed in November 1997 in Circuit Court, Orleans Parish, Louisiana, the plaintiffs brought an ETS class action against U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, on behalf of all residents of Louisiana who, though not themselves cigarette smokers, have been exposed to secondhand smoke from cigarettes which were manufactured by the defendants, and who allegedly suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. In October 2004, the trial court stayed this case pending the outcome of the appeal in Scott v. American Tobacco Co., Inc., discussed above under “— Medical Monitoring and Smoking Cessation Case.”

In Parsons v. A C & S, Inc., a case filed in February 1998 in Circuit Court, Ohio County, West Virginia, the plaintiff sued asbestos manufacturers, U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, seeking to recover $1 million in compensatory and punitive damages individually and an unspecified amount for the class in both compensatory and punitive damages. The class was brought on behalf of persons who allegedly have personal injury claims arising from their exposure to respirable asbestos fibers and cigarette smoke. The plaintiffs allege that Mrs. Parsons’ use of tobacco products and exposure to asbestos products caused her to develop lung cancer and to become addicted to tobacco. In December 2000, three defendants, Nitral Liquidators, Inc., Desseaux Corporation of North American and Armstrong World Industries, filed bankruptcy petitions in the U.S. Bankruptcy Court for the District of

130

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Delaware, In re Armstrong World Industries, Inc. Pursuant to section 362(a) of the Bankruptcy Code, Parsons is automatically stayed with respect to all defendants.

Finally, in Jones v. American Tobacco Co., Inc., a case filed in December 1998 in Circuit Court, Jackson County, Missouri, the defendants removed the case to the U.S. District Court for the Western District of Missouri in February 1999. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, by tobacco product users and purchasers on behalf of all similarly situated Missouri consumers. The plaintiffs allege that their use of the defendants’ tobacco products has caused them to become addicted to nicotine. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. The case was remanded to the Circuit Court in February 1999. There has been limited activity in this case.

Health-Care Cost Recovery Cases

Health-care cost recovery cases have been brought by a variety of plaintiffs. Other than certain governmental actions, these cases largely have been unsuccessful on remoteness grounds, which means that one who pays an injured person’s medical expenses is legally too remote to maintain an action against the person allegedly responsible for the injury.

As of December 31, 2011, three health-care cost recovery cases were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both, as discussed below after the discussion of the State Settlement Agreements. A limited number of claimants have filed suit against RJR Tobacco, its current or former affiliates, B&W and other tobacco industry defendants to recover funds for health care, medical and other assistance paid by foreign provincial governments in treating their citizens. For more information on these cases, see “— International Cases” below.

State Settlement Agreements.    In June 1994, the Mississippi Attorney General brought an action, Moore v. American Tobacco Co., against various industry members, including RJR Tobacco and B&W. This case was brought on behalf of the state to recover state funds paid for health care and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. Most other states, through their attorneys general or other state agencies, sued RJR Tobacco, B&W and other U.S. cigarette manufacturers based on similar theories. The cigarette manufacturer defendants, including RJR Tobacco and B&W, settled the first four of these cases scheduled for trial — Mississippi, Florida, Texas and Minnesota — by separate agreements with each such state.

On November 23, 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the Master Settlement Agreement with attorneys general representing the remaining 46 states, the District of Columbia, Puerto Rico, Guam, the Virgin Islands, American Samoa and the Northern Marianas. Effective on November 12, 1999, the MSA settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and released various additional present and future claims.

In the settling jurisdictions, the MSA released RJR Tobacco, B&W, and their affiliates and indemnitees, including RAI, from:

• all claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to past conduct arising out of the use, sale, distribution, manufacture, development, advertising, marketing or health effects of, the exposure to, or research, statements or warnings about, tobacco products; and

131

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

• all monetary claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to future conduct arising out of the use of or exposure to, tobacco products that have been manufactured in the ordinary course of business.

Set forth below are tables depicting the unadjusted tobacco industry settlement payment schedule and the settlement payment schedule for RAI’s operating subsidiaries under the State Settlement Agreements, and related information for 2009 and beyond:

Unadjusted Original Participating Manufacturers’ Settlement Payment Schedule

	2009			2010			2011		2012 and thereafter
First Four States’ Settlements:(1)
Mississippi Annual Payment	$	136		$	136		$	136	$	136
Florida Annual Payment		440			440			440		440
Texas Annual Payment		580			580			580		580
Minnesota Annual Payment		204			204			204		204
Remaining States’ Settlement:
Annual Payments(1)		8,004			8,004			8,004		8,004
Growers’ Trust(2)		295			295			—		—
Offset by federal tobacco buyout(2)		(295	)		(295	)		—		—
Total	$	9,364		$	9,364		$	9,364	$	9,364

RAI’s Operating Subsidiaries’ Settlement Expenses and Payment Schedule

Settlement expenses	$	2,540	$	2,496	$	2,435		—
Settlement cash payments	$	2,249	$	2,519	$	2,492		—
Projected settlement expenses							$	>2,400
Projected settlement cash payments							$	>2,400

⁽¹⁾ Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share. For further information, see “— State Settlement Agreements-Enforcement and Validity; Adjustments” below.

⁽²⁾ The Growers’ Trust payments expired December 2010 and were offset by certain obligations resulting from the federal tobacco buyout legislation, not included in this table, signed in October 2004. See “— Tobacco Buyout Legislation and Related Litigation” below.

The State Settlement Agreements also contain provisions restricting the marketing of tobacco products. Among these provisions are restrictions or prohibitions on the use of cartoon characters, brand-name sponsorships, apparel and other merchandise, outdoor and transit advertising, payments for product placement, free sampling and lobbying. Furthermore, the State Settlement Agreements required the dissolution of three industry-sponsored research and trade organizations.

The State Settlement Agreements have materially adversely affected RJR Tobacco’s shipment volumes. RAI believes that these settlement obligations may materially adversely affect the results of operations, cash flows or financial position of RAI and RJR Tobacco in future periods. The degree of the adverse impact will depend, among other things, on the rate of decline in U.S. cigarette sales in the premium and value categories, RJR Tobacco’s share of the domestic premium and value cigarette categories, and the effect of any resulting cost advantage of manufacturers not subject to the State Settlement Agreements.

132

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Department of Justice Case.    On September 22, 1999, the U.S. Department of Justice brought an action against RJR Tobacco, B&W and other tobacco companies in the U.S. District Court for the District of Columbia. The government initially sought to recover federal funds expended by the federal government in providing health care to smokers who developed diseases and injuries alleged to be smoking-related, based on several federal statutes. In addition, the government sought, pursuant to the civil provisions of RICO, disgorgement of profits the government contends were earned as a consequence of a RICO racketeering “enterprise.” In September 2000, the court dismissed the government’s claims asserted under the Medical Care Recovery Act as well as those under the Medicare Secondary Payer provisions of the Social Security Act, but did not dismiss the RICO claims. In February 2005, the U.S. Court of Appeals for the District of Columbia ruled that disgorgement is not an available remedy in this case. The government’s petition for writ of certiorari with the U.S. Supreme Court was denied in October 2005. The non-jury, bench trial began in September 2004, and closing arguments concluded in June 2005.

On August 17, 2006, the court found certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, but did not impose any direct financial penalties. The court instead enjoined the defendants from committing future racketeering acts, participating in certain trade organizations, making misrepresentations concerning smoking and health and youth marketing, and using certain brand descriptors such as “low tar,” “light,” “ultra light,” “mild” and “natural.” The court also ordered defendants to issue “corrective communications” on five subjects, including smoking and health and addiction, and to comply with further undertakings, including maintaining web sites of historical corporate documents and disseminating certain marketing information on a confidential basis to the government. In addition, the court placed restrictions on the ability of the defendants to dispose of certain assets for use in the United States, unless the transferee agrees to abide by the terms of the court’s order, and ordered the defendants to reimburse the U.S. Department of Justice its taxable costs incurred in connection with the case.

Certain defendants, including RJR Tobacco, filed notices of appeal to the U.S. Court of Appeals for the District of Columbia in September 2006. The government filed its notice of appeal in October 2006. In addition, the defendants, including RJR Tobacco, filed joint motions asking the district court to clarify and to stay its order pending the defendants’ appeal. On September 28, 2006, the district court denied the defendants’ motion to stay. On September 29, 2006, the defendants, including RJR Tobacco, filed a motion asking the court of appeals to stay the district court’s order pending the defendants’ appeal. The court granted the motion in October 2006.

In November 2006, the court of appeals stayed the appeals pending the trial court’s ruling on the defendants’ motion for clarification. The defendants’ motion was granted in part and denied in part. The defendants’ motion as to the meaning and applicability of the general injunctive relief of the August 2006 order was denied. The request for clarification as to the scope of the provisions in the order prohibiting the use of descriptors and requiring corrective statements at retail point of sale was granted. The court also ruled that the provisions prohibiting the use of express or implied health messages or descriptors do apply to the actions of the defendants taken outside of the United States.

In May 2009, the U.S. Court of Appeals largely affirmed the finding of liability against the tobacco defendants and remanded to the trial court for dismissal of the trade organizations. The court also largely affirmed the remedial order, including the denial of additional remedies, but vacated the order and remanded for further proceedings as to the following four discrete issues:

• the issue of the extent of Brown & Williamson Holdings’ control over tobacco operations was remanded for further fact finding and clarification;

• the remedial order was vacated to the extent that it binds all defendants’ subsidiaries and was remanded to the lower court for determination as to whether inclusion of the subsidiaries and which of the subsidiaries satisfy Rule 65(d) of the Federal Rules of Civil Procedure;

133

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

• the court held that the provision found in paragraph four of the injunction, concerning the use of any express or implied health message or health descriptor for any cigarette brand, should not be read to govern overseas sales. The issue was remanded to the lower court with instructions to reformulate it so as to exempt foreign activities that have no substantial, direct and foreseeable domestic effects; and

• the remedial order was vacated regarding “point of sale” displays and remanded for the district court to evaluate and make due provisions for the rights of innocent persons, either by abandoning this part of the remedial order or re-crafting a new version reflecting the rights of third parties.

RJR Tobacco and the other defendants, as well as the Department of Justice, filed petitions for writ of certiorari to the U.S. Supreme Court in February 2010. In June 2010, the U.S. Supreme Court denied the parties’ petitions for writ of certiorari. Post-remand proceedings are underway to determine the extent to which the original order will be implemented. The defendants filed a motion to vacatur, in which they moved to vacate the trial court’s injunctions and factual findings and dismiss the case in its entirety, on March 3, 2011. The court denied the motion on June 1, 2011. The defendants have filed a notice of appeal. Oral argument is scheduled for April 20, 2012. The trial court also issued an opinion on January 26, 2012, stating that it will not defer its decision on the corrective action statements pending the outcome of pending FDA litigation. In addition, the parties to the lawsuit entered into an agreement concerning certain technical obligations regarding their public websites. Pursuant to this agreement, RJR Tobacco agreed to deposit $3.125 million over the next three years into the registry of the district court.

International Cases.    Five health-care reimbursement cases are pending against RJR Tobacco, its current or former affiliates, or B&W outside the United States, one in Israel and four in Canada. All of the remaining Canadian provinces have indicated an intention to file similar cases. In these actions, foreign governments are seeking to recover for health care, medical and other assistance paid in treating their citizens for tobacco-related disease. No such actions are pending in the United States. Pursuant to the terms of the 1999 sale of RJR Tobacco’s international tobacco business, RJR Tobacco has tendered the defense of these actions to JTI. Subject to a reservation of rights, JTI has assumed the defense of RJR Tobacco and its current or former affiliates in these actions.

• British Columbia — In 1997, British Columbia enacted a statute, subsequently amended, which created a civil cause of action for the government to recover the costs of health-care benefits incurred for insured populations of British Columbia residents resulting from tobacco-related disease. An action brought on behalf of the Province of British Columbia pursuant to the statute against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and certain of its affiliates, was dismissed in February 2000 when the British Columbia Supreme Court ruled that the legislation was unconstitutional and set aside service ex juris against the foreign defendants for that reason. British Columbia then enacted a revised statute, pursuant to which an action was filed in January 2001 against many of the same defendants, including RJR Tobacco and one of its affiliates, in Supreme Court, British Columbia. In that action, the British Columbia government seeks to recover the present value of its total expenditures for health-care benefits provided for insured persons resulting from tobacco-related disease or the risk of tobacco-related disease caused by alleged breaches of duty by the manufacturers, the present value of its estimated total expenditures for health-care benefits that reasonably could be expected to be provided for those insured persons resulting from tobacco-related disease or the risk of tobacco-related disease in the future, court ordered interest, and costs, or in the alternative, special or increased costs. The government alleges that the defendants are liable under the British Columbia statute by reason of their “tobacco related wrongs,” which are alleged to include: selling defective products, failure to warn, sale of cigarettes to children and adolescents, illegal importation, strict liability, deceit and misrepresentation, violation of trade practice and competition acts, concerted action, and joint liability. RJR Tobacco and its affiliate filed statements of defense in January 2007. In February 2010, the trial date was adjourned, and no new date has been set.

134

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

• New Brunswick — In March 2008, a case was filed on behalf of Her Majesty the Queen in Right of the Province of New Brunswick, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Trial Division in the Court of Queen’s Bench of New Brunswick. The claim is brought pursuant to New Brunswick legislation enacted in 2008, which is substantially similar to the revised British Columbia statute described above. In this action, the New Brunswick government seeks to recover essentially the same types of damages that are being sought in the British Columbia action described above based on analogous theories of liability. RJR Tobacco and its affiliate filed statements of defense in March 2010.

• Ontario — In September 2009, a case was filed on behalf of the Province of Ontario, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Ontario Superior Court of Justice. The claim is brought pursuant to Ontario legislation enacted in 2009, which is substantially similar to the revised British Columbia statute described above. In this action, the Ontario government seeks to recover essentially the same types of damages that are being sought in the British Columbia and New Brunswick actions described above based on analogous theories of liability, although the government also asserted claims based on the illegal importation of cigarettes, which claims were deleted in an amended statement of claim filed in August 2010. The jurisdictional challenge brought by RJR Tobacco and its affiliate was denied by the trial court on January 4, 2012, and RJR Tobacco and its affiliate are pursuing an appeal.

• Newfoundland and Labrador — In February 2011, a case was filed on behalf of the Province of Newfoundland and Labrador, Canada, hereinafter Newfoundland, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the General Trial Division of the Supreme Court of Newfoundland and Labrador. The claim is brought pursuant to legislation passed in Newfoundland in 2001 and proclaimed in February 2011, which is substantially similar to the revised British Columbia statute described above. In this action, the Newfoundland government seeks to recover essentially the same types of damages that are being sought in the British Columbia, New Brunswick and Ontario actions described above based on analogous theories of liability. RJR and its affiliate have brought a motion challenging the jurisdiction of the Newfoundland court. A decision is pending.

• Israel — In September 1998, the General Health Services, Israel’s second largest health fund, filed a statement of claim against certain cigarette manufacturers and distributors, including RJR Tobacco, RJR Nabisco and B&W, in the District Court of Jerusalem, Israel. The plaintiff seeks to recover the present value of the total expenditure by the government for health-care benefits provided for insured persons resulting from tobacco-related disease or the risk of tobacco-related disease caused by alleged breaches of duty by the manufacturers, the present value of the estimated total expenditure by the government for health-care benefits that reasonably could be expected to be provided for those insured persons resulting from tobacco-related disease or the risk of tobacco-related disease in the future, court ordered interest, and costs, or in the alternative, special or increased costs. The plaintiff alleges that the defendants are liable under the following theories: defective product, failure to warn, sale of cigarettes to children and adolescents, strict liability, deceit and misrepresentation and violation of trade practice and competition acts. In 2002, the plaintiff obtained leave to serve RJR Tobacco and B&W outside the jurisdiction. On behalf of RJR Tobacco, JTI filed a motion challenging the grant of leave, which was denied. JTI appealed the decision to the Supreme Court of Israel alongside other defendants’ applications for a strike out of the claim. In July 2011, the Israeli Supreme Court granted PMI and BAT’s appeal of the rejection of their motion to strike out the claim. The court found that the claim should be struck in liminie on the grounds of remoteness. In August 2011, the Supreme Court granted RJR Tobacco’s appeal of the rejection of its motion to cancel service and all other pending motions for leave to appeal. The plaintiff filed a motion for the rehearing of the Supreme Court’s decisions in this regard. In November 2011, BAT and PMI filed responses to the motion.

135

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The following six putative Canadian class actions were filed against various Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in courts in the provinces of Alberta, British Columbia, Manitoba, Nova Scotia, and Saskatchewan, although the plaintiffs’ counsel have been actively pursuing only the action pending in Saskatchewan at this time:

• In Adams v. Canadian Tobacco Manufacturers’ Council, a case filed in July 2009 in the Court of Queen’s Bench for Saskatchewan against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals who were alive on July 10, 2009, and who have suffered, or who currently suffer, from chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed or distributed by the defendants.

• In Dorion v. Canadian Tobacco Manufacturers’ Council, a case filed in June 2009, in the Court of Queen’s Bench of Alberta against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, dependents and family members, who purchased or smoked cigarettes designed, manufactured, marketed or distributed by the defendants.

• In Kunka v. Canadian Tobacco Manufacturers’ Council, a case filed in 2009 in the Court of Queen’s Bench of Manitoba against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, and their dependents and family members, who purchased or smoked cigarettes manufactured by the defendants.

• In Semple v. Canadian Tobacco Manufacturers’ Council, a case filed in June 2009 in the Supreme Court of Nova Scotia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, dependents and family members, who purchased or smoked cigarettes designed, manufactured, marketed or distributed by the defendants for the period of January 1, 1954, to the expiry of the opt out period as set by the court.

• In Bourassa v. Imperial Tobacco Canada Limited, a case filed in June 2010 in the Supreme Court of British Columbia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, who were alive on June 12, 2007, and who have suffered, or who currently suffer from chronic respiratory diseases, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed, or distributed by the defendants.

• In McDermid v. Imperial Tobacco Canada Limited, a case filed in June 2010 in the Supreme Court of British Columbia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, who were alive on June 12, 2007, and who have suffered, or who currently suffer from heart disease, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed, or distributed by the defendants.

In each of these six cases, the plaintiffs allege fraud, fraudulent concealment, breach of warranty, breach of warranty of merchantability and of fitness for a particular purpose, failure to warn, design defects, negligence, breach of a “special duty” to children and adolescents, conspiracy, concert of action, unjust enrichment, market share liability, joint liability, and violations of various trade practices and competition statutes. The plaintiffs seek compensatory and aggravated damages; punitive or exemplary damages; the right to waive the torts described above and claim disgorgement of the amount of revenues or profits the defendants received from the

136

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

sale of tobacco products to putative class members; interest pursuant to the Pre-judgment Interest Act and other similar legislation; and other relief the court deems just. Pursuant to the terms of the 1999 sale of RJR Tobacco’s international tobacco business, RJR Tobacco has tendered the defense of these six actions to JTI. Subject to a reservation of rights, JTI has assumed the defense of RJR Tobacco and its current or former affiliates in these actions.

Native American Tribe Cases.    As of December 31, 2011, one Native American tribe case was pending before a tribal court against RJR Tobacco and B&W, Crow Creek Sioux Tribe v. American Tobacco Co., a case filed in September 1997 in Tribal Court, Crow Creek Sioux, South Dakota. The plaintiffs seek to recover actual and punitive damages, restitution, funding of a clinical cessation program, funding of a corrective public education program, and disgorgement of unjust profits from sales to minors. The plaintiffs claim that the defendants are liable under the following theories: unlawful marketing and targeting of minors, contributing to the delinquency of minors, unfair and deceptive acts or practices, unreasonable restraint of trade and unfair method of competition, negligence, negligence per se, conspiracy and restitution of unjust enrichment. The case is dormant.

Other Cases

In August 2009, RJR Tobacco and American Snuff Co. joined other tobacco manufacturers and a tobacco retailer in filing a lawsuit, Commonwealth Brands, Inc. v. United States of America, in the U.S. District Court for the Western District of Kentucky, challenging certain provisions of the Family Smoking Prevention and Tobacco Control Act, referred to as the FDA Tobacco Act, that severely restricts the few remaining channels available to communicate with adult tobacco consumers. RAI believes these provisions cannot be justified on any basis consistent with the demands of the First Amendment. The suit does not challenge the U.S. Congress’s decision to give the FDA regulatory authority over tobacco products, nor does it challenge the vast majority of the provisions of the new law. In November 2009, the court denied certain plaintiffs’ motion for preliminary injunction as to the modified risk tobacco products provision of the FDA Tobacco Act. The parties finished briefing their respective cross-motions for summary judgment in December 2009, and in January 2010, the court granted summary judgment for the plaintiffs so as to allow the continued use of color and imagery in labeling and advertising and the right to make statements that their products conform to FDA regulatory requirements. The court granted summary judgment to the U.S. Government as to all other challenged provisions. In March 2010, each side filed a notice of appeal with the Sixth Circuit Court of Appeals. Oral argument occurred July 27, 2011. A decision is pending.

On February 25, 2011, RJR Tobacco, Lorillard, Inc., and Lorillard Tobacco Company jointly filed a lawsuit, Lorillard, Inc. v. U.S. Food and Drug Administration, in the U.S. District Court for the District of Columbia, challenging the composition of the Tobacco Products Scientific Advisory Committee, referred to as the TPSAC, which had been established by the FDA. The complaint alleges that certain members of the TPSAC and certain members of its Constituents Subcommittee have financial and appearance conflicts of interest that are disqualifying under federal ethics law and regulations, and that the TPSAC is not “fairly balanced,” as required by the Federal Advisory Committee Act, referred to as FACA. In March 2011, the plaintiffs filed an amended complaint, which added an additional claim, based on a nonpublic meeting of members of the TPSAC, in violation of the FACA. The defendants filed a motion to dismiss in April 2011. A hearing date has not been scheduled. The court granted the plaintiffs’ unopposed motion to file a second amended complaint adding a count addressing the FDA’s refusal to produce all documents generated by the TPSAC and its subcommittee in preparation of the menthol report. The FDA filed a motion to dismiss the second amended complaint. A hearing on the motion is scheduled for February 14, 2012.

137

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

On August 16, 2011, RJR Tobacco and Santa Fe joined other tobacco manufacturers in a lawsuit, R. J. Reynolds Tobacco Co. v. U.S. Food and Drug Administration, in the U.S. District Court for the District of Columbia, challenging the final regulation specifying nine new graphic “warnings” pursuant to the FDA Tobacco Act violates the plaintiffs’ rights under the First Amendment to the U.S. Constitution and the Administrative Procedure Act, referred to as the APA. The court heard oral argument on the motion for preliminary injunction on September 21, 2011. On November 7, 2011, the court granted the plaintiffs’ motion for preliminary injunction, which stays the imposition of the graphic warning rule for 15 months following a final ruling from the district court as to the merits of the parties claims. On December 1, 2011, the government appealed the district court’s preliminary injunction ruling to the Court of Appeals for the D.C. Circuit. The appellate court has scheduled oral argument on the appeal for April 10, 2012. Concurrently, briefing is complete on the parties’ cross motions for summary judgment that are before the district court. Oral argument on the summary judgment motions occurred on February 1, 2012. The court stated that it would issue its ruling well before the April 10, 2012 appellate hearing.

For a detailed description of the FDA Tobacco Act, see “— Governmental Activity” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in Item 7.

Finally, RJR Tobacco and others brought suit against the City of Worcester, Massachusetts to enjoin enforcement of an ordinance prohibiting all outdoor advertising of tobacco products and any indoor advertising that is visible from the street. The suit, National Association of Tobacco Outlets, Inc. v. City of Worcester, was filed in the U.S. District Court for the Central Division of Massachusetts on June 17, 2011. The plaintiffs’ motions for preliminary injunction and summary judgment were heard on November 9, 2011, and the parties await a ruling. Enforcement of the ordinance has been stayed by agreement pending the ruling on the motion for a preliminary injunction.

State Settlement Agreements-Enforcement and Validity; Adjustments

As of December 31, 2011, there were 32 cases concerning the enforcement, validity or interpretation of the State Settlement Agreements in which RJR Tobacco or B&W is a party. This number includes those cases, discussed below, relating to disputed payments under the State Settlement Agreements.

The Vermont Attorney General filed suit in July 2005, in the Vermont Superior Court, Chittenden County, alleging that certain advertising for the Eclipse cigarette brand violated both the MSA and the Vermont Consumer Fraud Statute. The State of Vermont is seeking declaratory, injunctive, and monetary relief. The bench trial in this action began on October 6, 2008, and lasted a total of five weeks. Closing arguments occurred on March 11, 2009. On March 10, 2010, the court issued its opinion, finding that three of the advertising claims made by RJR Tobacco were not supported by the appropriate degree of scientific evidence. The court did, however, rule that the remaining six advertising claims challenged by the State of Vermont were not actionable. The court indicated that remedies and any damages to be awarded, as well as the issue of attorney’s fees and litigation expenses, will be addressed in additional proceedings. On March 22, 2010, RJR Tobacco filed a motion to amend findings of fact that it believes are demonstrably contrary to, or unsupported by, the record. On December 14, 2010, the court issued an order granting in part and denying in part RJR Tobacco’s motion. The parties will conduct a mediation on the remaining issues on February 14, 2012.

In April 2005, the Mississippi Attorney General notified B&W of its intent to seek approximately $3.9 million in additional payments under the Mississippi Settlement Agreement. The Mississippi Attorney General asserts that B&W failed to report in its net operating profit or its shipments, cigarettes manufactured by B&W under contract for Star Tobacco or its parent, Star Scientific, Inc. B&W advised the state that it did not owe the state any money. In August 2005, the Mississippi Attorney General filed in the Chancery Court of

138

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Jackson County, Mississippi, a Notice of Violation, Motion to Enforce Settlement Agreement, and Request for an Accounting by Defendant Brown & Williamson Holdings, Inc., formerly known as Brown & Williamson Tobacco Corporation. In this filing, Mississippi estimated that its damages exceeded $5.0 million. On August 24, 2011, the court entered an order finding in favor of the State on the Star contract manufacturing issue, that the total amount of the underpayment from B&W was approximately $3.8 million and that interest on the underpayment was approximately $4.3 million. The court appointed a special master to undertake an accounting of the benefit received by B&W for failure to include its profits from Star contract manufacturing in its net operating profits reported to the State. Finally, the court awarded the State attorneys’ fees and costs in an amount to be determined. B&W filed a motion to certify the Star contract issue for interlocutory appeal, pursuant to Rule 54 (b) of the Mississippi Rules of Civil Procedure. On January 9, 2012, that motion was denied.

In addition, in February 2010, the Mississippi Attorney General filed a motion alleging that RJR Tobacco had improperly failed to report shipments of certain categories of cigarette volumes, and for certain years had improperly reported its net operating profit. As a result, the State alleges that settlement payments to it were improperly reduced. RJR Tobacco disputes these allegations and is vigorously defending against them. Briefing with respect to these issues is underway, and a hearing on these issues was scheduled for January 24-25, 2012.

In May 2006, the State of Florida filed a motion, in the Circuit Court of the Fifteenth Judicial Circuit, in and for Palm Beach County, Florida, to enforce the Settlement Agreement, for an Accounting by Brown & Williamson Holdings, Inc., and for an Order of Contempt, raising substantially the same issues as raised by the Mississippi Attorney General and seeking approximately $12.4 million in additional payments under the Florida Settlement Agreement, as well as $17.0 million in interest payments. This matter is currently in the discovery phase.

In October 2008, Vibo Corporation, Inc. d/b/a General Tobacco, referred to as General, filed a complaint in the U.S. District Court for the Western District of Kentucky against RJR Tobacco and other participating manufacturers, referred to as PMs, under the MSA, and the Attorneys General of the 52 states and territories that are parties to the MSA. General sought, among other things, to enjoin enforcement of certain provisions of the MSA and an order relieving it of certain of its payment obligations under the MSA and, in the event such relief was not granted, rescission of General’s 2004 agreement to join the MSA. General also moved for a preliminary injunction that, among other things, would have enjoined the states from enforcing certain of General’s payment obligations under the MSA. In November 2008, RJR Tobacco and the other defendants moved to dismiss General’s complaint. In January 2009, the court issued a memorandum opinion and order granting the defendants’ motions and dismissing General’s lawsuit. Final judgment was entered on January 5, 2010. On January 13, 2010, General noticed its appeal of this decision. Oral argument occurred on October 6, 2011, before the U.S. Court of Appeals for the Sixth Circuit. A decision is pending.

In December 2007, nine states (California, Connecticut, Illinois, Maine, Maryland, New York, Ohio, Pennsylvania and Washington) sued RJR Tobacco claiming that an advertisement published in Rolling Stone magazine the prior month violated the MSA’s ban on the use of cartoons. The states asserted that the magazine’s content adjacent to a Camel gatefold advertisement included cartoon images prohibited by the MSA and that certain images used in the Camel ad itself were prohibited cartoons. In addition, three states (Connecticut, New York and Maryland) also claimed that a direct mail piece distributed by RJR Tobacco violated the MSA prohibition against distributing utilitarian items bearing a tobacco brand name. Each state sought injunctive relief and punitive monetary sanctions. Eight of the nine courts have since ruled that the states are not entitled to the punitive sanctions being sought. The issue has not been resolved definitively by the court in California at this time.

139

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Six of these magazine advertisement cases have been ruled upon following bench trials:

• In Maine, RJR Tobacco received a complete defense ruling.

• In Washington, the Washington Court of Appeals reversed, in part, a favorable ruling in favor of RJR Tobacco at the trial court, holding that some of the images used in the RJR Tobacco advertisement were cartoons, and remanded the case for further proceedings. The Washington Supreme Court declined to review the decision by the Court of Appeals. The case was settled in the second quarter of 2011 for a non-material amount.

• In Ohio, the court agreed that the Camel advertisement did not use any cartoons, but ruled that the company should have prevented the use of cartoons in magazine-created content next to the RJR Tobacco advertisement. No monetary sanctions were awarded. RJR Tobacco appealed this decision, and the Court of Appeals reversed the trial court’s ruling regarding RJR Tobacco’s duty to prevent the use of cartoons in adjacent magazine-created content. The State petitioned the Ohio Supreme Court for review, and that petition was denied.

• The court in California ruled that the company was not liable for preventing the use of cartoons in magazine-created content next to the RJR Tobacco advertisement, but that a few of the images in the RJR Tobacco advertisement itself were “technical” and unintentional cartoons. No monetary sanctions were awarded by the California court. The parties’ appeals are ongoing. The California Court of Appeals affirmed the judgment on the merits. In April 2011, the California Court of Appeals reversed the trial court’s award of attorneys’ fees to the State and remanded the case to the trial court with instructions to use the correct legal standard and prevailing market rates in determining the award of fees to either party. Oral argument occurred in October 2011. A final order was issued on October 6, 2011, finding the State to be the prevailing party for purposes of entitlement to attorneys’ fees. Discovery has ensued regarding hours and rates. A hearing is scheduled for March 27, 2012.

• The Pennsylvania court ruled against RJR Tobacco on both claims, agreeing with the Commonwealth that the RJR Tobacco advertisement contained unspecified cartoons and that RJR Tobacco was responsible for the cartoons included in the magazine-created content, regardless of whether the company was aware of it in advance. In addition, the Pennsylvania court ordered RJR Tobacco to pay for the creation of a single page youth smoking prevention advertisement in Rolling Stone issues in Pennsylvania within a year, or pay a penalty of approximately $302,000, if it fails to do so. RJR Tobacco appealed. In August 2010, the Pennsylvania Court of Appeals reversed the trial court on both claims. The Commonwealth filed a motion for reargument, which was denied in October 2010. In November 2010, the Commonwealth filed a petition for leave to appeal, which was denied in April 2011.

• In Illinois, RJR Tobacco received a complete defense ruling. The State requested reconsideration of the court’s ruling, and the court reaffirmed its ruling in favor of RJR Tobacco. The State filed an appeal. On June 30, 2011, the appellate court affirmed in part and reversed in part and remanded the case to the trial court to determine the State’s attorneys’ fees and costs. The appellate court reversed the ruling that found that RJR Tobacco did not use some images that were cartoons under the consent decree in its advertisement in Rolling Stone. The appellate court affirmed the ruling that RJR Tobacco did not “cause” Rolling Stone to “use” cartoons in the editorial portion of the gatefold and affirmed the ruling that the State was not entitled to any monetary sanctions for violating the consent decree. The parties settled the case with RJR Tobacco agreeing to reimburse the State its attorneys’ fees for a non-material amount.

The three remaining cases — in Maryland, New York and Connecticut — were individually settled in the first quarter of 2010 for a non-material amount.

140

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NPM Adjustment.    The MSA includes an adjustment, referred to as an NPM Adjustment, that potentially reduces the annual payment obligations of RJR Tobacco and the other PMs. Certain requirements, collectively referred to as the Adjustment Requirements, must be satisfied before the NPM Adjustment for a given year is available:

• an independent auditor designated under the MSA must determine that the PMs have experienced a market share loss beyond a triggering threshold to those manufacturers that do not participate in the MSA, such non-participating manufacturers referred to as NPMs; and

• in a binding arbitration proceeding, a firm of independent economic consultants must find that the disadvantages of the MSA were a significant factor contributing to the loss.

When the Adjustment Requirements are satisfied, the MSA provides that the NPM Adjustment applies to reduce the annual payment obligation of the PMs. However, an individual settling state may avoid its share of the NPM Adjustment if it had in place and diligently enforced during the entirety of the relevant year a “Qualifying Statute” that imposes escrow obligations on NPMs that are comparable to what the NPMs would have owed if they had joined the MSA. In such event, the state’s share of the NPM Adjustment is reallocated to other settling states, if any, that did not have in place and diligently enforce a Qualifying Statute.

NPM Adjustment Claim for 2003.    For 2003, the Adjustment Requirements were satisfied. As a result, in April 2006, RJR Tobacco placed approximately $647 million of its MSA payment into a disputed payments account, in accordance with a procedure established by the MSA. That amount represented RJR Tobacco’s share of the 2003 NPM Adjustment as calculated by the MSA independent auditor. In March 2007, the independent auditor issued revised calculations that reduced RJR Tobacco’s share of the NPM Adjustment for 2003 to approximately $615 million. As a result, in April 2007, RJR Tobacco instructed the independent auditor to release to the settling states approximately $32 million from the disputed payments account.

Following RJR Tobacco’s payment of a portion of its 2006 MSA payment into the disputed payments account, 37 of the settling states filed legal proceedings in their respective MSA courts seeking declaratory orders that they diligently enforced their Qualifying Statutes during 2003 and/or orders compelling RJR Tobacco and the other PMs that placed money in the disputed payments account to pay the disputed amounts to the settling states. In response, RJR Tobacco and other PMs, pursuant to the MSA’s arbitration provisions, moved to compel arbitration of the parties’ dispute concerning the 2003 NPM Adjustment, including the States’ diligent enforcement claims, before a single, nationwide arbitration panel of three former federal judges. The settling states opposed these motions, arguing, among other things, that the issue of diligent enforcement must be resolved by MSA courts in each of the 52 settling states and territories.

As of December 31, 2011, 47 of the 48 courts that had addressed the question whether the dispute concerning the 2003 NPM Adjustment is arbitrable had ruled that arbitration is required under the MSA. The orders compelling arbitration in these states are now final and/or non-appealable. The Montana Supreme Court ruled that the state of Montana did not agree to arbitrate the question of whether it diligently enforced a qualifying statute. Trial on Montana’s assertion of its diligent enforcement defense to the 2003 NPM Adjustment is set for trial on September 10, 2012. Discovery is underway.

As of January 2009, RJR Tobacco and certain other PMs entered into an Agreement Regarding Arbitration, referred to as the Arbitration Agreement, with 45 of the settling states, representing approximately 90% of the allocable share of the settling states. Pursuant to the Arbitration Agreement, signing states will have their ultimate liability (if any) with respect to the 2003 NPM Adjustment reduced by 20%, and RJR Tobacco and the other PMs that placed their share of the disputed 2005 NPM Adjustment (discussed below) into the disputed payments account have, without releasing or waiving any claims, authorized the release of those funds to the settling states.

141

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Montana is one of the settling states that signed the Arbitration Agreement. Thus, notwithstanding the ruling of the Montana Supreme Court with respect to the arbitrability of the diligent enforcement issue, Montana is contractually obligated to participate with the other states in the arbitration that will address all remaining issues related to the dispute pertaining to the 2003 NPM Adjustment.

The arbitration panel contemplated by the MSA and the Arbitration Agreement has been selected, and proceedings before the panel with respect to the 2003 NPM Adjustment Claim have begun. An initial administrative conference was held in July 2010, and subsequent proceedings have been held since then. Document and deposition discovery has been conducted pursuant to various orders of the arbitration panel. On November 3, 2011, RJR Tobacco and the other PMs advised the arbitration panel that they were not contesting the “diligent enforcement” of 12 states and the four pacific territories with a combined allocable share of less that 14 percent. The “diligent enforcement” of the remaining 35 settling states, DC and Puerto Rico was contested and will be the subject of further proceedings. A common issues hearing has been scheduled for April 2012 and state specific evidentiary hearings will begin in May 2012. State specific hearings will continue thereafter on a monthly basis until proceedings with respect to all contested states have been completed. It is anticipated that it will be 12 to 18 months before a decision on the merits with respect to the 2003 NPM Adjustment is reached.

Other NPM Adjustment Claims.    From 2006 to 2008, proceedings were initiated with respect to an NPM Adjustment for 2004, 2005 and 2006. The Adjustment Requirements were satisfied with respect to the NPM Adjustment for each of 2004, 2005 and 2006. As a result:

• in April 2007, RJR Tobacco placed approximately $561 million of its 2007 MSA payment (representing its share of the 2004 NPM Adjustment as calculated by the MSA independent auditor), and in April 2008, placed approximately $431 million of its 2008 MSA payment (representing its share of the 2005 NPM Adjustment as calculated by the independent auditor, net of certain slight adjustments to reflect revised independent auditor calculations of RJR Tobacco’s share of the 2003 and 2004 NPM Adjustments) into the disputed payments account. In 2009 and 2010, revised independent auditor calculations resulted in increases in RJR Tobacco’s 2005 NPM Adjustment, bringing the total amount of the adjustment to approximately $445 million; and

• in April 2009, RJR Tobacco retained approximately $406.5 million of its 2009 MSA payment to reflect its share of the 2006 NPM Adjustment as calculated by the independent auditor. Based on revised calculations by the MSA independent auditor, in April 2010, RJR Tobacco withheld an additional amount, bringing the total amount withheld with respect to the 2006 NPM Adjustment to approximately $420 million. Again based on revised calculations by the MSA independent auditor, in April 2011, RJR Tobacco paid approximately $1 million extra to account for a downward adjustment in its share of the 2006 NPM Adjustment.

The MSA permits PMs to retain disputed payment amounts pending resolution of the dispute. If the resolution of the dispute ultimately requires a PM to pay some or all of the disputed amount, then the amount deemed to be due includes interest calculated from the date the payment was originally due at the prime rate plus three percent.

In June 2009, RJR Tobacco, certain other PMs and the settling states entered into an agreement with respect to the 2007, 2008 and 2009 significant factor determinations. This agreement provides that the settling states will not contest that the disadvantages of the MSA were “a significant factor contributing to” the market share loss experienced by the PMs in those years. The stipulation pertaining to each of the three years will become effective in February of the year a final determination by the firm of independent economic consultants would otherwise have been expected (2010, 2011 and 2012, respectively), if the issue had been arbitrated on the merits. RJR

142

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Tobacco and the PMs will pay a total amount of $5 million into the States’ Antitrust/Consumer Protection Tobacco Enforcement Fund established under Section VIII(c) of the MSA for each year covered by that agreement, with RJR Tobacco paying approximately 47% of such amounts. On January 9, 2012, a new agreement with respect to significant factor determinations was entered into teams essentially identical to the earlier agreement, but pertaining to 2010, 2011 and 2012.

Based on the payment calculations of the MSA independent auditor and the agreement described above regarding in pertinent part the 2007 and 2008 significant factor determinations, the Adjustment Requirements were satisfied with respect to the NPM Adjustments for 2007 and 2008. As a result, in April 2010, RJR Tobacco placed approximately $448 million of its 2010 MSA payment (representing its share of the 2007 NPM Adjustment as calculated by the MSA independent auditor) into the disputed payments account, and in April 2011, it placed approximately $477 million of its 2011 MSA payment (representing its share of the 2008 NPM Adjustment as calculated by the MSA independent auditor) into the disputed payments account. RJR Tobacco’s 2011 payment into the disputed payments account was reduced by approximately $1.1 million to adjust for a downward revision by the independent auditor to RJR Tobacco’s share of the 2007 NPM Adjustment.

The table below summarizes the information discussed above with respect to the disputed portions of RJR Tobacco’s MSA payment obligations from 2003 through 2008 – the years as to which the Adjustment Requirements have been met:

Year for which NPM Adjustment Calculated		2003		2004		2005		2006		2007		2008
Year in which deduction from NPM may be taken		2006		2007		2008		2009		2010		2011
RJR Tobacco’s approximate share of disputed NPM Adjustment (millions)	$	615	$	562	$	445	$	419	$	447	$	477

In addition to the NPM Adjustment claims described above, RJR Tobacco has filed dispute notices with respect to its 2009 and 2010 annual MSA payments relating to the NPM Adjustments potentially applicable to those years. The amount at issue for those two years is approximately $937 million.

Due to the uncertainty over the final resolution of the NPM Adjustment claims asserted by RJR Tobacco, no assurances can be made related to the amounts, if any, that will be realized or any amounts (including interest) that will be owed.

Separately, on August 19, 2011, Idaho sent a letter on behalf of itself and 31 other states, stating their intent to initiate arbitration with respect to whether amounts used to measure the domestic cigarette market and to calculate PM payment obligations under the MSA should be the adjusted gross or the net number of cigarettes on which federal excise tax (including arbitrios de cigarillos) is paid. On December 15, 2011, the parties entered into an agreement regarding procedures for formation of arbitration panel with respect to this arbitration. Selection of arbitrators by the parties is underway.

Antitrust Cases

A number of tobacco wholesalers and consumers have sued U.S. cigarette manufacturers, including RJR Tobacco and B&W, in federal and state courts, alleging that cigarette manufacturers combined and conspired to set the price of cigarettes in violation of antitrust statutes and various state unfair business practices statutes. In these cases, the plaintiffs asked the court to certify the lawsuits as class actions on behalf of other persons who purchased cigarettes directly or indirectly from one or more of the defendants. As of December 31, 2011, all of the federal and state court cases on behalf of indirect purchasers had been dismissed, except for one state court case pending in Kansas.

143

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In Smith v. Philip Morris Cos., Inc., a case filed in February 2000, and pending in District Court, Seward County, Kansas, the court granted class certification in November 2001, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and the parent companies of the major U.S. cigarette manufacturers, including RJR, seeking to recover an unspecified amount in actual and punitive damages. The plaintiffs allege that the defendants participated in a conspiracy to fix or maintain the price of cigarettes sold in the United States. The parties are currently engaged in discovery. In November 2010, RJR Tobacco and B&W filed a motion for summary judgment. A hearing on the motion occurred on January 18, 2012. A decision is pending. Trial has been scheduled for July 16, 2012.

Other Litigation and Developments

JTI Claims for Indemnification.    By purchase agreement dated May 12, 1999, referred to as the 1999 Purchase Agreement, RJR and RJR Tobacco sold the international tobacco business to JTI. Under the 1999 Purchase Agreement, RJR and RJR Tobacco retained certain liabilities relating to the international tobacco business sold to JTI. Under its reading of the indemnification provisions of the 1999 Purchase Agreement, JTI has requested indemnification for damages allegedly arising out of these retained liabilities. As previously reported, a number of the indemnification claims between the parties relating to the activities of Northern Brands in Canada have been resolved. See note 6 for a discussion of the Comprehensive Agreement between RJR Tobacco and the Canadian federal, provincial and territorial governments, and Northern Brands’ plea agreement with the Ministry of the Attorney General of Ontario. Other matters for which JTI has requested indemnification for damages under the indemnification provisions of the 1999 Purchase Agreement are described below:

• In a letter dated March 31, 2006, counsel for JTI stated that JTI would be seeking indemnification under the 1999 Purchase Agreement for any damages it may incur or may have incurred arising out of a Southern District of New York grand jury investigation, a now-terminated Eastern District of North Carolina grand jury investigation, and various actions filed by the European Community and others in the U.S. District Court for the Eastern District of New York, referred to as the EDNY, against RJR Tobacco and certain of its affiliates on November 3, 2000, August 6, 2001, and (as discussed in greater detail below) October 30, 2002, and against JTI on January 11, 2002.

• JTI also has sought indemnification relating to a Statement of Claim filed on April 23, 2010, against JTI Macdonald Corp., referred to as JTI-MC, by the Ontario Flue-Cured Tobacco Growers’ Marketing Board, referred to as the Board, Andy J. Jacko, Brian Baswick, Ron Kichler, and Aprad Dobrenty, proceeding on their own behalf and on behalf of a putative class of Ontario tobacco producers that sold tobacco to JTI-MC during the period between January 1, 1986 and December 31, 1996, referred to as the Class Period, through the Board pursuant to certain agreements. The Statement of Claim seeks recovery for damages allegedly incurred by the class representatives and the putative class for tobacco sales during the Class Period made at the contract price for duty free or export cigarettes with respect to cigarettes that, rather than being sold duty free or for export, purportedly were sold in Canada, which allegedly breached one or more of a series of contracts dated between June 4, 1986, and July 3, 1996.

• Finally, JTI has advised RJR and RJR Tobacco of its view that, under the terms of the 1999 Purchase Agreement, RJR and RJR Tobacco are liable for a roughly $1.7 million judgment entered in 1998, plus interest and costs, in an action filed in Brazil by Lutz Hanneman, a former employee of a former RJR Tobacco subsidiary. RJR and RJR Tobacco deny that they are liable for this judgment under the terms of the 1999 Purchase Agreement.

Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have these and other unresolved indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco

144

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

disagree with JTI as to (1) what circumstances relating to any such matters may give rise to indemnification obligations by RJR and RJR Tobacco, and (2) the nature and extent of any such obligation. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to resolve their differences at a later time.

European Community.    On October 30, 2002, the European Community and ten of its member states filed a complaint in the EDNY against RJR, RJR Tobacco and several currently and formerly related companies. The complaint contains many of the same or similar allegations found in an earlier complaint, now dismissed, filed in August 2001 and also alleges that the defendants, together with certain identified and unidentified persons, engaged in money laundering and other conduct violating civil RICO and a variety of common laws. The complaint also alleges that the defendants manufactured cigarettes that were eventually sold in Iraq in violation of U.S. sanctions. The plaintiffs seek compensatory, punitive and treble damages among other types of relief. This matter has been stayed and largely inactive since November 24, 2009 when, with the court’s permission, the European Community and member states filed and served a second amended complaint. The second amended complaint added 16 member states as plaintiffs and RAI, RJR Tobacco and R. J. Reynolds Global Products Inc., referred to as GPI as defendants. The allegations contained in the second amended complaint are in most respects either identical or similar to those found in the prior complaint, but now add new allegations primarily regarding the activities of RAI, RJR Tobacco and GPI following the B&W business combination. Pursuant to a stipulation and order, the defendants filed a motion to dismiss the plaintiffs’ second amended complaint on February 15, 2010. Oral argument of the motion occurred on October 26, 2010. Supplemental briefs were then filed. Ruling on part of the defendants’ motion to dismiss, on March 8, 2011, the court dismissed the plaintiffs’ RICO claims, and reserved decision as to dismissal of the plaintiffs’ state-law claims. Thereafter, on May 13, 2011, the court granted the remaining portion of the defendants’ motion and dismissed the plaintiffs’ state-law claims based on the court’s lack of subject matter jurisdiction. On May 16, 2011, the clerk of court entered a judgment dismissing the action in its entirety. On June 10, 2011, the plaintiffs filed a notice of appeal with the U.S. Court of Appeals for the Second Circuit, appealing from the May 16, 2011 judgment, as well as the March 8, 2011 and May 13, 2011 orders that respectively resulted in the dismissal of their RICO and state-law claims. Briefing is complete. Oral argument has been scheduled for February 24, 2012.

Star Patent Infringement.    On May 23, 2001, and July 30, 2002, Star Scientific, Inc. filed two patent infringement actions, later consolidated, against RJR Tobacco in the U.S. District Court for the District of Maryland. The consolidated action, known as Star I, involved two patents (U.S. Patent Nos. 6,202,649 and 6,425,401), both entitled “Method of Treating Tobacco to Reduce Nitrosamine Content, and Products Produced Thereby.” Star accused RJR Tobacco of infringing certain claims of these patents during the 2001 and 2002 growing seasons and asked the court to: enter an injunction restraining RJR Tobacco from further acts of infringement; award Star damages, including a reasonable royalty, to compensate for the infringement; increase the damages due to willfulness; award pre-judgment and post-judgment interest and reasonable attorney fees; and order RJR Tobacco to deliver up to the court for destruction all products manufactured from any process that infringes any claim of either patent. RJR Tobacco filed counterclaims seeking a declaration that the asserted claims of Star’s patents are invalid, unenforceable and not infringed by RJR Tobacco. Between January 31 and February 8, 2005, the court held a first bench trial on RJR Tobacco’s affirmative defense and counterclaim based upon inequitable conduct. Additionally, in response to the court’s invitation, RJR Tobacco filed two summary judgment motions in January 2005.

In January 2007, the court granted RJR Tobacco’s motion for summary judgment of invalidity based on indefiniteness. The court granted in part and denied in part, RJR Tobacco’s other summary judgment motion concerning the effective filing date of Star’s patents. In June 2007, the court ruled that Star’s patents are unenforceable due to inequitable conduct by Star and its representatives in the U.S. Patent & Trademark Office, referred to as the PTO, and entered final judgment in favor of RJR Tobacco and against Star. Star filed a notice of appeal with the U.S. Court of Appeals for the Federal Circuit.

145

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In August 2008, the Federal Circuit issued a decision reversing the district court’s rulings against Star and remanded the case to the district court for further proceedings on the issues of validity and infringement. Star updated its reasonable royalty damages calculation to a range of $294.9 million to $362.1 million.

In late 2008, RJR Tobacco petitioned the PTO to reexamine the claims of Star’s patents at issue in Star I based on substantial new questions of patentability. The PTO agreed to reexamine the claims ex parte. The district court decided to move forward with the trial in Star I rather than await the outcome of the reexamination proceedings.

Trial began on May 18, 2009, and on June 16, 2009, the jury returned a verdict in favor of RJR Tobacco on every question put to it. The jury decided that RJR Tobacco had not infringed either of Star’s patents and that the patents were invalid on four independent bases.

Shortly after the start of the Star I jury trial, in May 2009, Star filed a follow-on lawsuit – Star II – in the U.S. District Court for the District of Maryland seeking damages for alleged infringement during the 2003 growing season and beyond of the two Star patents found invalid and not infringed in Star I. The district court stayed Star II pending the outcome of proceedings in Star I, and Star II was administratively closed pending further order of the district court upon the application, by December 31, 2012, of any party.

In November 2009, RJR Tobacco filed a bill of costs (later renewed) seeking reimbursement of its recoverable costs as the prevailing party in Star I, and also filed a motion seeking reimbursement of its attorney fees and excess costs incurred in defending Star I. In December 2009, the district court upheld the jury verdict by denying Star’s combined motion for judgment as a matter of law or new trial. The court entered judgment in RJR Tobacco’s favor and awarded RJR Tobacco all assessable costs. The court deferred proceedings with respect to RJR Tobacco’s motion for attorneys’ fees and excess costs pending final resolution of the reexamination and any appellate proceedings.

On Star’s request and without objection from RJR Tobacco, the district court deferred briefing on RJR Tobacco’s renewed bill of costs until after the resolution of appellate proceedings.

In December 2009, Star filed a notice of appeal in the Federal Circuit from the district court’s final judgment order. On August 26, 2011, the Federal Circuit issued a decision affirming the jury’s finding of non-infringement but reversing, in a split decision, on invalidity. Writing in dissent, Judge Dyk stated that he would affirm the jury’s finding of invalidity based upon indefiniteness.

On September 26, 2011, RJR Tobacco filed a combined petition for panel rehearing and rehearing en banc with the Federal Circuit seeking rehearing on whether Star’s patents at issue are invalid based upon indefiniteness. The Federal Circuit denied RJR Tobacco’s combined petition on November 29, 2011, and the Federal Circuit’s judgment issued as a mandate on December 15, 2011. Star I has now returned to the district court for further proceedings on RJR Tobacco’s bill of cost and motion for attorneys’ fees and excess costs. A status conference occurred on January 24, 2012. Star I and Star II have been stayed and referred to the magistrate judge for mediation purposes.

In the PTO reexamination proceeding, the PTO in March and April 2011 issued ex parte reexamination certificates confirming the patentability of the claims of the Star patents at issue in Star I. The PTO reexamination proceeding did not address the question of whether Star’s patents are invalid based upon indefiniteness.

146

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Other Matters.    In November, 2009, RAI and B&W were served with subpoenas issued by the Office of the Inspector General, U.S. Department of Defense, seeking two broad categories of documents in connection with a civil investigation:

• documents regarding the sale of U.S. manufactured cigarettes to the Army Air Force Exchange Service and the Navy Exchange Command either directly by the manufacturers or through distributors during the period January 1, 1998 through December 31, 2001; and

• documents regarding the sale of U.S. manufactured cigarettes by the manufacturers to civilian market customers for resale in non-federal excise tax markets during the periods January 1, 1998 through December 31, 2001 and September 1, 2008 through September 1, 2009.

RAI and RJRT have responded to the subpoenas, including the extent to which the subpoenas seek documents regarding the domestic tobacco operations acquired from B&W in 2004, and believes this matter is now closed.

In May 2011, RJR Tobacco and SFNTC received separate letters from counsel to Walgreen Co. regarding a 60-day notice served on Walgreen by a consumer group alleging violations of California’s Proposition 65. The group claims that Walgreen provided or sold products with containers or wrappers containing insufficient warning in violation of California law. Walgreen believes that RJR Tobacco and SFNTC provided the noticed products, and is requesting that RJR Tobacco and SFNTC pay for Walgreen’s defense, indemnify Walgreen and hold Walgreen harmless from all liability, loss or expense (including legal expense) related to sales of any products covered by the 60-day notice, manufactured or distributed to Walgreen by RJR Tobacco and SFNTC. In June 2011, RJR Tobacco submitted a reply to Walgreen’s counsel, and SFNTC submitted a reply in July 2011. Neither company has received a response from Walgreen’s counsel. RJR Tobacco and SFNTC each believes that it has valid defenses to Walgreen’s claims.

Finally, in the first quarter of 2005, Commonwealth Brands, Inc., referred to as Commonwealth, was served with an individual smoking and health case, Croft v. Akron Gasket in Cuyahoga County, Ohio. Commonwealth requested indemnity from RJR Tobacco pursuant to the Asset Purchase Agreement dated July 24, 1996, between Commonwealth and B&W, referred to as the 1996 Purchase Agreement. As a result of the B&W business combination, RJR Tobacco agreed to indemnify Commonwealth for this claim to the extent, if any, required by the 1996 Purchase Agreement. The scope of the indemnity will be at issue and has not been determined.

Smokeless Tobacco Litigation

As of December 31, 2011, American Snuff Co. was a defendant in six actions brought by individual plaintiffs in West Virginia state court seeking damages in connection with personal injuries allegedly sustained as a result of the usage of American Snuff Co.’s smokeless tobacco products. These actions are pending before the same West Virginia court as the 577 consolidated individual smoker cases against RJR Tobacco, B&W, as RJR Tobacco’s indemnitee, or both. Pursuant to the court’s December 3, 2001, order, the smokeless tobacco claims and defendants remain severed.

Pursuant to a second amended complaint filed in September 2006, American Snuff Co. is a defendant in Vassallo v. United States Tobacco Company, pending in the Eleventh Circuit Court in Miami-Dade County, Florida. The individual plaintiff alleges that he sustained personal injuries, including addiction and cancer, as a result of his use of smokeless tobacco products, allegedly including products manufactured by American Snuff Co. The plaintiff seeks unspecified compensatory and consequential damages in an amount greater than $15,000. There is not a punitive damages demand in this case, though the plaintiff retains the right to seek leave of court to add such a demand later. Discovery is underway.

147

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

American Snuff Co. was served with a complaint that was filed in October 2011 in the U.S. District Court for the Northern District of Mississippi, Vertison v. American Snuff Co., LLC. The plaintiff alleges that as a result of her use of the defendants’ smokeless tobacco products, she developed oral cancer. The plaintiff seeks unspecified compensatory and punitive damages. On January 13, 2012, American Snuff Co. filed its answer to the complaint.

Tobacco Buyout Legislation and Related Litigation

In 2004, legislation was passed eliminating the U.S. government’s tobacco production controls and price support program. The buyout of tobacco quota holders provided for in the Fair and Equitable Tobacco Reform Act, referred to as FETRA, is funded by a direct quarterly assessment on every tobacco product manufacturer and importer, on a market-share basis measured on volume to which federal excise tax is applied. The aggregate cost of the buyout to the industry is approximately $9.9 billion, including approximately $9.6 billion payable to quota tobacco holders and growers through industry assessments over ten years and approximately $290 million for the liquidation of quota tobacco stock. As a result of the tobacco buyout legislation, the MSA Phase II obligations established in 1999 continued as scheduled through the end of 2010, but were offset against the tobacco quota buyout obligations. RAI’s operating subsidiaries’ annual expense under FETRA for 2012 and thereafter, excluding the tobacco stock liquidation assessment, is estimated to be approximately $220 million to $240 million.

RAI’s operating subsidiaries recorded the FETRA assessment on a quarterly basis as cost of goods sold. RAI’s operating subsidiaries estimate that their overall share of the buyout will approximate $2.4 billion to $2.8 billion prior to the deduction of permitted offsets under the MSA. In addition, future market pricing could impact the carrying value of inventory, and adversely affect RJR Tobacco’s financial position and results of operations.

As noted above, the MSA Phase II obligations were offset against the tobacco quota buyout obligations. Because growers in two states, Maryland and Pennsylvania, did not participate in the quota system, they are not eligible for payments under FETRA. Given that the assessments paid by tobacco product manufacturers and importers under FETRA fully offset their MSA Phase II payment obligations, the growers in Maryland and Pennsylvania would no longer receive payments under the MSA Phase II program. Thus, the growers in these two states do not receive payments under either FETRA or the MSA Phase II program.

ERISA Litigation

In May 2002, in Tatum v. The R.J.R. Pension Investment Committee of the R. J. Reynolds Tobacco Company Capital Investment Plan, an employee of RJR Tobacco filed a class-action suit in the U.S. District Court for the Middle District of North Carolina, alleging that the defendants, RJR, RJR Tobacco, the RJR Employee Benefits Committee and the RJR Pension Investment Committee, violated the Employee Retirement Income Security Act of 1974, referred to as ERISA. The actions about which the plaintiff complains stem from a decision made in 1999 by RJR Nabisco Holdings Corp., subsequently renamed Nabisco Group Holdings Corp., referred to as NGH, to spin off RJR, thereby separating NGH’s tobacco business and food business. As part of the spin-off, the 401(k) plan for the previously related entities had to be divided into two separate plans for the now separate tobacco and food businesses. The plaintiff contends that the defendants breached their fiduciary duties to participants of the RJR 401(k) plan when the defendants removed the stock funds of the companies involved in the food business, NGH and Nabisco Holdings Corp., referred to as Nabisco, as investment options from the RJR 401(k) plan approximately six months after the spin-off. The plaintiff asserts that a November 1999 amendment (the “1999 Amendment”) that eliminated the NGH and Nabisco funds from the RJR 401(k) plan on January 31, 2000, contained sufficient discretion for the defendants to have retained the NGH and Nabisco funds

148

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

after January 31, 2000, and that the failure to exercise such discretion was a breach of fiduciary duty. In his complaint, the plaintiff requests, among other things, that the court require the defendants to pay as damages to the RJR 401(k) plan an amount equal to the subsequent appreciation that was purportedly lost as a result of the liquidation of the NGH and Nabisco funds.

In July 2002, the defendants filed a motion to dismiss, which the court granted in December 2003. In December 2004, the U.S. Court of Appeals for the Fourth Circuit reversed the dismissal of the complaint, holding that the 1999 Amendment did contain sufficient discretion for the defendants to have retained the NGH and Nabisco funds as of February 1, 2000, and remanded the case for further proceedings. The court granted the plaintiff leave to file an amended complaint and denied all pending motions as moot. In April 2007, the defendants moved to dismiss the amended complaint. The court granted the motion in part and denied it in part, dismissing all claims against the RJR Employee Benefits Committee and the RJR Pension Investment Committee. The remaining defendants, RJR and RJR Tobacco, filed their answer and affirmative defenses in June 2007. The plaintiff filed a motion for class certification, which the court granted in September 2008. The district court ordered mediation, but no resolution of the case was reached. In September 2008, each of the plaintiffs and the defendants filed motions for summary judgment, and in January 2009, the defendants filed a motion to decertify the class. A second mediation occurred in June 2009, but again no resolution of the case was reached. The district court overruled the motions for summary judgment and the motion to decertify the class.

A non-jury trial was held in January and February 2010. During closing arguments, the plaintiff argued for the first time that certain facts arising at trial showed that the 1999 Amendment was not validly adopted, and then moved to amend his complaint to conform to this evidence at trial. On June 1, 2011, the court granted the plaintiff’s motion to amend his complaint and found that the 1999 Amendment was invalid.

The parties filed their findings of fact and conclusions of law on February 4, 2011. A decision is pending.

Environmental Matters

RAI and its subsidiaries are subject to federal, state and local environmental laws and regulations concerning the discharge, storage, handling and disposal of hazardous or toxic substances. Such laws and regulations provide for significant fines, penalties and liabilities, sometimes without regard to whether the owner or operator of the property knew of, or was responsible for, the release or presence of hazardous or toxic substances. In addition, third parties may make claims against owners or operators of properties for personal injuries and property damage associated with releases of hazardous or toxic substances. In the past, RJR Tobacco has been named a potentially responsible party with third parties under the Comprehensive Environmental Response, Compensation and Liability Act with respect to several superfund sites. RAI and its subsidiaries are not aware of any current environmental matters that are expected to have a material adverse effect on the business, results of operations or financial position of RAI or its subsidiaries.

In September 2009, the U.S. Environmental Protection Agency, referred to as EPA, passed a rule which requires companies to monitor greenhouse gas, referred to as GHG, emissions beginning in January, 2010 and, depending upon the industry in which the particular company operates or the amount of the company’s GHG emissions, report these emissions to EPA on an annual basis, beginning in 2011. Based upon its GHG emission levels, RJR Tobacco submitted the required GHG emissions reports to the EPA pertaining to one of its facilities. RJR Tobacco is fully prepared to make annual submissions in accordance with the EPA’s regulations.

RAI and its operating subsidiaries believe that climate change is an environmental issue primarily driven by carbon dioxide emissions from the use of energy. RAI’s operating subsidiaries are working to reduce carbon dioxide emissions by minimizing the use of energy where cost effective, minimizing waste to landfills and

149

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

increasing recycling. Climate change is not viewed by RAI’s operating subsidiaries as a significant direct economic risk to their businesses, but rather an indirect risk involving the potential for a longer term general increase in the cost of doing business. Regulatory changes are difficult to predict, but the current regulatory risks to the business of RAI’s operating subsidiaries with respect to climate change are relatively low. Financial impacts will be driven more by the cost of natural gas and electricity. Efforts are made to mitigate the effect of increases in fuel costs directly impacting RAI’s operating subsidiaries by evaluating natural gas usage and market conditions, and occasionally purchasing forward contracts, limited to a three-year period, for natural gas. In addition, RAI’s operating subsidiaries are constantly evaluating electrical energy conservation measures and energy efficient equipment to mitigate impacts of increases in electrical energy costs.

Regulations promulgated by the EPA and other governmental agencies under various statutes have resulted in, and likely will continue to result in, substantial expenditures for pollution control, waste treatment, facility modification and similar activities. RAI and its subsidiaries are engaged in a continuing program to comply with federal, state and local environmental laws and regulations, and dependent upon the probability of occurrence and reasonable estimation of cost, accrue or disclose any material liability. Although it is difficult to reasonably estimate the portion of capital expenditures or other costs attributable to compliance with environmental laws and regulations, RAI does not expect such expenditures or other costs to have a material adverse effect on the business, results of operations or financial position of RAI or its subsidiaries.

Other Contingencies

In connection with the sale of the international tobacco business to JTI, pursuant to the 1999 Purchase Agreement, RJR and RJR Tobacco agreed to indemnify JTI against:

• any liabilities, costs and expenses arising out of the imposition or assessment of any tax with respect to the international tobacco business arising prior to the sale, other than as reflected on the closing balance sheet;

• any liabilities, costs and expenses that JTI or any of its affiliates, including the acquired entities, may incur after the sale with respect to any of RJR’s or RJR Tobacco’s employee benefit and welfare plans; and

• any liabilities, costs and expenses incurred by JTI or any of its affiliates arising out of certain activities of Northern Brands.

As described above in “— Litigation Affecting the Cigarette Industry — Other Litigation and Developments — JTI Claims for Indemnification,” RJR Tobacco has received claims for indemnification from JTI, and several of these have been resolved. Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have other unresolved indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree what circumstances described in such claims give rise to any indemnification obligations by RJR and RJR Tobacco and the nature and extent of any such obligation. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to resolve their differences at a later date.

RJR Tobacco, SFNTC and American Snuff Co. have entered into agreements to indemnify certain distributors and retailers from liability and related defense costs arising out of the sale or distribution of their products. Additionally, Santa Fe has entered into an agreement to indemnify a supplier from liability and related defense costs arising out of the sale or use of Santa Fe’s products. The cost has been, and is expected to be, insignificant. RJR Tobacco, Santa Fe and American Snuff Co. believe that the indemnified claims are substantially similar in nature and extent to the claims that they are already exposed to by virtue of their having manufactured those products.

150

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Except as otherwise noted above, RAI is not able to estimate the maximum potential amount of future payments, if any, related to these indemnification obligations.

Lease Commitments

RAI has operating lease agreements that are primarily for office space, automobiles, warehouse space and computer equipment. The majority of these leases expire within the next five years and some contain renewal or purchase options and escalation clauses or restrictions relating to subleases. Total rent expense was $18 million, $20 million and $20 million for 2011, 2010 and 2009, respectively.

Future minimum lease payments as of December 31, 2011 were as follows:

	Noncancellable Operating  Leases
2012	$	20
2013		18
2014		15
2015		9
2016		4
Total	$	66

Note 14 — Shareholders’ Equity

RAI’s authorized capital stock at December 31, 2011 and 2010, consisted of 100 million shares of preferred stock, par value $.01 per share, and 1.6 billion shares of common stock, par value $.0001 per share. Four million shares of the preferred stock are designated as Series A Junior Participating Preferred Stock, none of which is issued or outstanding. The Series A Junior Participating Preferred Stock will rank junior as to dividends and upon liquidation to all other series of RAI preferred stock, unless specified otherwise. Also, of the preferred stock, one million shares are designated as Series B Preferred Stock, all of which are issued and outstanding. The Series B Preferred Stock ranks senior upon liquidation, but not with respect to dividends, to all other series of RAI capital stock, unless specified otherwise. As a part of the B&W business combination, RJR is the holder of the outstanding Series B Preferred Stock. In each of 2011, 2010 and 2009, RAI declared $43 million in dividends to RJR with respect to the Series B Preferred Stock.

In 2004, RAI’s board of directors adopted a shareholder rights plan, pursuant to which RAI declared a dividend of one preferred stock purchase right on each share of RAI common stock outstanding on July 30, 2004. The board also authorized the issuance of rights for each share of RAI common stock issued after the dividend record date, until the occurrence of certain specified events. By virtue of RAI’s two-for-one stock split in both 2006 and 2010, the number of rights associated with each share of RAI common stock is .25. The rights will expire on July 30, 2014, unless earlier redeemed, exercised or exchanged under the terms of the rights plan.

The rights are not exercisable until a distribution date that is the earlier of:

• ten days following an announcement that a person or group, other than BAT and its subsidiaries, except in certain circumstances, has acquired beneficial ownership of at least 15% of RAI common stock, and

• ten business days, or such later date as may be determined by the board, following the announcement of a tender offer which would result in a person becoming an acquiring person.

151

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

If the acquiring person or tender offeror is BAT or one of its subsidiaries, then the foregoing 15% threshold is subject to adjustment. The rights are initially exercisable for 1/100th of a share of RAI’s Series A Junior Participating Preferred Stock at a purchase price of $130, subject to adjustment. Each fractional share of such preferred stock would give the holder approximately the same dividend, voting and liquidation rights as does one share of RAI common stock. Until the distribution date, the rights will be evidenced by RAI common stock certificates and trade with such shares. Upon the occurrence of certain events after the distribution date, holders of rights, other than the acquiring person, will be entitled to receive upon exercise of the right, in lieu of shares of preferred stock, RAI common stock or common stock of the acquiring corporation having in either case a market value of two times the exercise price of the right.

RAI’s board of directors declared the following quarterly cash dividends per share of RAI common stock in 2011, 2010 and 2009:

	2011		2010		2009
First	$	0.53	$	0.45	$	0.425
Second	$	0.53	$	0.45	$	0.425
Third	$	0.53	$	0.45	$	0.425
Fourth	$	0.56	$	0.49	$	0.450

On November 14, 2011, the board of directors of RAI authorized the repurchase, from time to time on or before mid-2014, of up to $2.5 billion of outstanding shares of RAI common stock in open-market or privately negotiated transactions. The repurchases are subject to prevailing market and business conditions, and the program may be terminated or suspended at any time. In connection with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI’s common stock. RAI, B&W and BAT also entered into Amendment No. 3 to the governance agreement, pursuant to which RAI has agreed that, so long as B&W’s ownership interest has not dropped below 25%, if RAI issues shares of its common stock or any other RAI equity security to certain designated persons, including its directors, officers or employees, then RAI will repurchase a number of shares of outstanding RAI common stock so that the number of outstanding shares of RAI common stock are not increased, and B&W’s ownership interest is not decreased, by such issuance after taking into account such repurchase. In addition, RAI repurchases shares of its common stock forfeited with respect to the tax liability associated with certain stock option exercises and vesting of restricted stock grants under the RAI Long-Term Incentive Plan, referred to as the LTIP.

Due to RAI’s incorporation in North Carolina, which does not recognize treasury shares, the shares repurchased are cancelled at the time of repurchase. As of December 31, 2011, RAI had repurchased and cancelled 6,776,637 shares of RAI common stock for $276 million under the above share repurchase program.

Additionally, during 2011, at a cost of $6 million, RAI purchased 162,257 shares that were forfeited with respect to tax liabilities associated with restricted stock vesting under its LTIP.

Changes in RAI common stock outstanding were as follows:

	2011			2010			2009
Shares outstanding at beginning of year		583,043,872			582,848,102			582,901,524
LTIP shares forfeited		(433	)		(7,501	)		(55,420	)
LTIP tax shares repurchased and cancelled		(162,257	)		(185,257	)		(308,882	)
Shares repurchased and cancelled		(6,776,637	)		—			—
Stock options exercised		—			362,284			245,280
Equity incentive award plan shares issued		30,654			26,244			65,600
Shares outstanding at end of year		576,135,199			583,043,872			582,848,102

152

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 15 — Stock Plans

As of December 31, 2011, RAI had two stock plans, the Equity Incentive Award Plan for Directors of RAI, referred to as the EIAP, and the Reynolds American Inc. 2009 Omnibus Incentive Compensation Plan, referred to as the Omnibus Plan.

Under the EIAP, RAI currently provides (1) grants of deferred stock units to eligible directors upon becoming a director or, provided the director did not receive an initial award upon his/her election to the board, upon appointment to the position of Non-Executive Chairman and (2) grants of deferred stock units to eligible directors on a quarterly and annual basis thereafter. Directors may elect to receive shares of common stock in lieu of their initial and annual grants of deferred stock units. A maximum of 2,000,000 shares of common stock may be issued under this plan, of which 1,112,305 shares were available for grant as of December 31, 2011. Deferred stock units granted under the EIAP have a value equal to, and bear dividend equivalents at the same rate as, one share of RAI common stock, and have no voting rights. The dividends are paid as additional units in an amount equal to the number of shares of RAI common stock that could be purchased with the dividends on the date of payment. Generally, distribution of a director’s deferred stock units will be made on January 2 following his or her last year of service on the board; however, for all grants made under the EIAP after December 31, 2007, a director may elect to receive his or her deferred stock units on the later of January 2 of a specified year or January 2 following his or her last year of service on the board. At the election of a director, distribution may be made in one lump sum or in up to ten annual installments. A director is paid in cash for the units granted quarterly and in common stock for the units granted initially and annually, unless the director elects to receive cash for the initial and annual grants. Cash payments are based on the average closing price of RAI common stock during December of the year preceding payment. Compensation expense related to the EIAP was $5 million during 2011, $4 million during 2010 and $3 million during 2009.

In 2009, the shareholders of RAI approved the Omnibus Plan. Awards to key employees under the Omnibus Plan may be in the form of cash awards, incentive or non-incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units or other awards. Subject to adjustments as set forth in the Omnibus Plan, the number of shares of RAI common stock that may be issued with respect to awards under the Omnibus Plan will not exceed 38,000,000 shares in the aggregate. The Omnibus Plan replaced the LTIP, which expired in 2009. The outstanding grants made under the LTIP prior to its expiration will remain outstanding in accordance with their terms. Upon retirement, a holder’s grant under the Omnibus Plan or LTIP generally vests on a pro rata basis for the portion of the vesting service period that has elapsed, thereby maintaining an appropriate approximation of forfeitures related to retirement.

Information regarding stock-based awards outstanding as of December 31, 2011, was as follows:

Grant Year	Plan	Number of Shares Granted		Grant Price		Type	Vesting Date		Number of Shares Cancelled		Number of Shares Vested
2009	LTIP		2,764,486	$	16.550	Restricted Stock Units		March 2, 2012		448,475		—
2010	Omnibus		1,980,166	$	26.620	Restricted Stock Units		March 1, 2013		353,655		—
2010	Omnibus		8,422	$	27.655	Restricted Stock Units		March 1, 2013		5,704		—
2010	Omnibus		2,758	$	29.425	Restricted Stock Units		March 1, 2013		—		—
2011	Omnibus		1,561,331	$	33.990	Restricted Stock Units		March 1, 2014		102,474		—
2011	Omnibus		3,874	$	39.590	Restricted Stock Units		March 1, 2014		—		—

The grant date fair value was based on the per share closing price of RAI common stock on the date of grant. The actual number of shares granted is fixed. The grants are accounted for as equity-based and compensation expense includes the vesting period elapsed.

153

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The restricted stock unit grants will be settled exclusively in shares of RAI common stock. Upon settlement, each grantee will receive a number of shares of RAI’s common stock equal to the product of the number of vested units and a percentage up to 150% based on the average RAI annual incentive award plan score over the three-year period ending on December 31 of the year prior to the vesting date.

Dividends paid on shares of RAI common stock will accumulate on the restricted stock units and be paid to the grantee on the vesting date. If RAI fails to pay its shareholders cumulative dividends of at least $5.10 per share for the three-year performance period ending December 31, 2011 (in the case of the 2009 restricted stock unit grants), $5.40 per share for the three-year performance period ending December 31, 2012 (in the case of the 2010 restricted stock unit grants), or $6.36 per share for the three-year performance period ending December 31, 2013 (in the case of the 2011 restricted stock unit grants), then each award will be reduced by an amount equal to three times the percentage of the dividend underpayment, up to a maximum reduction of 50%. Dividends accrued on the 2009 grants are included in current liabilities and the dividends accrued on the 2010 and 2011 grants are included in other noncurrent liabilities in the consolidated balance sheet as of December 31, 2011.

The changes in restricted RAI common stock and restricted stock units during 2011 were as follows:

	Stock and Stock Units			Weighted Average Grant Date Fair Value
Outstanding at beginning of year		4,845,861		$	21.87
Granted		1,565,205			34.00
Forfeited		(544,032	)		24.93
Vested		(456,305	)		30.94
Outstanding at end of year		5,410,729			24.30

Total compensation expense related to stock-based compensation and the related tax benefits recognized in selling, general and administrative expenses in the consolidated statements of income were as follows:

Grant/Type	2011		2010		2009
2006 restricted stock	$	—	$	—	$	(2	)
2007 restricted stock and performance shares		—		1		5
2008 restricted stock		1		5		5
2009 restricted stock units		12		16		14
2010 restricted stock units		12		15		—
2011 restricted stock units		13		—		—
Total compensation expense	$	38	$	37	$	22
Total related tax benefits	$	13	$	13	$	8

Cash payments related to stock-based compensation were $19 million and $16 million for the years ended 2010 and 2009, respectively.

154

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The amounts related to the 2008 and 2009 LTIP restricted stock unit grants and the 2010 and 2011 Omnibus restricted stock unit grants were included in the consolidated balance sheets as of December 31 as follows:

	2011		2010
Other current liabilities	$	15	$	—
Other noncurrent liabilities		10		14
Paid-in capital		81		58

As of December 31, 2011, there were $55 million of unrecognized compensation costs related to restricted stock units, calculated at the grant-date price, which are expected to be recognized over a weighted-average period of 1.83 years.

There were 40,000 stock options granted under the EIAP and outstanding at December 31, 2011, all of which were exercisable on such date at a per share exercise price of $17.45 with a remaining contractual life of 0.4 years.

RAI has a policy of issuing new shares of common stock to satisfy share option exercises. The changes in RAI’s stock options during 2011, 2010 and 2009 were as follows:

	2011				2010					2009
	Options		Weighted Average Exercise Price		Options			Weighted Average Exercise Price		Options			Weighted Average Exercise Price
Outstanding at beginning of year		40,000	$	17.45		485,468		$	7.64		776,348		$	7.38
Expired		—		—		(83,184	)		6.63		—			—
Exercised		—		—		(362,284	)		6.78		(290,880	)		6.95
Outstanding at end of year		40,000		17.45		40,000			17.45		485,468			7.64
Exercisable at end of year		40,000		17.45		40,000			17.45		485,468			7.64

The intrinsic value of options exercised was $7 million and $4 million for the years ended December 31, 2010 and 2009, respectively. The aggregate intrinsic value of fully vested outstanding and exercisable options at December 31, 2011, was $1 million.

Cash proceeds related to stock options exercised and excess tax benefits related to stock-based compensation were as follows:

	2011		2010		2009
Proceeds from exercise of stock options	$	—	$	2	$	2
Excess tax benefits from stock-based compensation		1		2		2

155

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Equity compensation plan information as of December 31, 2011, was as follows:

Plan Category	Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights			Weighted Average Exercise Price of Outstanding Options, Warrants and Rights		Number of  Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a))
	(a)			(b)		(c)
Equity Compensation Plans Approved by Security Holders		8,116,094	(2)	$	—		33,357,923
Equity Compensation Plans Not Approved by Security Holders(1)		40,000			17.45		1,112,305
Total		8,156,094	(2)		17.45		34,470,228

⁽¹⁾  The EIAP was approved by RJR’s sole shareholder, NGH, prior to RJR’s spin-off on June 15, 1999.

⁽²⁾  Consists of restricted stock units. These restricted stock units represent the maximum number, 150%, of shares to be awarded under the best-case targets that may not be achieved, and accordingly, may overstate expected dilution.

Note 16 — Retirement Benefits

RAI and certain of its subsidiaries sponsor a number of non-contributory defined benefit pension plans covering most of their employees, and also provide certain health and life insurance benefits for most of their retired employees and their dependents. These benefits are generally no longer provided to employees hired on or after January 1, 2004.

156

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The changes in benefit obligations and plan assets, as well as the funded status of these plans at December 31 were as follows:

	Pension Benefits						Postretirement Benefits
	2011			2010			2011			2010
Change in benefit obligation:
Obligation at beginning of year	$	5,529		$	5,270		$	1,436		$	1,351
Service cost		26			29			3			4
Interest cost		300			319			75			80
Actuarial loss		320			324			59			148
Plan amendments		—			—			(45	)		(51	)
Benefits paid		(397	)		(410	)		(94	)		(97	)
Settlements		(9	)		—			—			—
Curtailment		—			(3	)		—			1
One-time cost		(3	)		—			—			—
Obligation at end of year	$	5,766		$	5,529		$	1,434		$	1,436
Change in plan assets:
Fair value of plan assets at beginning of year	$	4,934		$	4,054		$	270		$	270
Actual return on plan assets		362			479			1			31
Employer contributions		220			811			78			66
Benefits paid		(397	)		(410	)		(94	)		(97	)
Settlements		(9	)		—			—			—
Fair value of plan assets at end of year	$	5,110		$	4,934		$	255		$	270
Funded status	$	(656	)	$	(595	)	$	(1,179	)	$	(1,166	)
Amounts recognized in the consolidated balance sheets consist of:
Noncurrent assets — other assets and deferred charges		7			3			—			—
Accrued benefit — other current liability		(9	)		(18	)		(74	)		(78	)
Accrued benefit — long-term retirement benefits		(654	)		(580	)		(1,105	)		(1,088	)
Net amount recognized		(656	)		(595	)		(1,179	)		(1,166	)
Accumulated other comprehensive loss		596			382			2			(23	)
Net amounts recognized in the consolidated balance sheets	$	(60	)	$	(213	)	$	(1,177	)	$	(1,189	)

Amounts included in accumulated other comprehensive loss were as follows as of December 31:

	2011									2010
	Pension Benefits			Postretirement Benefits			Total			Pension Benefits			Postretirement Benefits			Total
Prior service cost (credit)	$	26		$	(135	)	$	(109	)	$	30		$	(119	)	$	(89	)
Net actuarial loss		570			137			707			352			96			448
Deferred income taxes		(245	)		(23	)		(268	)		(160	)		(13	)		(173	)
Accumulated other comprehensive loss	$	351		$	(21	)	$	330		$	222		$	(36	)	$	186

157

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Changes in accumulated other comprehensive loss were as follows:

	2011									2010
	Pension Benefits			Postretirement Benefits			Total			Pension Benefits			Postretirement Benefits			Total
Prior service credit	$	—		$	(45	)	$	(45	)	$	—		$	(51	)	$	(51	)
Net actuarial loss		331			76			407			185			136			321
Amortization of prior service cost (credit)		(4	)		29			25			(4	)		24			20
One-time cost		(3	)		—			(3	)		—			—			—
MTM adjustment		(110	)		(35	)		(145	)		(3	)		(107	)		(110	)
Deferred income tax expense		(85	)		(10	)		(95	)		(72	)		(30	)		(102	)
Change in accumulated other comprehensive loss	$	129		$	15		$	144		$	106		$	(28	)	$	78

The prior service credit in postretirement benefits in 2011 reflects the adoption of plan amendments resulting from workforce changes and plan design changes to conform with standard Medicare Part D market place offerings. The prior service credit in postretirement benefits in 2010 reflects a reduction in benefits paid for prescription drugs in the Medicare Part D coverage gap in order to take advantage of pharmaceutical rebates beginning in 2011 under health care reform and workforce changes.

In March 2010, the Patient Protection and Affordable Care Act, referred to as the PPACA, as amended by the Health Care and Reconciliation Act of 2010, was signed into law. The PPACA mandates health care reforms with staggered effective dates from 2010 to 2018. The additional postretirement liability resulting from the material impacts of the PPACA have been included in the accumulated postretirement benefit obligation at December 31, 2011. Given the complexity of the PPACA and the extended time period in which implementation is expected to occur, further adjustments to the accumulated postretirement benefit obligation may be necessary in the future.

	Pension Benefits						Postretirement
	2011			2010			2011			2010
Weighted-average assumptions used to determine benefit obligations at December 31:
Discount rate		5.00	%		5.66	%		4.84	%		5.52	%
Rate of compensation increase		5.00	%		5.00	%		5.00	%		5.00	%

The measurement date used for all plans was December 31.

The accumulated benefit obligation, which represents benefits earned to date, for all pension plans was $5,660 million and $5,410 million for the years ended December 31, 2011 and 2010, respectively.

Pension plans experiencing accumulated benefit obligations, which represent benefits earned to date, in excess of plan assets are summarized below:

	December 31,
	2011		2010
Projected benefit obligation	$	5,737	$	5,499
Accumulated benefit obligation		5,630		5,380
Plan assets		5,074		4,901

158

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The components of the total benefit cost and assumptions are set forth below:

	Pension Benefits									Postretirement Benefits
	2011			2010			2009			2011			2010			2009
Components of total benefit cost:
Service cost	$	26		$	29		$	31		$	3		$	4		$	4
Interest cost		300			319			319			75			80			80
Expected return on plan assets		(373	)		(343	)		(264	)		(18	)		(18	)		(16	)
Amortization of prior service cost (credit)		4			4			4			(29	)		(24	)		(24	)
MTM adjustment		110			3			14			35			107			35
Curtailment		—			—			—			—			1			—
Special termination benefits		—			—			8			—			—			—
Settlements		—			—			1			—			—			—
Total benefit cost	$	67		$	12		$	113		$	66		$	150		$	79

RAI incurred special termination benefits due to changes in the organizational structure of RJR Tobacco and settlements due to early retirements under non-qualified pension plans. See note 5 for additional information regarding the restructuring.

The estimated prior service cost for pension plans that is expected to be amortized from accumulated other comprehensive loss into net periodic benefit cost during 2012 is $4 million. The estimated prior service credit for the postretirement plans that is expected to be amortized from accumulated other comprehensive loss into net postretirement health-care costs during 2012 is $21 million.

	Pension Benefits									Postretirement Benefits
	2011			2010			2009			2011			2010			2009
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31:
Discount rate		5.66	%		6.30	%		6.40	%		5.52	%		6.20	%		6.39	%
Expected long-term return on plan assets		7.73	%		8.24	%		8.24	%		7.00	%		7.00	%		6.80	%
Rate of compensation increase		5.00	%		5.00	%		5.00	%		5.00	%		5.00	%		5.00	%

RAI generally uses a hypothetical bond matching analysis to determine the discount rate. The discount rate modeling process involves selecting a portfolio of high quality corporate bonds whose cash flows, via coupons and maturities, match the projected cash flows of the obligations.

The overall expected long-term rate of return on assets assumptions for pension and postretirement assets are based on: (1) the target asset allocation for plan assets, (2) long-term capital markets forecasts for asset classes employed, and (3) excess return expectations of active management to the extent asset classes are actively managed.

For purposes of calculating the expected return on plan assets, RAI no longer uses an averaging technique for the market related value of plan assets, but instead uses the actual fair value of assets permitted under GAAP. In 2011, the combination of an increase in the fair value of plan assets, offset by a lower discount rate, resulted in an unfavorable change in funded status and a charge to accumulated other comprehensive loss. In 2010, the combination of an increase in the fair value of plan assets and lower prior services costs, offset by a lower discount rate, resulted in a favorable change in funded status and a charge to accumulated other comprehensive loss.

159

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Plan assets are invested using active investment strategies and multiple investment management firms. Managers within each asset class cover a range of investment styles and approaches and are combined in a way that controls for capitalization, style biases, and interest rate exposures, while focusing primarily on security selection as a means to add value. Risk is controlled through diversification among asset classes, managers, styles and securities. Risk is further controlled both at the manager and asset class level by assigning excess return and tracking error targets against related benchmark indices. Investment manager performance is evaluated against these targets.

In 2010, RAI adopted a risk mitigating strategy which seeks to balance pension plan returns with a reasonable level of funded status volatility. Based on this framework, the asset allocation has two primary components. The first component is the “hedging portfolio,” which uses extended duration fixed income holdings and derivatives to match a portion of the interest rate risk associated with the benefit obligations, thereby reducing expected funded status volatility. The second component is the “return seeking portfolio,” which is designed to enhance portfolio returns. The return seeking portfolio is broadly diversified across asset classes.

Allowable investment types include domestic equity, international equity, global equity, fixed income, real estate, private equity, hedge funds, global tactical asset allocation and commodities. The range of allowable investment types utilized for pension assets provides enhanced returns and more widely diversifies the plan. Domestic equities are composed of common stocks of large, medium and small companies. International equities include equity securities issued by companies domiciled outside the United States and in depository receipts, which represent ownership of securities of non-U.S. companies. Global equities include a combination of both U.S. and non-U.S. securities. Fixed income includes corporate debt obligations, fixed income securities issued or guaranteed by the U.S. government, and to a lesser extent by non-U.S. governments, mortgage backed securities, and dollar-denominated obligations issued in the United States by non-U.S. banks and corporations. Up to 15% of the fixed income assets can be in debt securities that are below investment grade. Real estate consists of publicly traded real estate investment trust securities and private real estate investments. Private equity consists of the unregistered securities of private and public companies. Hedge fund investments are diversified portfolios utilizing multiple strategies that invest primarily in public securities, including equities and fixed income. Global tactical asset allocation strategies evaluate relative value within and across asset categories and overweight the attractive markets/assets while simultaneously underweighting less attractive markets/assets. Once funded, commodities will utilize futures contracts to invest in a variety of energy, metal and agricultural goods.

For pension assets, futures and forward contracts are used for portfolio rebalancing and to approach fully invested portfolio positions. Otherwise, a small number of investment managers employ limited use of derivatives, including futures contracts, options on futures, forward contracts and interest rate swaps in place of direct investment in securities to gain efficient exposure to markets.

160

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

RAI’s pension and postretirement plans weighted-average asset allocations at December 31, 2011 and 2010, by asset category were as follows:

	Pension Plans
	2011 Target(1)			2011			2010 Target(1)			2010
Asset Category:
Domestic equities		9	%		11	%		27	%		28	%
International equities		11	%		13	%		13	%		12	%
Global equities		9	%		6	%		5	%		7	%
Fixed income		53	%		55	%		40	%		38	%
High yield fixed income		3	%		3	%		2	%		3	%
Hedge funds		4	%		5	%		7	%		6	%
Private equity		1	%		1	%		2	%		1	%
Real estate		4	%		4	%		2	%		3	%
Global tactical asset allocation		2	%		2	%		2	%		2	%
Commodities(2)		4	%		—	%		—	%		—	%
Total		100	%		100	%		100	%		100	%

⁽¹⁾ Allows for a rebalancing range of up to 5 percentage points around target asset allocations.

⁽²⁾  Commodities were approved in December 2011 and are expected to be funded in 2012.

	Postretirement Plans
	2011 Target(1)			2011			2010 Target(1)			2010
Asset Category:
Domestic equities		21	%		21	%		42	%		43	%
International equities		21	%		19	%		16	%		16	%
Fixed income		58	%		57	%		39	%		36	%
Hedge funds		—	%		—	%		1	%		1	%
Cash and other		—	%		3	%		2	%		4	%
Total		100	%		100	%		100	%		100	%

⁽¹⁾  Allows for a rebalancing range of up to 5 percentage points around target asset allocations.

RAI’s pension and postretirement plan assets, excluding uninvested cash and unsettled trades, carried at fair value on a recurring basis as of December 31, 2011, were as follows⁽¹⁾:

Pension Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	765	$	247	$	—	$	1,012
International equities		118		401		—		519
Global equities		322		—		—		322
Fixed income		40		2,082		36		2,158
High yield fixed income		—		144		—		144
Hedge funds		—		—		249		249
Private equity		—		—		46		46
Real estate		35		—		161		196
Global tactical asset allocation		—		91		—		91
Other		1		77		2		80
Total	$	1,281	$	3,042	$	494	$	4,817

161

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Postretirement Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	—	$	54	$	—	$	54
International equities		—		48		—		48
Fixed income		15		129		—		144
Other		—		6		—		6
Total	$	15	$	237	$	—	$	252

⁽¹⁾  See note 1 for additional information on the fair value hierarchy.

RAI’s pension and postretirement plan assets carried at fair value on a recurring basis as of December 31, 2010, were as follows⁽¹⁾:

Pension Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	781	$	246	$	—	$	1,027
International equities		126		468		—		594
Global equities		351		1		—		352
Fixed income		34		1,542		55		1,631
High yield fixed income		—		136		—		136
Hedge funds		—		2		274		276
Private equity		—		3		45		48
Real estate		46		20		90		156
Global tactical asset allocation		—		98		—		98
Other		4		564		3		571
Total	$	1,342	$	3,080	$	467	$	4,889

Postretirement Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	—	$	115	$	—	$	115
International equities		—		44		—		44
Fixed income		1		95		—		96
Hedge funds		—		—		1		1
Real estate and other		—		14		—		14
Total	$	1	$	268	$	1	$	270

⁽¹⁾ See note 1 for additional information on the fair value hierarchy.

Transfers of pension and postretirement plan assets in and out of Level 3 during 2011, by asset category were as follows:

	Balance as of January  1, 2011		Purchases, Sales, Issuances and Settlements (net)			Realized Gains			Unrealized Gains (Losses)			Transferred From Other Levels(1)		Balance as of December 31, 2011
Fixed income	$	55	$	(24	)	$	11		$	(8	)	$	2	$	36
Hedge funds		275		(19	)		47			(54	)		—		249
Private equity		45		(4	)		4			1			—		46
Real estate		90		54			1			16			—		161
Other		3		—			(1	)		—			—		2
Total	$	468	$	7		$	62		$	(45	)	$	2	$	494

⁽¹⁾ Transfers in and out of Level 3 occur using the fair value at the beginning of the period.

162

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Transfers of pension and postretirement plan assets in and out of Level 3 during 2010, by asset category were as follows:

	Balance as of January  1, 2010		Purchases, Sales, Issuances and Settlements (net)			Realized Gains		Unrealized Gains (Losses)			Transferred From Other Levels		Balance as of December 31, 2010
Fixed income	$	96	$	(54	)	$	18	$	(5	)	$	—	$	55
Hedge funds		291		(33	)		15		2			—		275
Private equity		43		(3	)		1		4			—		45
Real estate		31		52			—		7			—		90
Other		3		—			—		—			—		3
Total	$	464	$	(38	)	$	34	$	8		$	—	$	468

The fair value of pension and postretirement assets classified as fixed income and certain of those classified as real estate and hedge funds, classified as Level 3, was determined primarily using an income approach. This approach utilized the net asset value of the underlying investment fund adjusted for restrictions or illiquidity of the disposition of the interest, valuations provided by the fund’s cash flows, and the rights and obligations of the ownership interest of the fund.

The fair value of pension and postretirement assets classified as private equity and certain of those classified as real estate and hedge funds, classified as Level 3, was determined primarily using an income approach. The fair value was determined by qualified appraisers utilizing observable and unobservable data, including comparable transactions, the fair value of the underlying assets, discount rates, restrictions on disposing interests in the investment’s cash flows and other entity specific risk factors.

The fair value of pension and postretirement assets classified as other, classified as Level 3, was determined primarily using an income approach that utilized cash flow models and benchmarking strategies. This approach utilized observable inputs, including market-based interest rate curves, corporate credit spreads and corporate ratings. Additionally, unobservable factors incorporated into these models included default probability assumptions, potential recovery and discount rates.

Additional information relating to RAI’s significant postretirement plans is as follows:

	2011			2010
Weighted-average health-care cost trend rate assumed for the following year		12.94	%		15.18	%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)		5.00	%		5.00	%
Year that the rate reaches the ultimate trend rate		2018			2018

Assumed health-care cost trend rates have a significant effect on the amounts reported for the health-care plans. A one-percentage-point change in assumed health-care cost trend rates would have had the following effects at December 31, 2011:

	1-Percentage Point Increase		1-Percentage Point Decrease
Effect on total of service and interest cost components	$	4	$	(4	)
Effect on benefit obligation		75		(65	)

During 2012, RAI expects to contribute approximately $309 million to its pension plans and expects payments related to its postretirement plans to be $70 million.

163

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Estimated future benefits payments:

			Postretirement Benefits
Year	Pension Benefits		Gross Projected Benefit  Payments Before Medicare Part D Subsidies		Expected Medicare Part D Subsidies		Net Projected Benefit  Payments After Medicare Part D Subsidies
2012	$	407	$	109	$	3	$	106
2013		399		112		3		109
2014		395		113		4		109
2015		395		112		4		108
2016		397		111		4		107
2017-2021		1,951		530		26		504

RAI sponsors qualified defined contribution plans. The expense related to these plans was $37 million, $39 million and $40 million, in 2011, 2010 and 2009, respectively. Included in the plans is a non-leveraged employee stock ownership plan, which holds shares of the Reynolds Stock Fund. Participants can elect to contribute to the fund. Dividends paid on shares are reflected as a reduction of equity. All shares are considered outstanding for earnings per share computations.

Note 17 — Segment Information

RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane. During the fourth quarter of 2011, RAI elected to begin reporting the Santa Fe segment, which includes the primary operations of SFNTC. RAI has retrospectively revised segment disclosures for all periods presented. Although the operations and results of Santa Fe currently do not meet the quantitative criteria to be required to be reported, RAI management believes that reporting this segment is important to the financial statement user for additional understanding and transparency with respect to the aggregate operations and results of RAI’s subsidiaries that produce and market cigarettes in the U.S. Niconovum AB, among other RAI subsidiaries, is included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI.

RAI’s largest reportable operating segment, RJR Tobacco, is the second largest cigarette manufacturer in the United States. RJR Tobacco’s brands include many of the best-selling cigarettes in the United States: CAMEL, PALL MALL, WINSTON, KOOL, DORAL and SALEM. Those brands, and its other brands, including MISTY and CAPRI, are manufactured in a variety of styles and marketed in the United States. As part of its total tobacco strategy, RJR Tobacco also offers two types of smoke-free tobacco products, CAMEL Snus, and in certain lead markets, CAMEL Dissolvables. RJR Tobacco also manages contract manufacturing of cigarette and tobacco products through arrangements with BAT affiliates, and manages the export of tobacco products to certain U.S. territories, U.S. duty-free shops and U.S. overseas military bases.

American Snuff, is the second largest smokeless tobacco products manufacturer in the United States. American Snuff’s primary brands include its largest selling moist snuff brands, GRIZZLY and KODIAK.

Santa Fe manufactures and markets cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand, as well as manages RJR Tobacco’s super premium cigarette brands, DUNHILL and STATE EXPRESS 555, which are licensed from BAT.

164

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

RAI’s operating subsidiaries’ sales to foreign countries, primarily to related parties, for the years ended December 31, 2011, 2010 and 2009 were $610 million, $525 million and $548 million, respectively. Intersegment revenues and items below the operating income line of the consolidated statements of income are not presented by segment, since they are excluded from the measure of segment profitability reviewed by RAI’s chief operating decision maker. Additionally, information about total assets by segment is not reviewed by RAI’s chief operating decision maker and therefore is not disclosed.

Segment Data:

	2011			2010(3)			2009(3)
Net sales:
RJR Tobacco	$	7,297		$	7,350		$	7,334
American Snuff		648			719			673
Santa Fe		436			356			289
All Other		160			126			123
Consolidated net sales	$	8,541		$	8,551		$	8,419
Operating income:
RJR Tobacco	$	1,945		$	2,084		$	1,481
American Snuff		331			320			276
Santa Fe		198			135			98
All Other		18			(14	)		14
Corporate expense		(93	)		(93	)		(106	)
Consolidated operating income	$	2,399		$	2,432		$	1,763
Cash capital expenditures:
RJR Tobacco	$	55		$	52		$	55
American Snuff		106			104			75
Santa Fe		7			2			7
All Other		22			16			4
Consolidated capital expenditures	$	190		$	174		$	141
Depreciation and amortization expense:
RJR Tobacco	$	110		$	119		$	123
American Snuff		17			17			13
Santa Fe		5			7			6
All Other		6			8			2
Consolidated depreciation and amortization expense	$	138		$	151		$	144
Reconciliation to income from continuing operations before income taxes:
Operating income(1)(2)	$	2,399		$	2,432		$	1,763
Interest and debt expense		221			232			251
Interest income		(11	)		(12	)		(19	)
Other expense, net		3			7			9
Income from continuing operations before income taxes	$	2,186		$	2,205		$	1,522

⁽¹⁾ Includes restructuring and/or asset impairment charges of $38 million and $56 million for the years ended December 31, 2010 and 2009, respectively.

165

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

⁽²⁾ Includes trademark and/or goodwill impairment charges of $48 million, $32 million and $567 million for the years ended December 31, 2011, 2010 and 2009, respectively.

⁽³⁾ Revised financial data for 2010 and 2009 to reflect RAI’s elective change in accounting for pension and postretirement benefits. See note 1 to consolidated financial statements.

Sales made to McLane Company, Inc., a distributor, comprised approximately 27% of RAI’s revenue in each of 2011, 2010 and 2009. McLane Company, Inc. is a customer in all segments. No other customer accounted for 10% or more of RAI’s revenue during those periods.

Note 18 — Related Party Transactions

RAI and its operating subsidiaries engage in transactions with affiliates of BAT, which owns approximately 42% of RAI’s outstanding common stock. The following is a summary of balances and transactions with such BAT affiliates as of and for the years ended December 31:

Balances:

	2011		2010
Accounts receivable	$	67	$	48
Accounts payable		2		4
Deferred revenue		42		53

Significant transactions:

	2011		2010		2009
Net sales	$	479	$	381	$	404
Purchases		11		12		16
RAI common stock purchases from B&W		114		—		—
Research and development services billings		5		4		2

RAI’s operating subsidiaries sell contract-manufactured cigarettes and processed strip leaf to BAT affiliates. Pricing for contract manufactured cigarettes is based on negotiated cost, plus 10%, adjusted for contract years 2011 through 2014 with prices increasing or decreasing by a multiple equal to changes in the Producer Price Index, reported by the U.S. Bureau of Labor Statistics. Net sales to BAT affiliates, primarily cigarettes, represented approximately 6.0%, 4.0% and 5.0% of RAI’s total net sales in 2011, 2010 and 2009, respectively.

RJR Tobacco recorded deferred sales revenue relating to leaf sold to BAT affiliates that had not been delivered as of December 31, in each of 2011, 2010 and 2009, given that RJR Tobacco has a legal right to bill the BAT affiliates. Leaf sales revenue to BAT affiliates is recognized when the product is shipped to the customer.

RJR Tobacco performs certain research and development for BAT affiliates pursuant to a joint technology sharing agreement entered into as a part of the B&W business combination. These services were accrued and billed to BAT affiliates and were recorded in RJR Tobacco’s selling, general and administrative expenses, net of associated costs.

RAI’s operating subsidiaries also purchase unprocessed leaf at market prices, and import cigarettes at prices not to exceed manufacturing costs plus 10%, from BAT affiliates.

166

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In connection with RAI’s share repurchase program, RAI and B&W entered into an agreement on November 14, 2011, pursuant to which B&W agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI common stock. Under this agreement, RAI repurchased 2,806,637 shares of RAI common stock from B&W during 2011.

A member of the board of directors of RAI is also the president and chief executive officer of a company from which RJR Tobacco and American Snuff purchase certain raw materials. Such purchases during the year ended December 30, 2011, were approximately $1 million. Such purchases during the years ended December 30, 2010 and 2009, and related amounts due at December 30, 2011 and 2010, were less than $1 million. In addition to the purchases of raw materials, in July 2011, RJR Tobacco sold an airplane to this company for approximately $8 million.

Note 19 — RAI Guaranteed, Unsecured Notes — Condensed Consolidating Financial Statements

The following condensed consolidating financial statements relate to the guaranties of RAI’s $3.5 billion unsecured notes. See note 12 for additional information relating to these notes. RAI’s direct, wholly owned subsidiaries and certain of its indirectly owned subsidiaries have fully and unconditionally, and jointly and severally, guaranteed these notes. The following condensed consolidating financial statements include: the accounts and activities of RAI, the parent issuer; RJR, RJR Tobacco, American Snuff Co., SFNTC and certain of RAI’s other subsidiaries, the Guarantors; other indirect subsidiaries of RAI that are not Guarantors; and elimination adjustments.

167

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Condensed Consolidating Statements of Income

(Dollars in Millions)

	Parent Issuer			Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Net sales	$	—		$	7,971		$	116		$	(25	)	$	8,062
Net sales, related party		—			479			—			—			479
Net Sales		—			8,450			116			(25	)		8,541
Cost of products sold		—			4,460			29			(25	)		4,464
Selling, general and administrative expenses		129			1,386			91			—			1,606
Amortization expense		—			24			—			—			24
Trademark impairment charges		—			48			—			—			48
Operating income (loss)		(129	)		2,532			(4	)		—			2,399
Interest and debt expense		213			125			—			(117	)		221
Interest income		(118	)		(4	)		(6	)		117			(11	)
Other expense (income), net		8			(47	)		(1	)		43			3
Income (loss) before income taxes		(232	)		2,458			3			(43	)		2,186
Provision for (benefit from) income taxes		(89	)		875			(6	)		—			780
Equity income from subsidiaries		1,549			20			—			(1,569	)		—
Net income	$	1,406		$	1,603		$	9		$	(1,612	)	$	1,406
For the Year Ended December 31, 2010
Net sales	$	—		$	8,118		$	147		$	(95	)	$	8,170
Net sales, related party		—			381			—			—			381
Net Sales		—			8,499			147			(95	)		8,551
Cost of products sold		—			4,569			72			(97	)		4,544
Selling, general and administrative expenses		20			1,380			81			(1	)		1,480
Amortization expense		—			25			—			—			25
Asset impairment and exit charges		—			24			14			—			38
Trademark impairment charges		—			6			—			—			6
Goodwill impairment charge		—			26			—			—			26
Operating income (loss)		(20	)		2,469			(20	)		3			2,432
Interest and debt expense		223			127			1			(119	)		232
Interest income		(119	)		(4	)		(8	)		119			(12	)
Other expense (income), net		2			(39	)		1			43			7
Income (loss) before income taxes		(126	)		2,385			(14	)		(40	)		2,205
Provision for (benefit from) income taxes		(42	)		919			(10	)		1			868
Equity income (loss) from subsidiaries		1,205			(68	)		—			(1,137	)		—
Income (loss) from continuing operations		1,121			1,398			(4	)		(1,178	)		1,337
Losses from discontinued operations, net of tax		—			(142	)		(74	)		—			(216	)
Net income (loss)	$	1,121		$	1,256		$	(78	)	$	(1,178	)	$	1,121
For the Year Ended December 31, 2009
Net sales	$	—		$	7,985		$	162		$	(132	)	$	8,015
Net sales, related party		—			404			—			—			404
Net Sales		—			8,389			162			(132	)		8,419
Cost of products sold		—			4,544			76			(132	)		4,488
Selling, general and administrative expenses		20			1,425			72			—			1,517
Amortization expense		—			28			—			—			28
Restructuring charge		—			56			—			—			56
Trademark impairment charges		—			567			—			—			567
Operating income (loss)		(20	)		1,769			14			—			1,763
Interest and debt expense		242			123			1			(115	)		251
Interest income		(115	)		(9	)		(10	)		115			(19	)
Other expense (income), net		(4	)		(30	)		—			43			9
Income (loss) before income taxes		(143	)		1,685			23			(43	)		1,522
Provision for (benefit from) income taxes		(49	)		616			—			—			567
Equity income from subsidiaries		1,049			26			—			(1,075	)		—
Net income	$	955		$	1,095		$	23		$	(1,118	)	$	955

168

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Condensed Consolidating Statements of Cash Flows

(Dollars in Millions)

	Parent Issuer			Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Cash flows from (used in) operating activities	$	641		$	1,571		$	(3	)	$	(789	)	$	1,420
Cash flows from (used in) investing activities:
Proceeds from settlement of long-term investments		—			2			—			—			2
Capital expenditures		—			(190	)		—			—			(190	)
Net proceeds from sale of business		79			123			—			—			202
Proceeds from termination of joint venture		—			—			32			—			32
Return of intercompany investments		1,040			—			—			(1,040	)		—
Other, net		40			58			—			(84	)		14
Net cash flows from (used in) investing activities		1,159			(7	)		32			(1,124	)		60
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,212	)		(740	)		(6	)		746			(1,212	)
Repurchase of common stock		(282	)		—			—			—			(282	)
Repayments of long-term debt		(400	)		—			—			—			(400	)
Proceeds from termination of interest rate swaps		185			1			—			—			186
Dividends paid on preferred stock		(43	)		—			—			43			—
Distribution of equity		—			(1,040	)		—			1,040			—
Other, net		(47	)		(40	)		(3	)		84			(6	)
Net cash flows used in financing activities		(1,799	)		(1,819	)		(9	)		1,913			(1,714	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(5	)		—			(5	)
Net change in cash and cash equivalents		1			(255	)		15			—			(239	)
Cash and cash equivalents at beginning of year		327			1,616			252			—			2,195
Cash and cash equivalents at end of year	$	328		$	1,361		$	267		$	—		$	1,956
For the Year Ended December 31, 2010
Cash flows from operating activities	$	442		$	1,153		$	13		$	(343	)	$	1,265
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		—			4			—			—			4
Proceeds from settlement of long-term investments		—			13			—			—			13
Capital expenditures		—			(171	)		(3	)		—			(174	)
Proceeds from termination of joint venture		—			—			28			—			28
Return of intercompany investments		897			—			—			(897	)		—
Contributions to intercompany investments		—			(75	)		—			75			—
Other, net		40			26			—			(63	)		3
Net cash flows from (used in) investing activities		937			(203	)		25			(885	)		(126	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,049	)		(300	)		—			300			(1,049	)
Repurchase of common stock		(5	)		—			—			—			(5	)
Repayments of long-term debt		(300	)		—			—			—			(300	)
Dividends paid on preferred stock		(43	)		—			—			43			—
Receipt of equity		—			—			75			(75	)		—
Distribution of equity		—			(897	)		—			897			—
Other, net		(16	)		(40	)		(2	)		63			5
Net cash flows from (used in) financing activities		(1,413	)		(1,237	)		73			1,228			(1,349	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(11	)		—			(11	)
Net cash flow related to discontinued operations, net of tax		—			(233	)		(74	)		—			(307	)
Net change in cash and cash equivalents		(34	)		(520	)		26			—			(528	)
Cash and cash equivalents at beginning of year		361			2,136			226			—			2,723
Cash and cash equivalents at end of year	$	327		$	1,616		$	252		$	—		$	2,195

169

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

	Parent Issuer			Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2009
Cash flows from operating activities	$	678		$	1,630		$	29		$	(883	)	$	1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1			18			—			—			19
Proceeds from settlement of long-term investments		—			6			—			—			6
Capital expenditures		—			(137	)		(4	)		—			(141	)
Acquisition, net of cash acquired		—			—			(43	)		—			(43	)
Proceeds from termination of joint venture		—			—			24			—			24
Return of intercompany investments		610			—			—			(610	)		—
Other, net		40			29			—			(57	)		12
Net cash flows from (used in) investing activities		651			(84	)		(23	)		(667	)		(123	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(991	)		(840	)		—			840			(991	)
Repurchase of common stock		(5	)		—			—			—			(5	)
Repayments of long-term debt		(189	)		(11	)		—			—			(200	)
Dividends paid on preferred stock		(43	)		—			—			43			—
Distribution of equity		—			(610	)		—			610			—
Other, net		(12	)		(40	)		(1	)		57			4
Net cash flows used in financing activities		(1,240	)		(1,501	)		(1	)		1,550			(1,192	)
Effect of exchange rate changes on cash and cash equivalents		—			—			6			—			6
Net change in cash and cash equivalents		89			45			11			—			145
Cash and cash equivalents at beginning of year		272			2,091			215			—			2,578
Cash and cash equivalents at end of year	$	361		$	2,136		$	226		$	—		$	2,723

170

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Condensed Consolidating Balance Sheets

(Dollars in Millions)

	Parent Issuer		Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2011
Assets
Cash and cash equivalents	$	328	$	1,361	$	267	$	—		$	1,956
Accounts receivable		—		77		24		—			101
Accounts receivable, related party		—		67		—		—			67
Other receivables		95		50		39		(138	)		46
Inventories		—		929		38		—			967
Deferred income taxes, net		—		952		1		(8	)		945
Prepaid expenses and other		19		200		7		(1	)		225
Total current assets		442		3,636		376		(147	)		4,307
Property, plant and equipment, net		5		1,061		3		1			1,070
Trademarks and other intangible assets, net		—		2,553		49		—			2,602
Goodwill		—		7,999		11		—			8,010
Long-term intercompany notes		1,960		1,325		—		(3,285	)		—
Investment in subsidiaries		9,139		463		—		(9,602	)		—
Other assets and deferred charges		68		171		71		(45	)		265
Total assets	$	11,614	$	17,208	$	510	$	(13,078	)	$	16,254
Liabilities and shareholders’ equity
Accounts payable	$	—	$	107	$	6	$	—		$	113
Tobacco settlement accruals		—		2,530		—		—			2,530
Due to related party		—		2		—		—			2
Deferred revenue, related party		—		42		—		—			42
Current maturities of long-term debt		399		58		—		—			457
Other current liabilities		421		827		31		(147	)		1,132
Total current liabilities		820		3,566		37		(147	)		4,276
Intercompany notes and interest payable		1,325		1,960		—		(3,285	)		—
Long-term debt (less current maturities)		3,145		61		—		—			3,206
Deferred income taxes, net		—		553		3		(45	)		511
Long-term retirement benefits (less current portion)		48		1,699		12		—			1,759
Other noncurrent liabilities		25		224		2		—			251
Shareholders’ equity		6,251		9,145		456		(9,601	)		6,251
Total liabilities and shareholders’ equity	$	11,614	$	17,208	$	510	$	(13,078	)	$	16,254

171

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

	Parent Issuer		Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2010
Assets
Cash and cash equivalents	$	327	$	1,616	$	252	$	—		$	2,195
Accounts receivable		—		103		15		—			118
Accounts receivable, related party		—		48		—		—			48
Other receivables		80		161		35		(232	)		44
Inventories		—		1,022		34		(1	)		1,055
Deferred income taxes, net		10		934		2		—			946
Prepaid expenses and other		38		155		4		(2	)		195
Assets held for sale		—		201		—		—			201
Total current assets		455		4,240		342		(235	)		4,802
Property, plant and equipment, net		6		991		4		1			1,002
Trademarks and other intangible assets, net		—		2,625		50		—			2,675
Goodwill		—		7,991		19		—			8,010
Long-term intercompany notes		2,000		1,366		—		(3,366	)		—
Investment in subsidiaries		9,696		462		—		(10,158	)		—
Other assets and deferred charges		267		242		100		(20	)		589
Total assets	$	12,424	$	17,917	$	515	$	(13,778	)	$	17,078
Liabilities and shareholders’ equity
Accounts payable	$	—	$	175	$	4	$	—		$	179
Tobacco settlement accruals		—		2,589		—		—			2,589
Due to related party		—		4		—		—			4
Deferred revenue, related party		—		53		—		—			53
Current maturities of long-term debt		400		—		—		—			400
Other current liabilities		489		855		37		(234	)		1,147
Total current liabilities		889		3,676		41		(234	)		4,372
Intercompany notes and interest payable		1,366		2,000		—		(3,366	)		—
Long-term debt (less current maturities)		3,580		121		—		—			3,701
Deferred income taxes, net		—		535		3		(20	)		518
Long-term retirement benefits (less current portion)		34		1,622		12		—			1,668
Other noncurrent liabilities		45		262		2		—			309
Shareholders’ equity		6,510		9,701		457		(10,158	)		6,510
Total liabilities and shareholders’ equity	$	12,424	$	17,917	$	515	$	(13,778	)	$	17,078

172

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 20 — RJR Guaranteed, Unsecured Notes — Condensed Consolidating Financial Statements

The following condensed consolidating financial statements relate to the guaranties of RJR’s $58 million unsecured notes. See note 12 for additional information relating to these notes. RAI and certain of its direct or indirect, wholly owned subsidiaries, have fully and unconditionally, and jointly and severally, guaranteed these notes. The following condensed consolidating financial statements include: the accounts and activities of RAI, the parent Guarantor; RJR, the issuer of the debt securities; RJR Tobacco, and certain of RJR’s other subsidiaries, the other Guarantors; other subsidiaries of RAI and RJR, including SFNTC and American Snuff Co. that are not Guarantors; and elimination adjustments.

173

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Condensed Consolidating Statements of Income

(Dollars in Millions)

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Net sales	$	—		$	—		$	6,908		$	1,204		$	(50	)	$	8,062
Net sales, related party		—			—			478			1			—			479
Net Sales		—			—			7,386			1,205			(50	)		8,541
Cost of products sold		—			—			4,133			381			(50	)		4,464
Selling, general and administrative expenses		129			(7	)		1,164			320			—			1,606
Amortization expense		—			—			22			2			—			24
Trademark impairment charges		—			—			43			5			—			48
Operating income (loss)		(129	)		7			2,024			497			—			2,399
Interest and debt expense		213			8			—			162			(162	)		221
Interest income		(118	)		(5	)		(44	)		(6	)		162			(11	)
Other expense (income), net		8			(45	)		—			(3	)		43			3
Income (loss) before income taxes		(232	)		49			2,068			344			(43	)		2,186
Provision for (benefit from) income taxes		(89	)		1			752			116			—			780
Equity income from subsidiaries		1,549			1,344			28			—			(2,921	)		—
Net income	$	1,406		$	1,392		$	1,344		$	228		$	(2,964	)	$	1,406
For the Year Ended December 31, 2010
Net sales	$	—		$	—		$	7,093		$	1,230		$	(153	)	$	8,170
Net sales, related party		—			—			371			10			—			381
Net Sales		—			—			7,464			1,240			(153	)		8,551
Cost of products sold		—			—			4,264			435			(155	)		4,544
Selling, general and administrative expenses		20			(2	)		1,124			339			(1	)		1,480
Amortization expense		—			—			24			1			—			25
Asset impairment and exit charges		—			—			24			14			—			38
Trademark impairment charges		—			—			—			6			—			6
Goodwill impairment charge		—			—			—			26			—			26
Operating income (loss)		(20	)		2			2,028			419			3			2,432
Interest and debt expense		223			8			—			166			(165	)		232
Interest income		(119	)		(5	)		(45	)		(8	)		165			(12	)
Other expense (income), net		2			(43	)		8			(3	)		43			7
Income (loss) before income taxes		(126	)		42			2,065			264			(40	)		2,205
Provision for (benefit from) income taxes		(42	)		(2	)		814			97			1			868
Equity income from subsidiaries		1,205			951			5			—			(2,161	)		—
Income from continuing operations		1,121			995			1,256			167			(2,202	)		1,337
Gains (losses) from discontinued operations, net of tax		—			88			(230	)		(74	)		—			(216	)
Net income	$	1,121		$	1,083		$	1,026		$	93		$	(2,202	)	$	1,121
For the Year Ended December 31, 2009
Net sales	$	—		$	—		$	7,078		$	1,139		$	(202	)	$	8,015
Net sales, related party		—			—			396			8			—			404
Net Sales		—			—			7,474			1,147			(202	)		8,419
Cost of products sold		—			—			4,297			393			(202	)		4,488
Selling, general and administrative expenses		20			4			1,183			310			—			1,517
Amortization expense		—			—			27			1			—			28
Restructuring charge		—			—			56			—			—			56
Trademark impairment charges		—			—			491			76			—			567
Operating income (loss)		(20	)		(4	)		1,420			367			—			1,763
Interest and debt expense		242			8			1			171			(171	)		251
Interest income		(115	)		(8	)		(56	)		(11	)		171			(19	)
Other expense (income), net		(4	)		(31	)		2			(1	)		43			9
Income (loss) before income taxes		(143	)		27			1,473			208			(43	)		1,522
Provision for (benefit from) income taxes		(49	)		(5	)		562			59			—			567
Equity income from subsidiaries		1,049			939			26			—			(2,014	)		—
Net income	$	955		$	971		$	937		$	149		$	(2,057	)	$	955

174

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Condensed Consolidating Statements of Cash Flows

(Dollars in Millions)

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Cash flows from operating activities	$	641		$	1,319		$	1,195		$	313		$	(2,048	)	$	1,420
Cash flows from (used in) investing activities:
Proceeds from settlement of long-term investments		—			—			2			—			—			2
Capital expenditures		—			—			(55	)		(135	)		—			(190	)
Net proceeds from sale of business		79			—			123			—			—			202
Proceeds from termination of joint venture		—			—			—			32			—			32
Return of intercompany investments		1,040			340			—			—			(1,380	)		—
Other, net		40			20			91			—			(137	)		14
Net cash flows from (used in) investing activities		1,159			360			161			(103	)		(1,517	)		60
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,212	)		(740	)		(1,265	)		—			2,005			(1,212	)
Repurchase of common stock		(282	)		—			—			—			—			(282	)
Repayment of long-term debt		(400	)		—			—			—			—			(400	)
Proceeds from termination of interest rate swaps		185			1			—			—			—			186
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Distribution of equity		—			(910	)		(340	)		(130	)		1,380			—
Other, net		(47	)		(36	)		—			(60	)		137			(6	)
Net cash flows used in financing activities		(1,799	)		(1,685	)		(1,605	)		(190	)		3,565			(1,714	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			(5	)		—			(5	)
Net change in cash and cash equivalents		1			(6	)		(249	)		15			—			(239	)
Cash and cash equivalents at beginning of year		327			14			1,506			348			—			2,195
Cash and cash equivalents at end of year	$	328		$	8		$	1,257		$	363		$	—		$	1,956
For the Year Ended December 31, 2010
Cash flows from operating activities	$	442		$	445		$	947		$	179		$	(748	)	$	1,265
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		—			1			2			1			—			4
Proceeds from settlement of long-term investments		—			—			13			—			—			13
Capital expenditures		—			—			(52	)		(123	)		1			(174	)
Proceeds from termination of joint venture		—			—			—			28			—			28
Return on intercompany investments		897			795			—			—			(1,692	)		—
Contributions to intercompany investments		—			(75	)		—			—			75			—
Other, net		40			23			25			1			(86	)		3
Net cash flows from (used in) investing activities		937			744			(12	)		(93	)		(1,702	)		(126	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,049	)		(300	)		(405	)		—			705			(1,049	)
Repurchase of common stock		(5	)		—			—			—			—			(5	)
Repayment of long-term debt		(300	)		—			—			—			—			(300	)
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Receipt of equity		—			—			—			75			(75	)		—
Distribution of equity		—			(897	)		(795	)		—			1,692			—
Other, net		(16	)		1			—			(65	)		85			5
Net cash flows from (used in) financing activities		(1,413	)		(1,196	)		(1,200	)		10			2,450			(1,349	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			(11	)		—			(11	)
Net cash flows related to discontinued operations, net of tax benefit		—			(3	)		(230	)		(74	)		—			(307	)
Net change in cash and cash equivalents		(34	)		(10	)		(495	)		11			—			(528	)
Cash and cash equivalents at beginning of year		361			24			2,001			337			—			2,723
Cash and cash equivalents at end of year	$	327		$	14		$	1,506		$	348		$	—		$	2,195

175

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2009
Cash flows from operating activities	$	678		$	1,464		$	1,394		$	161		$	(2,243	)	$	1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1			5			12			1			—			19
Proceeds from settlement of long-term investments		—			—			6			—			—			6
Capital expenditures		—			—			(55	)		(86	)		—			(141	)
Acquisition, net of cash acquired		—			—			—			(43	)		—			(43	)
Proceeds from termination of joint venture		—			—			—			24			—			24
Return of intercompany investments		610			—			—			—			(610	)		—
Other, net		40			9			27			—			(64	)		12
Net cash flows from (used in) investing activities		651			14			(10	)		(104	)		(674	)		(123	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(991	)		(840	)		(1,360	)		—			2,200			(991	)
Repurchase of common stock		(5	)		—			—			—			—			(5	)
Repayment of long-term debt		(189	)		(11	)		—			—			—			(200	)
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Distribution of equity		—			(610	)		—			—			610			—
Other, net		(12	)		1			—			(49	)		64			4
Net cash flows used in financing activities		(1,240	)		(1,460	)		(1,360	)		(49	)		2,917			(1,192	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			6			—			6
Net change in cash and cash equivalents		89			18			24			14			—			145
Cash and cash equivalents at beginning of year		272			6			1,977			323			—			2,578
Cash and cash equivalents at end of year	$	361		$	24		$	2,001		$	337		$	—		$	2,723

176

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Condensed Consolidating Balance Sheets

(Dollars in Millions)

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2011
Assets
Cash and cash equivalents	$	328	$	8	$	1,257	$	363	$	—		$	1,956
Accounts receivable		—		—		62		39		—			101
Accounts receivable, related party		—		—		67		—		—			67
Other receivables		95		38		145		110		(342	)		46
Inventories		—		—		480		487		—			967
Deferred income taxes, net		—		1		907		45		(8	)		945
Prepaid expenses and other		19		—		178		28		—			225
Total current assets		442		47		3,096		1,072		(350	)		4,307
Property, plant and equipment, net		5		—		652		412		1			1,070
Trademarks and other intangible assets, net		—		—		1,251		1,351		—			2,602
Goodwill		—		—		5,303		2,707		—			8,010
Long-term intercompany notes		1,960		157		1,325		—		(3,442	)		—
Investment in subsidiaries		9,139		7,076		456		—		(16,671	)		—
Other assets and deferred charges		68		24		157		72		(56	)		265
Total assets	$	11,614	$	7,304	$	12,240	$	5,614	$	(20,518	)	$	16,254
Liabilities and shareholders’ equity
Accounts payable	$	—	$	—	$	87	$	26	$	—		$	113
Tobacco settlement accruals		—		—		2,461		69		—			2,530
Due to related party		—		—		2		—		—			2
Deferred revenue, related party		—		—		42		—		—			42
Current maturities of long-term debt		399		58		—		—		—			457
Other current liabilities		421		100		711		250		(350	)		1,132
Total current liabilities		820		158		3,303		345		(350	)		4,276
Intercompany notes and interest payable		1,325		—		—		2,117		(3,442	)		—
Long-term debt (less current maturities)		3,145		61		—		—		—			3,206
Deferred income taxes, net		—		—		60		507		(56	)		511
Long-term retirement benefits (less current portion)		48		24		1,579		108		—			1,759
Other noncurrent liabilities		25		1		222		3		—			251
Shareholders’ equity		6,251		7,060		7,076		2,534		(16,670	)		6,251
Total liabilities and shareholders’ equity	$	11,614	$	7,304	$	12,240	$	5,614	$	(20,518	)	$	16,254

177

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2010
Assets
Cash and cash equivalents	$	327	$	14	$	1,506	$	348	$	—		$	2,195
Accounts receivable		—		—		50		68		—			118
Accounts receivable, related party		—		—		48		—		—			48
Other receivables		80		33		225		90		(384	)		44
Inventories		—		—		600		456		(1	)		1,055
Deferred income taxes, net		10		1		892		43		—			946
Prepaid expenses and other		38		—		130		30		(3	)		195
Assets held for sale		—		—		20		181		—			201
Total current assets		455		48		3,471		1,216		(388	)		4,802
Property, plant and equipment, net		6		—		689		306		1			1,002
Trademarks and other intangible assets, net		—		—		1,316		1,359		—			2,675
Goodwill		—		—		5,303		2,707		—			8,010
Long-term intercompany notes		2,000		174		1,366		—		(3,540	)		—
Investment in subsidiaries		9,696		7,611		435		—		(17,742	)		—
Other assets and deferred charges		267		56		194		101		(29	)		589
Total assets	$	12,424	$	7,889	$	12,774	$	5,689	$	(21,698	)	$	17,078
Liabilities and shareholders’ equity
Accounts payable	$	—	$	—	$	103	$	76	$	—		$	179
Tobacco settlement accruals		—		—		2,532		57		—			2,589
Due to related party		—		—		4		—		—			4
Deferred revenue, related party		—		—		53		—		—			53
Current maturities of long-term debt		400		—		—		—		—			400
Other current liabilities		489		138		652		255		(387	)		1,147
Total current liabilities		889		138		3,344		388		(387	)		4,372
Intercompany notes and interest payable		1,366		—		—		2,174		(3,540	)		—
Long-term debt (less current maturities)		3,580		121		—		—		—			3,701
Deferred income taxes, net		—		—		76		471		(29	)		518
Long-term retirement benefits (less current portion)		34		25		1,496		113		—			1,668
Other noncurrent liabilities		45		12		247		5		—			309
Shareholders’ equity		6,510		7,593		7,611		2,538		(17,742	)		6,510
Total liabilities and shareholders’ equity	$	12,424	$	7,889	$	12,774	$	5,689	$	(21,698	)	$	17,078

178

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Note 21 — Quarterly Results of Operations (Unaudited)

	First			Second			Third			Fourth
		(2	)		(3	)		(4	)		(5	)
2011 (1)
Net sales	$	1,991		$	2,267		$	2,200		$	2,083
Gross profit		956			1,074			1,075			972
Net income		381			327			394			304
Per share data(10) :
Basic:
Net income		0.65			0.56			0.68			0.52
Diluted:
Net income		0.65			0.56			0.67			0.52
2010 (1)		(6	)		(7	)		(8	)		(9	)
Net sales	$	1,986		$	2,245		$	2,239		$	2,081
Gross profit		929			1,075			1,068			935
Net income		100			359			400			262
Per share data(10) :
Basic:
Income from continuing operations		0.54			0.62			0.69			0.45
Loss on discontinued operations, net of tax		(0.37	)		—			—			—
Net income		0.17			0.62			0.69			0.45
Diluted:
Income from continuing operations		0.54			0.61			0.68			0.45
Loss on discontinued operations, net of tax		(0.37	)		—			—			—
Net income		0.17			0.61			0.68			0.45

⁽¹⁾ As revised for the change in the method of recognizing pension expense. See note 1 for a discussion of the change and the impacts of the change for the year ended December 31, 2010.

⁽²⁾ For the quarter ended March 31, 2011, the retrospective change in recognizing pension expense increased gross profit by $26 million, net income by $28 million and earnings per share, basic and diluted by $0.04 and $0.05, respectively.

⁽³⁾ For the quarter ended June 30, 2011, the retrospective change in recognizing pension expense increased gross profit by $22 million, net income by $23 million and earnings per share, basic and diluted by $0.04.

⁽⁴⁾ For the quarter ended September 30, 2011, the retrospective change in recognizing pension expense increased gross profit by $23 million, net income by $27 million and earnings per share, basic and diluted by $0.05 and $0.04, respectively.

⁽⁵⁾ For the quarter ended December 31, 2011, includes $145 million of pension expense as a result of MTM adjustments. Fourth quarter of 2011 net income includes a $48 million trademark impairment charge.

⁽⁶⁾  For the quarter ended March 31, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $18 million, earnings per share, basic and diluted by $0.03.

⁽⁷⁾  For the quarter ended June 30, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $18 million and earnings per share, basic and diluted by $0.04 and $0.03, respectively. Second quarter of 2010 net income includes $38 million of asset impairment and exit charges.

179

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

⁽⁸⁾  For the quarter ended September 30, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $19 million and earnings per share, basic and diluted by $0.04 and $0.03, respectively.

⁽⁹⁾  For the quarter ended December 31, 2010, the retrospective change in recognizing pension expense decreased gross profit by $39 million, net income by $47 million and earnings per share, basic and diluted by $0.08. Fourth quarter of 2010 net income includes a $6 million trademark impairment charge and a $26 million goodwill impairment charge.

⁽¹⁰⁾ Income per share is computed independently for each of the periods presented. The sum of the income per share amounts for the quarters may not equal the total for the year.

Note 22 — Subsequent Event

During the first quarter of 2012, RAI announced that it has begun a comprehensive analysis of programs, activities and organizational structures within RAI and certain operating companies. This review is expected to be completed by the end of the first quarter, with the objective to reduce overall cost structures. Upon completion of the analysis, any resulting charges related to severance or other exit activities will be recognized, as appropriate.

180

Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.    Controls and Procedures

Disclosure Controls and Procedures

RAI’s chief executive officer and chief financial officer have concluded that RAI’s disclosure controls and procedures were effective as of the end of the period covered by this report, based on their evaluation of these controls and procedures.

Internal Control over Financial Reporting

Limitation on the Effectiveness of Controls

Internal controls are designed to provide reasonable assurance that assets are safeguarded and transactions are properly recorded, executed and reported in accordance with management’s authorization. The effectiveness of internal controls is supported by qualified personnel and an organization structure that provides an appropriate division of responsibility and formalized procedures. Internal audit regularly monitors the adequacy and effectiveness of internal controls, including reporting to RAI’s audit committee. Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable assurance and may not prevent or detect misstatements. See “Management’s Report on Internal Control over Financial Reporting” in Item 8 of Part II of this report.

Changes in Controls

There have been no changes in RAI’s internal controls over financial reporting that occurred during the fourth quarter that have materially affected, or are reasonably likely to materially affect, RAI’s internal controls over financial reporting.

Item 9B.    Other Information

None.

181

PART III

Item 10.    Directors, Executive Officers and Corporate Governance

Item 10 is incorporated by reference to the following sections of RAI’s definitive Proxy Statement to be filed with the SEC on or about March 23, 2012, referred to as the Proxy Statement: “The Board of Directors — Item 1: Election of Directors;” “The Board of Directors — Biographies of Board Members;” “The Board of Directors — Governance Agreement;” “The Board of Directors — Committees and Meetings of the Board of Directors — Audit and Finance Committee;” “The Board of Directors — Code of Conduct;” and “Security Ownership of Certain Beneficial Owners and Management — Section 16(a) Beneficial Ownership Reporting Compliance.” For information regarding the executive officers and certain significant employees of RAI, see “Executive Officers and Certain Significant Employees of the Registrant” in Item 1 of Part I of this report.

Item 11.    Executive Compensation

Item 11 is incorporated by reference to the following sections of the Proxy Statement: “Executive Compensation;” “Executive Compensation — Compensation Committee Report;” “The Board of Directors — Committees and Meetings of the Board of Directors — Compensation and Leadership Development Committee; Compensation Committee Interlocks and Insider Participation;” and “The Board of Directors — Director Compensation.”

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12 is incorporated by reference to the following sections of the Proxy Statement: “Security Ownership of Certain Beneficial Owners and Management — Stock Ownership of Principal Shareholders;” “Security Ownership of Certain Beneficial Owners and Management — Stock Ownership of Management;” and “The Board of Directors—Governance Agreement.” For information regarding securities authorized for issuance under equity compensation plans, see note 15 to consolidated financial statements in Item 8 of Part II to this report.

Item 13.    Certain Relationships and Related Transactions, and Director Independence

Item 13 is incorporated by reference to the following sections of the Proxy Statement: “Certain Relationships and Related Transactions;” and “The Board of Directors — Determination of Independence of Directors.”

Item 14.    Principal Accountant Fees and Services

Item 14 is incorporated by reference to the following sections of the Proxy Statement: “Audit Matters — Audit Committee’s Audit and Non-Audit Services Pre-Approval Policy;” and “Audit Matters — Fees of Independent Auditors.”

182

PART IV

Item 15.    Exhibits and Financial Statement Schedules

(a) The following documents are filed as a part of this report:

(1) Consolidated Statements of Income for the years ended December 31, 2011, 2010 and 2009.

Consolidated Statements of Comprehensive Income for the years ended December 31, 2011, 2010 and 2009.

Consolidated Statements of Cash Flows for the years ended December 31, 2011, 2010 and 2009.

Consolidated Balance Sheets as of December 31, 2011 and 2010.

Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2011, 2010 and 2009.

(2) Financial Statement Schedules have been omitted because the information required has been separately disclosed in the consolidated financial statements or notes.

(3) See (b) below.

(b) Exhibit Numbers 10.25 through 10.54 below are management contracts, compensatory plans or arrangements. The following exhibits are filed or furnished, as the case may be, as part of this report:

Exhibit Number
3.1	Amended and Restated Certificate of Incorporation of Reynolds American Inc. (incorporated by reference to Exhibit 1 to Reynolds American Inc.’s Form 8-A filed July 29, 2004).
3.2	Articles of Amendment of Amended and Restated Articles of Incorporation of Reynolds American Inc. (incorporated by reference to Exhibit 3.1 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2007, filed August 2, 2007).
3.3	Articles of Amendment of Amended and Restated Articles of Incorporation of Reynolds American Inc. (incorporated by reference to Exhibit 3.1 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, filed August 8, 2011).
3.4	Amended and Restated Bylaws of Reynolds American Inc., dated December 4, 2008 (incorporated by reference to Exhibit 3.1 to Reynolds American Inc.’s Form 8-K dated December 4, 2008).
4.1	Rights Agreement, between Reynolds American Inc. and The Bank of New York, as rights agent (incorporated by reference to Exhibit 3 to Reynolds American Inc.’s Form 8-A filed July 29, 2004).
4.2	Amended and Restated Indenture, dated as of July 24, 1995, between RJR Nabisco, Inc. and The Bank of New York (incorporated by reference to Exhibit 4.1 to RJR Nabisco, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 1995, filed August 8, 1995).
4.3	First Supplemental Indenture and Waiver, dated as of April 27, 1999, between RJR Nabisco, Inc. and The Bank of New York, to the Amended and Restated Indenture, dated as of July 24, 1995, between RJR Nabisco, Inc. and The Bank of New York, as successor trustee (incorporated by reference to Exhibit 10.3 to R.J. Reynolds Tobacco Holdings, Inc.’s Form 8-A filed May 19, 1999).

183

Exhibit Number
4.4	Indenture, dated as of May 20, 2002, by and among R.J. Reynolds Tobacco Holdings, Inc., R.J. Reynolds Tobacco Company, RJR Acquisition Corp. and The Bank of New York (incorporated by reference to Exhibit 4.3 to R.J. Reynolds Tobacco Holdings, Inc.’s Form 8-K dated May 15, 2002).
4.5	First Supplemental Indenture dated as of June 30, 2003, among GMB, Inc., FSH, Inc., R.J. Reynolds Tobacco Co., Santa Fe Natural Tobacco Company, Inc., RJR Packaging, LLC, R.J. Reynolds Tobacco Holdings, Inc., R.J. Reynolds Tobacco Company, RJR Acquisition Corp. and The Bank of New York, as Trustee, to the Indenture dated as of May 20, 2002, among R.J. Reynolds Tobacco Holdings, Inc., R.J. Reynolds Tobacco Company, RJR Acquisition Corp. and The Bank of New York, as Trustee (incorporated by reference to Exhibit 4.2 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003, filed August 8, 2003).
4.6	Second Supplemental Indenture, dated as of July 30, 2004, among R.J. Reynolds Tobacco Holdings, Inc., Reynolds American Inc., R.J. Reynolds Tobacco Company, RJR Acquisition Corp., GMB, Inc., FSH, Inc., R.J. Reynolds Tobacco Co., RJR Packaging, LLC, BWT Brands, Inc. and The Bank of New York, as Trustee, to the Indenture dated May 20, 2002, among R.J. Reynolds Tobacco Holdings, Inc., R.J. Reynolds Tobacco Company, RJR Acquisition Corp. and The Bank of New York (incorporated by reference to Exhibit 4.3 to Reynolds American Inc.’s Form 8-K dated July 30, 2004).
4.7	Third Supplemental Indenture, dated May 31, 2006, to Indenture, dated May 20, 2002, among R.J. Reynolds Tobacco Holdings, Inc., Reynolds American Inc. and certain subsidiaries of R.J. Reynolds Tobacco Holdings, Inc., as guarantors, and The Bank of New York Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.6 to Reynolds American Inc.’s Form 8-K dated May 31, 2006).
4.8	Fourth Supplemental Indenture, dated June 20, 2006, to Indenture, dated May 20, 2002, among R.J. Reynolds Tobacco Holdings, Inc., Reynolds American Inc. and certain subsidiaries of R.J. Reynolds Tobacco Holdings, Inc., as guarantors, and The Bank of New York Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.7 to Reynolds American Inc.’s Form 8-K dated June 20, 2006).
4.9	Fifth Supplemental Indenture, dated September 30, 2006, to Indenture, dated May 20, 2002, among R.J. Reynolds Tobacco Holdings, Inc., Reynolds American Inc. and certain subsidiaries of R.J. Reynolds Tobacco Holdings, Inc., as guarantors, and The Bank of New York Trust Company, N.A., as successor to The Bank of New York, as Trustee, as amended (incorporated by reference to Exhibit 4.2 to Reynolds American Inc.’s Form 8-K dated September 30, 2006).
4.10	Indenture, dated May 31, 2006, among Reynolds American Inc. and certain of its subsidiaries as guarantors and The Bank of New York Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to Reynolds American Inc.’s Form 8-K dated May 31, 2006).
4.11	First Supplemental Indenture, dated September 30, 2006, to Indenture, dated May 31, 2006, among Reynolds American Inc. and certain of its subsidiaries as guarantors, and The Bank of New York Trust Company, N.A., as successor to The Bank of New York, as Trustee (incorporated by reference to Exhibit 4.1 to Reynolds American Inc.’s Form 8-K dated September 30, 2006).
4.12	Second Supplemental Indenture, dated February 6, 2009, to Indenture, dated May 31, 2006, as supplemented by the First Supplemental Indenture, dated September 30, 2006, among Reynolds American Inc. and certain of its subsidiaries, as guarantors, and The Bank of New York Mellon Trust Company, N.A., f/k/a The Bank of New York Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.21 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, filed February 23, 2009).

184

Exhibit Number
4.13	In accordance with Item 601(b)(4)(iii) of Regulation S-K, Reynolds American Inc. agrees to furnish to the SEC, upon request, a copy of each instrument that defines the rights of holders of such long-term debt not filed or incorporated by reference as an exhibit to this Annual Report on Form 10-K.
10.1	Credit Agreement, dated as of July 29, 2011, among Reynolds American Inc., the agents and other parties named therein, and the lending institutions listed from time to time on Annex I thereto (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K, dated July 29, 2011).
10.2	Subsidiary Guarantee Agreement, dated as of July 29, 2011, among certain subsidiaries of Reynolds American Inc. as guarantors and JPMorgan Chase Bank, N.A. as administrative agent (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Form 8-K, dated July 29, 2011).
10.3	Formation Agreement, dated as of July 30, 2004, among Brown & Williamson Tobacco Corporation (n/k/a Brown & Williamson Holdings, Inc.), Brown & Williamson U.S.A., Inc. (n/k/a R.J. Reynolds Tobacco Company) and Reynolds American Inc. (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated July 30, 2004).
10.4	Governance Agreement, dated as of July 30, 2004, among British American Tobacco p.l.c., Brown & Williamson Tobacco Corporation (n/k/a Brown & Williamson Holdings, Inc.) and Reynolds American Inc. (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Form 8-K dated July 30, 2004).
10.5	Amendment No. 1, dated as of November 18, 2004, to the Governance Agreement, dated as of July 30, 2004, among British American Tobacco p.l.c., Brown & Williamson Holdings, Inc. and Reynolds American Inc. (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated November 18, 2004).
10.6	Amendment No. 2, dated April 29, 2008, to the Governance Agreement, dated as of July 30, 2004, as amended, by and among British American Tobacco p.l.c., Brown & Williamson Holdings, Inc. and Reynolds American Inc. (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Form 8-K dated April 29, 2008).
10.7	Amendment No. 3, dated November 11, 2011, to the Governance Agreement, dated as of July 30, 2004, as amended, by and among British American Tobacco p.l.c, Brown & Williamson Holdings, Inc. and Reynolds American Inc. (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Form 8-K dated November 14, 2011).
10.8	Non-Competition Agreement, dated as of July 30, 2004, between Reynolds American Inc. and British American Tobacco p.l.c. (incorporated by reference to Exhibit 10.3 to Reynolds American Inc.’s Form 8-K dated July 30, 2004).
10.9	Contract Manufacturing Agreement, dated as of July 30, 2004, by and between R.J. Reynolds Tobacco Company and B.A.T. (U.K. & Export) Limited (incorporated by reference to Exhibit 10.5 to Reynolds American Inc.’s Form 8-K dated July 30, 2004).
10.10	Amendment, effective January 2, 2007, to Contract Manufacturing Agreement, dated as of July 30, 2004, by and between R.J. Reynolds Tobacco Company and B.A.T. (U.K. & Export) Limited (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007, filed May 4, 2007).
10.11	American-blend Cigarette Manufacturing Agreement, dated May 26, 2010, by and between R.J. Reynolds Tobacco Company and BATUS Japan, Inc. (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated June 2, 2010).

185

Exhibit Number
10.12	Share Repurchase Agreement, dated November 11, 2011, by and between Reynolds American Inc. and Brown & Williamson Holdings, Inc. (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated November 14, 2011).
10.13	Purchase Agreement dated as of March 9, 1999, as amended and restated as of May 11, 1999, among R.J. Reynolds Tobacco Company, RJR Nabisco, Inc. and Japan Tobacco Inc. (incorporated by reference to Exhibit 2.1 to R.J. Reynolds Tobacco Holdings, Inc.’s Form 8-K dated May 12, 1999).
10.14	Settlement Agreement dated August 25, 1997, between the State of Florida and settling defendants in The State of Florida v. American Tobacco Co. (incorporated by reference to Exhibit 2 to R.J. Reynolds Tobacco Holdings, Inc.’s Form 8-K dated August 25, 1997).
10.15	Comprehensive Settlement Agreement and Release dated January 16, 1998, between the State of Texas and settling defendants in The State of Texas v. American Tobacco Co. (incorporated by reference to Exhibit 2 to R.J. Reynolds Tobacco Holdings, Inc.’s Form 8-K dated January 16, 1998).
10.16	Settlement Agreement and Release in re: The State of Minnesota v. Philip Morris, Inc., by and among the State of Minnesota, Blue Cross and Blue Shield of Minnesota and the various tobacco company defendants named therein, dated as of May 8, 1998 (incorporated by reference to Exhibit 99.1 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 30, 1998, filed May 15, 1998).
10.17	Settlement Agreement and Stipulation for Entry of Consent Judgment in re: The State of Minnesota v. Philip Morris, Inc., by and among the State of Minnesota, Blue Cross and Blue Shield of Minnesota and the various tobacco company defendants named therein, dated as of May 8, 1998 (incorporated by reference to Exhibit 99.2 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 30, 1998, filed May 15, 1998).
10.18	Form of Consent Judgment by Judge Kenneth J. Fitzpatrick, Judge of District Court in re: The State of Minnesota v. Philip Morris, Inc. (incorporated by reference to Exhibit 99.3 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 30, 1998, filed May 15, 1998).
10.19	Stipulation of Amendment to Settlement Agreement and for Entry of Agreed Order dated July 2, 1998, by and among the Mississippi Defendants, Mississippi and the Mississippi Counsel in connection with the Mississippi Action (incorporated by reference to Exhibit 99.2 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 1998, filed August 14, 1998).
10.20	Stipulation of Amendment to Settlement Agreement and for Entry of Consent Decree dated July 24, 1998, by and among the Texas Defendants, Texas and the Texas Counsel in connection with the Texas Action (incorporated by reference to Exhibit 99.4 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 1998, filed August 14, 1998).
10.21	Stipulation of Amendment to Settlement Agreement and for Entry of Consent Decree dated September 11, 1998, by and among the State of Florida and the tobacco companies named therein (incorporated by reference to Exhibit 99.1 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, filed November 12, 1998).
10.22	Master Settlement Agreement, referred to as the MSA, dated November 23, 1998, between the Settling States named in the MSA and the Participating Manufacturers also named therein (incorporated by reference to Exhibit 4 to R.J. Reynolds Tobacco Holdings, Inc.’s Form 8-K dated November 23, 1998).

186

Exhibit Number
10.23	Comprehensive Agreement, dated as of April 13, 2010, among R.J. Reynolds Tobacco Company and Her Majesty the Queen in Right of Canada and the Provinces and Territories listed on the signature pages attached thereto (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated April 16, 2010).
10.24	Agreed Statement of Facts, dated as of April 13, 2010, between Her Majesty the Queen and Northern Brands International, Inc. (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Form 8-K dated April 16, 2010).
10.25	Amended and Restated Directors and Officers Indemnification Agreement (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated February 1, 2005).
10.26	Reynolds American Inc. Outside Directors’ Compensation Summary, effective January 1, 2012.
10.27	Equity Incentive Award Plan for Directors of Reynolds American Inc., referred to as the EIAP (Amended and Restated Effective February 2, 2012).
10.28	Form of Deferred Stock Unit Agreement between Reynolds American Inc. and the Director named therein, pursuant to the EIAP (incorporated by reference to Exhibit 10.32 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, filed February 23, 2009).
10.29	Form of Deferred Stock Unit Agreement between R.J. Reynolds Tobacco Holdings, Inc. and the Director named therein, pursuant to the EIAP (incorporated by reference to Exhibit 10.9 to R.J. Reynolds Tobacco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 1999, filed August 16, 1999).
10.30	Deferred Compensation Plan for Directors of Reynolds American Inc. (Amended and Restated Effective November 30, 2007) (incorporated by reference to Exhibit 10.43 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, filed February 27, 2008).
10.31	Amended and Restated (effective as of May 11, 2007) Reynolds American Inc. Long-Term Incentive Plan (incorporated by reference to Exhibit 10.6 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2007, filed August 2, 2007).
10.32	Form of Performance Unit Agreement (three-year vesting), dated March 6, 2008, between Reynolds American Inc. and the grantee named therein (incorporated by reference to Exhibit 10.11 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, filed May 2, 2008).
10.33	Form of Performance Share Agreement (three-year vesting), dated March 2, 2009, between Reynolds American Inc. and the grantee named therein (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated March 2, 2009).
10.34	Form of Amendment No. 1 to the 2009 Performance Share Agreement (three-year vesting), dated March 22, 2010, between Reynolds American Inc. and the grantee named therein (incorporated by reference to Exhibit 10.3 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, filed April 29, 2010).
10.35	Reynolds American Inc. 2009 Omnibus Incentive Compensation Plan (incorporated by reference to Appendix A of Reynolds American Inc.’s definitive Proxy Statement on Schedule 14A filed on March 23, 2009).
10.36	Form of Performance Share Agreement (three-year vesting), dated March 1, 2010, between Reynolds American Inc. and the grantee named therein (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, filed April 29, 2010).

187

Exhibit Number
10.37	Form of Performance Share Agreement (three-year vesting), dated March 1, 2011, between Reynolds American Inc. and the grantee named therein (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, filed April 29, 2011).
10.38	Form of Restricted Stock Agreement, dated March 6, 2008, between Reynolds American Inc. and the grantee named therein (incorporated by reference to Exhibit 10.13 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, filed May 2, 2008).
10.39	Offer of Employment Letter, dated July 29, 2004, by Reynolds American Inc. and Susan M. Ivey, accepted by Ms. Ivey on July 30, 2004 (incorporated by reference to Exhibit 10.22 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004, filed November 5, 2004).
10.40	Letter Agreement, dated December 19, 2007, regarding Severance Benefits and Change of Control Protections and amending July 29, 2004, offer of employment letter, between Reynolds American Inc. and Susan M. Ivey (incorporated by reference to Exhibit 10.57 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, filed February 27, 2008).
10.41	Offer of Employment Letter, dated December 4, 2006, between R.J. Reynolds Tobacco Company and Daniel M. Delen (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007, filed May 4, 2007).
10.42	May 24, 1999, July 21, 1999, and June 16, 2000, Letter Agreements between R.J. Reynolds Tobacco Company and Thomas R. Adams (incorporated by reference to Exhibit 10.64 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, filed February 27, 2008).
10.43	Form of Amended Letter Agreement regarding Severance Benefits and Change of Control Protections between Reynolds American Inc. and the officer named therein (incorporated by reference to Exhibit 10.67 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, filed February 27, 2008).
10.44	Reynolds American Inc. Executive Severance Plan, as amended and restated effective August 1, 2009 (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated July 21, 2009).
10.45	Retention Trust Agreement dated May 13, 1998, by and between RJR Nabisco, Inc. and Wachovia Bank, N.A. (incorporated by reference to Exhibit 10.6 to RJR Nabisco Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 1998, filed August 14, 1998).
10.46	Amendment No. 1 to Retention Trust Agreement, dated May 13, 1998, by and between RJR Nabisco, Inc. and Wachovia Bank, N.A., dated October 1, 2006 (incorporated by reference to Exhibit 10.56 to Reynolds American Inc.’s S-4 filed October 3, 2006).
10.47	Amendment No. 2 to Retention Trust Agreement, dated May 13, 1998, as amended, by and between R.J. Reynolds Tobacco Holdings, Inc., as successor to RJR Nabisco, Inc., and Wachovia Bank, N.A. (incorporated by reference to Exhibit 10.66 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, filed February 27, 2007).
10.48	Supplemental Pension Plan for Executives of Brown & Williamson Tobacco Corporation (n/k/a Brown & Williamson Holdings, Inc.) (as amended and restated through January 1, 2012).

188

Exhibit Number
10.49	Form of Reynolds American Inc. Trust Agreement, by and among the executive officer named therein, J.P. Morgan Trust Company of Delaware, the trustee, as successor to United States Trust Company, N.A., and Reynolds American Inc., as administrative agent for the executive (incorporated by reference to Exhibit 10.65 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, filed February 23, 2009).
10.50	Brown & Williamson Tobacco Corporation (n/k/a Brown & Williamson Holdings, Inc.) Health Care Plan for Salaried Employees (as amended through July 29, 2004, by Amendment Nos. 1 and 2) (incorporated by reference to Exhibit 10.69 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004, filed March 9, 2005).
10.51	Amendment No. 3, entered into as of December 31, 2004, to the Brown & Williamson Tobacco Corporation (n/k/a Brown & Williamson Holdings, Inc.) Health Care Plan for Salaried Employees (incorporated by reference to Exhibit 10.70 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004, filed March 9, 2005).
10.52	Amendment No. 4, entered into as of April 20, 2005, to the Brown & Williamson Tobacco Corporation Health Care Plan for Salaried Employees (incorporated by reference to Exhibit 10.71 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, filed February 27, 2007).
10.53	Amendment No. 5, entered into as of December 29, 2006, to the Brown & Williamson Tobacco Corporation Health Care Plan for Salaried Employees (incorporated by reference to Exhibit 10.72 to Reynolds American Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, filed February 27, 2007).
10.54	Amendment No. 6, entered into as of December 19, 2011, to the Brown & Williamson Tobacco Corporation Health Care Plan for Salaried Employees.
10.55	Supply Agreement, dated May 2, 2005, by and between R.J. Reynolds Tobacco Company and Alcan Packaging Food and Tobacco Inc. (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated May 2, 2005).
10.56	First Amendment to Supply Agreement, dated September 16, 2005, by and between R.J. Reynolds Tobacco Company and Alcan Packaging Food and Tobacco Inc. (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, filed November 3, 2005).
10.57	Second Amendment to Supply Agreement, effective December 31, 2008, between R.J. Reynolds Tobacco Company and Alcan Packaging Food and Tobacco Inc. (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated December 31, 2008).
10.58	Supply Agreement, dated May 2, 2005, by and between R.J. Reynolds Tobacco Company and Alcoa Flexible Packaging, LLC (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Form 8-K dated May 2, 2005).
10.59	Letter, dated January 28, 2008, between R.J. Reynolds Tobacco Company and Alcoa Flexible Packaging, LLC regarding the May 2, 2005 Supply Agreement between the parties (incorporated by reference to Exhibit 10.6 to Reynolds American Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, filed May 2, 2008).
10.60	Supply Agreement, dated May 2, 2005, by and between R.J. Reynolds Tobacco Company and Mundet Inc. (incorporated by reference to Exhibit 10.3 to Reynolds American Inc.’s Form 8-K dated May 2, 2005).

189

Exhibit Number
10.61	Valuation Payment Settlement Agreement, dated February 20, 2008, by and between R.J. Reynolds Tobacco C.V. and Gallaher Limited (incorporated by reference to Exhibit 10.1 to Reynolds American Inc.’s Form 8-K dated February 20, 2008).
10.62	Guarantee of JT International Holding B.V., dated February 20, 2008, in favor of R.J. Reynolds Tobacco C.V. (incorporated by reference to Exhibit 10.2 to Reynolds American Inc.’s Form 8-K dated February 20, 2008).
12.1	Computation of Ratio of Earnings to Fixed Charges for each of the five years within the period ended December 31, 2011.
18.1	Letter on Change in Accounting Principles.
21.1	Subsidiaries of the Registrant.
23.1	Consent of Independent Registered Public Accounting Firm.
31.1	Certification of Chief Executive Officer relating to RAI’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011.
31.2	Certification of Chief Financial Officer relating to RAI’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011.
32.1*	Certification of Chief Executive Officer and Chief Financial Officer relating to RAI’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011, pursuant to Section 18 U.S.C. §1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101.INS	XBRL instance document
101.SCH	XBRL taxonomy extension schema
101.CAL	XBRL taxonomy extension calculation linkbase
101.LAB	XBRL taxonomy extension label linkbase
101.PRE	XBRL taxonomy extension presentation linkbase

* Exhibit is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subjected to the liabilities of that Section. This exhibit shall not be incorporated by reference into any given registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

190

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	REYNOLDS AMERICAN INC.
	(Registrant)
Dated: February 15, 2012	By:	/S/    DANIEL M. DELEN
		Daniel M. Delen
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

Signature	Title	Date
/S/    DANIEL M. DELEN         Daniel M. Delen	President, Chief Executive Officer and Director (principal executive officer)	February 15, 2012
/S/    THOMAS R. ADAMS         Thomas R. Adams	Executive Vice President and Chief Financial Officer (principal financial officer)	February 15, 2012
/S/    FREDERICK W. SMOTHERS         Frederick W. Smothers	Senior Vice President and Chief Accounting Officer (principal accounting officer)	February 15, 2012
/S/    THOMAS C. WAJNERT         Thomas C. Wajnert	Chairman of the Board and Director	February 15, 2012
/S/    JOHN P. DALY         John P. Daly	Director	February 15, 2012
/S/    MARTIN D. FEINSTEIN         Martin D. Feinstein	Director	February 15, 2012
/S/    LUC JOBIN         Luc Jobin	Director	February 15, 2012
/S/    H. RICHARD KAHLER         H. Richard Kahler	Director	February 15, 2012
/S/    HOLLY K. KOEPPEL         Holly K. Koeppel	Director	February 15, 2012
/S/    NANA MENSAH         Nana Mensah	Director	February 15, 2012

191

Signature	Title	Date
/S/    LIONEL L. NOWELL III         Lionel L. Nowell III	Director	February 15, 2012
/S/    H.G.L. POWELL         H.G.L. Powell	Director	February 15, 2012
/S/    RICHARD E. THORNBURGH         Richard E. Thornburgh	Director	February 15, 2012
/S/    NEIL R. WITHINGTON         Neil R. Withington	Director	February 15, 2012
/S/    JOHN J. ZILLMER         John J. Zillmer	Director	February 15, 2012

192

EX-10.26

Exhibit 10.26

REYNOLDS AMERICAN INC.

INDEPENDENT DIRECTORS’ COMPENSATION SUMMARY (Effective 1/1/2012)

1. Fees/Expense Reimbursement

Fees:	•    Board retainer fee of $60,000 per year. (Not paid to Non-Executive Chairman.)
	•    Non-Executive Chairman retainer fee of $270,000 per year.
	•    Non-Executive Chairman transitional services fee of $120,000 (renewed for an additional 12-month period, commencing Nov. 2011).
	•    Committee Chair retainer fees:
	$20,000 per year for the Audit and Finance Committee Chair;
	$10,000 per year for the Compensation and Leadership Development Committee Chair; and
	$10,000 per year for the Corporate Governance and Nominating Committee Chair.
	•    Committee meeting attendance fees of $1,500 per meeting. (Not paid to Non-Executive Chairman.)
	•    Board meeting attendance fees of $1,500 per meeting. (Not paid to Non-Executive Chairman.)

Fees are payable quarterly in arrears, but may be deferred in 25% increments in cash and/or in deferred stock units until termination of active directorship or until a selected year in the future. To be tax effective, an irrevocable deferral election must be made in the year prior to the year fees would otherwise be payable.

Expense Reimbursement: Directors are reimbursed for actual expenses incurred in connection with attendance at Board and committee meetings, including transportation and lodging expenses.

2. Equity Incentive Award Plan

• Upon election to the Board, an independent director receives an initial grant of 3,500 deferred stock units or, at the director’s election, 3,500 shares of RAI common stock.

• Annual grant of 4,000 deferred stock units (8,000 for Non-Executive Chairman) made at the time of the Annual Meeting and immediately vested. Director can elect to receive non-deferred award of 4,000 shares of RAI common stock (8,000 for Non-Executive Chairman) in lieu of deferred stock units.

• Quarterly grants of deferred stock units on the last day of each calendar quarter. Number of deferred stock units equal to $10,000 ($20,000 for Non-Executive Chairman) divided by the average of the closing price of a share of RAI common stock (as reported on the NYSE) for each business day during the last month of such calendar quarter.

• Initial and annual deferred stock units paid per director’s election in cash or RAI common stock, and quarterly deferred units paid in cash only, following termination of active directorship per director’s election in either a lump sum or in up to ten annual installments.

3. Life Insurance

Option to receive $50,000 or $100,000 non-contributory coverage while an active director. Imputed income will be calculated based on director’s end-of-year age and coverage amount.

4. Excess Liability Insurance

Eligible to receive $10,000,000 in Excess Liability coverage. No cash payment required; the fair market value will be imputed income to directors each year. Policy requires that directors have at least $300,000 underlying liability limit under a homeowner’s or other personal liability policy. Directors are obligated to pay for claims up to $300,000 not covered by this policy.

5. Business Travel Accident Insurance

$500,000 non-contributory coverage while an active director.

6. Matching Grants

Match of 1:1 for Educational/Arts/Cultural/Charitable Organizations – combined $10,000 maximum.

7. Director Education Programs

• Directors may attend one outside director education program per year at RAI’s expense.

• Directors are reimbursed for actual expenses incurred in connection with attendance at director education programs, including transportation and lodging expenses.

EX-10.27

Exhibit 10.27

EQUITY INCENTIVE AWARD PLAN FOR

DIRECTORS OF REYNOLDS AMERICAN INC.

(Amended and Restated Effective February 2, 2012)

Reynolds American Inc., a North Carolina corporation, hereby adopts this Equity Incentive Award Plan for Directors of Reynolds American Inc. (amended and restated effective February 2, 2012). The Plan is an amendment, restatement and continuation of the Amended and Restated Equity Incentive Award Plan for Directors of R.J. Reynolds Tobacco Holdings, Inc. and Subsidiaries. The purposes of this Plan are as follows:

(1) To further the growth, development and financial success of the Company by providing additional incentives to its Directors by assisting them to become owners of capital stock of the Company and thus to benefit directly from its growth, development and financial success.

(2) To enable the Company to obtain and retain the services of the type of Directors considered essential to the long-term success of the Company by providing and offering them an opportunity to become owners of capital stock of the Company.

ARTICLE I

DEFINITIONS

Section 1.1 General

Whenever the following terms are used in this Plan they shall have the meaning specified below unless the context clearly indicates to the contrary.

Section 1.2 Affiliate

“Affiliate” of any person shall mean another person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such first person.

Section 1.3 BAT

“BAT” shall mean, collectively, British American Tobacco, p.l.c., a public limited company incorporated under the laws of England and Wales, and its Affiliates.

Section 1.4 Board

“Board” shall mean the Board of Directors of the Company.

Section 1.5 Code

“Code” shall mean the Internal Revenue Code of 1986, as amended.

Section 1.6 Committee

“Committee” shall mean the Corporate Governance and Nominating Committee of the Board.

Section 1.7 Common Stock

“Common Stock” shall mean the common stock, par value $0.0001 per share, of the Company.

Section 1.8 Company

“Company” shall mean Reynolds American Inc., a North Carolina corporation.

Section 1.9 Director

“Director” shall mean a member of the Board.

Section 1.10 Eligible Director

“Eligible Director” shall mean a Director who qualifies as “independent” in accordance with Rule 303A.02 of the New York Stock Exchange listing standards, as such rule may be amended, supplemented or replaced from time to time; provided, however, that the Non-Executive Chairman shall be an Eligible Director, and provided further, that no “Investor Director” who is not an “Independent Director,” as such terms are defined in the Governance Agreement (as defined in Section 8.3(c)(i) of this Plan), shall be an “Eligible Director.”

Section 1.11 Grant

“Grant” shall mean an award made to a Participant pursuant to the Plan.

Section 1.12 Non-Executive Chairman

“Non-Executive Chairman” shall mean the Non-Executive Chairman of the Board.

Section 1.13 Option

“Option” shall mean an option granted under the Plan to purchase Common Stock.

Section 1.14 Option Price

“Option Price” shall have the meaning given in Section 4.2.

Section 1.15 Optionee

“Optionee” shall mean a Director to whom an Option is granted under the Plan.

- 2 -

Section 1.16 Participant

“Participant” shall mean a Director to whom a Grant has been made.

Section 1.17 Plan

“Plan” shall mean the Equity Incentive Award Plan for Directors of Reynolds American Inc.

Section 1.18 Secretary

“Secretary” shall mean the Secretary of the Company.

Section 1.19 Stock Award

“Stock Award” shall mean the annual award, either in the form of deferred stock units or shares of Common Stock, made pursuant to Article VI.

Section 1.20 Subsidiary

“Subsidiary” shall mean any corporation in an unbroken chain of corporations beginning with the Company if each of the corporations, or if each group of commonly controlled corporations, other than the last corporation in an unbroken chain then owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

ARTICLE II

SHARES SUBJECT TO PLAN

Section 2.1 Shares Subject to Plan

The shares of stock subject to Grant shall be shares of Common Stock. The aggregate number of shares of Common Stock which are available for Grants under the Plan shall not exceed 2,000,000. [Note: the number of shares of Common Stock available for grants increased as a result of the Company’s two-for-one stock split on August 14, 2006, and its two-for-one stock split on November 15, 2010.] Shares of Common Stock related to Grants that are forfeited, terminated, canceled, expire unexercised, settled in cash in lieu of stock or in such manner that all or some of the shares of Common Stock covered by a Grant are not issued to a Participant, shall immediately become available for Grants.

ARTICLE III

GRANTING OF OPTIONS

Section 3.1 Eligibility

Any Eligible Director shall be eligible to be granted Options as set forth in this Article III.

- 3 -

Section 3.2 Granting of Options to Directors

Options may be granted at any time and solely in the discretion of the Committee to each Eligible Director elected to serve on the Board. Such Options shall be subject to the terms and conditions set forth in Article IV.

ARTICLE IV

TERMS OF OPTIONS FOR DIRECTORS

Section 4.1 Option Agreement

A grant of Options to Eligible Directors shall be evidenced by a Stock Option Agreement, which shall be executed by the Optionee and an authorized officer of the Company and which shall incorporate the terms and conditions of this Article IV and such other terms and conditions as the Committee shall determine, consistent with the Plan.

Section 4.2 Option Price

The exercise price of each share of Common Stock subject to an Option granted pursuant to Section 3.2 shall be the final closing price of a share of Common Stock (as reported on the New York Stock Exchange consolidated tape) on the date of grant.

Section 4.3 Commencement of Exercisability

Options granted pursuant to Section 3.2 shall not be exercisable prior to six (6) months after the date of grant, and thereafter shall be exercisable in full, subject to applicable securities regulations.

Section 4.4 Expiration of Option

The Option shall expire and may not be exercised to any extent after the expiration of ten (10) years from the date the Option was granted.

ARTICLE V

EXERCISE OF OPTIONS

Section 5.1 Persons Eligible to Exercise

During the lifetime of the Optionee, only he or his guardian may exercise an Option granted to him, or any portion thereof. After the death of the Optionee, any exercisable portion of an Option may, prior to the time when such portion becomes unexercisable under Section 4.4, be exercised by his personal representative or by any person empowered to do so under the deceased Optionee’s will or under the then applicable laws of descent and distribution.

Section 5.2 Partial Exercise

At any time and from time to time prior to the time when any exercisable Option or exercisable portion thereof expires or becomes unexercisable under Section 4.4, such Option or portion thereof may be exercised in whole or in part; provided, however, that the Company shall not be required to issue fractional shares.

- 4 -

Section 5.3 Manner of Exercise

An exercisable Option, or any exercisable portion thereof, may be exercised solely by delivering to the Secretary or his office all of the following prior to the time when such Option or such portion becomes unexercisable:

(a) Notice in writing signed by the Optionee or other person then entitled to exercise such Option or portion thereof, stating that such Option or portion thereof is exercised;

(b) Full payment of the Option Price shall be made in cash, by check or a combination thereof, for the shares of Common Stock with respect to which such Option or portion thereof is thereby exercised, together with payment of any federal income or other tax required to be withheld by the Company with respect to such shares of Common Stock, in accordance with the terms of the Plan and of any applicable guidelines of the Committee in effect at the time. The requirement of payment will be deemed satisfied if the Participant has made arrangements satisfactory to the Company with a duly registered broker-dealer that is a member of the National Association of Securities Dealers, Inc. to sell on the date of exercise a sufficient number of shares of Common Stock being purchased so that the net proceeds of the sale transaction will at least equal the full exercise price and pursuant to which the broker-dealer undertakes to deliver the full exercise price to the Company not later than the later of (i) the settlement date of the sale transaction and (ii) the date on which the Company delivers to the broker-dealer the shares of Common Stock being purchased pursuant to the exercise of such Option. This method is known as the “broker-dealer exercise method” and is subject to the terms and conditions set forth herein, in the Option grant agreement and in guidelines established by the Committee;

(c) Such representations and documents as the Committee reasonably deems necessary or advisable to effect compliance with all applicable provisions of the Securities Act of 1933, as amended and any other federal, state or foreign securities laws or regulations. The Committee may, in its absolute discretion, also take whatever additional actions it deems appropriate to effect such compliance, including, without limitation, placing legends on share certificates and issuing stop-transfer orders to transfer agents and registrars; and

(d) In the event that the Option or portion thereof shall be exercised pursuant to Section 5.1 by any person or persons other than the Optionee, appropriate proof of the right of such person or persons to exercise the Option or portion thereof.

Section 5.4 Rights as Shareholders

The holders of Options shall not be, nor have any of the rights or privileges of, shareholders of the Company in respect of any shares of Common Stock purchasable upon the exercise of any part of an Option unless and until certificates representing such shares of Common Stock have been issued by the Company to such holders.

- 5 -

Section 5.5 Transfer Restrictions

The Committee, in its absolute discretion, may impose such restrictions on the transferability of the shares of Common Stock purchasable upon the exercise of an Option as it deems appropriate, and any such restriction shall be set forth in the respective Stock Option Agreement and may be referred to on the certificates evidencing such shares of Common Stock.

ARTICLE VI

STOCK AWARDS

Section 6.1 Granting of Initial Stock Award to Directors

(a) Each Eligible Director who is elected to serve on the Board shall receive an initial Stock Award as of the date of such Director’s initial election to serve on the Board (an “Initial Stock Award”). Such Initial Stock Award shall be granted only once to each Eligible Director as soon as practicable following the Director’s initial election to serve on the Board and shall be subject to the terms and conditions set forth in this Article VI. Notwithstanding this Section 6.1(a), in the event of the appointment of an existing Director who was an employee of the Company to the position of Non-Executive Chairman and such Director has not yet received an Initial Stock Award, the Non-Executive Chairman shall receive an Initial Stock Award upon his or her appointment to the position of Non-Executive Chairman.

(b) Except as provided in Section 6.1(c) below, the Initial Stock Award shall be made in the form of deferred stock units, as described in Section 6.4. Each Eligible Director shall receive an Initial Stock Award of 3,500 deferred stock units.

(c) Notwithstanding the foregoing, an Eligible Director may elect to receive the Initial Stock Award in the form of shares of Common Stock. The election to receive shares of Common Stock must be made in writing no later than the date a Director becomes a Director (or in the case of a Non-Executive Chairman, the date of his or her appointment). An election to receive shares of Common Stock shall be irrevocable by the Director.

Section 6.2 Granting of Annual Stock Awards

(a) Each Eligible Director shall receive an annual Stock Award as of the date of the Company’s annual meeting of shareholders or the one (1) year anniversary of the preceding year’s annual meeting of shareholders, if no meeting has been scheduled for such subsequent year, provided that the Director serves on the Board immediately following such date (an “Annual Stock Award”).

(b) Except as provided in Section 6.2(c) below, the Annual Stock Award shall be made in the form of deferred stock units, as described in Section 6.4. Each Eligible Director shall receive an Annual Stock Award of 4,000 (or in the case of a Non-Executive Chairman, 8,000) deferred stock units). [Note: the number of shares of Common Stock constituting an Annual Stock Award increased as a result of the Company’s two-for-one stock split on August 14, 2006, and its stock split on November 15, 2010.]

- 6 -

(c) Notwithstanding the foregoing, an Eligible Director or the Non-Executive Chairman may elect to receive the Annual Stock Award in the form of shares of Common Stock. The election to receive shares of Common Stock must be made in writing by December 31 of the year preceding the year during which the Annual Stock Award would otherwise be granted or, if later, the date a Director becomes a Director (or in the case of a Non-Executive Chairman, the date of his or her appointment). An election to receive shares of Common Stock shall be irrevocable by the Director and shall be effective only for the year immediately following the date on which it was filed (or in the case of a new Director or a new Non-Executive Chairman, through December 31 of the year during which the election was made).

Section 6.3 Grant of Quarterly Stock Awards

(a) Each Eligible Director shall receive a quarterly Stock Award on the last day of each calendar quarter, provided that the Director has served on the Board at any time during such calendar quarter (a “Quarterly Stock Award”).

(b) The Quarterly Stock Award shall be made in the form of deferred stock units, as described in Section 6.4. The number of deferred stock units to be credited to each Eligible Director’s account on the last day of each calendar quarter shall be determined pursuant to the following formula: $10,000 (or in the case of a Non-Executive Chairman, $20,000) divided by the average of the final closing price of a share of Common Stock (as reported on the New York Stock Exchange consolidated tape) for each business day during the last month of such calendar quarter. In the event an Eligible Director has served on the Board or in the position of Non-Executive Chairman for less than an entire quarter, the number of deferred stock units to be credited to his or her account on the last day of such quarter shall be prorated based on the actual number of days of his or her service on the Board during the quarter.

Section 6.4 Deferred Stock Units

Each deferred stock unit shall be equal in value to one (1) share of Common Stock. As of the date any dividend is paid to shareholders of Common Stock, each Participant shall be credited with additional deferred stock units equal to the number of shares of Common Stock (including fractions of a share) that could have been purchased at the closing price of Common Stock on such date with the dividend paid on the number of shares of Common Stock to which such Participant’s deferred stock units are equivalent on the record date for such dividend. In case of dividends paid in property, the dividend shall be deemed to be the fair market value of the property at the time of distribution of the dividend, as determined by the Committee.

Section 6.5 Distribution of Deferred Stock Units

(a) For all Grants made under this Plan on or prior to December 31, 2004, the distribution of a Participant’s deferred stock units will be made as follows:

(i) Unless as otherwise elected in Section 6.5(a)(ii), payment of a Participant’s deferred stock units shall be made in one (1) lump sum as soon as practicable following the end of the year in which the Participant ceases to be a Director.

- 7 -

(ii) At the election of the Participant made in writing and delivered to the Committee at any time on or before December 1 of the year of termination of the Participant’s service as a Director, distribution of all of his or her deferred stock units, commencing as soon as practicable following the end of the year in which the Participant ceases to be a Director, shall be made in any number of annual installments not exceeding ten (10). Any such election, unless made irrevocable by its terms, may be changed by written notice to the Committee at any time prior to December 1 of the year of a Participant’s termination of his or her service as a Director.

(b) For all Grants made under this Plan after December 31, 2004 and on or prior to December 31, 2007, the distribution of a Participant’s deferred stock units will be made in the following manner. According to the election made by each Participant on an annual election form provided by the Company to the Participant prior to December 31 of the year preceding the grant of any award under this Plan in the next Plan year or, if later, within thirty (30) days after the date a Director becomes a Director (or in the case of a Non-Executive Chairman, within thirty (30) days after his or her appointment), payment of a Participant’s deferred stock units will be made either in a lump sum or in any number of annual installments not exceeding ten (10), on (or commencing on) January 2 following the termination of his or her service as a Director.

(c) For all Grants made under this Plan after December 31, 2007, the distribution of a Participant’s deferred stock units will be made in the following manner. Each Participant shall elect annually to have payment of his or her deferred stock units with respect to a grant (i) be made either in a lump sum or in any number of annual installments not exceeding ten (10), and (ii) be paid either (A) on (or commencing on) January 2 following the termination of his or her service as a Director, or (B) on (or commencing on) the later of January 2 of the year specified and January 2 following the termination of his or her service as a Director. Such election by each Participant shall be made on an annual election form provided by the Company prior to December 31 of the year preceding the grant of any award under this Plan in the next Plan year or, if later, no later than the date a Director becomes a Director (or in the case of a Non-Executive Chairman, the date of his or her appointment). If a Participant fails to make an election with respect to a grant of deferred stock units in any Plan year, payment of such deferred stock units shall be made in a lump sum on January 2 following the termination of his or her service as a Director.

(d) Elections made pursuant to Section 6.5(b) and (c) are not irrevocable; provided, however, (A) any subsequent election may not be effective until twelve (12) months after the date the election is made, (B) any subsequent election relating to payments scheduled for a particular date or dates must be made at least twelve (12) months prior to the date of the first scheduled payment, and (C) any subsequent election for distributions, other than those triggered by disability, death or an unforeseeable emergency, must delay distribution by at least five (5) years from the original distribution date.

(e) Distribution of a Participant’s deferred stock units received in connection with such Participant’s Quarterly Stock Awards shall be made only in cash. Subject to 8.3(b) hereof, distribution of a Participant’s deferred stock units received in connection with such Participant’s Initial Stock Award and Annual Stock Awards shall be made in cash or stock, at the election of the Participant made in writing and delivered to the Committee at any time on or before

- 8 -

December 1 of the year of termination of the Participant’s service as a Director. Subject to 8.3(b) hereof, if distribution is made in cash, the amount of distribution shall be determined by multiplying the number of deferred stock units attributable to the installment by the average of the final closing price of a share of Common Stock (as reported on the New York Stock Exchange consolidated tape) on each business day in the month of December immediately prior to the year in which the installment is to be paid. If distribution is made in stock, any fractional shares of stock shall be paid in cash equal to the value of the fractional share multiplied by the final closing price of a share of Common Stock (as reported on the New York Stock Exchange consolidated tape) on the last business day immediately preceding the date of distribution.

(f) For purposes of Section 6.5(b) and Section 6.5(c), termination of service as a Director shall be the Director’s separation from service with the Company within the meaning of Section 409A of the Code.

(g) Notwithstanding the foregoing provisions of this Section 6.5, with respect to grants made under this Plan after December 31, 2004, in the event that a Participant is a “specified employee,” determined pursuant to procedures adopted by the Company in compliance with Section 409A of the Code, at the time of termination of service as a Director, as provided in Section 6.5(f), the distribution of deferred units to be made following the termination of service as a Director shall be paid no earlier than the first day of the seventh month following the date such termination of service as a Director occurs (or if earlier, on the date of death).

Section 6.6 Installment Amount

In the event a Participant has elected to receive distribution of his or her deferred stock units in more than one (1) installment, the amount of each installment shall be determined by multiplying the current number of deferred stock units by a fraction, the numerator of which is one (1), and the denominator of which is the number of installments yet to be paid.

Section 6.7 Distribution upon Death

In the event of the death of a Participant, whether before or after ceasing to serve as a Director, any deferred stock units to which he or she was entitled, shall be converted to cash and distributed in a lump sum to such person or persons or the survivors thereof, including corporations, unincorporated associations or trusts, as the Participant may have designated. All such designations shall be made in writing signed by the Participant and delivered to the Committee. A Participant may from time to time revoke or change any such designation by written notice to the Committee. If there is no unrevoked designation on file with the Committee at the time of the Participant’s death, or if the person or persons designated therein shall have all predeceased the Participant or otherwise ceased to exist, such distributions shall be made in accordance with the Participant’s will or in the absence of a will, to the administrator of the Participant’s estate. The person entitled to receive payment pursuant to this Section 6.7 shall be responsible for notifying the Committee of the Participant’s death. Any distribution under this Section 6.7 shall be made as soon as reasonably practicable following the end of the fiscal quarter in which the Participant’s death occurs. In this case, a Participant’s deferred stock units shall be converted to cash by multiplying the number of whole and fractional shares of Common Stock to which the Participant’s deferred stock units are equivalent by the average of the final closing price of a share of Common Stock (as reported on the New York Stock Exchange consolidated tape) on each business day during the last month of the calendar quarter prior to the date of death.

- 9 -

Section 6.8 Withholding Taxes

The Company shall deduct from all distributions under the Plan any taxes required to be withheld by federal, state, or local governments.

Section 6.9 Terms and Conditions

All Stock Awards shall be subject to the terms and conditions of this Article VI and such other terms and conditions as the Committee shall determine, consistent with the Plan.

ARTICLE VII

ADMINISTRATION

Section 7.1 Plan Administrator

The Plan shall be administered by the Committee.

Section 7.2 Duties and Powers of Committee

It shall be the duty of the Committee to conduct the general administration of the Plan in accordance with its provisions. The Committee shall have the power to interpret the Plan and the Grants and to adopt such rules for the administration, interpretation, and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. Any such interpretations and rules shall be consistent with the basic purpose of the Plan to make Grants. In its absolute discretion, the Board may at any time and from time to time exercise any and all rights and duties of the Committee under the Plan. The Committee may act either by vote at a telephonic or other meeting or by unanimous written consent in lieu of a meeting.

Section 7.3 Compensation; Professional Assistance; Good Faith Actions

Members of the Committee shall not receive compensation for their services as members in connection with the administration of the Plan, but all expenses and liabilities they incur in connection with the administration of the Plan shall be borne by the Company. The Committee may employ attorneys, consultants, accountants, appraisers, brokers or other persons. The Committee, the Company, the Directors and the officers of the Company shall be entitled to rely upon the advice, opinions or valuations of any such persons. All actions taken and all interpretations and determinations made by the Committee in good faith shall be final and binding upon all Participants, the Company and all other interested persons. No member of the Committee shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or the Grants, and all members of the Committee shall be fully protected by the Company with respect to any such action, determination or interpretation.

- 10 -

ARTICLE VIII

MISCELLANEOUS PROVISIONS

Section 8.1 Amendment, Suspension or Termination of the Plan

The Plan may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Board. Except as expressly permitted by the terms of the Plan, neither the amendment, suspension nor termination of the Plan shall, without the consent of the Participant alter or impair any rights or obligations under any Grant theretofore granted. No Grant may be made during any period of suspension nor after termination of the Plan.

Section 8.2 Effect of Plan Upon Other Options and Compensation Plans

Nothing in this Plan shall be construed to limit the right of the Company or any of its Subsidiaries (a) to establish any other forms of incentives or compensation for Directors of the Company or any of its Subsidiaries or (b) to grant or assume options other than under this Plan in connection with any proper corporate purpose, including, but not by way of limitation, the grant or assumption of options in connection with the acquisition by purchase, lease, merger, consolidation or otherwise, of the business, stock or assets of any corporation, firm, association or other entity.

Section 8.3 Adjustments

(a) In the event of any change in the outstanding Common Stock by reason of a stock split, spin-off, stock dividend, stock combination or reclassification, recapitalization or merger, change of control, or similar event, the Committee shall (i) adjust appropriately the number of shares of Common Stock subject to the Plan and available for or covered by Grants, the number of deferred stock units or shares of Common Stock constituting Initial Stock Awards and Annual Stock Awards in Sections 6.1 and 6.2 hereof and share prices related to outstanding Grants and (ii) make such other revisions to outstanding Grants as it deems are equitably required. Any such adjustment made by the Committee shall be final and binding upon all Participants, the Company and all other interested persons.

(b) In the event of a Change of Control (as defined in Section 8.3(c) hereof):

(i) Options granted pursuant to Article III hereof shall become fully vested and exercisable; provided, however, that

(A) for each Option with an exercise price less than the value of the consideration for a share of Common Stock in the Change of Control transaction (the “Transaction Consideration”), the Committee may, in its sole discretion, elect to make a cash payment to Participants in cancellation of such Options in an amount equal to the product of (1) and (2), where (1) is the excess of Transaction Consideration over the exercise price, and (2) is the number of shares of Common Stock subject to the Options being cancelled, which amount shall be paid at the same time as the Transaction Consideration is paid to holders of Common Stock, and in any case no later than March 15 of the year succeeding the year in which such event of a Change of Control occurred; and

- 11 -

(B) for each Option with an exercise price greater than the Transaction Consideration, the Committee may, in its sole discretion, elect to cancel such Options without any payment to Participants holding such Options.

(ii) (A) Deferred stock units granted pursuant to Article VI hereof and described in Section 6.5(a) shall be distributed to Participants in a single lump sum as soon as practicable following the event of a Change of Control.

(B) Deferred stock units granted pursuant to Article VI hereof and described in Section 6.5(b) and Section 6.5(c) shall be distributed to Participants:

(1) in a single lump sum on the date of a Change of Control that is also a “change in the ownership or effective control” of the Company for purposes of Section 409A of the Code; or

(2) in the event a Change of Control is not a “change in the ownership or effective control” of the Company for purposes of Section 409A of the Code, at the time provided in Article VI hereof.

(C) Notwithstanding the foregoing provisions of this Section 8.3(b)(ii), in the event of a Change of Control, the Committee may, in its sole discretion, elect to make the distribution with respect to deferred stock units in cash in lieu of shares of Common Stock with respect to Initial Stock Awards and Annual Stock Awards. With respect to any distribution made in cash, the amount of the distribution shall be determined by multiplying the number of deferred stock units by the Transaction Consideration.

(c) For purposes of the Plan, a “Change of Control” shall mean the first to occur of the following events:

(i) an individual, corporation, partnership, group, associate or other entity or “person”, as such term is defined in Section 14(d) of the Securities Exchange Act of 1934 (the “Exchange Act”), other than the Company or any employee benefit plans sponsored by the Company, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of thirty percent (30%) or more of the combined voting power of the Company’s outstanding securities ordinarily having the right to vote at elections of directors; provided, however, that the acquisition of Company securities by BAT pursuant to the Business Combination Agreement, dated as of October 27, 2003, between R.J. Reynolds Tobacco Holdings, Inc. (“RJR”) and Brown & Williamson Tobacco Corporation (“B&W”), as thereafter amended (the “BCA”) or as expressly permitted by the Governance Agreement, dated as of July 30, 2004, among British American Tobacco, p.l.c., B&W and the Company (the “Governance Agreement”), shall not be considered a Change of Control for purposes of this subsection (i);

- 12 -

(ii) individuals who constitute the Board (or who have been designated as directors in accordance with Section 1.09 of the BCA) on July 30, 2004 (the “Incumbent Board”) cease for any reason to constitute at least a majority thereof, provided that any person becoming a director subsequent to such date whose election, or nomination for election by the Company’s shareholders, was (A) approved by a vote of at least three-quarters of the directors comprising the Incumbent Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee of the Company for director) or (B) made in accordance with Section 2.01 of the Governance Agreement, but excluding for this purpose any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of an individual, corporation, partnership, group, associate or other entity or “person” other than the Board, shall be, for purposes of this paragraph (ii), considered as though such person were a member of the Incumbent Board; or

(iii) the approval by the shareholders of the Company of a plan or agreement providing (A) for a merger or consolidation of the Company other than with a wholly-owned Subsidiary and other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, or (B) for a sale, exchange or other disposition of all or substantially all of the assets of the Company, other than any such transaction where the transferee of all or substantially all of the assets of the Company is a wholly owned subsidiary or an entity more than fifty percent (50%) of the combined voting power of the voting securities of which is represented by voting securities of the Company outstanding immediately prior to the transaction (either remaining outstanding or by being converted into voting securities of the transferee entity). If any of the events enumerated in this paragraph (iii) occur, the Board shall determine the effective date of the Change of Control resulting therefrom for purposes of the Plan or the Grants hereunder.

Section 8.4 Compliance with Section 409A of the Code

The Plan is intended to comply with Section 409A of the Code and shall be construed and interpreted in accordance with such intent. Each payment pursuant to this Plan shall be considered a separate payment and not one of a series of payments for purposes of Section 409A of the Code.

- 13 -

Section 8.5 Titles

Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of the Plan.

Section 8.6 Pronouns

The masculine pronoun shall include the feminine and neutral and the singular shall include the plural, where the context so indicates.

Section 8.7 Governing Law

All questions arising in respect of the Plan, including those pertaining to its validity, interpretation and administration, shall be governed, controlled and determined in accordance with the applicable provisions of federal law and, to the extent not preempted by federal law, the laws of the State of North Carolina.

- 14 -

EX-10.48

Exhibit 10.48

SUPPLEMENTAL PENSION PLAN

FOR EXECUTIVES OF

BROWN & WILLIAMSON TOBACCO CORPORATION

(Restated as of January 1, 2012)

SUPPLEMENTAL PENSION PLAN

FOR EXECUTIVES OF

BROWN & WILLIAMSON TOBACCO CORPORATION

(RESTATED AS OF JANUARY 1, 2012)

TABLE OF CONTENTS

		Page
ARTICLE 1.	DEFINITIONS		1
1.01	Actuarial Basis		1
1.02	Basic Plan		2
1.03	Company		2
1.04	PIP; PIP Award		2
1.05	Employer		2
1.06	ERISA Excess Plan		3
1.07	Interest		3
1.08	Participant		3
1.09	Plan		3
1.10	Supplemental Benefit		3
1.11	Supplemental Salary		3
ARTICLE 2.	PARTICIPATION		5
2.01	Participation		5
2.02	SERP Trust Individuals		6
ARTICLE 3.	BENEFITS		6
3.01	Eligibility		6
3.02	Amount of Supplemental Benefit		7
3.03	Dependents’ Benefits		9
ARTICLE 4.	METHOD OF PAYMENT		10
4.01	Payments On or After July 1, 1990		10
4.02	Plan Unfunded		10
4.03	Delay in Payment		10
4.04	Withholding		11
ARTICLE 5.	AMENDMENT AND TERMINATION		11
5.01	Right to Amend or Terminate Reserved		11
5.02	Action to Bind Employers		11
5.03	Change in Basic Plan		11
ARTICLE 6.	ADMINISTRATION		11
6.01	Administration		11

-i-

TABLE OF CONTENTS

(continued)

		Page
ARTICLE 7.	MISCELLANEOUS		11
7.01	Payment to Incompetent		11
7.02	Spendthrift Clause		12
7.03	Usage		12
7.04	Data		12
7.05	Separability		12
7.06	Captions		12
7.07	Right of Discharge Reserved		12
7.08	Other Benefits Unaffected		12
ARTICLE 8.	EFFECTIVE DATE, ETC		12
8.01	Effective Date		12

-ii-

SUPPLEMENTAL PENSION PLAN

FOR EXECUTIVES OF

BROWN & WILLIAMSON TOBACCO CORPORATION

(Restated as of January 1, 2012)

PREAMBLE

Effective January 1, 1991, Brown & Williamson Tobacco Corporation assumed all liabilities for the Supplemental Pension Plan for Executives of Brown & Williamson Tobacco Corporation (formerly the Supplemental Pension Plan for Executives of BATUS Inc. and Brown & Williamson Tobacco Corporation), and simultaneously restated the Plan to incorporate certain amendments approved by the Company.

Effective generally as of January 1, 2012, the Plan is restated in its entirety as set forth herein to incorporate the changes made by the prior Amendments to the Plan.

Notwithstanding the foregoing, the right to and amount of any pension payable to a Participant or beneficiary shall in all events be determined in accordance with the terms of the Plan as in effect at the time of termination of employment.

ARTICLE 1.

DEFINITIONS

The following terms when used in this Plan shall have the designated meaning unless a different meaning is clearly required by the context. Defined terms in the Basic Plan which are used in this Plan (including, without limitation, spouse and child) shall have the meanings given to them in the Basic Plan unless a different meaning is given below or is clearly required by the context.

1.01 Actuarial Basis.

(a) The term “Actuarial Basis” means a benefit computed on the basis of the actuarial principles adopted by the Company, subject to subsection (b) below.

(b) For purposes of determining the present value of the amount payable under Section 3.02, the following assumptions shall be used effective October 1, 1995:

(1) Interest:

(2) with respect to any portion (or all) of the accrued amount for which the Company has not provided an external source of payment prior to the time actual payment becomes due under Article 3, the lower of (i) the average of the monthly interest rates used to determine the commuted value of pensions under the Basic Plan for the 36 month period immediately preceding the Participant’s termination of employment, or (ii) the interest rate used to determine the commuted value of pensions under the Basic Plan for the month immediately preceding the Participant’s termination of employment.

(3) with respect to any portion (or all) of the accrued amount for which the Company has provided an alternate source of payment (whether in trust or otherwise) prior to the time actual payment becomes due under Article 3, the monthly interest rate used shall be determined pursuant to paragraph (A) above (but assuming the Participant had terminated employment as of the date of determination). A separate calculation shall be made for each such payment, and the interest rate applicable to each such calculation shall be established at the time of payment, and shall not be subject to change in the future as it relates to that payment.

(4) Mortality: the mortality table used under the Basic Plan to determine the commuted value of pensions at the time present value is determined.

1.02 Basic Plan. The term “Basic Plan” means the Retirement Plan for Salaried Employees of Brown & Williamson Tobacco Corporation and Certain Affiliates, and, as applicable, its predecessor plan.

1.03 Company. The word “Company” means, effective the date of closing (the “Closing”) of the transactions contemplated by the Business Combination Agreement dated October 27, 2003, between Brown & Williamson Tobacco Corporation and R.J. Reynolds Tobacco Holdings, Inc. (the “Business Combination”), Reynolds American Inc., and any successor thereto (“RAI”). Prior to Closing the word “Company” means Brown & Williamson Tobacco Corporation, and any successor thereto (“B&W”). Effective immediately prior to Closing, B&W shall be deemed to have withdrawn from and shall no longer maintain the Plan for its employees.

1.04 PIP; PIP Award.

(a) Except as provided in subsection (b) below, effective January 1, 2002, the Performance Incentive Plan (“PIP”) replaces and supersedes the Executive Incentive Plan (“E1P”), the Management Incentive Plan (“MIP”) and the Competitive Annual Bonus (“CAB”). A “PIP Award” is an award of incentive compensation applicable to a Participant for a calendar year and may include a pension-eligible component. Prior to the year 2002, the CAB award was not pension eligible; consequently the CAB component of a PIP Award for and after 2002 is not pension-eligible. By way of example, but not exclusion, for calendar years commencing on and after January 1, 2002, the sole annual incentive compensation plan that may include a pension-eligible component is the PIP, and for calendar years prior to 2002, plans that may include a pension-eligible component include the EIP and MIP.

(b) The Performance Incentive Plan, described in subsection (a) above, does not apply to Plan Participants seconded to an affiliate of the Company as of May 1, 2002. For such Participants, the Management Incentive Plan (“MIP”), as in effect on December 31, 2001, shall continue to apply for purposes of calculating Supplemental Salary.

1.05 Employer. The word “Employer” means Reynolds American Inc., and any subsidiary or affiliate of the Employer which is approved for inclusion in the Plan by the Company.

2

1.06 ERISA Excess Plan. The term “ERISA Excess Plan” means the portion of this Plan established by the Employer solely for the purpose of paying benefits based on the provisions of the Basic Plan (or other applicable plan) for certain employees in excess of the limitations on benefits imposed by Section 415 of the Internal Revenue Code of 1986, as amended. That portion of the Plan maintained for such purpose shall be treated as a separate plan which is an excess benefit plan, as defined by ERISA Section (3)(36).

1.07 Interest. The word “Interest” means the rate of interest established from time to time by the Company, in its discretion, for deferred PIP account balances.

1.08 Participant. The word “Participant” means a participant in the Basic Plan who satisfies the requirements for participation set out in Article 2 of the Plan.

1.09 Plan. The word “Plan” means the Supplemental Pension Plan for Executives of Brown & Williamson Tobacco Corporation, as in effect from time to time.

1.10 Supplemental Benefit. The term “Supplemental Benefit” means the benefit described in Section 3.02 hereof.

1.11 Supplemental Salary.

(a) The term “Supplemental Salary” shall mean the sum of Paragraphs (1) through and including (5) as follows:

(1) Average PIP Award. Subject to subsections (b) through (e) below, a Participant’s Average PIP Award shall be the greater of:

(A) a Participant’s Average PIP Award (whether or not deferred) for the three performance years immediately preceding the calendar year in which a Supplemental Benefit becomes payable to the Participant (or if applicable his spouse or dependents); provided that if any such Participant has not received a PIP Award for one or more of such three years, his award for such year shall be treated as zero dollars; or

(B) the amount obtained by multiplying the Participant’s annual rate of salary at the time a Supplemental Benefit becomes payable to the Participant (or if applicable his spouse or dependents) by the EIP/MIP percentage that was, or would have been, applicable to such Participant’s current position or level (i.e. the Participant’s employment position or level at the time the Supplemental Benefit becomes payable) at the “Commendable” level for the 2001 performance year.

Notwithstanding the foregoing, with respect to a Participant who enters into regular employment (as defined in Section 2.01(b)(2)) with RAI after Closing (as defined in Section 1.03), a Participant’s Average PIP Award shall be the greater of (i) the amount calculated under paragraph (B) above, or (ii) an amount equal to the Participant’s base annual compensation rate at the time of employment termination with RAI (or an affiliate), multiplied by B&W’s average performance rating percentage for 2001, 2002 and 2003 applicable to such Participant.

3

(2) Excess Pensionable Salary. The excess of the amount that would have been the Participant’s pensionable salary under the Basic Plan, but for the limitations of Section 401(a)(17) of the Internal Revenue Code of 1986 or any similar provision of subsequent law, over the Participant’s actual pensionable salary under the Basic Plan.

(3) Deferred Compensation. All amounts that would have constituted pensionable salary under the Basic Plan but for the fact that the receipt of these amounts was deferred, including without limitation, amounts deferred under the Deferred Compensation Plan for Executives of Brown & Williamson Tobacco Corporation, as amended from time to time.

(4) Special Contractual Arrangements. Effective for special contractual arrangements entered into on or after January 1, 1993, and to the extent provided in or required by any such arrangement, all amounts that would have constituted pensionable salary under the Basic Plan, but for the limits of Section 401(a)(17) of the Internal Revenue Code of 1986, or any similar provision of subsequent law, over the sum of the Participant’s pensionable salary determined under paragraphs (1), (2) and (3) above.

(5) Deemed Separation Pay. With respect to a Participant’s period of separation pay under the Reynolds American Salary and Benefit Continuation Plan, the period of severance benefits under the Reynolds American Inc. Executive Severance Plan or the period of severance under any individualized agreement providing for severance (collectively the “Severance Period”), full compensation (defined as the Participant’s base salary in effect at the time of the Participant’s Separation from Service, as defined in Section 3.01) during the Severance Period; provided, however, except for a Participant listed on Schedule A (a “Scheduled Participant”), effective for Participants who receive a notice of termination on or after January 1, 2010, this Section l.ll(a)(5) will no longer apply and with respect to Scheduled Participants, beginning January 1, 2010, the period for which full compensation will be taken into account will be three years following the Scheduled Participants Separation from Service, as defined in Section 3.01.

(b) For purposes of subsection (a)(l) above, disability shall be deemed to occur on the date the Participant first commences a period of absence that leads to a determination of disability under the Basic Plan.

(c) Except as specifically provided by written agreement between the Company and a Participant, Supplemental Salary shall include an Average PIP Award only for Participants who were Participants in the Plan on December 31, 1990, and who continue to be employed in an PIP-eligible position thereafter (or, in the event the Company terminates or modifies the PIP or similar annual incentive or bonus program in a manner described in subsection (e) below, were in eligible PIP positions at the time of such termination or modification). Subject to any such agreement, Supplemental Salary shall not include an Average PIP Award for a Participant who:

(1) was not a Participant in the Plan on December 31,1990; or

4

(2) becomes a Participant on or after January 1, 1991, whether as a result of initial employment, reemployment following a termination of employment (voluntary, involuntary, disability or otherwise), promotion, transfer or otherwise.

(d) The Average PIP Award for a Participant who becomes ineligible to participate in PIP for any reason prior to termination of employment, disability or death (other than by reason of the termination of the Plan or modification of the PIP or similar annual incentive or bonus program in a manner described in subsection (e) below) shall be calculated pursuant to subsection (a) above, by assuming the Supplemental Benefit of such Participant is or becomes payable in the year in which such Participant first becomes ineligible to so participate.

(e) If the EIP/MIP percentages in effect for the 2001 performance year are amended, terminated or replaced by a plan or program that has lower payout targets or opportunities than the EIP/MIP in effect as of January 1, 2001, e.g. if, with respect to a performance year subsequent to 2001, the percentage award applicable to the “Commendable” level for a Participant is lowered by the Company below the percentage award applicable to such Participant at the “Commendable” level for 2001, such Participant’s Average PIP Award (or, if applicable, Average EIP/MIP Award), shall be determined and paid out at the time of such amendment, termination or replacement, and shall be the greater of (i) the amount determined under subsection (a)(l)(A) above, or (ii) the amount obtained by multiplying the Participant’s rate of salary at the time of such amendment, termination or replacement by the EIP/MIP percentage applicable to such Participant at the “Commendable” level for the 2001 performance year.

ARTICLE 2.

PARTICIPATION

2.01 Participation.

(a) Any participant in the Basic Plan who (1) is eligible to participate in the PIP (prior to January 1, 1991), (2) is eligible to and elects to defer pensionable salary under the Deferred Compensation Plan for Executives of Brown & Williamson Tobacco Corporation, (3) receives compensation that would be included in the Participant’s pensionable salary under the Basic Plan but for the limitations of Section 401(a)(17) of the Internal Revenue Code of 1986 or any similar provision of subsequent law, or (4) would be eligible for an additional benefit under the Basic Plan but for the limitations of Section 415 of the Internal Revenue Code of 1986 or any similar provision of subsequent law, shall automatically become a Participant in this Plan.

(b) Effective as of Closing (as defined in Section 1.03), the following classes of employees shall be excluded from eligibility to participate in the Plan:

(1) any individual who was not an employee of the Company (as defined in Section 1.03) immediately prior to Closing; and

5

(2) any individual who was not a participant in (or an Eligible Employee with respect to and as defined in) the Basic Plan at the time he or she entered into “regular employment” with RAI at and after Closing. For this purpose, the term “regular employment” means full- or part-time ongoing employment with RAI that is not classified by RAI as transitional employment. An employee is considered to be in “transitional employment” if his or her employment is transferred to RAI in connection with the Business Combination and the employee is employed within the B&W Division of RAI for a limited period of time (a “transition period”).

2.02 SERP Trust Individuals.

(a) Pursuant to the Business Combination Agreement dated October 27, 2003, between Brown & Williamson Tobacco Corporation and R.J. Reynolds Tobacco Holdings, Inc. (the “BCA”), (i) Liabilities (as defined in the formation agreement under the BCA (the “Formation Agreement”)) under the Plan were retained by B&W (or an affiliate) to the extent they pertain or relate to the service and/or accrued benefits of the SERP Trust Individuals (as defined in Section 1.01 of the Formation Agreement and listed on Schedule 1.01(b) thereto as R. Baker, C.D. Brown, W. Carpenter, C. Dawson, M. DiCio, J. Eckmann, H. Frick, J. Graas, S. Ivey, M. Kovatch, R. Lewis, M. McGraw, R. Miller, C. Schoenbachler, D. Snyder, R. Stowe, R. Van Hess, and P. Wessel) prior to the Employment Transfer Time (as defined in the Formation Agreement), calculated on the assumption that each SERP’ Trust Individual’s employment terminated immediately prior to the Employment Transfer Time, and (ii) rights in the assets of the trusts established pursuant to the Secular Trust Agreements with the SERP Trust Individuals (as defined in Section 1.01 of the Formation Agreement and listed on Schedule 1.01(b) thereto) were retained by B&W to the extent such assets were held in an account thereunder for the purpose of providing a fund to pay benefits under the Plan (defined in the Secular Trust Agreement as the “SERP Account”).

(b) Notwithstanding any provision of the Plan to the contrary, effective as of the Employment Transfer Time the Plan (and the Company) shall have no liability for any Liability described above (nor shall the Company or the Plan have a claim to any Assets related thereto). To the extent a benefit is payable under the Plan to any SERP Trust Individual for periods of service performed for the Company after the Employment Transfer Time, such benefit shall take into account and be reduced by the liability retained by B&W referred to in subsection (a) above to the extent necessary to prevent a duplication of benefit payments.

ARTICLE 3.

BENEFITS

3.01 Eligibility. A Participant shall be entitled to receive a Supplemental Benefit under this Plan only upon (a) Separation from Service with a vested benefit under the Basic Plan, or (b) death. A “Separation from Service” shall be deemed to have occurred on the date on

6

which the level of bona fide services reasonably anticipated to be performed by the Participant for the Company and all affiliated companies is forty-five percent or less of the average level of bona fide services performed by the Participant during the immediately preceding thirty-six month period (or full period of service if the Participant has been providing services for less than thirty-six months).

3.02 Amount of Supplemental Benefit.

(a) The amount of a Participant’s Supplemental Benefit shall be equal to the actuarial value of the benefit to which the Participant would be entitled under the Basic Plan (without regard to Section 3.03 thereof) and the ERISA Excess Plan in the aggregate (determined after applying Section 3.03 of the Basic Plan), with the following adjustments:

(1) the Participant’s Supplemental Salary were included in his or her pensionable salary under the Basic Plan;

(2) any additional pensionable and qualifying service granted under any special contractual arrangement entered into on or after January 1, 1993, were included in his or her pensionable and qualifying service under the Basic Plan;

(3) any incremental benefit granted pursuant to subsection (e) of this Section 3.02;

(4) the Participant’s Basic Plan Qualifying Service will be deemed to include service during the Severance Period, provided, however, except for a Scheduled Participant, effective for Participants who receive a notice of termination on or after January 1, 2010, this Section 3.02(a)(4) will no longer apply and with respect to Scheduled Participants, beginning January 1, 2010, the Severance Period will be deemed to be three years following the Scheduled Participant’s Separation from Service, as defined in Section 3.01; and

(5) for purposes of determining any early retirement reductions and actuarial values, a Participant’s age will be deemed to be no less than his age at the end of the Severance Period,

offset by the actuarial value of the benefit payable under the Basic Plan, and subject to Section 2.02(b).

(b) Notwithstanding subsection (a) above, if a Participant becomes ineligible to participate in PIP for any reason after having become a Participant hereunder, that portion of such a Participant’s Supplemental Benefit which is based on an Average PIP Award (if any) shall be calculated by disregarding pensionable service (as defined in the Basic Plan) earned during and after the year such Participant first became ineligible to participate in PIP.

(c) If the Company provides an alternate source of payment for all or any portion of a Participant’s accrued or projected Supplemental Benefit at any time before or on (or as of) the date the Participant becomes entitled thereto under Section 3.01, and payment to such alternate source results in the immediate taxation thereof, such accrued or projected

7

Supplemental Benefit shall be reduced by the estimated tax liability attributable thereto (the tax rate to be used for this calculation shall be an assumed retiree tax rate for the Participant, as determined by the Company in its sole discretion) (the “after-tax benefit”), and such estimated after-tax benefit shall be increased by the tax paid with respect thereto; provided that in no event shall such prior payment or payments be deemed to be a discharge of the Company’s obligation for all or any part of the Supplemental Benefit due under this Article 3 prior to the time the Participant becomes entitled to the payment thereof under Section 3.01. The amount of Supplemental Benefit due under this subsection (c) shall be paid as provided in Section 4.01(b).

(d) A Participant who (i) is a corporate Vice President on, or as of, July 15, 1997, (ii) is or becomes entitled to payment of a Supplemental Benefit under Section 3.01, and (iii) whose benefit is provided (in part or entirely) through an alternate source of payment as described in subsection (c) above, shall, at the time such Supplemental Benefit first becomes payable under the Plan, be entitled to an additional cash amount calculated as follows: the ratio of the “Projected Installment Sum” over the “Projected Employee Grantor Trust Sum”, expressed as a percentage, minus one (1), with the resulting percentage multiplied by the Supplemental Benefit (after adjustment to an after-tax value at the time the benefit first becomes payable). Such additional cash amount shall, at the time of payment, be increased by an amount sufficient to pay income taxes thereon (inclusive of taxes on the increase). For purposes of this subsection (d), the following terms have the following meanings:

(1) “Projected Installment Sum” means the sum of the after-tax present value of each projected installment payment of the Supplemental Benefit, assuming that the Supplemental Benefit is paid in 10 annual installments, the first being paid on the first anniversary of the Participant’s termination of employment. The amount of each projected annual installment shall be determined by multiplying the Account balance (including principal and accumulated notional earnings) as of the date the installment payment is due by a fraction, the numerator of which is one (1) and the denominator of which is the number of annual payments (including the payment then due) remaining to be paid; and by then reducing such amount by the projected tax effect related to such payment (State and local tax rates shall be taken into account only to the extent the State or locality of the Participant’s residence, at the time the Participant first becomes entitled to payment under Section 3.01, imposes taxes on such payments). Notional earnings shall apply monthly to the unpaid Account balance as follows: the monthly rate of return shall be the greater of (i) the monthly equivalent of the annual yield on 10 year Treasury constant maturities as quoted in the Federal Reserve Statistical Release, as of the date of Supplemental Benefit entitlement (as set forth in Section 3.01) or (ii) the average of such monthly rates for the 36 month period ending with the month immediately preceding the month of such Supplemental Benefit entitlement.

8

(2) “Projected Employee Grantor Trust Sum” means the sum of the present value of each projected installment payment of the Supplemental Benefit (after adjustment of the said Supplemental Benefit to an after-tax value at the time the benefit first becomes payable), assuming that the said adjusted Supplemental Benefit is paid in 10 annual installments in the manner described in paragraph (1) above (except that notional earnings on the unpaid balance shall be applied after adjustment for taxes).

Such amount shall be paid as provided in Section 4.01(b) as soon as after the Participant becomes entitled a Supplemental Benefit under Section 3.01 above.

(e) A Participant who is eligible to participate in the Plan by virtue of his or her eligibility to participate in the PIP prior to January 1, 1991, or whose employment classification is at the AVP (or equivalent) level or above, shall, unless otherwise specifically excluded from eligibility for the benefit described in this subsection (e) through a separate written agreement between the Company and the Participant, be entitled to elect to receive an incremental Supplemental Benefit equal to the incremental benefit provided under Section 4.04 of the Basic Plan and adjusted using the same methodology described in subsection (c) (except that the Participant’s current tax rate shall be used to calculate the amount of after-tax benefit attributable to such incremental benefit), subject in all events to the same terms, conditions and exclusions of said Basic Plan Section 4.04 that apply to participants therein (including without limitation age and service requirements and the exclusions listed in items (1) through (5) of subsection (a) thereof). The incremental Supplemental Benefit payable under this subsection (e) shall be paid as provided in Section 4.01(b).

(f) This subsection (f) shall apply only to Participants who are entitled to a Supplemental Benefit by virtue of participation in SERIB (as such acronym is defined in Section 2.01(b)) and whose Release Date thereunder is August 1, 2001 or later. The cash value of a Supplemental Benefit to which any such Participant is entitled shall be calculated as of February 1, 2001, and at the Participant’s employment termination date on or after August 1, 2001. The Participant shall be entitled to the greater of the two calculations. Such amount shall be paid as follows:

(1) Payments to Participants whose benefit is paid to an alternate source of payment (as described in Section 3.02(c)) shall be made directly to such alternate source of payment. An initial deposit of the benefit due shall be made concurrent with other payments to such alternate source in January, 2001, based on the Participant’s projected Release Date on or after August 1, 2001. If required, any additional amounts due will be paid upon actual termination of employment.

(2) Payments to all other Participants may be made as soon as practicable after July 1, 2001, based on the value of the Supplemental Benefit as of February 1, 2001, irrespective of whether the Participant has actually terminated employment (subject to any election by a Participant to defer payment). If required, any additional amounts due will be paid upon actual termination of employment.

3.03 Dependents’ Benefits.

(a) If dependents’ benefits are payable under Article 8 of the Basic Plan to the surviving spouse or child of a retired Participant who had not yet received payment of benefits

9

under Section 4.01, or of a Participant who died during employment (but not a Participant who terminated employment prior to retirement with vested rights, whether or not payment of such Participant’s pension had begun), such spouse or child shall be entitled to a Supplemental Benefit equal to the additional benefit to which he would be entitled under the Basic Plan and the ERISA Excess Plan in the aggregate if the Participant’s Supplemental Salary were included in his pensionable salary as defined in the Basic Plan (subject to the restrictions on pensionable service set forth in Section 3.02(b) hereof, if applicable to the Participant).

(b) A Supplemental Benefit payable under subsection (a) above shall be paid in a single cash payment, determined on an Actuarial Basis, commencing on the first day of the month following the Participant’s death.

ARTICLE 4.

METHOD OF PAYMENT

4.01 Payments On or After July 1, 1990.

(a) Subject to Section 4.01(b), the aggregate benefits to which a Participant is entitled under this Plan shall be paid in a single cash payment, determined on an Actuarial Basis, and such payment shall be made on the first day of the month following the Participant’s Separation from Service.

(b) Notwithstanding anything in this Plan to the contrary, in the event that the Participant is deemed to be a “specified employee,” determined pursuant to procedures adopted by the Company in compliance with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), on the date of the Participant’s Separation from Service, then to the extent necessary to comply with Code Section 409A, the amount that would otherwise be payable pursuant to this Plan during the six-month period immediately following the date of the Participant’s Separation from Service (the “Delay Period”) will instead be paid or made available on the earlier of (i) the last business day of the seventh month after the date of the Participant’s Separation from Service, or (ii) the Participant’s death (the “Initial Payment Date”). Any payment that, but for the requirements of this Section 4.01(b), would be paid during the Delay Period shall be paid on the Initial Payment Date, together with interest thereon calculated at the applicable rate specified in the Basic Plan for calculating lump sum benefits.

4.02 Plan Unfunded. All benefit payments under the Plan shall be made directly by the Employer out of its general assets.

4.03 Delay in Payment. If payment of benefits under the Basic Plan in respect of a Participant or his spouse or child begins prior to determination of the PIP award for the previous calendar year, payment of his Supplemental Benefit (if any) shall be delayed until the amount of such prior year’s PIP award is determined. Upon such a determination, the Supplemental Benefit shall be paid in an amount retroactive to the date that payment of benefits under the Basic Plan began. Interest shall not accrue, nor be or become payable, with respect to such retroactive payments.

10

4.04 Withholding. All payments under the Plan shall be subject to any applicable withholding requirements imposed by any tax or other law.

ARTICLE 5.

AMENDMENT AND TERMINATION

5.01 Right to Amend or Terminate Reserved. The Company may at any time amend the Plan in any respect or terminate the Plan. However, no such amendment or termination shall deprive any Participant of any accrued benefit to which such Participant has a nonforfeitable right (determined in accordance with the rules of the Plan in effect immediately prior to the date of such amendment or termination), other than for the purpose of providing an offset for additional governmental benefits or for additional benefits provided by an Employer.

5.02 Action to Bind Employers. By adoption of the Plan, each corporation included with the Employer designates the Company as its agent to administer the Plan in accordance with Article 6 hereof. The Company shall have the further right to amend or terminate the Plan and furnish written notice of such action and a copy of any such amendment to any such corporation, whereupon such amendment or termination shall become binding upon such corporation.

5.03 Change in Basic Plan. If the Basic Plan and ERISA Excess Plan shall be amended to change in any way the benefits applicable to any Participant, spouse, or child, or shall be replaced in whole or in part by any successor plan, the provisions of the Plan shall apply based on the provisions of the Basic Plan and/or ERISA Excess Plan as so amended, or such successor plan, which are applicable to such Participant, spouse or child unless otherwise provided by the Company.

ARTICLE 6.

ADMINISTRATION

6.01 Administration. The Company, through its duly designated agents, shall make all determinations required of it by the terms of the Plan, and its constructions and interpretations of the Plan, as well as its determinations as to rights and obligations under the Plan, shall be final and binding upon all persons.

ARTICLE 7.

MISCELLANEOUS

7.01 Payment to Incompetent. If any person entitled to benefits under this Plan shall be a child or shall be either physically or mentally incompetent in the judgment of the Company, such benefits may be paid to the person to whom the corresponding benefits under the Basic Plan are paid under Section 8.06(d) or 14.06 thereof, whichever is applicable.

11

7.02 Spendthrift Clause. No benefit, distribution or payment under the Plan may be anticipated, assigned (either at law or in equity), alienated or subject to attachment, garnishment, levy, execution or other legal or equitable process.

7.03 Usage. Whenever applicable, the masculine gender, when used in the Plan, will include the feminine gender, and the singular will include the plural.

7.04 Data. Any Participant entitled to benefits under the Plan must furnish to the Company such documents, evidence or information as the Company considers necessary or desirable for the purpose of administering the Plan, or to protect the Company; and it is a condition of the Plan that each such Participant must furnish promptly true and complete data, evidence or information and sign such documents as the Company may require before any benefits become payable under the Plan.

7.05 Separability. If any provision of the Plan is held invalid or unenforceable, its invalidity or unenforceability will not affect any other provisions of the Plan, and the Plan will be construed and enforced as if such provision had not been included therein.

7.06 Captions. The captions contained herein and the table of contents prefixed hereto are inserted only as a matter of convenience and for reference and in no way define, limit, enlarge or describe the scope or intent of the Plan nor shall, in any way, affect the Plan or the construction of any provision thereof.

7.07 Right of Discharge Reserved. The establishment of the Plan shall not be construed to confer upon an employee or Participant any legal right to be retained in the employ of the Employer or give any employee or any other person any right to benefits, except to the extent expressly provided for hereunder. All employees will remain subject to discharge to the same extent as if the Plan had never been adopted, and may be treated without regard to the effect such treatment might have upon them under the Plan.

7.08 Other Benefits Unaffected. Nothing in this Plan shall be construed to require that a Participant’s Supplemental Salary or PIP awards be taken into account in determining his benefits under the Employer’s life insurance plan, profit-sharing plans, death-in-service payments (including payments under Section 9 of the Basic Plan), or any other benefit program.

ARTICLE 8.

EFFECTIVE DATE, ETC.

8.01 Effective Date. This Restatement shall be effective as of January 1, 2012, except as otherwise specifically provided herein. The original effective date of the Plan was January 1, 1981. No benefits shall be payable under the Plan in respect of employees who retired, terminated employment or died prior to such date, or to their spouses or children.

12

IN WITNESS WHEREOF, the Company has caused this restatement to be executed as of the day and year first above written.

REYNOLDS AMERICAN INC.
By:
Title:	Senior vice President, Deputy General
	Counsel and Secretary

13

EX-10.54

Exhibit 10.54

AMENDMENT NO. 6

TO THE

BROWN & WILLIAMSON TOBACCO CORPORATION

HEALTH CARE PLAN

FOR SALARIED EMPLOYEES

(A BENEFIT UNDER THE BROWN & WILLIAMSON TOBACCO CORPORATION

WELFARE & FRINGE BENEFIT PLAN AND THE REYNOLDS AMERICAN

OMNIBUS WELFARE BENEFITS PLAN)

THIS AMENDMENT NO. 6 to the Brown & Williamson Tobacco Corporation Health Care Plan for Salaried Employees (the “Plan”), as amended through March 8, 2004, is made and entered into this 19^th day of December, 2011. Unless otherwise indicated below, the provisions of this Amendment shall be effective as of January 1, 2011.

W I T N E S S E T H:

WHEREAS, Section 14.01 of the Plan provides that, except as provided in Subsection 2.08(e) of the Plan, Reynolds American Inc. (“RAI”) may amend the Plan from time to time;

WHEREAS, Subsection 2.08(e) of the Plan provides that if an amendment would impact a participant who has a fully vested and non-forfeitable right to coverage, RAI may only amend the Plan if the amendment is either mandated by law or provides the same or greater overall coverage;

WHEREAS, the RAI Employee Benefits Committee (the “Committee”) by actions taken on December 29, 2006, July 28, 2010 and December 19, 2011 authorized amendments to the Plan to (i) clarify that there are no longer any active employees participating in the Plan, (ii) expand the definition of dependent child, (iii) clarify the definition of spouse, (iv) expand the coverage of mental health and substance abuse benefits, (v) expand the coverage of preventive care benefits, (vi) expand the coverage of emergency room services, and (vii) make certain other clarifications, all of which amendments are either mandated by law or result in the Plan providing the same or greater overall coverage; and

WHEREAS, such actions of the Committee further authorized the members of the Committee to perform any and all acts and execute any and all documents that they may deem necessary to effectuate the Committee’s resolutions.

NOW, THEREFORE, the Plan is hereby amended as follows:

1.

The Preamble to the Plan is amended to clarify the historical amendments to the Plan by adding the following new paragraph at the end thereof;

“The Plan was originally a benefit solely under the Brown & Williamson Tobacco Corporation Welfare & Fringe Benefit Plan (the “B&W Wrap Plan”). The Plan, as restated effective January 1, 2002, was subsequently amended to reflect that the Brown & Williamson Tobacco Corporation (“B&W”) was acquired by R.J.

Reynolds Tobacco Holdings, Inc. and that Reynolds American Inc. would thereafter be the Plan’s Sponsor. The Plan was further amended on December 29, 2006 to transfer certain participants, whose benefits were not funded through a trust, from the B&W Wrap Plan to the Reynolds American Omnibus Welfare Benefits Plan (the “Omnibus Plan”) effective January 1, 2007. Benefits funded through a trust continue to be provided under the B&W Wrap Plan. As such, the benefits provided under the Plan are benefits provided under either the B&W Wrap Plan and the Omnibus Plan, depending on the source of funding for such benefits.”

2.

The Table of Contents of the Plan is hereby amended to (a) add a line for “1.66A Sponsoring Company” after the line for “1.66 Skilled Nursing Facility” and the corresponding page number reference, and (b) add a line for “5.02 Transfer of Programs to Omnibus Plan” in chronological order and the corresponding page number reference.

3.

Because there are no longer any active employees participating in the Plan, all references to active employees, the flexible benefits plan, vision care coverage, dental care coverage, the employee assistance program, and continuation of coverage while on family medical leave should be disregarded, including, without limitation, references to such items in Sections 2.01, 2.02, 2.03, 2.04, 2.07, 7.0 l(c), and 12.05; Articles 8, 9, and 10; and Schedules A and B.

4.

Section 1.05 of the Plan is clarified to correct the first cross-reference therein from “Section 13.06(a)(5)” to “Section 13.04.”

5.

Subsections 1.18(a)-(c) of the Plan is amended effective January 1, 2011 to replace the existing text with the following:

“(a) Prior to January 1, 2011, the word “Dependent” means an Employee-Participant’s, or a Retired Participant’s (subject to Section 2.08), Spouse, any unmarried child under age 21, any unmarried child under age 25 who attends school as a full-time student, and any eligible unmarried handicapped child. Notwithstanding any other provision of this Section 1.18, an individual shall be classified as a Dependent if and only if that individual is a dependent of the Employee-Participant within the meaning of section 152 of the Code, except that this sentence shall not apply to any child for whom the Employee-Participant or the Spouse-Participant has a legal obligation, under a divorce decree or other court order, to provide health care expenses. The term “child” includes a natural child, a stepchild and a legally adopted child. Subject to the above age restrictions, the term “child” also includes a child for whom legal guardianship (which includes the obligation to provide health care expenses) has been awarded to the Employee-Participant, and any child for whom the Employee-Participant or the Spouse-Participant has a legal obligation, under a divorce decree or other

2

court order, to provide health care expenses. A child will be considered handicapped if, but only if, the Claims Administrator determines that he or she satisfies each of the following requirements: (1) the child is not able to earn his or her own living because of a mental or physical disability that is expected to continue indefinitely; (2) such disability commenced while the child was a Dependent-Participant and prior to the child’s attaining age 21, or age 25 if he or she attends school as a full-time student; and (3) the child depends on the Employee-Participant for more than 50 percent of his or her support. A child shall not be eligible for Dependent coverage if the child is married. The Plan may require proof of a child’s marital status and handicapped status from time to time.

On or after January 1, 2011, the word “Dependent” means a Retired Participant’s (subject to Section 2.08) Spouse, unmarried children under age 26, and eligible unmarried handicapped children. The term “child” includes a natural child, a stepchild and a legally adopted child. The term “child” also includes a child for whom legal guardianship (which includes the obligation to provide health care expenses) has been awarded to the Retired Participant, and any child for whom the Retired Participant or the Spouse-Participant has a legal obligation, under a divorce decree or other court order, to provide health care expenses. A child will be considered handicapped if, but only if, the Claims Administrator determines that he or she satisfies each of the following requirements: (1) the child is not able to earn his or her own living because of a mental or physical disability that is expected to continue indefinitely; (2) such disability commenced while the child was a Dependent-Participant and prior to the child’s attaining age 26 (or such earlier age when the child would have otherwise lost coverage under the terms of the Plan in effect at such time); and (3) the child depends on the Retired Participant for more than 50 percent of his or her support. A handicapped child shall not be eligible for Dependent coverage if the child is married. The Plan may require proof of a child’s marital status and handicapped status from time to time.

(b) Prior to January 1, 2011, “Dependent” excludes anyone covered as an Employee or Retired Participant. On and after January 1, 2011, “Dependent” excludes any Spouse covered as an Employee or Retired Participant. Prior to November 1, 2001, the term “Dependent” excluded anyone in active military service, subject to Section 12.07. No Employee-Participant shall be eligible for benefits as a Dependent-Participant, and no Dependent-Participant shall be eligible for benefits as an Employee-Participant. No person may be a Dependent of more than one Employee (except in case of divorce).

(c) The term “adopted child” as used in subsection (a) above shall include dependent children placed with an Employee-Participant (prior to January 1, 2011) or a Retired Participant (on or after January 1, 2011) for adoption, irrespective of whether the adoption has become final. For this purpose the words “placed” or “placement” mean the assignment and retention by the Employee-Participant or Retired Participant, as applicable, of a legal obligation for total or partial support of such child in anticipation of adoption of such child.”

3

6.

Section 2.02 of the Plan is amended to add the following at the end thereof:

“Notwithstanding the foregoing, a one-time special enrollment period is provided to Dependent children who previously aged out of eligibility for coverage and are again eligible effective January 1, 2011 as a result of the change in the definition of the term Dependent. This special enrollment period allows such Dependent children to re-enroll for coverage effective January 1, 2011. On and after January 1, 2011, a child who is a Dependent with respect to a Retired Employee may be enrolled for coverage under the Plan, but only if the child is enrolled within 31 days of the date on which the child first meets the definition of Dependent.”

7.

Subsections 1.18(d) and 2.08(h)(2) are each amended to add the following sentence at the beginning of each such Section:

“Effective January 1, 2011, the following text is inapplicable because the full-time student requirement is eliminated from the definition of Dependent.”

8.

Subsection 1.67(a) of the Plan is clarified by adding the following sentence at the end thereof: “The terms ‘Spouse’ and ‘Surviving Spouse’ shall not include a same-sex spouse.”

9.

Subsection 2.08(h)(i) of the Plan is clarified by adding “(or a successor Medicare program)” after “Medicare Plus Choice” each time it appears in such Subsection.

10.

Section 3.02 of the Plan is amended to add the following sentences at the end of the first paragraph:

“Effective January 1, 2011, preventive care benefits will be paid with no cost sharing on the terms set forth in the provisions of Section 2713 of the Public Health Services Act that are incorporated under Section 715(a)(l) of ERISA and the guidance issued thereunder. In addition, effective January 1, 2011, mental health and substance abuse benefits are paid with the same or better treatment limitations and financial requirements as similar medical and surgical benefits.”

11.

Section 3.02 of the Plan is amended by adding the following new row to the table immediately prior to the row entitled “Ambulance”:

Allergy Serum If the allergy serum is supplied by a pharmacy 20% of Covered Charges after Deductible 20% of Covered Charges after Deductible 10% of Covered Charges after Deductible

4

12.

Section 3.02 of the Plan is amended by deleting the text in column (c) of the table in the row entitled “Hospital Emergency Room” and replacing it with the following:

“$50 Copayment (Waived if admitted) for emergency services”

13.

Section 3.02 of the Plan is clarified to correct the typographical error by deleting the text in column (a) of the table in the row entitled “Infertility Treatment” and replacing it with the following:

“Infertility Treatment

Office Visits, including tests and office surgical procedures for diagnosis of infertility

Surgical procedures for diagnosis of infertility performed outside of Physician’s office”

14.

Section 3.02 of the Plan in column (a) of the table in the row entitled “Mental Health and Substance Abuse Conditions” is amended to add the following sentence at the end therof:

“Effective January 1, 2011, no day or visit limits apply to benefits for Mental Health or Substance Abuse Conditions.”

15.

Subsections 3.11 (a) and (b) of the Plan are each amended to add the following sentence at the end of each such Subsection:

“Effective January 1, 2011, no day or visit limits apply to benefits for Mental Health Conditions.”

16.

Subsection 3.12(a) of the Plan is amended to delete the first sentence thereof and replace it with the following:

“The plan covers obstetrical care for Employee-Participants, Retired Participants, and Dependent-Participants (including a Spouse, Surviving Spouse, or a Dependent child).”

5

17.

Subsections 3.18(a) and (b) of the Plan are each amended to add the following sentence at the end of each such Subsection:

“Effective January 1, 2011, no day or visit limits apply to benefits for Substance Abuse Conditions.”

18.

Subsection 5.01(a)(ll) of the Plan is amended to delete the first sentence thereof and replace it with the following:

“Services or supplies for cosmetic purposes, except for correction of defects incurred through Injury.”

19.

Article V of the Plan is amended to add a new Section 5.02 to read as follows:

“5.02 Transfer of Programs to Omnibus Plan. Effective as of January 1, 2007, certain benefit programs paid either from the general assets of the Company or a Related Company or through insurance contracts were transferred to the Reynolds American Omnibus Welfare Benefits Plan and as of such date were no longer benefits provided under this Plan. The transferred benefit programs are:

(a) all programs covering active Employees;

(b) all COBRA continuation coverage;

(c) all programs covering retirees of the former American Tobacco Company;

(d) all medical coverage for former employees on long term disability; and

(e) medical coverage for Retired Participants with “Rule of 70” coverage eligibility.”

20.

Subsection 10.02(a) of the Plan is amended by adding the following at the end thereof:

“(6) A proceeding in bankruptcy under Title 11 of the United States Code filed with respect to the Plan Sponsor.”

21.

Subsection 10.05(a)(2) of the Plan is amended by adding the following at the end thereof:

“Notwithstanding the foregoing, in the case of a Qualifying Event that is the bankruptcy of the Plan Sponsor, the period of Continuation Coverage for the Retired Participant lasts until her or her death, and for any Spouse or Dependent child who is a Qualified Beneficiary until the date that is 36 months after the date of the Retired Participant’s death.”

6

22.

Subsections 10.09(a) and (c) of the Plan are each amended by adding “bankruptcy,” after “reduction of hours,” in the first sentence of each such Subsection.

23.

Section 12.03 of the Plan is clarified to correct the cross-reference therein from “Section 13.06(a)(4)” to “established under Section 13.02.”

24.

Subsection 12.08(b)(l) of the Plan is amended by adding the following after Subsection 12.08(b)(l)(A) and relettering the remaining Subsections in alphabetical order:

“(B) The designated Security Official;”

25.

Section 14.01 of the Plan is amended by adding the following at the end thereof:

“Notwithstanding anything herein to the contrary, to the extent the Sponsoring Company has amended the Plan to provide benefits in excess of those in effect on December 31, 2010, the Sponsoring Company reserves the right at any time and from time to time to amend the Plan to eliminate such benefits in whole or in part.”

26.

Except as amended by this Amendment No. 6, the Plan shall remain in full force and effect.

IN WITNESS WHEREOF, the undersigned member of the Committee has executed this Amendment No. 6 as of the day and year first above written.

RAI Employee Benefits Committee
By:
	McDare P. Folan, III Secretary

7

EX-12.1

EXHIBIT 12.1

REYNOLDS AMERICAN INC.

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in Millions)

(Unaudited)

	For The Years Ended December 31,
	2011		2010(1)		2009(1)		2008(1)			2007(1)
Earnings before fixed charges:
Income from continuing operations before income taxes	$	2,186	$	2,205	$	1,522	$	2,128		$	2,073
Deduct: Income on equity investment		—		—		—		(1	)		(13	)
		2,186		2,205		1,522		2,127			2,060
Interest and debt expense		221		232		251		275			338
Interest portion of rental expense		6		7		7		7			7
Earnings before fixed charges	$	2,413	$	2,444	$	1,780	$	2,409		$	2,405
Fixed charges:
Interest and debt expense	$	221	$	232	$	251	$	275		$	338
Interest portion of rental expense		6		7		7		7			7
Total fixed charges	$	227	$	239	$	258	$	282		$	345
Ratio of earnings to fixed charges		10.6		10.2		6.9		8.5			7.0

⁽¹⁾ Financial data for 2007 through 2010 has been adjusted to reflect RAI’s elective change in accounting for pension and postretirement benefits. See Item 8, note 1 to consolidated financial statements.

EX-18.1

Exhibit 18.1

February 15, 2012

Reynolds American Inc.

401 North Main Street

Winston-Salem, North Carolina 27101

Ladies and Gentlemen:

We have audited the consolidated balance sheets of Reynolds American Inc. (the “Company”) as of December 31, 2011 and 2010, and the related consolidated statements of income, shareholders’ equity and comprehensive income and cash flows for each of the years in the three-year period ended December 31, 2011, and have reported thereon under date of February 15, 2012. The aforementioned consolidated financial statements and our audit report thereon are included in the Company’s annual report on Form 10-K for the year ended December 31, 2011. As stated in Note 1 to those financial statements, the Company changed its method of accounting for pension and postretirement benefits to immediately recognize actuarial gains and losses in its operating results in the year in which they occur, to the extent they exceed 10 percent of the greater of the fair value of plan assets or the plans’ projected benefit obligation, referred to as the corridor, and to use the fair value of plan assets for purposes of calculating the expected return on plan assets and the corridor. Note 1 also states that the newly adopted accounting principles are intended to improve the transparency of the Company’s operating results by more quickly recognizing the effects of current economic and interest rate trends on plan investments and assumptions. In accordance with your request, we have reviewed and discussed with Company officials the circumstances and business judgment and planning upon which the decision to make this change in the method of accounting was based.

With regard to the aforementioned accounting change, authoritative criteria have not been established for evaluating the preferability of one acceptable method of accounting over another acceptable method. However, for purposes of the Company’s compliance with the requirements of the Securities and Exchange Commission, we are furnishing this letter.

Based on our review and discussion, with reliance on management’s business judgment and planning, we concur that the newly adopted method of accounting is preferable in the Company’s circumstances.

Very truly yours,

/s/ KPMG LLP

Greensboro, North Carolina

February 15, 2012

EX-21.1

Exhibit 21.1

REYNOLDS AMERICAN INC. SUBSIDIARIES

(As of 2/3/2012)

Name of Entity	Place of Incorporation
American Snuff Company, LLC	Delaware
Conwood Holdings, Inc.	Delaware
Niconovum AB	Sweden
Niconovum USA, Inc.	North Carolina
Northern Brands International, Inc.	Delaware
Quezon Holdings, B.V.	Netherlands
R. J. Reynolds Global Products, Inc.	Delaware
R.J. Reynolds Tobacco B.V.	Netherlands
R.J. Reynolds Tobacco (CI), Co.	Cayman Islands
R.J. Reynolds Tobacco Co.	Delaware
R. J. Reynolds Tobacco Company	North Carolina
R.J. Reynolds Tobacco C.V.	Netherlands
R.J. Reynolds Tobacco Holdings, Inc.	Delaware
R. J. Reynolds Tobacco International, Inc.	Delaware
Reynolds Asia – Pacific Limited	Hong Kong
Reynolds Finance Company	Delaware
Reynolds Innovations Inc.	North Carolina
Reynolds International Holdings B.V.	Netherlands
Reynolds Technologies, Inc.	Delaware
RAI International, Inc.	Delaware
RAI Services Company	North Carolina
RJR Realty Relocation Services, Inc.	North Carolina
Rosswil LLC	Delaware
Santa Fe Natural Tobacco Company: Germany GmbH	Germany
Santa Fe Natural Tobacco Company, Inc.	New Mexico
Santa Fe Natural Tobacco Company Italy S.r.L.	Italy
Santa Fe Natural Tobacco Company Japan K.K.	Japan
SFNTC/RSM, LLC	New Mexico
S.F. Imports, Inc.	Delaware
SFR Tobacco International GmbH	Switzerland

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Reynolds American Inc.:

We consent to the incorporation by reference in the registration statements (Nos. 333-117813, 333-117814, 333-117815, and 333-159009) on Form S-8 and (No. 333-167129) on Form S-3 of Reynolds American Inc. of our reports dated February 15, 2012, with respect to the consolidated balance sheets of Reynolds American Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, shareholders’ equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011, and the effectiveness of internal control over financial reporting as of December 31, 2011, which reports appear in the December 31, 2011 annual report on Form 10-K of Reynolds American Inc.

Our report dated February 15, 2012, on the consolidated balance sheets of Reynolds American Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, shareholders’ equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011, contains an explanatory paragraph that states that the Company has elected to change its method of accounting for pension and postretirement benefits in 2011.

/s/ KPMG LLP

Greensboro, North Carolina

February 15, 2012

EX-31.1

EXHIBIT 31.1

I, Daniel M. Delen, certify that:

1. I have reviewed this annual report on Form 10-K of Reynolds American Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 15, 2012

/s/ Daniel M. Delen

Daniel M. Delen

President and

Chief Executive Officer

EX-31.2

EXHIBIT 31.2

I, Thomas R. Adams, certify that:

1. I have reviewed this annual report on Form 10-K of Reynolds American Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 15, 2012

/s/ Thomas R. Adams

Thomas R. Adams

Executive Vice President and

Chief Financial Officer

EX-32.1

EXHIBIT 32.1

REYNOLDS AMERICAN INC.

Certification Pursuant to 18 U.S.C. §1350

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Daniel M. Delen, Chief Executive Officer, and Thomas R. Adams, Chief Financial Officer, of Reynolds American Inc. (“RAI”), hereby certifies, to his knowledge, that:

1) RAI’s Annual Report on Form 10-K for the year ended December 31, 2011, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in RAI’s Annual Report on Form 10-K for the year ended December 31, 2011, fairly presents, in all material respects, the financial condition and results of operations of RAI.

EXECUTED this 15^th day of February, 2012.

/s/ Daniel M. Delen

Daniel M. Delen, President and

Chief Executive Officer of Reynolds American Inc.

/s/ Thomas R. Adams

Thomas R. Adams, Executive Vice President and

Chief Financial Officer of Reynolds American Inc.

XML

Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2011

Other Current Liabilities [Abstract]

Other Current Liabilities

	2011		2010
Payroll and employee benefits	$	134	$	188
Pension and other postretirement benefits		83		96
Marketing and advertising		100		133
Declared dividends		323		285
Excise, franchise and property tax		158		160
Restructuring		5		36
Tobacco quota buyout		86		57
Individual Engle Progeny cases accrual		64		—
Other		179		192
	$	1,132	$	1,147

XML

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Details 2) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Assets
Cash and cash equivalents	$ 1,956	$ 2,195	$ 2,723	$ 2,578
Accounts receivable	101	118
Accounts receivable, related party	67	48
Other receivables	46	44
Inventories	967	1,055
Deferred income taxes, net	945	946
Prepaid expenses and other	225	195
Assets held for sale	0	201
Total current assets	4,307	4,802
Property, plant and equipment, net	1,070	1,002
Trademarks and other intangible assets, net	2,602	2,675
Goodwill	8,010	8,010
Other assets and deferred charges	265	589
Total assets	16,254	17,078
Liabilities and shareholders' equity
Accounts payable	113	179
Tobacco settlement accruals	2,530	2,589
Due to related party	2	4
Deferred revenue, related party	42	53
Current maturities of long-term debt	457	400
Other current liabilities	1,132	1,147
Total current liabilities	4,276	4,372
Long-term debt (less current maturities)	3,206	3,701
Deferred income taxes, net	511	518
Long-term retirement benefits (less current portion)	1,759	1,668
Other noncurrent liabilities	251	309
Total shareholders' equity	6,251	6,510	6,498	6,237
Total liabilities and shareholders' equity	16,254	17,078
RAI [Member]
Assets
Cash and cash equivalents	328	327	361	272
Other receivables	95	80
Deferred income taxes, net		10
Prepaid expenses and other	19	38
Total current assets	442	455
Property, plant and equipment, net	5	6
Long-term intercompany notes	1,960	2,000
Investment in subsidiaries	9,139	9,696
Other assets and deferred charges	68	267
Total assets	11,614	12,424
Liabilities and shareholders' equity
Current maturities of long-term debt	399	400
Other current liabilities	421	489
Total current liabilities	820	889
Intercompany notes and interest payable	1,325	1,366
Long-term debt (less current maturities)	3,145	3,580
Long-term retirement benefits (less current portion)	48	34
Other noncurrent liabilities	25	45
Total shareholders' equity	6,251	6,510
Total liabilities and shareholders' equity	11,614	12,424
Guarantors [Member]
Assets
Cash and cash equivalents	1,361	1,616	2,136	2,091
Accounts receivable	77	103
Accounts receivable, related party	67	48
Other receivables	50	161
Inventories	929	1,022
Deferred income taxes, net	952	934
Prepaid expenses and other	200	155
Assets held for sale		201
Total current assets	3,636	4,240
Property, plant and equipment, net	1,061	991
Trademarks and other intangible assets, net	2,553	2,625
Goodwill	7,999	7,991
Long-term intercompany notes	1,325	1,366
Investment in subsidiaries	463	462
Other assets and deferred charges	171	242
Total assets	17,208	17,917
Liabilities and shareholders' equity
Accounts payable	107	175
Tobacco settlement accruals	2,530	2,589
Due to related party	2	4
Deferred revenue, related party	42	53
Current maturities of long-term debt	58
Other current liabilities	827	855
Total current liabilities	3,566	3,676
Intercompany notes and interest payable	1,960	2,000
Long-term debt (less current maturities)	61	121
Deferred income taxes, net	553	535
Long-term retirement benefits (less current portion)	1,699	1,622
Other noncurrent liabilities	224	262
Total shareholders' equity	9,145	9,701
Total liabilities and shareholders' equity	17,208	17,917
Non-Guarantors [Member]
Assets
Cash and cash equivalents	267	252	226	215
Accounts receivable	24	15
Other receivables	39	35
Inventories	38	34
Deferred income taxes, net	1	2
Prepaid expenses and other	7	4
Total current assets	376	342
Property, plant and equipment, net	3	4
Trademarks and other intangible assets, net	49	50
Goodwill	11	19
Other assets and deferred charges	71	100
Total assets	510	515
Liabilities and shareholders' equity
Accounts payable	6	4
Other current liabilities	31	37
Total current liabilities	37	41
Deferred income taxes, net	3	3
Long-term retirement benefits (less current portion)	12	12
Other noncurrent liabilities	2	2
Total shareholders' equity	456	457
Total liabilities and shareholders' equity	510	515
Eliminations [Member]
Assets
Other receivables	(138)	(232)
Inventories		(1)
Deferred income taxes, net	(8)
Prepaid expenses and other	(1)	(2)
Total current assets	(147)	(235)
Property, plant and equipment, net	1	1
Long-term intercompany notes	(3,285)	(3,366)
Investment in subsidiaries	(9,602)	(10,158)
Other assets and deferred charges	(45)	(20)
Total assets	(13,078)	(13,778)
Liabilities and shareholders' equity
Other current liabilities	(147)	(234)
Total current liabilities	(147)	(234)
Intercompany notes and interest payable	(3,285)	(3,366)
Deferred income taxes, net	(45)	(20)
Total shareholders' equity	(9,601)	(10,158)
Total liabilities and shareholders' equity	$ (13,078)	$ (13,778)

XML

Fair Value (Details) (Recurring [Member], USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Cash and cash equivalents:
Cash equivalents	$ 1,473	$ 2,136
Other assets and deferred charges:
Auction rate securities	63	61
Mortgage-backed security	12	14
Marketable equity security	5	24
Assets held in grantor trusts	1	12
Other Assets [Member]
Other assets and deferred charges:
Interest rate swaps - fixed to floating rate		227
Other Liabilities [Member]
Other noncurrent liabilities:
Interest rate swaps - floating to fixed rate		(22)
Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents:
Cash equivalents	1,473	2,136
Other assets and deferred charges:
Marketable equity security	5	24
Assets held in grantor trusts	1	12
Fair Value, Inputs, Level 2 [Member] | Other Assets [Member]
Other assets and deferred charges:
Interest rate swaps - fixed to floating rate		227
Fair Value, Inputs, Level 2 [Member] | Other Liabilities [Member]
Other noncurrent liabilities:
Interest rate swaps - floating to fixed rate		(22)
Fair Value, Inputs, Level 3 [Member]
Other assets and deferred charges:
Auction rate securities	63	61
Mortgage-backed security	$ 12	$ 14

XML

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Tables)

12 Months Ended

Dec. 31, 2011

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements [Abstract]

Condensed Consolidating Statements of Income

Condensed Consolidating Statements of Income

(Dollars in Millions)

	Parent Issuer			Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Net sales	$	—		$	7,971		$	116		$	(25	)	$	8,062
Net sales, related party		—			479			—			—			479
Net Sales		—			8,450			116			(25	)		8,541
Cost of products sold		—			4,460			29			(25	)		4,464
Selling, general and administrative expenses		129			1,386			91			—			1,606
Amortization expense		—			24			—			—			24
Trademark impairment charges		—			48			—			—			48
Operating income (loss)		(129	)		2,532			(4	)		—			2,399
Interest and debt expense		213			125			—			(117	)		221
Interest income		(118	)		(4	)		(6	)		117			(11	)
Other expense (income), net		8			(47	)		(1	)		43			3
Income (loss) before income taxes		(232	)		2,458			3			(43	)		2,186
Provision for (benefit from) income taxes		(89	)		875			(6	)		—			780
Equity income from subsidiaries		1,549			20			—			(1,569	)		—
Net income	$	1,406		$	1,603		$	9		$	(1,612	)	$	1,406
For the Year Ended December 31, 2010
Net sales	$	—		$	8,118		$	147		$	(95	)	$	8,170
Net sales, related party		—			381			—			—			381
Net Sales		—			8,499			147			(95	)		8,551
Cost of products sold		—			4,569			72			(97	)		4,544
Selling, general and administrative expenses		20			1,380			81			(1	)		1,480
Amortization expense		—			25			—			—			25
Asset impairment and exit charges		—			24			14			—			38
Trademark impairment charges		—			6			—			—			6
Goodwill impairment charge		—			26			—			—			26
Operating income (loss)		(20	)		2,469			(20	)		3			2,432
Interest and debt expense		223			127			1			(119	)		232
Interest income		(119	)		(4	)		(8	)		119			(12	)
Other expense (income), net		2			(39	)		1			43			7
Income (loss) before income taxes		(126	)		2,385			(14	)		(40	)		2,205
Provision for (benefit from) income taxes		(42	)		919			(10	)		1			868
Equity income (loss) from subsidiaries		1,205			(68	)		—			(1,137	)		—
Income (loss) from continuing operations		1,121			1,398			(4	)		(1,178	)		1,337
Losses from discontinued operations, net of tax		—			(142	)		(74	)		—			(216	)
Net income (loss)	$	1,121		$	1,256		$	(78	)	$	(1,178	)	$	1,121
For the Year Ended December 31, 2009
Net sales	$	—		$	7,985		$	162		$	(132	)	$	8,015
Net sales, related party		—			404			—			—			404
Net Sales		—			8,389			162			(132	)		8,419
Cost of products sold		—			4,544			76			(132	)		4,488
Selling, general and administrative expenses		20			1,425			72			—			1,517
Amortization expense		—			28			—			—			28
Restructuring charge		—			56			—			—			56
Trademark impairment charges		—			567			—			—			567
Operating income (loss)		(20	)		1,769			14			—			1,763
Interest and debt expense		242			123			1			(115	)		251
Interest income		(115	)		(9	)		(10	)		115			(19	)
Other expense (income), net		(4	)		(30	)		—			43			9
Income (loss) before income taxes		(143	)		1,685			23			(43	)		1,522
Provision for (benefit from) income taxes		(49	)		616			—			—			567
Equity income from subsidiaries		1,049			26			—			(1,075	)		—
Net income	$	955		$	1,095		$	23		$	(1,118	)	$	955

Condensed Consolidating Statements of Cash Flows

Condensed Consolidating Statements of Cash Flows

(Dollars in Millions)

	Parent Issuer			Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Cash flows from (used in) operating activities	$	641		$	1,571		$	(3	)	$	(789	)	$	1,420
Cash flows from (used in) investing activities:
Proceeds from settlement of long-term investments		—			2			—			—			2
Capital expenditures		—			(190	)		—			—			(190	)
Net proceeds from sale of business		79			123			—			—			202
Proceeds from termination of joint venture		—			—			32			—			32
Return of intercompany investments		1,040			—			—			(1,040	)		—
Other, net		40			58			—			(84	)		14
Net cash flows from (used in) investing activities		1,159			(7	)		32			(1,124	)		60
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,212	)		(740	)		(6	)		746			(1,212	)
Repurchase of common stock		(282	)		—			—			—			(282	)
Repayments of long-term debt		(400	)		—			—			—			(400	)
Proceeds from termination of interest rate swaps		185			1			—			—			186
Dividends paid on preferred stock		(43	)		—			—			43			—
Distribution of equity		—			(1,040	)		—			1,040			—
Other, net		(47	)		(40	)		(3	)		84			(6	)
Net cash flows used in financing activities		(1,799	)		(1,819	)		(9	)		1,913			(1,714	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(5	)		—			(5	)
Net change in cash and cash equivalents		1			(255	)		15			—			(239	)
Cash and cash equivalents at beginning of year		327			1,616			252			—			2,195
Cash and cash equivalents at end of year	$	328		$	1,361		$	267		$	—		$	1,956
For the Year Ended December 31, 2010
Cash flows from operating activities	$	442		$	1,153		$	13		$	(343	)	$	1,265
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		—			4			—			—			4
Proceeds from settlement of long-term investments		—			13			—			—			13
Capital expenditures		—			(171	)		(3	)		—			(174	)
Proceeds from termination of joint venture		—			—			28			—			28
Return of intercompany investments		897			—			—			(897	)		—
Contributions to intercompany investments		—			(75	)		—			75			—
Other, net		40			26			—			(63	)		3
Net cash flows from (used in) investing activities		937			(203	)		25			(885	)		(126	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,049	)		(300	)		—			300			(1,049	)
Repurchase of common stock		(5	)		—			—			—			(5	)
Repayments of long-term debt		(300	)		—			—			—			(300	)
Dividends paid on preferred stock		(43	)		—			—			43			—
Receipt of equity		—			—			75			(75	)		—
Distribution of equity		—			(897	)		—			897			—
Other, net		(16	)		(40	)		(2	)		63			5
Net cash flows from (used in) financing activities		(1,413	)		(1,237	)		73			1,228			(1,349	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(11	)		—			(11	)
Net cash flow related to discontinued operations, net of tax		—			(233	)		(74	)		—			(307	)
Net change in cash and cash equivalents		(34	)		(520	)		26			—			(528	)
Cash and cash equivalents at beginning of year		361			2,136			226			—			2,723
Cash and cash equivalents at end of year	$	327		$	1,616		$	252		$	—		$	2,195
For the Year Ended December 31, 2009
Cash flows from operating activities	$	678		$	1,630		$	29		$	(883	)	$	1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1			18			—			—			19
Proceeds from settlement of long-term investments		—			6			—			—			6
Capital expenditures		—			(137	)		(4	)		—			(141	)
Acquisition, net of cash acquired		—			—			(43	)		—			(43	)
Proceeds from termination of joint venture		—			—			24			—			24
Return of intercompany investments		610			—			—			(610	)		—
Other, net		40			29			—			(57	)		12
Net cash flows from (used in) investing activities		651			(84	)		(23	)		(667	)		(123	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(991	)		(840	)		—			840			(991	)
Repurchase of common stock		(5	)		—			—			—			(5	)
Repayments of long-term debt		(189	)		(11	)		—			—			(200	)
Dividends paid on preferred stock		(43	)		—			—			43			—
Distribution of equity		—			(610	)		—			610			—
Other, net		(12	)		(40	)		(1	)		57			4
Net cash flows used in financing activities		(1,240	)		(1,501	)		(1	)		1,550			(1,192	)
Effect of exchange rate changes on cash and cash equivalents		—			—			6			—			6
Net change in cash and cash equivalents		89			45			11			—			145
Cash and cash equivalents at beginning of year		272			2,091			215			—			2,578
Cash and cash equivalents at end of year	$	361		$	2,136		$	226		$	—		$	2,723

Condensed Consolidating Balance Sheets

Condensed Consolidating Balance Sheets

(Dollars in Millions)

	Parent Issuer		Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2011
Assets
Cash and cash equivalents	$	328	$	1,361	$	267	$	—		$	1,956
Accounts receivable		—		77		24		—			101
Accounts receivable, related party		—		67		—		—			67
Other receivables		95		50		39		(138	)		46
Inventories		—		929		38		—			967
Deferred income taxes, net		—		952		1		(8	)		945
Prepaid expenses and other		19		200		7		(1	)		225
Total current assets		442		3,636		376		(147	)		4,307
Property, plant and equipment, net		5		1,061		3		1			1,070
Trademarks and other intangible assets, net		—		2,553		49		—			2,602
Goodwill		—		7,999		11		—			8,010
Long-term intercompany notes		1,960		1,325		—		(3,285	)		—
Investment in subsidiaries		9,139		463		—		(9,602	)		—
Other assets and deferred charges		68		171		71		(45	)		265
Total assets	$	11,614	$	17,208	$	510	$	(13,078	)	$	16,254
Liabilities and shareholders’ equity
Accounts payable	$	—	$	107	$	6	$	—		$	113
Tobacco settlement accruals		—		2,530		—		—			2,530
Due to related party		—		2		—		—			2
Deferred revenue, related party		—		42		—		—			42
Current maturities of long-term debt		399		58		—		—			457
Other current liabilities		421		827		31		(147	)		1,132
Total current liabilities		820		3,566		37		(147	)		4,276
Intercompany notes and interest payable		1,325		1,960		—		(3,285	)		—
Long-term debt (less current maturities)		3,145		61		—		—			3,206
Deferred income taxes, net		—		553		3		(45	)		511
Long-term retirement benefits (less current portion)		48		1,699		12		—			1,759
Other noncurrent liabilities		25		224		2		—			251
Shareholders’ equity		6,251		9,145		456		(9,601	)		6,251
Total liabilities and shareholders’ equity	$	11,614	$	17,208	$	510	$	(13,078	)	$	16,254

	Parent Issuer		Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2010
Assets
Cash and cash equivalents	$	327	$	1,616	$	252	$	—		$	2,195
Accounts receivable		—		103		15		—			118
Accounts receivable, related party		—		48		—		—			48
Other receivables		80		161		35		(232	)		44
Inventories		—		1,022		34		(1	)		1,055
Deferred income taxes, net		10		934		2		—			946
Prepaid expenses and other		38		155		4		(2	)		195
Assets held for sale		—		201		—		—			201
Total current assets		455		4,240		342		(235	)		4,802
Property, plant and equipment, net		6		991		4		1			1,002
Trademarks and other intangible assets, net		—		2,625		50		—			2,675
Goodwill		—		7,991		19		—			8,010
Long-term intercompany notes		2,000		1,366		—		(3,366	)		—
Investment in subsidiaries		9,696		462		—		(10,158	)		—
Other assets and deferred charges		267		242		100		(20	)		589
Total assets	$	12,424	$	17,917	$	515	$	(13,778	)	$	17,078
Liabilities and shareholders’ equity
Accounts payable	$	—	$	175	$	4	$	—		$	179
Tobacco settlement accruals		—		2,589		—		—			2,589
Due to related party		—		4		—		—			4
Deferred revenue, related party		—		53		—		—			53
Current maturities of long-term debt		400		—		—		—			400
Other current liabilities		489		855		37		(234	)		1,147
Total current liabilities		889		3,676		41		(234	)		4,372
Intercompany notes and interest payable		1,366		2,000		—		(3,366	)		—
Long-term debt (less current maturities)		3,580		121		—		—			3,701
Deferred income taxes, net		—		535		3		(20	)		518
Long-term retirement benefits (less current portion)		34		1,622		12		—			1,668
Other noncurrent liabilities		45		262		2		—			309
Shareholders’ equity		6,510		9,701		457		(10,158	)		6,510
Total liabilities and shareholders’ equity	$	12,424	$	17,917	$	515	$	(13,778	)	$	17,078

XML

Income Per Share (Details) (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Components of the calculation of income per share
Income from continuing operations									$ 1,406	$ 1,337	$ 955
Losses from discontinued operations, net of tax								(216)		(216)
Net income	$ 304	$ 394	$ 327	$ 381	$ 262	$ 400	$ 359	$ 100	$ 1,406	$ 1,121	$ 955
Basic weighted average shares, in thousands									582,320	582,996	582,761
Effect of dilutive potential shares:
Stock units									3,063	1,858	891
Diluted weighted average shares, in thousands									585,383	584,854	583,652

XML

Fair Value (Details 1) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011		Dec. 31, 2010
Financial assets classified as level 3 Investments
Cost	$ 124		$ 126
Gross Unrealized (Loss)/Gain	(49)	[1]	(51)	[1]
Estimated Fair Value	75		75
Auction rate securities [Member]
Financial assets classified as level 3 Investments
Cost	99		99
Gross Unrealized (Loss)/Gain	(36)	[1]	(38)	[1]
Estimated Fair Value	63		61
Mortgage-backed security [Member]
Financial assets classified as level 3 Investments
Cost	25		27
Gross Unrealized (Loss)/Gain	(13)	[1]	(13)	[1]
Estimated Fair Value	$ 12		$ 14

[1] Unrealized losses, net of tax, are reported in accumulated other comprehensive loss in RAI's condensed consolidated balance sheets as of December 31, 2011 and 2010.

XML

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2011
Verdicts in individual cases, pending [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
Compensatory Damages (as adjusted)	$ 40,625,500
Punitive Damages-adjusted	173,030,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
Compensatory Damages (as adjusted)	40,625,500
Punitive Damages-adjusted	173,030,000
Verdicts in individual cases, accrued [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
Compensatory Damages (as adjusted)	13,790,000
Punitive Damages-adjusted	39,500,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
Compensatory Damages (as adjusted)	13,790,000
Punitive Damages-adjusted	39,500,000
Martin [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	66.00%
Compensatory Damages (as adjusted)	3,300,000
Punitive Damages-adjusted	25,000,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	66.00%
Compensatory Damages (as adjusted)	3,300,000
Punitive Damages-adjusted	25,000,000
Campbell [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	39.00%
Compensatory Damages (as adjusted)	3,040,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	39.00%
Compensatory Damages (as adjusted)	3,040,000
Punitive Damages-adjusted	0
Gray [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	60.00%
Compensatory Damages (as adjusted)	4,200,000
Punitive Damages-adjusted	2,000,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	60.00%
Compensatory Damages (as adjusted)	4,200,000
Punitive Damages-adjusted	2,000,000
Hall [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	65.00%
Compensatory Damages (as adjusted)	3,250,000
Punitive Damages-adjusted	12,500,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	65.00%
Compensatory Damages (as adjusted)	3,250,000
Punitive Damages-adjusted	12,500,000
Sherman [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	50.00%
Compensatory Damages (as adjusted)	775,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	50.00%
Compensatory Damages (as adjusted)	775,000
Punitive Damages-adjusted	0
Brown [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	50.00%
Compensatory Damages (as adjusted)	600,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	50.00%
Compensatory Damages (as adjusted)	600,000
Punitive Damages-adjusted	0
Douglas [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	5.00%
Compensatory Damages (as adjusted)	250,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	5.00%
Compensatory Damages (as adjusted)	250,000
Punitive Damages-adjusted	0
Cohen [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	33.30%
Compensatory Damages (as adjusted)	3,300,000
Punitive Damages-adjusted	10,000,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	33.30%
Compensatory Damages (as adjusted)	3,300,000
Punitive Damages-adjusted	10,000,000
Clay [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	60.00%
Compensatory Damages (as adjusted)	2,100,000
Punitive Damages-adjusted	17,000,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	60.00%
Compensatory Damages (as adjusted)	2,100,000
Punitive Damages-adjusted	17,000,000
Townsend [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	51.00%
Compensatory Damages (as adjusted)	5,500,000
Punitive Damages-adjusted	40,800,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	51.00%
Compensatory Damages (as adjusted)	5,500,000
Punitive Damages-adjusted	40,800,000
Putney [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	4,500,000
Punitive Damages-adjusted	2,500,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	4,500,000
Punitive Damages-adjusted	2,500,000
Grossman [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	25.00%
Compensatory Damages (as adjusted)	484,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	25.00%
Compensatory Damages (as adjusted)	484,000
Punitive Damages-adjusted	0
Buonomo [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	77.50%
Compensatory Damages (as adjusted)	4,060,000
Punitive Damages-adjusted	15,700,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	77.50%
Compensatory Damages (as adjusted)	4,060,000
Punitive Damages-adjusted	15,700,000
Alexander [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	51.00%
Compensatory Damages (as adjusted)	1,275,000
Punitive Damages-adjusted	2,500,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	51.00%
Compensatory Damages (as adjusted)	1,275,000
Punitive Damages-adjusted	2,500,000
Piendle [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	27.50%
Compensatory Damages (as adjusted)	1,100,000
Punitive Damages-adjusted	180,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	27.50%
Compensatory Damages (as adjusted)	1,100,000
Punitive Damages-adjusted	180,000
Koballa [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	300,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	300,000
Punitive Damages-adjusted	0
Webb [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	90.00%
Compensatory Damages (as adjusted)	7,200,000
Punitive Damages-adjusted	72,000,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	90.00%
Compensatory Damages (as adjusted)	7,200,000
Punitive Damages-adjusted	72,000,000
Kirkland [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	10.00%
Compensatory Damages (as adjusted)	10,000
Punitive Damages-adjusted	250,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	10.00%
Compensatory Damages (as adjusted)	10,000
Punitive Damages-adjusted	250,000
Huish [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	25.00%
Compensatory Damages (as adjusted)	188,000
Punitive Damages-adjusted	1,500,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	25.00%
Compensatory Damages (as adjusted)	188,000
Punitive Damages-adjusted	1,500,000
Mack [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	51.00%
Compensatory Damages (as adjusted)	510,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	51.00%
Compensatory Damages (as adjusted)	510,000
Punitive Damages-adjusted	0
Andy Allen [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	45.00%
Compensatory Damages (as adjusted)	2,700,000
Punitive Damages-adjusted	8,100,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	45.00%
Compensatory Damages (as adjusted)	2,700,000
Punitive Damages-adjusted	8,100,000
Jewett [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	20.00%
Compensatory Damages (as adjusted)	219,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	20.00%
Compensatory Damages (as adjusted)	219,000
Punitive Damages-adjusted	0
Reese [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	1,100,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	1,100,000
Punitive Damages-adjusted	0
Soffer [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	40.00%
Compensatory Damages (as adjusted)	2,000,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	40.00%
Compensatory Damages (as adjusted)	2,000,000
Punitive Damages-adjusted	0
Ciccone [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	1,000,000
Punitive Damages-adjusted	50,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	1,000,000
Punitive Damages-adjusted	50,000
Weingart [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	3.00%
Compensatory Damages (as adjusted)	4,500
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	3.00%
Compensatory Damages (as adjusted)	4,500
Punitive Damages-adjusted	0
Bowman [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	450,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	450,000
Punitive Damages-adjusted	0
Sury [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	20.00%
Compensatory Damages (as adjusted)	200,000
Punitive Damages-adjusted	0
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	20.00%
Compensatory Damages (as adjusted)	200,000
Punitive Damages-adjusted	0
Hallgren [Member]
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	25.00%
Compensatory Damages (as adjusted)	500,000
Punitive Damages-adjusted	750,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	25.00%
Compensatory Damages (as adjusted)	500,000
Punitive Damages-adjusted	750,000
Ward
Verdicts in the individual Engle Progeny cases that have been tried and remain pending
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	300,000
Punitive Damages-adjusted	1,700,000
Verdicts in the individual Engle Progeny cases that have been tried and accrued for
RJR Tobacco Allocation of Fault	30.00%
Compensatory Damages (as adjusted)	300,000
Punitive Damages-adjusted	$ 1,700,000

XML

Retirement Benefits (Details 11) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Effect of one-percentage-point change in assumed health-care cost trend rates
1-Percentage Point Increase	$ 4
1-Percentage Point Decrease	(4)
1-Percentage Point Increase	75
1-Percentage Point Decrease	$ (65)

XML

Segment Information (Tables)

12 Months Ended

Dec. 31, 2011

Segment Information [Abstract]

Segment Information Related to Sales, Income, and Assets

	2011			2010(3)			2009(3)
Net sales:
RJR Tobacco	$	7,297		$	7,350		$	7,334
American Snuff		648			719			673
Santa Fe		436			356			289
All Other		160			126			123
Consolidated net sales	$	8,541		$	8,551		$	8,419
Operating income:
RJR Tobacco	$	1,945		$	2,084		$	1,481
American Snuff		331			320			276
Santa Fe		198			135			98
All Other		18			(14	)		14
Corporate expense		(93	)		(93	)		(106	)
Consolidated operating income	$	2,399		$	2,432		$	1,763
Cash capital expenditures:
RJR Tobacco	$	55		$	52		$	55
American Snuff		106			104			75
Santa Fe		7			2			7
All Other		22			16			4
Consolidated capital expenditures	$	190		$	174		$	141
Depreciation and amortization expense:
RJR Tobacco	$	110		$	119		$	123
American Snuff		17			17			13
Santa Fe		5			7			6
All Other		6			8			2
Consolidated depreciation and amortization expense	$	138		$	151		$	144
Reconciliation to income from continuing operations before income taxes:
Operating income (1)(2)	$	2,399		$	2,432		$	1,763
Interest and debt expense		221			232			251
Interest income		(11	)		(12	)		(19	)
Other expense, net		3			7			9
Income from continuing operations before income taxes	$	2,186		$	2,205		$	1,522

⁽¹⁾ Includes restructuring and/or asset impairment charges of $38 million and $56 million for the years ended December 31, 2010 and 2009, respectively.

⁽²⁾ Includes trademark and/or goodwill impairment charges of $48 million, $32 million and $567 million for the years ended December 31, 2011, 2010 and 2009, respectively.

⁽³⁾ Revised financial data for 2010 and 2009 to reflect RAI’s elective change in accounting for pension and postretirement benefits. See note 1 to consolidated financial statements.

XML

Business and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2011

Business and Summary of Significant Accounting Policies [Abstract]

Certain component of cost of products sold

	2011		2010		2009
State Settlement Agreements	$	2,435	$	2,496	$	2,540
Federal tobacco quota buyout		229		243		240
FDA user fees		120		75		22

Impacts of all revisions made to the financial statements

Consolidated statements of income:

	For the Year Ended December 31, 2010							For the Year Ended December 31, 2009
	Previously Reported		Revised		Effect Of Change			Previously Reported		Revised		Effect Of Change
Cost of products sold	$	4,544	$	4,544	$	—		$	4,485	$	4,488	$	3
Selling, general and administrative expenses		1,493		1,480		(13	)		1,508		1,517		9
Operating income		2,419		2,432		13			1,775		1,763		(12	)
Income from continuing operations before income taxes		2,192		2,205		13			1,534		1,522		(12	)
Provision for income taxes		863		868		5			572		567		(5	)
Income from continuing operations		1,329		1,337		8			962		955		(7	)
Net income		1,113		1,121		8			962		955		(7	)
Earnings per share — basic		1.91		1.92		0.01			1.65		1.64		(0.01	)
Earnings per share — diluted		1.90		1.92		0.02			1.65		1.64		(0.01	)

Consolidated balance sheet:

	December 31, 2010
	Previously Reported			Revised			Effect Of Change
Accumulated deficit	$	(547	)	$	(1,807	)	$	(1,260	)
Accumulated other comprehensive loss		(1,478	)		(218	)		1,260

Consolidated statements of cash flows:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Cash flows from operating activities:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Deferred income tax expense (benefit)		182			187			5			(154	)		(159	)		(5	)
Pension and postretirement		(702	)		(715	)		(13	)		(181	)		(169	)		12

Consolidated statements of shareholders’ equity and comprehensive income:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Accumulated deficit:
Beginning balance	$	(579	)	$	(1,847	)	$	(1,268	)	$	(531	)	$	(1,792	)	$	(1,261	)
Net income		1,113			1,121			8			962			955			(7	)
Ending balance		(547	)		(1,807	)		(1,260	)		(579	)		(1,847	)		(1,268	)
Accumulated other comprehensive income (loss):
Beginning balance	$	(1,421	)	$	(153	)	$	1,268		$	(1,695	)	$	(434	)	$	1,261
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7
Ending balance		(1,478	)		(218	)		1,260			(1,421	)		(153	)		1,268
Comprehensive income:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7

XML

Commitments and Contingencies (Details 1) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Disputed portion of MSA payment obligation
Year for which NPM Adjustment Calculated year one	2003
Year for which NPM Adjustment Calculated year two	2004
Year for which NPM Adjustment Calculated year three	2005
Year for which NPM Adjustment Calculated year four	2006
Year for which NPM Adjustment Calculated year five	2007
Year for which NPM Adjustment Calculated year six	2008
Year in which deduction from NPM may be taken year one	2006
Year in which deduction from NPM may be taken year two	2007
Year in which deduction from NPM may be taken year three	2008
Year in which deduction from NPM may be taken year four	2009
Year in which deduction from NPM may be taken year five	2010
Year in which deduction from NPM may be taken year six	2011
RJR Tobacco's approximate share of disputed NPM adjustment amount year one	$ 615
RJR Tobacco's approximate share of disputed NPM adjustment amount year two	562
RJR Tobacco's approximate share of disputed NPM adjustment amount year three	445
RJR Tobacco's approximate share of disputed NPM adjustment amount year four	419
RJR Tobacco's approximate share of disputed NPM adjustment amount year five	447
RJR Tobacco's approximate share of disputed NPM adjustment amount year six	477
2009 [Member]
Remaining States' Settlement
Annual Payments	8,004	[1]
Growers' Trust	295	[2]
Offset by federal tobacco buyout	(295)	[2]
Total	9,364
RAI's Operating Subsidiaries' Settlement Expenses and Payment Schedule
Settlement Expenses	2,540
Settlement cash payments	2,249
2009 [Member] | Mississippi [Member]
First Four States' Settlements
Annual Settlement Payment	136	[1]
2009 [Member] | Florida [Member]
First Four States' Settlements
Annual Settlement Payment	440	[1]
2009 [Member] | Texas [Member]
First Four States' Settlements
Annual Settlement Payment	580	[1]
2009 [Member] | Minnesota [Member]
First Four States' Settlements
Annual Settlement Payment	204	[1]
2010 [Member]
Remaining States' Settlement
Annual Payments	8,004	[1]
Growers' Trust	295	[2]
Offset by federal tobacco buyout	(295)	[2]
Total	9,364
RAI's Operating Subsidiaries' Settlement Expenses and Payment Schedule
Settlement Expenses	2,496
Settlement cash payments	2,519
2010 [Member] | Mississippi [Member]
First Four States' Settlements
Annual Settlement Payment	136	[1]
2010 [Member] | Florida [Member]
First Four States' Settlements
Annual Settlement Payment	440	[1]
2010 [Member] | Texas [Member]
First Four States' Settlements
Annual Settlement Payment	580	[1]
2010 [Member] | Minnesota [Member]
First Four States' Settlements
Annual Settlement Payment	204	[1]
2011 [Member]
Remaining States' Settlement
Annual Payments	8,004
Total	9,364
RAI's Operating Subsidiaries' Settlement Expenses and Payment Schedule
Settlement Expenses	2,435
Settlement cash payments	2,492
2011 [Member] | Mississippi [Member]
First Four States' Settlements
Annual Settlement Payment	136
2011 [Member] | Florida [Member]
First Four States' Settlements
Annual Settlement Payment	440
2011 [Member] | Texas [Member]
First Four States' Settlements
Annual Settlement Payment	580
2011 [Member] | Minnesota [Member]
First Four States' Settlements
Annual Settlement Payment	204
2012 and thereafter [Member]
Remaining States' Settlement
Annual Payments	8,004	[1]
Total	9,364
RAI's Operating Subsidiaries' Settlement Expenses and Payment Schedule
Projected settlement expenses	>2,400
Projected settlement cash payments	>2,400
2012 and thereafter [Member] | Mississippi [Member]
First Four States' Settlements
Annual Settlement Payment	136	[1]
2012 and thereafter [Member] | Florida [Member]
First Four States' Settlements
Annual Settlement Payment	440	[1]
2012 and thereafter [Member] | Texas [Member]
First Four States' Settlements
Annual Settlement Payment	580	[1]
2012 and thereafter [Member] | Minnesota [Member]
First Four States' Settlements
Annual Settlement Payment	$ 204	[1]

[1] Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share. For further information, see "- State Settlement Agreements-Enforcement and Validity; Adjustments" below.

[2] The Growers' Trust payments expired December 2010 and were offset by certain obligations resulting from the federal tobacco buyout legislation, not included in this table, signed in October 2004. See "- Tobacco Buyout Legislation and Related Litigation" below.

XML

Quarterly Results of Operations (Unaudited) (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Quarterly Results of Operations
Net sales	$ 2,083	$ 2,200	$ 2,267	$ 1,991	$ 2,081	$ 2,239	$ 2,245	$ 1,986	$ 8,541	$ 8,551	$ 8,419
Gross Profit	972	1,075	1,074	956	935	1,068	1,075	929
Net income	$ 304	$ 394	$ 327	$ 381	$ 262	$ 400	$ 359	$ 100	$ 1,406	$ 1,121	$ 955
Basic:
Income from continuing operations					$ 0.45	$ 0.69	$ 0.62	$ 0.54	$ 2.41	$ 2.29	$ 1.64
Loss from discontinued operations, net of tax								$ (0.37)		$ (0.37)
Net income	$ 0.52	$ 0.68	$ 0.56	$ 0.65	$ 0.45	$ 0.69	$ 0.62	$ 0.17	$ 2.41	$ 1.92	$ 1.64
Diluted:
Income from continuing operations					$ 0.45	$ 0.68	$ 0.61	$ 0.54	$ 2.40	$ 2.29	$ 1.64
Loss from discontinued operations, net of tax								$ (0.37)		$ (0.37)
Net income	$ 0.52	$ 0.67	$ 0.56	$ 0.65	$ 0.45	$ 0.68	$ 0.61	$ 0.17	$ 2.40	$ 1.92	$ 1.64

XML

Income Taxes (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended		12 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Current:
Federal			$ 572	$ 545	$ 592
State and other			108	136	134
Subtotal			680	681	726
Deferred:
Federal			80	160	(154)
State and other			20	27	(5)
Subtotal			100	187	(159)
Provision for income taxes			780	868	567
Deferred tax assets:
Pension and other postretirement liabilities			707	714
Tobacco settlement accruals			1,006	1,031
Other accrued liabilities			81	70
Other noncurrent liabilities			154	141
Subtotal			1,948	1,956
Less: Valuation Allowance			(33)
Deferred tax asset			1,915	1,956
Deferred tax liabilities:
LIFO inventories			(162)	(200)
Property and equipment			(239)	(218)
Trademarks and other intangibles			(950)	(978)
Other			(130)	(132)
Total deferred tax liabilities			(1,481)	(1,528)
Net deferred tax asset			434	428
Current and noncurrent components of deferred tax assets (liabilities)
Current deferred tax assets			945	946
Noncurrent deferred tax liabilities			(511)	(518)
Net deferred tax asset			434	428
Pre-tax income for domestic and foreign operations
Domestic (includes U.S. exports)			2,157	2,204	1,495
Foreign			29	1	27
Income from continuing operations before income taxes			2,186	2,205	1,522
Differences between the provision for income taxes from continuing operations and income taxes
Income taxes computed at statutory U.S. federal income tax rates			765	771	533
State and local income taxes, net of federal tax benefits			96	101	80
Domestic manufacturing deduction			(60)	(54)	(41)
Other items, net			(21)	50	(5)
Provision for income taxes from continuing operations			780	868	567
Effective tax rate			35.70%	39.40%	37.30%
Reconciliation of the unrecognized gross tax benefits
Balance at beginning of year	127	94	127	94	97
Gross increases related to current period tax positions			6	37	6
Gross increases related to tax positions in prior periods			1	4	3
Gross decreases related to tax positions in prior periods			(1)	(1)	(4)
Gross increase (decreases) related to audit settlements paid			1	(4)	(3)
Gross decreases related to lapse of applicable statute of limitations	(22)		(6)	(3)	(5)
Balance at end of year			128	127	94
Income Taxes (Textual) [Abstract]
Federal capital loss carryforward			95
Valuation allowance			33
Decrease in tax attributable	22		6	3	5
Health care reform expense		27
Undistributed foreign earnings			445
Accumulated and undistributed foreign earnings invested overseas			68
Planned overseas investment of undistributed foreign earnings			15
Recorded deferred income taxes			129
Accumulated earnings in excess of its historical and planned overseas investments			362
Deferred tax benefits included in accumulated other comprehensive loss for retirement benefits			268	173
Other comprehensive income unrealized holding gain loss on long term investments arising during period tax			19
Unrealized gain/loss on long-term investments			6	13	2
Gross accruals for unrecognized income tax benefits, including interest and penalties, reflected in other noncurrent liabilities			165	193
Interest and penalties accrued by RAI related to accruals for income taxes reflected in income tax expense			28	57
Unrecognized tax benefits, income tax penalties accrued			10	9
Unrecognized tax benefits including interest and penalties			110
Income tax examination assessment			37
Significant change in unrecognized tax benefits is reasonably possible, estimated rate of change			$ 12

XML

Stock Plans (Details 4) (USD $)	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2011
Changes In Stock Options
Outstanding at beginning of year	485,468	776,348	40,000
Weighted Average Exercise Price, Outstanding at beginning of year	$ 7.64	$ 7.38	$ 17.45
Expired	(83,184)
Weighted Average Exercise Price, Expired	$ 6.63
Exercised	(362,284)	(290,880)
Weighted Average Exercise Price, Exercised	$ 6.78	$ 6.95
Outstanding at end of year	40,000	485,468	40,000
Weighted Average Exercise Price, Outstanding at end of year	$ 17.45	$ 7.64	$ 17.45
Options, Exercisable at end of year	40,000	485,468	40,000
Weighted Average Exercise Price, Exercisable at end of year	$ 17.45	$ 7.64	$ 17.45

XML

Fair Value (Details 3) (Trademarks [Member], USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2010	Nov. 30, 2010
Intangible nonfinancial assets measured at fair value on nonrecurring basis
Intangible Assets Excluding Goodwill Fair Value Disclosure		$ 81
Impairment	(48)
Fair Value, Inputs, Level 1 [Member]
Intangible nonfinancial assets measured at fair value on nonrecurring basis
Intangible Assets Excluding Goodwill Fair Value Disclosure		0
Fair Value, Inputs, Level 2 [Member]
Intangible nonfinancial assets measured at fair value on nonrecurring basis
Intangible Assets Excluding Goodwill Fair Value Disclosure		0
Fair Value, Inputs, Level 3 [Member]
Intangible nonfinancial assets measured at fair value on nonrecurring basis
Intangible Assets Excluding Goodwill Fair Value Disclosure		$ 81

XML

Related Party Transactions (Details) (USD $) In Millions, except Share data, unless otherwise specified	1 Months Ended		12 Months Ended
	Nov. 30, 2011	Jul. 31, 2011	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Summary of balances and transactions
Accounts receivable			$ 67	$ 48
Accounts payable			2	4
Deferred revenue			42	53
Net sales			479	381	404
RAI common stock purchases from B&W			114
Related Party Transactions (Textual) [Abstract]
Percentage of maximum purchase price of imported cigarettes from related party			10.00%
Revenue percentage from related parties			6.00%	4.00%	5.00%
Percentage of RTI's out standing common stock	42.00%		42.00%
Repurchased stock from B&W			2,806,637
Related party transaction purchases from related party			less than 1 million
Related party transaction purchases amount			1
Sale of airplane		8
Purchases [Member]
Related Party Transaction [Line Items]
Purchases, Research and development services billings			11	12	16
Research And Development Services Billings [Member]
Related Party Transaction [Line Items]
Purchases, Research and development services billings			$ 5	$ 4	$ 2

XML

Long-Term Debt (Details 1) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011
Maturities of RAI and RJR Notes, net of discounts
2012	$ 451
2013	684
2015	199
2016	773
2017 and thereafter	1,397
Total	3,504
RAI [Member]
Maturities of RAI and RJR Notes, net of discounts
2012	393
2013	624
2015	199
2016	773
2017 and thereafter	1,397
Total	3,386
RJR [Member]
Maturities of RAI and RJR Notes, net of discounts
2012	58
2013	60
Total	$ 118

XML

Stock Plans (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2011
Changes in restricted RAI common stock and restricted stock units
Outstanding at beginning of year	4,845,861
Weighted Average Grant Date Fair Value, Outstanding at beginning of year	$ 21.87
Granted	1,565,205
Weighted Average Grant Date Fair Value, Granted	$ 34.00
Forfeited	(544,032)
Weighted Average Grant Date Fair Value, Forfeited	$ 24.93
Vested	(456,305)
Weighted Average Grant Date Fair Value, Vested	$ 30.94
Outstanding at end of year	5,410,729
Weighted Average Grant Date Fair Value, Outstanding at end of year	$ 24.30

XML

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended																			12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2011 Mississippi [Member]	Dec. 31, 2011 Florida [Member]	Dec. 31, 2011 Martin [Member]	Dec. 31, 2011 Campbell [Member]	Dec. 31, 2011 Gray [Member]	Dec. 31, 2011 Hall [Member]	Dec. 31, 2011 Bowman [Member]	Dec. 31, 2011 Engle [Member]	Dec. 31, 2011 Engle [Member] Florida [Member]	Dec. 31, 2011 Scott [Member]	Sep. 30, 2011 Eiser [Member]	Dec. 31, 2011 Frankson [Member]	Dec. 31, 2011 Smith [Member]	Dec. 31, 2011 Izzarelli [Member]	Dec. 31, 2011 Sherman [Member]	Dec. 31, 2011 Brown [Member]	Dec. 31, 2011 Grossman [Member]	Dec. 31, 2011 Douglas [Member]	Dec. 31, 2011 Cohen [Member]	Dec. 31, 2011 Clay [Member]	Dec. 31, 2011 Putney [Member]	Dec. 31, 2011 Townsend [Member]	Dec. 31, 2011 Alexander [Member]	Dec. 31, 2011 Soffer [Member]	Dec. 31, 2011 Piendle [Member]	Dec. 31, 2011 Koballa [Member]	Dec. 31, 2011 Webb [Member]	Dec. 31, 2011 Kirkland [Member]	Dec. 31, 2011 Huish [Member]	Dec. 31, 2011 Mack [Member]	Dec. 31, 2011 Tullo [Member]	Dec. 31, 2011 Andy Allen [Member]	Dec. 31, 2011 Jewett [Member]	Dec. 31, 2011 Reese [Member]	Dec. 31, 2011 Ciccone [Member]	Dec. 31, 2011 Weingart [Member]	Dec. 31, 2011 Buonomo [Member]	Dec. 31, 2011 Sury [Member]	Dec. 31, 2011 Hallgren [Member]	Dec. 31, 2011 Ward	Dec. 31, 2011 Broin [Member] Lawsuits	Sep. 30, 2011 Broin [Member]	Dec. 31, 2011 Price [Member]	Dec. 31, 2011 Parsons [Member]	Dec. 31, 2011 Cleary [Member]	Dec. 31, 2011 Vassallo [Member]	Dec. 31, 2011 DOJ [Member]	Dec. 31, 2011 Light case [Member]	Dec. 31, 2011 Rolling Stone [Member]	Dec. 31, 2011 2003 NPM Adjustment [Member]	Dec. 31, 2011 2004 NPM Adjustment [Member]	Dec. 31, 2011 2005 NPM Adjustment [Member]	Dec. 31, 2011 2006 NPM Adjustment [Member]	Dec. 31, 2011 2007 NPM Adjustment [Member]	Dec. 31, 2011 2008 NPM Adjustment [Member]	Dec. 31, 2011 2009 & 2010 NPM [Member]	Dec. 31, 2011 Star [Member]	Dec. 31, 2011 JTI Judgment [member]	Dec. 31, 2011 FETRA Buyout [Member]
Loss Contingencies [Line Items]
Compensatory Damages						$ 5,000,000	$ 7,800,000	$ 7,000,000	$ 5,000,000	$ 1,500,000					$ 350,000	$ 2,000,000	$ 13,900,000	$ 1,550,000	$ 1,200,000	$ 1,900,000	$ 5,000,000	$ 10,000,000	$ 3,500,000	$ 15,100,000	$ 10,800,000	$ 2,500,000	$ 5,000,000	$ 4,000,000	$ 1,000,000	$ 8,000,000	$ 100,000	$ 750,000	$ 1,000,000	$ 4,500,000	$ 6,000,000	$ 1,100,000	$ 3,600,000	$ 3,200,000	$ 150,000	$ 5,200,000	$ 1,000,000	$ 2,000,000	$ 1,000,000			$ 7,100,000,000
Punitive Damages						25,000,000		2,000,000	12,500,000		145,000,000,000				20,000,000	20,000,000	3,970,000					20,000,000	18,000,000	5,000,000	80,000,000	2,500,000		180,000		72,000,000	250,000	3,000,000			17,000,000			50,000		25,000,000	0	750,000	1,700,000			3,000,000,000
Compensatory Damages - Adjusted						3,300,000	3,040,000	4,200,000	3,250,000	450,000					500,000	500,000	8,080,000	775,000	600,000	484,000	250,000	3,300,000	2,100,000	4,500,000	5,500,000	1,275,000	2,000,000	1,100,000	300,000	7,200,000	10,000	188,000	510,000		2,700,000	219,000	1,100,000	1,000,000	4,500	4,060,000	200,000	500,000	300,000
Punitive Damages-adjusted						25,000,000	0	2,000,000	12,500,000	0					5,000,000	1,500,000		0	0	0	0	10,000,000	17,000,000	2,500,000	40,800,000	2,500,000	0	180,000	0	72,000,000	250,000	1,500,000	0		8,100,000	0	0	50,000	4,500	15,700,000	0	750,000	1,700,000
Total damages											100,000,000,000		591,000,000	0	6,800,000		11,950,000										2,000,000					1,690,000			19,700,000										300,000,000			75,000	15,000
Bond	4,500					5,000,000	3,000,000	5,000,000	5,000,000	450,000			50,000,000		8,018,000			900,000	700,000	484,000	250,000	2,500,000	4,700,000	2,400,000	5,000,000	3,800,000	2,000,000	1,280,000	300,000	5,000,000	260,000	1,690,000	510,000			218,600	1,070,000	1,000,000		5,000,000						12,000,000,000
Bond Replacement						15,000,000		6,200,000	15,000,000				25,000,000
Judgment Sought Against Each Defendant							15,000							50,000						15,000		15,000												15,000													1,000,000
Payment of damages and interest																700,000
Punitive Damages 1											36,300,000,000
Punitive Damages 2											17,600,000,000				6,000,000
Trust Fund Deposit													263,000,000
Amended Verdict													263,000,000
Required deposits by defendants													242,000,000
Share of damages													139,000,000
Revised Share Of Punitive Damages 2															4,000,000
Punitive Damages 3															2,000,000
Florida Bond Cap Total												200,000,000
Florida Bond Cap Per Case												5,000,000
Judgment interest awarded																	15,800,000
Judgment Interest Per Day Awarded																	4,000
Amended Final Judgment																	28,100,000
Annual installment of settlement																																												100,000,000
Fees and expenses																																												49,000,000
Fees And Expenses 1																																												86,000,000
Fees And Expenses 2																																												57,000,000
Lower range of damages																																																			50,000
Upper range of damages																																																			75,000
Deposit Into Court Registry Regarding Public Website																																																		3,125,000
Payment Sought Under State Settlement Agreement				3,900,000	12,400,000
Damages state settlement agreement 1				5,000,000
Damages State Settlement Agreement 2				3,800,000
Interest Payment Sought Under State Settlement Agreement				4,300,000	17,000,000
Court Penalty																																																				302,000
Lower range of royalty																																																												294,900,000
Upper range of royalty																																																												362,100,000
MSA Disputed Payment																																																					647,000,000	561,000,000	431,000,000		448,000,000	477,000,000
Reduced MSA Disputed Payment																																																					615,000,000
Released MSA Disputed Payment																																																					32,000,000
Adjustment amount after independent auditor calculations																																																							445,000,000
First MSA Payment Withheld																																																								406,500,000
Revised first MSA payment withheld																																																								420,000,000
Additional adjustment amount of MSA payment																																																								1,000,000
Additional downward adjustment amount of MSA payment																																																									1,100,000
Total of dispute notices for NPM adjustments																																																											937,000,000
Judgment Entered Against JTI in Brazil That JTI Believes RJR and RJR Tobacco Liable For																																																													1,700,000
Total Cost of FETRA buyout																																																														9,900,000,000
FETRA payable to Quota tobacco holders																																																														9,600,000,000
Liquidation of Quota tobacco stock																																																														290,000,000
Lower range of FETRA annual expense																																																														220,000,000
Upper range of FETRA annual expense																																																														240,000,000
Lower range of share of FETRA buyout																																																														2,400,000,000
Upper range of share of FETRA buyout																																																														2,800,000,000
Lawsuits pending																																												2,586
Final judgment amount																				483,682
Commitments And Contingencies (Numeric) [Abstract]
BAT legal indemnification	1,000,000	1,000,000	1,000,000
Engle Progeny Accrual	64,000,000
Engle Progeny Damages	53,000,000
Engle Verdict Interest and Fees	11,000,000
Growers Trust Fund	5,200,000,000
Antitrust/CPTEF	5,000,000
Engle Progeny Compensatory Damages	54,415,500
Engle Progeny Punitive Damages	212,530,000
Total Damages Engle Progeny	266,945,500
Rent expense	$ 18,000,000	$ 20,000,000	$ 20,000,000

XML

Stock Plans (Details 2) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Compensation Expense Related To Stock Based Compensation And Related Tax Benefits
Total compensation expense	$ 38	$ 37	$ 22
Total related tax benefits	13	13	8
2006 restricted stock [Member]
Compensation Expense Related To Stock Based Compensation And Related Tax Benefits
Total compensation expense			(2)
2007 restricted stock and performance shares [Member]
Compensation Expense Related To Stock Based Compensation And Related Tax Benefits
Total compensation expense		1	5
2008 restricted stock [Member]
Compensation Expense Related To Stock Based Compensation And Related Tax Benefits
Total compensation expense	1	5	5
2009 restricted stock units [Member]
Compensation Expense Related To Stock Based Compensation And Related Tax Benefits
Total compensation expense	12	16	14
2010 restricted stock units [Member]
Compensation Expense Related To Stock Based Compensation And Related Tax Benefits
Total compensation expense	12	15
2011 restricted stock units [Member]
Compensation Expense Related To Stock Based Compensation And Related Tax Benefits
Total compensation expense	$ 13

XML

Long-Term Debt (Details Textual) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Long Term Debt (Textual) [Abstract]
RAI repaid of matured floating notes	$ 400	$ 300	$ 200
RAI [Member]
Long Term Debt (Textual) [Abstract]
RAI repaid of matured floating notes	400	300	189
9.25%, notes due 2013 [Member] | RJR [Member]
Debt Instrument [Line Items]
Interest rate of debt	9.25%	9.25%
Outstanding principal amount	60	60
7.25% guaranteed, notes due 2012 [Member] | RAI [Member]
Debt Instrument [Line Items]
Interest rate of debt	7.25%	7.25%
Outstanding principal amount		412
7.25% guaranteed, notes due 2012 [Member] | RJR [Member]
Debt Instrument [Line Items]
Interest rate of debt	7.25%	7.25%
Outstanding principal amount		61
7.3% guaranteed, notes due 2015 [Member] | RAI [Member]
Debt Instrument [Line Items]
Interest rate of debt	7.30%	7.30%
Outstanding principal amount	199	199
6.75% guaranteed, notes due 2017 [Member] | RAI [Member]
Debt Instrument [Line Items]
Interest rate of debt	6.75%	6.75%
Outstanding principal amount	797	811
7.25% guaranteed, notes due 2013 [Member] | RAI [Member]
Debt Instrument [Line Items]
Interest rate of debt	7.25%	7.25%
Outstanding principal amount	624	623
7.25% guaranteed, notes due 2037 [Member] | RAI [Member]
Debt Instrument [Line Items]
Interest rate of debt	7.25%	7.25%
Outstanding principal amount	448	448
7.625% guaranteed, notes due 2016 [Member] | RAI [Member]
Debt Instrument [Line Items]
Interest rate of debt	7.625%	7.625%
Outstanding principal amount	829	838
7.75% guaranteed, notes due 2018 [Member] | RAI [Member]
Debt Instrument [Line Items]
Interest rate of debt	7.75%	7.75%
Outstanding principal amount	$ 249	$ 249

XML

Inventories (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Components of inventories
Leaf tobacco	$ 885	$ 997
Other raw materials	44	44
Work in process	60	64
Finished products	139	122
Other	24	25
Total	1,152	1,252
Less LIFO allowance	185	197
Inventory Net	967	1,055
Inventories (Textual) [Abstract]
Inventories under LIFO Method	466	600
Expenses (Income) from LIFO inventory changes	$ 12	$ 7	$ 78

XML

Retirement Benefits

12 Months Ended

Dec. 31, 2011

Retirement Benefits [Abstract]

Retirement Benefits

Note 16 — Retirement Benefits

RAI and certain of its subsidiaries sponsor a number of non-contributory defined benefit pension plans covering most of their employees, and also provide certain health and life insurance benefits for most of their retired employees and their dependents. These benefits are generally no longer provided to employees hired on or after January 1, 2004.

The changes in benefit obligations and plan assets, as well as the funded status of these plans at December 31 were as follows:

	Pension Benefits						Postretirement Benefits
	2011			2010			2011			2010
Change in benefit obligation:
Obligation at beginning of year	$	5,529		$	5,270		$	1,436		$	1,351
Service cost		26			29			3			4
Interest cost		300			319			75			80
Actuarial loss		320			324			59			148
Plan amendments		—			—			(45	)		(51	)
Benefits paid		(397	)		(410	)		(94	)		(97	)
Settlements		(9	)		—			—			—
Curtailment		—			(3	)		—			1
One-time cost		(3	)		—			—			—
Obligation at end of year	$	5,766		$	5,529		$	1,434		$	1,436
Change in plan assets:
Fair value of plan assets at beginning of year	$	4,934		$	4,054		$	270		$	270
Actual return on plan assets		362			479			1			31
Employer contributions		220			811			78			66
Benefits paid		(397	)		(410	)		(94	)		(97	)
Settlements		(9	)		—			—			—
Fair value of plan assets at end of year	$	5,110		$	4,934		$	255		$	270
Funded status	$	(656	)	$	(595	)	$	(1,179	)	$	(1,166	)
Amounts recognized in the consolidated balance sheets consist of:
Noncurrent assets — other assets and deferred charges		7			3			—			—
Accrued benefit — other current liability		(9	)		(18	)		(74	)		(78	)
Accrued benefit — long-term retirement benefits		(654	)		(580	)		(1,105	)		(1,088	)
Net amount recognized		(656	)		(595	)		(1,179	)		(1,166	)
Accumulated other comprehensive loss		596			382			2			(23	)
Net amounts recognized in the consolidated balance sheets	$	(60	)	$	(213	)	$	(1,177	)	$	(1,189	)

Amounts included in accumulated other comprehensive loss were as follows as of December 31:

	2011									2010
	Pension Benefits			Postretirement Benefits			Total			Pension Benefits			Postretirement Benefits			Total
Prior service cost (credit)	$	26		$	(135	)	$	(109	)	$	30		$	(119	)	$	(89	)
Net actuarial loss		570			137			707			352			96			448
Deferred income taxes		(245	)		(23	)		(268	)		(160	)		(13	)		(173	)
Accumulated other comprehensive loss	$	351		$	(21	)	$	330		$	222		$	(36	)	$	186

Changes in accumulated other comprehensive loss were as follows:

	2011									2010
	Pension Benefits			Postretirement Benefits			Total			Pension Benefits			Postretirement Benefits			Total
Prior service credit	$	—		$	(45	)	$	(45	)	$	—		$	(51	)	$	(51	)
Net actuarial loss		331			76			407			185			136			321
Amortization of prior service cost (credit)		(4	)		29			25			(4	)		24			20
One-time cost		(3	)		—			(3	)		—			—			—
MTM adjustment		(110	)		(35	)		(145	)		(3	)		(107	)		(110	)
Deferred income tax expense		(85	)		(10	)		(95	)		(72	)		(30	)		(102	)
Change in accumulated other comprehensive loss	$	129		$	15		$	144		$	106		$	(28	)	$	78

The prior service credit in postretirement benefits in 2011 reflects the adoption of plan amendments resulting from workforce changes and plan design changes to conform with standard Medicare Part D market place offerings. The prior service credit in postretirement benefits in 2010 reflects a reduction in benefits paid for prescription drugs in the Medicare Part D coverage gap in order to take advantage of pharmaceutical rebates beginning in 2011 under health care reform and workforce changes.

In March 2010, the Patient Protection and Affordable Care Act, referred to as the PPACA, as amended by the Health Care and Reconciliation Act of 2010, was signed into law. The PPACA mandates health care reforms with staggered effective dates from 2010 to 2018. The additional postretirement liability resulting from the material impacts of the PPACA have been included in the accumulated postretirement benefit obligation at December 31, 2011. Given the complexity of the PPACA and the extended time period in which implementation is expected to occur, further adjustments to the accumulated postretirement benefit obligation may be necessary in the future.

	Pension Benefits						Postretirement
	2011			2010			2011			2010
Weighted-average assumptions used to determine benefit obligations at December 31:
Discount rate		5.00	%		5.66	%		4.84	%		5.52	%
Rate of compensation increase		5.00	%		5.00	%		5.00	%		5.00	%

The measurement date used for all plans was December 31.

The accumulated benefit obligation, which represents benefits earned to date, for all pension plans was $5,660 million and $5,410 million for the years ended December 31, 2011 and 2010, respectively.

Pension plans experiencing accumulated benefit obligations, which represent benefits earned to date, in excess of plan assets are summarized below:

	December 31,
	2011		2010
Projected benefit obligation	$	5,737	$	5,499
Accumulated benefit obligation		5,630		5,380
Plan assets		5,074		4,901

The components of the total benefit cost and assumptions are set forth below:

	Pension Benefits									Postretirement Benefits
	2011			2010			2009			2011			2010			2009
Components of total benefit cost:
Service cost	$	26		$	29		$	31		$	3		$	4		$	4
Interest cost		300			319			319			75			80			80
Expected return on plan assets		(373	)		(343	)		(264	)		(18	)		(18	)		(16	)
Amortization of prior service cost (credit)		4			4			4			(29	)		(24	)		(24	)
MTM adjustment		110			3			14			35			107			35
Curtailment		—			—			—			—			1			—
Special termination benefits		—			—			8			—			—			—
Settlements		—			—			1			—			—			—
Total benefit cost	$	67		$	12		$	113		$	66		$	150		$	79

RAI incurred special termination benefits due to changes in the organizational structure of RJR Tobacco and settlements due to early retirements under non-qualified pension plans. See note 5 for additional information regarding the restructuring.

The estimated prior service cost for pension plans that is expected to be amortized from accumulated other comprehensive loss into net periodic benefit cost during 2012 is $4 million. The estimated prior service credit for the postretirement plans that is expected to be amortized from accumulated other comprehensive loss into net postretirement health-care costs during 2012 is $21 million.

	Pension Benefits									Postretirement Benefits
	2011			2010			2009			2011			2010			2009
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31:
Discount rate		5.66	%		6.30	%		6.40	%		5.52	%		6.20	%		6.39	%
Expected long-term return on plan assets		7.73	%		8.24	%		8.24	%		7.00	%		7.00	%		6.80	%
Rate of compensation increase		5.00	%		5.00	%		5.00	%		5.00	%		5.00	%		5.00	%

RAI generally uses a hypothetical bond matching analysis to determine the discount rate. The discount rate modeling process involves selecting a portfolio of high quality corporate bonds whose cash flows, via coupons and maturities, match the projected cash flows of the obligations.

The overall expected long-term rate of return on assets assumptions for pension and postretirement assets are based on: (1) the target asset allocation for plan assets, (2) long-term capital markets forecasts for asset classes employed, and (3) excess return expectations of active management to the extent asset classes are actively managed.

For purposes of calculating the expected return on plan assets, RAI no longer uses an averaging technique for the market related value of plan assets, but instead uses the actual fair value of assets permitted under GAAP. In 2011, the combination of an increase in the fair value of plan assets, offset by a lower discount rate, resulted in an unfavorable change in funded status and a charge to accumulated other comprehensive loss. In 2010, the combination of an increase in the fair value of plan assets and lower prior services costs, offset by a lower discount rate, resulted in a favorable change in funded status and a charge to accumulated other comprehensive loss.

Plan assets are invested using active investment strategies and multiple investment management firms. Managers within each asset class cover a range of investment styles and approaches and are combined in a way that controls for capitalization, style biases, and interest rate exposures, while focusing primarily on security selection as a means to add value. Risk is controlled through diversification among asset classes, managers, styles and securities. Risk is further controlled both at the manager and asset class level by assigning excess return and tracking error targets against related benchmark indices. Investment manager performance is evaluated against these targets.

In 2010, RAI adopted a risk mitigating strategy which seeks to balance pension plan returns with a reasonable level of funded status volatility. Based on this framework, the asset allocation has two primary components. The first component is the “hedging portfolio,” which uses extended duration fixed income holdings and derivatives to match a portion of the interest rate risk associated with the benefit obligations, thereby reducing expected funded status volatility. The second component is the “return seeking portfolio,” which is designed to enhance portfolio returns. The return seeking portfolio is broadly diversified across asset classes.

Allowable investment types include domestic equity, international equity, global equity, fixed income, real estate, private equity, hedge funds, global tactical asset allocation and commodities. The range of allowable investment types utilized for pension assets provides enhanced returns and more widely diversifies the plan. Domestic equities are composed of common stocks of large, medium and small companies. International equities include equity securities issued by companies domiciled outside the United States and in depository receipts, which represent ownership of securities of non-U.S. companies. Global equities include a combination of both U.S. and non-U.S. securities. Fixed income includes corporate debt obligations, fixed income securities issued or guaranteed by the U.S. government, and to a lesser extent by non-U.S. governments, mortgage backed securities, and dollar-denominated obligations issued in the United States by non-U.S. banks and corporations. Up to 15% of the fixed income assets can be in debt securities that are below investment grade. Real estate consists of publicly traded real estate investment trust securities and private real estate investments. Private equity consists of the unregistered securities of private and public companies. Hedge fund investments are diversified portfolios utilizing multiple strategies that invest primarily in public securities, including equities and fixed income. Global tactical asset allocation strategies evaluate relative value within and across asset categories and overweight the attractive markets/assets while simultaneously underweighting less attractive markets/assets. Once funded, commodities will utilize futures contracts to invest in a variety of energy, metal and agricultural goods.

For pension assets, futures and forward contracts are used for portfolio rebalancing and to approach fully invested portfolio positions. Otherwise, a small number of investment managers employ limited use of derivatives, including futures contracts, options on futures, forward contracts and interest rate swaps in place of direct investment in securities to gain efficient exposure to markets.

RAI’s pension and postretirement plans weighted-average asset allocations at December 31, 2011 and 2010, by asset category were as follows:

	Pension Plans
	2011 Target(1 )			2011			2010 Target(1 )			2010
Asset Category:
Domestic equities		9	%		11	%		27	%		28	%
International equities		11	%		13	%		13	%		12	%
Global equities		9	%		6	%		5	%		7	%
Fixed income		53	%		55	%		40	%		38	%
High yield fixed income		3	%		3	%		2	%		3	%
Hedge funds		4	%		5	%		7	%		6	%
Private equity		1	%		1	%		2	%		1	%
Real estate		4	%		4	%		2	%		3	%
Global tactical asset allocation		2	%		2	%		2	%		2	%
Commodities (2)		4	%		—	%		—	%		—	%
Total		100	%		100	%		100	%		100	%

⁽¹⁾ Allows for a rebalancing range of up to 5 percentage points around target asset allocations.

⁽²⁾  Commodities were approved in December 2011 and are expected to be funded in 2012.

	Postretirement Plans
	2011 Target(1 )			2011			2010 Target(1 )			2010
Asset Category:
Domestic equities		21	%		21	%		42	%		43	%
International equities		21	%		19	%		16	%		16	%
Fixed income		58	%		57	%		39	%		36	%
Hedge funds		—	%		—	%		1	%		1	%
Cash and other		—	%		3	%		2	%		4	%
Total		100	%		100	%		100	%		100	%

⁽¹⁾  Allows for a rebalancing range of up to 5 percentage points around target asset allocations.

RAI’s pension and postretirement plan assets, excluding uninvested cash and unsettled trades, carried at fair value on a recurring basis as of December 31, 2011, were as follows⁽¹⁾ :

Pension Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	765	$	247	$	—	$	1,012
International equities		118		401		—		519
Global equities		322		—		—		322
Fixed income		40		2,082		36		2,158
High yield fixed income		—		144		—		144
Hedge funds		—		—		249		249
Private equity		—		—		46		46
Real estate		35		—		161		196
Global tactical asset allocation		—		91		—		91
Other		1		77		2		80
Total	$	1,281	$	3,042	$	494	$	4,817

Postretirement Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	—	$	54	$	—	$	54
International equities		—		48		—		48
Fixed income		15		129		—		144
Other		—		6		—		6
Total	$	15	$	237	$	—	$	252

⁽¹⁾  See note 1 for additional information on the fair value hierarchy.

RAI’s pension and postretirement plan assets carried at fair value on a recurring basis as of December 31, 2010, were as follows⁽¹⁾:

Pension Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	781	$	246	$	—	$	1,027
International equities		126		468		—		594
Global equities		351		1		—		352
Fixed income		34		1,542		55		1,631
High yield fixed income		—		136		—		136
Hedge funds		—		2		274		276
Private equity		—		3		45		48
Real estate		46		20		90		156
Global tactical asset allocation		—		98		—		98
Other		4		564		3		571
Total	$	1,342	$	3,080	$	467	$	4,889

Postretirement Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	—	$	115	$	—	$	115
International equities		—		44		—		44
Fixed income		1		95		—		96
Hedge funds		—		—		1		1
Real estate and other		—		14		—		14
Total	$	1	$	268	$	1	$	270

⁽¹⁾ See note 1 for additional information on the fair value hierarchy.

Transfers of pension and postretirement plan assets in and out of Level 3 during 2011, by asset category were as follows:

	Balance as of January  1, 2011		Purchases, Sales, Issuances and Settlements (net)			Realized Gains			Unrealized Gains (Losses)			Transferred From Other Levels(1)		Balance as of December 31, 2011
Fixed income	$	55	$	(24	)	$	11		$	(8	)	$	2	$	36
Hedge funds		275		(19	)		47			(54	)		—		249
Private equity		45		(4	)		4			1			—		46
Real estate		90		54			1			16			—		161
Other		3		—			(1	)		—			—		2
Total	$	468	$	7		$	62		$	(45	)	$	2	$	494

⁽¹⁾ Transfers in and out of Level 3 occur using the fair value at the beginning of the period.

Transfers of pension and postretirement plan assets in and out of Level 3 during 2010, by asset category were as follows:

	Balance as of January  1, 2010		Purchases, Sales, Issuances and Settlements (net)			Realized Gains		Unrealized Gains (Losses)			Transferred From Other Levels		Balance as of December 31, 2010
Fixed income	$	96	$	(54	)	$	18	$	(5	)	$	—	$	55
Hedge funds		291		(33	)		15		2			—		275
Private equity		43		(3	)		1		4			—		45
Real estate		31		52			—		7			—		90
Other		3		—			—		—			—		3
Total	$	464	$	(38	)	$	34	$	8		$	—	$	468

The fair value of pension and postretirement assets classified as fixed income and certain of those classified as real estate and hedge funds, classified as Level 3, was determined primarily using an income approach. This approach utilized the net asset value of the underlying investment fund adjusted for restrictions or illiquidity of the disposition of the interest, valuations provided by the fund’s cash flows, and the rights and obligations of the ownership interest of the fund.

The fair value of pension and postretirement assets classified as private equity and certain of those classified as real estate and hedge funds, classified as Level 3, was determined primarily using an income approach. The fair value was determined by qualified appraisers utilizing observable and unobservable data, including comparable transactions, the fair value of the underlying assets, discount rates, restrictions on disposing interests in the investment’s cash flows and other entity specific risk factors.

The fair value of pension and postretirement assets classified as other, classified as Level 3, was determined primarily using an income approach that utilized cash flow models and benchmarking strategies. This approach utilized observable inputs, including market-based interest rate curves, corporate credit spreads and corporate ratings. Additionally, unobservable factors incorporated into these models included default probability assumptions, potential recovery and discount rates.

Additional information relating to RAI’s significant postretirement plans is as follows:

	2011			2010
Weighted-average health-care cost trend rate assumed for the following year		12.94	%		15.18	%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)		5.00	%		5.00	%
Year that the rate reaches the ultimate trend rate		2018			2018

Assumed health-care cost trend rates have a significant effect on the amounts reported for the health-care plans. A one-percentage-point change in assumed health-care cost trend rates would have had the following effects at December 31, 2011:

	1-Percentage Point Increase		1-Percentage Point Decrease
Effect on total of service and interest cost components	$	4	$	(4	)
Effect on benefit obligation		75		(65	)

During 2012, RAI expects to contribute approximately $309 million to its pension plans and expects payments related to its postretirement plans to be $70 million.

Estimated future benefits payments:

			Postretirement Benefits
Year	Pension Benefits		Gross Projected Benefit  Payments Before Medicare Part D Subsidies		Expected Medicare Part D Subsidies		Net Projected Benefit  Payments After Medicare Part D Subsidies
2012	$	407	$	109	$	3	$	106
2013		399		112		3		109
2014		395		113		4		109
2015		395		112		4		108
2016		397		111		4		107
2017-2021		1,951		530		26		504

RAI sponsors qualified defined contribution plans. The expense related to these plans was $37 million, $39 million and $40 million, in 2011, 2010 and 2009, respectively. Included in the plans is a non-leveraged employee stock ownership plan, which holds shares of the Reynolds Stock Fund. Participants can elect to contribute to the fund. Dividends paid on shares are reflected as a reduction of equity. All shares are considered outstanding for earnings per share computations.

XML

Quarterly Results of Operations (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2011

Quarterly Results of Operations [Abstract]

Quarterly results of operations

	First			Second			Third			Fourth
		(2	)		(3	)		(4	)		(5	)
2011 (1)
Net sales	$	1,991		$	2,267		$	2,200		$	2,083
Gross profit		956			1,074			1,075			972
Net income		381			327			394			304
Per share data (10) :
Basic:
Net income		0.65			0.56			0.68			0.52
Diluted:
Net income		0.65			0.56			0.67			0.52
2010 (1)		(6	)		(7	)		(8	)		(9	)
Net sales	$	1,986		$	2,245		$	2,239		$	2,081
Gross profit		929			1,075			1,068			935
Net income		100			359			400			262
Per share data (10) :
Basic:
Income from continuing operations		0.54			0.62			0.69			0.45
Loss on discontinued operations, net of tax		(0.37	)		—			—			—
Net income		0.17			0.62			0.69			0.45
Diluted:
Income from continuing operations		0.54			0.61			0.68			0.45
Loss on discontinued operations, net of tax		(0.37	)		—			—			—
Net income		0.17			0.61			0.68			0.45

⁽¹⁾ As revised for the change in the method of recognizing pension expense. See note 1 for a discussion of the change and the impacts of the change for the year ended December 31, 2010.

⁽²⁾ For the quarter ended March 31, 2011, the retrospective change in recognizing pension expense increased gross profit by $26 million, net income by $28 million and earnings per share, basic and diluted by $0.04 and $0.05, respectively.

⁽³⁾ For the quarter ended June 30, 2011, the retrospective change in recognizing pension expense increased gross profit by $22 million, net income by $23 million and earnings per share, basic and diluted by $0.04.

⁽⁴⁾ For the quarter ended September 30, 2011, the retrospective change in recognizing pension expense increased gross profit by $23 million, net income by $27 million and earnings per share, basic and diluted by $0.05 and $0.04, respectively.

⁽⁵⁾ For the quarter ended December 31, 2011, includes $145 million of pension expense as a result of MTM adjustments. Fourth quarter of 2011 net income includes a $48 million trademark impairment charge.

⁽⁶⁾  For the quarter ended March 31, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $18 million, earnings per share, basic and diluted by $0.03.

⁽⁷⁾  For the quarter ended June 30, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $18 million and earnings per share, basic and diluted by $0.04 and $0.03, respectively. Second quarter of 2010 net income includes $38 million of asset impairment and exit charges.

⁽⁸⁾  For the quarter ended September 30, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $19 million and earnings per share, basic and diluted by $0.04 and $0.03, respectively.

⁽⁹⁾  For the quarter ended December 31, 2010, the retrospective change in recognizing pension expense decreased gross profit by $39 million, net income by $47 million and earnings per share, basic and diluted by $0.08. Fourth quarter of 2010 net income includes a $6 million trademark impairment charge and a $26 million goodwill impairment charge.

⁽¹⁰⁾ Income per share is computed independently for each of the periods presented. The sum of the income per share amounts for the quarters may not equal the total for the year.

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2011

Commitments and Contingencies [Abstract]

Categories of the U.S. tobacco-related cases pending against RJR Tobacco

Case Type	RJR Tobacco’s Case  Numbers as of December 31, 2011			Change in Number of Cases Since September 30, 2011 Increase/(Decrease)			Page Reference
Individual Smoking and Health		97			4			112
West Virginia IPIC (Number of Plaintiffs)*		1(577	)		(– 11	)		114
Engle Progeny (Number of Plaintiffs)**		6,561 (7,852	)		– 32 (– 47	)		115
Broin II		2,586			No Change			125
Class-Action		13			– 2			125
Health-Care Cost Recovery		3			No Change			131
State Settlement Agreements-Enforcement and Validity; Adjustments		32			– 1			138
Antitrust		1			No Change			143
Other Litigation and Developments		12			– 3			144

* Includes as one case the 577 cases pending as a consolidated action In Re: Tobacco Litigation Individual Personal Injury Cases, sometimes referred to as West Virginia IPIC cases, described below. The West Virginia IPIC cases have been separated from the Individual Smoking and Health cases for reporting purposes.

** The Engle Progeny cases have been separated from the Individual Smoking and Health cases for reporting purposes. The number of cases may decrease as the result of many of the multiple plaintiff federal court cases either being dismissed or consolidated.

Verdicts in the individual Engle Progeny cases that have been tried and remain pending

Plaintiff Case Name	RJR Tobacco Allocation of Fault			Compensatory Damages (as adjusted)*		Punitive Damages		Appeal Status
Martin		66	%	$	3,300,000	$	25,000,000	USSC petition filed
Campbell		39	%		3,040,000		—	USSC petition filed
Gray		60	%		4,200,000		2,000,000	USSC petition filed
Hall		65	%		3,250,000		12,500,000	USSC petition filed
Totals				$	13,790,000	$	39,500,000

* Compensatory damages are adjusted to reflect the reduction required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments should they ever have to be paid.

Plaintiff Case Name	RJR Tobacco Allocation of Fault			Compensatory Damages (as adjusted)*		Punitive Damages		Appeal Status
Sherman		50	%	$	775,000	$	—	Pending — Fourth DCA
Brown		50	%		600,000		—	Notice to invoke discretionary jurisdiction of Florida Supreme Court pending
Douglas		5	%		250,000		—	Pending — Second DCA
Cohen		33.3	%		3,300,000		10,000,000	Pending — Fourth DCA
Clay		60	%		2,100,000		17,000,000	Affirmed by First DCA per curiam; seeking further review
Townsend		51	%		5,500,000		40,800,000	Pending — First DCA
Putney		30	%		4,500,000		2,500,000	Pending — Fourth DCA
Grossman		25	%		484,000		—	Pending — Fourth DCA
Buonomo		77.5	%		4,060,000		15,700,000	Pending — Fourth DCA
Alexander		51	%		1,275,000		2,500,000	Affirmed by First DCA per curiam; seeking further review
Piendle		27.5	%		1,100,000		180,000	Pending — Fourth DCA
Koballa		30	%		300,000		—	Pending — Fifth DCA***
Webb		90	%		7,200,000		72,000,000	Pending — First DCA
Kirkland		10	%		10,000		250,000	Pending — Second DCA
Huish		25	%		188,000		1,500,000	Pending — First DCA
Mack		51	%		510,000		—	Pending — First DCA
Andy Allen		45	%	$	2,700,000	$	8,100,000	Pending — First DCA
Jewett		20	%		219,000		—	Pending — First DCA
Reese		30	%		1,100,000		—	Pending — Third DCA
Soffer		40	%		2,000,000		—	Pending — First DCA
Ciccone		30	%		1,000,000		50,000	Pending — Fourth DCA
Weingart		3	%		4,500		—	Pending — Fourth DCA
Bowman		30	%		450,000		—	Pending — First DCA
Sury		20	%		200,000		—	Post-trial motions pending**
Hallgren		25	%		500,000		750,000	Post-trial motions pending**
Ward		30	%		300,000		1,700,000	Post-trial motion pending**
Totals				$	40,625,500	$	173,030,000

* Compensatory damages are adjusted to reflect the reduction required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments should they ever have to be paid.

** Should the pending post-trial motions be denied, RJR Tobacco will file a notice of appeal with the DCA in which the cases are pending.

*** The court in Koballa found RJR Tobacco not liable for the plaintiff’s injuries, but awarded damages. For a detailed description of the case, see “— Engle and Engle Progeny Cases” below.

Commitments and Contingencies related to settlements

Unadjusted Original Participating Manufacturers’ Settlement Payment Schedule

	2009			2010			2011		2012 and thereafter
First Four States’ Settlements: (1)
Mississippi Annual Payment	$	136		$	136		$	136	$	136
Florida Annual Payment		440			440			440		440
Texas Annual Payment		580			580			580		580
Minnesota Annual Payment		204			204			204		204
Remaining States’ Settlement:
Annual Payments (1)		8,004			8,004			8,004		8,004
Growers’ Trust (2)		295			295			—		—
Offset by federal tobacco buyout (2)		(295	)		(295	)		—		—
Total	$	9,364		$	9,364		$	9,364	$	9,364

RAI’s Operating Subsidiaries’ Settlement Expenses and Payment Schedule

Settlement expenses	$	2,540	$	2,496	$	2,435		—
Settlement cash payments	$	2,249	$	2,519	$	2,492		—
Projected settlement expenses							$	>2,400
Projected settlement cash payments							$	>2,400

⁽¹⁾ Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share. For further information, see “— State Settlement Agreements-Enforcement and Validity; Adjustments” below.

⁽²⁾ The Growers’ Trust payments expired December 2010 and were offset by certain obligations resulting from the federal tobacco buyout legislation, not included in this table, signed in October 2004. See “— Tobacco Buyout Legislation and Related Litigation” below.

Disputed portion of MSA payment obligation

Year for which NPM Adjustment Calculated		2003		2004		2005		2006		2007		2008
Year in which deduction from NPM may be taken		2006		2007		2008		2009		2010		2011
RJR Tobacco’s approximate share of disputed NPM Adjustment (millions)	$	615	$	562	$	445	$	419	$	447	$	477

Noncancellable operating leases future minimum lease payments

	Noncancellable Operating  Leases
2012	$	20
2013		18
2014		15
2015		9
2016		4
Total	$	66

XML

Long-Term Debt (Details) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Long-term debt, net of discounts and including fair value adjustments
Total long-term debt (less current maturities)	$ 3,206	$ 3,701
Current maturities of long-term debt	457	400
Total	3,663	4,101
RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total long-term debt (less current maturities)	3,145	3,580
Current maturities of long-term debt	399	400
Total	3,146	3,580
RJR [Member]
Long-term debt, net of discounts and including fair value adjustments
Total	60	121
9.25%, notes due 2013 [Member] | RJR [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt	60	60
7.25% guaranteed, notes due 2012 [Member] | RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt		412
7.25% guaranteed, notes due 2012 [Member] | RJR [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt		61
7.3% guaranteed, notes due 2015 [Member] | RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt	199	199
6.75% guaranteed, notes due 2017 [Member] | RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt	797	811
7.25% guaranteed, notes due 2013 [Member] | RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt	624	623
7.25% guaranteed, notes due 2037 [Member] | RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt	448	448
7.625% guaranteed, notes due 2016 [Member] | RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt	829	838
7.75% guaranteed, notes due 2018 [Member] | RAI [Member]
Long-term debt, net of discounts and including fair value adjustments
Total RAI debt	$ 249	$ 249

XML

Retirement Benefits (Details 4) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Accumulated benefit obligations
Projected benefit obligation	$ 5,737	$ 5,499
Accumulated benefit obligation	5,630	5,380
Plan assets	$ 5,074	$ 4,901

XML

Income Per Share (Tables)

12 Months Ended

Dec. 31, 2011

Income Per Share [Abstract]

Components of the calculation of income per share

	For the Years Ended December 31,
	2011		2010			2009
Income from continuing operations	$	1,406	$	1,337		$	955
Losses from discontinued operations		—		(216	)		—
Net income	$	1,406	$	1,121		$	955
Basic weighted average shares, in thousands		582,320		582,996			582,761
Effect of dilutive potential shares:
Stock units		3,063		1,858			891
Diluted weighted average shares, in thousands		585,383		584,854			583,652

XML

Business and Summary of Significant Accounting Policies (Details 1) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended													12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009		Dec. 31, 2011 Accumulated Deficit [Member]	Dec. 31, 2010 Accumulated Deficit [Member]	Dec. 31, 2009 Accumulated Deficit [Member]	Dec. 31, 2011 Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2010 Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2009 Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2008 Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2011 Comprehensive income (loss) [Member]	Dec. 31, 2010 Comprehensive income (loss) [Member]	Dec. 31, 2009 Comprehensive income (loss) [Member]	Dec. 31, 2010 Previously Reported [Member]		Dec. 31, 2009 Previously Reported [Member]	Dec. 31, 2010 Previously Reported [Member] Accumulated Deficit [Member]	Dec. 31, 2009 Previously Reported [Member] Accumulated Deficit [Member]	Dec. 31, 2010 Previously Reported [Member] Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2009 Previously Reported [Member] Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2010 Previously Reported [Member] Comprehensive income (loss) [Member]	Dec. 31, 2009 Previously Reported [Member] Comprehensive income (loss) [Member]	Dec. 31, 2010 Revised [Member]	Dec. 31, 2009 Revised [Member]	Dec. 31, 2010 Revised [Member] Accumulated Deficit [Member]	Dec. 31, 2009 Revised [Member] Accumulated Deficit [Member]	Dec. 31, 2010 Revised [Member] Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2009 Revised [Member] Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2010 Revised [Member] Comprehensive income (loss) [Member]	Dec. 31, 2009 Revised [Member] Comprehensive income (loss) [Member]	Dec. 31, 2010 Effect Of Change [Member]	Dec. 31, 2009 Effect Of Change [Member]	Dec. 31, 2010 Effect Of Change [Member] Accumulated Deficit [Member]	Dec. 31, 2009 Effect Of Change [Member] Accumulated Deficit [Member]	Dec. 31, 2010 Effect Of Change [Member] Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2009 Effect Of Change [Member] Accumulated Other Comprehensive Loss [Member]	Dec. 31, 2010 Effect Of Change [Member] Comprehensive income (loss) [Member]	Dec. 31, 2009 Effect Of Change [Member] Comprehensive income (loss) [Member]
Consolidated statements of income:
Cost of products sold									$ 4,464	[1]	$ 4,544	[1]	$ 4,488	[1]											$ 4,544		$ 4,485							$ 4,544	$ 4,488								$ 3
Selling, general and administrative expenses									1,606		1,480		1,517												1,493		1,508							1,480	1,517							(13)	9
Operating income									2,399		2,432		1,763												2,419		1,775							2,432	1,763							13	(12)
Income from continuing operations before income taxes									2,186		2,205		1,522												2,192		1,534							2,205	1,522							13	(12)
Provision for income taxes									780		868		567												863		572							868	567							5	(5)
Income from continuing operations									1,406		1,337		955												1,329	[1]	962							1,337	955							8	(7)
Net income	304	394	327	381	262	400	359	100	1,406		1,121		955		1,406	1,121	955					1,406	1,121	955	1,113		962	1,113	962			1,113	962	1,121	955	1,121	955			1,121	955	8	(7)	8	(7)			8	(7)
Earnings per share - basic	$ 0.52	$ 0.68	$ 0.56	$ 0.65	$ 0.45	$ 0.69	$ 0.62	$ 0.17	$ 2.41		$ 1.92		$ 1.64												$ 1.91		$ 1.65							$ 1.92	$ 1.64							$ 0.01	$ (0.01)
Earnings per share - diluted	$ 0.52	$ 0.67	$ 0.56	$ 0.65	$ 0.45	$ 0.68	$ 0.61	$ 0.17	$ 2.40		$ 1.92		$ 1.64												$ 1.90		$ 1.65							$ 1.92	$ 1.64							$ 0.02	$ (0.01)
Consolidated balance sheet:
Accumulated deficit	(1,660)				(1,807)				(1,660)		(1,807)														(547)									(1,807)								(1,260)
Accumulated other comprehensive loss	(382)				(218)				(382)		(218)														(1,478)									(218)								1,260
Cash flows from (used in) operating activities:
Net income	304	394	327	381	262	400	359	100	1,406		1,121		955		1,406	1,121	955					1,406	1,121	955	1,113		962	1,113	962			1,113	962	1,121	955	1,121	955			1,121	955	8	(7)	8	(7)			8	(7)
Deferred income tax expense (benefit)									100		187		(159)												182		(154)							187	(159)							5	(5)
Pension and postretirement									(165)		(715)		(169)												(702)		(181)							(715)	(169)							(13)	12
Consolidated statements of shareholders' equity and comprehensive income (loss):
Beginning Balance				6,510				6,498	6,510		6,498		6,237		(1,807)	(1,847)	(1,792)	(382)	(218)	(153)	(434)							(579)	(531)	(1,421)	(1,695)					(1,847)	(1,792)	(153)	(434)					(1,268)	(1,261)	1,268	1,261
Pension and other postretirement benefit adjustments																														-70	267	-70	267					-78	274	-78	274					-8	7	-8	7
Net income	304	394	327	381	262	400	359	100	1,406		1,121		955		1,406	1,121	955					1,406	1,121	955	1,113		962	1,113	962			1,113	962	1,121	955	1,121	955			1,121	955	8	(7)	8	(7)			8	(7)
Ending Balance	$ 6,251				$ 6,510				$ 6,251		$ 6,510		$ 6,498		$ (1,660)	$ (1,807)	$ (1,847)	$ (382)	$ (218)	$ (153)	$ (434)							$ (547)	$ (579)	$ (1,478)	$ (1,421)					$ (1,807)	$ (1,847)	$ (218)	$ (153)					$ (1,260)	$ (1,268)	$ 1,260	$ 1,268

[1] Excludes excise taxes of $4,107 million, $4,340 million and $3,927 million for the years ended December 31, 2011, 2010 and 2009, respectively.

XML

Restructuring Charges (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Activities in restructuring reserves
Original accrual			$ 56
2009 Restructuring Charge [Member]
Activities in restructuring reserves
Original accrual			56
Utilized	(24)	(22)	(8)
Ending Balance	2	26	48	0
2008 Restructuring Charge [Member]
Activities in restructuring reserves
Original accrual				91
Utilized	(10)	(27)	(38)	(12)
Adjusted				(1)
Ending Balance	$ 3	$ 13	$ 40	$ 78

XML

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Details 1) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Condensed Consolidating Statements of Cash Flows
Net cash flows from operating activities	$ 1,420	$ 1,265	$ 1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		4	19
Proceeds from settlement of long-term investments	2	13	6
Capital expenditures	(190)	(174)	(141)
Net proceeds from sale of business	202
Acquisition, net of cash acquired			(43)
Proceeds from termination of joint venture	32	28	24
Other, net	14	3	12
Net cash flows from (used in) investing activities	60	(126)	(123)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(1,212)	(1,049)	(991)
Repurchase of common stock	(282)	(5)	(5)
Repayments of long-term debt	(400)	(300)	(200)
Proceeds from termination of interest rate swaps	186
Other, net	(6)	5	4
Net cash flows used in financing activities	(1,714)	(1,349)	(1,192)
Effect of exchange rate changes on cash and cash equivalents	(5)	(11)	6
Net cash flows related to discontinued operations, net of tax benefit		(307)
Net change in cash and cash equivalents	(239)	(528)	145
Cash and cash equivalents at beginning of year	2,195	2,723	2,578
Cash and cash equivalents at end of year	1,956	2,195	2,723
RAI [Member]
Condensed Consolidating Statements of Cash Flows
Net cash flows from operating activities	641	442	678
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments			1
Net proceeds from sale of business	79
Return of intercompany investments	1,040	897	610
Other, net	40	40	40
Net cash flows from (used in) investing activities	1,159	937	651
Cash flows from (used in) financing activities:
Dividends paid on common stock	(1,212)	(1,049)	(991)
Repurchase of common stock	(282)	(5)	(5)
Repayments of long-term debt	(400)	(300)	(189)
Proceeds from termination of interest rate swaps	185
Dividends paid on preferred stock	(43)	(43)	(43)
Other, net	(47)	(16)	(12)
Net cash flows used in financing activities	(1,799)	(1,413)	(1,240)
Net change in cash and cash equivalents	1	(34)	89
Cash and cash equivalents at beginning of year	327	361	272
Cash and cash equivalents at end of year	328	327	361
Guarantors [Member]
Condensed Consolidating Statements of Cash Flows
Net cash flows from operating activities	1,571	1,153	1,630
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		4	18
Proceeds from settlement of long-term investments	2	13	6
Capital expenditures	(190)	(171)	(137)
Net proceeds from sale of business	123
Contributions to intercompany investments		(75)
Other, net	58	26	29
Net cash flows from (used in) investing activities	(7)	(203)	(84)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(740)	(300)	(840)
Repayments of long-term debt			(11)
Proceeds from termination of interest rate swaps	1
Distribution of equity	(1,040)	(897)	(610)
Other, net	(40)	(40)	(40)
Net cash flows used in financing activities	(1,819)	(1,237)	(1,501)
Net cash flows related to discontinued operations, net of tax benefit		(233)
Net change in cash and cash equivalents	(255)	(520)	45
Cash and cash equivalents at beginning of year	1,616	2,136	2,091
Cash and cash equivalents at end of year	1,361	1,616	2,136
Non-Guarantors [Member]
Condensed Consolidating Statements of Cash Flows
Net cash flows from operating activities	(3)	13	29
Cash flows from (used in) investing activities:
Capital expenditures		(3)	(4)
Acquisition, net of cash acquired			(43)
Proceeds from termination of joint venture	32	28	24
Net cash flows from (used in) investing activities	32	25	(23)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(6)
Receipt of equity		75
Other, net	(3)	(2)	(1)
Net cash flows used in financing activities	(9)	73	(1)
Effect of exchange rate changes on cash and cash equivalents	(5)	(11)	6
Net cash flows related to discontinued operations, net of tax benefit		(74)
Net change in cash and cash equivalents	15	26	11
Cash and cash equivalents at beginning of year	252	226	215
Cash and cash equivalents at end of year	267	252	226
Eliminations [Member]
Condensed Consolidating Statements of Cash Flows
Net cash flows from operating activities	(789)	(343)	(883)
Cash flows from (used in) investing activities:
Return of intercompany investments	(1,040)	(897)	(610)
Contributions to intercompany investments		75
Other, net	(84)	(63)	(57)
Net cash flows from (used in) investing activities	(1,124)	(885)	(667)
Cash flows from (used in) financing activities:
Dividends paid on common stock	746	300	840
Dividends paid on preferred stock	43	43	43
Receipt of equity		(75)
Distribution of equity	1,040	897	610
Other, net	84	63	57
Net cash flows used in financing activities	$ 1,913	$ 1,228	$ 1,550

XML

Intangible Assets (Details 1) (USD $) In Millions, unless otherwise specified					12 Months Ended												12 Months Ended			12 Months Ended				12 Months Ended
	Dec. 31, 2011 Santa Fe [Member]	Dec. 31, 2010 Santa Fe [Member]	Dec. 31, 2009 Santa Fe [Member]	Dec. 31, 2008 Santa Fe [Member]	Dec. 31, 2011 All Other [Member]	Dec. 31, 2010 All Other [Member]	Dec. 31, 2008 All Other [Member]	Dec. 31, 2010 Trademarks [Member]	Dec. 31, 2009 Trademarks [Member]	Dec. 31, 2008 Trademarks [Member]	Dec. 31, 2011 Trademarks [Member] RJR Tobacco [Member]	Dec. 31, 2010 Trademarks [Member] RJR Tobacco [Member]	Dec. 31, 2008 Trademarks [Member] RJR Tobacco [Member]	Dec. 31, 2010 Trademarks [Member] American Snuff [Member]	Dec. 31, 2008 Trademarks [Member] American Snuff [Member]	Dec. 31, 2011 Trademarks [Member] American Snuff [Member]	Dec. 31, 2011 Trademarks [Member] Consolidated [Member]	Dec. 31, 2010 Trademarks [Member] Consolidated [Member]	Dec. 31, 2008 Other Intangible Assets [Member]	Dec. 31, 2008 Other Intangible Assets [Member] RJR Tobacco [Member]	Dec. 31, 2011 Other Intangible Assets [Member] RJR Tobacco [Member]	Dec. 31, 2010 Other Intangible Assets [Member] RJR Tobacco [Member]	Dec. 31, 2009 Other Intangible Assets [Member] RJR Tobacco [Member]	Dec. 31, 2011 Other Intangible Assets [Member] Consolidated [Member]	Dec. 31, 2010 Other Intangible Assets [Member] Consolidated [Member]
Indefinite-lived:
Beginning Balance	$ 155	$ 155	$ 155	$ 155	$ 50	$ 47			$ 3,030		$ 1,152	$ 1,163		$ 1,152		$ 1,136	$ 2,443	$ 2,470	$ 103		$ 99	$ 99	$ 99	$ 149	$ 146
Impairment charge									(6)	(560)	(43)		(490)	(6)	(70)		(43)
Intersegment transfer							(44)													44
Acquisition of Niconovum AB							43												43
Foreign currency translation					(1)	3																		(1)	3
Reclassified as held for sale												(11)		(3)				(14)
Reclassified to finite-lived								(7)						(7)
Ending Balance	$ 155	$ 155	$ 155	$ 155	$ 49	$ 50	$ 48			$ 3,030	$ 1,109	$ 1,152	$ 1,653	$ 1,136	$ 1,222	$ 1,136	$ 2,400	$ 2,443	$ 103	$ 55	$ 99	$ 99	$ 99	$ 148	$ 149

XML

Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2011

Related Party Transactions [Abstract]

Summary of balances and transactions

Balances:

	2011		2010
Accounts receivable	$	67	$	48
Accounts payable		2		4
Deferred revenue		42		53

Significant transactions:

	2011		2010		2009
Net sales	$	479	$	381	$	404
Purchases		11		12		16
RAI common stock purchases from B&W		114		—		—
Research and development services billings		5		4		2

XML

Consolidated Statements of Shareholders' Equity and Comprehensive Income (Parenthetical) (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
0140 - Statement - Consolidated Statements of Shareholders' Equity and Comprehensive Income [Abstract]
Tax expense/benefit, retirement benefits	$ (95)	$ (102)	$ 182
Unrealized gain/loss on long-term investments	6	13	2
Tax expense/benefit, cumulative translation adjustment	$ 4	$ 10	$ 7
Annualized dividend per share	$ 2.15	$ 1.84	$ 1.73

XML

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Details 2) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Assets
Cash and cash equivalents	$ 1,956	$ 2,195	$ 2,723	$ 2,578
Accounts receivable	101	118
Accounts receivable, related party	67	48
Other receivables	46	44
Inventories	967	1,055
Deferred income taxes, net	945	946
Prepaid expenses and other	225	195
Assets held for sale	0	201
Total current assets	4,307	4,802
Property, plant and equipment, net	1,070	1,002
Trademarks and other intangible assets, net	2,602	2,675
Goodwill	8,010	8,010
Other assets and deferred charges	265	589
Total assets	16,254	17,078
Liabilities and shareholders' equity
Accounts payable	113	179
Tobacco settlement accruals	2,530	2,589
Due to related party	2	4
Deferred revenue, related party	42	53
Current maturities of long-term debt	457	400
Other current liabilities	1,132	1,147
Total current liabilities	4,276	4,372
Long-term debt (less current maturities)	3,206	3,701
Deferred income taxes, net	511	518
Long-term retirement benefits (less current portion)	1,759	1,668
Other noncurrent liabilities	251	309
Total shareholders' equity	6,251	6,510	6,498	6,237
Total liabilities and shareholders' equity	16,254	17,078
RAI [Member]
Assets
Cash and cash equivalents	328	327	361	272
Other receivables	95	80
Deferred income taxes, net		10
Prepaid expenses and other	19	38
Total current assets	442	455
Property, plant and equipment, net	5	6
Long-term intercompany notes	1,960	2,000
Investment in subsidiaries	9,139	9,696
Other assets and deferred charges	68	267
Total assets	11,614	12,424
Liabilities and shareholders' equity
Current maturities of long-term debt	399	400
Other current liabilities	421	489
Total current liabilities	820	889
Intercompany notes and interest payable	1,325	1,366
Long-term debt (less current maturities)	3,145	3,580
Long-term retirement benefits (less current portion)	48	34
Other noncurrent liabilities	25	45
Total shareholders' equity	6,251	6,510
Total liabilities and shareholders' equity	11,614	12,424
Guarantors [Member]
Assets
Cash and cash equivalents	1,361	1,616	2,136	2,091
Accounts receivable	77	103
Accounts receivable, related party	67	48
Other receivables	50	161
Inventories	929	1,022
Deferred income taxes, net	952	934
Prepaid expenses and other	200	155
Assets held for sale		201
Total current assets	3,636	4,240
Property, plant and equipment, net	1,061	991
Trademarks and other intangible assets, net	2,553	2,625
Goodwill	7,999	7,991
Long-term intercompany notes	1,325	1,366
Investment in subsidiaries	463	462
Other assets and deferred charges	171	242
Total assets	17,208	17,917
Liabilities and shareholders' equity
Accounts payable	107	175
Tobacco settlement accruals	2,530	2,589
Due to related party	2	4
Deferred revenue, related party	42	53
Current maturities of long-term debt	58
Other current liabilities	827	855
Total current liabilities	3,566	3,676
Intercompany notes and interest payable	1,960	2,000
Long-term debt (less current maturities)	61	121
Deferred income taxes, net	553	535
Long-term retirement benefits (less current portion)	1,699	1,622
Other noncurrent liabilities	224	262
Total shareholders' equity	9,145	9,701
Total liabilities and shareholders' equity	17,208	17,917
Non-Guarantors [Member]
Assets
Cash and cash equivalents	267	252	226	215
Accounts receivable	24	15
Other receivables	39	35
Inventories	38	34
Deferred income taxes, net	1	2
Prepaid expenses and other	7	4
Total current assets	376	342
Property, plant and equipment, net	3	4
Trademarks and other intangible assets, net	49	50
Goodwill	11	19
Other assets and deferred charges	71	100
Total assets	510	515
Liabilities and shareholders' equity
Accounts payable	6	4
Other current liabilities	31	37
Total current liabilities	37	41
Deferred income taxes, net	3	3
Long-term retirement benefits (less current portion)	12	12
Other noncurrent liabilities	2	2
Total shareholders' equity	456	457
Total liabilities and shareholders' equity	510	515
Eliminations [Member]
Assets
Other receivables	(138)	(232)
Inventories		(1)
Deferred income taxes, net	(8)
Prepaid expenses and other	(1)	(2)
Total current assets	(147)	(235)
Property, plant and equipment, net	1	1
Long-term intercompany notes	(3,285)	(3,366)
Investment in subsidiaries	(9,602)	(10,158)
Other assets and deferred charges	(45)	(20)
Total assets	(13,078)	(13,778)
Liabilities and shareholders' equity
Other current liabilities	(147)	(234)
Total current liabilities	(147)	(234)
Intercompany notes and interest payable	(3,285)	(3,366)
Deferred income taxes, net	(45)	(20)
Total shareholders' equity	(9,601)	(10,158)
Total liabilities and shareholders' equity	(13,078)	(13,778)
Subsidiaries [Member] | RAI [Member]
Assets
Cash and cash equivalents	328	327	361	272
Other receivables	95	80
Deferred income taxes, net		10
Prepaid expenses and other	19	38
Total current assets	442	455
Property, plant and equipment, net	5	6
Long-term intercompany notes	1,960	2,000
Investment in subsidiaries	9,139	9,696
Other assets and deferred charges	68	267
Total assets	11,614	12,424
Liabilities and shareholders' equity
Current maturities of long-term debt	399	400
Other current liabilities	421	489
Total current liabilities	820	889
Intercompany notes and interest payable	1,325	1,366
Long-term debt (less current maturities)	3,145	3,580
Long-term retirement benefits (less current portion)	48	34
Other noncurrent liabilities	25	45
Total shareholders' equity	6,251	6,510
Total liabilities and shareholders' equity	11,614	12,424
Subsidiaries [Member] | Issuer [Member]
Assets
Cash and cash equivalents	8	14	24	6
Other receivables	38	33
Deferred income taxes, net	1	1
Total current assets	47	48
Long-term intercompany notes	157	174
Investment in subsidiaries	7,076	7,611
Other assets and deferred charges	24	56
Total assets	7,304	7,889
Liabilities and shareholders' equity
Current maturities of long-term debt	58
Other current liabilities	100	138
Total current liabilities	158	138
Long-term debt (less current maturities)	61	121
Long-term retirement benefits (less current portion)	24	25
Other noncurrent liabilities	1	12
Total shareholders' equity	7,060	7,593
Total liabilities and shareholders' equity	7,304	7,889
Subsidiaries [Member] | Guarantors [Member]
Assets
Cash and cash equivalents	1,257	1,506	2,001	1,977
Accounts receivable	62	50
Accounts receivable, related party	67	48
Other receivables	145	225
Inventories	480	600
Deferred income taxes, net	907	892
Prepaid expenses and other	178	130
Assets held for sale		20
Total current assets	3,096	3,471
Property, plant and equipment, net	652	689
Trademarks and other intangible assets, net	1,251	1,316
Goodwill	5,303	5,303
Long-term intercompany notes	1,325	1,366
Investment in subsidiaries	456	435
Other assets and deferred charges	157	194
Total assets	12,240	12,774
Liabilities and shareholders' equity
Accounts payable	87	103
Tobacco settlement accruals	2,461	2,532
Due to related party	2	4
Deferred revenue, related party	42	53
Other current liabilities	711	652
Total current liabilities	3,303	3,344
Deferred income taxes, net	60	76
Long-term retirement benefits (less current portion)	1,579	1,496
Other noncurrent liabilities	222	247
Total shareholders' equity	7,076	7,611
Total liabilities and shareholders' equity	12,240	12,774
Subsidiaries [Member] | Non-Guarantors [Member]
Assets
Cash and cash equivalents	363	348	337	323
Accounts receivable	39	68
Other receivables	110	90
Inventories	487	456
Deferred income taxes, net	45	43
Prepaid expenses and other	28	30
Assets held for sale		181
Total current assets	1,072	1,216
Property, plant and equipment, net	412	306
Trademarks and other intangible assets, net	1,351	1,359
Goodwill	2,707	2,707
Other assets and deferred charges	72	101
Total assets	5,614	5,689
Liabilities and shareholders' equity
Accounts payable	26	76
Tobacco settlement accruals	69	57
Other current liabilities	250	255
Total current liabilities	345	388
Intercompany notes and interest payable	2,117	2,174
Deferred income taxes, net	507	471
Long-term retirement benefits (less current portion)	108	113
Other noncurrent liabilities	3	5
Total shareholders' equity	2,534	2,538
Total liabilities and shareholders' equity	5,614	5,689
Subsidiaries [Member] | Eliminations [Member]
Assets
Other receivables	(342)	(384)
Inventories		(1)
Deferred income taxes, net	(8)
Prepaid expenses and other		(3)
Total current assets	(350)	(388)
Property, plant and equipment, net	1	1
Long-term intercompany notes	(3,442)	(3,540)
Investment in subsidiaries	(16,671)	(17,742)
Other assets and deferred charges	(56)	(29)
Total assets	(20,518)	(21,698)
Liabilities and shareholders' equity
Other current liabilities	(350)	(387)
Total current liabilities	(350)	(387)
Intercompany notes and interest payable	(3,442)	(3,540)
Deferred income taxes, net	(56)	(29)
Total shareholders' equity	(16,670)	(17,742)
Total liabilities and shareholders' equity	$ (20,518)	$ (21,698)

XML

Intangible Assets (Details 2) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Finite-Lived Intangible Assets, Net [Abstract]
Ending Balance	$ 54
Trademarks [Member] | RJR Tobacco [Member]
Finite-Lived Intangible Assets, Net [Abstract]
Amortization	(7)	(9)	(12)
Impairment charge			(1)
Ending Balance	4	11	20
Beginning Balance	11	20	33
Trademarks [Member] | American Snuff [Member]
Finite-Lived Intangible Assets, Net [Abstract]
Amortization	(2)	(1)	(1)
Impairment charge	(5)		(6)
Reclassified as held for sale		(1)
Reclassified to indefinite-lived		7
Ending Balance	11	18	13
Beginning Balance	18	13	20
Trademarks [Member] | Consolidated [Member]
Finite-Lived Intangible Assets, Net [Abstract]
Amortization	(9)	(10)	(13)
Impairment charge	(5)		(7)
Reclassified as held for sale		(1)
Reclassified to indefinite-lived		7
Ending Balance	15	29	33
Beginning Balance	29	33	53
Other Intangible Assets [Member] | RJR Tobacco [Member]
Finite-Lived Intangible Assets, Net [Abstract]
Amortization	(15)	(15)	(15)
Ending Balance	39	54	69
Beginning Balance	54	69	84
Other Intangible Assets [Member] | Consolidated [Member]
Finite-Lived Intangible Assets, Net [Abstract]
Amortization	(15)	(15)	(15)
Ending Balance	39	54	69
Beginning Balance	$ 54	$ 69	$ 84

XML

Shareholders Equity (Tables)

12 Months Ended

Dec. 31, 2011

Shareholders' Equity [Abstract]

Declared quarterly cash dividends per share of common stock

	2011		2010		2009
First	$	0.53	$	0.45	$	0.425
Second	$	0.53	$	0.45	$	0.425
Third	$	0.53	$	0.45	$	0.425
Fourth	$	0.56	$	0.49	$	0.450

Changes in common stock outstanding

	2011			2010			2009
Shares outstanding at beginning of year		583,043,872			582,848,102			582,901,524
LTIP shares forfeited		(433	)		(7,501	)		(55,420	)
LTIP tax shares repurchased and cancelled		(162,257	)		(185,257	)		(308,882	)
Shares repurchased and cancelled		(6,776,637	)		—			—
Stock options exercised		—			362,284			245,280
Equity incentive award plan shares issued		30,654			26,244			65,600
Shares outstanding at end of year		576,135,199			583,043,872			582,848,102

XML

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements

12 Months Ended

Dec. 31, 2011

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements [Abstract]

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements

Note 20 — RJR Guaranteed, Unsecured Notes — Condensed Consolidating Financial Statements

The following condensed consolidating financial statements relate to the guaranties of RJR’s $58 million unsecured notes. See note 12 for additional information relating to these notes. RAI and certain of its direct or indirect, wholly owned subsidiaries, have fully and unconditionally, and jointly and severally, guaranteed these notes. The following condensed consolidating financial statements include: the accounts and activities of RAI, the parent Guarantor; RJR, the issuer of the debt securities; RJR Tobacco, and certain of RJR’s other subsidiaries, the other Guarantors; other subsidiaries of RAI and RJR, including SFNTC and American Snuff Co. that are not Guarantors; and elimination adjustments.

Condensed Consolidating Statements of Income

(Dollars in Millions)

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Net sales	$	—		$	—		$	6,908		$	1,204		$	(50	)	$	8,062
Net sales, related party		—			—			478			1			—			479
Net Sales		—			—			7,386			1,205			(50	)		8,541
Cost of products sold		—			—			4,133			381			(50	)		4,464
Selling, general and administrative expenses		129			(7	)		1,164			320			—			1,606
Amortization expense		—			—			22			2			—			24
Trademark impairment charges		—			—			43			5			—			48
Operating income (loss)		(129	)		7			2,024			497			—			2,399
Interest and debt expense		213			8			—			162			(162	)		221
Interest income		(118	)		(5	)		(44	)		(6	)		162			(11	)
Other expense (income), net		8			(45	)		—			(3	)		43			3
Income (loss) before income taxes		(232	)		49			2,068			344			(43	)		2,186
Provision for (benefit from) income taxes		(89	)		1			752			116			—			780
Equity income from subsidiaries		1,549			1,344			28			—			(2,921	)		—
Net income	$	1,406		$	1,392		$	1,344		$	228		$	(2,964	)	$	1,406
For the Year Ended December 31, 2010
Net sales	$	—		$	—		$	7,093		$	1,230		$	(153	)	$	8,170
Net sales, related party		—			—			371			10			—			381
Net Sales		—			—			7,464			1,240			(153	)		8,551
Cost of products sold		—			—			4,264			435			(155	)		4,544
Selling, general and administrative expenses		20			(2	)		1,124			339			(1	)		1,480
Amortization expense		—			—			24			1			—			25
Asset impairment and exit charges		—			—			24			14			—			38
Trademark impairment charges		—			—			—			6			—			6
Goodwill impairment charge		—			—			—			26			—			26
Operating income (loss)		(20	)		2			2,028			419			3			2,432
Interest and debt expense		223			8			—			166			(165	)		232
Interest income		(119	)		(5	)		(45	)		(8	)		165			(12	)
Other expense (income), net		2			(43	)		8			(3	)		43			7
Income (loss) before income taxes		(126	)		42			2,065			264			(40	)		2,205
Provision for (benefit from) income taxes		(42	)		(2	)		814			97			1			868
Equity income from subsidiaries		1,205			951			5			—			(2,161	)		—
Income from continuing operations		1,121			995			1,256			167			(2,202	)		1,337
Gains (losses) from discontinued operations, net of tax		—			88			(230	)		(74	)		—			(216	)
Net income	$	1,121		$	1,083		$	1,026		$	93		$	(2,202	)	$	1,121
For the Year Ended December 31, 2009
Net sales	$	—		$	—		$	7,078		$	1,139		$	(202	)	$	8,015
Net sales, related party		—			—			396			8			—			404
Net Sales		—			—			7,474			1,147			(202	)		8,419
Cost of products sold		—			—			4,297			393			(202	)		4,488
Selling, general and administrative expenses		20			4			1,183			310			—			1,517
Amortization expense		—			—			27			1			—			28
Restructuring charge		—			—			56			—			—			56
Trademark impairment charges		—			—			491			76			—			567
Operating income (loss)		(20	)		(4	)		1,420			367			—			1,763
Interest and debt expense		242			8			1			171			(171	)		251
Interest income		(115	)		(8	)		(56	)		(11	)		171			(19	)
Other expense (income), net		(4	)		(31	)		2			(1	)		43			9
Income (loss) before income taxes		(143	)		27			1,473			208			(43	)		1,522
Provision for (benefit from) income taxes		(49	)		(5	)		562			59			—			567
Equity income from subsidiaries		1,049			939			26			—			(2,014	)		—
Net income	$	955		$	971		$	937		$	149		$	(2,057	)	$	955

Condensed Consolidating Statements of Cash Flows

(Dollars in Millions)

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Cash flows from operating activities	$	641		$	1,319		$	1,195		$	313		$	(2,048	)	$	1,420
Cash flows from (used in) investing activities:
Proceeds from settlement of long-term investments		—			—			2			—			—			2
Capital expenditures		—			—			(55	)		(135	)		—			(190	)
Net proceeds from sale of business		79			—			123			—			—			202
Proceeds from termination of joint venture		—			—			—			32			—			32
Return of intercompany investments		1,040			340			—			—			(1,380	)		—
Other, net		40			20			91			—			(137	)		14
Net cash flows from (used in) investing activities		1,159			360			161			(103	)		(1,517	)		60
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,212	)		(740	)		(1,265	)		—			2,005			(1,212	)
Repurchase of common stock		(282	)		—			—			—			—			(282	)
Repayment of long-term debt		(400	)		—			—			—			—			(400	)
Proceeds from termination of interest rate swaps		185			1			—			—			—			186
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Distribution of equity		—			(910	)		(340	)		(130	)		1,380			—
Other, net		(47	)		(36	)		—			(60	)		137			(6	)
Net cash flows used in financing activities		(1,799	)		(1,685	)		(1,605	)		(190	)		3,565			(1,714	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			(5	)		—			(5	)
Net change in cash and cash equivalents		1			(6	)		(249	)		15			—			(239	)
Cash and cash equivalents at beginning of year		327			14			1,506			348			—			2,195
Cash and cash equivalents at end of year	$	328		$	8		$	1,257		$	363		$	—		$	1,956
For the Year Ended December 31, 2010
Cash flows from operating activities	$	442		$	445		$	947		$	179		$	(748	)	$	1,265
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		—			1			2			1			—			4
Proceeds from settlement of long-term investments		—			—			13			—			—			13
Capital expenditures		—			—			(52	)		(123	)		1			(174	)
Proceeds from termination of joint venture		—			—			—			28			—			28
Return on intercompany investments		897			795			—			—			(1,692	)		—
Contributions to intercompany investments		—			(75	)		—			—			75			—
Other, net		40			23			25			1			(86	)		3
Net cash flows from (used in) investing activities		937			744			(12	)		(93	)		(1,702	)		(126	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,049	)		(300	)		(405	)		—			705			(1,049	)
Repurchase of common stock		(5	)		—			—			—			—			(5	)
Repayment of long-term debt		(300	)		—			—			—			—			(300	)
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Receipt of equity		—			—			—			75			(75	)		—
Distribution of equity		—			(897	)		(795	)		—			1,692			—
Other, net		(16	)		1			—			(65	)		85			5
Net cash flows from (used in) financing activities		(1,413	)		(1,196	)		(1,200	)		10			2,450			(1,349	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			(11	)		—			(11	)
Net cash flows related to discontinued operations, net of tax benefit		—			(3	)		(230	)		(74	)		—			(307	)
Net change in cash and cash equivalents		(34	)		(10	)		(495	)		11			—			(528	)
Cash and cash equivalents at beginning of year		361			24			2,001			337			—			2,723
Cash and cash equivalents at end of year	$	327		$	14		$	1,506		$	348		$	—		$	2,195

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2009
Cash flows from operating activities	$	678		$	1,464		$	1,394		$	161		$	(2,243	)	$	1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1			5			12			1			—			19
Proceeds from settlement of long-term investments		—			—			6			—			—			6
Capital expenditures		—			—			(55	)		(86	)		—			(141	)
Acquisition, net of cash acquired		—			—			—			(43	)		—			(43	)
Proceeds from termination of joint venture		—			—			—			24			—			24
Return of intercompany investments		610			—			—			—			(610	)		—
Other, net		40			9			27			—			(64	)		12
Net cash flows from (used in) investing activities		651			14			(10	)		(104	)		(674	)		(123	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(991	)		(840	)		(1,360	)		—			2,200			(991	)
Repurchase of common stock		(5	)		—			—			—			—			(5	)
Repayment of long-term debt		(189	)		(11	)		—			—			—			(200	)
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Distribution of equity		—			(610	)		—			—			610			—
Other, net		(12	)		1			—			(49	)		64			4
Net cash flows used in financing activities		(1,240	)		(1,460	)		(1,360	)		(49	)		2,917			(1,192	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			6			—			6
Net change in cash and cash equivalents		89			18			24			14			—			145
Cash and cash equivalents at beginning of year		272			6			1,977			323			—			2,578
Cash and cash equivalents at end of year	$	361		$	24		$	2,001		$	337		$	—		$	2,723

Condensed Consolidating Balance Sheets

(Dollars in Millions)

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2011
Assets
Cash and cash equivalents	$	328	$	8	$	1,257	$	363	$	—		$	1,956
Accounts receivable		—		—		62		39		—			101
Accounts receivable, related party		—		—		67		—		—			67
Other receivables		95		38		145		110		(342	)		46
Inventories		—		—		480		487		—			967
Deferred income taxes, net		—		1		907		45		(8	)		945
Prepaid expenses and other		19		—		178		28		—			225
Total current assets		442		47		3,096		1,072		(350	)		4,307
Property, plant and equipment, net		5		—		652		412		1			1,070
Trademarks and other intangible assets, net		—		—		1,251		1,351		—			2,602
Goodwill		—		—		5,303		2,707		—			8,010
Long-term intercompany notes		1,960		157		1,325		—		(3,442	)		—
Investment in subsidiaries		9,139		7,076		456		—		(16,671	)		—
Other assets and deferred charges		68		24		157		72		(56	)		265
Total assets	$	11,614	$	7,304	$	12,240	$	5,614	$	(20,518	)	$	16,254
Liabilities and shareholders’ equity
Accounts payable	$	—	$	—	$	87	$	26	$	—		$	113
Tobacco settlement accruals		—		—		2,461		69		—			2,530
Due to related party		—		—		2		—		—			2
Deferred revenue, related party		—		—		42		—		—			42
Current maturities of long-term debt		399		58		—		—		—			457
Other current liabilities		421		100		711		250		(350	)		1,132
Total current liabilities		820		158		3,303		345		(350	)		4,276
Intercompany notes and interest payable		1,325		—		—		2,117		(3,442	)		—
Long-term debt (less current maturities)		3,145		61		—		—		—			3,206
Deferred income taxes, net		—		—		60		507		(56	)		511
Long-term retirement benefits (less current portion)		48		24		1,579		108		—			1,759
Other noncurrent liabilities		25		1		222		3		—			251
Shareholders’ equity		6,251		7,060		7,076		2,534		(16,670	)		6,251
Total liabilities and shareholders’ equity	$	11,614	$	7,304	$	12,240	$	5,614	$	(20,518	)	$	16,254

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2010
Assets
Cash and cash equivalents	$	327	$	14	$	1,506	$	348	$	—		$	2,195
Accounts receivable		—		—		50		68		—			118
Accounts receivable, related party		—		—		48		—		—			48
Other receivables		80		33		225		90		(384	)		44
Inventories		—		—		600		456		(1	)		1,055
Deferred income taxes, net		10		1		892		43		—			946
Prepaid expenses and other		38		—		130		30		(3	)		195
Assets held for sale		—		—		20		181		—			201
Total current assets		455		48		3,471		1,216		(388	)		4,802
Property, plant and equipment, net		6		—		689		306		1			1,002
Trademarks and other intangible assets, net		—		—		1,316		1,359		—			2,675
Goodwill		—		—		5,303		2,707		—			8,010
Long-term intercompany notes		2,000		174		1,366		—		(3,540	)		—
Investment in subsidiaries		9,696		7,611		435		—		(17,742	)		—
Other assets and deferred charges		267		56		194		101		(29	)		589
Total assets	$	12,424	$	7,889	$	12,774	$	5,689	$	(21,698	)	$	17,078
Liabilities and shareholders’ equity
Accounts payable	$	—	$	—	$	103	$	76	$	—		$	179
Tobacco settlement accruals		—		—		2,532		57		—			2,589
Due to related party		—		—		4		—		—			4
Deferred revenue, related party		—		—		53		—		—			53
Current maturities of long-term debt		400		—		—		—		—			400
Other current liabilities		489		138		652		255		(387	)		1,147
Total current liabilities		889		138		3,344		388		(387	)		4,372
Intercompany notes and interest payable		1,366		—		—		2,174		(3,540	)		—
Long-term debt (less current maturities)		3,580		121		—		—		—			3,701
Deferred income taxes, net		—		—		76		471		(29	)		518
Long-term retirement benefits (less current portion)		34		25		1,496		113		—			1,668
Other noncurrent liabilities		45		12		247		5		—			309
Shareholders’ equity		6,510		7,593		7,611		2,538		(17,742	)		6,510
Total liabilities and shareholders’ equity	$	12,424	$	7,889	$	12,774	$	5,689	$	(21,698	)	$	17,078

XML

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements

12 Months Ended

Dec. 31, 2011

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements [Abstract]

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements

Note 19 — RAI Guaranteed, Unsecured Notes — Condensed Consolidating Financial Statements

The following condensed consolidating financial statements relate to the guaranties of RAI’s $3.5 billion unsecured notes. See note 12 for additional information relating to these notes. RAI’s direct, wholly owned subsidiaries and certain of its indirectly owned subsidiaries have fully and unconditionally, and jointly and severally, guaranteed these notes. The following condensed consolidating financial statements include: the accounts and activities of RAI, the parent issuer; RJR, RJR Tobacco, American Snuff Co., SFNTC and certain of RAI’s other subsidiaries, the Guarantors; other indirect subsidiaries of RAI that are not Guarantors; and elimination adjustments.

Condensed Consolidating Statements of Income

(Dollars in Millions)

	Parent Issuer			Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Net sales	$	—		$	7,971		$	116		$	(25	)	$	8,062
Net sales, related party		—			479			—			—			479
Net Sales		—			8,450			116			(25	)		8,541
Cost of products sold		—			4,460			29			(25	)		4,464
Selling, general and administrative expenses		129			1,386			91			—			1,606
Amortization expense		—			24			—			—			24
Trademark impairment charges		—			48			—			—			48
Operating income (loss)		(129	)		2,532			(4	)		—			2,399
Interest and debt expense		213			125			—			(117	)		221
Interest income		(118	)		(4	)		(6	)		117			(11	)
Other expense (income), net		8			(47	)		(1	)		43			3
Income (loss) before income taxes		(232	)		2,458			3			(43	)		2,186
Provision for (benefit from) income taxes		(89	)		875			(6	)		—			780
Equity income from subsidiaries		1,549			20			—			(1,569	)		—
Net income	$	1,406		$	1,603		$	9		$	(1,612	)	$	1,406
For the Year Ended December 31, 2010
Net sales	$	—		$	8,118		$	147		$	(95	)	$	8,170
Net sales, related party		—			381			—			—			381
Net Sales		—			8,499			147			(95	)		8,551
Cost of products sold		—			4,569			72			(97	)		4,544
Selling, general and administrative expenses		20			1,380			81			(1	)		1,480
Amortization expense		—			25			—			—			25
Asset impairment and exit charges		—			24			14			—			38
Trademark impairment charges		—			6			—			—			6
Goodwill impairment charge		—			26			—			—			26
Operating income (loss)		(20	)		2,469			(20	)		3			2,432
Interest and debt expense		223			127			1			(119	)		232
Interest income		(119	)		(4	)		(8	)		119			(12	)
Other expense (income), net		2			(39	)		1			43			7
Income (loss) before income taxes		(126	)		2,385			(14	)		(40	)		2,205
Provision for (benefit from) income taxes		(42	)		919			(10	)		1			868
Equity income (loss) from subsidiaries		1,205			(68	)		—			(1,137	)		—
Income (loss) from continuing operations		1,121			1,398			(4	)		(1,178	)		1,337
Losses from discontinued operations, net of tax		—			(142	)		(74	)		—			(216	)
Net income (loss)	$	1,121		$	1,256		$	(78	)	$	(1,178	)	$	1,121
For the Year Ended December 31, 2009
Net sales	$	—		$	7,985		$	162		$	(132	)	$	8,015
Net sales, related party		—			404			—			—			404
Net Sales		—			8,389			162			(132	)		8,419
Cost of products sold		—			4,544			76			(132	)		4,488
Selling, general and administrative expenses		20			1,425			72			—			1,517
Amortization expense		—			28			—			—			28
Restructuring charge		—			56			—			—			56
Trademark impairment charges		—			567			—			—			567
Operating income (loss)		(20	)		1,769			14			—			1,763
Interest and debt expense		242			123			1			(115	)		251
Interest income		(115	)		(9	)		(10	)		115			(19	)
Other expense (income), net		(4	)		(30	)		—			43			9
Income (loss) before income taxes		(143	)		1,685			23			(43	)		1,522
Provision for (benefit from) income taxes		(49	)		616			—			—			567
Equity income from subsidiaries		1,049			26			—			(1,075	)		—
Net income	$	955		$	1,095		$	23		$	(1,118	)	$	955

Condensed Consolidating Statements of Cash Flows

(Dollars in Millions)

	Parent Issuer			Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Cash flows from (used in) operating activities	$	641		$	1,571		$	(3	)	$	(789	)	$	1,420
Cash flows from (used in) investing activities:
Proceeds from settlement of long-term investments		—			2			—			—			2
Capital expenditures		—			(190	)		—			—			(190	)
Net proceeds from sale of business		79			123			—			—			202
Proceeds from termination of joint venture		—			—			32			—			32
Return of intercompany investments		1,040			—			—			(1,040	)		—
Other, net		40			58			—			(84	)		14
Net cash flows from (used in) investing activities		1,159			(7	)		32			(1,124	)		60
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,212	)		(740	)		(6	)		746			(1,212	)
Repurchase of common stock		(282	)		—			—			—			(282	)
Repayments of long-term debt		(400	)		—			—			—			(400	)
Proceeds from termination of interest rate swaps		185			1			—			—			186
Dividends paid on preferred stock		(43	)		—			—			43			—
Distribution of equity		—			(1,040	)		—			1,040			—
Other, net		(47	)		(40	)		(3	)		84			(6	)
Net cash flows used in financing activities		(1,799	)		(1,819	)		(9	)		1,913			(1,714	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(5	)		—			(5	)
Net change in cash and cash equivalents		1			(255	)		15			—			(239	)
Cash and cash equivalents at beginning of year		327			1,616			252			—			2,195
Cash and cash equivalents at end of year	$	328		$	1,361		$	267		$	—		$	1,956
For the Year Ended December 31, 2010
Cash flows from operating activities	$	442		$	1,153		$	13		$	(343	)	$	1,265
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		—			4			—			—			4
Proceeds from settlement of long-term investments		—			13			—			—			13
Capital expenditures		—			(171	)		(3	)		—			(174	)
Proceeds from termination of joint venture		—			—			28			—			28
Return of intercompany investments		897			—			—			(897	)		—
Contributions to intercompany investments		—			(75	)		—			75			—
Other, net		40			26			—			(63	)		3
Net cash flows from (used in) investing activities		937			(203	)		25			(885	)		(126	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,049	)		(300	)		—			300			(1,049	)
Repurchase of common stock		(5	)		—			—			—			(5	)
Repayments of long-term debt		(300	)		—			—			—			(300	)
Dividends paid on preferred stock		(43	)		—			—			43			—
Receipt of equity		—			—			75			(75	)		—
Distribution of equity		—			(897	)		—			897			—
Other, net		(16	)		(40	)		(2	)		63			5
Net cash flows from (used in) financing activities		(1,413	)		(1,237	)		73			1,228			(1,349	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(11	)		—			(11	)
Net cash flow related to discontinued operations, net of tax		—			(233	)		(74	)		—			(307	)
Net change in cash and cash equivalents		(34	)		(520	)		26			—			(528	)
Cash and cash equivalents at beginning of year		361			2,136			226			—			2,723
Cash and cash equivalents at end of year	$	327		$	1,616		$	252		$	—		$	2,195
For the Year Ended December 31, 2009
Cash flows from operating activities	$	678		$	1,630		$	29		$	(883	)	$	1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1			18			—			—			19
Proceeds from settlement of long-term investments		—			6			—			—			6
Capital expenditures		—			(137	)		(4	)		—			(141	)
Acquisition, net of cash acquired		—			—			(43	)		—			(43	)
Proceeds from termination of joint venture		—			—			24			—			24
Return of intercompany investments		610			—			—			(610	)		—
Other, net		40			29			—			(57	)		12
Net cash flows from (used in) investing activities		651			(84	)		(23	)		(667	)		(123	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(991	)		(840	)		—			840			(991	)
Repurchase of common stock		(5	)		—			—			—			(5	)
Repayments of long-term debt		(189	)		(11	)		—			—			(200	)
Dividends paid on preferred stock		(43	)		—			—			43			—
Distribution of equity		—			(610	)		—			610			—
Other, net		(12	)		(40	)		(1	)		57			4
Net cash flows used in financing activities		(1,240	)		(1,501	)		(1	)		1,550			(1,192	)
Effect of exchange rate changes on cash and cash equivalents		—			—			6			—			6
Net change in cash and cash equivalents		89			45			11			—			145
Cash and cash equivalents at beginning of year		272			2,091			215			—			2,578
Cash and cash equivalents at end of year	$	361		$	2,136		$	226		$	—		$	2,723

Condensed Consolidating Balance Sheets

(Dollars in Millions)

	Parent Issuer		Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2011
Assets
Cash and cash equivalents	$	328	$	1,361	$	267	$	—		$	1,956
Accounts receivable		—		77		24		—			101
Accounts receivable, related party		—		67		—		—			67
Other receivables		95		50		39		(138	)		46
Inventories		—		929		38		—			967
Deferred income taxes, net		—		952		1		(8	)		945
Prepaid expenses and other		19		200		7		(1	)		225
Total current assets		442		3,636		376		(147	)		4,307
Property, plant and equipment, net		5		1,061		3		1			1,070
Trademarks and other intangible assets, net		—		2,553		49		—			2,602
Goodwill		—		7,999		11		—			8,010
Long-term intercompany notes		1,960		1,325		—		(3,285	)		—
Investment in subsidiaries		9,139		463		—		(9,602	)		—
Other assets and deferred charges		68		171		71		(45	)		265
Total assets	$	11,614	$	17,208	$	510	$	(13,078	)	$	16,254
Liabilities and shareholders’ equity
Accounts payable	$	—	$	107	$	6	$	—		$	113
Tobacco settlement accruals		—		2,530		—		—			2,530
Due to related party		—		2		—		—			2
Deferred revenue, related party		—		42		—		—			42
Current maturities of long-term debt		399		58		—		—			457
Other current liabilities		421		827		31		(147	)		1,132
Total current liabilities		820		3,566		37		(147	)		4,276
Intercompany notes and interest payable		1,325		1,960		—		(3,285	)		—
Long-term debt (less current maturities)		3,145		61		—		—			3,206
Deferred income taxes, net		—		553		3		(45	)		511
Long-term retirement benefits (less current portion)		48		1,699		12		—			1,759
Other noncurrent liabilities		25		224		2		—			251
Shareholders’ equity		6,251		9,145		456		(9,601	)		6,251
Total liabilities and shareholders’ equity	$	11,614	$	17,208	$	510	$	(13,078	)	$	16,254

	Parent Issuer		Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2010
Assets
Cash and cash equivalents	$	327	$	1,616	$	252	$	—		$	2,195
Accounts receivable		—		103		15		—			118
Accounts receivable, related party		—		48		—		—			48
Other receivables		80		161		35		(232	)		44
Inventories		—		1,022		34		(1	)		1,055
Deferred income taxes, net		10		934		2		—			946
Prepaid expenses and other		38		155		4		(2	)		195
Assets held for sale		—		201		—		—			201
Total current assets		455		4,240		342		(235	)		4,802
Property, plant and equipment, net		6		991		4		1			1,002
Trademarks and other intangible assets, net		—		2,625		50		—			2,675
Goodwill		—		7,991		19		—			8,010
Long-term intercompany notes		2,000		1,366		—		(3,366	)		—
Investment in subsidiaries		9,696		462		—		(10,158	)		—
Other assets and deferred charges		267		242		100		(20	)		589
Total assets	$	12,424	$	17,917	$	515	$	(13,778	)	$	17,078
Liabilities and shareholders’ equity
Accounts payable	$	—	$	175	$	4	$	—		$	179
Tobacco settlement accruals		—		2,589		—		—			2,589
Due to related party		—		4		—		—			4
Deferred revenue, related party		—		53		—		—			53
Current maturities of long-term debt		400		—		—		—			400
Other current liabilities		489		855		37		(234	)		1,147
Total current liabilities		889		3,676		41		(234	)		4,372
Intercompany notes and interest payable		1,366		2,000		—		(3,366	)		—
Long-term debt (less current maturities)		3,580		121		—		—			3,701
Deferred income taxes, net		—		535		3		(20	)		518
Long-term retirement benefits (less current portion)		34		1,622		12		—			1,668
Other noncurrent liabilities		45		262		2		—			309
Shareholders’ equity		6,510		9,701		457		(10,158	)		6,510
Total liabilities and shareholders’ equity	$	12,424	$	17,917	$	515	$	(13,778	)	$	17,078

XML

Retirement Benefits (Details 7)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Pension Benefits [Member]
Asset Category: (Target)
Total, Target	100.00%	100.00%
Asset Category: (Actual)
Total, Actual	100.00%	100.00%
Postretirement Benefits [Member]
Asset Category: (Target)
Total, Target	100.00%	100.00%
Asset Category: (Actual)
Total, Actual	100.00%	100.00%
Domestic Equities [Member] | Pension Benefits [Member]
Asset Category: (Target)
Equity Securities, Target	9.00%	27.00%
Asset Category: (Actual)
Equity Securities	11.00%	28.00%
Domestic Equities [Member] | Postretirement Benefits [Member]
Asset Category: (Target)
Equity Securities, Target	21.00%	42.00%
Asset Category: (Actual)
Equity Securities	21.00%	43.00%
International Equities [Member] | Pension Benefits [Member]
Asset Category: (Target)
Equity Securities, Target	11.00%	13.00%
Asset Category: (Actual)
Equity Securities	13.00%	12.00%
International Equities [Member] | Postretirement Benefits [Member]
Asset Category: (Target)
Equity Securities, Target	21.00%	16.00%
Asset Category: (Actual)
Equity Securities	19.00%	16.00%
Global Equities [Member] | Pension Benefits [Member]
Asset Category: (Target)
Equity Securities, Target	9.00%	5.00%
Asset Category: (Actual)
Equity Securities	6.00%	7.00%
Fixed Income [Member] | Pension Benefits [Member]
Asset Category: (Target)
Debt Securities, Target	53.00%	40.00%
Asset Category: (Actual)
Debt Securities	55.00%	38.00%
Fixed Income [Member] | Postretirement Benefits [Member]
Asset Category: (Target)
Debt Securities, Target	58.00%	39.00%
Asset Category: (Actual)
Debt Securities	57.00%	36.00%
High Yield Fixed Income [Member] | Pension Benefits [Member]
Asset Category: (Target)
Debt Securities, Target	3.00%	2.00%
Asset Category: (Actual)
Debt Securities	3.00%	3.00%
Hedge Funds [Member] | Pension Benefits [Member]
Asset Category: (Target)
Asset allocation, Target	4.00%	7.00%
Asset Category: (Actual)
Asset allocation	5.00%	6.00%
Hedge Funds [Member] | Postretirement Benefits [Member]
Asset Category: (Target)
Debt Securities, Target		1.00%
Asset Category: (Actual)
Debt Securities		1.00%
Private Equity [Member] | Pension Benefits [Member]
Asset Category: (Target)
Asset allocation, Target	1.00%	2.00%
Asset Category: (Actual)
Asset allocation	1.00%	1.00%
Real Estate [Member] | Pension Benefits [Member]
Asset Category: (Target)
Real Estate, Target	4.00%	2.00%
Asset Category: (Actual)
Real Estate	4.00%	3.00%
Global Tactical Asset Allocation [Member] | Pension Benefits [Member]
Asset Category: (Target)
Asset allocation, Target	2.00%	2.00%
Asset Category: (Actual)
Asset allocation	2.00%	2.00%
Commodities [Member] | Pension Benefits [Member]
Asset Category: (Target)
Asset allocation, Target	4.00%
Cash and Cash Equivalents [Member] | Postretirement Benefits [Member]
Asset Category: (Target)
Real Estate And Other, Target		2.00%
Asset Category: (Actual)
Real Estate And Other, Actual	3.00%	4.00%

XML

Fair Value (Details 2) (USD $) In Millions, unless otherwise specified			12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011 Auction rate securities [Member]	Dec. 31, 2011 Mortgage-backed security [Member]
Changes In Level 3 Investments
Cost, Beginning Balance	$ 124	$ 126	$ 99	$ 27
Gross Unrealized Gain Losses, Beginning Balance			(38)	(13)
Estimated Fair Value, Beginning Balance	75	75	61	14
Unrealized loss / gains			2
Redemptions				(2)
Cost, Ending Balance	124	126	99	25
Gross Unrealized Gain Losses, Ending Balance			(36)	(13)
Estimated Fair Value, Ending Balance	$ 75	$ 75	$ 63	$ 12

XML

Stock Plans (Tables)

12 Months Ended

Dec. 31, 2011

Stock Plans [Abstract]

Information regarding stock-based awards outstanding

Grant Year	Plan	Number of Shares Granted		Grant Price		Type	Vesting Date		Number of Shares Cancelled		Number of Shares Vested
2009	LTIP		2,764,486	$	16.550	Restricted Stock Units		March 2, 2012		448,475		—
2010	Omnibus		1,980,166	$	26.620	Restricted Stock Units		March 1, 2013		353,655		—
2010	Omnibus		8,422	$	27.655	Restricted Stock Units		March 1, 2013		5,704		—
2010	Omnibus		2,758	$	29.425	Restricted Stock Units		March 1, 2013		—		—
2011	Omnibus		1,561,331	$	33.990	Restricted Stock Units		March 1, 2014		102,474		—
2011	Omnibus		3,874	$	39.590	Restricted Stock Units		March 1, 2014		—		—

Changes in restricted RAI common stock and restricted stock units

	Stock and Stock Units			Weighted Average Grant Date Fair Value
Outstanding at beginning of year		4,845,861		$	21.87
Granted		1,565,205			34.00
Forfeited		(544,032	)		24.93
Vested		(456,305	)		30.94
Outstanding at end of year		5,410,729			24.30

Compensation Expense Related To Stock Based Compensation And Related Tax Benefits

Grant/Type	2011		2010		2009
2006 restricted stock	$	—	$	—	$	(2	)
2007 restricted stock and performance shares		—		1		5
2008 restricted stock		1		5		5
2009 restricted stock units		12		16		14
2010 restricted stock units		12		15		—
2011 restricted stock units		13		—		—
Total compensation expense	$	38	$	37	$	22
Total related tax benefits	$	13	$	13	$	8

Amounts related to performance share grants, restricted stock grants, restricted stock units grant

	2011		2010
Other current liabilities	$	15	$	—
Other noncurrent liabilities		10		14
Paid-in capital		81		58

Changes in RAI's stock options

	2011				2010					2009
	Options		Weighted Average Exercise Price		Options			Weighted Average Exercise Price		Options			Weighted Average Exercise Price
Outstanding at beginning of year		40,000	$	17.45		485,468		$	7.64		776,348		$	7.38
Expired		—		—		(83,184	)		6.63		—			—
Exercised		—		—		(362,284	)		6.78		(290,880	)		6.95
Outstanding at end of year		40,000		17.45		40,000			17.45		485,468			7.64
Exercisable at end of year		40,000		17.45		40,000			17.45		485,468			7.64

Cash Proceeds Related To Stock Options Exercised And Excess Tax Benefits Related To Stock Based Compensation Table Text Block

	2011		2010		2009
Proceeds from exercise of stock options	$	—	$	2	$	2
Excess tax benefits from stock-based compensation		1		2		2

Equity compensation plan information

Plan Category	Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights			Weighted Average Exercise Price of Outstanding Options, Warrants and Rights		Number of  Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a))
	(a)			(b)		(c)
Equity Compensation Plans Approved by Security Holders		8,116,094	(2)	$	—		33,357,923
Equity Compensation Plans Not Approved by Security Holders (1)		40,000			17.45		1,112,305
Total		8,156,094	(2)		17.45		34,470,228

⁽¹⁾  The EIAP was approved by RJR’s sole shareholder, NGH, prior to RJR’s spin-off on June 15, 1999.

⁽²⁾  Consists of restricted stock units. These restricted stock units represent the maximum number, 150%, of shares to be awarded under the best-case targets that may not be achieved, and accordingly, may overstate expected dilution.

XML

Quarterly Results of Operations (Unaudited)

12 Months Ended

Dec. 31, 2011

Quarterly Results of Operations [Abstract]

Quarterly Results of Operations (Unaudited)

Note 21 — Quarterly Results of Operations (Unaudited)

	First			Second			Third			Fourth
		(2	)		(3	)		(4	)		(5	)
2011 (1)
Net sales	$	1,991		$	2,267		$	2,200		$	2,083
Gross profit		956			1,074			1,075			972
Net income		381			327			394			304
Per share data (10) :
Basic:
Net income		0.65			0.56			0.68			0.52
Diluted:
Net income		0.65			0.56			0.67			0.52
2010 (1)		(6	)		(7	)		(8	)		(9	)
Net sales	$	1,986		$	2,245		$	2,239		$	2,081
Gross profit		929			1,075			1,068			935
Net income		100			359			400			262
Per share data (10) :
Basic:
Income from continuing operations		0.54			0.62			0.69			0.45
Loss on discontinued operations, net of tax		(0.37	)		—			—			—
Net income		0.17			0.62			0.69			0.45
Diluted:
Income from continuing operations		0.54			0.61			0.68			0.45
Loss on discontinued operations, net of tax		(0.37	)		—			—			—
Net income		0.17			0.61			0.68			0.45

⁽¹⁾ As revised for the change in the method of recognizing pension expense. See note 1 for a discussion of the change and the impacts of the change for the year ended December 31, 2010.

⁽²⁾ For the quarter ended March 31, 2011, the retrospective change in recognizing pension expense increased gross profit by $26 million, net income by $28 million and earnings per share, basic and diluted by $0.04 and $0.05, respectively.

⁽³⁾ For the quarter ended June 30, 2011, the retrospective change in recognizing pension expense increased gross profit by $22 million, net income by $23 million and earnings per share, basic and diluted by $0.04.

⁽⁴⁾ For the quarter ended September 30, 2011, the retrospective change in recognizing pension expense increased gross profit by $23 million, net income by $27 million and earnings per share, basic and diluted by $0.05 and $0.04, respectively.

⁽⁵⁾ For the quarter ended December 31, 2011, includes $145 million of pension expense as a result of MTM adjustments. Fourth quarter of 2011 net income includes a $48 million trademark impairment charge.

⁽⁶⁾  For the quarter ended March 31, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $18 million, earnings per share, basic and diluted by $0.03.

⁽⁷⁾  For the quarter ended June 30, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $18 million and earnings per share, basic and diluted by $0.04 and $0.03, respectively. Second quarter of 2010 net income includes $38 million of asset impairment and exit charges.

⁽⁸⁾  For the quarter ended September 30, 2010, the retrospective change in recognizing pension expense increased gross profit by $13 million, net income by $19 million and earnings per share, basic and diluted by $0.04 and $0.03, respectively.

⁽⁹⁾  For the quarter ended December 31, 2010, the retrospective change in recognizing pension expense decreased gross profit by $39 million, net income by $47 million and earnings per share, basic and diluted by $0.08. Fourth quarter of 2010 net income includes a $6 million trademark impairment charge and a $26 million goodwill impairment charge.

⁽¹⁰⁾ Income per share is computed independently for each of the periods presented. The sum of the income per share amounts for the quarters may not equal the total for the year.

XML

Subsequent Event

12 Months Ended

Dec. 31, 2011

Subsequent Events [Abstract]

Subsequent Event

Note 22 — Subsequent Event

During the first quarter of 2012, RAI announced that it has begun a comprehensive analysis of programs, activities and organizational structures within RAI and certain operating companies. This review is expected to be completed by the end of the first quarter, with the objective to reduce overall cost structures. Upon completion of the analysis, any resulting charges related to severance or other exit activities will be recognized, as appropriate.

XML

Consolidated Statements of Shareholders' Equity and Comprehensive Income (USD $) In Millions	Total	Common Stock	Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Comprehensive Income
Beginning Balance at Dec. 31, 2008	$ 6,237	$ 0	$ 8,463	$ (1,792)	$ (434)
Net income	955			955		955
Retirement benefits, net of $182 tax expense; $102 tax benefit; $95 tax benefit	274				274	274
Unrealized loss on long-term investments, net of $2 tax expense; $13 tax expense; $6 tax benefit	4				4	4
Cumulative translation adjustment and other, net of tax (benefit) expense of $7 tax expense ; $10 tax benefit; $4 tax benefit	3				3	3
Total comprehensive income						1,236
Dividends - $1.73 / $1.84 / $2.15 per share	(1,010)			(1,010)
Equity incentive award plan and stock-based compensation	38		38
Common stock repurchased	(5)		(5)
Excess tax benefit on stock-based compensation plans	2		2
Ending Balance at Dec. 31, 2009	6,498	0	8,498	(1,847)	(153)
Net income	1,121			1,121		1,121
Retirement benefits, net of $182 tax expense; $102 tax benefit; $95 tax benefit	(78)				(78)	(78)
Unrealized loss on long-term investments, net of $2 tax expense; $13 tax expense; $6 tax benefit	21				21	21
Cumulative translation adjustment and other, net of tax (benefit) expense of $7 tax expense ; $10 tax benefit; $4 tax benefit	(8)				(8)	(8)
Total comprehensive income						1,056
Dividends - $1.73 / $1.84 / $2.15 per share	(1,081)			(1,081)
Equity incentive award plan and stock-based compensation	40		40
Common stock repurchased	(5)		(5)
Excess tax benefit on stock-based compensation plans	2		2
Ending Balance at Dec. 31, 2010	6,510	0	8,535	(1,807)	(218)
Net income	1,406			1,406		1,406
Retirement benefits, net of $182 tax expense; $102 tax benefit; $95 tax benefit	(144)				(144)	(144)
Unrealized loss on long-term investments, net of $2 tax expense; $13 tax expense; $6 tax benefit	(12)				(12)	(12)
Cumulative translation adjustment and other, net of tax (benefit) expense of $7 tax expense ; $10 tax benefit; $4 tax benefit	(8)				(8)	(8)
Total comprehensive income						1,242
Dividends - $1.73 / $1.84 / $2.15 per share	(1,259)			(1,259)
Equity incentive award plan and stock-based compensation	39		39
Common stock repurchased	(282)		(282)
Excess tax benefit on stock-based compensation plans	1		1
Ending Balance at Dec. 31, 2011	$ 6,251	$ 0	$ 8,293	$ (1,660)	$ (382)

XML

Business and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2011

Business and Summary of Significant Accounting Policies [Abstract]

Overview

Overview

The consolidated financial statements include the accounts of Reynolds American Inc., referred to as RAI, and its wholly owned subsidiaries. RAI’s wholly owned operating subsidiaries include R. J. Reynolds Tobacco Company; American Snuff Company, LLC, referred to as American Snuff Co.; Santa Fe Natural Tobacco Company, Inc., referred to as SFNTC; and Niconovum AB.

RAI was incorporated as a holding company in the state of North Carolina on January 5, 2004, and its common stock is listed on the NYSE under the symbol “RAI.” On July 30, 2004, the U.S. assets, liabilities and operations of Brown & Williamson Tobacco Corporation, now known as Brown & Williamson Holdings, Inc., referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c., referred to as BAT, were combined with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR. These July 30, 2004, transactions generally are referred to as the B&W business combination.

References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a New Jersey corporation and a wholly owned subsidiary of RJR. References to RJR Tobacco on and subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W and R. J. Reynolds Tobacco Company, a North Carolina corporation.

RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane, Limited, referred to as Lane. During the fourth quarter of 2011, RAI elected to begin reporting the Santa Fe segment, which includes the primary operations of SFNTC. RAI has retrospectively revised segment disclosures for all periods presented. Although the operations and results of Santa Fe currently do not meet the quantitative criteria to be required to be reported, RAI management believes that reporting this segment is important to the financial statement user for additional understanding and transparency with respect to the aggregate operations and results of RAI’s subsidiaries that produce and market cigarettes in the U.S. Niconovum AB, among other RAI subsidiaries, is included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI.

As a result of the B&W business combination, Lane became a wholly owned subsidiary of RAI. On February 28, 2011, RAI completed the sale of all of the capital stock of Lane and certain other assets related to the Lane operations, to an affiliate of Scandinavian Tobacco Group A/S, referred to as STG, for net proceeds of $202 million in cash. The assets and liabilities of the disposal group were classified as held for sale as of December 31, 2010, and its results of operations were included through February 28, 2011, in income from continuing operations in the American Snuff segment.

RAI’s operating subsidiaries primarily conduct their business in the United States.

Basis of presentation

Basis of Presentation

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, referred to as GAAP, requires estimates and assumptions to be made that affect the reported amounts in the consolidated financial statements and accompanying notes. Volatile credit and equity markets, changes to regulatory and legal environments, and consumer spending may affect the uncertainty inherent in such estimates and assumptions. Actual results could differ from those estimates. Certain reclassifications were made to conform prior years’ financial statements to the current presentation.

All dollar amounts, other than per share amounts, are presented in millions, except for amounts set forth in note 13 and as otherwise noted.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash balances are recorded net of book overdrafts when a bank right-of-offset exists. All other book overdrafts are recorded in accounts payable. Cash equivalents may include money market funds, commercial paper and time deposits in major institutions to minimize investment risk. As short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase, cash equivalents have carrying values that approximate fair values.

Fair Value Measurement

Fair Value Measurement

RAI determines fair value of assets and liabilities using a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.

The levels of the fair value hierarchy are:

Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2: inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3: inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

Investments

Investments

Marketable securities are classified as available-for-sale and are carried at fair value. RAI reviews these investments on a quarterly basis to determine if it is probable that RAI will realize some portion of the unrealized loss and to determine the classification of the impairment as temporary or other-than-temporary. For those securities that RAI does not intend to sell and it is more likely than not that RAI will not be required to sell the securities prior to recovery, RAI recognizes the credit loss component of an other-than-temporary impairment in earnings, and recognizes the noncredit component in other comprehensive loss. All losses deemed to be other than temporarily impaired are recorded in earnings.

Inventories

Inventories

Inventories are stated at the lower of cost or market. The cost of tobacco inventories is determined principally under the last-in, first-out, or LIFO, method and is calculated at the end of each year. The cost of work in process and finished goods includes materials, direct labor, variable costs and overhead and full absorption of fixed manufacturing overhead. Stocks of tobacco, which have an operating cycle that exceeds 12 months due to aging requirements, are classified as current assets, consistent with recognized industry practice.

Long-lived Assets

Long-lived Assets

Long-lived assets, such as property, plant and equipment, trademarks and other intangible assets with finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the book value of the asset may not be recoverable. Impairment of the carrying value of long-lived assets would be indicated if the best estimate of future undiscounted cash flows expected to be generated by the asset grouping is less than its carrying value. If an impairment is indicated, any loss is measured as the difference between estimated fair value and carrying value and is recognized in operating income.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Useful lives range from 20 to 50 years for buildings and improvements, and from 3 to 30 years for machinery and equipment. The cost and related accumulated depreciation of assets sold or retired are removed from the accounts and the gain or loss on disposition is recognized in operating income.

Intangible Assets

Intangible Assets

Intangible assets include goodwill, trademarks and other intangible assets and are capitalized when acquired. The determination of fair value involves considerable estimates and judgment. In particular, the fair value of a reporting unit involves, among other things, developing forecasts of future cash flows, determining an appropriate discount rate, and when goodwill impairment is implied, determining the fair value of individual assets and liabilities, including unrecorded intangibles. Although RAI believes it has based its impairment testing and impairment charges on reasonable estimates and assumptions, the use of different estimates and assumptions could result in materially different results. Generally, if the current competitive or regulatory environment worsens or RAI’s operating companies’ strategic initiatives adversely affect their financial performance, the fair value of goodwill, trademarks and other intangible assets could be impaired in future periods. Trademarks and other intangible assets with indefinite lives are not amortized, but are tested for impairment annually, in the fourth quarter, and more frequently if events and circumstances indicate that the asset might be impaired.

Accounting for Derivative Instruments and Hedging Activities

Accounting for Derivative Instruments and Hedging Activities

RAI measures any derivative instruments, including certain derivative instruments embedded in other contracts, at fair value and records them in the balance sheet as either an asset or liability. Changes in fair value of derivatives are recorded in earnings unless hedge accounting criteria are met. For derivatives designated as fair value hedges, the changes in fair value of both the derivative instrument and the hedged item are recorded in earnings. For derivatives designated as cash flow hedges, the effective portions of changes in the fair value of the derivative are reported in accumulated other comprehensive loss. The ineffective portions of hedges are recognized in earnings in the current period.

RAI formally assesses at inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item, and formally designates as a hedge those derivatives that qualify for hedge accounting. If it is determined that a derivative is not highly effective as a hedge or if a derivative ceases to be a highly effective hedge, RAI will discontinue hedge accounting prospectively. Any unrecognized gain or loss will be deferred and recognized into income as the formerly hedged item is recognized in earnings. At December 31, 2010, RAI had no derivative instruments classified as hedges, and at December 31, 2011, had no derivative instruments.

Software Costs

Software Costs

Computer software and software development costs incurred in connection with developing or obtaining computer software for internal use that has an extended useful life are capitalized. These costs are amortized over their estimated useful life, which is typically five years or less. During 2011 and 2010, costs of $24 million and $22 million, respectively, were capitalized or included in construction-in-process. At each of December 31, 2011 and 2010, the unamortized balance was $64 million. Software amortization expense was $24 million, $30 million and $26 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Revenue Recognition

Revenue Recognition

Revenue from product sales is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the seller’s price to the buyer is fixed or determinable, and collectibility is reasonably assured. These criteria are generally met when title and risk of loss pass to the customer. Payments received in advance of shipments are deferred and recorded in other accrued liabilities until shipment occurs. Certain sales of leaf to a related party, considered as bill-and-hold for accounting purposes, are recorded as deferred revenue when all of the above revenue recognition criteria are met except delivery, postponed at the customer’s request. Revenue is subsequently recognized upon delivery. The revenues recorded are presented net of excise tax collected on behalf of government authorities.

Shipping and handling costs are classified as cost of products sold. Net sales include certain sales incentives, including retail discounting, promotional allowances and coupons.

Cost of Products Sold

Cost of Products Sold

Cost of products sold includes the expenses for the Master Settlement Agreement, referred to as the MSA, and other settlement agreements with the states of Mississippi, Florida, Texas and Minnesota, which together with the MSA are collectively referred to as the State Settlement Agreements; the federal tobacco quota buyout; and the user fees charged by the U.S. Food and Drug Administration, referred to as the FDA, were as follows for the years ended December 31:

	2011		2010		2009
State Settlement Agreements	$	2,435	$	2,496	$	2,540
Federal tobacco quota buyout		229		243		240
FDA user fees		120		75		22

Advertising

Advertising

Advertising costs, which are expensed as incurred, were $65 million, $72 million and $69 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Research and Development

Research and Development

Research and development costs, which are expensed as incurred, were $69 million, $71 million and $68 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Income Taxes

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Interest and penalties related to uncertain tax positions are accounted for as tax expense. Federal income taxes for RAI and its subsidiaries are calculated on a consolidated basis. State income taxes for RAI and its subsidiaries are primarily calculated on a separate return basis.

RAI accounts for uncertain tax positions which require that a position taken or expected to be taken in a tax return be recognized in the financial statements when it is more likely than not (a likelihood of more than 50 percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement.

Stock-Based Compensation

Stock-Based Compensation

Stock-based compensation expense is recognized for all forms of share-based payment awards, including shares issued to employees under stock options and restricted stock units.

Litigation Contingencies

Litigation Contingencies

RAI discloses information concerning litigation for which an unfavorable outcome is more than remote. RAI and its subsidiaries record their legal expenses and other litigation costs and related administrative costs as selling, general and administrative expenses as those costs are incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated. When the reasonable estimate is a range, the recorded loss will be the best estimate within the range. If no amount in the range is a better estimate than any other amount, the minimum amount of the range will be recorded.

Pension and Postretirement

Pension and Postretirement

Pension and postretirement benefits require balance sheet recognition of the net asset or liability for the overfunded or underfunded status of defined benefit pension and other postretirement benefit plans, on a plan-by-plan basis, and recognition of changes in the funded status in the year in which the changes occur.

Changes in benefit obligations due to plan amendments, referred to as prior service costs, are amortized on a straight-line basis over the average remaining service period for active employees. These changes are reported in accumulated other comprehensive loss, as a separate component of shareholders’ equity. Changes in the amount of either the benefit obligation or the value of plan assets resulting from experience different from that assumed or from changes in assumptions are referred to as actuarial gains and losses.

In November 2011, RAI elected to change its method of accounting for pension and postretirement benefits. Historically, RAI has recognized actuarial gains and losses in accumulated other comprehensive loss in its consolidated balance sheets on an annual basis, amortizing them into operating results over the average future service period of active employees in these plans, to the extent such gains and losses were in excess of 10 percent of the greater of the market-related value of plan assets or the plan’s projected benefit obligation, referred to as the corridor. RAI has elected to immediately recognize actuarial gains and losses in its operating results in the year in which they occur, to the extent they exceed the corridor. Actuarial gains and losses outside the corridor are generally recognized annually as of December 31, and are recorded as a mark-to-market, referred to as MTM, adjustment. Additionally, for purposes of calculating the expected return on plan assets, RAI will no longer use an averaging technique permitted under GAAP for the market-related value of plan assets, but instead will use the actual fair value of plan assets. These changes are intended to improve the transparency of RAI’s operating results by more quickly recognizing the effects of current economic and interest rate trends on plan investments and assumptions.

These changes have been reported through retrospective application of the new policy to all periods presented. The impacts of all revisions made to the financial statements are summarized below:

Consolidated statements of income:

	For the Year Ended December 31, 2010							For the Year Ended December 31, 2009
	Previously Reported		Revised		Effect Of Change			Previously Reported		Revised		Effect Of Change
Cost of products sold	$	4,544	$	4,544	$	—		$	4,485	$	4,488	$	3
Selling, general and administrative expenses		1,493		1,480		(13	)		1,508		1,517		9
Operating income		2,419		2,432		13			1,775		1,763		(12	)
Income from continuing operations before income taxes		2,192		2,205		13			1,534		1,522		(12	)
Provision for income taxes		863		868		5			572		567		(5	)
Income from continuing operations		1,329		1,337		8			962		955		(7	)
Net income		1,113		1,121		8			962		955		(7	)
Earnings per share — basic		1.91		1.92		0.01			1.65		1.64		(0.01	)
Earnings per share — diluted		1.90		1.92		0.02			1.65		1.64		(0.01	)

Consolidated balance sheet:

	December 31, 2010
	Previously Reported			Revised			Effect Of Change
Accumulated deficit	$	(547	)	$	(1,807	)	$	(1,260	)
Accumulated other comprehensive loss		(1,478	)		(218	)		1,260

Consolidated statements of cash flows:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Cash flows from operating activities:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Deferred income tax expense (benefit)		182			187			5			(154	)		(159	)		(5	)
Pension and postretirement		(702	)		(715	)		(13	)		(181	)		(169	)		12

Consolidated statements of shareholders’ equity and comprehensive income:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Accumulated deficit:
Beginning balance	$	(579	)	$	(1,847	)	$	(1,268	)	$	(531	)	$	(1,792	)	$	(1,261	)
Net income		1,113			1,121			8			962			955			(7	)
Ending balance		(547	)		(1,807	)		(1,260	)		(579	)		(1,847	)		(1,268	)
Accumulated other comprehensive income (loss):
Beginning balance	$	(1,421	)	$	(153	)	$	1,268		$	(1,695	)	$	(434	)	$	1,261
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7
Ending balance		(1,478	)		(218	)		1,260			(1,421	)		(153	)		1,268
Comprehensive income:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board, referred to as FASB, amended certain accounting and disclosure requirements related to fair value measurements. For fair value measurements categorized as Level 1 and Level 2, requirements have been expanded to include disclosures of transfers between these levels. For fair value measurements categorized as Level 3, a reporting entity should disclose quantitative information of the unobservable inputs and assumptions, a description of the valuation processes and a qualitative discussion about the sensitivity of the fair value measurement to changes in unobservable inputs. The guidance is effective for RAI for interim and annual reporting periods beginning January 1, 2012, and is not expected to have a material impact on RAI’s results of operations, cash flows or financial position.

In June 2011, the FASB issued amended guidance which requires comprehensive income to be reported in either a single statement or in two consecutive statements reporting net income and other comprehensive income. The amendment eliminates the option to report other comprehensive income and its components in the statement of changes in shareholders’ equity. The guidance is effective for fiscal years, and interim periods within those years, beginning January 1, 2012. In December 2011, the FASB deferred the changes related to the presentation of reclassification adjustments. The adoption of the amendment will have no impact on RAI’s results of operations, cash flows or financial position.

In September 2011, the FASB issued amended guidance that permits an entity to make a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount before applying the current two-step goodwill impairment test. If an entity concludes that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, it would not be required to perform the two-step impairment test for that reporting unit. The guidance is effective for RAI for interim and annual reporting periods beginning January 1, 2012, and will not have a material impact on RAI’s results of operations, cash flows or financial position.

XML

Shareholders' Equity (Details 1)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Changes in common stock outstanding
Shares outstanding at beginning of year	583,043,872	582,848,102	582,901,524
LTIP shares forfeited	(433)	(7,501)	(55,420)
LTIP tax shares repurchased and cancelled	(162,257)	(185,257)	(308,882)
Shares repurchased and cancelled	(6,776,637)
Stock options exercised		362,284	245,280
Equity incentive award plan shares issued	30,654	26,244	65,600
Shares outstanding at end of year	576,135,199	583,043,872	582,848,102

XML

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Condensed Consolidating Statements of Income
Net sales									$ 8,062	[1]	$ 8,170	[1]	$ 8,015	[1]
Net sales, related party									479		381		404
Net sales	2,083	2,200	2,267	1,991	2,081	2,239	2,245	1,986	8,541		8,551		8,419
Cost of products sold									4,464	[1]	4,544	[1]	4,488	[1]
Selling, general and administrative expenses									1,606		1,480		1,517
Amortization expense									24		25		28
Restructuring charge													56
Asset impairment and exit charges											38		56
Trademark impairment charges	48				6				48		6		567
Goodwill impairment charge					26						26
Operating income (loss)									2,399		2,432		1,763
Interest and debt expense									221		232		251
Interest income									(11)		(12)		(19)
Other expense, net									3		7		9
Income from continuing operations before income taxes									2,186		2,205		1,522
Provision for (benefit from) income taxes									780		868		567
Income from continuing operations									1,406		1,337		955
Losses from discontinued operations, net of tax								(216)			(216)
Net income (loss)	304	394	327	381	262	400	359	100	1,406		1,121		955
RAI [Member]
Condensed Consolidating Statements of Income
Selling, general and administrative expenses									129		20		20
Operating income (loss)									(129)		(20)		(20)
Interest and debt expense									213		223		242
Interest income									(118)		(119)		(115)
Other expense, net									8		2		(4)
Income from continuing operations before income taxes									(232)		(126)		(143)
Provision for (benefit from) income taxes									(89)		(42)		(49)
Equity income (loss) from subsidiaries									1,549		1,205		1,049
Income from continuing operations											1,121
Net income (loss)									1,406		1,121		955
Guarantors [Member]
Condensed Consolidating Statements of Income
Net sales									7,971		8,118		7,985
Net sales, related party									479		381		404
Net sales									8,450		8,499		8,389
Cost of products sold									4,460		4,569		4,544
Selling, general and administrative expenses									1,386		1,380		1,425
Amortization expense									24		25		28
Restructuring charge													56
Asset impairment and exit charges											24
Trademark impairment charges									48		6		567
Goodwill impairment charge											26
Operating income (loss)									2,532		2,469		1,769
Interest and debt expense									125		127		123
Interest income									(4)		(4)		(9)
Other expense, net									(47)		(39)		(30)
Income from continuing operations before income taxes									2,458		2,385		1,685
Provision for (benefit from) income taxes									875		919		616
Equity income (loss) from subsidiaries									20		(68)		26
Income from continuing operations											1,398
Losses from discontinued operations, net of tax											(142)
Net income (loss)									1,603		1,256		1,095
Non-Guarantors [Member]
Condensed Consolidating Statements of Income
Net sales									116		147		162
Net sales									116		147		162
Cost of products sold									29		72		76
Selling, general and administrative expenses									91		81		72
Asset impairment and exit charges											14
Operating income (loss)									(4)		(20)		14
Interest and debt expense											1		1
Interest income									(6)		(8)		(10)
Other expense, net									(1)		1
Income from continuing operations before income taxes									3		(14)		23
Provision for (benefit from) income taxes									(6)		(10)
Income from continuing operations											(4)
Losses from discontinued operations, net of tax											(74)
Net income (loss)									9		(78)		23
Eliminations [Member]
Condensed Consolidating Statements of Income
Net sales									(25)		(95)		(132)
Net sales									(25)		(95)		(132)
Cost of products sold									(25)		(97)		(132)
Selling, general and administrative expenses											(1)
Operating income (loss)											3
Interest and debt expense									(117)		(119)		(115)
Interest income									117		119		115
Other expense, net									43		43		43
Income from continuing operations before income taxes									(43)		(40)		(43)
Provision for (benefit from) income taxes											1
Equity income (loss) from subsidiaries									(1,569)		(1,137)		(1,075)
Income from continuing operations											(1,178)
Net income (loss)									(1,612)		(1,178)		(1,118)
Subsidiaries [Member] | RAI [Member]
Condensed Consolidating Statements of Income
Selling, general and administrative expenses									129		20		20
Operating income (loss)									(129)		(20)		(20)
Interest and debt expense									213		223		242
Interest income									(118)		(119)		(115)
Other expense, net									8		2		(4)
Income from continuing operations before income taxes									(232)		(126)		(143)
Provision for (benefit from) income taxes									(89)		(42)		(49)
Equity income (loss) from subsidiaries									1,549		1,205		1,049
Income from continuing operations											1,121
Net income (loss)									1,406		1,121		955
Subsidiaries [Member] | Issuer [Member]
Condensed Consolidating Statements of Income
Selling, general and administrative expenses									(7)		(2)		4
Operating income (loss)									7		2		(4)
Interest and debt expense									8		8		8
Interest income									(5)		(5)		(8)
Other expense, net									(45)		(43)		(31)
Income from continuing operations before income taxes									49		42		27
Provision for (benefit from) income taxes									1		(2)		(5)
Equity income (loss) from subsidiaries									1,344		951		939
Income from continuing operations											995
Losses from discontinued operations, net of tax											88
Net income (loss)									1,392		1,083		971
Subsidiaries [Member] | Guarantors [Member]
Condensed Consolidating Statements of Income
Net sales									6,908		7,093		7,078
Net sales, related party									478		371		396
Net sales									7,386		7,464		7,474
Cost of products sold									4,133		4,264		4,297
Selling, general and administrative expenses									1,164		1,124		1,183
Amortization expense									22		24		27
Restructuring charge													56
Asset impairment and exit charges											24
Trademark impairment charges									43				491
Operating income (loss)									2,024		2,028		1,420
Interest and debt expense													1
Interest income									(44)		(45)		(56)
Other expense, net											8		2
Income from continuing operations before income taxes									2,068		2,065		1,473
Provision for (benefit from) income taxes									752		814		562
Equity income (loss) from subsidiaries									28		5		26
Income from continuing operations											1,256
Losses from discontinued operations, net of tax											(230)
Net income (loss)									1,344		1,026		937
Subsidiaries [Member] | Non-Guarantors [Member]
Condensed Consolidating Statements of Income
Net sales									1,204		1,230		1,139
Net sales, related party									1		10		8
Net sales									1,205		1,240		1,147
Cost of products sold									381		435		393
Selling, general and administrative expenses									320		339		310
Amortization expense									2		1		1
Asset impairment and exit charges											14
Trademark impairment charges									5		6		76
Goodwill impairment charge											26
Operating income (loss)									497		419		367
Interest and debt expense									162		166		171
Interest income									(6)		(8)		(11)
Other expense, net									(3)		(3)		(1)
Income from continuing operations before income taxes									344		264		208
Provision for (benefit from) income taxes									116		97		59
Income from continuing operations											167
Losses from discontinued operations, net of tax											(74)
Net income (loss)									228		93		149
Subsidiaries [Member] | Eliminations [Member]
Condensed Consolidating Statements of Income
Net sales									(50)		(153)		(202)
Net sales									(50)		(153)		(202)
Cost of products sold									(50)		(155)		(202)
Selling, general and administrative expenses											(1)
Operating income (loss)											3
Interest and debt expense									(162)		(165)		(171)
Interest income									162		165		171
Other expense, net									43		43		43
Income from continuing operations before income taxes									(43)		(40)		(43)
Provision for (benefit from) income taxes											1
Equity income (loss) from subsidiaries									(2,921)		(2,161)		(2,014)
Income from continuing operations											(2,202)
Net income (loss)									$ (2,964)		$ (2,202)		$ (2,057)

[1] Excludes excise taxes of $4,107 million, $4,340 million and $3,927 million for the years ended December 31, 2011, 2010 and 2009, respectively.

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Provision for income taxes from continuing operations

	2011		2010		2009
Current:
Federal	$	572	$	545	$	592
State and other		108		136		134
		680		681		726
Deferred:
Federal		80		160		(154	)
State and other		20		27		(5	)
		100		187		(159	)
	$	780	$	868	$	567

Significant Components of deferred tax assets (liabilities)

	2011			2010
Deferred tax assets:
Pension and other postretirement liabilities	$	707		$	714
Tobacco settlement accruals		1,006			1,031
Other accrued liabilities		81			70
Other noncurrent liabilities		154			141
Subtotal		1,948			1,956
Less: valuation allowance		(33	)		—
		1,915			1,956
Deferred tax liabilities:
LIFO inventories		(162	)		(200	)
Property and equipment		(239	)		(218	)
Trademarks and other intangibles		(950	)		(978	)
Other		(130	)		(132	)
		(1,481	)		(1,528	)
Net deferred tax asset	$	434		$	428

Current and noncurrent components of deferred tax assets (liabilities)

	2011			2010
Current deferred tax assets	$	945		$	946
Noncurrent deferred tax liabilities		(511	)		(518	)
	$	434		$	428

Pre-tax income for domestic and foreign operations

	2011		2010		2009
Domestic (includes U.S. exports)	$	2,157	$	2,204	$	1,495
Foreign		29		1		27
	$	2,186	$	2,205	$	1,522

Differences between the provision for income taxes from continuing operations and income taxes

	2011			2010			2009
Income taxes computed at statutory U.S. federal income tax rates	$	765		$	771		$	533
State and local income taxes, net of federal tax benefits		96			101			80
Domestic manufacturing deduction		(60	)		(54	)		(41	)
Other items, net		(21	)		50			(5	)
Provision for income taxes from continuing operations	$	780		$	868		$	567
Effective tax rate		35.7	%		39.4	%		37.3	%

Reconciliation of the unrecognized gross tax benefits

	2011			2010			2009
Balance at beginning of year	$	127		$	94		$	97
Gross increases related to current period tax positions		6			37			6
Gross increases related to tax positions in prior periods		1			4			3
Gross decreases related to tax positions in prior periods		(1	)		(1	)		(4	)
Gross increases (decreases) related to audit settlements		1			(4	)		(3	)
Gross decreases related to lapse of applicable statute of limitations		(6	)		(3	)		(5	)
Balance at end of year	$	128		$	127		$	94

XML

Business and Summary of Significant Accounting Policies (Details Textual) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 Y	Dec. 31, 2010	Dec. 31, 2009
Business and Summary of Significant Accounting Policies (Textual) [Abstract]
Proceeds from divestiture of interest in subsidiaries	$ 202
Operating cycle period of inventories	12 months
Capitalized computer software additions	24	22
Capitalized computer software unamortized balance	64	64
Software amortization expense	24	30	26
Maximum estimated useful life of software (in years)	5.0
Advertising costs incurred	65	72	69
Research and development costs	$ 69	$ 71	$ 68
Recognized tax position realized upon ultimate settlement	50.00%
Defined benefit plan corridor percentage	10.00%
Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives, minimum (in years)	20
Estimated useful lives, maximum (in years)	50
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives, minimum (in years)	3
Estimated useful lives, maximum (in years)	30

XML

Other Current Liabilities (Details) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Other Current Liabilities
Payroll and employee benefits	$ 134	$ 188
Pension and other postretirement benefits	83	96
Marketing and advertising	100	133
Other current liabilities	323	285
Excise, franchise and property tax	158	160
Restructuring	5	36
Tobacco quota Buyout	86	57
Other	179	192
Individual Engle Progeny cases accrual	64
Other current liabilities	$ 1,132	$ 1,147

XML

Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended												12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 30, 2009	Jun. 30, 2009	Mar. 31, 2009	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Consolidated Statements of Income [Abstract]
Net sales													$ 8,062	[1]	$ 8,170	[1]	$ 8,015	[1]
Net sales, related party													479		381		404
Net sales	2,083	2,200	2,267	1,991	2,081	2,239	2,245	1,986					8,541		8,551		8,419
Costs and expenses:
Cost of products sold													4,464	[1]	4,544	[1]	4,488	[1]
Selling, general and administrative expenses													1,606		1,480		1,517
Amortization expense													24		25		28
Asset impairment and exit charges															38		56
Trademark impairment charges	48				6								48		6		567
Goodwill impairment charge					26										26
Restructuring charge																	56
Operating income													2,399		2,432		1,763
Interest and debt expense													221		232		251
Interest income													(11)		(12)		(19)
Other expense, net													3		7		9
Income from continuing operations before income taxes													2,186		2,205		1,522
Provision for income taxes													780		868		567
Income from continuing operations													1,406		1,337		955
Losses from discontinued operations, net of tax								(216)							(216)
Net income	$ 304	$ 394	$ 327	$ 381	$ 262	$ 400	$ 359	$ 100					$ 1,406		$ 1,121		$ 955
Basic income per share:
Income from continuing operations					$ 0.45	$ 0.69	$ 0.62	$ 0.54					$ 2.41		$ 2.29		$ 1.64
Loss from discontinued operations, net of tax								$ (0.37)							$ (0.37)
Net income	$ 0.52	$ 0.68	$ 0.56	$ 0.65	$ 0.45	$ 0.69	$ 0.62	$ 0.17					$ 2.41		$ 1.92		$ 1.64
Diluted income per share:
Income from continuing operations					$ 0.45	$ 0.68	$ 0.61	$ 0.54					$ 2.40		$ 2.29		$ 1.64
Loss from discontinued operations, net of tax								$ (0.37)							$ (0.37)
Net income	$ 0.52	$ 0.67	$ 0.56	$ 0.65	$ 0.45	$ 0.68	$ 0.61	$ 0.17					$ 2.40		$ 1.92		$ 1.64
Dividends declared per share	$ 0.56	$ 0.53	$ 0.53	$ 0.53	$ 0.49	$ 0.45	$ 0.45	$ 0.45	$ 0.450	$ 0.425	$ 0.425	$ 0.425	$ 2.15		$ 1.84		$ 1.73

[1] Excludes excise taxes of $4,107 million, $4,340 million and $3,927 million for the years ended December 31, 2011, 2010 and 2009, respectively.

XML

Retirement Benefits (Tables)

12 Months Ended

Dec. 31, 2011

Retirement Benefits [Abstract]

Changes in benefit obligations and plan assets and the funded status

	Pension Benefits						Postretirement Benefits
	2011			2010			2011			2010
Change in benefit obligation:
Obligation at beginning of year	$	5,529		$	5,270		$	1,436		$	1,351
Service cost		26			29			3			4
Interest cost		300			319			75			80
Actuarial loss		320			324			59			148
Plan amendments		—			—			(45	)		(51	)
Benefits paid		(397	)		(410	)		(94	)		(97	)
Settlements		(9	)		—			—			—
Curtailment		—			(3	)		—			1
One-time cost		(3	)		—			—			—
Obligation at end of year	$	5,766		$	5,529		$	1,434		$	1,436
Change in plan assets:
Fair value of plan assets at beginning of year	$	4,934		$	4,054		$	270		$	270
Actual return on plan assets		362			479			1			31
Employer contributions		220			811			78			66
Benefits paid		(397	)		(410	)		(94	)		(97	)
Settlements		(9	)		—			—			—
Fair value of plan assets at end of year	$	5,110		$	4,934		$	255		$	270
Funded status	$	(656	)	$	(595	)	$	(1,179	)	$	(1,166	)
Amounts recognized in the consolidated balance sheets consist of:
Noncurrent assets — other assets and deferred charges		7			3			—			—
Accrued benefit — other current liability		(9	)		(18	)		(74	)		(78	)
Accrued benefit — long-term retirement benefits		(654	)		(580	)		(1,105	)		(1,088	)
Net amount recognized		(656	)		(595	)		(1,179	)		(1,166	)
Accumulated other comprehensive loss		596			382			2			(23	)
Net amounts recognized in the consolidated balance sheets	$	(60	)	$	(213	)	$	(1,177	)	$	(1,189	)

Accumulated other comprehensive loss

	2011									2010
	Pension Benefits			Postretirement Benefits			Total			Pension Benefits			Postretirement Benefits			Total
Prior service cost (credit)	$	26		$	(135	)	$	(109	)	$	30		$	(119	)	$	(89	)
Net actuarial loss		570			137			707			352			96			448
Deferred income taxes		(245	)		(23	)		(268	)		(160	)		(13	)		(173	)
Accumulated other comprehensive loss	$	351		$	(21	)	$	330		$	222		$	(36	)	$	186

Changes in accumulated other comprehensive loss

	2011									2010
	Pension Benefits			Postretirement Benefits			Total			Pension Benefits			Postretirement Benefits			Total
Prior service credit	$	—		$	(45	)	$	(45	)	$	—		$	(51	)	$	(51	)
Net actuarial loss		331			76			407			185			136			321
Amortization of prior service cost (credit)		(4	)		29			25			(4	)		24			20
One-time cost		(3	)		—			(3	)		—			—			—
MTM adjustment		(110	)		(35	)		(145	)		(3	)		(107	)		(110	)
Deferred income tax expense		(85	)		(10	)		(95	)		(72	)		(30	)		(102	)
Change in accumulated other comprehensive loss	$	129		$	15		$	144		$	106		$	(28	)	$	78

Weighted-average assumptions used to determine benefit obligations

	Pension Benefits						Postretirement
	2011			2010			2011			2010
Weighted-average assumptions used to determine benefit obligations at December 31:
Discount rate		5.00	%		5.66	%		4.84	%		5.52	%
Rate of compensation increase		5.00	%		5.00	%		5.00	%		5.00	%

Accumulated benefit obligations

	December 31,
	2011		2010
Projected benefit obligation	$	5,737	$	5,499
Accumulated benefit obligation		5,630		5,380
Plan assets		5,074		4,901

Components of the total benefit cost and assumptions

	Pension Benefits									Postretirement Benefits
	2011			2010			2009			2011			2010			2009
Components of total benefit cost:
Service cost	$	26		$	29		$	31		$	3		$	4		$	4
Interest cost		300			319			319			75			80			80
Expected return on plan assets		(373	)		(343	)		(264	)		(18	)		(18	)		(16	)
Amortization of prior service cost (credit)		4			4			4			(29	)		(24	)		(24	)
MTM adjustment		110			3			14			35			107			35
Curtailment		—			—			—			—			1			—
Special termination benefits		—			—			8			—			—			—
Settlements		—			—			1			—			—			—
Total benefit cost	$	67		$	12		$	113		$	66		$	150		$	79

Weighted-average assumptions used to determine net periodic benefit cost

	Pension Benefits									Postretirement Benefits
	2011			2010			2009			2011			2010			2009
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31:
Discount rate		5.66	%		6.30	%		6.40	%		5.52	%		6.20	%		6.39	%
Expected long-term return on plan assets		7.73	%		8.24	%		8.24	%		7.00	%		7.00	%		6.80	%
Rate of compensation increase		5.00	%		5.00	%		5.00	%		5.00	%		5.00	%		5.00	%

Pension and postretirement plans weighted-average asset allocations

	Pension Plans
	2011 Target(1 )			2011			2010 Target(1 )			2010
Asset Category:
Domestic equities		9	%		11	%		27	%		28	%
International equities		11	%		13	%		13	%		12	%
Global equities		9	%		6	%		5	%		7	%
Fixed income		53	%		55	%		40	%		38	%
High yield fixed income		3	%		3	%		2	%		3	%
Hedge funds		4	%		5	%		7	%		6	%
Private equity		1	%		1	%		2	%		1	%
Real estate		4	%		4	%		2	%		3	%
Global tactical asset allocation		2	%		2	%		2	%		2	%
Commodities (2)		4	%		—	%		—	%		—	%
Total		100	%		100	%		100	%		100	%

⁽¹⁾ Allows for a rebalancing range of up to 5 percentage points around target asset allocations.

⁽²⁾  Commodities were approved in December 2011 and are expected to be funded in 2012.

	Postretirement Plans
	2011 Target(1 )			2011			2010 Target(1 )			2010
Asset Category:
Domestic equities		21	%		21	%		42	%		43	%
International equities		21	%		19	%		16	%		16	%
Fixed income		58	%		57	%		39	%		36	%
Hedge funds		—	%		—	%		1	%		1	%
Cash and other		—	%		3	%		2	%		4	%
Total		100	%		100	%		100	%		100	%

⁽¹⁾  Allows for a rebalancing range of up to 5 percentage points around target asset allocations.

Pension and postretirement plan assets carried at fair value

Pension Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	765	$	247	$	—	$	1,012
International equities		118		401		—		519
Global equities		322		—		—		322
Fixed income		40		2,082		36		2,158
High yield fixed income		—		144		—		144
Hedge funds		—		—		249		249
Private equity		—		—		46		46
Real estate		35		—		161		196
Global tactical asset allocation		—		91		—		91
Other		1		77		2		80
Total	$	1,281	$	3,042	$	494	$	4,817

Postretirement Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	—	$	54	$	—	$	54
International equities		—		48		—		48
Fixed income		15		129		—		144
Other		—		6		—		6
Total	$	15	$	237	$	—	$	252

⁽¹⁾  See note 1 for additional information on the fair value hierarchy.

Pension Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	781	$	246	$	—	$	1,027
International equities		126		468		—		594
Global equities		351		1		—		352
Fixed income		34		1,542		55		1,631
High yield fixed income		—		136		—		136
Hedge funds		—		2		274		276
Private equity		—		3		45		48
Real estate		46		20		90		156
Global tactical asset allocation		—		98		—		98
Other		4		564		3		571
Total	$	1,342	$	3,080	$	467	$	4,889

Postretirement Plans	Level 1		Level 2		Level 3		Total
Asset Category:
Domestic equities	$	—	$	115	$	—	$	115
International equities		—		44		—		44
Fixed income		1		95		—		96
Hedge funds		—		—		1		1
Real estate and other		—		14		—		14
Total	$	1	$	268	$	1	$	270

⁽¹⁾ See note 1 for additional information on the fair value hierarchy.

Transfers of pension and postretirement plan assets in and out of Level 3

	Balance as of January  1, 2011		Purchases, Sales, Issuances and Settlements (net)			Realized Gains			Unrealized Gains (Losses)			Transferred From Other Levels(1)		Balance as of December 31, 2011
Fixed income	$	55	$	(24	)	$	11		$	(8	)	$	2	$	36
Hedge funds		275		(19	)		47			(54	)		—		249
Private equity		45		(4	)		4			1			—		46
Real estate		90		54			1			16			—		161
Other		3		—			(1	)		—			—		2
Total	$	468	$	7		$	62		$	(45	)	$	2	$	494

⁽¹⁾ Transfers in and out of Level 3 occur using the fair value at the beginning of the period.

	Balance as of January  1, 2010		Purchases, Sales, Issuances and Settlements (net)			Realized Gains		Unrealized Gains (Losses)			Transferred From Other Levels		Balance as of December 31, 2010
Fixed income	$	96	$	(54	)	$	18	$	(5	)	$	—	$	55
Hedge funds		291		(33	)		15		2			—		275
Private equity		43		(3	)		1		4			—		45
Real estate		31		52			—		7			—		90
Other		3		—			—		—			—		3
Total	$	464	$	(38	)	$	34	$	8		$	—	$	468

Additional information relating to significant postretirement plans

	2011			2010
Weighted-average health-care cost trend rate assumed for the following year		12.94	%		15.18	%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)		5.00	%		5.00	%
Year that the rate reaches the ultimate trend rate		2018			2018

Effect of one-percentage-point change in assumed health-care cost trend rates

	1-Percentage Point Increase		1-Percentage Point Decrease
Effect on total of service and interest cost components	$	4	$	(4	)
Effect on benefit obligation		75		(65	)

Estimated future benefits payments

			Postretirement Benefits
Year	Pension Benefits		Gross Projected Benefit  Payments Before Medicare Part D Subsidies		Expected Medicare Part D Subsidies		Net Projected Benefit  Payments After Medicare Part D Subsidies
2012	$	407	$	109	$	3	$	106
2013		399		112		3		109
2014		395		113		4		109
2015		395		112		4		108
2016		397		111		4		107
2017-2021		1,951		530		26		504

XML

Retirement Benefits (Details 3)	Dec. 31, 2011	Dec. 31, 2010
Pension Benefits [Member]
Weighted-average assumptions used to determine benefit obligations at December 31
Discount rate	5.00%	5.66%
Rate of compensation increase	5.00%	5.00%
Postretirement Benefits [Member]
Weighted-average assumptions used to determine benefit obligations at December 31
Discount rate	4.84%	5.52%
Rate of compensation increase	5.00%	5.00%

XML

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Details Textual) (RAI [Member], USD $) In Millions, unless otherwise specified	Dec. 31, 2011
RAI [Member]
Guaranteed Unsecured Notes Financial Statements Parent (Numeric) [Abstract]
RAI's unsecured notes	$ 3,500

XML

Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 1,956	$ 2,195
Accounts receivable	101	118
Accounts receivable, related party	67	48
Other receivables	46	44
Inventories	967	1,055
Deferred income taxes, net	945	946
Prepaid expenses and other	225	195
Assets held for sale	0	201
Total current assets	4,307	4,802
Property, plant and equipment, at cost:
Land and land improvements	91	89
Buildings and leasehold improvements	748	656
Machinery and equipment	1,756	1,700
Construction-in-process	90	157
Total property, plant and equipment	2,685	2,602
Less accumulated depreciation	1,615	1,600
Property, plant and equipment, net	1,070	1,002
Trademarks and other intangible assets, net of accumulated amortization (2011 - $696; 2010 - $672)	2,602	2,675
Goodwill	8,010	8,010
Other assets and deferred charges	265	589
Total assets	16,254	17,078
Current liabilities:
Accounts payable	113	179
Tobacco settlement accruals	2,530	2,589
Due to related party	2	4
Deferred revenue, related party	42	53
Current maturities of long-term debt	457	400
Other current liabilities	1,132	1,147
Total current liabilities	4,276	4,372
Long-term debt (less current maturities)	3,206	3,701
Deferred income taxes, net	511	518
Long-term retirement benefits (less current portion)	1,759	1,668
Other noncurrent liabilities	251	309
Commitments and contingencies:
Shareholders' equity:
Common stock (shares issued: 2011 - 576,135,199; 2010 - 583,043,872)
Paid-in capital	8,293	8,535
Accumulated deficit	(1,660)	(1,807)
Accumulated other comprehensive loss - (Defined benefit pension and post-retirement plans: 2011 - $(330) and 2010 - $(186), net of tax)	(382)	(218)
Total shareholders' equity	6,251	6,510
Total liabilities and shareholders' equity	$ 16,254	$ 17,078

XML

Retirement Benefits (Details 1) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Accumulated other comprehensive loss
Prior service cost (credit)	$ (109)	$ (89)
Net actuarial loss	707	448
Deferred income taxes	(268)	(173)
Accumulated other comprehensive loss	330	186
Pension Benefits [Member]
Accumulated other comprehensive loss
Prior service cost (credit)	26	30
Net actuarial loss	570	352
Deferred income taxes	(245)	(160)
Accumulated other comprehensive loss	351	222
Postretirement Benefits [Member]
Accumulated other comprehensive loss
Prior service cost (credit)	(135)	(119)
Net actuarial loss	137	96
Deferred income taxes	(23)	(13)
Accumulated other comprehensive loss	$ (21)	$ (36)

XML

Fair Value (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Jan. 07, 2009	Jan. 06, 2009
Fair Value Measurement (Textual) [Abstract]
Estimated fair value of RAI's and RJR's outstanding long-term notes	$ 4,000,000,000	$ 4,300,000,000
Debt weighted average interest rate	5.90%	5.40%
Floating to fixed interest rate swap, designated as hedges	0			258,000,000
Floating to fixed interest rate swap, Total				321,000,000
Interest rate swaps terminated			100,000,000
Gain on termination of interest rate swap agreement that will be amortized to effectively reduce interest expense over the remaining life of the notes	159,000,000	198,000,000	12,000,000
Proceeds from Derivative Instrument, Financing Activities	186,000,000
Debt covered by fixed interest rate	1,600,000,000
Decrease fixed rate of interest	4.00%
Floating to fixed [Member]
Derivative [Line Items]
Offsetting floating to fixed interest rate swap agreements in the notional amount	1,500,000,000
Fixed to floating [Member]
Derivative [Line Items]
Offsetting floating to fixed interest rate swap agreements in the notional amount	$ 1,500,000,000

XML

Retirement Benefits (Details 6)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Benefits [Member]
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31:
Discount rate	5.66%	6.30%	6.40%
Expected long-term return on plan assets	7.73%	8.24%	8.24%
Rate of compensation increase	5.00%	5.00%	5.00%
Postretirement Benefits [Member]
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31:
Discount rate	5.52%	6.20%	6.39%
Expected long-term return on plan assets	7.00%	7.00%	6.80%
Rate of compensation increase	5.00%	5.00%	5.00%

XML

Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2011

Intangible Assets [Abstract]

Changes in Carrying Amounts of Goodwill by Segment

	RJR Tobacco			American Snuff			Santa Fe		All Other		Consolidated
Balance as of December 31, 2008
Goodwill	$	9,065		$	2,650		$	197	$	27	$	11,939
Less: Accumulated impairment charges		(3,763	)		(2	)		—		—		(3,765	)
Net goodwill balance as of December 31, 2008		5,302			2,648			197		27		8,174
2009 Activity
Acquisition of Niconovum AB		—			—			—		11		11
Balance as of December 31, 2009
Goodwill		9,065			2,650			197		38		11,950
Less: Accumulated impairment charges		(3,763	)		(2	)		—		—		(3,765	)
Net goodwill balance as of December 31, 2009		5,302			2,648			197		38		8,185
2010 Activity
Reclassified as held for sale	$	—		$	(149	)	$	—	$	—	$	(149	)
Impairment charge		—			(26	)		—		—		(26	)
		—			(175	)		—		—		(175	)
Balance as of December 31, 2010 and 2011
Goodwill		9,065			2,501			197		38		11,801
Less: Accumulated impairment charges		(3,763	)		(28	)		—		—		(3,791	)
Net goodwill balance as of December 31, 2010 and 2011	$	5,302		$	2,473		$	197	$	38	$	8,010

Carrying amounts of indefinite-lived intangible assets by segment not subject to amortization

	RJR Tobacco					American Snuff			Santa Fe		All Other			Consolidated
	Trademarks			Other		Trademarks			Trademarks		Other			Trademarks			Other
Balance as of December 31, 2008	$	1,653		$	55	$	1,222		$	155	$	48		$	3,030		$	103
Impairment charge		(490	)		—		(70	)		—		—			(560	)		—
Intersegment transfer		—			44		—			—		(44	)		—			—
Acquisition of Niconovum AB		—			—		—			—		43			—			43
Balance as of December 31, 2009	$	1,163		$	99	$	1,152		$	155	$	47		$	2,470		$	146
Impairment charge		—			—		(6	)		—		—			(6	)		—
Foreign currency translation		—			—		—			—		3			—			3
Reclassified as held for sale		(11	)		—		(3	)		—		—			(14	)		—
Reclassified to finite-lived		—			—		(7	)		—		—			(7	)		—
Balance as of December 31, 2010	$	1,152		$	99	$	1,136		$	155	$	50		$	2,443		$	149
Impairment charge		(43	)		—		—			—		—			(43	)		—
Foreign currency translation		—			—		—			—		(1	)		—			(1	)
Balance as of December 31, 2011	$	1,109		$	99	$	1,136		$	155	$	49		$	2,400		$	148

Changes in carrying amounts of finite-lived intangible assets by segment subject to amortization

	RJR Tobacco						American Snuff			Consolidated
	Trademarks			Other			Trademarks			Trademarks			Other
Balance as of December 31, 2008	$	33		$	84		$	20		$	53		$	84
Amortization		(12	)		(15	)		(1	)		(13	)		(15	)
Impairment charge		(1	)		—			(6	)		(7	)		—
Balance as of December 31, 2009		20			69			13			33			69
Amortization		(9	)		(15	)		(1	)		(10	)		(15	)
Reclassified as held for sale		—			—			(1	)		(1	)		—
Reclassified from indefinite-lived		—			—			7			7			—
Balance as of December 31, 2010		11			54			18			29			54
Amortization		(7	)		(15	)		(2	)		(9	)		(15	)
Impairment charge		—			—			(5	)		(5	)		—
Balance as of December 31, 2011	$	4		$	39		$	11		$	15		$	39

Details of finite lived intangible assets

	Gross		Accumulated Amortization		Net
Finite-lived:
Contract manufacturing agreements	$	151	$	112	$	39
Trademarks		96		81		15
Indefinite-lived		3,051		503		2,548
	$	3,298	$	696	$	2,602

Finite lived intangible assets future amortization expense

Year	Amount
2012	$	21
2013		16
2014		10
2015		1
2016		1
Thereafter		5
	$	54

XML

Intangible Assets (Details Textual) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 Y	Dec. 31, 2009
Finite-Lived Intangible Assets [Line Items]
Trade brand Maximum useful life	5.0
Estimated future cash flows discount rate based on a weighted average cost of capital	10.50%
Intangible Assets (Textual) [Abstract]
Increase in the federal excise tax per pack of cigarettes		$ 0.62
RJR Tobacco [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated future cash flows discount rate based on a weighted average cost of capital	10.25%
American Snuff [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated future cash flows discount rate based on a weighted average cost of capital	10.25%
Santa Fe [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated future cash flows discount rate based on a weighted average cost of capital	11.00%
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Trade brand Minimum useful life	1
Trade brand Maximum useful life	17

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2011

Commitments and Contingencies [Abstract]

Commitments and Contingencies

Note 13 — Commitments and Contingencies

Tobacco Litigation — General

Introduction

Various legal proceedings or claims, including litigation claiming that cancer and other diseases, as well as addiction, have resulted from the use of, or exposure to, RAI’s operating subsidiaries’ products, are pending or may be instituted against RJR Tobacco, American Snuff Co. or their affiliates, including RAI and RJR, or indemnitees, including B&W. These pending legal proceedings include claims relating to cigarette products manufactured by RJR Tobacco or certain of its affiliates and indemnitees, as well as claims relating to smokeless tobacco products manufactured by American Snuff Co. A discussion of the legal proceedings relating to cigarette products is set forth below under the heading “— Litigation Affecting the Cigarette Industry.” All of the references under that heading to tobacco-related litigation, smoking and health litigation and other similar references are references to legal proceedings relating to cigarette products and are not references to legal proceedings involving smokeless tobacco products, and case numbers under that heading include only cases involving cigarette products. The legal proceedings relating to the smokeless tobacco products manufactured by American Snuff Co. are discussed separately under the heading “— Smokeless Tobacco Litigation” below.

In connection with the B&W business combination, RJR Tobacco has agreed to indemnify B&W and its affiliates, including its indirect parent, BAT, against certain liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. As a result of this indemnity, RJR Tobacco has assumed the defense of pending B&W-specific tobacco-related litigation, has paid the judgments and costs related to certain pre-business combination tobacco-related litigation of B&W, and has posted bonds on behalf of B&W, where necessary, in connection with cases decided since the B&W business combination. In addition, pursuant to this indemnity, RJR Tobacco expensed less than $1 million during each of 2011, 2010 and 2009 for funds to be reimbursed to BAT for costs and expenses incurred arising out of certain tobacco-related litigation.

Certain Terms and Phrases

Certain terms and phrases used in this disclosure may require some explanation. The term “judgment” or “final judgment” refers to the final decision of the court resolving the dispute and determining the rights and obligations of the parties. At the trial court level, for example, a final judgment generally is entered by the court after a jury verdict and after post-verdict motions have been decided. In most cases, the losing party can appeal a verdict only after a final judgment has been entered by the trial court.

The term “damages” refers to the amount of money sought by a plaintiff in a complaint, or awarded to a party by a jury or, in some cases, by a judge. “Compensatory damages” are awarded to compensate the prevailing party for actual losses suffered, if liability is proved. In cases in which there is a finding that a defendant has acted willfully, maliciously or fraudulently, generally based on a higher burden of proof than is required for a finding of liability for compensatory damages, a plaintiff also may be awarded “punitive damages.” Although damages may be awarded at the trial court stage, a losing party generally may be protected from paying any damages until all appellate avenues have been exhausted by posting a supersedeas bond. The amount of such a bond is governed by the law of the relevant jurisdiction and generally is set at the amount of damages plus some measure of statutory interest, modified at the discretion of the appropriate court or subject to limits set by court or statute.

The term “settlement” refers to certain types of cases in which cigarette manufacturers, including RJR Tobacco and B&W, have agreed to resolve disputes with certain plaintiffs without resolving the case through trial. The principal terms of certain settlements entered into by RJR Tobacco and B&W are explained below under “— Accounting for Tobacco-Related Litigation Contingencies.”

Theories of Recovery

The plaintiffs seek recovery on a variety of legal theories, including negligence, strict liability in tort, design defect, special duty, voluntary undertaking, breach of warranty, failure to warn, fraud, misrepresentation, unfair trade practices, conspiracy, unjust enrichment, medical monitoring, public nuisance and violations of state and federal antitrust laws. In certain of these cases, the plaintiffs claim that cigarette smoking exacerbated injuries caused by exposure to asbestos.

The plaintiffs seek various forms of relief, including compensatory and punitive damages, treble or multiple damages and statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and other equitable relief. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.

Defenses

The defenses raised by RJR Tobacco, American Snuff Co. and their affiliates and indemnitees include, where applicable and otherwise appropriate, preemption by the Federal Cigarette Labeling and Advertising Act of some or all claims arising after 1969, or by the Comprehensive Smokeless Tobacco Health Education Act for claims arising after 1986, the lack of any defect in the product, assumption of the risk, contributory or comparative fault, lack of proximate cause, remoteness, lack of standing and statutes of limitations or repose. RAI and RJR have asserted additional defenses, including jurisdictional defenses, in many of the cases in which they are named.

Accounting for Tobacco-Related Litigation Contingencies

In accordance with GAAP, RAI and its subsidiaries, including RJR Tobacco, American Snuff Co. and SFNTC, as applicable, record any loss concerning litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. For the reasons set forth below, RAI’s management continues to conclude that the loss of any particular pending smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular claim concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual basis, is not probable, except for four Engle Progeny cases described below.

RJR Tobacco and its affiliates believe that they have valid defenses to the smoking and health tobacco litigation claims against them, as well as valid bases for appeal of adverse verdicts against them. RAI, RJR Tobacco and their affiliates and indemnitees have, through their counsel, filed pleadings and memoranda in pending smoking and health tobacco litigation that set forth and discuss a number of grounds and defenses that they and their counsel believe have a valid basis in law and fact. With the exception of Engle Progeny cases, described below, RJR Tobacco and its affiliates and indemnitees continue to win the majority of smoking and health tobacco litigation claims that reach trial, and a very high percentage of the tobacco-related litigation claims brought against them continue to be dismissed at or before trial. Based on their experience in the smoking and health tobacco litigation against them and the strength of the defenses available to them in such litigation, RJR Tobacco and its affiliates believe that their successful defense of smoking and health tobacco litigation in the past will continue in the future.

An accrual of $64 million has been recorded in RAI’s consolidated balance sheet as of December 31, 2011 for the four Engle Progeny cases, described below, that have proceeded through the appellate process in the state of Florida. RJR Tobacco is seeking further review of these four cases by the U.S. Supreme Court. This amount includes $53 million for compensatory and punitive damages and $11 million for attorneys’ fees and statutory interest through December 31, 2011. No other liabilities for pending smoking and health litigation have been recorded as of December 31, 2011.

Generally, RJR Tobacco and its affiliates and indemnitees have not settled, and currently RJR Tobacco and its affiliates do not intend to settle, any smoking and health tobacco litigation claims. It is the policy of RJR Tobacco and its affiliates to vigorously defend all tobacco-related litigation claims.

The only material settlements of smoking and health tobacco litigation claims reached by RJR Tobacco and B&W involved:

• the State Settlement Agreements and the funding by various tobacco companies of a $5.2 billion trust fund contemplated by the MSA to benefit tobacco growers; and

• the original Broin flight attendant case discussed below under “— Litigation Affecting the Cigarette Industry — Broin II Cases.”

The circumstances surrounding the State Settlement Agreements and the funding of a trust fund to benefit the tobacco growers are readily distinguishable from the current categories of smoking and health cases involving RJR Tobacco or its affiliates and indemnitees. The claims underlying the State Settlement Agreements were brought on behalf of the states to recover funds paid for health care and medical and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. The State Settlement Agreements settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and contain releases of various additional present and future claims. In accordance with the MSA, various tobacco companies agreed to fund a $5.2 billion trust fund to be used to address the possible adverse economic impact of the MSA on tobacco growers. A discussion of the State Settlement Agreements, and a table depicting the related payment schedule, is set forth below under “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — State Settlement Agreements.”

The states were a unique set of plaintiffs and are not involved in any of the smoking and health cases remaining against RJR Tobacco or its affiliates and indemnitees. Although RJR Tobacco and certain of its affiliates and indemnitees continue to be defendants in health-care cost recovery cases similar in theory to the state cases but involving other plaintiffs, such as Native American tribes and foreign governments, the vast majority of such cases have been dismissed on legal grounds. RJR Tobacco and its affiliates, including RAI, believe that the same legal principles that have resulted in dismissal of health-care cost recovery cases either at the trial court level or on appeal should compel dismissal of the similar pending cases.

As with claims that were resolved by the State Settlement Agreements, the other cases settled by RJR Tobacco can be distinguished from existing cases pending against RJR Tobacco and its affiliates and indemnitees. The original Broin case, discussed below under “— Litigation Affecting the Cigarette Industry — Broin II Cases,” was settled in the middle of trial during negotiations concerning a possible nation-wide settlement of claims similar to those underlying the State Settlement Agreements.

RJR Tobacco’s Comprehensive Agreement with the Canadian federal, provincial and territorial governments resolved all civil claims related to the movement of contraband tobacco products in Canada during the period 1985 through 1999 that the Canadian governments could assert against RJR Tobacco and its affiliates. These claims were separate from any smoking and health tobacco litigation. A discussion of the Canadian matters and the related settlement are set forth in note 6.

Likewise, RJR Tobacco and B&W separately settled the antitrust case DeLoach v. Philip Morris Cos., Inc., which was brought by a unique class of plaintiffs: a class of all tobacco growers and tobacco allotment holders. The plaintiffs asserted that the defendants conspired to fix the price of tobacco leaf and to destroy the federal government’s tobacco quota and price support program. Despite legal defenses they believed to be valid, RJR Tobacco and B&W separately settled this case to avoid a long and contentious trial with the tobacco growers. The DeLoach case and the antitrust case currently pending against RJR Tobacco and B&W involve different types of plaintiffs and different theories of recovery under the antitrust laws than the smoking and health cases pending against RJR Tobacco and its affiliates and indemnitees.

Finally, as discussed under “— Litigation Affecting the Cigarette Industry — State Settlement Agreements — Enforcement and Validity; Adjustments,” RJR Tobacco and B&W each has settled certain cases brought by states concerning the enforcement of State Settlement Agreements. Despite legal defenses believed to be valid, these cases were settled to avoid further contentious litigation with the states involved. These enforcement actions involve alleged breaches of State Settlement Agreements based on specific actions taken by particular defendants. Accordingly, any future enforcement actions involving State Settlement Agreements will be reviewed by RJR Tobacco on the merits and should not be affected by the settlement of prior enforcement cases.

American Snuff Co. also believes that it has valid defenses to the smokeless tobacco litigation against it. American Snuff Co. asserted and will continue to assert some or all of these defenses in each case at the time and in the manner deemed appropriate by American Snuff Co. and its counsel. No verdict or judgment has been returned or entered against American Snuff Co. on any claim for personal injuries allegedly resulting from the use of smokeless tobacco. American Snuff Co. intends to defend vigorously all smokeless tobacco litigation claims asserted against it. No liability for pending smokeless tobacco litigation was recorded in RAI’s consolidated balance sheet as of December 31, 2011.

Cautionary Statement

Even though RAI’s management continues to conclude that the loss of any particular pending smoking and health tobacco litigation claim (except for the four Engle Progeny cases described below) against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular case concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual case-by-case basis, is not probable, the possibility of material losses related to such litigation is more than remote. Litigation is subject to many uncertainties, and generally, it is not possible to predict the outcome of any particular litigation pending against RJR Tobacco, American Snuff Co. or their affiliates or indemnitees, or to reasonably estimate the amount or range of any possible loss.

Although RJR Tobacco believes that it has valid bases for appeals of adverse verdicts in its pending cases, and RJR Tobacco and RAI believe they have valid defenses to all actions, and intend to defend all actions vigorously, it is possible that there could be further adverse developments in pending cases, and that additional cases could be decided unfavorably against RAI, RJR Tobacco or their affiliates or indemnitees. Determinations of liability or adverse rulings in such cases or in similar cases involving other cigarette manufacturers as defendants, even if such judgments are not final, could have a material adverse effect on the litigation against RJR Tobacco or its affiliates or indemnitees and could encourage the commencement of additional tobacco-related litigation. In addition, a number of political, legislative, regulatory and other developments relating to the tobacco industry and cigarette smoking have received wide media attention. These developments may negatively affect the outcomes of tobacco-related legal actions and encourage the commencement of additional similar litigation.

Although it is impossible to predict the outcome of such events on pending litigation and the rate new lawsuits are filed against RJR Tobacco or its affiliates or indemnitees, a significant increase in litigation or in adverse outcomes for tobacco defendants, or difficulties in obtaining the bonding required to stay execution of judgments on appeal, could have a material adverse effect on any or all of these entities. Moreover, notwithstanding the quality of defenses available to RJR Tobacco and its affiliates and indemnitees in litigation matters, it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against RJR Tobacco or its affiliates or indemnitees.

Similarly, smokeless tobacco litigation is subject to many uncertainties. Notwithstanding the quality of defenses available to American Snuff Co., it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against American Snuff Co.

Litigation Affecting the Cigarette Industry

Overview

Introduction.    In connection with the B&W business combination, RJR Tobacco agreed to indemnify B&W and its affiliates against, among other things, certain litigation liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. Accordingly, the cases discussed below include cases brought solely against RJR Tobacco and its affiliates, including RAI and RJR; cases brought against both RJR Tobacco, its affiliates and B&W; and cases brought solely against B&W and assumed by RJR Tobacco in the B&W business combination.

During the fourth quarter of 2011, 19 tobacco-related cases, including nine Engle Progeny cases, were served against RJR Tobacco or its affiliates or indemnitees. On December 31, 2011, there were 170 cases pending against RJR Tobacco or its affiliates or indemnitees: 159 in the United States; 10 in Canada and one in Israel, as compared with 198 total cases on December 31, 2010. The U.S. case number does not include the 577 individual smoker cases pending in West Virginia state court as a consolidated action, 6,561 Engle Progeny cases (as hereinafter defined), involving approximately 7,852 individual plaintiffs, and 2,586 Broin II cases (as hereinafter defined), pending in the United States against RJR Tobacco or its affiliates or indemnitees. Of the U.S. cases pending on December 31, 2011, 18 are pending in federal court, 140 in state court, primarily in the following states: Florida (29 cases); Missouri (19 cases); New York (17 cases); Maryland (13 cases); Louisiana (12 cases); and California (11 cases).

The following table lists the categories of the U.S. tobacco-related cases pending against RJR Tobacco or its affiliates or indemnitees as of December 31, 2011, compared with the number of cases pending against RJR Tobacco, its affiliates or indemnitees as of September 30, 2011, as reported in RAI’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2011, filed with the SEC on October 28, 2011, and a cross-reference to the discussion of each case type.

Case Type	RJR Tobacco’s Case  Numbers as of December 31, 2011			Change in Number of Cases Since September 30, 2011 Increase/(Decrease)			Page Reference
Individual Smoking and Health		97			4			112
West Virginia IPIC (Number of Plaintiffs)*		1(577	)		(– 11	)		114
Engle Progeny (Number of Plaintiffs)**		6,561 (7,852	)		– 32 (– 47	)		115
Broin II		2,586			No Change			125
Class-Action		13			– 2			125
Health-Care Cost Recovery		3			No Change			131
State Settlement Agreements-Enforcement and Validity; Adjustments		32			– 1			138
Antitrust		1			No Change			143
Other Litigation and Developments		12			– 3			144

* Includes as one case the 577 cases pending as a consolidated action In Re: Tobacco Litigation Individual Personal Injury Cases, sometimes referred to as West Virginia IPIC cases, described below. The West Virginia IPIC cases have been separated from the Individual Smoking and Health cases for reporting purposes.

** The Engle Progeny cases have been separated from the Individual Smoking and Health cases for reporting purposes. The number of cases may decrease as the result of many of the multiple plaintiff federal court cases either being dismissed or consolidated.

The following cases against RJR Tobacco and B&W have attracted significant attention: the Florida state court class-action case, Engle v. R. J. Reynolds Tobacco Co. and the related Engle Progeny cases, the Louisiana state court class-action case, Scott v. American Tobacco Co., and the case brought by the U.S. Department of Justice under the federal Racketeer Influenced and Corrupt Organizations Act, referred to as RICO.

In 2000, a jury in Engle rendered a punitive damages verdict in favor of the “Florida class” of approximately $145 billion against all defendants. In July 2006, the Florida Supreme Court, among other things, affirmed an appellate court’s reversal of the punitive damages award, decertified the class going forward, preserved several class-wide findings from the trial, including that nicotine is addictive and cigarettes are defectively designed, and authorized class members to avail themselves of these findings in individual lawsuits under certain conditions. After subsequent motions were resolved, the Florida Supreme Court issued its mandate on January 11, 2007, thus beginning a one-year period in which former class members were permitted to file individual lawsuits. In October 2007, the U.S. Supreme Court denied the defendants’ petition for writ of certiorari.

Individual Engle Progeny cases are pending in both federal and state court in Florida. As of December 31, 2011, 3,246 cases were pending in federal court, and 3,315 cases were pending in state court. These cases include approximately 7,852 plaintiffs. The number of cases will likely change due to individual plaintiffs being severed from multi-plaintiff cases and multi-plaintiff federal cases being dismissed or consolidated. In addition, as of December 31, 2011, RJR Tobacco was aware of 46 additional cases that had been filed but not served (with 319 plaintiffs). Fifty-seven trials have occurred in Florida state court since 2009, and numerous state court trials are scheduled for 2012.

As Engle Progeny litigation has progressed, the federal and state court systems have adopted different rules to govern those cases, and both have courts issuing conflicting opinions. For example, in Bernice Brown v. R. J. Reynolds Tobacco Co., the U.S. Court of Appeals for the Eleventh Circuit, referred to as the Eleventh Circuit, held that the preserved Engle findings establish only those issues “actually adjudicated” in the Engle class trial. In other words, based on the decision in Bernice Brown, the Engle findings would not prevent RJR Tobacco and other defendants from raising issues and defenses that were not, or may not have been, resolved against them in Engle. The court further held that an Engle Progeny plaintiff bears the burden of showing, to a “reasonable degree of certainty,” that any issue the plaintiff seeks to treat as established in his favor was, in fact, actually raised and resolved in Engle. The court held that these standards were required by Florida preclusion law, and it reserved judgment on the question of whether the same standards were also required by the Due Process Clause of the U.S. Constitution. Prior to the Eleventh Circuit decision in Bernice Brown, three federal district court judges (including the judge in Bernice Brown) concluded that any broader use of the preserved Engle findings would violate both Florida preclusion law and federal due process.

The state courts in Florida, however, have taken two entirely different approaches since Bernice Brown. In Martin v. R. J. Reynolds Tobacco Co., the First District Court of Appeal, referred to as the First DCA, held that the Engle findings establish not only facts that were “actually adjudicated” in favor of the class in Engle, but also all facts that could have been decided in favor of the class. The court in Martin thus held that, “no matter the wording of the findings” in Engle, individual Engle Progeny plaintiffs need not “demonstrate the relevance of the findings to their lawsuits” in order to prevent litigation on otherwise contested issues of misconduct. The court in Martin expressly disagreed with the Eleventh Circuit decision in Bernice Brown on this point.

In Jimmie Lee Brown v. R. J. Reynolds Tobacco Co., the Fourth District Court of Appeal, referred to as the Fourth DCA, expressly disagreed with both Bernice Brown and Martin on the proper use of the Engle findings. Like Martin, but unlike Bernice Brown, the court in Jimmie Lee Brown held that the Engle findings establish certain issues of misconduct in every Engle Progeny case. Unlike Martin, however, the court in Jimmie Lee Brown held that class membership was not sufficient to establish claims for strict liability and negligence. The court held that, in addition to proving that addiction caused an injury to the smoker, the plaintiff also was required to prove that a product defect or negligence caused that injury. RJR Tobacco has sought further review of Jimmie Lee Brown in the Florida Supreme Court.

Finally, and most recently, in Waggoner v. R. J. Reynolds Tobacco Co., a district judge of the U.S. District Court for the Middle District of Florida adopted the preclusion standards set forth in Jimmie Lee Brown for Engle Progeny cases pending in federal court. The judge in Waggoner concluded that Martin and Jimmie Lee Brown effectively overruled Bernice Brown on questions of Florida law. The judge further held that the rule adopted in Martin and Jimmie Lee Brown, giving preclusive effect to any facts that the Engle jury could have decided against the defendants, does not violate due process. The Waggoner decision thus conflicts with the decisions of the other federal district judges who previously addressed the due process question. RJR Tobacco has sought interlocutory review of Waggoner in the Eleventh Circuit.

The Florida Supreme Court, the First DCA, and the Fourth DCA thus far have failed to address the due process argument. The First DCA in Martin did not mention due process, despite it being one of RJR Tobacco’s central contentions on appeal. Moreover, in five subsequent individual Engle Progeny appeals, the First DCA refused to issue any opinion; instead, it affirmed the plaintiffs’ verdicts by per curiam orders citing Martin with no explanation. The First DCA and the Fourth DCA have both refused to certify the question of the proper use of the Engle findings as one of exceptional importance warranting review by the Florida Supreme Court, even though that question affects every Engle Progeny case and notwithstanding the explicit disagreement between the state and federal courts on this issue. Moreover, on July 19, 2011, the Florida Supreme Court refused to exercise its discretionary jurisdiction to review Martin and issued summary denial of petitions in Campbell, Gray and Hall, which are discussed specifically below in “— Engle and Engle Progeny Cases.”

The Fourth DCA in Jimmie Lee Brown recognized RJR Tobacco’s due process argument as an important issue, but held that until the Florida Supreme Court addresses the issue, it is bound to follow the Florida Supreme Court’s opinion in Engle. To date, no other Florida District Court of Appeal has addressed the issues on which the Bernice Brown, Martin and Jimmie Lee Brown courts were divided, but RJR Tobacco has pending appeals presenting these issues in the Second, Third and Fifth Florida District Courts of Appeal. RJR Tobacco is seeking review of its due process claims in the U.S. Supreme Court, sometimes referred to as the USSC, in Martin, as well as in Campbell, Gray and Hall.

In 2011, based on its evaluation of the Martin, Campbell, Gray and Hall cases, RJR Tobacco reflected an accrual for loss of $64 million on these cases ($53 million for compensatory and punitive damages and $11 million for attorneys’ fees and statutory interest through December 31, 2011). The following chart reflects the details related to these verdicts:

Plaintiff Case Name	RJR Tobacco Allocation of Fault			Compensatory Damages (as adjusted)*		Punitive Damages		Appeal Status
Martin		66	%	$	3,300,000	$	25,000,000	USSC petition filed
Campbell		39	%		3,040,000		—	USSC petition filed
Gray		60	%		4,200,000		2,000,000	USSC petition filed
Hall		65	%		3,250,000		12,500,000	USSC petition filed
Totals				$	13,790,000	$	39,500,000

* Compensatory damages are adjusted to reflect the reduction required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments should they ever have to be paid.

The following chart reflects the verdicts in the individual Engle Progeny cases that have been tried and remain pending as of December 31, 2011, in which a verdict has been returned in favor of the plaintiffs and against RJR Tobacco or B&W, or both, for which RJR Tobacco has reflected no liability as of December 31, 2011. It does not include the mistrials or verdicts returned in favor of RJR Tobacco or B&W, or both.

Plaintiff Case Name	RJR Tobacco Allocation of Fault			Compensatory Damages (as adjusted)*		Punitive Damages		Appeal Status
Sherman		50	%	$	775,000	$	—	Pending — Fourth DCA
Brown		50	%		600,000		—	Notice to invoke discretionary jurisdiction of Florida Supreme Court pending
Douglas		5	%		250,000		—	Pending — Second DCA
Cohen		33.3	%		3,300,000		10,000,000	Pending — Fourth DCA
Clay		60	%		2,100,000		17,000,000	Affirmed by First DCA per curiam; seeking further review
Townsend		51	%		5,500,000		40,800,000	Pending — First DCA
Putney		30	%		4,500,000		2,500,000	Pending — Fourth DCA
Grossman		25	%		484,000		—	Pending — Fourth DCA
Buonomo		77.5	%		4,060,000		15,700,000	Pending — Fourth DCA
Alexander		51	%		1,275,000		2,500,000	Affirmed by First DCA per curiam; seeking further review
Piendle		27.5	%		1,100,000		180,000	Pending — Fourth DCA
Koballa		30	%		300,000		—	Pending — Fifth DCA***
Webb		90	%		7,200,000		72,000,000	Pending — First DCA
Kirkland		10	%		10,000		250,000	Pending — Second DCA
Huish		25	%		188,000		1,500,000	Pending — First DCA
Mack		51	%		510,000		—	Pending — First DCA
Andy Allen		45	%	$	2,700,000	$	8,100,000	Pending — First DCA
Jewett		20	%		219,000		—	Pending — First DCA
Reese		30	%		1,100,000		—	Pending — Third DCA
Soffer		40	%		2,000,000		—	Pending — First DCA
Ciccone		30	%		1,000,000		50,000	Pending — Fourth DCA
Weingart		3	%		4,500		—	Pending — Fourth DCA
Bowman		30	%		450,000		—	Pending — First DCA
Sury		20	%		200,000		—	Post-trial motions pending**
Hallgren		25	%		500,000		750,000	Post-trial motions pending**
Ward		30	%		300,000		1,700,000	Post-trial motion pending**
Totals				$	40,625,500	$	173,030,000

* Compensatory damages are adjusted to reflect the reduction required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments should they ever have to be paid.

** Should the pending post-trial motions be denied, RJR Tobacco will file a notice of appeal with the DCA in which the cases are pending.

*** The court in Koballa found RJR Tobacco not liable for the plaintiff’s injuries, but awarded damages. For a detailed description of the case, see “— Engle and Engle Progeny Cases” below.

As of December 31, 2011, jury verdicts in favor of the Engle Progeny plaintiffs had been entered against RJR Tobacco in the total amount of $54,415,500 in compensatory damages (as adjusted) and $212,530,000 in punitive damages, for a total of $266,945,500. All of these verdicts are at various stages in the appellate process, including Martin, Campbell, Gray and Hall, which RJR Tobacco is seeking review by the USSC. Except for those four cases, no liability for pending smoking and health litigation related to Engle Progeny cases was recorded in RAI’s consolidated balance sheet as of December 31, 2011. RJR Tobacco continues to believe that it has valid defenses in these cases, including the state preclusion law and federal due process issues that impact all Engle Progeny cases. RJR Tobacco has petitioned the USSC to review its due process claims in the Martin, Campbell, Gray and Hall cases and will do so in other cases as necessary and appropriate. Should RJR Tobacco not prevail in any particular individual Engle Progeny case or determine that in any individual Engle Progeny case an unfavorable outcome has become probable and the amount can be reasonably estimated, a loss would be recognized, which could have a material adverse effect on earnings and cash flows of RAI in a particular fiscal quarter or fiscal year.

This recognition of Engle Progeny cases as of December 31, 2011, is consistent with RAI’s and RJR Tobacco’s historic recognition related to such smoking and health litigation claims. It is the policy of RJR Tobacco and its affiliates to vigorously defend all such claims, including Engle Progeny cases. It is also the policy of RJR Tobacco to record any loss concerning litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. Accordingly, although RJR Tobacco has petitioned the USSC for review in the Martin, Campbell, Gray and Hall cases, RJR Tobacco recognized a liability for each of these cases as of December 31, 2011.

In 2004, a jury in Scott returned a verdict in favor of the “Louisiana class” for $591 million to establish a state-wide smoking cessation program. In 2007, the Louisiana Court of Appeal upheld class certification, significantly reduced the scope of recovery, and remanded the case for further proceedings. The Louisiana and U.S. Supreme Courts denied the defendants’ applications for writ of certiorari. In July 2008, the trial court entered an amended judgment in favor of the class for approximately $263 million plus interest from June 30, 2004. In April 2010, the Louisiana Fourth Circuit Court of Appeal amended the final judgment, and as amended, affirmed the judgment. Pursuant to the judgment, the defendants were required to deposit with the court $242 million with judicial interest from July 21, 2008, until paid. In September 2010, the defendants’ application for writ of certiorari with the Louisiana Supreme Court and emergency motion to stay execution of judgment in the Supreme Court of Louisiana were denied. The U.S. Supreme Court also granted the application to stay the judgment pending applicants’ timely filing, and the Court’s disposition, of a petition for writ of certiorari. The defendants’ petition for writ of certiorari in the U.S. Supreme Court was denied on June 27, 2011. RJR Tobacco accrued $139 million, the portion of the judgment allocated to RJR Tobacco and B&W, in the second quarter of 2011. RJR Tobacco paid the judgment in August 2011. In December 2011, the plaintiffs filed a motion for assessment of attorneys’ fees and costs for the prosecution of the case.

In the U.S. Department of Justice case, brought in 1999 in the U.S. District Court for the District of Columbia, the government sought, among other forms of relief, the disgorgement of profits pursuant to the civil provisions of RICO. The U.S. Court of Appeals for the District of Columbia ruled in 2005 that disgorgement is not an available remedy in the case. The bench trial ended in June 2005, and the court, in August 2006, issued its ruling, among other things, finding certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, imposing no direct financial penalties on the defendants, but ordering the defendants to make certain “corrective communications” in a variety of media and enjoining the defendants from using certain brand descriptors. Both sides appealed to the U.S. Court of Appeals for the District of Columbia. In May 2009, the U.S. Court of Appeals largely affirmed the findings against the tobacco company defendants and remanded to the trial court for further proceedings. The U.S. Supreme Court denied the parties’ petitions for writ of certiorari in June 2010. Post-remand proceedings are underway.

For a detailed description of these cases, see “— Engle and Engle Progeny Cases,” “— Class-Action Suits — Medical Monitoring and Smoking Cessation Case” and “— Health-Care Cost Recovery Cases — Department of Justice Case” below.

In November 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the MSA with 46 U.S. states, Washington, D.C. and certain U.S. territories and possessions. These cigarette manufacturers previously settled four other cases, brought on behalf of Mississippi, Florida, Texas and Minnesota, by separate agreements with each state. These State Settlement Agreements:

• settled all health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions;

• released the major U.S. cigarette manufacturers from various additional present and potential future claims;

• imposed future payment obligations in perpetuity on RJR Tobacco, B&W and other major U.S. cigarette manufacturers; and

• placed significant restrictions on their ability to market and sell cigarettes and smokeless tobacco products.

Payments under the State Settlement Agreements are subject to various adjustments for, among other things, the volume of cigarettes sold, relevant market share and inflation. See “— Health-Care Cost Recovery Cases — State Settlement Agreements” below for a detailed discussion of the State Settlement Agreements, including RAI’s operating subsidiaries’ monetary obligations under these agreements. RJR Tobacco records the allocation of settlement charges as products are shipped.

Scheduled Trials.    Trial schedules are subject to change, and many cases are dismissed before trial. It is likely, however, that RJR Tobacco and other cigarette manufacturers will continue to face an increased number of tobacco-related trials when compared to recent years. There are seven cases, exclusive of Engle Progeny cases, scheduled for trial as of December 31, 2011 through December 31, 2012, for RJR Tobacco or its affiliates and indemnitees: three other non-smoking and health cases, two individual smoking and health cases, one antitrust case and one class action. There are 62 Engle Progeny cases against RJR Tobacco and/or B&W set for trial through December 31, 2012, but it is not known how many of these cases will actually be tried.

Trial Results.    From January 1, 2009 through December 31, 2011, 64 smoking and health and health-care cost recovery cases in which RJR Tobacco or B&W were defendants were tried, including 9 trials for cases where mistrials were declared in the original proceedings. Verdicts in favor of RJR Tobacco, B&W and, in some cases, RJR Tobacco, B&W and other defendants, were returned in 35 cases, including 17 mistrials, tried in Florida (30), Missouri (2) and West Virginia (3). Verdicts in favor of the plaintiffs were returned in 27 cases tried in Florida and one in Connecticut. One case in Florida was dismissed during trial.

In the fourth quarter of 2011, four Engle Progeny cases in which RJR Tobacco was a defendant were tried:

• In Junious v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants on October 20, 2011.

• In Szymanski v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants on October 20, 2011.

• In Sury v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, William Sury, 60% at fault, RJR Tobacco 20% at fault, and the other defendant 20% at fault, and awarded $1 million in compensatory damages and no punitive damages.

• In Cox v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco on December 16, 2011.

For a detailed description of the above-described cases, see “— Engle and Engle Progeny Cases” below.

In addition, since the end of the fourth quarter of 2011, jurors returned verdicts in the following Engle Progeny cases:

• In Hallgren v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Claire Hallgren, 50% at fault, RJR Tobacco to be 25% at fault, and the other defendant 25% at fault, and awarded $2 million in compensatory damages and $750,000 in punitive damages against each defendant.

• In Ward v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Mattie Ward, 50% at fault, RJR Tobacco to be 30% at fault, and the remaining defendants collectively to be 20% at fault, and awarded $1 million in compensatory damages and $1.7 million in punitive damages against RJR Tobacco only.

• In Larkin v. R. J. Reynolds Tobacco Co., the court declared a mistrial after the jury informed the court that they were unable to reach a verdict.

For a detailed description of the above-described cases, see “— Engle and Engle Progeny Cases” below.

In the fourth quarter of 2011, no non-Engle Progeny individual smoking and health cases in which RJR Tobacco was a defendant were tried.

The following chart reflects the verdicts in the smoking and health cases or health-care cost recovery cases that have been tried and remain pending as of December 31, 2011, in which verdicts have been returned in favor of the plaintiffs and against RJR Tobacco or B&W, or both.

Date of Verdict	Case Name/Type	Jurisdiction	Verdict	Cross-Reference to Post-Trial Status
December 18, 2003	Frankson v. Brown & Williamson Tobacco Corp. [Individual]	Supreme Court, Kings County (Brooklyn, NY)	$350,000 in compensatory damages; 50% fault assigned to B&W; $20 million in punitive damages, of which $6 million was assigned to B&W, and $2 million to a predecessor company.	See “— Individual Smoking and Health Cases” below.
February 2, 2005	Smith v. Brown & Williamson Tobacco Corp. [Individual]	Circuit Court, Jackson County (Independence, MO)	$2 million in compensatory damages; 25% of fault assigned to B&W, which reduced the award to $500,000; $20 million in punitive damages. In August 2009, a new trial on punitive damages was conducted and the jury awarded $1.5 million.	See “— Individual Smoking and Health Cases” below.
August 17, 2006	United States v. Philip Morris USA, Inc. [Governmental Health-Care Cost Recovery]	U.S. District Court, District of Columbia (Washington, DC)	RJR Tobacco and B&W were found liable for civil RICO claims; were enjoined from using certain brand descriptors and from making certain misrepresentations; and were ordered to make corrective communications on five subjects, including smoking and health and addiction, to reimburse the U.S. Department of Justice appropriate costs associated with the lawsuit, and to maintain document web sites.	See “— Health-Care Cost Recovery Cases - Department of Justice Case” below.
May 5, 2009	Sherman v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$1.55 million in compensatory damages; 50% of fault assigned to RJR Tobacco, which reduced the award to $775,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 22, 2009	Brown v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$1.2 million in compensatory damages; 50% of fault assigned to RJR Tobacco, which reduced the award to $600,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 29, 2009	Martin v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$5 million in compensatory damages; 66% of fault assigned to RJR Tobacco, which reduced the award to $3.3 million; $25 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
August 19, 2009	Campbell v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$7.8 million in compensatory damages; 39% of fault assigned to RJR Tobacco, which reduced the award to $3.04 million. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
February 8, 2010	Gray v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$7 million in compensatory damages; 60% of fault assigned to RJR Tobacco, which reduced the award to $4.2 million; $2 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
March 10, 2010	Douglas v. Philip Morris USA, Inc. [Engle Progeny]	Circuit Court, Hillsborough County, (Tampa, FL)	$5 million in compensatory damages; 5% of fault assigned to RJR Tobacco, which reduced the award to $250,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
March 11, 2010	Hall v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$5 million in compensatory damages; 65% of fault assigned to RJR Tobacco, which reduced the award to $3.25 million; $12.5 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
March 10, 2010	Cohen v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$10 million in compensatory damages; 33.3% of fault assigned to RJR Tobacco, which reduced the award to $3.3 million; $20 million in punitive damages, of which $10 million was assigned to RJR Tobacco.	See “— Engle and Engle Progeny Cases” below.
April 13, 2010	Clay v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$3.5 million in compensatory damages; 60% of fault assigned to RJR Tobacco, which reduced the award to $2.1 million; $18 million in punitive damages, of which $17 million was assigned to RJR Tobacco.	See “— Engle and Engle Progeny Cases” below.
April 21, 2010	Townsend v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$10.8 million in compensatory damages and $80 million punitive damages; 51% of fault assigned to RJR Tobacco, which reduced the award to $5.5 million in compensatory damages; $40.8 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
April 26, 2010	Putney v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$15.1 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $4.5 million; $5 million in punitive damages, of which $2.5 million was assigned to RJR Tobacco.	See “— Engle and Engle Progeny Cases” below.
April 29, 2010	Grossman v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$1.9 million in compensatory damages; 25% of fault assigned to RJR Tobacco, which reduced the award to $484,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 20, 2010	Buonomo v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$5.2 million in compensatory damages; 77.5% of fault assigned to RJR Tobacco, which reduced the award to $4.06 million; $25 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
May 26, 2010	Izzarelli v. R. J. Reynolds Tobacco Co. [Individual S&H]	U.S. District Court, District of Connecticut, (Bridgeport, CT)	$13.9 million in compensatory damages; 58% of fault assigned to RJR Tobacco, which reduced the award to $8.08 million against RJR Tobacco; $3.97 million in punitive damages.	See “— Individual Smoking and Health Cases” below.
June 18, 2010	Alexander v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$2.5 million in compensatory damages; 51% of fault assigned to RJR Tobacco, which reduced the award to $1.275 million; $2.5 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
August 5, 2010	Piendle v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Palm Beach County, (West Palm Beach, FL)	$4 million in compensatory damages; 27.5% of fault assigned to RJR Tobacco, which reduced the award to $1.1 million; $180,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.
November 15, 2010	Webb v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Levy County, (Bronson, FL)	$8 million in compensatory damages; 90% of fault assigned to RJR Tobacco, which reduced the award to $7.2 million; $72 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
February 10, 2011	Kirkland v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Hillsborough County, (Tampa, FL)	$100,000 in compensatory damages; 10% of fault assigned to RJR Tobacco, which reduced the award to $10,000; $250,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.
February 22, 2011	Huish v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$750,000 in compensatory damages; 25% of fault assigned to RJR Tobacco, which reduced the award to $187,500; $1.5 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.
March 18, 2011	Mack v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$1 million in compensatory damages; 51% of fault assigned to RJR Tobacco, which reduced the award to $510,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
April 26, 2011	Andy Allen v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$6 million in compensatory damages; 45% of fault assigned to RJR Tobacco, which reduced the award to $2.7 million; $17 million in punitive damages against each defendant awarded.	See “— Engle and Engle Progeny Cases” below.
May 20, 2011	Jewett v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$1.1 million in compensatory damages; 20% of fault assigned to RJR Tobacco, which reduced the award to $218,600. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
May 20, 2011	Reese v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Miami-Dade County, (Miami, FL)	$3.6 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $1.1 million. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
June 16, 2011	Soffer v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Alachua County, (Gainesville, FL)	$5 million in compensatory damages; 40% of fault assigned to RJR Tobacco, which reduced the award to $2 million. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
July 15, 2011	Ciccone v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Broward County, (Ft. Lauderdale, FL)	$3.2 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $1 million; $50,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.
July 19, 2011	Weingart v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Palm Beach County, (West Palm Beach, FL)	Jury did not award damages; however, the plaintiff was awarded $150,000 on September 16, 2011.	See “— Engle and Engle Progeny Cases” below.
September 23, 2011	Bowman v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$1.5 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $450,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
November 28, 2011	Sury v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Duval County, (Jacksonville, FL)	$1 million in compensatory damages; 20% of fault assigned to RJR Tobacco, which reduced the award to $200,000. No punitive damages awarded.	See “— Engle and Engle Progeny Cases” below.
January 24, 2012	Hallgren v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Highlands County, (Sebring, FL)	$2 million in compensatory damages; 25% of fault assigned to RJR Tobacco, which reduced the award to $500,000; $750,000 in punitive damages.	See “— Engle and Engle Progeny Cases” below.
January 25, 2012	Ward v. R. J. Reynolds Tobacco Co. [Engle Progeny]	Circuit Court, Escambia County, (Pensacola, FL)	$1 million in compensatory damages; 30% of fault assigned to RJR Tobacco, which reduced the award to $300,000; $1.7 million in punitive damages.	See “— Engle and Engle Progeny Cases” below.

Individual Smoking and Health Cases

As of December 31, 2011, 97 individual cases were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both. This category of cases includes smoking and health cases alleging personal injury brought by or on behalf of individual plaintiffs, but does not include the Broin II, Engle Progeny or West Virginia IPIC cases discussed below. A total of 94 of the individual cases are brought by or on behalf of individual smokers or their survivors, while the remaining three cases are brought by or on behalf of individuals or their survivors alleging personal injury as a result of exposure to environmental tobacco smoke, referred to as ETS.

Below is a description of the individual smoking and health cases against RJR Tobacco or B&W, or both, which went to trial or were decided during the period from January 1, 2011 to December 31, 2011, or remained on appeal as of December 31, 2011.

On August 15, 2003, the jury returned a verdict in favor of B&W in Eiser v. Brown & Williamson Tobacco Corp., a case filed in March 1999 in the Court of Common Pleas, Philadelphia County, Pennsylvania. The plaintiff, Lois Eiser, sought compensatory and punitive damages in an amount in excess of $50,000, together with interest, costs and attorneys’ fees in this wrongful death action against B&W. In January 2006, the Superior Court of Pennsylvania affirmed the verdict. The Pennsylvania Supreme Court granted the plaintiff’s petition to appeal, and on December 28, 2007, remanded the case to the Superior Court for further review of certain issues. In August 2010, the Superior Court of Pennsylvania entered a memorandum affirming the final judgment. In December 2011, the plaintiff’s petition for permission to appeal to the Pennsylvania Supreme Court was denied. The deadline for the plaintiff to file a petition for writ of certiorari with the U.S. Supreme Court is March 5, 2012.

On December 18, 2003, the jury returned a verdict in favor of the plaintiff in Frankson v. Brown & Williamson Tobacco Corp., a case filed in August 2000 in Supreme Court, Kings County, New York, awarded $350,000 in compensatory damages and eventually returned a verdict of $20 million in punitive damages against the defendants in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco, who was dismissed prior to trial, and B&W. Other manufacturers were dismissed before trial. The plaintiff, Gladys Frankson, alleged that Mr. Frankson became addicted to nicotine, was unable to cease smoking, developed lung cancer and died as a result. The defendants as a group and the deceased smoker were each found to be 50% at fault. On January 9, 2004, the jury awarded $20 million in punitive damages, assigning $6 million to B&W and $2 million to American Tobacco, a predecessor company to B&W. In June 2004, the parties’ post-trial motions were denied by the trial judge, except that the trial judge granted a new trial unless the parties consented to an increase in compensatory damages to $500,000 and a decrease in punitive damages to $5 million, of which $4 million would be assigned to B&W. The plaintiff stipulated to the reduction in punitive damages in January 2005. Defendants filed a notice of appeal of the orders on post-trial motions in January 2005. In July 2006, the Appellate Division, New York Supreme Court, Second Department, directed that the plaintiffs’ claims for design defect be dismissed, but otherwise affirmed the orders denying defendants’ post-trial motions. Following remand from this appellate decision, the plaintiff withdrew her request for additur of the compensatory damages, and in December 2006, the trial judge granted this request, and reinstated the original $350,000 compensatory damages jury verdict.

On June 26, 2007, final judgment was entered against the defendants in the amount of approximately $6.8 million, including interest through the date the judgment was entered and costs. The defendants filed a notice of appeal to the Appellate Division, New York Supreme Court, Second Department. Pursuant to its agreement to indemnify B&W, RJR Tobacco posted a supersedeas bond in the amount of $8.018 million. In September 2009, the New York Supreme Court, Appellate Division, affirmed the compensatory damages award, set aside the punitive damages award and remanded the case to the Kings County Supreme Court for a new trial on punitive damages. No date has been set for the punitive damages retrial.

On February 1, 2005, the jury returned a split verdict in Smith v. Brown & Williamson Tobacco Corp., a case filed in May 2003 in Circuit Court, Jackson County, Missouri, finding in favor of B&W on two counts, fraudulent concealment and conspiracy, and finding in favor of the plaintiffs on negligence, which incorporates failure to warn and product defect claims. The plaintiff, Lincoln Smith, claimed that the defendant’s tobacco products caused Mrs. Smith’s death from lung cancer. The plaintiffs were awarded $2 million in compensatory damages and $20 million in punitive damages; however, the jury found the plaintiff to be 75% at fault and B&W 25% at fault, and thus the compensatory award was reduced to $500,000. B&W appealed to the Missouri Court of Appeals, and in July 2007, the court affirmed the compensatory damages and ordered a new trial on punitive damages. In December 2008, the Missouri Court of Appeals issued an opinion that affirmed in part, reversed in part, and remanded the case for further proceedings on the issue of punitive damages. Trial on the issue of punitive damages began in July 2009. On July 29, 2009, RJR Tobacco, on behalf of B&W, paid the compensatory damages verdict, plus interest, in the amount of approximately $700,000. In August 2009, the jury returned a verdict for the plaintiffs, finding B&W liable for damages for aggravating circumstances, and on August 20, 2009, awarded the plaintiffs $1.5 million in punitive damages. The court denied the plaintiffs’ and the defendant’s post-trial motions. B&W and the plaintiffs filed notices of appeal in December 2009. Oral argument occurred on September 28, 2011. A decision is pending.

On May 26, 2010, a jury returned a verdict in favor of the plaintiff in Izzarelli v. R. J. Reynolds Tobacco Co., a case filed in December 1999 in the U.S. District Court for the District of Connecticut. The plaintiff sought to recover damages for personal injuries that the plaintiff alleges she sustained as a result of unsafe and unreasonably dangerous cigarette products and for economic losses she sustained as a result of unfair trade practices of the defendant. The jury found RJR Tobacco to be 58% at fault and the plaintiff to be 42% at fault, awarded $13.9 million in compensatory damages and found the plaintiff to be entitled to punitive damages. In December 2010, the court awarded the plaintiff $3.97 million in punitive damages. Final judgment was entered on December 30, 2010, in the amount of $11.95 million. The court granted the plaintiff’s motion for offer of judgment interest, and awarded the plaintiff $15.8 million for the period of December 6, 1999 up to and including December 5, 2010, and approximately $4,000 per day thereafter until an amended judgment was entered. The amended judgment was entered in the amount of approximately $28.1 million on March 4, 2011. The court denied RJR Tobacco’s motion for a new trial in August 2011, and RJR Tobacco filed a notice of appeal in September 2011. Briefing is underway.

On May 19, 2011, a jury returned a verdict in favor of RJR Tobacco in Hargroves v. R. J. Reynolds Tobacco Co., a case filed in December 2005 in the Circuit Court, Hillsborough County, Florida. The plaintiff alleged that as a result of using the defendant’s products, the decedent, Debra Hargroves, suffered from lung cancer, emphysema, heart disease and other smoking-related diseases and/or conditions. Final judgment was entered, and the plaintiff filed a motion for a new trial. At a hearing in June 2011, the court denied the plaintiff’s motion. The plaintiff filed a notice of appeal, and RJR Tobacco filed a notice of cross appeal in August 2011. Briefing is underway.

West Virginia IPIC

In West Virginia, as of December 31, 2011, 577 individual claims remain pending in a consolidated action, In re: Tobacco Litigation Individual Personal Injury Cases. The defendants are Philip Morris, Lorillard and RJR Tobacco (including claims concerning The American Tobacco Company and B&W). The Case Management Order currently calls for these cases to be resolved in a two phase procedure — a common issue trial in Phase I, and, if plaintiffs prevail on one or more issues, a Phase II, consisting of individual trials of liability, medical causation, compensatory damages and punitive damages for each of the individual plaintiffs. The Phase I trial will focus on whether defendants manufactured defective products, whether their conduct was tortious and whether their conduct meets the standard for a potential award of punitive damages under West Virginia law. There will be no lump sum award of punitive damages and the Phase I jury will not be asked to set a punitive multiplier. Instead, if the jury finds that a defendant’s conduct meets the punitive standard, then plaintiffs in their individual trials in Phase II will have the chance to ask Phase II juries to consider awarding punitive damages to each plaintiff on a case-by-case basis. Phase I trials were initiated twice in 2010 in Kanawha County (Charleston), resulting in mistrials in February and June 2010, due to an inability to find a sufficient number of impartial jurors from which to select a jury. The court moved the case to Ohio County (Wheeling), and the Phase I trial commenced again on October 19, 2011. The court declared a mistrial on November 8, 2011. A new trial date has not been scheduled.

Engle and Engle Progeny Cases

Trial began in July 1998 in Engle v. R. J. Reynolds Tobacco Co., a case filed in May 1994, in Circuit Court, Miami-Dade County, Florida, in which a class consisting of Florida residents, or their survivors, alleged diseases or medical conditions caused by their alleged “addiction” to cigarettes. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking actual damages and punitive damages in excess of $100 billion each and the creation of a medical fund to compensate individuals for future health-care costs. In July 1999, the jury found against RJR Tobacco, B&W and the other cigarette-manufacturer defendants in the initial phase, which included common issues related to certain elements of liability, general causation and a potential award of, or entitlement to, punitive damages.

On July 14, 2000, in the second phase of the trial, the jury returned a punitive damages verdict in favor of the “Florida class” of approximately $145 billion against all the defendants, with approximately $36.3 billion and $17.6 billion being assigned to RJR Tobacco and B&W, respectively.

In November 2000, the trial judge denied all post-trial motions and entered judgment. The Florida Third District Court of Appeal, referred to as Third DCA, reversed the trial court’s final judgment and remanded the case to the Miami-Dade County Circuit Court with instructions to decertify the class. The class appealed, and the Florida Supreme Court accepted the case in May 2004.

In July 2006, the court affirmed the dismissal of the punitive damages award and decertified the class, on a going-forward basis. The court preserved a number of class-wide findings from Phase I of the trial, including that cigarettes can cause certain diseases, that nicotine is addictive and that defendants placed defective and unreasonably dangerous cigarettes on the market, and authorized former class members to avail themselves of those findings under certain conditions in individual lawsuits, provided they commence those lawsuits within one year of the date the court’s decision became final. The court specified that the eligible plaintiffs are confined to those Florida citizen residents who suffered or died from smoking-related illnesses that “manifested” themselves on or before November 21, 1996, and that were caused by an addiction to cigarettes that contain nicotine.

In August 2006, RJR Tobacco and the other defendants filed a rehearing motion arguing, among other things, that the findings from the Engle trial were not sufficiently specific to serve as the basis for further proceedings and that the Florida Supreme Court’s decision denied the defendants due process. The plaintiffs also filed a rehearing motion arguing that some smokers who became sick after November 21, 1996, and who were therefore not class members, should nevertheless have the statute of limitations tolled since they may have refrained from filing suit earlier in the mistaken belief that they were Engle class members. In December 2006, the Florida Supreme Court withdrew its July 2006, decision and issued a revised opinion, in which it set aside the jury’s findings of a conspiracy to misrepresent and clarified that the Engle jury’s finding on express warranty were preserved for use by eligible plaintiffs. The court also denied the plaintiffs’ motion and confirmed that the eligible plaintiffs were limited to those individuals who developed alleged smoking-related illnesses that manifested themselves on or before November 21, 1996.

In the fourth quarter of 2007, the defendants’ petition for writ of certiorari and petition for rehearing with the U.S. Supreme Court were both denied.

Pursuant to the Florida Supreme Court’s July 2006, ruling in Engle v. R. J. Reynolds Tobacco Co., which decertified the class, eligible plaintiffs had one year from January 11, 2007, in which to file individual lawsuits. In addition, some individuals who filed suit prior to January 11, 2007, and who claimed they meet the conditions in Engle, also attempted to avail themselves of the Engle ruling. Lawsuits by individuals requesting the benefit of the Engle ruling, whether filed before or after the January 11, 2007, mandate, are referred to as the Engle Progeny cases. As of December 31, 2011, RJR Tobacco had been served in 6,561 Engle Progeny cases in both state and federal courts in Florida. These cases include approximately 7,852 plaintiffs. The number of cases will likely change due to individual plaintiffs being severed from multi-plaintiff cases. Many of these cases are in active discovery or nearing trial.

Three federal district courts ruled that the findings in the first phase of the Engle proceedings cannot be used to satisfy elements of plaintiffs’ claims, and two of those rulings, in Bernice Brown v. R. J. Reynolds Tobacco Co. and Burr v. Philip Morris USA, Inc., were certified by the trial court for interlocutory review. In July 2010, the Eleventh Circuit held, as a matter of Florida law, that the findings from the first phase of the Engle proceedings cannot be given greater effect than what the Engle jury found. Because it rejected plaintiffs’ approach on state-law grounds, the court did not find it necessary to consider whether that approach would violate the Due Process Clause of the U.S. Constitution.

On December 14, 2010, the First DCA rejected the Eleventh Circuit’s holding and concluded, in the Martin v. R. J. Reynolds Tobacco Co. case, that the Engle findings “establish the conduct of elements” of plaintiffs’ claims. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s request to review the decision of the intermediate state appellate court. On September 21, 2011, the Fourth DCA in Jimmie Lee Brown disagreed on state-law grounds with the First DCA’s decision in Martin as well as the Eleventh Circuit and in Bernice Brown. RJR Tobacco has sought review of Jimmie Lee Brown with the Florida Supreme Court. The defendants also asked the federal district court in Jacksonville to rule on their constitutional due process objection to the use of the Engle findings to satisfy elements of plaintiffs’ claims. The court ruled that application of the Engle findings would not violate the defendants’ due process rights. The defendants have moved to certify the issue for appeal to the Eleventh Circuit. A decision is pending.

In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applied to all Engle Progeny cases in the aggregate. In May, 2011, Florida removed the provision that allowed it to expire on December 31, 2012. The bond cap for any given individual Engle Progeny case varies depending on the number of judgments in effect at a given time, but never exceeds $5 million per case. The legislation, which became effective in June 2009 and 2011, applies to judgments entered after the original 2009 effective date. The plaintiffs have challenged the constitutionality of the bond cap in four of the cases discussed below. The Alachua County court upheld the bond cap in three of those cases, and the Escambia County court upheld the bond cap in the fourth case. The First DCA affirmed the trial court’s decision in all four cases. The First DCA issued a written opinion in Hall v. R. J. Reynolds Tobacco Co., on July 12, 2011, explaining why the statute is constitutional. The court also stated that the issues are likely to continue until they are definitively resolved by the Florida Supreme Court. As a result, the court certified to the Florida Supreme Court the question of whether the bond cap violates the Florida Constitution by limiting the amount of the bond necessary to obtain an automatic stay of the judgment against a signatory to the tobacco settlement agreement with the State of Florida. On January 23, 2012, the Florida Supreme Court decided to accept jurisdiction over the issue. Briefing is underway.

Below is a description of the Engle Progeny cases against RJR Tobacco or B&W, or both, which went to trial or were decided during the period from January 1, 2011 to December 31, 2011, or remained on appeal as of December 31, 2011.

On May 5, 2009, in Sherman v. R. J. Reynolds Tobacco Co., a case filed in September 2007 in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff. The plaintiff, Melba Sherman, alleged that as a result of using the defendant’s products, the decedent, John Sherman, developed lung cancer and died. The plaintiff sought compensatory damages and an unspecified amount of punitive damages. On May 8, 2009, the jury awarded compensatory damages of $1.55 million and found the decedent to be 50% at fault. No punitive damages were awarded. The court entered final judgment in the amount of $775,000 in June 2009. RJR Tobacco filed a notice of appeal to the Fourth DCA, and posted a supersedeas bond in the amount of approximately $900,000. The plaintiff filed a notice of cross appeal of the final judgment in July 2009. Oral argument occurred on May 10, 2011. A decision is pending.

On May 20, 2009, in Jimmie Lee Brown v. R. J. Reynolds Tobacco Co., a case filed in March 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff. The plaintiff alleged that the decedent, Roger Brown, developed smoking related diseases, which resulted in his death. The plaintiff sought compensatory damages and an unspecified amount of punitive damages. The jury later returned a verdict that the decedent was 50% at fault for his injuries and awarded compensatory damages of $1.2 million. No punitive damages were awarded. In June 2009, RJR Tobacco’s post-trial motions were denied, and the court entered final judgment in the amount of $600,000. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of approximately $700,000 in July 2009. In September 2011, the Fourth DCA affirmed the trial court’s judgment. RJR Tobacco filed a motion for certification to the Florida Supreme Court, which was denied on October 21, 2011. RJR Tobacco filed a notice to invoke discretionary jurisdiction of the Florida Supreme Court. A decision is pending.

On May 29, 2009, in Martin v. R. J. Reynolds Tobacco Co., a case filed in October 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 66% at fault for the decedent’s injuries, and awarded $5 million in compensatory damages. The plaintiff alleged that as a result of Benny Martin’s use of the defendant’s tobacco products, he developed lung cancer and other medical conditions and died. The plaintiff, Mathilde Martin, sought an unspecified amount of compensatory and punitive damages. On June 1, 2009, the jury returned a punitive damages award of $25 million. In September 2009, the court entered final judgment, awarding the plaintiff the sum of $3.3 million in compensatory damages and $25 million in punitive damages, and RJR Tobacco filed a notice of appeal to the First DCA. In October 2009, RJR Tobacco posted a supersedeas bond in the amount of approximately $5 million, and the plaintiff filed a notice of cross appeal of the final judgment. The First DCA affirmed the final judgment in December 2010. RJR Tobacco asked the Florida Supreme Court to accept jurisdiction and review the decision of the First DCA. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s request to review the decision. RJR Tobacco posted a supersedeas bond in the amount of $15 million in July 2011. The bond will replace the original bond that was posted and stay execution of the judgment to allow RJR Tobacco to seek review with the U.S. Supreme Court. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

On August 19, 2009, in Campbell v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Betty Campbell, to be 57% at fault, RJR Tobacco to be 39% at fault and the remaining defendants to be 4% at fault, and awarded $7.8 million in compensatory damages. No punitive damages were awarded. The plaintiff alleged that as a result of Mrs. Campbell’s addiction to cigarettes, she suffered and died from various smoking related diseases, including chronic obstructive pulmonary disease. The plaintiff sought judgment against each defendant for an amount in excess of $15,000, taxable costs, punitive damages and interest. In September 2009, the court entered final judgment against RJR Tobacco in the amount of $3.04 million. RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of approximately $3 million in January 2010. In March 2011, the Florida First DCA affirmed per curian the trial court’s decision based on its prior ruling in Martin. RJR Tobacco moved the First DCA to certify the case as one of great public importance, which is the first step in seeking review by the Florida Supreme Court, but the court denied the motion. The defendants filed a notice to invoke discretionary jurisdiction of the Florida Supreme Court. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s petition to review the decision. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

On February 5, 2010, in Gray v. R. J. Reynolds Tobacco Co., a case filed in November 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, Carolyn Gray. The jury found the decedent, Charles Gray, to be 40% at fault and RJR Tobacco to be 60% at fault for Mr. Gray’s injuries, and awarded $7 million in compensatory damages. On February 8, 2010, the jury awarded $2 million in punitive damages. Mrs. Gray alleged that as a result of her husband’s addiction and use of RJR Tobacco’s products, he died from lung cancer. Mrs. Gray sought an unspecified amount of compensatory and punitive damages. In March 2010, the court entered final judgment against RJR Tobacco in the amount of $4.2 million in compensatory damages and $2 million in punitive damages. In July 2010, RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of $5 million. In June 2011, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. The defendants filed a notice to invoke discretionary jurisdiction of the Florida Supreme Court. On July 20, 2011, the Florida Supreme Court denied RJR Tobacco’s petition to review the decision. RJR Tobacco posted a supersedeas bond in the amount of $6.2 million in July 2011. The bond will replace the original bond that was posted and stay execution of the judgment to allow RJR Tobacco to seek review with the U.S. Supreme Court. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

On February 25, 2010, in Grossman v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Broward County, Florida, the court declared a mistrial due to the jury’s inability to reach a decision. The plaintiff alleged that as a result of the addiction of the decedent, Laura Grossman, to cigarettes, she developed lung cancer and died. The plaintiff sought damages in excess of $15,000 and all taxable costs and interest. Retrial began in March 2010. On April 21, 2010, the jury returned a verdict in favor of the plaintiff in Phase I, finding that the decedent was addicted to cigarettes containing nicotine and the addiction was the legal cause of her death by lung cancer. On April 29, 2010, the jury awarded $1.9 million in compensatory damages and no punitive damages. The jury also found RJR Tobacco to be 25% at fault, the decedent to be 70% at fault and the decedent’s spouse to be 5% at fault. Final judgment was entered in June 2010, in the amount of $483,682. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of approximately $484,000 in July 2010. The plaintiff filed a notice of cross appeal. Briefing is complete. Oral argument has not been scheduled.

On March 10, 2010, in Douglas v. Philip Morris USA, Inc., a case filed in October 2007 in Circuit Court, Hillsborough County, Florida, a jury returned a verdict for the plaintiff, found the decedent, Charlotte Douglas, to be 50% at fault, RJR Tobacco to be 5% at fault and the remaining defendants to be 45% at fault, and awarded $5 million in compensatory damages. No punitive damages were awarded. The plaintiff alleged that as a result of the decedent’s addiction to smoking the defendants’ cigarettes, she suffered bodily injury and died. In March 2010, the court entered final judgment against RJR Tobacco in the amount of $250,000. RJR Tobacco filed a notice of appeal to the Second District Court of Appeal, referred to as the Second DCA, and posted a supersedeas bond in the amount of $250,000. Oral argument occurred on October 4, 2011. A decision is pending.

In Hall v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Alachua County, Florida, the jury returned a verdict in favor of the plaintiff on March 11, 2010. The jury also found the decedent, Arthur Hall, to be 35% at fault and RJR Tobacco to be 65% at fault, and awarded $5 million in compensatory damages. On March 12, 2010, the jury returned a $12.5 million punitive damages award. The plaintiff alleged that as a result of the decedent’s use of the defendant’s products he suffered from lung cancer and died. In March 2010, the court entered final judgment in the amount of $3.25 million in compensatory damages and $12.5 million in punitive damages. RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of $5 million in May 2010. The plaintiff filed a notice of cross appeal. In May 2011, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. RJR Tobacco filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. On July 19, 2011, the Florida Supreme Court denied RJR Tobacco’s petition to review the decision. RJR Tobacco posted a supersedeas bond in the amount of $15 million in July 2011. The bond will replace the original bond that was posted and stay execution of the judgment to allow RJR Tobacco to seek review with the U.S. Supreme Court. RJR Tobacco filed a petition for writ of certiorari with the U.S. Supreme Court on December 16, 2011.

On March 10, 2010, in Cohen v. R. J. Reynolds Tobacco Co., a case filed in May 2007 in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff. The plaintiff alleged that the decedent, Nathan Cohen, developed lung cancer as a result of using the defendants’ products, and sought in excess of $15,000 compensatory damages and unspecified punitive damages. On March 24, 2010, the jury awarded the plaintiff $10 million in compensatory damages, and found the decedent to be 33.3% at fault, RJR Tobacco to be 33.3% at fault and the remaining defendant to be 33.3% at fault. The jury also awarded $20 million in punitive damages, of which $10 million was assigned to RJR Tobacco. In July 2010, the court entered final judgment against RJR Tobacco in the amount of $3.33 million in compensatory damages and $10 million in punitive damages and the plaintiff filed a motion to amend or alter the final judgment. The court entered an amended judgment in September 2010 to include interest from the date of the verdict. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $2.5 million in October 2010. Briefing is complete. Oral argument has not been scheduled.

On April 13, 2010, in Clay v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Janie Mae Clay, to be 30% at fault, RJR Tobacco to be 60% at fault and the remaining defendant to be 10% at fault, and awarded $3.5 million in compensatory damages. The plaintiff alleged that the decedent developed addiction, chronic obstructive pulmonary disease and other conditions and diseases as a result of using the defendants’ products. On April 14, 2010, the jury awarded $18 million in punitive damages, of which $17 million was assigned to RJR Tobacco. The court entered final judgment against RJR Tobacco in the amount of $2.1 million in compensatory damages and $17 million in punitive damages in September 2010. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of approximately $4.7 million. The plaintiff filed a notice of cross appeal. Oral argument occurred on January 17, 2012. On January 25, 2012, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. RJR Tobacco intends to seek further review of the decision.

On April 26, 2010, in Putney v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Broward County, Florida, the jury returned a verdict in favor of the plaintiff, finding the decedent, Margot Putney, to be 35% at fault, RJR Tobacco to be 30% at fault and the remaining defendants to be 35% at fault, and awarded $15.1 million in compensatory damages and $2.5 million in punitive damages each against RJR Tobacco and the remaining defendants. The plaintiff alleged that the decedent, Margot Putney, suffered from nicotine addiction and lung cancer as a result of using the defendants’ products. In August 2010, final judgment was entered against RJR Tobacco in the amount of $4.5 million in compensatory damages, and $2.5 million in punitive damages. RJR Tobacco filed a notice of appeal and the plaintiff filed a notice of cross appeal. In December 2010, the court entered an amended final judgment to provide that interest would run from April 26, 2010. The defendants filed a joint notice of appeal to the Fourth DCA of the amended final judgment, and RJR Tobacco posted a supersedeas bond in the amount of approximately $2.4 million. Briefing is underway.

On April 21, 2010, in Townsend v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Alachua County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 51% at fault and the decedent, Frank Townsend, to be 49% at fault, and awarded $10.8 million in compensatory damages and $80 million in punitive damages. The plaintiff alleged that the decedent suffered from lung cancer and other conditions and diseases as a result of smoking the defendant’s products. Final judgment was entered on April 29, 2010, in the amount of $5.5 million in compensatory damages and $40.8 million in punitive damages, which represents 51% of the original damages awards. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $5 million. Oral argument occurred on October 19, 2011. A decision is pending.

On May 20, 2010, in Buonomo v. R. J. Reynolds Tobacco Co., a case filed in October 2007 in the Circuit Court, Broward County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 77.5% at fault and the decedent, Matthew Buonomo, to be 22.5% at fault, and awarded $5.2 million in compensatory damages and $25 million in punitive damages. The plaintiff alleged that the decedent was addicted to cigarettes and as a result developed one or more smoking related medical conditions and/or diseases. Post-trial motions were denied, but the court, in accordance with the Florida statutory limitation on punitive damage awards, ordered the punitive damage award of $25 million be reduced to $15.7 million — three times the compensatory damages award of $5.2 million. In August 2010, the court entered final judgment in the amount of $4.06 million in compensatory damages and $15.7 million in punitive damages. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $5 million. The plaintiff also filed a notice of appeal. Briefing is complete. Oral argument has not been scheduled.

In Frazier v. Philip Morris USA Inc., a case filed in December 2007 in the Circuit Court, Miami-Dade County, Florida, the court declared a mistrial on May 14, 2010, due to the inability to seat a jury. The plaintiff alleged that as a result of smoking defendants’, including RJR Tobacco’s, products she developed chronic obstructive pulmonary disease. Retrial began on September 20, 2010. In October 2010, the jury returned a verdict in favor of the defendants. The plaintiff’s post-trial motions were denied and final judgment was entered in February 2011. The plaintiff filed a notice of appeal to the Third DCA, and the defendants filed a cross appeal. Oral argument occurred on February 14, 2012. A decision is pending.

On June 18, 2010, in Alexander v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Alachua County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 51% at fault and the defendant to be 49% at fault, and awarded $2.5 million in compensatory damages and $2.5 million in punitive damages. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent suffered from chronic obstructive pulmonary disease, lung cancer and emphysema. In July 2010, the court entered final judgment in the amount of $1.275 million in compensatory damages and $2.5 million in punitive damages. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of approximately $3.8 million in September 2010. The plaintiff filed a notice of cross appeal. Oral argument occurred on January 17, 2012. On January 25, 2012, the First DCA affirmed per curiam the trial court’s decision based on its prior ruling in Martin. RJR Tobacco intends to seek further review of the decision.

On August 5, 2010, in Piendle v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Palm Beach County, Florida, the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 27.5% at fault, the defendant to be 45% at fault and the remaining defendants to be 27.5% at fault, and awarded $4 million in compensatory damages. On August 19, 2010, the jury returned a punitive damages verdict in the amount of $180,000 against RJR Tobacco. The plaintiff’s motion for new trial as to the amount of the punitive damages was denied. In September 2010, the court entered final judgment against RJR Tobacco in the amount of $1.1 million in compensatory damages and $180,000 in punitive damages. The defendants have filed a notice of appeal to the Fourth DCA. In February 2011, RJR Tobacco posted a supersedeas bond in the amount of $1.28 million. Briefing is complete. Oral argument has not been scheduled.

On August 26, 2010, in Budnick v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco. The case was filed in December 2007, in the Circuit Court, Broward County, Florida. The plaintiff alleged that the decedent, Leonard Budnick, was addicted to cigarettes manufactured by the defendants, and as a result, developed one or more smoking related medical conditions and/or diseases. In September 2010, the court denied the motion for a new trial and entered final judgment pursuant to the jury’s verdict. The plaintiff filed a notice of appeal to the Fourth DCA. Briefing is underway.

On October 29, 2010, in Koballa v. Philip Morris USA Inc., the court declared a mistrial after the jury informed the court that they were unable to reach a verdict. The case was filed in December 2007, in the Circuit Court, Volusia County, Florida against tobacco industry defendants, including RJR Tobacco. The plaintiff alleges that as a result of the use of the defendants’ defective and unreasonably dangerous tobacco products, she suffers from, or has suffered from, nicotine addiction, lung cancer and other smoking related medical conditions and/or diseases. Retrial began on March 21, 2011, and on March 31, 2011, the jury returned an inconsistent verdict. The jury found that RJR Tobacco was not liable for the plaintiff’s injuries, but found that her past injuries were worth $1 million with the plaintiff being 70% at fault and RJR Tobacco 30% at fault. Post-trial motions were filed, and RJR Tobacco included a request to enter judgment in favor of RJR Tobacco. In August 2011, the court denied RJR Tobacco’s post-trial motions and entered final judgment. RJR Tobacco filed a notice of appeal to the Fifth DCA and posted a supersedeas bond in the amount of $300,000. Briefing is underway.

On November 4, 2010, in Vasko v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco. The jury found that the plaintiff’s claim was barred by the statute of limitations. The case was filed in January 2008, in the Circuit Court, Broward County, Florida. The plaintiff alleged that the decedent, John Vasko, was addicted to cigarettes manufactured by the defendants, and as a result, developed one or more smoking related medical conditions and/or diseases, including lung cancer. Final judgment was entered, and the plaintiff filed a notice of appeal to the Fourth DCA. Briefing is underway.

On November 15, 2010, in Webb v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 90% at fault and the decedent, James Horner, to be 10% at fault, and awarded $8 million in compensatory damages and $72 million in punitive damages. The case was filed in December 2007, in the Circuit Court, Levy County, Florida. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent developed one or more smoking related medical conditions and/or diseases. The court entered final judgment in November 2010. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $5 million. The plaintiff filed a notice of cross appeal. Oral argument occurred on October 12, 2011. A decision is pending.

On January 5, 2011, in Smith v. R. J. Reynolds Tobacco Co., the court declared a mistrial due to the inability to seat a jury. The case was filed in January 2008 in the Circuit Court, Jackson County, Florida. The plaintiff alleged that he was addicted to cigarettes manufactured by the defendants, and as a result, developed lung cancer. Retrial was scheduled to begin on November 28, 2011; however, the court continued the trial date until March 5, 2012.

On February 10, 2011, in Kirkland v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 10% at fault and the plaintiff to be 90% at fault, and awarded $100,000 in compensatory damages. The jury also awarded the plaintiff $250,000 in punitive damages. The case was filed in January 2008, in the Circuit Court, Hillsborough County, Florida. The plaintiff alleged that he was addicted to cigarettes, and as a result, developed larynx cancer and other smoking related medical conditions and/or diseases. The plaintiff’s post-trial motions were denied, and final judgment was entered in March 2011. The plaintiff filed a notice of appeal to the Second DCA on April 12, 2011. RJR Tobacco filed a motion to dismiss the appeal as premature due to the trial court not ruling on RJR Tobacco’s post-trial motions. The motion to dismiss the appeal was denied, however, the appellate court relinquished jurisdiction for 45 days to allow the trial court to address the outstanding post-trial motions. RJR Tobacco’s post-trial motions were denied in July 2011. RJR Tobacco filed a notice of cross appeal and posted a supersedeas bond in the amount of $260,000. Briefing is underway. In January 2012, the plaintiff voluntarily dismissed his appeal. RJR Tobacco’s appeal remains pending.

On February 22, 2011, in Huish v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 25% at fault, the decedent, John Huish, to be 50% at fault and the remaining defendant to be 25% at fault, and awarded $750,000 in compensatory damages and $3 million in punitive damages, $1.5 million to each defendant. The case was filed in January 2008, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent suffered from lung cancer and other smoking related medical conditions and/or diseases. Final judgment was entered in the amount of $1.69 million against each defendant. Post-trial motions were denied, and the defendants filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $1.69 million. Briefing is complete. Oral argument is scheduled for March 21, 2012.

On March 18, 2011, in Mack v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 51% at fault and the decedent, Peter Mack, Sr., to be 49% at fault, and awarded $1 million in compensatory damages. No punitive damages were awarded. The case was filed in June 2008, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that due to the decedent’s addiction to cigarettes, he developed bronchitis and lung cancer. Post-trial motions were denied, and final judgment was entered in April 2011. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $510,000 in May 2011. Briefing is complete. Oral argument has not been scheduled.

On March 28, 2011, in Oliva v. R. J. Reynolds Tobacco Co., a jury returned a verdict in favor of the defendants, including RJR Tobacco. The case was filed in November 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that as a result of smoking the defendants’ cigarettes, he developed chronic obstructive pulmonary disease and other smoking related diseases. Final judgment was entered, and the plaintiff’s motion for a new trial was denied. The plaintiff filed a notice of appeal to the First DCA, and the defendants filed a notice of cross appeal in June 2011. Briefing is underway.

On April 13, 2011, in Tullo v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco and the plaintiff, but against the remaining defendants. The jury awarded $4.5 million in compensatory damages and no punitive damages. The jury found the decedent, Dominick Tullo, to be 45% at fault and the remaining defendants cumulatively to be 55% at fault. The case was filed in December 2007, in the Circuit Court, Palm Beach County, Florida. The plaintiff alleged that the decedent was addicted to cigarettes manufactured by the defendants, and as a result, developed chronic obstructive pulmonary disease and other smoking related illnesses and/or diseases. The plaintiff sought in excess of $15,000 against each defendant, taxable costs and interest. The court denied the plaintiff’s motion for a new trial against RJR Tobacco and denied the remaining defendants’ post-trial motions in June 2011. The remaining defendants have filed an appeal to the Fourth DCA, and the plaintiff filed a cross appeal. The plaintiff also filed a notice of appeal of the order denying the plaintiff’s motion for new trial against RJR Tobacco. RJR Tobacco filed a cross appeal of the same order. Briefing is underway.

On April 26, 2011, in Andy Allen v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 45% at fault, the decedent, Patricia Allen, to be 40% at fault and the remaining defendant to be 15% at fault, and awarded $6 million in compensatory damages and $17 million in punitive damages against each defendant. The case was filed in September 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent developed chronic obstructive pulmonary disease. Final judgment was entered against RJR Tobacco in the amount of $19.7 million in May 2011. On October 17, 2011, the court entered a remittance of the punitive damages to $8.1 million and denied all other post-trial motions. The defendants filed a joint notice of appeal, and the plaintiff filed a notice of cross appeal in November 2011. Briefing will begin in March 2012.

On May 20, 2011, in Reese v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 30% at fault, and awarded $3.6 million in compensatory damages and no punitive damages. The case was filed in September 2007, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that as a result of smoking the defendant’s products, she became addicted and developed laryngeal cancer, peripheral vascular disease and chronic obstructive pulmonary disease. The court entered final judgment on May 25, 2011. In September 2011, the court denied RJR Tobacco’s post-trial motions. RJR Tobacco filed a notice of appeal to the Third DCA and posted a supersedeas bond in the amount of $1.07 million. Briefing will begin in March 2012.

On May 20, 2011, in Jewett v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 20% at fault, the decedent, Barbara Jewett, to be 70% at fault and the remaining defendant to be 10% at fault, and awarded $1.1 million in compensatory damages and no punitive damages. The case was filed in December 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that the decedent, Barbara Jewett, was addicted to cigarettes and as a result of her addiction, developed chronic obstructive pulmonary disease, emphysema and respiratory failure. The defendants’ post-trial motions were denied in May 2011 and July 2011. Final judgment was entered in June 2011. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $218,600. Briefing is underway.

On June 16, 2011, in Soffer v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 40% at fault, the decedent, Maurice Soffer, to be 60% at fault, and awarded $5 million in compensatory damages and no punitive damages. The case was filed in December 2007, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that the decedent was addicted to cigarettes and, as a result, developed lung cancer and other smoking-related conditions and/or diseases. Post-trial motions were denied. Final judgment was entered against RJR Tobacco in the amount of $2 million. The plaintiff filed a notice of appeal to the First DCA in July 2011. RJR Tobacco filed a notice of cross appeal and posted a supersedeas bond in the amount of $2 million. Briefing is underway.

On July 15, 2011, in Ciccone v. R. J. Reynolds Tobacco Co., the jury returned a verdict finding the plaintiff is a member of the Engle class. The case was filed in August 2004, in the Circuit Court, Broward County, Florida. The plaintiff alleged that as a result of the use of the defendant’s tobacco products, the decedent, George Ciccone, suffered from nicotine addiction and one or more smoking related diseases and/or medical conditions. On July 21, 2011, the jury awarded approximately $3.2 million in compensatory damages and $50,000 in punitive damages. The jury found the plaintiff to be 70% at fault and RJR Tobacco to be 30% at fault. In August 2011, the court denied RJR Tobacco’s post-trial motions. Final judgment was entered, and RJR Tobacco filed a notice of appeal. RJR Tobacco posted a supersedeas bond in the amount of approximately $1 million on October 17, 2011. Briefing is underway.

On July 19, 2011, in Weingart v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff; however, they refused to award compensatory or punitive damages and found the plaintiff to be 91% at fault. The case was filed in November 2007, in the Circuit Court, Palm Beach County, Florida. The plaintiff alleged that as a result of using the defendants’ tobacco products, the decedent, Claire Weingart, developed lung cancer and other smoking related diseases and/or medical conditions. In September 2011, the court granted the plaintiff’s motion for additur or new trial. The plaintiff was awarded $150,000 as an additur for pain and suffering damages. Final judgment was entered in the amount of $4,500, against each defendant and the defendants filed a joint notice of appeal to the Fourth DCA in November 2011. RJR Tobacco posted a supersedeas bond in the amount of $4,500. Briefing is underway.

On September 15, 2011, in Ojeda v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco. The case was filed in October 2007, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent, Juan Ojeda, suffered from one or more smoking-related medical conditions and or diseases. The plaintiff filed a motion for a new trial, and a hearing is scheduled for March 7, 2012. Final judgment was entered September 26, 2011. The plaintiff filed a conditional notice of appeal in October 2011. The conditional status is based on the pending motion for new trial. RJR Tobacco filed a conditional notice of cross appeal in November 2011. A hearing on the motion for new trial has not been scheduled.

On September 23, 2011, in Bowman v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent to be 70% at fault and RJR Tobacco to be 30% at fault, and awarded $1.5 million in compensatory damages and no punitive damages. The case was filed in November 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent, Michael Bowman, suffered from esophageal cancer. The court denied the defendant’s post-trial motions and entered final judgment in October 2011. RJR Tobacco filed a notice of appeal and posted a supersedeas bond in the amount of $450,000. Briefing is underway.

On October 20, 2011, in Junious v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants. The case was filed in July 2007, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that as a result of the use of the defendants’ products, the decedent, Annie Ingraham, suffered from chronic obstructive pulmonary disease. Final judgment was entered in November 2011. The plaintiff’s motion for a new trial was denied on December 16, 2011. The plaintiff filed a notice of appeal in January 2012. Briefing has not yet begun.

On October 20, 2011, in Szymanski v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants. The case was filed in November 2007, in the Circuit Court, Lee County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the plaintiff suffers from various smoking-related conditions and diseases. The plaintiff filed a motion for a new trial. Final judgment was entered in November 2011. On December 5, 2011, the parties stipulated to a dismissal with prejudice. The court granted the motion on December 7, 2011.

On November 28, 2011, in Sury v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, William Sury, to be 60% at fault, RJR Tobacco to be 20% at fault, and the remaining defendant to be 20% at fault, and awarded $1 million in compensatory damages and no punitive damages. The case was filed in November 2007, in the Circuit Court, Duval County, Florida. The plaintiff alleged that as a result of the use of the defendants’ products, the decedent, William Sury, suffered from lung cancer. Post-trial motions were filed in December 2011. Decisions are pending.

On December 16, 2011, in Cox v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants. The case was filed in January 2008, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent, Roland Cox, suffered from lung cancer. Final judgment was entered, the plaintiff filed a notice of appeal and RJR Tobacco filed a notice of cross appeal in January 2012.

On January 24, 2012, in Hallgren v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Claire Hallgren, to be 50% at fault, RJR Tobacco to be 25% at fault, and the remaining defendant to be 25% at fault, and awarded $2 million in compensatory damages and $750,000 in punitive damages. The case was filed in April 2007, in the Circuit Court, Highlands County, Florida. The plaintiff alleged that the decedent was addicted to the defendants’ products, and as a result, suffered from lung cancer. Post-trial motions are pending.

On January 25, 2012, in Ward v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Mattie Ward, to be 50% at fault, RJR Tobacco to be 30% at fault, and the remaining defendants to collectively be 20% at fault, and awarded $1 million in compensatory damages and $1.7 million in punitive damages. The case was filed in December 2007, in the Circuit Court, Escambia County, Florida. The plaintiff alleged that the decedent was addicted to the defendants’ products, and as a result, suffered from chronic obstructive pulmonary disease and other smoking related conditions and/or diseases. Post-trial motions are pending.

On February 2, 2012, in Larkin v. R. J. Reynolds Tobacco Co., the court declared a mistrial after the jury informed the court that they could not reach a verdict. The case was filed in January 2002, in the Circuit Court, Miami-Dade County, Florida. The plaintiff alleged that the decedent, Carole Larkin, was addicted to the defendant’s products, and as a result, suffered from oral cancer. A new trial date has not been scheduled.

Broin II Cases

RJR Tobacco, B&W and other cigarette manufacturer defendants settled Broin v. Philip Morris, Inc. in October 1997. This case had been brought in Florida state court on behalf of flight attendants alleged to have suffered from diseases or ailments caused by exposure to ETS in airplane cabins. The settlement agreement required the participating tobacco companies to pay a total of $300 million in three annual $100 million installments, allocated among the companies by market share, to fund research on the early detection and cure of diseases associated with tobacco smoke. It also required those companies to pay a total of $49 million for the plaintiffs’ counsel’s fees and expenses. RJR Tobacco’s portion of these payments was approximately $86 million; B&W’s portion of these payments was approximately $57 million. The settlement agreement bars class members from bringing aggregate claims or obtaining punitive damages and also bars individual claims to the extent that they are based on fraud, misrepresentation, conspiracy to commit fraud or misrepresentation, RICO, suppression, concealment or any other alleged intentional or willful conduct. The defendants agreed that, in any individual case brought by a class member, the defendant will bear the burden of proof with respect to whether ETS can cause certain specifically enumerated diseases, referred to as “general causation.” With respect to all other issues relating to liability, including whether an individual plaintiff’s disease was caused by his or her exposure to ETS in airplane cabins, referred to as “specific causation,” the individual plaintiff will have the burden of proof. On September 7, 1999, the Florida Supreme Court approved the settlement. The Broin II cases arose out of the settlement of this case.

On October 5, 2000, the Broin court entered an order applicable to all Broin II cases that the terms of the Broin settlement agreement do not require the individual Broin II plaintiffs to prove the elements of strict liability, breach of warranty or negligence. Under this order, there is a rebuttable presumption in the plaintiffs’ favor on those elements, and the plaintiffs bear the burden of proving that their alleged adverse health effects actually were caused by exposure to ETS in airplane cabins, that is, specific causation.

As of December 31, 2011, there were 2,586 Broin II lawsuits pending in Florida. There have been no Broin II trials since 2007.

Class-Action Suits

Overview. As of December 31, 2011, 13 class-action cases, exclusive of one antitrust class action, were pending in the United States against RJR Tobacco or its affiliates or indemnitees. In 1996, the Fifth Circuit Court of Appeals in Castano v. American Tobacco Co. overturned the certification of a nation-wide class of persons whose claims related to alleged addiction to tobacco products. Since this ruling by the Fifth Circuit, most class-action suits have sought certification of state-wide, rather than nation-wide, classes. Class-action suits based on claims similar to those asserted in Castano or claims that class members are at a greater risk of injury or injured by the use of tobacco or exposure to ETS are pending against RJR Tobacco and its affiliates and indemnitees in state or federal courts in California, Illinois, Louisiana, Minnesota, Missouri, West Virginia and Arizona. All pending class-action cases are discussed below.

The pending class actions against RJR Tobacco or its affiliates or indemnitees include eight cases alleging that the use of the term “lights” constitutes unfair and deceptive trade practices under state law or violates the federal RICO statute. Such suits are pending in state or federal courts in Illinois, Minnesota, Missouri, California and Arizona and are discussed below under “— ‘Lights’ Cases.”

Finally, certain third-party payers have filed health-care cost recovery actions in the form of class actions. These cases are discussed below under “— Health-Care Cost Recovery Cases.”

Few smoker class-action complaints have been certified or, if certified, have survived on appeal. Eighteen federal courts, including two courts of appeals, and most state courts that have considered the issue have rejected class certification in such cases. Apart from the Castano case discussed above, only two smoker class actions have been certified by a federal court — In re Simon (II) Litigation, and Schwab [McLaughlin] v. Philip Morris USA, Inc., discussed below under “— ‘Lights’ Cases,” both of which were filed in the U.S. District Court for the Eastern District of New York and ultimately decertified.

Medical Monitoring and Smoking Cessation Case. On November 5, 1998, in Scott v. American Tobacco Co., a case filed in District Court, Orleans Parish, Louisiana, the trial court certified a medical monitoring or smoking cessation class of Louisiana residents who were smokers on or before May 24, 1996. The case was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover an unspecified amount of damages to pay for medical monitoring and smoking cessation programs. In July 2003, the jury returned a verdict in favor of the defendants on the plaintiffs’ claim for medical monitoring and found that cigarettes were not defectively designed. However, the jury also made certain findings against the defendants on claims relating to fraud, conspiracy, marketing to minors and smoking cessation. Notwithstanding these findings, this portion of the trial did not determine liability as to any class member or class representative. What primarily remained in the case was a class-wide claim that the defendants pay for a program to help people stop smoking.

In May 2004, the jury returned a verdict in the amount of $591 million on the class’s claim for a smoking cessation program. In September 2004, the defendants posted a $50 million bond, pursuant to legislation that limits the amount of the bond to $50 million collectively for MSA signatories, and noticed their appeal. RJR Tobacco posted $25 million (the portions for RJR Tobacco and B&W) towards the bond. In February 2007, the Louisiana Court of Appeals upheld the class certification and found the defendants responsible for funding smoking cessation for eligible class members. The appellate court also ruled, however, that the defendants were not liable for any post-1988 claims, rejected the award of prejudgment interest, struck eight of the 12 components of the smoking cessation program and remanded the case for further proceedings. In particular, the appellate court ruled that no class member, who began smoking after September 1, 1988, could receive any relief, and that only those smokers, whose claims accrued on or before September 1, 1988, would be eligible for the smoking cessation program. The plaintiffs had previously expressly represented to the trial court that none of their claims accrued before 1988 and that the class claims did not accrue until around 1996, when the case was filed. The defendants’ application for writ of certiorari with the Louisiana Supreme Court was denied in January 2008. The defendants’ petition for writ of certiorari with the U.S. Supreme Court was denied in June 2008. In July 2008, the trial court entered an amended judgment in the case, finding that the defendants are jointly and severally liable for funding the cost of a court-supervised smoking cessation program and ordered the defendants to deposit approximately $263 million together with interest from June 30, 2004, into a trust for the funding of the program. The court also stated that it would favorably consider a motion to return to defendants a portion of unused funds at the close of each program year in the event the monies allocated for the preceding program year were not fully expended because of a reduction in class size or underutilization by the remaining plaintiffs.

In December 2008, the trial court judge signed an order granting the defendants an appeal from the amended judgment. In April 2010, the court of appeals amended but largely affirmed the trial court’s July 2008 judgment and ordered the defendants to deposit with the court $242 million with judicial interest from July 21, 2008, until paid. The defendants’ motion for rehearing was denied. In September 2010, the defendants’ application for writ of certiorari or review and their emergency motion to stay execution of judgment with the Louisiana Supreme Court were denied. In September 2010, the U.S. Supreme Court granted the defendant’s motion to stay the judgment pending applicants’ timely filing, and the Court’s disposition, of a petition for writ of certiorari. The defendants filed a petition for writ of certiorari in the U.S. Supreme Court in December 2010. The court denied the petition on June 27, 2011. RJR Tobacco accrued $139 million, the portions of the judgment allocated to RJR Tobacco and B&W, in the second quarter of 2011. RJR Tobacco paid the judgment in August 2011.

In December 2011, the plaintiffs filed a motion for assessment of attorneys’ fees and costs for the prosecution of the case. Briefing is underway. On January 6, 2012, the defendants filed exceptions and motion to strike. A hearing on the defendants’ exceptions and a motion to strike occurred on February 3, 2012. A hearing on the plaintiffs’ motion for fees and costs is scheduled for June 18, 2012.

California Business and Professions Code Cases.    On April 11, 2001, in Brown v. American Tobacco Co., Inc., a case filed in June 1997 in Superior Court, San Diego County, California, the court granted in part the plaintiffs’ motion for certification of a class composed of residents of California who smoked at least one of the defendants’ cigarettes from June 10, 1993 through April 23, 2001, and who were exposed to the defendants’ marketing and advertising activities in California. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover restitution, disgorgement of profits and other equitable relief under California Business and Professions Code § 17200 et seq. and § 17500 et seq. However, the underlying substantive claims have been reduced to include primarily allegations regarding the use of the descriptor “lights” and statements made during the class period about the health risks of cigarettes. Certification was granted as to the plaintiffs’ claims that the defendants violated § 17200 of the California Business and Professions Code pertaining to unfair competition. The court, however, refused to certify the class under the California Legal Remedies Act and on the plaintiffs’ common law claims. In March 2005, the court granted the defendants’ motion to decertify the class, and in September 2006, the California Court of Appeal affirmed the order decertifying the class. In November 2006, the plaintiffs’ petition for review with the California Supreme Court was granted, and in May 2009, the court reversed the decision of the trial court, and the California Court of Appeal that decertified the class and remanded the case to the trial court for further proceedings. In March 2010, the trial court found that the plaintiffs’ “lights” claims were not preempted by the Federal Cigarette Labeling and Advertising Act and denied the defendants’ second motion for summary judgment. The plaintiffs filed a tenth amended complaint in September 2010. RJR Tobacco and B&W filed their answers to the complaint. Subsequently, on February 24, 2011, the court found that the named class representatives were not adequate, were not typical, and lacked standing. The plaintiffs’ motion for reconsideration was denied. The court granted the plaintiffs’ motion to amend the complaint by adding new class representatives and denied the defendants’ motion to dismiss. The plaintiffs filed an eleventh amended complaint adding new class representatives in July 2011. Trial is scheduled for October 5, 2012. The defendants have filed motions challenging the standing of the newly named class representatives and to decertify the case. A hearing is scheduled for March 21, 2012.

In Sateriale v. R. J. Reynolds Tobacco Co., a class action filed in November 2009 in the U.S. District Court for the Central District of California, the plaintiffs brought the case on behalf of all persons who tried unsuccessfully to redeem Camel Cash certificates from 1991 through March 31, 2007, or who held Camel Cash certificates as of March 31, 2007. The plaintiffs allege that in response to the defendants’ action to discontinue redemption of Camel Cash as of March 31, 2007, customers, like the plaintiffs, attempted to exchange their Camel Cash for merchandise and that the defendants, however, did not have any merchandise to exchange for Camel Cash. The plaintiffs allege unfair business practices, deceptive practices, breach of contract and promissory estoppel. The plaintiffs seek injunctive relief, actual damages, costs and expenses. In January 2010, the defendants filed a motion to dismiss, which prompted the plaintiffs to file an amended complaint in February 2010. The class definition changed to a class consisting of all persons who reside in the U.S. and tried unsuccessfully to redeem Camel Cash certificates, from October 1, 2006 (six months before the defendant ended the Camel Cash program) or who held Camel Cash certificates as of March 31, 2007. The plaintiffs also brought the class on behalf of a proposed California subclass, consisting of all California residents meeting the same criteria. In May 2010, RJR Tobacco’s motion to dismiss the amended complaint for lack of jurisdiction over subject matter and, alternatively, for failure to state a claim was granted with leave to amend. The plaintiffs filed a second amended complaint. In July 2010, RJR Tobacco’s motion to dismiss the second amended complaint was granted with leave to amend. The plaintiffs filed a third amended complaint, and RJR Tobacco filed a motion to dismiss it in September 2010. In December 2010, the court granted RJR Tobacco’s motion to dismiss with prejudice. Final judgment was entered by the court and the plaintiffs filed a notice of appeal in January 2011. Briefing is complete. Oral argument has not been scheduled.

“Lights” Cases. As noted above, “lights” class-action cases are pending against RJR Tobacco or B&W in Illinois (2), Missouri (2), Minnesota (2), California (1) and Arizona (1). The classes in these cases generally seek to recover $50,000 to $75,000 per class member for compensatory and punitive damages, injunctive and other forms of relief, and attorneys’ fees and costs from RJR Tobacco and/or B&W. In general, the plaintiffs allege that RJR Tobacco or B&W made false and misleading claims that “lights” cigarettes were lower in tar and nicotine and/or were less hazardous or less mutagenic than other cigarettes. The cases typically are filed pursuant to state consumer protection and related statutes.

Many of these “lights” cases were stayed pending review of the Good v. Altria Group, Inc. case by the U.S. Supreme Court. In that “lights” class-action case pending against Altria Group, Inc. and Philip Morris USA, the U.S. Supreme Court decided that these claims are not preempted by the Federal Cigarette Labeling and Advertising Act or by the Federal Trade Commission’s, referred to as FTC, historic regulation of the industry. Since this decision in December 2008, a number of the stayed cases have become active again.

The seminal “lights” class-action case involves RJR Tobacco’s competitor, Philip Morris, Inc. Trial began in Price v. Philip Morris, Inc. in January 2003. In March 2003, the trial judge entered judgment against Philip Morris in the amount of $7.1 billion in compensatory damages and $3 billion in punitive damages to the State of Illinois. Based on Illinois law, the bond required to stay execution of the judgment was set initially at $12 billion. Philip Morris pursued various avenues of relief from the $12 billion bond requirement. On December 15, 2005, the Illinois Supreme Court reversed the lower court’s decision and sent the case back to the trial court with instructions to dismiss the case. On December 5, 2006, the trial court granted the defendant’s motion to dismiss and for entry of final judgment. The case was dismissed with prejudice the same day. In December 2008, the plaintiffs filed a petition for relief from judgment, stating that the U.S. Supreme Court’s decision in Good v. Altria Group, Inc. rejected the basis for the reversal. The trial court granted the defendant’s motion to dismiss the plaintiffs’ petition for relief from judgment in February 2009. In March 2009, the plaintiffs filed a notice of appeal to the Illinois Appellate Court, Fifth Judicial District, requesting a reversal of the February 2009 order and remand to the circuit court. On February 24, 2011, the appellate court entered an order, concluding that the two-year time limit for filing a petition for relief from a final judgment began to run when the trial court dismissed the plaintiffs’ lawsuit on December 18, 2006. The appellate court therefore found that the petition was timely, reversed the order of the trial court, and remanded the case for further proceedings. Philip Morris filed a petition for leave to appeal to the Illinois Supreme Court. On September 28, 2011, the Illinois Supreme Court denied Philip Morris’ petition for leave to appeal and returned the case to the trial court for further proceedings.

In Turner v. R. J. Reynolds Tobacco Co., a case filed in February 2000 in Circuit Court, Madison County, Illinois, a judge certified a class in November 2001. In June 2003, RJR Tobacco filed a motion to stay the case pending Philip Morris’s appeal of the Price v. Philip Morris Inc. case mentioned above, which the judge denied in July 2003. In October 2003, the Illinois Fifth District Court of Appeals denied RJR Tobacco’s emergency stay/supremacy order request. In November 2003, the Illinois Supreme Court granted RJR Tobacco’s motion for a stay pending the court’s final appeal decision in Price. On October 11, 2007, the Illinois Fifth District Court of Appeals dismissed RJR Tobacco’s appeal of the court’s denial of its emergency stay/supremacy order request and remanded the case to the circuit court. There is currently no activity in the case.

In Howard v. Brown & Williamson Tobacco Corp., another case filed in February 2000 in Circuit Court, Madison County, Illinois, a judge certified a class in December 2001. In June 2003, the trial judge issued an order staying all proceedings pending resolution of the Price v. Philip Morris, Inc. case mentioned above. The plaintiffs appealed this stay order to the Illinois Fifth District Court of Appeals, which affirmed the Circuit Court’s stay order in August 2005. There is currently no activity in the case.

A “lights” class-action case is pending against each of RJR Tobacco and B&W in Missouri. In Collora v. R. J. Reynolds Tobacco Co., a case filed in May 2000 in Circuit Court, St. Louis County, Missouri, a judge in St. Louis certified a class in December 2003. In April 2007, the court granted the plaintiffs’ motion to reassign Collora and the following cases to a single general division: Craft v. Philip Morris Companies, Inc. and Black v. Brown & Williamson Tobacco Corp., discussed below. In April 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc. A nominal trial date of January 10, 2011 was scheduled, but it did not proceed at that time. There is currently no activity in the case.

In Black v. Brown & Williamson Tobacco Corp., a case filed in November 2000 in Circuit Court, City of St. Louis, Missouri, B&W removed the case to the U.S. District Court for the Eastern District of Missouri. The plaintiffs filed a motion to remand, which was granted in March 2006. In April 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc. A nominal trial date of January 10, 2011, was scheduled, but it did not proceed at that time. There is currently no activity in the case.

In Dahl v. R. J. Reynolds Tobacco Co., a case filed in April 2003, and pending in District Court, Hennepin County, Minnesota, a judge dismissed the case in May 2005, ruling the “lights” claims are preempted by the Federal Cigarette Labeling and Advertising Act. In July 2005, the plaintiffs appealed to the Minnesota Court of Appeals for the Fourth Judicial District. During the pendency of the appeal, RJR Tobacco removed the case to the U.S. District Court for the District of Minnesota. In February 2007, the Eighth Circuit remanded the case to the Minnesota Court of Appeals, which in December 2007, reversed the judgment and remanded the case to the District Court. In January 2009, the Minnesota Supreme Court issued an order vacating the February 2008 order that granted RJR Tobacco’s petition for review. In July 2009, the plaintiffs in this case and in Thompson v. R. J. Reynolds Tobacco Co., discussed below, filed a motion to consolidate for discovery and trial. In October 2009, the court companioned the two cases and reserved its ruling on the motion to consolidate, which it said will be reevaluated as discovery progresses. In February 2010, a stipulation and order was entered to stay proceedings in this case and in Thompson until completion of all appellate review in Curtis v. Altria Group, Inc. There is currently no activity in the case.

In Thompson v. R. J. Reynolds Tobacco Co., a case filed in February 2005 in District Court, Hennepin County, Minnesota, RJR Tobacco removed the case to the U.S. District Court for the District of Minnesota. In October 2007, the U.S. District Court remanded the case to state district court. In May 2009, the court entered an agreed scheduling order that bifurcates merits and class certification discovery. The parties are engaged in class certification discovery. In July 2009, the plaintiffs in this case and in Dahl v. R. J. Reynolds Tobacco Co. filed a motion to consolidate for discovery and trial. In October 2009, the court companioned the two cases and reserved its ruling on the motion to consolidate, which it said will be reevaluated as discovery progresses. In February 2010, a stipulation and order was entered to stay proceedings in this case and in Dahl until completion of all appellate review in Curtis v. Altria Group, Inc. There is currently no activity in the case.

In Cleary v. Philip Morris, Inc., a case filed in June 1998, and pending in Circuit Court, Cook County, Illinois, the plaintiffs filed their motion for class certification in December 2001, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W. The case was brought on behalf of persons who have allegedly been injured by (1) the defendants’ purported conspiracy pursuant to which defendants concealed material facts regarding the addictive nature of nicotine, (2) the defendants’ alleged acts of targeting their advertising and marketing to minors, and (3) the defendants’ claimed breach of the public right to defendants’ compliance with the laws prohibiting the distribution of cigarettes to minors. The plaintiffs requested that the defendants be required to disgorge all profits unjustly received through their sale of cigarettes to plaintiffs and the class, which in no event will be greater than $75,000 per each class member, inclusive of punitive damages, interest and costs. In March 2006, the court dismissed count V, public nuisance, and count VI, unjust enrichment. The plaintiffs filed an amended complaint in March 2009, to add a claim of unjust enrichment and, to include in the class, individuals who smoked “light” cigarettes. RJR Tobacco and B&W answered the amended complaint in March 2009. In July 2009, the plaintiffs filed an additional motion for class certification. In September 2009, the court granted the defendants’ motion for summary judgment on the pleadings concerning the “lights” claims as to all defendants other than Philip Morris. In February 2010, the court denied the plaintiffs’ motion for class certification of all three putative classes. However, the court ruled that the plaintiffs may reinstate the class dealing with the conspiracy to conceal the addictive nature of nicotine if they identify a new class representative. In April 2010, the court granted the plaintiffs’ motion to file a fourth amended complaint and withdraw the motion to reinstate count I by identifying a new plaintiff. The defendants filed a motion to dismiss the plaintiffs’ fourth amended complaint, which was granted in June 2010. The court denied the plaintiffs’ motion to reconsider, and in August 2010, the plaintiffs filed a notice of appeal in the U.S. Court of Appeals for the Seventh Circuit. In August 2011, the Seventh Circuit affirmed the trial court’s judgment. The plaintiffs’ petition for rehearing with a suggestion for rehearing en banc was denied on November 15, 2011. The deadline to file a petition for writ of certiorari with the U.S. Supreme Court is February 13, 2012.

In Shaffer v. R. J. Reynolds Tobacco Co., a case filed in October 2009 in the Superior Court of Pima County, Arizona against RJR Tobacco, RAI and other defendants, the plaintiffs brought the case on behalf of all persons residing in Arizona who purchased, not for resale, defendants’ cigarettes labeled as “light” or “ultra-light” from the date of the defendants’ first sales of such cigarettes in Arizona to the date of judgment. The plaintiffs allege consumer fraud, concealment, non-disclosure, negligent misrepresentation and unjust enrichment. The plaintiffs seek a variety of damages, including compensatory, restitutionary and punitive damages. In November 2009, the defendants removed the case to the U.S. District Court for the District of Arizona, and RJR Tobacco and RAI filed their answers to the complaint. Discovery is underway. The plaintiffs filed a motion for partial summary judgment on the grounds of the purported collateral estoppel effect of certain findings in United States v. Philip Morris USA, Inc.

Finally, also see the above discussion of Brown v. American Tobacco Co., Inc., under “— California Business and Professions Code Cases.”

As referred to in the “Cautionary Statements,” in the event RJR Tobacco and its affiliates or indemnitees lose one or more of the pending “lights” class-action suits, RJR Tobacco could face bonding difficulties depending upon the amount of damages ordered, if any, which could have a material adverse effect on RJR Tobacco’s, and consequently RAI’s, results of operations, cash flows or financial position.

Other Class Actions.    In Young v. American Tobacco Co., Inc., a case filed in November 1997 in Circuit Court, Orleans Parish, Louisiana, the plaintiffs brought an ETS class action against U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, on behalf of all residents of Louisiana who, though not themselves cigarette smokers, have been exposed to secondhand smoke from cigarettes which were manufactured by the defendants, and who allegedly suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. In October 2004, the trial court stayed this case pending the outcome of the appeal in Scott v. American Tobacco Co., Inc., discussed above under “— Medical Monitoring and Smoking Cessation Case.”

In Parsons v. A C & S, Inc., a case filed in February 1998 in Circuit Court, Ohio County, West Virginia, the plaintiff sued asbestos manufacturers, U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, seeking to recover $1 million in compensatory and punitive damages individually and an unspecified amount for the class in both compensatory and punitive damages. The class was brought on behalf of persons who allegedly have personal injury claims arising from their exposure to respirable asbestos fibers and cigarette smoke. The plaintiffs allege that Mrs. Parsons’ use of tobacco products and exposure to asbestos products caused her to develop lung cancer and to become addicted to tobacco. In December 2000, three defendants, Nitral Liquidators, Inc., Desseaux Corporation of North American and Armstrong World Industries, filed bankruptcy petitions in the U.S. Bankruptcy Court for the District of Delaware, In re Armstrong World Industries, Inc. Pursuant to section 362(a) of the Bankruptcy Code, Parsons is automatically stayed with respect to all defendants.

Finally, in Jones v. American Tobacco Co., Inc., a case filed in December 1998 in Circuit Court, Jackson County, Missouri, the defendants removed the case to the U.S. District Court for the Western District of Missouri in February 1999. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, by tobacco product users and purchasers on behalf of all similarly situated Missouri consumers. The plaintiffs allege that their use of the defendants’ tobacco products has caused them to become addicted to nicotine. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. The case was remanded to the Circuit Court in February 1999. There has been limited activity in this case.

Health-Care Cost Recovery Cases

Health-care cost recovery cases have been brought by a variety of plaintiffs. Other than certain governmental actions, these cases largely have been unsuccessful on remoteness grounds, which means that one who pays an injured person’s medical expenses is legally too remote to maintain an action against the person allegedly responsible for the injury.

As of December 31, 2011, three health-care cost recovery cases were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both, as discussed below after the discussion of the State Settlement Agreements. A limited number of claimants have filed suit against RJR Tobacco, its current or former affiliates, B&W and other tobacco industry defendants to recover funds for health care, medical and other assistance paid by foreign provincial governments in treating their citizens. For more information on these cases, see “— International Cases” below.

State Settlement Agreements.    In June 1994, the Mississippi Attorney General brought an action, Moore v. American Tobacco Co., against various industry members, including RJR Tobacco and B&W. This case was brought on behalf of the state to recover state funds paid for health care and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. Most other states, through their attorneys general or other state agencies, sued RJR Tobacco, B&W and other U.S. cigarette manufacturers based on similar theories. The cigarette manufacturer defendants, including RJR Tobacco and B&W, settled the first four of these cases scheduled for trial — Mississippi, Florida, Texas and Minnesota — by separate agreements with each such state.

On November 23, 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the Master Settlement Agreement with attorneys general representing the remaining 46 states, the District of Columbia, Puerto Rico, Guam, the Virgin Islands, American Samoa and the Northern Marianas. Effective on November 12, 1999, the MSA settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and released various additional present and future claims.

In the settling jurisdictions, the MSA released RJR Tobacco, B&W, and their affiliates and indemnitees, including RAI, from:

• all claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to past conduct arising out of the use, sale, distribution, manufacture, development, advertising, marketing or health effects of, the exposure to, or research, statements or warnings about, tobacco products; and

• all monetary claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to future conduct arising out of the use of or exposure to, tobacco products that have been manufactured in the ordinary course of business.

Set forth below are tables depicting the unadjusted tobacco industry settlement payment schedule and the settlement payment schedule for RAI’s operating subsidiaries under the State Settlement Agreements, and related information for 2009 and beyond:

Unadjusted Original Participating Manufacturers’ Settlement Payment Schedule

	2009			2010			2011		2012 and thereafter
First Four States’ Settlements: (1)
Mississippi Annual Payment	$	136		$	136		$	136	$	136
Florida Annual Payment		440			440			440		440
Texas Annual Payment		580			580			580		580
Minnesota Annual Payment		204			204			204		204
Remaining States’ Settlement:
Annual Payments (1)		8,004			8,004			8,004		8,004
Growers’ Trust (2)		295			295			—		—
Offset by federal tobacco buyout (2)		(295	)		(295	)		—		—
Total	$	9,364		$	9,364		$	9,364	$	9,364

RAI’s Operating Subsidiaries’ Settlement Expenses and Payment Schedule

Settlement expenses	$	2,540	$	2,496	$	2,435		—
Settlement cash payments	$	2,249	$	2,519	$	2,492		—
Projected settlement expenses							$	>2,400
Projected settlement cash payments							$	>2,400

⁽¹⁾ Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share. For further information, see “— State Settlement Agreements-Enforcement and Validity; Adjustments” below.

⁽²⁾ The Growers’ Trust payments expired December 2010 and were offset by certain obligations resulting from the federal tobacco buyout legislation, not included in this table, signed in October 2004. See “— Tobacco Buyout Legislation and Related Litigation” below.

The State Settlement Agreements also contain provisions restricting the marketing of tobacco products. Among these provisions are restrictions or prohibitions on the use of cartoon characters, brand-name sponsorships, apparel and other merchandise, outdoor and transit advertising, payments for product placement, free sampling and lobbying. Furthermore, the State Settlement Agreements required the dissolution of three industry-sponsored research and trade organizations.

The State Settlement Agreements have materially adversely affected RJR Tobacco’s shipment volumes. RAI believes that these settlement obligations may materially adversely affect the results of operations, cash flows or financial position of RAI and RJR Tobacco in future periods. The degree of the adverse impact will depend, among other things, on the rate of decline in U.S. cigarette sales in the premium and value categories, RJR Tobacco’s share of the domestic premium and value cigarette categories, and the effect of any resulting cost advantage of manufacturers not subject to the State Settlement Agreements.

Department of Justice Case.    On September 22, 1999, the U.S. Department of Justice brought an action against RJR Tobacco, B&W and other tobacco companies in the U.S. District Court for the District of Columbia. The government initially sought to recover federal funds expended by the federal government in providing health care to smokers who developed diseases and injuries alleged to be smoking-related, based on several federal statutes. In addition, the government sought, pursuant to the civil provisions of RICO, disgorgement of profits the government contends were earned as a consequence of a RICO racketeering “enterprise.” In September 2000, the court dismissed the government’s claims asserted under the Medical Care Recovery Act as well as those under the Medicare Secondary Payer provisions of the Social Security Act, but did not dismiss the RICO claims. In February 2005, the U.S. Court of Appeals for the District of Columbia ruled that disgorgement is not an available remedy in this case. The government’s petition for writ of certiorari with the U.S. Supreme Court was denied in October 2005. The non-jury, bench trial began in September 2004, and closing arguments concluded in June 2005.

On August 17, 2006, the court found certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, but did not impose any direct financial penalties. The court instead enjoined the defendants from committing future racketeering acts, participating in certain trade organizations, making misrepresentations concerning smoking and health and youth marketing, and using certain brand descriptors such as “low tar,” “light,” “ultra light,” “mild” and “natural.” The court also ordered defendants to issue “corrective communications” on five subjects, including smoking and health and addiction, and to comply with further undertakings, including maintaining web sites of historical corporate documents and disseminating certain marketing information on a confidential basis to the government. In addition, the court placed restrictions on the ability of the defendants to dispose of certain assets for use in the United States, unless the transferee agrees to abide by the terms of the court’s order, and ordered the defendants to reimburse the U.S. Department of Justice its taxable costs incurred in connection with the case.

Certain defendants, including RJR Tobacco, filed notices of appeal to the U.S. Court of Appeals for the District of Columbia in September 2006. The government filed its notice of appeal in October 2006. In addition, the defendants, including RJR Tobacco, filed joint motions asking the district court to clarify and to stay its order pending the defendants’ appeal. On September 28, 2006, the district court denied the defendants’ motion to stay. On September 29, 2006, the defendants, including RJR Tobacco, filed a motion asking the court of appeals to stay the district court’s order pending the defendants’ appeal. The court granted the motion in October 2006.

In November 2006, the court of appeals stayed the appeals pending the trial court’s ruling on the defendants’ motion for clarification. The defendants’ motion was granted in part and denied in part. The defendants’ motion as to the meaning and applicability of the general injunctive relief of the August 2006 order was denied. The request for clarification as to the scope of the provisions in the order prohibiting the use of descriptors and requiring corrective statements at retail point of sale was granted. The court also ruled that the provisions prohibiting the use of express or implied health messages or descriptors do apply to the actions of the defendants taken outside of the United States.

In May 2009, the U.S. Court of Appeals largely affirmed the finding of liability against the tobacco defendants and remanded to the trial court for dismissal of the trade organizations. The court also largely affirmed the remedial order, including the denial of additional remedies, but vacated the order and remanded for further proceedings as to the following four discrete issues:

• the issue of the extent of Brown & Williamson Holdings’ control over tobacco operations was remanded for further fact finding and clarification;

• the remedial order was vacated to the extent that it binds all defendants’ subsidiaries and was remanded to the lower court for determination as to whether inclusion of the subsidiaries and which of the subsidiaries satisfy Rule 65(d) of the Federal Rules of Civil Procedure;

• the court held that the provision found in paragraph four of the injunction, concerning the use of any express or implied health message or health descriptor for any cigarette brand, should not be read to govern overseas sales. The issue was remanded to the lower court with instructions to reformulate it so as to exempt foreign activities that have no substantial, direct and foreseeable domestic effects; and

• the remedial order was vacated regarding “point of sale” displays and remanded for the district court to evaluate and make due provisions for the rights of innocent persons, either by abandoning this part of the remedial order or re-crafting a new version reflecting the rights of third parties.

RJR Tobacco and the other defendants, as well as the Department of Justice, filed petitions for writ of certiorari to the U.S. Supreme Court in February 2010. In June 2010, the U.S. Supreme Court denied the parties’ petitions for writ of certiorari. Post-remand proceedings are underway to determine the extent to which the original order will be implemented. The defendants filed a motion to vacatur, in which they moved to vacate the trial court’s injunctions and factual findings and dismiss the case in its entirety, on March 3, 2011. The court denied the motion on June 1, 2011. The defendants have filed a notice of appeal. Oral argument is scheduled for April 20, 2012. The trial court also issued an opinion on January 26, 2012, stating that it will not defer its decision on the corrective action statements pending the outcome of pending FDA litigation. In addition, the parties to the lawsuit entered into an agreement concerning certain technical obligations regarding their public websites. Pursuant to this agreement, RJR Tobacco agreed to deposit $3.125 million over the next three years into the registry of the district court.

International Cases.    Five health-care reimbursement cases are pending against RJR Tobacco, its current or former affiliates, or B&W outside the United States, one in Israel and four in Canada. All of the remaining Canadian provinces have indicated an intention to file similar cases. In these actions, foreign governments are seeking to recover for health care, medical and other assistance paid in treating their citizens for tobacco-related disease. No such actions are pending in the United States. Pursuant to the terms of the 1999 sale of RJR Tobacco’s international tobacco business, RJR Tobacco has tendered the defense of these actions to JTI. Subject to a reservation of rights, JTI has assumed the defense of RJR Tobacco and its current or former affiliates in these actions.

• British Columbia — In 1997, British Columbia enacted a statute, subsequently amended, which created a civil cause of action for the government to recover the costs of health-care benefits incurred for insured populations of British Columbia residents resulting from tobacco-related disease. An action brought on behalf of the Province of British Columbia pursuant to the statute against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and certain of its affiliates, was dismissed in February 2000 when the British Columbia Supreme Court ruled that the legislation was unconstitutional and set aside service ex juris against the foreign defendants for that reason. British Columbia then enacted a revised statute, pursuant to which an action was filed in January 2001 against many of the same defendants, including RJR Tobacco and one of its affiliates, in Supreme Court, British Columbia. In that action, the British Columbia government seeks to recover the present value of its total expenditures for health-care benefits provided for insured persons resulting from tobacco-related disease or the risk of tobacco-related disease caused by alleged breaches of duty by the manufacturers, the present value of its estimated total expenditures for health-care benefits that reasonably could be expected to be provided for those insured persons resulting from tobacco-related disease or the risk of tobacco-related disease in the future, court ordered interest, and costs, or in the alternative, special or increased costs. The government alleges that the defendants are liable under the British Columbia statute by reason of their “tobacco related wrongs,” which are alleged to include: selling defective products, failure to warn, sale of cigarettes to children and adolescents, illegal importation, strict liability, deceit and misrepresentation, violation of trade practice and competition acts, concerted action, and joint liability. RJR Tobacco and its affiliate filed statements of defense in January 2007. In February 2010, the trial date was adjourned, and no new date has been set.

• New Brunswick — In March 2008, a case was filed on behalf of Her Majesty the Queen in Right of the Province of New Brunswick, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Trial Division in the Court of Queen’s Bench of New Brunswick. The claim is brought pursuant to New Brunswick legislation enacted in 2008, which is substantially similar to the revised British Columbia statute described above. In this action, the New Brunswick government seeks to recover essentially the same types of damages that are being sought in the British Columbia action described above based on analogous theories of liability. RJR Tobacco and its affiliate filed statements of defense in March 2010.

• Ontario — In September 2009, a case was filed on behalf of the Province of Ontario, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Ontario Superior Court of Justice. The claim is brought pursuant to Ontario legislation enacted in 2009, which is substantially similar to the revised British Columbia statute described above. In this action, the Ontario government seeks to recover essentially the same types of damages that are being sought in the British Columbia and New Brunswick actions described above based on analogous theories of liability, although the government also asserted claims based on the illegal importation of cigarettes, which claims were deleted in an amended statement of claim filed in August 2010. The jurisdictional challenge brought by RJR Tobacco and its affiliate was denied by the trial court on January 4, 2012, and RJR Tobacco and its affiliate are pursuing an appeal.

• Newfoundland and Labrador — In February 2011, a case was filed on behalf of the Province of Newfoundland and Labrador, Canada, hereinafter Newfoundland, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the General Trial Division of the Supreme Court of Newfoundland and Labrador. The claim is brought pursuant to legislation passed in Newfoundland in 2001 and proclaimed in February 2011, which is substantially similar to the revised British Columbia statute described above. In this action, the Newfoundland government seeks to recover essentially the same types of damages that are being sought in the British Columbia, New Brunswick and Ontario actions described above based on analogous theories of liability. RJR and its affiliate have brought a motion challenging the jurisdiction of the Newfoundland court. A decision is pending.

• Israel — In September 1998, the General Health Services, Israel’s second largest health fund, filed a statement of claim against certain cigarette manufacturers and distributors, including RJR Tobacco, RJR Nabisco and B&W, in the District Court of Jerusalem, Israel. The plaintiff seeks to recover the present value of the total expenditure by the government for health-care benefits provided for insured persons resulting from tobacco-related disease or the risk of tobacco-related disease caused by alleged breaches of duty by the manufacturers, the present value of the estimated total expenditure by the government for health-care benefits that reasonably could be expected to be provided for those insured persons resulting from tobacco-related disease or the risk of tobacco-related disease in the future, court ordered interest, and costs, or in the alternative, special or increased costs. The plaintiff alleges that the defendants are liable under the following theories: defective product, failure to warn, sale of cigarettes to children and adolescents, strict liability, deceit and misrepresentation and violation of trade practice and competition acts. In 2002, the plaintiff obtained leave to serve RJR Tobacco and B&W outside the jurisdiction. On behalf of RJR Tobacco, JTI filed a motion challenging the grant of leave, which was denied. JTI appealed the decision to the Supreme Court of Israel alongside other defendants’ applications for a strike out of the claim. In July 2011, the Israeli Supreme Court granted PMI and BAT’s appeal of the rejection of their motion to strike out the claim. The court found that the claim should be struck in liminie on the grounds of remoteness. In August 2011, the Supreme Court granted RJR Tobacco’s appeal of the rejection of its motion to cancel service and all other pending motions for leave to appeal. The plaintiff filed a motion for the rehearing of the Supreme Court’s decisions in this regard. In November 2011, BAT and PMI filed responses to the motion.

The following six putative Canadian class actions were filed against various Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in courts in the provinces of Alberta, British Columbia, Manitoba, Nova Scotia, and Saskatchewan, although the plaintiffs’ counsel have been actively pursuing only the action pending in Saskatchewan at this time:

• In Adams v. Canadian Tobacco Manufacturers’ Council, a case filed in July 2009 in the Court of Queen’s Bench for Saskatchewan against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals who were alive on July 10, 2009, and who have suffered, or who currently suffer, from chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed or distributed by the defendants.

• In Dorion v. Canadian Tobacco Manufacturers’ Council, a case filed in June 2009, in the Court of Queen’s Bench of Alberta against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, dependents and family members, who purchased or smoked cigarettes designed, manufactured, marketed or distributed by the defendants.

• In Kunka v. Canadian Tobacco Manufacturers’ Council, a case filed in 2009 in the Court of Queen’s Bench of Manitoba against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, and their dependents and family members, who purchased or smoked cigarettes manufactured by the defendants.

• In Semple v. Canadian Tobacco Manufacturers’ Council, a case filed in June 2009 in the Supreme Court of Nova Scotia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, dependents and family members, who purchased or smoked cigarettes designed, manufactured, marketed or distributed by the defendants for the period of January 1, 1954, to the expiry of the opt out period as set by the court.

• In Bourassa v. Imperial Tobacco Canada Limited, a case filed in June 2010 in the Supreme Court of British Columbia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, who were alive on June 12, 2007, and who have suffered, or who currently suffer from chronic respiratory diseases, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed, or distributed by the defendants.

• In McDermid v. Imperial Tobacco Canada Limited, a case filed in June 2010 in the Supreme Court of British Columbia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiffs brought the case on behalf of all individuals, including their estates, who were alive on June 12, 2007, and who have suffered, or who currently suffer from heart disease, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed, or distributed by the defendants.

In each of these six cases, the plaintiffs allege fraud, fraudulent concealment, breach of warranty, breach of warranty of merchantability and of fitness for a particular purpose, failure to warn, design defects, negligence, breach of a “special duty” to children and adolescents, conspiracy, concert of action, unjust enrichment, market share liability, joint liability, and violations of various trade practices and competition statutes. The plaintiffs seek compensatory and aggravated damages; punitive or exemplary damages; the right to waive the torts described above and claim disgorgement of the amount of revenues or profits the defendants received from the sale of tobacco products to putative class members; interest pursuant to the Pre-judgment Interest Act and other similar legislation; and other relief the court deems just. Pursuant to the terms of the 1999 sale of RJR Tobacco’s international tobacco business, RJR Tobacco has tendered the defense of these six actions to JTI. Subject to a reservation of rights, JTI has assumed the defense of RJR Tobacco and its current or former affiliates in these actions.

Native American Tribe Cases.    As of December 31, 2011, one Native American tribe case was pending before a tribal court against RJR Tobacco and B&W, Crow Creek Sioux Tribe v. American Tobacco Co., a case filed in September 1997 in Tribal Court, Crow Creek Sioux, South Dakota. The plaintiffs seek to recover actual and punitive damages, restitution, funding of a clinical cessation program, funding of a corrective public education program, and disgorgement of unjust profits from sales to minors. The plaintiffs claim that the defendants are liable under the following theories: unlawful marketing and targeting of minors, contributing to the delinquency of minors, unfair and deceptive acts or practices, unreasonable restraint of trade and unfair method of competition, negligence, negligence per se, conspiracy and restitution of unjust enrichment. The case is dormant.

Other Cases

In August 2009, RJR Tobacco and American Snuff Co. joined other tobacco manufacturers and a tobacco retailer in filing a lawsuit, Commonwealth Brands, Inc. v. United States of America, in the U.S. District Court for the Western District of Kentucky, challenging certain provisions of the Family Smoking Prevention and Tobacco Control Act, referred to as the FDA Tobacco Act, that severely restricts the few remaining channels available to communicate with adult tobacco consumers. RAI believes these provisions cannot be justified on any basis consistent with the demands of the First Amendment. The suit does not challenge the U.S. Congress’s decision to give the FDA regulatory authority over tobacco products, nor does it challenge the vast majority of the provisions of the new law. In November 2009, the court denied certain plaintiffs’ motion for preliminary injunction as to the modified risk tobacco products provision of the FDA Tobacco Act. The parties finished briefing their respective cross-motions for summary judgment in December 2009, and in January 2010, the court granted summary judgment for the plaintiffs so as to allow the continued use of color and imagery in labeling and advertising and the right to make statements that their products conform to FDA regulatory requirements. The court granted summary judgment to the U.S. Government as to all other challenged provisions. In March 2010, each side filed a notice of appeal with the Sixth Circuit Court of Appeals. Oral argument occurred July 27, 2011. A decision is pending.

On February 25, 2011, RJR Tobacco, Lorillard, Inc., and Lorillard Tobacco Company jointly filed a lawsuit, Lorillard, Inc. v. U.S. Food and Drug Administration, in the U.S. District Court for the District of Columbia, challenging the composition of the Tobacco Products Scientific Advisory Committee, referred to as the TPSAC, which had been established by the FDA. The complaint alleges that certain members of the TPSAC and certain members of its Constituents Subcommittee have financial and appearance conflicts of interest that are disqualifying under federal ethics law and regulations, and that the TPSAC is not “fairly balanced,” as required by the Federal Advisory Committee Act, referred to as FACA. In March 2011, the plaintiffs filed an amended complaint, which added an additional claim, based on a nonpublic meeting of members of the TPSAC, in violation of the FACA. The defendants filed a motion to dismiss in April 2011. A hearing date has not been scheduled. The court granted the plaintiffs’ unopposed motion to file a second amended complaint adding a count addressing the FDA’s refusal to produce all documents generated by the TPSAC and its subcommittee in preparation of the menthol report. The FDA filed a motion to dismiss the second amended complaint. A hearing on the motion is scheduled for February 14, 2012.

On August 16, 2011, RJR Tobacco and Santa Fe joined other tobacco manufacturers in a lawsuit, R. J. Reynolds Tobacco Co. v. U.S. Food and Drug Administration, in the U.S. District Court for the District of Columbia, challenging the final regulation specifying nine new graphic “warnings” pursuant to the FDA Tobacco Act violates the plaintiffs’ rights under the First Amendment to the U.S. Constitution and the Administrative Procedure Act, referred to as the APA. The court heard oral argument on the motion for preliminary injunction on September 21, 2011. On November 7, 2011, the court granted the plaintiffs’ motion for preliminary injunction, which stays the imposition of the graphic warning rule for 15 months following a final ruling from the district court as to the merits of the parties claims. On December 1, 2011, the government appealed the district court’s preliminary injunction ruling to the Court of Appeals for the D.C. Circuit. The appellate court has scheduled oral argument on the appeal for April 10, 2012. Concurrently, briefing is complete on the parties’ cross motions for summary judgment that are before the district court. Oral argument on the summary judgment motions occurred on February 1, 2012. The court stated that it would issue its ruling well before the April 10, 2012 appellate hearing.

For a detailed description of the FDA Tobacco Act, see “— Governmental Activity” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in Item 7.

Finally, RJR Tobacco and others brought suit against the City of Worcester, Massachusetts to enjoin enforcement of an ordinance prohibiting all outdoor advertising of tobacco products and any indoor advertising that is visible from the street. The suit, National Association of Tobacco Outlets, Inc. v. City of Worcester, was filed in the U.S. District Court for the Central Division of Massachusetts on June 17, 2011. The plaintiffs’ motions for preliminary injunction and summary judgment were heard on November 9, 2011, and the parties await a ruling. Enforcement of the ordinance has been stayed by agreement pending the ruling on the motion for a preliminary injunction.

State Settlement Agreements-Enforcement and Validity; Adjustments

As of December 31, 2011, there were 32 cases concerning the enforcement, validity or interpretation of the State Settlement Agreements in which RJR Tobacco or B&W is a party. This number includes those cases, discussed below, relating to disputed payments under the State Settlement Agreements.

The Vermont Attorney General filed suit in July 2005, in the Vermont Superior Court, Chittenden County, alleging that certain advertising for the Eclipse cigarette brand violated both the MSA and the Vermont Consumer Fraud Statute. The State of Vermont is seeking declaratory, injunctive, and monetary relief. The bench trial in this action began on October 6, 2008, and lasted a total of five weeks. Closing arguments occurred on March 11, 2009. On March 10, 2010, the court issued its opinion, finding that three of the advertising claims made by RJR Tobacco were not supported by the appropriate degree of scientific evidence. The court did, however, rule that the remaining six advertising claims challenged by the State of Vermont were not actionable. The court indicated that remedies and any damages to be awarded, as well as the issue of attorney’s fees and litigation expenses, will be addressed in additional proceedings. On March 22, 2010, RJR Tobacco filed a motion to amend findings of fact that it believes are demonstrably contrary to, or unsupported by, the record. On December 14, 2010, the court issued an order granting in part and denying in part RJR Tobacco’s motion. The parties will conduct a mediation on the remaining issues on February 14, 2012.

In April 2005, the Mississippi Attorney General notified B&W of its intent to seek approximately $3.9 million in additional payments under the Mississippi Settlement Agreement. The Mississippi Attorney General asserts that B&W failed to report in its net operating profit or its shipments, cigarettes manufactured by B&W under contract for Star Tobacco or its parent, Star Scientific, Inc. B&W advised the state that it did not owe the state any money. In August 2005, the Mississippi Attorney General filed in the Chancery Court of Jackson County, Mississippi, a Notice of Violation, Motion to Enforce Settlement Agreement, and Request for an Accounting by Defendant Brown & Williamson Holdings, Inc., formerly known as Brown & Williamson Tobacco Corporation. In this filing, Mississippi estimated that its damages exceeded $5.0 million. On August 24, 2011, the court entered an order finding in favor of the State on the Star contract manufacturing issue, that the total amount of the underpayment from B&W was approximately $3.8 million and that interest on the underpayment was approximately $4.3 million. The court appointed a special master to undertake an accounting of the benefit received by B&W for failure to include its profits from Star contract manufacturing in its net operating profits reported to the State. Finally, the court awarded the State attorneys’ fees and costs in an amount to be determined. B&W filed a motion to certify the Star contract issue for interlocutory appeal, pursuant to Rule 54 (b) of the Mississippi Rules of Civil Procedure. On January 9, 2012, that motion was denied.

In addition, in February 2010, the Mississippi Attorney General filed a motion alleging that RJR Tobacco had improperly failed to report shipments of certain categories of cigarette volumes, and for certain years had improperly reported its net operating profit. As a result, the State alleges that settlement payments to it were improperly reduced. RJR Tobacco disputes these allegations and is vigorously defending against them. Briefing with respect to these issues is underway, and a hearing on these issues was scheduled for January 24-25, 2012.

In May 2006, the State of Florida filed a motion, in the Circuit Court of the Fifteenth Judicial Circuit, in and for Palm Beach County, Florida, to enforce the Settlement Agreement, for an Accounting by Brown & Williamson Holdings, Inc., and for an Order of Contempt, raising substantially the same issues as raised by the Mississippi Attorney General and seeking approximately $12.4 million in additional payments under the Florida Settlement Agreement, as well as $17.0 million in interest payments. This matter is currently in the discovery phase.

In October 2008, Vibo Corporation, Inc. d/b/a General Tobacco, referred to as General, filed a complaint in the U.S. District Court for the Western District of Kentucky against RJR Tobacco and other participating manufacturers, referred to as PMs, under the MSA, and the Attorneys General of the 52 states and territories that are parties to the MSA. General sought, among other things, to enjoin enforcement of certain provisions of the MSA and an order relieving it of certain of its payment obligations under the MSA and, in the event such relief was not granted, rescission of General’s 2004 agreement to join the MSA. General also moved for a preliminary injunction that, among other things, would have enjoined the states from enforcing certain of General’s payment obligations under the MSA. In November 2008, RJR Tobacco and the other defendants moved to dismiss General’s complaint. In January 2009, the court issued a memorandum opinion and order granting the defendants’ motions and dismissing General’s lawsuit. Final judgment was entered on January 5, 2010. On January 13, 2010, General noticed its appeal of this decision. Oral argument occurred on October 6, 2011, before the U.S. Court of Appeals for the Sixth Circuit. A decision is pending.

In December 2007, nine states (California, Connecticut, Illinois, Maine, Maryland, New York, Ohio, Pennsylvania and Washington) sued RJR Tobacco claiming that an advertisement published in Rolling Stone magazine the prior month violated the MSA’s ban on the use of cartoons. The states asserted that the magazine’s content adjacent to a Camel gatefold advertisement included cartoon images prohibited by the MSA and that certain images used in the Camel ad itself were prohibited cartoons. In addition, three states (Connecticut, New York and Maryland) also claimed that a direct mail piece distributed by RJR Tobacco violated the MSA prohibition against distributing utilitarian items bearing a tobacco brand name. Each state sought injunctive relief and punitive monetary sanctions. Eight of the nine courts have since ruled that the states are not entitled to the punitive sanctions being sought. The issue has not been resolved definitively by the court in California at this time.

Six of these magazine advertisement cases have been ruled upon following bench trials:

• In Maine, RJR Tobacco received a complete defense ruling.

• In Washington, the Washington Court of Appeals reversed, in part, a favorable ruling in favor of RJR Tobacco at the trial court, holding that some of the images used in the RJR Tobacco advertisement were cartoons, and remanded the case for further proceedings. The Washington Supreme Court declined to review the decision by the Court of Appeals. The case was settled in the second quarter of 2011 for a non-material amount.

• In Ohio, the court agreed that the Camel advertisement did not use any cartoons, but ruled that the company should have prevented the use of cartoons in magazine-created content next to the RJR Tobacco advertisement. No monetary sanctions were awarded. RJR Tobacco appealed this decision, and the Court of Appeals reversed the trial court’s ruling regarding RJR Tobacco’s duty to prevent the use of cartoons in adjacent magazine-created content. The State petitioned the Ohio Supreme Court for review, and that petition was denied.

• The court in California ruled that the company was not liable for preventing the use of cartoons in magazine-created content next to the RJR Tobacco advertisement, but that a few of the images in the RJR Tobacco advertisement itself were “technical” and unintentional cartoons. No monetary sanctions were awarded by the California court. The parties’ appeals are ongoing. The California Court of Appeals affirmed the judgment on the merits. In April 2011, the California Court of Appeals reversed the trial court’s award of attorneys’ fees to the State and remanded the case to the trial court with instructions to use the correct legal standard and prevailing market rates in determining the award of fees to either party. Oral argument occurred in October 2011. A final order was issued on October 6, 2011, finding the State to be the prevailing party for purposes of entitlement to attorneys’ fees. Discovery has ensued regarding hours and rates. A hearing is scheduled for March 27, 2012.

• The Pennsylvania court ruled against RJR Tobacco on both claims, agreeing with the Commonwealth that the RJR Tobacco advertisement contained unspecified cartoons and that RJR Tobacco was responsible for the cartoons included in the magazine-created content, regardless of whether the company was aware of it in advance. In addition, the Pennsylvania court ordered RJR Tobacco to pay for the creation of a single page youth smoking prevention advertisement in Rolling Stone issues in Pennsylvania within a year, or pay a penalty of approximately $302,000, if it fails to do so. RJR Tobacco appealed. In August 2010, the Pennsylvania Court of Appeals reversed the trial court on both claims. The Commonwealth filed a motion for reargument, which was denied in October 2010. In November 2010, the Commonwealth filed a petition for leave to appeal, which was denied in April 2011.

• In Illinois, RJR Tobacco received a complete defense ruling. The State requested reconsideration of the court’s ruling, and the court reaffirmed its ruling in favor of RJR Tobacco. The State filed an appeal. On June 30, 2011, the appellate court affirmed in part and reversed in part and remanded the case to the trial court to determine the State’s attorneys’ fees and costs. The appellate court reversed the ruling that found that RJR Tobacco did not use some images that were cartoons under the consent decree in its advertisement in Rolling Stone. The appellate court affirmed the ruling that RJR Tobacco did not “cause” Rolling Stone to “use” cartoons in the editorial portion of the gatefold and affirmed the ruling that the State was not entitled to any monetary sanctions for violating the consent decree. The parties settled the case with RJR Tobacco agreeing to reimburse the State its attorneys’ fees for a non-material amount.

The three remaining cases — in Maryland, New York and Connecticut — were individually settled in the first quarter of 2010 for a non-material amount.

NPM Adjustment.    The MSA includes an adjustment, referred to as an NPM Adjustment, that potentially reduces the annual payment obligations of RJR Tobacco and the other PMs. Certain requirements, collectively referred to as the Adjustment Requirements, must be satisfied before the NPM Adjustment for a given year is available:

• an independent auditor designated under the MSA must determine that the PMs have experienced a market share loss beyond a triggering threshold to those manufacturers that do not participate in the MSA, such non-participating manufacturers referred to as NPMs; and

• in a binding arbitration proceeding, a firm of independent economic consultants must find that the disadvantages of the MSA were a significant factor contributing to the loss.

When the Adjustment Requirements are satisfied, the MSA provides that the NPM Adjustment applies to reduce the annual payment obligation of the PMs. However, an individual settling state may avoid its share of the NPM Adjustment if it had in place and diligently enforced during the entirety of the relevant year a “Qualifying Statute” that imposes escrow obligations on NPMs that are comparable to what the NPMs would have owed if they had joined the MSA. In such event, the state’s share of the NPM Adjustment is reallocated to other settling states, if any, that did not have in place and diligently enforce a Qualifying Statute.

NPM Adjustment Claim for 2003.    For 2003, the Adjustment Requirements were satisfied. As a result, in April 2006, RJR Tobacco placed approximately $647 million of its MSA payment into a disputed payments account, in accordance with a procedure established by the MSA. That amount represented RJR Tobacco’s share of the 2003 NPM Adjustment as calculated by the MSA independent auditor. In March 2007, the independent auditor issued revised calculations that reduced RJR Tobacco’s share of the NPM Adjustment for 2003 to approximately $615 million. As a result, in April 2007, RJR Tobacco instructed the independent auditor to release to the settling states approximately $32 million from the disputed payments account.

Following RJR Tobacco’s payment of a portion of its 2006 MSA payment into the disputed payments account, 37 of the settling states filed legal proceedings in their respective MSA courts seeking declaratory orders that they diligently enforced their Qualifying Statutes during 2003 and/or orders compelling RJR Tobacco and the other PMs that placed money in the disputed payments account to pay the disputed amounts to the settling states. In response, RJR Tobacco and other PMs, pursuant to the MSA’s arbitration provisions, moved to compel arbitration of the parties’ dispute concerning the 2003 NPM Adjustment, including the States’ diligent enforcement claims, before a single, nationwide arbitration panel of three former federal judges. The settling states opposed these motions, arguing, among other things, that the issue of diligent enforcement must be resolved by MSA courts in each of the 52 settling states and territories.

As of December 31, 2011, 47 of the 48 courts that had addressed the question whether the dispute concerning the 2003 NPM Adjustment is arbitrable had ruled that arbitration is required under the MSA. The orders compelling arbitration in these states are now final and/or non-appealable. The Montana Supreme Court ruled that the state of Montana did not agree to arbitrate the question of whether it diligently enforced a qualifying statute. Trial on Montana’s assertion of its diligent enforcement defense to the 2003 NPM Adjustment is set for trial on September 10, 2012. Discovery is underway.

As of January 2009, RJR Tobacco and certain other PMs entered into an Agreement Regarding Arbitration, referred to as the Arbitration Agreement, with 45 of the settling states, representing approximately 90% of the allocable share of the settling states. Pursuant to the Arbitration Agreement, signing states will have their ultimate liability (if any) with respect to the 2003 NPM Adjustment reduced by 20%, and RJR Tobacco and the other PMs that placed their share of the disputed 2005 NPM Adjustment (discussed below) into the disputed payments account have, without releasing or waiving any claims, authorized the release of those funds to the settling states.

Montana is one of the settling states that signed the Arbitration Agreement. Thus, notwithstanding the ruling of the Montana Supreme Court with respect to the arbitrability of the diligent enforcement issue, Montana is contractually obligated to participate with the other states in the arbitration that will address all remaining issues related to the dispute pertaining to the 2003 NPM Adjustment.

The arbitration panel contemplated by the MSA and the Arbitration Agreement has been selected, and proceedings before the panel with respect to the 2003 NPM Adjustment Claim have begun. An initial administrative conference was held in July 2010, and subsequent proceedings have been held since then. Document and deposition discovery has been conducted pursuant to various orders of the arbitration panel. On November 3, 2011, RJR Tobacco and the other PMs advised the arbitration panel that they were not contesting the “diligent enforcement” of 12 states and the four pacific territories with a combined allocable share of less that 14 percent. The “diligent enforcement” of the remaining 35 settling states, DC and Puerto Rico was contested and will be the subject of further proceedings. A common issues hearing has been scheduled for April 2012 and state specific evidentiary hearings will begin in May 2012. State specific hearings will continue thereafter on a monthly basis until proceedings with respect to all contested states have been completed. It is anticipated that it will be 12 to 18 months before a decision on the merits with respect to the 2003 NPM Adjustment is reached.

Other NPM Adjustment Claims.    From 2006 to 2008, proceedings were initiated with respect to an NPM Adjustment for 2004, 2005 and 2006. The Adjustment Requirements were satisfied with respect to the NPM Adjustment for each of 2004, 2005 and 2006. As a result:

• in April 2007, RJR Tobacco placed approximately $561 million of its 2007 MSA payment (representing its share of the 2004 NPM Adjustment as calculated by the MSA independent auditor), and in April 2008, placed approximately $431 million of its 2008 MSA payment (representing its share of the 2005 NPM Adjustment as calculated by the independent auditor, net of certain slight adjustments to reflect revised independent auditor calculations of RJR Tobacco’s share of the 2003 and 2004 NPM Adjustments) into the disputed payments account. In 2009 and 2010, revised independent auditor calculations resulted in increases in RJR Tobacco’s 2005 NPM Adjustment, bringing the total amount of the adjustment to approximately $445 million; and

• in April 2009, RJR Tobacco retained approximately $406.5 million of its 2009 MSA payment to reflect its share of the 2006 NPM Adjustment as calculated by the independent auditor. Based on revised calculations by the MSA independent auditor, in April 2010, RJR Tobacco withheld an additional amount, bringing the total amount withheld with respect to the 2006 NPM Adjustment to approximately $420 million. Again based on revised calculations by the MSA independent auditor, in April 2011, RJR Tobacco paid approximately $1 million extra to account for a downward adjustment in its share of the 2006 NPM Adjustment.

The MSA permits PMs to retain disputed payment amounts pending resolution of the dispute. If the resolution of the dispute ultimately requires a PM to pay some or all of the disputed amount, then the amount deemed to be due includes interest calculated from the date the payment was originally due at the prime rate plus three percent.

In June 2009, RJR Tobacco, certain other PMs and the settling states entered into an agreement with respect to the 2007, 2008 and 2009 significant factor determinations. This agreement provides that the settling states will not contest that the disadvantages of the MSA were “a significant factor contributing to” the market share loss experienced by the PMs in those years. The stipulation pertaining to each of the three years will become effective in February of the year a final determination by the firm of independent economic consultants would otherwise have been expected (2010, 2011 and 2012, respectively), if the issue had been arbitrated on the merits. RJR Tobacco and the PMs will pay a total amount of $5 million into the States’ Antitrust/Consumer Protection Tobacco Enforcement Fund established under Section VIII(c) of the MSA for each year covered by that agreement, with RJR Tobacco paying approximately 47% of such amounts. On January 9, 2012, a new agreement with respect to significant factor determinations was entered into teams essentially identical to the earlier agreement, but pertaining to 2010, 2011 and 2012.

Based on the payment calculations of the MSA independent auditor and the agreement described above regarding in pertinent part the 2007 and 2008 significant factor determinations, the Adjustment Requirements were satisfied with respect to the NPM Adjustments for 2007 and 2008. As a result, in April 2010, RJR Tobacco placed approximately $448 million of its 2010 MSA payment (representing its share of the 2007 NPM Adjustment as calculated by the MSA independent auditor) into the disputed payments account, and in April 2011, it placed approximately $477 million of its 2011 MSA payment (representing its share of the 2008 NPM Adjustment as calculated by the MSA independent auditor) into the disputed payments account. RJR Tobacco’s 2011 payment into the disputed payments account was reduced by approximately $1.1 million to adjust for a downward revision by the independent auditor to RJR Tobacco’s share of the 2007 NPM Adjustment.

The table below summarizes the information discussed above with respect to the disputed portions of RJR Tobacco’s MSA payment obligations from 2003 through 2008 – the years as to which the Adjustment Requirements have been met:

Year for which NPM Adjustment Calculated		2003		2004		2005		2006		2007		2008
Year in which deduction from NPM may be taken		2006		2007		2008		2009		2010		2011
RJR Tobacco’s approximate share of disputed NPM Adjustment (millions)	$	615	$	562	$	445	$	419	$	447	$	477

In addition to the NPM Adjustment claims described above, RJR Tobacco has filed dispute notices with respect to its 2009 and 2010 annual MSA payments relating to the NPM Adjustments potentially applicable to those years. The amount at issue for those two years is approximately $937 million.

Due to the uncertainty over the final resolution of the NPM Adjustment claims asserted by RJR Tobacco, no assurances can be made related to the amounts, if any, that will be realized or any amounts (including interest) that will be owed.

Separately, on August 19, 2011, Idaho sent a letter on behalf of itself and 31 other states, stating their intent to initiate arbitration with respect to whether amounts used to measure the domestic cigarette market and to calculate PM payment obligations under the MSA should be the adjusted gross or the net number of cigarettes on which federal excise tax (including arbitrios de cigarillos) is paid. On December 15, 2011, the parties entered into an agreement regarding procedures for formation of arbitration panel with respect to this arbitration. Selection of arbitrators by the parties is underway.

Antitrust Cases

A number of tobacco wholesalers and consumers have sued U.S. cigarette manufacturers, including RJR Tobacco and B&W, in federal and state courts, alleging that cigarette manufacturers combined and conspired to set the price of cigarettes in violation of antitrust statutes and various state unfair business practices statutes. In these cases, the plaintiffs asked the court to certify the lawsuits as class actions on behalf of other persons who purchased cigarettes directly or indirectly from one or more of the defendants. As of December 31, 2011, all of the federal and state court cases on behalf of indirect purchasers had been dismissed, except for one state court case pending in Kansas.

In Smith v. Philip Morris Cos., Inc., a case filed in February 2000, and pending in District Court, Seward County, Kansas, the court granted class certification in November 2001, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and the parent companies of the major U.S. cigarette manufacturers, including RJR, seeking to recover an unspecified amount in actual and punitive damages. The plaintiffs allege that the defendants participated in a conspiracy to fix or maintain the price of cigarettes sold in the United States. The parties are currently engaged in discovery. In November 2010, RJR Tobacco and B&W filed a motion for summary judgment. A hearing on the motion occurred on January 18, 2012. A decision is pending. Trial has been scheduled for July 16, 2012.

Other Litigation and Developments

JTI Claims for Indemnification.    By purchase agreement dated May 12, 1999, referred to as the 1999 Purchase Agreement, RJR and RJR Tobacco sold the international tobacco business to JTI. Under the 1999 Purchase Agreement, RJR and RJR Tobacco retained certain liabilities relating to the international tobacco business sold to JTI. Under its reading of the indemnification provisions of the 1999 Purchase Agreement, JTI has requested indemnification for damages allegedly arising out of these retained liabilities. As previously reported, a number of the indemnification claims between the parties relating to the activities of Northern Brands in Canada have been resolved. See note 6 for a discussion of the Comprehensive Agreement between RJR Tobacco and the Canadian federal, provincial and territorial governments, and Northern Brands’ plea agreement with the Ministry of the Attorney General of Ontario. Other matters for which JTI has requested indemnification for damages under the indemnification provisions of the 1999 Purchase Agreement are described below:

• In a letter dated March 31, 2006, counsel for JTI stated that JTI would be seeking indemnification under the 1999 Purchase Agreement for any damages it may incur or may have incurred arising out of a Southern District of New York grand jury investigation, a now-terminated Eastern District of North Carolina grand jury investigation, and various actions filed by the European Community and others in the U.S. District Court for the Eastern District of New York, referred to as the EDNY, against RJR Tobacco and certain of its affiliates on November 3, 2000, August 6, 2001, and (as discussed in greater detail below) October 30, 2002, and against JTI on January 11, 2002.

• JTI also has sought indemnification relating to a Statement of Claim filed on April 23, 2010, against JTI Macdonald Corp., referred to as JTI-MC, by the Ontario Flue-Cured Tobacco Growers’ Marketing Board, referred to as the Board, Andy J. Jacko, Brian Baswick, Ron Kichler, and Aprad Dobrenty, proceeding on their own behalf and on behalf of a putative class of Ontario tobacco producers that sold tobacco to JTI-MC during the period between January 1, 1986 and December 31, 1996, referred to as the Class Period, through the Board pursuant to certain agreements. The Statement of Claim seeks recovery for damages allegedly incurred by the class representatives and the putative class for tobacco sales during the Class Period made at the contract price for duty free or export cigarettes with respect to cigarettes that, rather than being sold duty free or for export, purportedly were sold in Canada, which allegedly breached one or more of a series of contracts dated between June 4, 1986, and July 3, 1996.

• Finally, JTI has advised RJR and RJR Tobacco of its view that, under the terms of the 1999 Purchase Agreement, RJR and RJR Tobacco are liable for a roughly $1.7 million judgment entered in 1998, plus interest and costs, in an action filed in Brazil by Lutz Hanneman, a former employee of a former RJR Tobacco subsidiary. RJR and RJR Tobacco deny that they are liable for this judgment under the terms of the 1999 Purchase Agreement.

Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have these and other unresolved indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree with JTI as to (1) what circumstances relating to any such matters may give rise to indemnification obligations by RJR and RJR Tobacco, and (2) the nature and extent of any such obligation. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to resolve their differences at a later time.

European Community.    On October 30, 2002, the European Community and ten of its member states filed a complaint in the EDNY against RJR, RJR Tobacco and several currently and formerly related companies. The complaint contains many of the same or similar allegations found in an earlier complaint, now dismissed, filed in August 2001 and also alleges that the defendants, together with certain identified and unidentified persons, engaged in money laundering and other conduct violating civil RICO and a variety of common laws. The complaint also alleges that the defendants manufactured cigarettes that were eventually sold in Iraq in violation of U.S. sanctions. The plaintiffs seek compensatory, punitive and treble damages among other types of relief. This matter has been stayed and largely inactive since November 24, 2009 when, with the court’s permission, the European Community and member states filed and served a second amended complaint. The second amended complaint added 16 member states as plaintiffs and RAI, RJR Tobacco and R. J. Reynolds Global Products Inc., referred to as GPI as defendants. The allegations contained in the second amended complaint are in most respects either identical or similar to those found in the prior complaint, but now add new allegations primarily regarding the activities of RAI, RJR Tobacco and GPI following the B&W business combination. Pursuant to a stipulation and order, the defendants filed a motion to dismiss the plaintiffs’ second amended complaint on February 15, 2010. Oral argument of the motion occurred on October 26, 2010. Supplemental briefs were then filed. Ruling on part of the defendants’ motion to dismiss, on March 8, 2011, the court dismissed the plaintiffs’ RICO claims, and reserved decision as to dismissal of the plaintiffs’ state-law claims. Thereafter, on May 13, 2011, the court granted the remaining portion of the defendants’ motion and dismissed the plaintiffs’ state-law claims based on the court’s lack of subject matter jurisdiction. On May 16, 2011, the clerk of court entered a judgment dismissing the action in its entirety. On June 10, 2011, the plaintiffs filed a notice of appeal with the U.S. Court of Appeals for the Second Circuit, appealing from the May 16, 2011 judgment, as well as the March 8, 2011 and May 13, 2011 orders that respectively resulted in the dismissal of their RICO and state-law claims. Briefing is complete. Oral argument has been scheduled for February 24, 2012.

Star Patent Infringement.    On May 23, 2001, and July 30, 2002, Star Scientific, Inc. filed two patent infringement actions, later consolidated, against RJR Tobacco in the U.S. District Court for the District of Maryland. The consolidated action, known as Star I, involved two patents (U.S. Patent Nos. 6,202,649 and 6,425,401), both entitled “Method of Treating Tobacco to Reduce Nitrosamine Content, and Products Produced Thereby.” Star accused RJR Tobacco of infringing certain claims of these patents during the 2001 and 2002 growing seasons and asked the court to: enter an injunction restraining RJR Tobacco from further acts of infringement; award Star damages, including a reasonable royalty, to compensate for the infringement; increase the damages due to willfulness; award pre-judgment and post-judgment interest and reasonable attorney fees; and order RJR Tobacco to deliver up to the court for destruction all products manufactured from any process that infringes any claim of either patent. RJR Tobacco filed counterclaims seeking a declaration that the asserted claims of Star’s patents are invalid, unenforceable and not infringed by RJR Tobacco. Between January 31 and February 8, 2005, the court held a first bench trial on RJR Tobacco’s affirmative defense and counterclaim based upon inequitable conduct. Additionally, in response to the court’s invitation, RJR Tobacco filed two summary judgment motions in January 2005.

In January 2007, the court granted RJR Tobacco’s motion for summary judgment of invalidity based on indefiniteness. The court granted in part and denied in part, RJR Tobacco’s other summary judgment motion concerning the effective filing date of Star’s patents. In June 2007, the court ruled that Star’s patents are unenforceable due to inequitable conduct by Star and its representatives in the U.S. Patent & Trademark Office, referred to as the PTO, and entered final judgment in favor of RJR Tobacco and against Star. Star filed a notice of appeal with the U.S. Court of Appeals for the Federal Circuit.

In August 2008, the Federal Circuit issued a decision reversing the district court’s rulings against Star and remanded the case to the district court for further proceedings on the issues of validity and infringement. Star updated its reasonable royalty damages calculation to a range of $294.9 million to $362.1 million.

In late 2008, RJR Tobacco petitioned the PTO to reexamine the claims of Star’s patents at issue in Star I based on substantial new questions of patentability. The PTO agreed to reexamine the claims ex parte. The district court decided to move forward with the trial in Star I rather than await the outcome of the reexamination proceedings.

Trial began on May 18, 2009, and on June 16, 2009, the jury returned a verdict in favor of RJR Tobacco on every question put to it. The jury decided that RJR Tobacco had not infringed either of Star’s patents and that the patents were invalid on four independent bases.

Shortly after the start of the Star I jury trial, in May 2009, Star filed a follow-on lawsuit – Star II – in the U.S. District Court for the District of Maryland seeking damages for alleged infringement during the 2003 growing season and beyond of the two Star patents found invalid and not infringed in Star I. The district court stayed Star II pending the outcome of proceedings in Star I, and Star II was administratively closed pending further order of the district court upon the application, by December 31, 2012, of any party.

In November 2009, RJR Tobacco filed a bill of costs (later renewed) seeking reimbursement of its recoverable costs as the prevailing party in Star I, and also filed a motion seeking reimbursement of its attorney fees and excess costs incurred in defending Star I. In December 2009, the district court upheld the jury verdict by denying Star’s combined motion for judgment as a matter of law or new trial. The court entered judgment in RJR Tobacco’s favor and awarded RJR Tobacco all assessable costs. The court deferred proceedings with respect to RJR Tobacco’s motion for attorneys’ fees and excess costs pending final resolution of the reexamination and any appellate proceedings.

On Star’s request and without objection from RJR Tobacco, the district court deferred briefing on RJR Tobacco’s renewed bill of costs until after the resolution of appellate proceedings.

In December 2009, Star filed a notice of appeal in the Federal Circuit from the district court’s final judgment order. On August 26, 2011, the Federal Circuit issued a decision affirming the jury’s finding of non-infringement but reversing, in a split decision, on invalidity. Writing in dissent, Judge Dyk stated that he would affirm the jury’s finding of invalidity based upon indefiniteness.

On September 26, 2011, RJR Tobacco filed a combined petition for panel rehearing and rehearing en banc with the Federal Circuit seeking rehearing on whether Star’s patents at issue are invalid based upon indefiniteness. The Federal Circuit denied RJR Tobacco’s combined petition on November 29, 2011, and the Federal Circuit’s judgment issued as a mandate on December 15, 2011. Star I has now returned to the district court for further proceedings on RJR Tobacco’s bill of cost and motion for attorneys’ fees and excess costs. A status conference occurred on January 24, 2012. Star I and Star II have been stayed and referred to the magistrate judge for mediation purposes.

In the PTO reexamination proceeding, the PTO in March and April 2011 issued ex parte reexamination certificates confirming the patentability of the claims of the Star patents at issue in Star I. The PTO reexamination proceeding did not address the question of whether Star’s patents are invalid based upon indefiniteness.

Other Matters.    In November, 2009, RAI and B&W were served with subpoenas issued by the Office of the Inspector General, U.S. Department of Defense, seeking two broad categories of documents in connection with a civil investigation:

• documents regarding the sale of U.S. manufactured cigarettes to the Army Air Force Exchange Service and the Navy Exchange Command either directly by the manufacturers or through distributors during the period January 1, 1998 through December 31, 2001; and

• documents regarding the sale of U.S. manufactured cigarettes by the manufacturers to civilian market customers for resale in non-federal excise tax markets during the periods January 1, 1998 through December 31, 2001 and September 1, 2008 through September 1, 2009.

RAI and RJRT have responded to the subpoenas, including the extent to which the subpoenas seek documents regarding the domestic tobacco operations acquired from B&W in 2004, and believes this matter is now closed.

In May 2011, RJR Tobacco and SFNTC received separate letters from counsel to Walgreen Co. regarding a 60-day notice served on Walgreen by a consumer group alleging violations of California’s Proposition 65. The group claims that Walgreen provided or sold products with containers or wrappers containing insufficient warning in violation of California law. Walgreen believes that RJR Tobacco and SFNTC provided the noticed products, and is requesting that RJR Tobacco and SFNTC pay for Walgreen’s defense, indemnify Walgreen and hold Walgreen harmless from all liability, loss or expense (including legal expense) related to sales of any products covered by the 60-day notice, manufactured or distributed to Walgreen by RJR Tobacco and SFNTC. In June 2011, RJR Tobacco submitted a reply to Walgreen’s counsel, and SFNTC submitted a reply in July 2011. Neither company has received a response from Walgreen’s counsel. RJR Tobacco and SFNTC each believes that it has valid defenses to Walgreen’s claims.

Finally, in the first quarter of 2005, Commonwealth Brands, Inc., referred to as Commonwealth, was served with an individual smoking and health case, Croft v. Akron Gasket in Cuyahoga County, Ohio. Commonwealth requested indemnity from RJR Tobacco pursuant to the Asset Purchase Agreement dated July 24, 1996, between Commonwealth and B&W, referred to as the 1996 Purchase Agreement. As a result of the B&W business combination, RJR Tobacco agreed to indemnify Commonwealth for this claim to the extent, if any, required by the 1996 Purchase Agreement. The scope of the indemnity will be at issue and has not been determined.

Smokeless Tobacco Litigation

As of December 31, 2011, American Snuff Co. was a defendant in six actions brought by individual plaintiffs in West Virginia state court seeking damages in connection with personal injuries allegedly sustained as a result of the usage of American Snuff Co.’s smokeless tobacco products. These actions are pending before the same West Virginia court as the 577 consolidated individual smoker cases against RJR Tobacco, B&W, as RJR Tobacco’s indemnitee, or both. Pursuant to the court’s December 3, 2001, order, the smokeless tobacco claims and defendants remain severed.

Pursuant to a second amended complaint filed in September 2006, American Snuff Co. is a defendant in Vassallo v. United States Tobacco Company, pending in the Eleventh Circuit Court in Miami-Dade County, Florida. The individual plaintiff alleges that he sustained personal injuries, including addiction and cancer, as a result of his use of smokeless tobacco products, allegedly including products manufactured by American Snuff Co. The plaintiff seeks unspecified compensatory and consequential damages in an amount greater than $15,000. There is not a punitive damages demand in this case, though the plaintiff retains the right to seek leave of court to add such a demand later. Discovery is underway.

American Snuff Co. was served with a complaint that was filed in October 2011 in the U.S. District Court for the Northern District of Mississippi, Vertison v. American Snuff Co., LLC. The plaintiff alleges that as a result of her use of the defendants’ smokeless tobacco products, she developed oral cancer. The plaintiff seeks unspecified compensatory and punitive damages. On January 13, 2012, American Snuff Co. filed its answer to the complaint.

Tobacco Buyout Legislation and Related Litigation

In 2004, legislation was passed eliminating the U.S. government’s tobacco production controls and price support program. The buyout of tobacco quota holders provided for in the Fair and Equitable Tobacco Reform Act, referred to as FETRA, is funded by a direct quarterly assessment on every tobacco product manufacturer and importer, on a market-share basis measured on volume to which federal excise tax is applied. The aggregate cost of the buyout to the industry is approximately $9.9 billion, including approximately $9.6 billion payable to quota tobacco holders and growers through industry assessments over ten years and approximately $290 million for the liquidation of quota tobacco stock. As a result of the tobacco buyout legislation, the MSA Phase II obligations established in 1999 continued as scheduled through the end of 2010, but were offset against the tobacco quota buyout obligations. RAI’s operating subsidiaries’ annual expense under FETRA for 2012 and thereafter, excluding the tobacco stock liquidation assessment, is estimated to be approximately $220 million to $240 million.

RAI’s operating subsidiaries recorded the FETRA assessment on a quarterly basis as cost of goods sold. RAI’s operating subsidiaries estimate that their overall share of the buyout will approximate $2.4 billion to $2.8 billion prior to the deduction of permitted offsets under the MSA. In addition, future market pricing could impact the carrying value of inventory, and adversely affect RJR Tobacco’s financial position and results of operations.

As noted above, the MSA Phase II obligations were offset against the tobacco quota buyout obligations. Because growers in two states, Maryland and Pennsylvania, did not participate in the quota system, they are not eligible for payments under FETRA. Given that the assessments paid by tobacco product manufacturers and importers under FETRA fully offset their MSA Phase II payment obligations, the growers in Maryland and Pennsylvania would no longer receive payments under the MSA Phase II program. Thus, the growers in these two states do not receive payments under either FETRA or the MSA Phase II program.

ERISA Litigation

In May 2002, in Tatum v. The R.J.R. Pension Investment Committee of the R. J. Reynolds Tobacco Company Capital Investment Plan, an employee of RJR Tobacco filed a class-action suit in the U.S. District Court for the Middle District of North Carolina, alleging that the defendants, RJR, RJR Tobacco, the RJR Employee Benefits Committee and the RJR Pension Investment Committee, violated the Employee Retirement Income Security Act of 1974, referred to as ERISA. The actions about which the plaintiff complains stem from a decision made in 1999 by RJR Nabisco Holdings Corp., subsequently renamed Nabisco Group Holdings Corp., referred to as NGH, to spin off RJR, thereby separating NGH’s tobacco business and food business. As part of the spin-off, the 401(k) plan for the previously related entities had to be divided into two separate plans for the now separate tobacco and food businesses. The plaintiff contends that the defendants breached their fiduciary duties to participants of the RJR 401(k) plan when the defendants removed the stock funds of the companies involved in the food business, NGH and Nabisco Holdings Corp., referred to as Nabisco, as investment options from the RJR 401(k) plan approximately six months after the spin-off. The plaintiff asserts that a November 1999 amendment (the “1999 Amendment”) that eliminated the NGH and Nabisco funds from the RJR 401(k) plan on January 31, 2000, contained sufficient discretion for the defendants to have retained the NGH and Nabisco funds after January 31, 2000, and that the failure to exercise such discretion was a breach of fiduciary duty. In his complaint, the plaintiff requests, among other things, that the court require the defendants to pay as damages to the RJR 401(k) plan an amount equal to the subsequent appreciation that was purportedly lost as a result of the liquidation of the NGH and Nabisco funds.

In July 2002, the defendants filed a motion to dismiss, which the court granted in December 2003. In December 2004, the U.S. Court of Appeals for the Fourth Circuit reversed the dismissal of the complaint, holding that the 1999 Amendment did contain sufficient discretion for the defendants to have retained the NGH and Nabisco funds as of February 1, 2000, and remanded the case for further proceedings. The court granted the plaintiff leave to file an amended complaint and denied all pending motions as moot. In April 2007, the defendants moved to dismiss the amended complaint. The court granted the motion in part and denied it in part, dismissing all claims against the RJR Employee Benefits Committee and the RJR Pension Investment Committee. The remaining defendants, RJR and RJR Tobacco, filed their answer and affirmative defenses in June 2007. The plaintiff filed a motion for class certification, which the court granted in September 2008. The district court ordered mediation, but no resolution of the case was reached. In September 2008, each of the plaintiffs and the defendants filed motions for summary judgment, and in January 2009, the defendants filed a motion to decertify the class. A second mediation occurred in June 2009, but again no resolution of the case was reached. The district court overruled the motions for summary judgment and the motion to decertify the class.

A non-jury trial was held in January and February 2010. During closing arguments, the plaintiff argued for the first time that certain facts arising at trial showed that the 1999 Amendment was not validly adopted, and then moved to amend his complaint to conform to this evidence at trial. On June 1, 2011, the court granted the plaintiff’s motion to amend his complaint and found that the 1999 Amendment was invalid.

The parties filed their findings of fact and conclusions of law on February 4, 2011. A decision is pending.

Environmental Matters

RAI and its subsidiaries are subject to federal, state and local environmental laws and regulations concerning the discharge, storage, handling and disposal of hazardous or toxic substances. Such laws and regulations provide for significant fines, penalties and liabilities, sometimes without regard to whether the owner or operator of the property knew of, or was responsible for, the release or presence of hazardous or toxic substances. In addition, third parties may make claims against owners or operators of properties for personal injuries and property damage associated with releases of hazardous or toxic substances. In the past, RJR Tobacco has been named a potentially responsible party with third parties under the Comprehensive Environmental Response, Compensation and Liability Act with respect to several superfund sites. RAI and its subsidiaries are not aware of any current environmental matters that are expected to have a material adverse effect on the business, results of operations or financial position of RAI or its subsidiaries.

In September 2009, the U.S. Environmental Protection Agency, referred to as EPA, passed a rule which requires companies to monitor greenhouse gas, referred to as GHG, emissions beginning in January, 2010 and, depending upon the industry in which the particular company operates or the amount of the company’s GHG emissions, report these emissions to EPA on an annual basis, beginning in 2011. Based upon its GHG emission levels, RJR Tobacco submitted the required GHG emissions reports to the EPA pertaining to one of its facilities. RJR Tobacco is fully prepared to make annual submissions in accordance with the EPA’s regulations.

RAI and its operating subsidiaries believe that climate change is an environmental issue primarily driven by carbon dioxide emissions from the use of energy. RAI’s operating subsidiaries are working to reduce carbon dioxide emissions by minimizing the use of energy where cost effective, minimizing waste to landfills and increasing recycling. Climate change is not viewed by RAI’s operating subsidiaries as a significant direct economic risk to their businesses, but rather an indirect risk involving the potential for a longer term general increase in the cost of doing business. Regulatory changes are difficult to predict, but the current regulatory risks to the business of RAI’s operating subsidiaries with respect to climate change are relatively low. Financial impacts will be driven more by the cost of natural gas and electricity. Efforts are made to mitigate the effect of increases in fuel costs directly impacting RAI’s operating subsidiaries by evaluating natural gas usage and market conditions, and occasionally purchasing forward contracts, limited to a three-year period, for natural gas. In addition, RAI’s operating subsidiaries are constantly evaluating electrical energy conservation measures and energy efficient equipment to mitigate impacts of increases in electrical energy costs.

Regulations promulgated by the EPA and other governmental agencies under various statutes have resulted in, and likely will continue to result in, substantial expenditures for pollution control, waste treatment, facility modification and similar activities. RAI and its subsidiaries are engaged in a continuing program to comply with federal, state and local environmental laws and regulations, and dependent upon the probability of occurrence and reasonable estimation of cost, accrue or disclose any material liability. Although it is difficult to reasonably estimate the portion of capital expenditures or other costs attributable to compliance with environmental laws and regulations, RAI does not expect such expenditures or other costs to have a material adverse effect on the business, results of operations or financial position of RAI or its subsidiaries.

Other Contingencies

In connection with the sale of the international tobacco business to JTI, pursuant to the 1999 Purchase Agreement, RJR and RJR Tobacco agreed to indemnify JTI against:

• any liabilities, costs and expenses arising out of the imposition or assessment of any tax with respect to the international tobacco business arising prior to the sale, other than as reflected on the closing balance sheet;

• any liabilities, costs and expenses that JTI or any of its affiliates, including the acquired entities, may incur after the sale with respect to any of RJR’s or RJR Tobacco’s employee benefit and welfare plans; and

• any liabilities, costs and expenses incurred by JTI or any of its affiliates arising out of certain activities of Northern Brands.

As described above in “— Litigation Affecting the Cigarette Industry — Other Litigation and Developments — JTI Claims for Indemnification,” RJR Tobacco has received claims for indemnification from JTI, and several of these have been resolved. Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have other unresolved indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree what circumstances described in such claims give rise to any indemnification obligations by RJR and RJR Tobacco and the nature and extent of any such obligation. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to resolve their differences at a later date.

RJR Tobacco, SFNTC and American Snuff Co. have entered into agreements to indemnify certain distributors and retailers from liability and related defense costs arising out of the sale or distribution of their products. Additionally, Santa Fe has entered into an agreement to indemnify a supplier from liability and related defense costs arising out of the sale or use of Santa Fe’s products. The cost has been, and is expected to be, insignificant. RJR Tobacco, Santa Fe and American Snuff Co. believe that the indemnified claims are substantially similar in nature and extent to the claims that they are already exposed to by virtue of their having manufactured those products.

Except as otherwise noted above, RAI is not able to estimate the maximum potential amount of future payments, if any, related to these indemnification obligations.

Lease Commitments

RAI has operating lease agreements that are primarily for office space, automobiles, warehouse space and computer equipment. The majority of these leases expire within the next five years and some contain renewal or purchase options and escalation clauses or restrictions relating to subleases. Total rent expense was $18 million, $20 million and $20 million for 2011, 2010 and 2009, respectively.

Future minimum lease payments as of December 31, 2011 were as follows:

	Noncancellable Operating  Leases
2012	$	20
2013		18
2014		15
2015		9
2016		4
Total	$	66

XML

Restructuring Charges (Tables)

12 Months Ended

Dec. 31, 2011

Restructuring Charges [Abstract]

Activities in restructuring reserves

	2009 Restructuring Charge			2008 Restructuring Charge
Original accrual	$	—		$	91
Utilized in 2008		—			(12	)
Adjusted in 2008		—			(1	)
Balance as of December 31, 2008		—			78
Original accrual		56			—
Utilized in 2009		(8	)		(38	)
Balance as of December 31, 2009		48			40
Utilized in 2010		(22	)		(27	)
Balance as of December 31, 2010		26			13
Utilized in 2011		(24	)		(10	)
Balance as of December 31, 2011	$	2		$	3

XML

Retirement Benefits (Details 5) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011 Pension Benefits [Member]	Dec. 31, 2010 Pension Benefits [Member]	Dec. 31, 2009 Pension Benefits [Member]	Dec. 31, 2011 Postretirement Benefits [Member]	Dec. 31, 2010 Postretirement Benefits [Member]	Dec. 31, 2009 Postretirement Benefits [Member]
Components of total benefit cost:
Service cost				$ 26	$ 29	$ 31	$ 3	$ 4	$ 4
Interest cost				300	319	319	75	80	80
Expected return on plan assets				(373)	(343)	(264)	(18)	(18)	(16)
Amortization of prior service cost (credit)				4	4	4	(29)	(24)	(24)
Pension expense as a result of MTM adjustments	145	145	110	110	3	14	35	107	35
Curtailment				0			0	1
Special termination benefits				0		8	0
Settlements				0		1	0
Total benefit cost				$ 67	$ 12	$ 113	$ 66	$ 150	$ 79

XML

Stock Plans

12 Months Ended

Dec. 31, 2011

Stock Plans [Abstract]

Stock Plans

Note 15 — Stock Plans

As of December 31, 2011, RAI had two stock plans, the Equity Incentive Award Plan for Directors of RAI, referred to as the EIAP, and the Reynolds American Inc. 2009 Omnibus Incentive Compensation Plan, referred to as the Omnibus Plan.

Under the EIAP, RAI currently provides (1) grants of deferred stock units to eligible directors upon becoming a director or, provided the director did not receive an initial award upon his/her election to the board, upon appointment to the position of Non-Executive Chairman and (2) grants of deferred stock units to eligible directors on a quarterly and annual basis thereafter. Directors may elect to receive shares of common stock in lieu of their initial and annual grants of deferred stock units. A maximum of 2,000,000 shares of common stock may be issued under this plan, of which 1,112,305 shares were available for grant as of December 31, 2011. Deferred stock units granted under the EIAP have a value equal to, and bear dividend equivalents at the same rate as, one share of RAI common stock, and have no voting rights. The dividends are paid as additional units in an amount equal to the number of shares of RAI common stock that could be purchased with the dividends on the date of payment. Generally, distribution of a director’s deferred stock units will be made on January 2 following his or her last year of service on the board; however, for all grants made under the EIAP after December 31, 2007, a director may elect to receive his or her deferred stock units on the later of January 2 of a specified year or January 2 following his or her last year of service on the board. At the election of a director, distribution may be made in one lump sum or in up to ten annual installments. A director is paid in cash for the units granted quarterly and in common stock for the units granted initially and annually, unless the director elects to receive cash for the initial and annual grants. Cash payments are based on the average closing price of RAI common stock during December of the year preceding payment. Compensation expense related to the EIAP was $5 million during 2011, $4 million during 2010 and $3 million during 2009.

In 2009, the shareholders of RAI approved the Omnibus Plan. Awards to key employees under the Omnibus Plan may be in the form of cash awards, incentive or non-incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units or other awards. Subject to adjustments as set forth in the Omnibus Plan, the number of shares of RAI common stock that may be issued with respect to awards under the Omnibus Plan will not exceed 38,000,000 shares in the aggregate. The Omnibus Plan replaced the LTIP, which expired in 2009. The outstanding grants made under the LTIP prior to its expiration will remain outstanding in accordance with their terms. Upon retirement, a holder’s grant under the Omnibus Plan or LTIP generally vests on a pro rata basis for the portion of the vesting service period that has elapsed, thereby maintaining an appropriate approximation of forfeitures related to retirement.

Information regarding stock-based awards outstanding as of December 31, 2011, was as follows:

Grant Year	Plan	Number of Shares Granted		Grant Price		Type	Vesting Date		Number of Shares Cancelled		Number of Shares Vested
2009	LTIP		2,764,486	$	16.550	Restricted Stock Units		March 2, 2012		448,475		—
2010	Omnibus		1,980,166	$	26.620	Restricted Stock Units		March 1, 2013		353,655		—
2010	Omnibus		8,422	$	27.655	Restricted Stock Units		March 1, 2013		5,704		—
2010	Omnibus		2,758	$	29.425	Restricted Stock Units		March 1, 2013		—		—
2011	Omnibus		1,561,331	$	33.990	Restricted Stock Units		March 1, 2014		102,474		—
2011	Omnibus		3,874	$	39.590	Restricted Stock Units		March 1, 2014		—		—

The grant date fair value was based on the per share closing price of RAI common stock on the date of grant. The actual number of shares granted is fixed. The grants are accounted for as equity-based and compensation expense includes the vesting period elapsed.

The restricted stock unit grants will be settled exclusively in shares of RAI common stock. Upon settlement, each grantee will receive a number of shares of RAI’s common stock equal to the product of the number of vested units and a percentage up to 150% based on the average RAI annual incentive award plan score over the three-year period ending on December 31 of the year prior to the vesting date.

Dividends paid on shares of RAI common stock will accumulate on the restricted stock units and be paid to the grantee on the vesting date. If RAI fails to pay its shareholders cumulative dividends of at least $5.10 per share for the three-year performance period ending December 31, 2011 (in the case of the 2009 restricted stock unit grants), $5.40 per share for the three-year performance period ending December 31, 2012 (in the case of the 2010 restricted stock unit grants), or $6.36 per share for the three-year performance period ending December 31, 2013 (in the case of the 2011 restricted stock unit grants), then each award will be reduced by an amount equal to three times the percentage of the dividend underpayment, up to a maximum reduction of 50%. Dividends accrued on the 2009 grants are included in current liabilities and the dividends accrued on the 2010 and 2011 grants are included in other noncurrent liabilities in the consolidated balance sheet as of December 31, 2011.

The changes in restricted RAI common stock and restricted stock units during 2011 were as follows:

	Stock and Stock Units			Weighted Average Grant Date Fair Value
Outstanding at beginning of year		4,845,861		$	21.87
Granted		1,565,205			34.00
Forfeited		(544,032	)		24.93
Vested		(456,305	)		30.94
Outstanding at end of year		5,410,729			24.30

Total compensation expense related to stock-based compensation and the related tax benefits recognized in selling, general and administrative expenses in the consolidated statements of income were as follows:

Grant/Type	2011		2010		2009
2006 restricted stock	$	—	$	—	$	(2	)
2007 restricted stock and performance shares		—		1		5
2008 restricted stock		1		5		5
2009 restricted stock units		12		16		14
2010 restricted stock units		12		15		—
2011 restricted stock units		13		—		—
Total compensation expense	$	38	$	37	$	22
Total related tax benefits	$	13	$	13	$	8

Cash payments related to stock-based compensation were $19 million and $16 million for the years ended 2010 and 2009, respectively.

The amounts related to the 2008 and 2009 LTIP restricted stock unit grants and the 2010 and 2011 Omnibus restricted stock unit grants were included in the consolidated balance sheets as of December 31 as follows:

	2011		2010
Other current liabilities	$	15	$	—
Other noncurrent liabilities		10		14
Paid-in capital		81		58

As of December 31, 2011, there were $55 million of unrecognized compensation costs related to restricted stock units, calculated at the grant-date price, which are expected to be recognized over a weighted-average period of 1.83 years.

There were 40,000 stock options granted under the EIAP and outstanding at December 31, 2011, all of which were exercisable on such date at a per share exercise price of $17.45 with a remaining contractual life of 0.4 years.

RAI has a policy of issuing new shares of common stock to satisfy share option exercises. The changes in RAI’s stock options during 2011, 2010 and 2009 were as follows:

	2011				2010					2009
	Options		Weighted Average Exercise Price		Options			Weighted Average Exercise Price		Options			Weighted Average Exercise Price
Outstanding at beginning of year		40,000	$	17.45		485,468		$	7.64		776,348		$	7.38
Expired		—		—		(83,184	)		6.63		—			—
Exercised		—		—		(362,284	)		6.78		(290,880	)		6.95
Outstanding at end of year		40,000		17.45		40,000			17.45		485,468			7.64
Exercisable at end of year		40,000		17.45		40,000			17.45		485,468			7.64

The intrinsic value of options exercised was $7 million and $4 million for the years ended December 31, 2010 and 2009, respectively. The aggregate intrinsic value of fully vested outstanding and exercisable options at December 31, 2011, was $1 million.

Cash proceeds related to stock options exercised and excess tax benefits related to stock-based compensation were as follows:

	2011		2010		2009
Proceeds from exercise of stock options	$	—	$	2	$	2
Excess tax benefits from stock-based compensation		1		2		2

Equity compensation plan information as of December 31, 2011, was as follows:

Plan Category	Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights			Weighted Average Exercise Price of Outstanding Options, Warrants and Rights		Number of  Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a))
	(a)			(b)		(c)
Equity Compensation Plans Approved by Security Holders		8,116,094	(2)	$	—		33,357,923
Equity Compensation Plans Not Approved by Security Holders (1)		40,000			17.45		1,112,305
Total		8,156,094	(2)		17.45		34,470,228

⁽¹⁾  The EIAP was approved by RJR’s sole shareholder, NGH, prior to RJR’s spin-off on June 15, 1999.

⁽²⁾  Consists of restricted stock units. These restricted stock units represent the maximum number, 150%, of shares to be awarded under the best-case targets that may not be achieved, and accordingly, may overstate expected dilution.

XML

Restructuring Charges (Details Textual)	12 Months Ended
	Dec. 31, 2011 Person
2009 Restructuring Charge [Member]
Restructuring Charges (Textual) [Abstract]
Number of employees eliminated in restructuring	400
2008 Restructuring Charge [Member]
Restructuring Charges (Textual) [Abstract]
Number of employees eliminated in restructuring	600

XML

Segment Information (Details Textual) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Segment Information (Textual) [Abstract]
Sales Revenue from foreign countries, Operating Subsidiaries	$ 610	$ 525	$ 548
Asset impairment and exit charges		38	56
Trademark/goodwill impairment charges	$ 48	$ 32	$ 567
Distributor's portion of sales revenue	27.00%	27.00%	27.00%
Other Customer Revenue greater than 10% of total revenue	10.00%	10.00%	10.00%

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Millions, except Share data, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Consolidated Balance Sheets [Abstract]
Accumulated amortization	$ 696	$ 672
Common stock, shares issued	576,135,199	583,043,872
Defined benefit pension and post-retirement plans	$ (330)	$ (186)

XML

Consolidated Statements of Income (Parenthetical) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements of Income [Abstract]
Excise taxes	$ 4,107	$ 4,340	$ 3,927

XML

Inventories

12 Months Ended

Dec. 31, 2011

Inventories [Abstract]

Inventories

Note 8 — Inventories

The major components of inventories at December 31 were as follows:

	2011		2010
Leaf tobacco	$	885	$	997
Other raw materials		44		44
Work in process		60		64
Finished products		139		122
Other		24		25
Total		1,152		1,252
Less LIFO allowance		185		197
	$	967	$	1,055

Inventories valued under the LIFO method were $466 million and $600 million at December 31, 2011 and 2010, respectively, net of the LIFO allowance. The LIFO allowance reflects the excess of the current cost of LIFO inventories at December 31, 2011 and 2010, over the amount at which these inventories were carried on the consolidated balance sheets. RAI recorded income of $12 million from LIFO inventory changes during 2011 and recorded expense of $7 million and $78 million from LIFO inventory changes during 2010 and 2009, respectively.

XML

Retirement Benefits (Details 10)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Additional information relating to significant postretirement plans
Weighted-average health-care cost trend rate assumed for the following year	12.94%	15.18%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5.00%	5.00%
Year that the rate reaches the ultimate trend rate	2018	2018

XML

Retirement Benefits (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Amounts recognized in the consolidated balance sheets consist of:
Noncurrent assets other assets and deferred charges	$ 265	$ 589
Accrued benefit other current liability	(83)	(96)
Accrued benefit long-term retirement benefits	(1,759)	(1,668)
Pension Benefits [Member]
Change in benefit obligation:
Obligation at beginning of year	5,529	5,270
Service cost	26	29	31
Interest cost	300	319	319
Actuarial loss	320	324
Plan amendments	0
Benefits paid	(397)	(410)
Settlements	(9)
Curtailment	0	(3)
One-time cost	(3)	0
Obligation at end of year	5,766	5,529	5,270
Change in plan assets:
Fair value of plan assets at beginning of year	4,934	4,054
Actual return on plan assets	362	479
Employer contributions	220	811
Benefits paid	(397)	(410)
Settlements	(9)
Fair value of plan assets at end of year	5,110	4,934	4,054
Funded status	(656)	(595)
Amounts recognized in the consolidated balance sheets consist of:
Noncurrent assets other assets and deferred charges	7	3
Accrued benefit other current liability	(9)	(18)
Accrued benefit long-term retirement benefits	(654)	(580)
Net amount recognized	(656)	(595)
Accumulated other comprehensive loss	596	382
Net amounts recognized in the consolidated balance sheets	(60)	(213)
Postretirement Benefits [Member]
Change in benefit obligation:
Obligation at beginning of year	1,436	1,351
Service cost	3	4	4
Interest cost	75	80	80
Actuarial loss	59	148
Plan amendments	(45)	(51)
Benefits paid	(94)	(97)
Settlements	0
Curtailment	0	1
One-time cost	0	0
Obligation at end of year	1,434	1,436	1,351
Change in plan assets:
Fair value of plan assets at beginning of year	270	270
Actual return on plan assets	1	31
Employer contributions	78	66
Benefits paid	(94)	(97)
Settlements	0
Fair value of plan assets at end of year	255	270	270
Funded status	(1,179)	(1,166)
Amounts recognized in the consolidated balance sheets consist of:
Noncurrent assets other assets and deferred charges	0
Accrued benefit other current liability	(74)	(78)
Accrued benefit long-term retirement benefits	(1,105)	(1,088)
Net amount recognized	(1,179)	(1,166)
Accumulated other comprehensive loss	2	(23)
Net amounts recognized in the consolidated balance sheets	$ (1,177)	$ (1,189)

XML

Stock Plans (Details 6) (USD $)	12 Months Ended
	Dec. 31, 2011
Equity compensation plan information
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights	8,156,094
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights	$ 17.45
Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans	34,470,228
Equity compensation plans approved by security holders [Member]
Equity compensation plan information
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights	8,116,094
Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans	33,357,923
Equity compensation plans not approved by security holders [Member]
Equity compensation plan information
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights	40,000
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights	$ 17.45
Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans	1,112,305

XML

Quarterly Results of Operations (Unaudited) (Details Textual) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Quarterly Results of Operations (Textual) [Abstract]
Gross profit change		$ 23	$ 22	$ 26	$ (39)	$ 13	$ 13	$ 13
Net income change		27	23	28	(47)	19	18	18
Earnings per share basic change		$ 0.05	$ 0.04	$ 0.04	$ (0.08)	$ 0.04	$ 0.04	$ 0.03
Earnings per share diluted change		$ 0.04	$ 0.04	$ 0.05	$ (0.08)	$ 0.03	$ 0.03	$ 0.03
Pension expense as a result of MTM adjustments	145								145	110
Asset Impairment and exit charges							38
Trademark impairment charges	48				6				48	6	567
Goodwill impairment charge					$ 26					$ 26

XML

Document and Entity Information (USD $) In Billions, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Jan. 27, 2012	Jun. 30, 2011
Document and Entity Information [Abstract]
Entity Registrant Name	REYNOLDS AMERICAN INC
Entity Central Index Key	0001275283
Document Type	10-K
Document Period End Date	Dec. 31, 2011
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	FY
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 12.5
Entity Common Stock, Shares Outstanding		576,142,238

XML

Other Current Liabilities

12 Months Ended

Dec. 31, 2011

Other Current Liabilities [Abstract]

Other Current Liabilities

Note 9 — Other Current Liabilities

Other current liabilities at December 31 included the following:

	2011		2010
Payroll and employee benefits	$	134	$	188
Pension and other postretirement benefits		83		96
Marketing and advertising		100		133
Declared dividends		323		285
Excise, franchise and property tax		158		160
Restructuring		5		36
Tobacco quota buyout		86		57
Individual Engle Progeny cases accrual		64		—
Other		179		192
	$	1,132	$	1,147

XML

Commitments and Contingencies (Details 2) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011
Noncancellable operating leases future minimum lease payments
2012	$ 20
2013	18
2014	15
2015	9
2016	4
Total	$ 66

XML

Stock Plans (Details 5) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash proceeds related to stock options exercised and excess tax benefits related to stock-based compensation
Proceeds from exercise of stock options		$ 2	$ 2
Excess tax benefits from stock-based compensation	$ 1	$ 2	$ 2

XML

Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash flows from (used in) operating activities:
Net income	$ 1,406	$ 1,121	$ 955
Losses from discontinued operations, net of tax		216
Adjustments to reconcile to net cash flows from (used in) continuing operating activities:
Depreciation and amortization	138	151	144
Asset impairment and exit charges, net of cash payments		37
Restructuring charge, net of cash payments	(35)	(51)	7
Trademark impairment charges	48	6	567
Goodwill impairment charge		26
Deferred income tax expense (benefit)	100	187	(159)
Other changes that provided (used) cash:
Accounts and other receivables	12	(3)
Inventories	88	164	(49)
Related party, net	(32)	45	2
Accounts payable	(66)	(17)	(10)
Accrued liabilities, including income taxes and other working capital	10	(64)	(191)
Litigation bonds	(35)	(21)	(23)
Tobacco settlement	(58)	(22)	291
Pension and postretirement	(165)	(715)	(169)
Other, net	9	205	89
Net cash flows from operating activities	1,420	1,265	1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		4	19
Proceeds from settlement of long-term investments	2	13	6
Capital expenditures	(190)	(174)	(141)
Acquisition, net of cash acquired			(43)
Net proceeds from sale of business	202
Proceeds from termination of joint venture	32	28	24
Other, net	14	3	12
Net cash flows from (used in) investing activities	60	(126)	(123)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(1,212)	(1,049)	(991)
Repurchase of common stock	(282)	(5)	(5)
Repayments of long-term debt	(400)	(300)	(200)
Proceeds from termination of interest rate swaps	186
Other, net	(6)	5	4
Net cash flows used in financing activities	(1,714)	(1,349)	(1,192)
Effect of exchange rate changes on cash and cash equivalents	(5)	(11)	6
Net cash flow related to discontinued operations, net of tax benefit		(307)
Net change in cash and cash equivalents	(239)	(528)	145
Cash and cash equivalents at beginning of year	2,195	2,723	2,578
Cash and cash equivalents at end of year	1,956	2,195	2,723
Income taxes paid, net of refunds	694	573	709
Interest paid, net of capitalized interest (2011 - $3; 2010 - $3; 2009 - $1)	$ 232	$ 231	$ 245

XML

Intangible Assets

12 Months Ended

Dec. 31, 2011

Intangible Assets [Abstract]

Intangible Assets

Note 3 — Intangible Assets

The changes in the carrying amounts of goodwill by segment were as follows:

	RJR Tobacco			American Snuff			Santa Fe		All Other		Consolidated
Balance as of December 31, 2008
Goodwill	$	9,065		$	2,650		$	197	$	27	$	11,939
Less: Accumulated impairment charges		(3,763	)		(2	)		—		—		(3,765	)
Net goodwill balance as of December 31, 2008		5,302			2,648			197		27		8,174
2009 Activity
Acquisition of Niconovum AB		—			—			—		11		11
Balance as of December 31, 2009
Goodwill		9,065			2,650			197		38		11,950
Less: Accumulated impairment charges		(3,763	)		(2	)		—		—		(3,765	)
Net goodwill balance as of December 31, 2009		5,302			2,648			197		38		8,185
2010 Activity
Reclassified as held for sale	$	—		$	(149	)	$	—	$	—	$	(149	)
Impairment charge		—			(26	)		—		—		(26	)
		—			(175	)		—		—		(175	)
Balance as of December 31, 2010 and 2011
Goodwill		9,065			2,501			197		38		11,801
Less: Accumulated impairment charges		(3,763	)		(28	)		—		—		(3,791	)
Net goodwill balance as of December 31, 2010 and 2011	$	5,302		$	2,473		$	197	$	38	$	8,010

The changes in the carrying amounts of indefinite-lived intangible assets by segment not subject to amortization were as follows:

	RJR Tobacco					American Snuff			Santa Fe		All Other			Consolidated
	Trademarks			Other		Trademarks			Trademarks		Other			Trademarks			Other
Balance as of December 31, 2008	$	1,653		$	55	$	1,222		$	155	$	48		$	3,030		$	103
Impairment charge		(490	)		—		(70	)		—		—			(560	)		—
Intersegment transfer		—			44		—			—		(44	)		—			—
Acquisition of Niconovum AB		—			—		—			—		43			—			43
Balance as of December 31, 2009	$	1,163		$	99	$	1,152		$	155	$	47		$	2,470		$	146
Impairment charge		—			—		(6	)		—		—			(6	)		—
Foreign currency translation		—			—		—			—		3			—			3
Reclassified as held for sale		(11	)		—		(3	)		—		—			(14	)		—
Reclassified to finite-lived		—			—		(7	)		—		—			(7	)		—
Balance as of December 31, 2010	$	1,152		$	99	$	1,136		$	155	$	50		$	2,443		$	149
Impairment charge		(43	)		—		—			—		—			(43	)		—
Foreign currency translation		—			—		—			—		(1	)		—			(1	)
Balance as of December 31, 2011	$	1,109		$	99	$	1,136		$	155	$	49		$	2,400		$	148

The changes in the carrying amounts of finite-lived intangible assets by segment subject to amortization were as follows:

	RJR Tobacco						American Snuff			Consolidated
	Trademarks			Other			Trademarks			Trademarks			Other
Balance as of December 31, 2008	$	33		$	84		$	20		$	53		$	84
Amortization		(12	)		(15	)		(1	)		(13	)		(15	)
Impairment charge		(1	)		—			(6	)		(7	)		—
Balance as of December 31, 2009		20			69			13			33			69
Amortization		(9	)		(15	)		(1	)		(10	)		(15	)
Reclassified as held for sale		—			—			(1	)		(1	)		—
Reclassified from indefinite-lived		—			—			7			7			—
Balance as of December 31, 2010		11			54			18			29			54
Amortization		(7	)		(15	)		(2	)		(9	)		(15	)
Impairment charge		—			—			(5	)		(5	)		—
Balance as of December 31, 2011	$	4		$	39		$	11		$	15		$	39

Details of intangible assets as of December 31, 2011, were as follows:

	Gross		Accumulated Amortization		Net
Finite-lived:
Contract manufacturing agreements	$	151	$	112	$	39
Trademarks		96		81		15
Indefinite-lived		3,051		503		2,548
	$	3,298	$	696	$	2,602

The estimated remaining amortization associated with finite-lived intangible assets is expected to be expensed as follows:

Year	Amount
2012	$	21
2013		16
2014		10
2015		1
2016		1
Thereafter		5
	$	54

The impairment testing of trademarks in the fourth quarters of 2011 and 2010 assumed an increased rate of decline in projected net sales of certain brands, compared with that assumed in the prior year strategic plan. As a result, during 2011, impairment was indicated primarily on RJR Tobacco’s DORAL brand and several loose leaf brands at American Snuff. During 2010, American Snuff recorded a trademark impairment charge on one loose leaf brand, and reclassified the trademark as finite-lived.

The annual impairment testing of trademarks in 2009 included modification to the previously anticipated level of support among certain brands, and an increased rate of decline in projected net sales of certain brands, compared with that assumed in the prior year strategic plan. Also, in 2009, an increase of $0.62 in the federal excise tax per pack of cigarettes, as well as significant tax increases on other tobacco products, were expected to adversely impact the net sales of RAI’s operating subsidiaries. The federal excise tax increase was considered a triggering event requiring the testing for impairment of the carrying value of trademarks and goodwill during the first quarter of 2009.

The analysis of the fair value of trademarks was based on estimates of fair value on an income approach using a discounted cash flow valuation model under a relief from royalty methodology. The relief from royalty model includes the estimates of the royalty rate that a market participant might assume, projected revenues and judgment regarding the 10.50% discount rate applied to those estimated cash flows. The determination of the discount rate was based on a cost of equity model, using a risk-free rate, adjusted by a stock beta-adjusted risk premium and a size premium.

As a result of these analyses, RJR Tobacco and American Snuff recorded trademark impairment charges based on the excess of certain brands’ carrying values over their estimated fair values. These trademark impairment charges are reflected as decreases in the carrying value of the trademarks in the consolidated balance sheets as of December 31, 2011 and 2010, as trademark impairment charges in the consolidated statements of income for the years ended December 31, 2011, 2010 and 2009, and had no impact on cash flows. In addition, certain brands indicated that a finite life was probable. As a result, these brands are being amortized over their remaining lives, which range from 1 to 17 years, consistent with the pattern of economic benefits estimated to be received.

For the annual impairment testing of the goodwill of RAI’s reporting units, each reporting unit’s estimated fair value was compared with its carrying value. A reporting unit is an operating segment or one level below an operating segment. The determination of estimated fair value of each reporting unit was calculated primarily utilizing an income approach model, based on the present value of the estimated future cash flows of the reporting unit assuming a discount rate of 10.25% for each of RJR Tobacco and American Snuff and 11% for Santa Fe. The determination of the discount rate was based on a weighted average cost of capital. Additionally, the aggregate estimated fair value of the reporting units, determined with the use of the income approach model, was compared with RAI’s market capitalization. The estimated fair value of each reporting unit was substantially greater than its respective carrying value.

In connection with management’s decision, in the fourth quarter of 2011, to report the domestic operations and results of Santa Fe, the goodwill of Santa Fe was allocated based on a relative fair value between domestic and international operations, and reported under Santa Fe and All Other, respectively.

During 2010, RAI determined that it was probable that it would dispose of the operations of Lane, which were included in the American Snuff segment. In accordance with accounting guidance, the assets of the disposal group were reclassified as assets held for sale, and liabilities held for sale were included in other current liabilities, in the consolidated balance sheet at December 31, 2010.

In connection with this determination, the goodwill of American Snuff was allocated between the disposal group and the retained operations based on relative fair values, and the resulting goodwill was tested for impairment in the same manner as annual testing described above. Because the fair value of the disposal group was less than its carrying value, an associated goodwill impairment charge was recorded by American Snuff in 2010. This charge was reflected as a decrease in the carrying value of goodwill in the consolidated balance sheet as of December 31, 2010, as goodwill impairment charge in the consolidated statement of income for the year ended December 31, 2010 and had no impact on cash flows.

XML

Fair Value Measurement

12 Months Ended

Dec. 31, 2011

Fair Value Measurement [Abstract]

Fair Value Measurement

Note 2 — Fair Value Measurement

Fair Value of Financial Assets and Liabilities

Financial assets carried at fair value as of December 31, 2011, were as follows:

	Level 1		Level 2		Level 3		Total
Cash and cash equivalents:
Cash equivalents	$	1,473	$	—	$	—	$	1,473
Other assets and deferred charges:
Auction rate securities		—		—		63		63
Mortgage-backed security		—		—		12		12
Marketable equity security		5		—		—		5
Assets held in grantor trusts		1		—		—		1

Financial assets (liabilities) carried at fair value as of December 31, 2010, were as follows:

	Level 1		Level 2			Level 3		Total
Cash and cash equivalents:
Cash equivalents	$	2,136	$	—		$	—	$	2,136
Other assets and deferred charges:
Auction rate securities		—		—			61		61
Mortgage-backed security		—		—			14		14
Marketable equity security		24		—			—		24
Assets held in grantor trusts		12		—			—		12
Interest rate swaps — fixed to floating rate		—		227			—		227
Other noncurrent liabilities:
Interest rate swaps — floating to fixed rate		—		(22	)		—		(22	)

There were no changes among the levels during the years ended December 31, 2011 and 2010.

RAI has investments in auction rate securities linked to corporate credit risk, investments in auction rate securities related to financial insurance companies, an investment in a mortgage-backed security and an investment in a marketable equity security. The unrealized gains and losses, net of tax, were included in other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2011 and 2010. The realized losses were recorded in other expense, net in RAI’s consolidated statement of income for the years ended December 31, 2011, 2010 and 2009. The funds associated with the auction rate securities will not be accessible until a successful auction occurs or a buyer is found.

RAI reviews these investments on a quarterly basis to determine if it is probable that RAI will realize some portion of the unrealized loss and to determine the classification of the impairment as temporary or other-than-temporary. RAI recognizes the credit loss component of an other-than-temporary impairment of its debt securities in earnings and the noncredit component in other comprehensive loss for those securities in which RAI does not intend to sell and it is more likely than not that RAI will not be required to sell the securities prior to recovery.

In determining if the difference between amortized cost and estimated fair value of the auction rate securities or the mortgage-backed security was deemed either temporary or other-than-temporary impairment, RAI evaluated each type of long-term investment using a set of criteria, including decline in value, duration of the decline, period until anticipated recovery, nature of investment, probability of recovery, financial condition and near-term prospects of the issuer, RAI’s intent and ability to retain the investment, attributes of the decline in value, status with rating agencies, status of principal and interest payments and any other issues related to the underlying securities. To assess credit losses, RAI uses historical default rates, debt ratings, credit default swap spreads and recovery rates. RAI has the intent and ability to hold these investments for a period of time sufficient to allow for the recovery in market value.

The fair value of the auction rate securities, composed of securities of certain financial insurance companies or linked to the longer-term credit risk of a diverse range of corporations, including, but not limited to, manufacturing, financial and insurance sectors, classified as Level 3, utilized an income approach model and was based upon the weighted average present value of future cash payments, given the probability of certain events occurring within the market. RAI considers the market for its auction rate securities to be inactive. The income approach model utilized observable inputs, including LIBOR-based interest rate curves, corporate credit spreads and corporate ratings/market valuations. Additionally, unobservable factors incorporated into the model included default probability assumptions, recovery potential and how these factors changed as ratings on the underlying collateral migrated from one level to another. Maturity dates for the auction rate securities begin in 2017.

The fair value for the mortgage-backed security, classified as Level 3, utilized a market approach and was based upon the calculation of an overall weighted average valuation, derived from the actual, or modeled, market pricing of the specific collateral. The market approach utilized actual pricing inputs when observable and modeled pricing when unobservable. RAI has deemed the market for its mortgage-backed security to be inactive. The maturity of the mortgage-backed security has been extended to March 2012, with the annual option to extend an additional year. Given the underlying collateral and RAI’s intent to continue to extend this security, it is classified as a noncurrent asset.

RAI determined the change in the fair value of the investment in a marketable equity security using quoted market prices as of December 31.

Financial assets classified as Level 3 investments were as follows:

	December 31, 2011							December 31, 2010
	Cost		Gross Unrealized Loss(1)			Estimated Fair  Value		Cost		Gross Unrealized Loss(1)			Estimated Fair  Value
Auction rate securities	$	99	$	(36	)	$	63	$	99	$	(38	)	$	61
Mortgage-backed security		25		(13	)		12		27		(13	)		14
	$	124	$	(49	)	$	75	$	126	$	(51	)	$	75

⁽¹⁾  Unrealized losses, net of tax, are reported in accumulated other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2011 and 2010.

The changes in the Level 3 investments as of December 31, 2011, were as follows:

	Auction Rate Securities
	Cost		Gross (Loss)  Gain			Estimated Fair  Value
Balance as of January 1, 2011	$	99	$	(38	)	$	61
Unrealized gains		—		2			2
Balance as of December 31, 2011	$	99	$	(36	)	$	63

	Mortgage-Backed Security
	Cost			Gross Loss			Estimated Fair  Value
Balance as of January 1, 2011	$	27		$	(13	)	$	14
Redemptions		(2	)		—			(2	)
Balance as of December 31, 2011	$	25		$	(13	)	$	12

During 2010, the fair value of the interest rate swaps, classified as Level 2, utilized a market approach model using the notional amount of the interest rate swap multiplied by the observable inputs of time to maturity, interest rates and credit spreads.

Fair Value of Nonfinancial Assets

The fair value of the trademarks measured on a nonrecurring basis, classified as Level 3, represent certain trademarks, for which impairment during the fourth quarter of 2011 reduced their book value to fair value. The fair value determinations utilized an income approach model and were based on a discounted cash flow valuation model under a relief from royalty methodology. This approach utilized unobservable factors, such as royalty rate, projected revenues and a discount rate, applied to the estimated cash flows. The determination of the discount rate was based on a cost of equity model, using a risk-free rate, adjusted by a stock beta-adjusted risk premium and a size premium.

Nonfinancial assets measured at fair value on a nonrecurring basis were as follows:

	Level 1		Level 2		Level 3		Total		Total Loss
Trademarks, November 30, 2011	$	—	$	—	$	81	$	81	$	(48	)

Fair Value of Debt

The estimated fair value of RAI’s and RJR’s outstanding long-term notes in the aggregate, was $4.0 billion and $4.3 billion with an effective average annual interest rate of approximately 5.9% and 5.4%, as of December 31, 2011 and 2010, respectively. The fair values are based on available market quotes, credit spreads and discounted cash flows.

Interest Rate Management

From time to time, RAI and RJR use interest rate swaps to manage interest rate risk on a portion of their respective debt obligations. Historically, the interest rate swap agreements were derivative instruments that qualified for hedge accounting. RAI and RJR assess at the inception of the hedge whether the hedging derivatives are highly effective in offsetting changes in fair value of the hedged item. Ineffectiveness results when changes in the market value of the hedged debt are not completely offset by changes in the market value of the interest rate swap. As detailed below, at December 31, 2010, RAI and RJR had no derivative instruments designated as hedges, and at December 31, 2011, had no derivative instruments.

On January 6, 2009, the fair value of RAI’s and RJR’s fixed to floating interest rate swaps, designated as hedges, was $258 million. RAI and RJR locked in the value of these swaps by entering into offsetting floating to fixed interest rate swap agreements in the notional amount of $1.5 billion with maturity dates ranging from June 1, 2012 to June 15, 2017. The floating to fixed interest rate swaps were entered into with the same financial institution that holds a notional amount of $1.5 billion of fixed to floating interest rate swaps and have a legal right of offset. The future cash flows, established as a result of entering into the January 6, 2009, floating to fixed interest rate swaps, total $321 million, and are being amortized and effectively reduce net interest costs over the remaining life of the notes. Concurrent with entering the floating to fixed interest rate swap agreements on January 6, 2009, which were not designated as hedging instruments, RAI and RJR removed the designation of fair value hedge from the fixed to floating interest rate swaps.

On January 7, 2009, RAI and RJR terminated an interest rate swap agreement in the notional amount of $100 million with a maturity date of June 1, 2012. The resulting gain of approximately $12 million is being amortized to effectively reduce interest expense over the remaining life of the notes. The unamortized portion of this gain as well as the locked in value of the interest rate swaps on January 6, 2009, totaling $159 million and $198 million as of December 31, 2011 and 2010, respectively, were included in long-term debt (less current maturities) in the consolidated balance sheets.

As a result of these actions, RAI and RJR have economically decreased the fixed rate on $1.6 billion of debt to a fixed rate of interest of approximately 4.0%.

During September 2011, RAI and RJR terminated the original and offsetting interest rate swap agreements, each with a notional amount of $1.5 billion and maturity dates ranging from June 1, 2012 to June 15, 2017. RAI and RJR received a total of $186 million cash in exchange for foregoing the future cash inflows associated with these swaps. These actions did not change the effective fixed rate of interest associated with the underlying debt. As of December 31, 2011, RAI and RJR had no outstanding interest rate swaps.

Interest rate swaps impacted the consolidated statements of income for the years ended December 31 as follows:

	2011			2010			2009
Interest and debt expense (income)	$	(47	)	$	(48	)	$	(47	)
Other expense (income), net		4			(3	)		(9	)

XML

Shareholders' Equity

12 Months Ended

Dec. 31, 2011

Shareholders' Equity [Abstract]

Shareholders' Equity

Note 14 — Shareholders’ Equity

RAI’s authorized capital stock at December 31, 2011 and 2010, consisted of 100 million shares of preferred stock, par value $.01 per share, and 1.6 billion shares of common stock, par value $.0001 per share. Four million shares of the preferred stock are designated as Series A Junior Participating Preferred Stock, none of which is issued or outstanding. The Series A Junior Participating Preferred Stock will rank junior as to dividends and upon liquidation to all other series of RAI preferred stock, unless specified otherwise. Also, of the preferred stock, one million shares are designated as Series B Preferred Stock, all of which are issued and outstanding. The Series B Preferred Stock ranks senior upon liquidation, but not with respect to dividends, to all other series of RAI capital stock, unless specified otherwise. As a part of the B&W business combination, RJR is the holder of the outstanding Series B Preferred Stock. In each of 2011, 2010 and 2009, RAI declared $43 million in dividends to RJR with respect to the Series B Preferred Stock.

In 2004, RAI’s board of directors adopted a shareholder rights plan, pursuant to which RAI declared a dividend of one preferred stock purchase right on each share of RAI common stock outstanding on July 30, 2004. The board also authorized the issuance of rights for each share of RAI common stock issued after the dividend record date, until the occurrence of certain specified events. By virtue of RAI’s two-for-one stock split in both 2006 and 2010, the number of rights associated with each share of RAI common stock is .25. The rights will expire on July 30, 2014, unless earlier redeemed, exercised or exchanged under the terms of the rights plan.

The rights are not exercisable until a distribution date that is the earlier of:

• ten days following an announcement that a person or group, other than BAT and its subsidiaries, except in certain circumstances, has acquired beneficial ownership of at least 15% of RAI common stock, and

• ten business days, or such later date as may be determined by the board, following the announcement of a tender offer which would result in a person becoming an acquiring person.

If the acquiring person or tender offeror is BAT or one of its subsidiaries, then the foregoing 15% threshold is subject to adjustment. The rights are initially exercisable for 1/100th of a share of RAI’s Series A Junior Participating Preferred Stock at a purchase price of $130, subject to adjustment. Each fractional share of such preferred stock would give the holder approximately the same dividend, voting and liquidation rights as does one share of RAI common stock. Until the distribution date, the rights will be evidenced by RAI common stock certificates and trade with such shares. Upon the occurrence of certain events after the distribution date, holders of rights, other than the acquiring person, will be entitled to receive upon exercise of the right, in lieu of shares of preferred stock, RAI common stock or common stock of the acquiring corporation having in either case a market value of two times the exercise price of the right.

RAI’s board of directors declared the following quarterly cash dividends per share of RAI common stock in 2011, 2010 and 2009:

	2011		2010		2009
First	$	0.53	$	0.45	$	0.425
Second	$	0.53	$	0.45	$	0.425
Third	$	0.53	$	0.45	$	0.425
Fourth	$	0.56	$	0.49	$	0.450

On November 14, 2011, the board of directors of RAI authorized the repurchase, from time to time on or before mid-2014, of up to $2.5 billion of outstanding shares of RAI common stock in open-market or privately negotiated transactions. The repurchases are subject to prevailing market and business conditions, and the program may be terminated or suspended at any time. In connection with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI’s common stock. RAI, B&W and BAT also entered into Amendment No. 3 to the governance agreement, pursuant to which RAI has agreed that, so long as B&W’s ownership interest has not dropped below 25%, if RAI issues shares of its common stock or any other RAI equity security to certain designated persons, including its directors, officers or employees, then RAI will repurchase a number of shares of outstanding RAI common stock so that the number of outstanding shares of RAI common stock are not increased, and B&W’s ownership interest is not decreased, by such issuance after taking into account such repurchase. In addition, RAI repurchases shares of its common stock forfeited with respect to the tax liability associated with certain stock option exercises and vesting of restricted stock grants under the RAI Long-Term Incentive Plan, referred to as the LTIP.

Due to RAI’s incorporation in North Carolina, which does not recognize treasury shares, the shares repurchased are cancelled at the time of repurchase. As of December 31, 2011, RAI had repurchased and cancelled 6,776,637 shares of RAI common stock for $276 million under the above share repurchase program.

Additionally, during 2011, at a cost of $6 million, RAI purchased 162,257 shares that were forfeited with respect to tax liabilities associated with restricted stock vesting under its LTIP.

Changes in RAI common stock outstanding were as follows:

	2011			2010			2009
Shares outstanding at beginning of year		583,043,872			582,848,102			582,901,524
LTIP shares forfeited		(433	)		(7,501	)		(55,420	)
LTIP tax shares repurchased and cancelled		(162,257	)		(185,257	)		(308,882	)
Shares repurchased and cancelled		(6,776,637	)		—			—
Stock options exercised		—			362,284			245,280
Equity incentive award plan shares issued		30,654			26,244			65,600
Shares outstanding at end of year		576,135,199			583,043,872			582,848,102

XML

Income Taxes

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Income Taxes

Note 10 — Income Taxes

The components of the provision for income taxes from continuing operations for the years ended December 31 were as follows:

	2011		2010		2009
Current:
Federal	$	572	$	545	$	592
State and other		108		136		134
		680		681		726
Deferred:
Federal		80		160		(154	)
State and other		20		27		(5	)
		100		187		(159	)
	$	780	$	868	$	567

Significant components of deferred tax assets and liabilities for the years ended December 31 included the following:

	2011			2010
Deferred tax assets:
Pension and other postretirement liabilities	$	707		$	714
Tobacco settlement accruals		1,006			1,031
Other accrued liabilities		81			70
Other noncurrent liabilities		154			141
Subtotal		1,948			1,956
Less: valuation allowance		(33	)		—
		1,915			1,956
Deferred tax liabilities:
LIFO inventories		(162	)		(200	)
Property and equipment		(239	)		(218	)
Trademarks and other intangibles		(950	)		(978	)
Other		(130	)		(132	)
		(1,481	)		(1,528	)
Net deferred tax asset	$	434		$	428

The current and noncurrent components of deferred tax assets and liabilities for the years ended December 31 were as follows:

	2011			2010
Current deferred tax assets	$	945		$	946
Noncurrent deferred tax liabilities		(511	)		(518	)
	$	434		$	428

At December 31, 2011, RAI had a $95 million federal capital loss carryforward resulting from the February 28, 2011, sale of Lane. The federal capital loss carryforward expires in 2016 and can be utilized only to the extent net capital gains are generated during the carryforward period.

In 2011, a $33 million valuation allowance was established to fully offset a deferred tax asset related to the federal capital loss carryforward. RAI believes it is unlikely that this deferred tax asset will be realized through the expected generation of future net capital gains. No valuation allowance was established on other deferred tax assets as of the year ended December 31, 2011 or 2010, as RAI believes it is more likely than not that all of such deferred tax assets will be realized through the expected generation of future taxable income.

Pre-tax income for domestic and foreign operations for the years ended December 31 consisted of the following:

	2011		2010		2009
Domestic (includes U.S. exports)	$	2,157	$	2,204	$	1,495
Foreign		29		1		27
	$	2,186	$	2,205	$	1,522

The differences between the provision for income taxes from continuing operations and income taxes computed at statutory U.S. federal income tax rates for the years ended December 31 were as follows:

	2011			2010			2009
Income taxes computed at statutory U.S. federal income tax rates	$	765		$	771		$	533
State and local income taxes, net of federal tax benefits		96			101			80
Domestic manufacturing deduction		(60	)		(54	)		(41	)
Other items, net		(21	)		50			(5	)
Provision for income taxes from continuing operations	$	780		$	868		$	567
Effective tax rate		35.7	%		39.4	%		37.3	%

The effective tax rate for 2011 was favorably impacted by a $22 million decrease in tax attributable to the reversal of tax reserves and interest on a state statute expiration. The effective tax rate for 2010 was unfavorably impacted by a $27 million increase in tax attributable to the Patient Protection and Affordable Care Act of 2010 and the Health Care and Education Reconciliation Act of 2010. The effective tax rate for 2009 was unfavorably impacted by increases in unrecognized income tax benefits and increases in tax attributable to accumulated and undistributed foreign earnings.

At December 31, 2011, there were $445 million of accumulated and undistributed foreign earnings. Of this amount, RAI has invested $68 million and has plans to invest $15 million overseas. RAI has recorded deferred income taxes of $129 million on the $362 million of accumulated earnings in excess of its historical and planned overseas investments.

The deferred tax benefits included in accumulated other comprehensive loss were $268 million for retirement benefits and $19 million for unrealized losses on long-term investments as of December 31, 2011, and were $173 million for retirement benefits and $13 million for unrealized losses on long-term investments as of December 31, 2010.

The gross accruals for unrecognized income tax benefits, including interest and penalties, reflected in other noncurrent liabilities were $165 million and $193 million at December 31, 2011 and 2010, respectively. RAI accrues interest and penalties related to accruals for income taxes and reflects these amounts in income tax expense. The gross amount of interest accrued at December 31, 2011 and 2010, was $28 million and $57 million, respectively. The gross amount of penalties accrued at December 31, 2011 and 2010 was $10 million and $9 million, respectively.

A reconciliation of the unrecognized gross tax benefits is as follows:

	2011			2010			2009
Balance at beginning of year	$	127		$	94		$	97
Gross increases related to current period tax positions		6			37			6
Gross increases related to tax positions in prior periods		1			4			3
Gross decreases related to tax positions in prior periods		(1	)		(1	)		(4	)
Gross increases (decreases) related to audit settlements		1			(4	)		(3	)
Gross decreases related to lapse of applicable statute of limitations		(6	)		(3	)		(5	)
Balance at end of year	$	128		$	127		$	94

At December 31, 2011, $110 million of unrecognized tax benefits including interest and penalties, if recognized, would decrease RAI’s effective tax rate.

RAI and its subsidiaries are subject to income taxes in the United States, certain foreign jurisdictions and multiple state jurisdictions. A number of years may elapse before a particular matter, for which RAI has established an accrual, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. RAI’s major taxing jurisdictions and related open tax audits are discussed below.

RAI filed a federal consolidated income tax return for the years through 2010. The statute of limitations remains open for the years 2007 through 2010. There are no IRS examinations scheduled at this time for these open years.

In 2007, the State of North Carolina completed its examination of RJR Tobacco for years 2000 through 2002 and issued a total assessment of $37 million. The state concluded that the returns filed by RJR Tobacco did not reflect the company’s true net earnings as defined by North Carolina statutes. RJR Tobacco filed a protest in January 2008. RJR Tobacco will continue to work with North Carolina to resolve issues identified and assessed for years 2000 through 2002. In the event a complete resolution of this audit is reached during the next 12 months, RJR Tobacco could recognize additional expense of up to $12 million, inclusive of tax, interest, net of federal benefit, and penalties.

XML

Shareholders' Equity (Details Textual) (USD $)	1 Months Ended	12 Months Ended
	Nov. 30, 2011	Dec. 31, 2011 Right Stock	Dec. 31, 2010	Dec. 31, 2009
Authorized preferred stock, shares		100,000,000	100,000,000
Shareholders Equity (Textual) [Abstract]
Authorized preferred stock, par value		$ 0.01	$ 0.01
Authorized common stock, shares		1,600,000,000	1,600,000,000
Authorized common stock, par value		$ 0.0001	$ 0.0001
Dividends declared with respect to Series B Preferred Stock		$ 43,000,000	$ 43,000,000	$ 43,000,000
Declaration of Dividend		1
Stock split		two-for-one stock split
Number of rights associated with each share of common stock		0.25
Number of times of exercise price right holder entitled to receive common stock		2
Distribution date		10 days
Acquired minimum beneficial ownership of RAI common stock for rights exercisable		15.00%
Rights exercisable for RAI's series A Junior participating preferred stock at purchase price		130
Share of RAIs Series A Junior rights exercisable		0.01
Outstanding shares of RAI common stock		2,500,000,000
Ownership percentage of RAI's common stock	42.00%	42.00%
Shares repurchased and cancelled		6,776,637
Common stock repurchased		(282,000,000)	(5,000,000)	(5,000,000)
Cost of shares purchased that forfeited with respect to tax liabilities associated with restricted stock vesting		$ 6,000,000
Number of shares purchased that forfeited with respect to tax liabilities associated with restricted stock vesting under its LTIP		162,257	185,257	308,882
Series A Preferred Stock [Member]
Authorized preferred stock, shares		4,000,000
Preferred stock, issued shares
Preferred stock, outstanding shares
Series B Preferred Stock [Member
Authorized preferred stock, shares		1,000,000
Preferred stock, issued shares		1,000,000
Preferred stock, outstanding shares		1,000,000

XML

Discontinued Operations

12 Months Ended

Dec. 31, 2011

Discontinued Operations [Abstract]

Discontinued Operations

Note 6 — Discontinued Operations

In 1999, RJR and RJR Tobacco sold the international tobacco business to an affiliate of Japan Tobacco Inc., referred to as JTI. Northern Brands International, Inc., referred to as Northern Brands, was part of the international business of R.J. Reynolds International B.V., a former Netherlands subsidiary of RJR Tobacco, which was managed by RJR-Macdonald, Inc., referred to as RJR-MI. Northern Brands ceased being an operating company in 1997 and has been an inactive subsidiary of RJR since that time.

Effective April 13, 2010, RJR Tobacco entered into a comprehensive agreement with the Canadian federal, provincial and territorial governments, referred to as the Comprehensive Agreement, resolving a variety of civil claims related to cigarette smuggling in Canada during the period from 1985 through 1999. The Comprehensive Agreement covers all civil claims related to the movement of contraband tobacco products in Canada during the period 1985 through 1999 that the governments have asserted or could assert against RJR Tobacco and its affiliates. On April 13, 2010, RJR Tobacco paid the governments a total of CAD $325 million to bring this complex, lengthy and costly litigation to an end.

Separately, on April 13, 2010, Northern Brands entered into a plea agreement with the Ministry of the Attorney General of Ontario. Under the terms of this agreement, Northern Brands pled guilty to a one count violation of the Canadian Criminal Code for conspiring to aid other persons to sell and be in possession of tobacco products that were not packaged and stamped in conformity with the Canadian Excise Act during the period February 18, 1993 through December 31, 1996. The Judge of the Ontario Court of Justice accepted the plea by Northern Brands and required it to pay a fine of CAD $75 million, which was paid on April 13, 2010. By this plea, the criminal charges that were originally commenced against Northern Brands and certain of its affiliates in 2003 and any other charges that could be commenced against Northern Brands and its affiliates by the Canadian governments relating to contraband tobacco activities have now come to an end.

In addition to the $91 million liability previously accrued by RJR, an adjustment to reflect the impact of the separate RJR Tobacco settlement to resolve civil claims and the separate Northern Brands plea agreement, in the aggregate of $307 million, or $216 million after tax, was recorded during the first quarter of 2010.

This accrual adjustment was included in losses from discontinued operations in the consolidated statement of income for the year ended December 31, 2010. Of the aggregate accrual adjustments of $307 million, $303 million, or $213 million after tax, is classified as a loss on discontinued operations, and $4 million, or $3 million after tax, is classified as a loss on the sale of discontinued operations. The payments by RJR Tobacco of $324 million, offset by a realized tax benefit of $91 million, and by Northern Brands of $74 million have been included as net cash flows related to discontinued operations, net of tax benefit, in the consolidated statement of cash flows for the year ended December 31, 2010.

XML

Intangible Assets (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended							12 Months Ended												12 Months Ended
	Dec. 31, 2010	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2011	Dec. 31, 2011 RJR Tobacco [Member]	Dec. 31, 2010 RJR Tobacco [Member]	Dec. 31, 2009 RJR Tobacco [Member]	Dec. 31, 2008 RJR Tobacco [Member]	Dec. 31, 2011 American Snuff [Member]	Dec. 31, 2010 American Snuff [Member]	Dec. 31, 2009 American Snuff [Member]	Dec. 31, 2008 American Snuff [Member]	Dec. 31, 2011 Santa Fe [Member]	Dec. 31, 2010 Santa Fe [Member]	Dec. 31, 2009 Santa Fe [Member]	Dec. 31, 2008 Santa Fe [Member]	Dec. 31, 2011 All Other [Member]	Dec. 31, 2010 All Other [Member]	Dec. 31, 2009 All Other [Member]	Dec. 31, 2008 All Other [Member]	Dec. 31, 2011 Consolidated [Member]	Dec. 31, 2010 Consolidated [Member]	Dec. 31, 2009 Consolidated [Member]	Dec. 31, 2008 Consolidated [Member]
Changes in Carrying Amounts of Goodwill by Segment
Goodwill					$ 9,065	$ 9,065	$ 9,065	$ 9,065	$ 2,501	$ 2,501	$ 2,650	$ 2,650	$ 197	$ 197	$ 197	$ 197	$ 38	$ 38	$ 38	$ 27	$ 11,801	$ 11,801	$ 11,950	$ 11,939
Less: Accumulated impairment losses	0	0			(3,763)	(3,763)	(3,763)	(3,763)	(28)	(28)	(2)	(2)	0	0	0	0	0		0	0	(3,791)	(3,791)	(3,765)	(3,765)
Acquisition of Niconovum AB			11																				11
Reclassified as held for sale									(149)												(149)
Impairment charge	26	26							(26)												(26)
Gross										(175)												(175)
Net goodwill balance	$ 8,010	$ 8,010		$ 8,010	$ 5,302	$ 5,302	$ 5,302	$ 5,302	$ 2,473	$ 2,473	$ 2,648	$ 2,648	$ 197	$ 197	$ 197	$ 197	$ 38	$ 38	$ 38	$ 27	$ 8,010	$ 8,010	$ 8,185	$ 8,174

XML

RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Condensed Consolidating Statements of Income
Net sales									$ 8,062	[1]	$ 8,170	[1]	$ 8,015	[1]
Net sales, related party									479		381		404
Net sales	2,083	2,200	2,267	1,991	2,081	2,239	2,245	1,986	8,541		8,551		8,419
Cost of products sold									4,464	[1]	4,544	[1]	4,488	[1]
Selling, general and administrative expenses									1,606		1,480		1,517
Amortization expense									24		25		28
Asset impairment and exit charges											38		56
Trademark impairment charges	48				6				48		6		567
Goodwill impairment charge					26						26
Restructuring charge													56
Operating income (loss)									2,399		2,432		1,763
Interest and debt expense									221		232		251
Interest income									(11)		(12)		(19)
Other expense, net									3		7		9
Income from continuing operations before income taxes									2,186		2,205		1,522
Provision for (benefit from) income taxes									780		868		567
Income from continuing operations									1,406		1,337		955
Losses from discontinued operations, net of tax								(216)			(216)
Net income (loss)	304	394	327	381	262	400	359	100	1,406		1,121		955
RAI [Member]
Condensed Consolidating Statements of Income
Selling, general and administrative expenses									129		20		20
Operating income (loss)									(129)		(20)		(20)
Interest and debt expense									213		223		242
Interest income									(118)		(119)		(115)
Other expense, net									8		2		(4)
Income from continuing operations before income taxes									(232)		(126)		(143)
Provision for (benefit from) income taxes									(89)		(42)		(49)
Equity income (loss) from subsidiaries									1,549		1,205		1,049
Income from continuing operations											1,121
Net income (loss)									1,406		1,121		955
Guarantors [Member]
Condensed Consolidating Statements of Income
Net sales									7,971		8,118		7,985
Net sales, related party									479		381		404
Net sales									8,450		8,499		8,389
Cost of products sold									4,460		4,569		4,544
Selling, general and administrative expenses									1,386		1,380		1,425
Amortization expense									24		25		28
Asset impairment and exit charges											24
Trademark impairment charges									48		6		567
Goodwill impairment charge											26
Restructuring charge													56
Operating income (loss)									2,532		2,469		1,769
Interest and debt expense									125		127		123
Interest income									(4)		(4)		(9)
Other expense, net									(47)		(39)		(30)
Income from continuing operations before income taxes									2,458		2,385		1,685
Provision for (benefit from) income taxes									875		919		616
Equity income (loss) from subsidiaries									20		(68)		26
Income from continuing operations											1,398
Losses from discontinued operations, net of tax											(142)
Net income (loss)									1,603		1,256		1,095
Non-Guarantors [Member]
Condensed Consolidating Statements of Income
Net sales									116		147		162
Net sales									116		147		162
Cost of products sold									29		72		76
Selling, general and administrative expenses									91		81		72
Asset impairment and exit charges											14
Operating income (loss)									(4)		(20)		14
Interest and debt expense											1		1
Interest income									(6)		(8)		(10)
Other expense, net									(1)		1
Income from continuing operations before income taxes									3		(14)		23
Provision for (benefit from) income taxes									(6)		(10)
Income from continuing operations											(4)
Losses from discontinued operations, net of tax											(74)
Net income (loss)									9		(78)		23
Eliminations [Member]
Condensed Consolidating Statements of Income
Net sales									(25)		(95)		(132)
Net sales									(25)		(95)		(132)
Cost of products sold									(25)		(97)		(132)
Selling, general and administrative expenses											(1)
Operating income (loss)											3
Interest and debt expense									(117)		(119)		(115)
Interest income									117		119		115
Other expense, net									43		43		43
Income from continuing operations before income taxes									(43)		(40)		(43)
Provision for (benefit from) income taxes											1
Equity income (loss) from subsidiaries									(1,569)		(1,137)		(1,075)
Income from continuing operations											(1,178)
Net income (loss)									$ (1,612)		$ (1,178)		$ (1,118)

[1] Excludes excise taxes of $4,107 million, $4,340 million and $3,927 million for the years ended December 31, 2011, 2010 and 2009, respectively.

XML

Asset Impairment and Exit Charges

12 Months Ended

Dec. 31, 2011

Asset Impairment and Exit Charges [Abstract]

Asset Impairment and Exit Charges

Note 4 — Asset Impairment and Exit Charges

On May 28, 2010, RAI announced that its operating companies were taking steps to optimize cigarette-manufacturing efficiencies, while complying with new regulatory requirements. During 2010, RJR Tobacco announced plans to close the Whitaker Park cigarette manufacturing facility by mid-2011 which, due to additional demand, has been extended to early 2012, and a factory in Yabucoa, Puerto Rico has closed. Production from those facilities will be transferred to RJR Tobacco’s facility in Tobaccoville, North Carolina. As a result of these actions, approximately 60 manufacturing positions in Puerto Rico were eliminated, and affected employees received severance benefits. In connection with these actions, during 2010, RJR Tobacco recorded an asset impairment of $24 million, and $14 million was recorded in the All Other segment, primarily for asset impairment, and to a lesser extent, severance that was substantially paid during 2010.

XML

Restructuring Charges

12 Months Ended

Dec. 31, 2011

Restructuring Charges [Abstract]

Restructuring Charges

Note 5 — Restructuring Charges

2009 Restructuring Charge

In 2009, RJR Tobacco announced the elimination of approximately 400 full-time production positions substantially completed by December 31, 2010. The cash benefits were substantially paid by December 31, 2011.

2008 Restructuring Charge

In 2008, RAI and RJR Tobacco announced changes in their organizational structures to streamline non-core business processes and programs in order to allocate additional resources to strategic growth initiatives. The reorganizations resulted in the elimination of approximately 600 full-time jobs. The cash benefits were substantially paid by December 31, 2011.

The activity in the restructuring accruals, comprised of employee severance and related benefits, was as follows:

	2009 Restructuring Charge			2008 Restructuring Charge
Original accrual	$	—		$	91
Utilized in 2008		—			(12	)
Adjusted in 2008		—			(1	)
Balance as of December 31, 2008		—			78
Original accrual		56			—
Utilized in 2009		(8	)		(38	)
Balance as of December 31, 2009		48			40
Utilized in 2010		(22	)		(27	)
Balance as of December 31, 2010		26			13
Utilized in 2011		(24	)		(10	)
Balance as of December 31, 2011	$	2		$	3

The restructuring accruals were included in the consolidated balance sheet as of December 31, 2011 in other current liabilities.

XML

Income Per Share

12 Months Ended

Dec. 31, 2011

Income Per Share [Abstract]

Income Per Share

Note 7 — Income Per Share

The components of the calculation of income per share were as follows:

	For the Years Ended December 31,
	2011		2010			2009
Income from continuing operations	$	1,406	$	1,337		$	955
Losses from discontinued operations		—		(216	)		—
Net income	$	1,406	$	1,121		$	955
Basic weighted average shares, in thousands		582,320		582,996			582,761
Effect of dilutive potential shares:
Stock units		3,063		1,858			891
Diluted weighted average shares, in thousands		585,383		584,854			583,652

XML

Intangible Assets (Details 4) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Finite Lived Intangible Assets Future Amortization Expense
2012	$ 21
2013	16
2014	10
2015	1
2016	1
Thereafter	5
Net	$ 54

XML

Stock Plans (Details) (USD $)	12 Months Ended
	Dec. 31, 2011
Grant One [Member]
Information regarding stock-based awards outstanding
Number of Shares Granted	2,764,486
Grant Price	$ 16.550
Number of Shares Cancelled	448,475
Number of Shares Vested	0
Grant Two [Member]
Information regarding stock-based awards outstanding
Number of Shares Granted	1,980,166
Grant Price	26.620
Number of Shares Cancelled	353,655
Number of Shares Vested	0
Grant Three [Member]
Information regarding stock-based awards outstanding
Number of Shares Granted	8,422
Grant Price	27.655
Number of Shares Cancelled	5,704
Number of Shares Vested	0
Grant Four [Member]
Information regarding stock-based awards outstanding
Number of Shares Granted	2,758
Grant Price	29.425
Number of Shares Vested	0
Grant Five [Member]
Information regarding stock-based awards outstanding
Number of Shares Granted	1,561,331
Grant Price	33.990
Number of Shares Cancelled	102,474
Number of Shares Vested	0
Grant Six [Member]
Information regarding stock-based awards outstanding
Number of Shares Granted	3,874
Grant Price	$ 39.590
Number of Shares Vested	0

XML

Asset Impairment and Exit Charges (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2011 Person
Asset Impairment and Exit Charges (Textual) [Abstract]
Asset impairment and exit charges	$ 38	$ 56
Number of employees eliminated in plant closure			60
RJR Tobacco [Member]
Asset Impairment and Exit Charges (Textual) [Abstract]
Asset impairment and exit charges	24
Other Segments [Member]
Asset Impairment and Exit Charges (Textual) [Abstract]
Asset impairment and exit charges	$ 14

XML

Retirement Benefits (Details 9) (Fair Value, Inputs, Level 3 [Member], USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Transfers of pension and postretirement plan assets in and out of Level 3
Fair value of plan assets at beginning of year	$ 468	$ 464
Purchases, Sales, Issuances and Settlements (net)	7	(38)
Realized Gains (Losses)	62	34
Unrealized Gains (Losses)	(45)	8
Transferred From Other Levels(1)	2	0
Fair value of plan assets at end of year	494	468
Fixed Income [Member]
Transfers of pension and postretirement plan assets in and out of Level 3
Fair value of plan assets at beginning of year	55	96
Purchases, Sales, Issuances and Settlements (net)	(24)	(54)
Realized Gains (Losses)	11	18
Unrealized Gains (Losses)	(8)	(5)
Transferred From Other Levels(1)	2	0
Fair value of plan assets at end of year	36	55
Hedge Funds [Member]
Transfers of pension and postretirement plan assets in and out of Level 3
Fair value of plan assets at beginning of year	275	291
Purchases, Sales, Issuances and Settlements (net)	(19)	(33)
Realized Gains (Losses)	47	15
Unrealized Gains (Losses)	(54)	2
Transferred From Other Levels(1)		0
Fair value of plan assets at end of year	249	275
Private Equity [Member]
Transfers of pension and postretirement plan assets in and out of Level 3
Fair value of plan assets at beginning of year	45	43
Purchases, Sales, Issuances and Settlements (net)	(4)	(3)
Realized Gains (Losses)	4	1
Unrealized Gains (Losses)	1	4
Transferred From Other Levels(1)		0
Fair value of plan assets at end of year	46	45
Real Estate [Member]
Transfers of pension and postretirement plan assets in and out of Level 3
Fair value of plan assets at beginning of year	90	31
Purchases, Sales, Issuances and Settlements (net)	54	52
Realized Gains (Losses)	1
Unrealized Gains (Losses)	16	7
Transferred From Other Levels(1)		0
Fair value of plan assets at end of year	161	90
Other [Member]
Transfers of pension and postretirement plan assets in and out of Level 3
Fair value of plan assets at beginning of year	3	3
Realized Gains (Losses)	(1)
Transferred From Other Levels(1)		0
Fair value of plan assets at end of year	$ 2	$ 3

XML

Intangible Assets (Details 3) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Details of finite lived intangible assets
Gross	$ 3,298
Accumulated amortization	696	672
Net	2,602	2,675
Contractual Rights [Member]
Details of finite lived intangible assets
Gross	151
Accumulated amortization	112
Net	39
Trademarks [Member]
Details of finite lived intangible assets
Gross	96
Accumulated amortization	81
Net	15
Indefinite lived intangible assets [Member]
Details of finite lived intangible assets
Gross	3,051
Accumulated amortization	503
Net	$ 2,548

XML

Stock Plans (Details Textual) (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 Y	Dec. 31, 2010	Dec. 31, 2009
Stock Plans (Numeric) [Abstract]
Issuable common stock under Equity Incentive Award Plan	2,000,000
Shares available for grant under Equity Incentive Award Plan	1,112,305
Compensation expense related to Equity Incentive Award Plan	$ 5	$ 4	$ 3
Common shares issuable under Omnibus Plan	38,000,000
Restricted stock unit award adjustment upper end of range	150.00%
Cumulative dividend threshold	$ 6.36	$ 5.40	$ 5.10
Restricted stock unit award adjustment	50.00%
Payments related to stock-based compensation		19	16
Unrecognized compensation costs related to restricted stock units	$ 55,000,000
Weighted-average period of unrecognized compensation costs	1.83
Stock options granted under EIAP	40,000
Weighted average exercise price of stock options granted under EIAP	$ 17.45
Stock options granted under EIAP, remaining contractual term	0.4
Intrinsic value of options exercised		7	4
Intrinsic value of fully vested outstanding and exercisable options	$ 1

XML

Fair Value Measurement (Tables)

12 Months Ended

Dec. 31, 2011

Fair Value Measurement [Abstract]

Fair value of financial assets and liabilities

	Level 1		Level 2		Level 3		Total
Cash and cash equivalents:
Cash equivalents	$	1,473	$	—	$	—	$	1,473
Other assets and deferred charges:
Auction rate securities		—		—		63		63
Mortgage-backed security		—		—		12		12
Marketable equity security		5		—		—		5
Assets held in grantor trusts		1		—		—		1

	Level 1		Level 2			Level 3		Total
Cash and cash equivalents:
Cash equivalents	$	2,136	$	—		$	—	$	2,136
Other assets and deferred charges:
Auction rate securities		—		—			61		61
Mortgage-backed security		—		—			14		14
Marketable equity security		24		—			—		24
Assets held in grantor trusts		12		—			—		12
Interest rate swaps — fixed to floating rate		—		227			—		227
Other noncurrent liabilities:
Interest rate swaps — floating to fixed rate		—		(22	)		—		(22	)

Financial assets classified as level 3 Investments

	December 31, 2011							December 31, 2010
	Cost		Gross Unrealized Loss(1)			Estimated Fair  Value		Cost		Gross Unrealized Loss(1)			Estimated Fair  Value
Auction rate securities	$	99	$	(36	)	$	63	$	99	$	(38	)	$	61
Mortgage-backed security		25		(13	)		12		27		(13	)		14
	$	124	$	(49	)	$	75	$	126	$	(51	)	$	75

⁽¹⁾  Unrealized losses, net of tax, are reported in accumulated other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2011 and 2010.

Changes In Level 3 Investments

	Auction Rate Securities
	Cost		Gross (Loss)  Gain			Estimated Fair  Value
Balance as of January 1, 2011	$	99	$	(38	)	$	61
Unrealized gains		—		2			2
Balance as of December 31, 2011	$	99	$	(36	)	$	63

	Mortgage-Backed Security
	Cost			Gross Loss			Estimated Fair  Value
Balance as of January 1, 2011	$	27		$	(13	)	$	14
Redemptions		(2	)		—			(2	)
Balance as of December 31, 2011	$	25		$	(13	)	$	12

Intangible nonfinancial assets measured at fair value on nonrecurring basis

	Level 1		Level 2		Level 3		Total		Total Loss
Trademarks, November 30, 2011	$	—	$	—	$	81	$	81	$	(48	)

Impact of Interest rate swaps on Income Statement

Interest rate swaps impacted the consolidated statements of income for the years ended December 31 as follows:

	2011			2010			2009
Interest and debt expense (income)	$	(47	)	$	(48	)	$	(47	)
Other expense (income), net		4			(3	)		(9	)

XML

Business and Summary of Significant Accounting Policies (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Certain component of cost of products sold
State Settlement Agreements	$ 2,435	$ 2,496	$ 2,540
Federal tobacco quota buyout	229	243	240
FDA user fees	$ 120	$ 75	$ 22

XML

Long-Term Debt

12 Months Ended

Dec. 31, 2011

Borrowing Arrangements/Long-Term Debt [Abstract]

Long-Term Debt

Note 12 — Long-Term Debt

Long-term debt, net of discounts and including adjustments associated with interest rate swaps, as of December 31 consisted of the following:

	2011		2010
RJR debt:
9.25%, notes due 2013	$	60	$	60
7.25% guaranteed, notes due 2012		—		61
Total RJR debt		60		121
RAI debt:
6.75% guaranteed, notes due 2017		797		811
7.25% guaranteed, notes due 2012		—		412
7.25% guaranteed, notes due 2013		624		623
7.25% guaranteed, notes due 2037		448		448
7.3% guaranteed, notes due 2015		199		199
7.625% guaranteed, notes due 2016		829		838
7.75% guaranteed, notes due 2018		249		249
Total RAI debt		3,146		3,580
Total long-term debt (less current maturities)		3,206		3,701
Current maturities of long-term debt		457		400
	$	3,663	$	4,101

As of December 31, 2011, the maturities of RAI’s and RJR’s notes, net of discounts, were as follows:

Year	RAI		RJR		Total
2012	$	393	$	58	$	451
2013		624		60		684
2015		199		—		199
2016		773		—		773
2017 and thereafter		1,397		—		1,397
	$	3,386	$	118	$	3,504

In conjunction with their obligations under the Credit Agreement, RAI’s Material Subsidiaries, including RJR, RJR Tobacco, American Snuff Co. and SFNTC, among others, guarantee the RAI Notes.

At their option, RAI and RJR, as applicable, may redeem any or all of their outstanding fixed-rate notes, except RJR’s 9.25% notes due in 2013, $60 million in principal amount of which was outstanding as of December 31, 2011, in whole or in part at any time, subject to the payment of a make-whole premium. On June 15, 2011, RAI repaid $400 million of matured floating rate notes from existing cash.

XML

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Details 1) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	$ 1,420	$ 1,265	$ 1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		4	19
Proceeds from settlement of long-term investments	2	13	6
Capital expenditures	(190)	(174)	(141)
Acquisition, net of cash acquired			(43)
Net proceeds from sale of business	202
Proceeds from termination of joint venture	32	28	24
Other, net	14	3	12
Net cash flows from (used in) investing activities	60	(126)	(123)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(1,212)	(1,049)	(991)
Repurchase of common stock	(282)	(5)	(5)
Repayments of long-term debt	(400)	(300)	(200)
Proceeds from termination of interest rate swaps	186
Other, net	(6)	5	4
Net cash flows used in financing activities	(1,714)	(1,349)	(1,192)
Effect of exchange rate changes on cash and cash equivalents	(5)	(11)	6
Net cash flows related to discontinued operations, net of tax benefit		(307)
Net change in cash and cash equivalents	(239)	(528)	145
Cash and cash equivalents at beginning of year	2,195	2,723	2,578
Cash and cash equivalents at end of year	1,956	2,195	2,723
RAI [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	641	442	678
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments			1
Net proceeds from sale of business	79
Return of intercompany investments	1,040	897	610
Other, net	40	40	40
Net cash flows from (used in) investing activities	1,159	937	651
Cash flows from (used in) financing activities:
Dividends paid on common stock	(1,212)	(1,049)	(991)
Repurchase of common stock	(282)	(5)	(5)
Repayments of long-term debt	(400)	(300)	(189)
Proceeds from termination of interest rate swaps	185
Dividends paid on preferred stock	(43)	(43)	(43)
Other, net	(47)	(16)	(12)
Net cash flows used in financing activities	(1,799)	(1,413)	(1,240)
Net change in cash and cash equivalents	1	(34)	89
Cash and cash equivalents at beginning of year	327	361	272
Cash and cash equivalents at end of year	328	327	361
Guarantors [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	1,571	1,153	1,630
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		4	18
Proceeds from settlement of long-term investments	2	13	6
Capital expenditures	(190)	(171)	(137)
Net proceeds from sale of business	123
Contributions to intercompany investments		(75)
Other, net	58	26	29
Net cash flows from (used in) investing activities	(7)	(203)	(84)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(740)	(300)	(840)
Repayments of long-term debt			(11)
Proceeds from termination of interest rate swaps	1
Distribution of equity	(1,040)	(897)	(610)
Other, net	(40)	(40)	(40)
Net cash flows used in financing activities	(1,819)	(1,237)	(1,501)
Net cash flows related to discontinued operations, net of tax benefit		(233)
Net change in cash and cash equivalents	(255)	(520)	45
Cash and cash equivalents at beginning of year	1,616	2,136	2,091
Cash and cash equivalents at end of year	1,361	1,616	2,136
Non-Guarantors [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	(3)	13	29
Cash flows from (used in) investing activities:
Capital expenditures		(3)	(4)
Acquisition, net of cash acquired			(43)
Proceeds from termination of joint venture	32	28	24
Net cash flows from (used in) investing activities	32	25	(23)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(6)
Receipt of equity		75
Other, net	(3)	(2)	(1)
Net cash flows used in financing activities	(9)	73	(1)
Effect of exchange rate changes on cash and cash equivalents	(5)	(11)	6
Net cash flows related to discontinued operations, net of tax benefit		(74)
Net change in cash and cash equivalents	15	26	11
Cash and cash equivalents at beginning of year	252	226	215
Cash and cash equivalents at end of year	267	252	226
Eliminations [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	(789)	(343)	(883)
Cash flows from (used in) investing activities:
Return of intercompany investments	(1,040)	(897)	(610)
Contributions to intercompany investments		75
Other, net	(84)	(63)	(57)
Net cash flows from (used in) investing activities	(1,124)	(885)	(667)
Cash flows from (used in) financing activities:
Dividends paid on common stock	746	300	840
Dividends paid on preferred stock	43	43	43
Receipt of equity		(75)
Distribution of equity	1,040	897	610
Other, net	84	63	57
Net cash flows used in financing activities	1,913	1,228	1,550
Subsidiaries [Member]
Cash flows from (used in) financing activities:
Net change in cash and cash equivalents	(239)
Subsidiaries [Member] | RAI [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	641	442	678
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments			1
Net proceeds from sale of business	79
Return of intercompany investments	1,040	897	610
Other, net	40	40	40
Net cash flows from (used in) investing activities	1,159	937	651
Cash flows from (used in) financing activities:
Dividends paid on common stock	(1,212)	(1,049)	(991)
Repurchase of common stock	(282)	(5)	(5)
Repayments of long-term debt	(400)	(300)	(189)
Proceeds from termination of interest rate swaps	185
Dividends paid on preferred stock	(43)	(43)	(43)
Other, net	(47)	(16)	(12)
Net cash flows used in financing activities	(1,799)	(1,413)	(1,240)
Net change in cash and cash equivalents	1	(34)	89
Cash and cash equivalents at beginning of year	327	361	272
Cash and cash equivalents at end of year	328	327	361
Subsidiaries [Member] | Issuer [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	1,319	445	1,464
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1	5
Return of intercompany investments	340	795
Contributions to intercompany investments		(75)
Other, net	20	23	9
Net cash flows from (used in) investing activities	360	744	14
Cash flows from (used in) financing activities:
Dividends paid on common stock	(740)	(300)	(840)
Repayments of long-term debt			(11)
Proceeds from termination of interest rate swaps	1
Distribution of equity	(910)	(897)	(610)
Other, net	(36)	1	1
Net cash flows used in financing activities	(1,685)	(1,196)	(1,460)
Net cash flows related to discontinued operations, net of tax benefit		(3)
Net change in cash and cash equivalents	(6)	(10)	18
Cash and cash equivalents at beginning of year	14	24	6
Cash and cash equivalents at end of year	8	14	24
Subsidiaries [Member] | Guarantors [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	1,195	947	1,394
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		2	12
Proceeds from settlement of long-term investments	2	13	6
Capital expenditures	(55)	(52)	(55)
Net proceeds from sale of business	123
Other, net	91	25	27
Net cash flows from (used in) investing activities	161	(12)	(10)
Cash flows from (used in) financing activities:
Dividends paid on common stock	(1,265)	(405)	(1,360)
Distribution of equity	(340)	(795)
Net cash flows used in financing activities	(1,605)	(1,200)	(1,360)
Net cash flows related to discontinued operations, net of tax benefit		(230)
Net change in cash and cash equivalents	(249)	(495)	24
Cash and cash equivalents at beginning of year	1,506	2,001	1,977
Cash and cash equivalents at end of year	1,257	1,506	2,001
Subsidiaries [Member] | Non-Guarantors [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	313	179	161
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1	1
Capital expenditures	(135)	(123)	(86)
Acquisition, net of cash acquired			(43)
Proceeds from termination of joint venture	32	28	24
Other, net		1
Net cash flows from (used in) investing activities	(103)	(93)	(104)
Cash flows from (used in) financing activities:
Receipt of equity		75
Distribution of equity	(130)
Other, net	(60)	(65)	(49)
Net cash flows used in financing activities	(190)	10	(49)
Effect of exchange rate changes on cash and cash equivalents	(5)	(11)	6
Net cash flows related to discontinued operations, net of tax benefit		(74)
Net change in cash and cash equivalents	15	11	14
Cash and cash equivalents at beginning of year	348	337	323
Cash and cash equivalents at end of year	363	348	337
Subsidiaries [Member] | Eliminations [Member]
Condensed Consolidating Statements of Cash Flows
Cash flows from operating activities	(2,048)	(748)	(2,243)
Cash flows from (used in) investing activities:
Capital expenditures		1
Return of intercompany investments	(1,380)	(1,692)	(610)
Contributions to intercompany investments		75
Other, net	(137)	(86)	(64)
Net cash flows from (used in) investing activities	(1,517)	(1,702)	(674)
Cash flows from (used in) financing activities:
Dividends paid on common stock	2,005	705	2,200
Dividends paid on preferred stock	43	43	43
Receipt of equity		(75)
Distribution of equity	1,380	1,692	610
Other, net	137	85	64
Net cash flows used in financing activities	$ 3,565	$ 2,450	$ 2,917

XML

Segment Information

12 Months Ended

Dec. 31, 2011

Segment Information [Abstract]

Segment Information

Note 17 — Segment Information

RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane. During the fourth quarter of 2011, RAI elected to begin reporting the Santa Fe segment, which includes the primary operations of SFNTC. RAI has retrospectively revised segment disclosures for all periods presented. Although the operations and results of Santa Fe currently do not meet the quantitative criteria to be required to be reported, RAI management believes that reporting this segment is important to the financial statement user for additional understanding and transparency with respect to the aggregate operations and results of RAI’s subsidiaries that produce and market cigarettes in the U.S. Niconovum AB, among other RAI subsidiaries, is included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI.

RAI’s largest reportable operating segment, RJR Tobacco, is the second largest cigarette manufacturer in the United States. RJR Tobacco’s brands include many of the best-selling cigarettes in the United States: CAMEL, PALL MALL, WINSTON, KOOL, DORAL and SALEM. Those brands, and its other brands, including MISTY and CAPRI, are manufactured in a variety of styles and marketed in the United States. As part of its total tobacco strategy, RJR Tobacco also offers two types of smoke-free tobacco products, CAMEL Snus, and in certain lead markets, CAMEL Dissolvables. RJR Tobacco also manages contract manufacturing of cigarette and tobacco products through arrangements with BAT affiliates, and manages the export of tobacco products to certain U.S. territories, U.S. duty-free shops and U.S. overseas military bases.

American Snuff, is the second largest smokeless tobacco products manufacturer in the United States. American Snuff’s primary brands include its largest selling moist snuff brands, GRIZZLY and KODIAK.

Santa Fe manufactures and markets cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand, as well as manages RJR Tobacco’s super premium cigarette brands, DUNHILL and STATE EXPRESS 555, which are licensed from BAT.

RAI’s operating subsidiaries’ sales to foreign countries, primarily to related parties, for the years ended December 31, 2011, 2010 and 2009 were $610 million, $525 million and $548 million, respectively. Intersegment revenues and items below the operating income line of the consolidated statements of income are not presented by segment, since they are excluded from the measure of segment profitability reviewed by RAI’s chief operating decision maker. Additionally, information about total assets by segment is not reviewed by RAI’s chief operating decision maker and therefore is not disclosed.

Segment Data:

	2011			2010(3)			2009(3)
Net sales:
RJR Tobacco	$	7,297		$	7,350		$	7,334
American Snuff		648			719			673
Santa Fe		436			356			289
All Other		160			126			123
Consolidated net sales	$	8,541		$	8,551		$	8,419
Operating income:
RJR Tobacco	$	1,945		$	2,084		$	1,481
American Snuff		331			320			276
Santa Fe		198			135			98
All Other		18			(14	)		14
Corporate expense		(93	)		(93	)		(106	)
Consolidated operating income	$	2,399		$	2,432		$	1,763
Cash capital expenditures:
RJR Tobacco	$	55		$	52		$	55
American Snuff		106			104			75
Santa Fe		7			2			7
All Other		22			16			4
Consolidated capital expenditures	$	190		$	174		$	141
Depreciation and amortization expense:
RJR Tobacco	$	110		$	119		$	123
American Snuff		17			17			13
Santa Fe		5			7			6
All Other		6			8			2
Consolidated depreciation and amortization expense	$	138		$	151		$	144
Reconciliation to income from continuing operations before income taxes:
Operating income (1)(2)	$	2,399		$	2,432		$	1,763
Interest and debt expense		221			232			251
Interest income		(11	)		(12	)		(19	)
Other expense, net		3			7			9
Income from continuing operations before income taxes	$	2,186		$	2,205		$	1,522

⁽¹⁾ Includes restructuring and/or asset impairment charges of $38 million and $56 million for the years ended December 31, 2010 and 2009, respectively.

⁽²⁾ Includes trademark and/or goodwill impairment charges of $48 million, $32 million and $567 million for the years ended December 31, 2011, 2010 and 2009, respectively.

⁽³⁾ Revised financial data for 2010 and 2009 to reflect RAI’s elective change in accounting for pension and postretirement benefits. See note 1 to consolidated financial statements.

Sales made to McLane Company, Inc., a distributor, comprised approximately 27% of RAI’s revenue in each of 2011, 2010 and 2009. McLane Company, Inc. is a customer in all segments. No other customer accounted for 10% or more of RAI’s revenue during those periods.

XML

Retirement Benefits (Details 2) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Changes in accumulated other comprehensive loss
Prior service credit		$ (45)	$ (51)
Net actuarial loss		407	321
Amortization of prior service cost (credit)		25	20
One-time cost		(3)	0
MTM adjustment	(145)	(145)	(110)
Deferred income tax expense		95	102	(182)
Change in accumulated other comprehensive loss		144	78
Pension Benefits [Member]
Changes in accumulated other comprehensive loss
Prior service credit		0	0
Net actuarial loss		331	185
Amortization of prior service cost (credit)		(4)	(4)
One-time cost		(3)	0
MTM adjustment		(110)	(3)	(14)
Deferred income tax expense		85	72
Change in accumulated other comprehensive loss		129	106
Postretirement Benefits [Member]
Changes in accumulated other comprehensive loss
Prior service credit		(45)	(51)
Net actuarial loss		76	136
Amortization of prior service cost (credit)		29	24
One-time cost		0	0
MTM adjustment		(35)	(107)	(35)
Deferred income tax expense		10	30
Change in accumulated other comprehensive loss		$ 15	$ (28)

XML

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Tables)

12 Months Ended

Dec. 31, 2011

RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements [Abstract]

Condensed Consolidating Statements of Income

Condensed Consolidating Statements of Income

(Dollars in Millions)

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Net sales	$	—		$	—		$	6,908		$	1,204		$	(50	)	$	8,062
Net sales, related party		—			—			478			1			—			479
Net Sales		—			—			7,386			1,205			(50	)		8,541
Cost of products sold		—			—			4,133			381			(50	)		4,464
Selling, general and administrative expenses		129			(7	)		1,164			320			—			1,606
Amortization expense		—			—			22			2			—			24
Trademark impairment charges		—			—			43			5			—			48
Operating income (loss)		(129	)		7			2,024			497			—			2,399
Interest and debt expense		213			8			—			162			(162	)		221
Interest income		(118	)		(5	)		(44	)		(6	)		162			(11	)
Other expense (income), net		8			(45	)		—			(3	)		43			3
Income (loss) before income taxes		(232	)		49			2,068			344			(43	)		2,186
Provision for (benefit from) income taxes		(89	)		1			752			116			—			780
Equity income from subsidiaries		1,549			1,344			28			—			(2,921	)		—
Net income	$	1,406		$	1,392		$	1,344		$	228		$	(2,964	)	$	1,406
For the Year Ended December 31, 2010
Net sales	$	—		$	—		$	7,093		$	1,230		$	(153	)	$	8,170
Net sales, related party		—			—			371			10			—			381
Net Sales		—			—			7,464			1,240			(153	)		8,551
Cost of products sold		—			—			4,264			435			(155	)		4,544
Selling, general and administrative expenses		20			(2	)		1,124			339			(1	)		1,480
Amortization expense		—			—			24			1			—			25
Asset impairment and exit charges		—			—			24			14			—			38
Trademark impairment charges		—			—			—			6			—			6
Goodwill impairment charge		—			—			—			26			—			26
Operating income (loss)		(20	)		2			2,028			419			3			2,432
Interest and debt expense		223			8			—			166			(165	)		232
Interest income		(119	)		(5	)		(45	)		(8	)		165			(12	)
Other expense (income), net		2			(43	)		8			(3	)		43			7
Income (loss) before income taxes		(126	)		42			2,065			264			(40	)		2,205
Provision for (benefit from) income taxes		(42	)		(2	)		814			97			1			868
Equity income from subsidiaries		1,205			951			5			—			(2,161	)		—
Income from continuing operations		1,121			995			1,256			167			(2,202	)		1,337
Gains (losses) from discontinued operations, net of tax		—			88			(230	)		(74	)		—			(216	)
Net income	$	1,121		$	1,083		$	1,026		$	93		$	(2,202	)	$	1,121
For the Year Ended December 31, 2009
Net sales	$	—		$	—		$	7,078		$	1,139		$	(202	)	$	8,015
Net sales, related party		—			—			396			8			—			404
Net Sales		—			—			7,474			1,147			(202	)		8,419
Cost of products sold		—			—			4,297			393			(202	)		4,488
Selling, general and administrative expenses		20			4			1,183			310			—			1,517
Amortization expense		—			—			27			1			—			28
Restructuring charge		—			—			56			—			—			56
Trademark impairment charges		—			—			491			76			—			567
Operating income (loss)		(20	)		(4	)		1,420			367			—			1,763
Interest and debt expense		242			8			1			171			(171	)		251
Interest income		(115	)		(8	)		(56	)		(11	)		171			(19	)
Other expense (income), net		(4	)		(31	)		2			(1	)		43			9
Income (loss) before income taxes		(143	)		27			1,473			208			(43	)		1,522
Provision for (benefit from) income taxes		(49	)		(5	)		562			59			—			567
Equity income from subsidiaries		1,049			939			26			—			(2,014	)		—
Net income	$	955		$	971		$	937		$	149		$	(2,057	)	$	955

Condensed Consolidating Statements of Cash Flows

Condensed Consolidating Statements of Cash Flows

(Dollars in Millions)

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2011
Cash flows from operating activities	$	641		$	1,319		$	1,195		$	313		$	(2,048	)	$	1,420
Cash flows from (used in) investing activities:
Proceeds from settlement of long-term investments		—			—			2			—			—			2
Capital expenditures		—			—			(55	)		(135	)		—			(190	)
Net proceeds from sale of business		79			—			123			—			—			202
Proceeds from termination of joint venture		—			—			—			32			—			32
Return of intercompany investments		1,040			340			—			—			(1,380	)		—
Other, net		40			20			91			—			(137	)		14
Net cash flows from (used in) investing activities		1,159			360			161			(103	)		(1,517	)		60
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,212	)		(740	)		(1,265	)		—			2,005			(1,212	)
Repurchase of common stock		(282	)		—			—			—			—			(282	)
Repayment of long-term debt		(400	)		—			—			—			—			(400	)
Proceeds from termination of interest rate swaps		185			1			—			—			—			186
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Distribution of equity		—			(910	)		(340	)		(130	)		1,380			—
Other, net		(47	)		(36	)		—			(60	)		137			(6	)
Net cash flows used in financing activities		(1,799	)		(1,685	)		(1,605	)		(190	)		3,565			(1,714	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			(5	)		—			(5	)
Net change in cash and cash equivalents		1			(6	)		(249	)		15			—			(239	)
Cash and cash equivalents at beginning of year		327			14			1,506			348			—			2,195
Cash and cash equivalents at end of year	$	328		$	8		$	1,257		$	363		$	—		$	1,956
For the Year Ended December 31, 2010
Cash flows from operating activities	$	442		$	445		$	947		$	179		$	(748	)	$	1,265
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		—			1			2			1			—			4
Proceeds from settlement of long-term investments		—			—			13			—			—			13
Capital expenditures		—			—			(52	)		(123	)		1			(174	)
Proceeds from termination of joint venture		—			—			—			28			—			28
Return on intercompany investments		897			795			—			—			(1,692	)		—
Contributions to intercompany investments		—			(75	)		—			—			75			—
Other, net		40			23			25			1			(86	)		3
Net cash flows from (used in) investing activities		937			744			(12	)		(93	)		(1,702	)		(126	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(1,049	)		(300	)		(405	)		—			705			(1,049	)
Repurchase of common stock		(5	)		—			—			—			—			(5	)
Repayment of long-term debt		(300	)		—			—			—			—			(300	)
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Receipt of equity		—			—			—			75			(75	)		—
Distribution of equity		—			(897	)		(795	)		—			1,692			—
Other, net		(16	)		1			—			(65	)		85			5
Net cash flows from (used in) financing activities		(1,413	)		(1,196	)		(1,200	)		10			2,450			(1,349	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			(11	)		—			(11	)
Net cash flows related to discontinued operations, net of tax benefit		—			(3	)		(230	)		(74	)		—			(307	)
Net change in cash and cash equivalents		(34	)		(10	)		(495	)		11			—			(528	)
Cash and cash equivalents at beginning of year		361			24			2,001			337			—			2,723
Cash and cash equivalents at end of year	$	327		$	14		$	1,506		$	348		$	—		$	2,195

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
For the Year Ended December 31, 2009
Cash flows from operating activities	$	678		$	1,464		$	1,394		$	161		$	(2,243	)	$	1,454
Cash flows from (used in) investing activities:
Proceeds from settlement of short-term investments		1			5			12			1			—			19
Proceeds from settlement of long-term investments		—			—			6			—			—			6
Capital expenditures		—			—			(55	)		(86	)		—			(141	)
Acquisition, net of cash acquired		—			—			—			(43	)		—			(43	)
Proceeds from termination of joint venture		—			—			—			24			—			24
Return of intercompany investments		610			—			—			—			(610	)		—
Other, net		40			9			27			—			(64	)		12
Net cash flows from (used in) investing activities		651			14			(10	)		(104	)		(674	)		(123	)
Cash flows from (used in) financing activities:
Dividends paid on common stock		(991	)		(840	)		(1,360	)		—			2,200			(991	)
Repurchase of common stock		(5	)		—			—			—			—			(5	)
Repayment of long-term debt		(189	)		(11	)		—			—			—			(200	)
Dividends paid on preferred stock		(43	)		—			—			—			43			—
Distribution of equity		—			(610	)		—			—			610			—
Other, net		(12	)		1			—			(49	)		64			4
Net cash flows used in financing activities		(1,240	)		(1,460	)		(1,360	)		(49	)		2,917			(1,192	)
Effect of exchange rate changes on cash and cash equivalents		—			—			—			6			—			6
Net change in cash and cash equivalents		89			18			24			14			—			145
Cash and cash equivalents at beginning of year		272			6			1,977			323			—			2,578
Cash and cash equivalents at end of year	$	361		$	24		$	2,001		$	337		$	—		$	2,723

Condensed Consolidating Balance Sheets

Condensed Consolidating Balance Sheets

(Dollars in Millions)

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2011
Assets
Cash and cash equivalents	$	328	$	8	$	1,257	$	363	$	—		$	1,956
Accounts receivable		—		—		62		39		—			101
Accounts receivable, related party		—		—		67		—		—			67
Other receivables		95		38		145		110		(342	)		46
Inventories		—		—		480		487		—			967
Deferred income taxes, net		—		1		907		45		(8	)		945
Prepaid expenses and other		19		—		178		28		—			225
Total current assets		442		47		3,096		1,072		(350	)		4,307
Property, plant and equipment, net		5		—		652		412		1			1,070
Trademarks and other intangible assets, net		—		—		1,251		1,351		—			2,602
Goodwill		—		—		5,303		2,707		—			8,010
Long-term intercompany notes		1,960		157		1,325		—		(3,442	)		—
Investment in subsidiaries		9,139		7,076		456		—		(16,671	)		—
Other assets and deferred charges		68		24		157		72		(56	)		265
Total assets	$	11,614	$	7,304	$	12,240	$	5,614	$	(20,518	)	$	16,254
Liabilities and shareholders’ equity
Accounts payable	$	—	$	—	$	87	$	26	$	—		$	113
Tobacco settlement accruals		—		—		2,461		69		—			2,530
Due to related party		—		—		2		—		—			2
Deferred revenue, related party		—		—		42		—		—			42
Current maturities of long-term debt		399		58		—		—		—			457
Other current liabilities		421		100		711		250		(350	)		1,132
Total current liabilities		820		158		3,303		345		(350	)		4,276
Intercompany notes and interest payable		1,325		—		—		2,117		(3,442	)		—
Long-term debt (less current maturities)		3,145		61		—		—		—			3,206
Deferred income taxes, net		—		—		60		507		(56	)		511
Long-term retirement benefits (less current portion)		48		24		1,579		108		—			1,759
Other noncurrent liabilities		25		1		222		3		—			251
Shareholders’ equity		6,251		7,060		7,076		2,534		(16,670	)		6,251
Total liabilities and shareholders’ equity	$	11,614	$	7,304	$	12,240	$	5,614	$	(20,518	)	$	16,254

	Parent Guarantor		Issuer		Other Guarantors		Non- Guarantors		Eliminations			Consolidated
December 31, 2010
Assets
Cash and cash equivalents	$	327	$	14	$	1,506	$	348	$	—		$	2,195
Accounts receivable		—		—		50		68		—			118
Accounts receivable, related party		—		—		48		—		—			48
Other receivables		80		33		225		90		(384	)		44
Inventories		—		—		600		456		(1	)		1,055
Deferred income taxes, net		10		1		892		43		—			946
Prepaid expenses and other		38		—		130		30		(3	)		195
Assets held for sale		—		—		20		181		—			201
Total current assets		455		48		3,471		1,216		(388	)		4,802
Property, plant and equipment, net		6		—		689		306		1			1,002
Trademarks and other intangible assets, net		—		—		1,316		1,359		—			2,675
Goodwill		—		—		5,303		2,707		—			8,010
Long-term intercompany notes		2,000		174		1,366		—		(3,540	)		—
Investment in subsidiaries		9,696		7,611		435		—		(17,742	)		—
Other assets and deferred charges		267		56		194		101		(29	)		589
Total assets	$	12,424	$	7,889	$	12,774	$	5,689	$	(21,698	)	$	17,078
Liabilities and shareholders’ equity
Accounts payable	$	—	$	—	$	103	$	76	$	—		$	179
Tobacco settlement accruals		—		—		2,532		57		—			2,589
Due to related party		—		—		4		—		—			4
Deferred revenue, related party		—		—		53		—		—			53
Current maturities of long-term debt		400		—		—		—		—			400
Other current liabilities		489		138		652		255		(387	)		1,147
Total current liabilities		889		138		3,344		388		(387	)		4,372
Intercompany notes and interest payable		1,366		—		—		2,174		(3,540	)		—
Long-term debt (less current maturities)		3,580		121		—		—		—			3,701
Deferred income taxes, net		—		—		76		471		(29	)		518
Long-term retirement benefits (less current portion)		34		25		1,496		113		—			1,668
Other noncurrent liabilities		45		12		247		5		—			309
Shareholders’ equity		6,510		7,593		7,611		2,538		(17,742	)		6,510
Total liabilities and shareholders’ equity	$	12,424	$	7,889	$	12,774	$	5,689	$	(21,698	)	$	17,078

XML

Retirement Benefits (Details 12) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011
Estimated future benefits payments
2012	$ 407
2013	399
2014	395
2015	395
2016	397
2017-2021	1,951
Gross Projected Benefit Payments Before Medicare Part D Subsidies
2012	109
2013	112
2014	113
2015	112
2016	111
2017-2021	530
Expected Medicare Part D Subsidies
2012	3
2013	3
2014	4
2015	4
2016	4
2017-2021	26
Net Projected Benefit Payments After Medicare Part D Subsidies
2012	106
2013	109
2014	109
2015	108
2016	107
2017-2021	$ 504

XML

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2011

Borrowing Arrangements/Long-Term Debt [Abstract]

Long-term debt, net of discounts and including fair value adjustments

	2011		2010
RJR debt:
9.25%, notes due 2013	$	60	$	60
7.25% guaranteed, notes due 2012		—		61
Total RJR debt		60		121
RAI debt:
6.75% guaranteed, notes due 2017		797		811
7.25% guaranteed, notes due 2012		—		412
7.25% guaranteed, notes due 2013		624		623
7.25% guaranteed, notes due 2037		448		448
7.3% guaranteed, notes due 2015		199		199
7.625% guaranteed, notes due 2016		829		838
7.75% guaranteed, notes due 2018		249		249
Total RAI debt		3,146		3,580
Total long-term debt (less current maturities)		3,206		3,701
Current maturities of long-term debt		457		400
	$	3,663	$	4,101

Maturities of parent company and wholly owned company notes net of discount and excluding fair value adjustments

Year	RAI		RJR		Total
2012	$	393	$	58	$	451
2013		624		60		684
2015		199		—		199
2016		773		—		773
2017 and thereafter		1,397		—		1,397
	$	3,386	$	118	$	3,504

XML

Segment Information (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Net sales:
Net sales	$ 8,541	$ 8,551	$ 8,419
Operating income:
Operating income	2,399	2,432	1,763
Cash capital expenditures:
Consolidated capital expenditures	190	174	141
Depreciation and amortization expense:
Depreciation and amortization	138	151	144
Reconciliation to income from continuing operations before income taxes:
Interest and debt expense	221	232	251
Interest income	(11)	(12)	(19)
Other expense, net	3	7	9
Income from continuing operations before income taxes	2,186	2,205	1,522
RJR Tobacco [Member]
Net sales:
Net sales	7,297	7,350	7,334
Operating income:
Operating income	1,945	2,084	1,481
Cash capital expenditures:
Consolidated capital expenditures	55	52	55
Depreciation and amortization expense:
Depreciation and amortization	110	119	123
American Snuff [Member]
Net sales:
Net sales	648	719	673
Operating income:
Operating income	331	320	276
Cash capital expenditures:
Consolidated capital expenditures	106	104	75
Depreciation and amortization expense:
Depreciation and amortization	17	17	13
Santa Fe [Member]
Net sales:
Net sales	436	356	289
Operating income:
Operating income	198	135	98
Cash capital expenditures:
Consolidated capital expenditures	7	2	7
Depreciation and amortization expense:
Depreciation and amortization	5	7	6
All Other [Member]
Net sales:
Net sales	160	126	123
Operating income:
Operating income	18	(14)	14
Cash capital expenditures:
Consolidated capital expenditures	22	16	4
Depreciation and amortization expense:
Depreciation and amortization	6	8	2
Corporate Expense [Member]
Operating income:
Operating income	$ (93)	$ (93)	$ (106)

XML

Consolidated Statements of Cash Flows (Parenthetical) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements of Cash Flows [Abstract]
Capitalized interest	$ 3	$ 3	$ 1

XML

Stock Plans (Details 3) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Amounts related to performance share grants, restricted stock grants, restricted stock units grant
Other current liabilities	$ 15
Other noncurrent liabilities	10	14
Paid-in capital	$ 81	$ 58

XML

Business and Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2011

Business and Summary of Significant Accounting Policies [Abstract]

Business and Summary of Significant Accounting Policies

Note 1 — Business and Summary of Significant Accounting Policies

Overview

The consolidated financial statements include the accounts of Reynolds American Inc., referred to as RAI, and its wholly owned subsidiaries. RAI’s wholly owned operating subsidiaries include R. J. Reynolds Tobacco Company; American Snuff Company, LLC, referred to as American Snuff Co.; Santa Fe Natural Tobacco Company, Inc., referred to as SFNTC; and Niconovum AB.

RAI was incorporated as a holding company in the state of North Carolina on January 5, 2004, and its common stock is listed on the NYSE under the symbol “RAI.” On July 30, 2004, the U.S. assets, liabilities and operations of Brown & Williamson Tobacco Corporation, now known as Brown & Williamson Holdings, Inc., referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c., referred to as BAT, were combined with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR. These July 30, 2004, transactions generally are referred to as the B&W business combination.

References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a New Jersey corporation and a wholly owned subsidiary of RJR. References to RJR Tobacco on and subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W and R. J. Reynolds Tobacco Company, a North Carolina corporation.

RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. and, prior to its sale, Lane, Limited, referred to as Lane. During the fourth quarter of 2011, RAI elected to begin reporting the Santa Fe segment, which includes the primary operations of SFNTC. RAI has retrospectively revised segment disclosures for all periods presented. Although the operations and results of Santa Fe currently do not meet the quantitative criteria to be required to be reported, RAI management believes that reporting this segment is important to the financial statement user for additional understanding and transparency with respect to the aggregate operations and results of RAI’s subsidiaries that produce and market cigarettes in the U.S. Niconovum AB, among other RAI subsidiaries, is included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI.

As a result of the B&W business combination, Lane became a wholly owned subsidiary of RAI. On February 28, 2011, RAI completed the sale of all of the capital stock of Lane and certain other assets related to the Lane operations, to an affiliate of Scandinavian Tobacco Group A/S, referred to as STG, for net proceeds of $202 million in cash. The assets and liabilities of the disposal group were classified as held for sale as of December 31, 2010, and its results of operations were included through February 28, 2011, in income from continuing operations in the American Snuff segment.

RAI’s operating subsidiaries primarily conduct their business in the United States.

Basis of Presentation

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, referred to as GAAP, requires estimates and assumptions to be made that affect the reported amounts in the consolidated financial statements and accompanying notes. Volatile credit and equity markets, changes to regulatory and legal environments, and consumer spending may affect the uncertainty inherent in such estimates and assumptions. Actual results could differ from those estimates. Certain reclassifications were made to conform prior years’ financial statements to the current presentation.

All dollar amounts, other than per share amounts, are presented in millions, except for amounts set forth in note 13 and as otherwise noted.

Cash and Cash Equivalents

Cash balances are recorded net of book overdrafts when a bank right-of-offset exists. All other book overdrafts are recorded in accounts payable. Cash equivalents may include money market funds, commercial paper and time deposits in major institutions to minimize investment risk. As short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase, cash equivalents have carrying values that approximate fair values.

Fair Value Measurement

RAI determines fair value of assets and liabilities using a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.

The levels of the fair value hierarchy are:

Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2: inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3: inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

Investments

Marketable securities are classified as available-for-sale and are carried at fair value. RAI reviews these investments on a quarterly basis to determine if it is probable that RAI will realize some portion of the unrealized loss and to determine the classification of the impairment as temporary or other-than-temporary. For those securities that RAI does not intend to sell and it is more likely than not that RAI will not be required to sell the securities prior to recovery, RAI recognizes the credit loss component of an other-than-temporary impairment in earnings, and recognizes the noncredit component in other comprehensive loss. All losses deemed to be other than temporarily impaired are recorded in earnings.

Inventories

Inventories are stated at the lower of cost or market. The cost of tobacco inventories is determined principally under the last-in, first-out, or LIFO, method and is calculated at the end of each year. The cost of work in process and finished goods includes materials, direct labor, variable costs and overhead and full absorption of fixed manufacturing overhead. Stocks of tobacco, which have an operating cycle that exceeds 12 months due to aging requirements, are classified as current assets, consistent with recognized industry practice.

Long-lived Assets

Long-lived assets, such as property, plant and equipment, trademarks and other intangible assets with finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the book value of the asset may not be recoverable. Impairment of the carrying value of long-lived assets would be indicated if the best estimate of future undiscounted cash flows expected to be generated by the asset grouping is less than its carrying value. If an impairment is indicated, any loss is measured as the difference between estimated fair value and carrying value and is recognized in operating income.

Property, Plant and Equipment

Property, plant and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Useful lives range from 20 to 50 years for buildings and improvements, and from 3 to 30 years for machinery and equipment. The cost and related accumulated depreciation of assets sold or retired are removed from the accounts and the gain or loss on disposition is recognized in operating income.

Intangible Assets

Intangible assets include goodwill, trademarks and other intangible assets and are capitalized when acquired. The determination of fair value involves considerable estimates and judgment. In particular, the fair value of a reporting unit involves, among other things, developing forecasts of future cash flows, determining an appropriate discount rate, and when goodwill impairment is implied, determining the fair value of individual assets and liabilities, including unrecorded intangibles. Although RAI believes it has based its impairment testing and impairment charges on reasonable estimates and assumptions, the use of different estimates and assumptions could result in materially different results. Generally, if the current competitive or regulatory environment worsens or RAI’s operating companies’ strategic initiatives adversely affect their financial performance, the fair value of goodwill, trademarks and other intangible assets could be impaired in future periods. Trademarks and other intangible assets with indefinite lives are not amortized, but are tested for impairment annually, in the fourth quarter, and more frequently if events and circumstances indicate that the asset might be impaired.

Accounting for Derivative Instruments and Hedging Activities

RAI measures any derivative instruments, including certain derivative instruments embedded in other contracts, at fair value and records them in the balance sheet as either an asset or liability. Changes in fair value of derivatives are recorded in earnings unless hedge accounting criteria are met. For derivatives designated as fair value hedges, the changes in fair value of both the derivative instrument and the hedged item are recorded in earnings. For derivatives designated as cash flow hedges, the effective portions of changes in the fair value of the derivative are reported in accumulated other comprehensive loss. The ineffective portions of hedges are recognized in earnings in the current period.

RAI formally assesses at inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item, and formally designates as a hedge those derivatives that qualify for hedge accounting. If it is determined that a derivative is not highly effective as a hedge or if a derivative ceases to be a highly effective hedge, RAI will discontinue hedge accounting prospectively. Any unrecognized gain or loss will be deferred and recognized into income as the formerly hedged item is recognized in earnings. At December 31, 2010, RAI had no derivative instruments classified as hedges, and at December 31, 2011, had no derivative instruments.

Software Costs

Computer software and software development costs incurred in connection with developing or obtaining computer software for internal use that has an extended useful life are capitalized. These costs are amortized over their estimated useful life, which is typically five years or less. During 2011 and 2010, costs of $24 million and $22 million, respectively, were capitalized or included in construction-in-process. At each of December 31, 2011 and 2010, the unamortized balance was $64 million. Software amortization expense was $24 million, $30 million and $26 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Revenue Recognition

Revenue from product sales is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the seller’s price to the buyer is fixed or determinable, and collectibility is reasonably assured. These criteria are generally met when title and risk of loss pass to the customer. Payments received in advance of shipments are deferred and recorded in other accrued liabilities until shipment occurs. Certain sales of leaf to a related party, considered as bill-and-hold for accounting purposes, are recorded as deferred revenue when all of the above revenue recognition criteria are met except delivery, postponed at the customer’s request. Revenue is subsequently recognized upon delivery. The revenues recorded are presented net of excise tax collected on behalf of government authorities.

Shipping and handling costs are classified as cost of products sold. Net sales include certain sales incentives, including retail discounting, promotional allowances and coupons.

Cost of Products Sold

Cost of products sold includes the expenses for the Master Settlement Agreement, referred to as the MSA, and other settlement agreements with the states of Mississippi, Florida, Texas and Minnesota, which together with the MSA are collectively referred to as the State Settlement Agreements; the federal tobacco quota buyout; and the user fees charged by the U.S. Food and Drug Administration, referred to as the FDA, were as follows for the years ended December 31:

	2011		2010		2009
State Settlement Agreements	$	2,435	$	2,496	$	2,540
Federal tobacco quota buyout		229		243		240
FDA user fees		120		75		22

Advertising

Advertising costs, which are expensed as incurred, were $65 million, $72 million and $69 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Research and Development

Research and development costs, which are expensed as incurred, were $69 million, $71 million and $68 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Interest and penalties related to uncertain tax positions are accounted for as tax expense. Federal income taxes for RAI and its subsidiaries are calculated on a consolidated basis. State income taxes for RAI and its subsidiaries are primarily calculated on a separate return basis.

RAI accounts for uncertain tax positions which require that a position taken or expected to be taken in a tax return be recognized in the financial statements when it is more likely than not (a likelihood of more than 50 percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement.

Stock-Based Compensation

Stock-based compensation expense is recognized for all forms of share-based payment awards, including shares issued to employees under stock options and restricted stock units.

Litigation Contingencies

RAI discloses information concerning litigation for which an unfavorable outcome is more than remote. RAI and its subsidiaries record their legal expenses and other litigation costs and related administrative costs as selling, general and administrative expenses as those costs are incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated. When the reasonable estimate is a range, the recorded loss will be the best estimate within the range. If no amount in the range is a better estimate than any other amount, the minimum amount of the range will be recorded.

Pension and Postretirement

Pension and postretirement benefits require balance sheet recognition of the net asset or liability for the overfunded or underfunded status of defined benefit pension and other postretirement benefit plans, on a plan-by-plan basis, and recognition of changes in the funded status in the year in which the changes occur.

Changes in benefit obligations due to plan amendments, referred to as prior service costs, are amortized on a straight-line basis over the average remaining service period for active employees. These changes are reported in accumulated other comprehensive loss, as a separate component of shareholders’ equity. Changes in the amount of either the benefit obligation or the value of plan assets resulting from experience different from that assumed or from changes in assumptions are referred to as actuarial gains and losses.

In November 2011, RAI elected to change its method of accounting for pension and postretirement benefits. Historically, RAI has recognized actuarial gains and losses in accumulated other comprehensive loss in its consolidated balance sheets on an annual basis, amortizing them into operating results over the average future service period of active employees in these plans, to the extent such gains and losses were in excess of 10 percent of the greater of the market-related value of plan assets or the plan’s projected benefit obligation, referred to as the corridor. RAI has elected to immediately recognize actuarial gains and losses in its operating results in the year in which they occur, to the extent they exceed the corridor. Actuarial gains and losses outside the corridor are generally recognized annually as of December 31, and are recorded as a mark-to-market, referred to as MTM, adjustment. Additionally, for purposes of calculating the expected return on plan assets, RAI will no longer use an averaging technique permitted under GAAP for the market-related value of plan assets, but instead will use the actual fair value of plan assets. These changes are intended to improve the transparency of RAI’s operating results by more quickly recognizing the effects of current economic and interest rate trends on plan investments and assumptions.

These changes have been reported through retrospective application of the new policy to all periods presented. The impacts of all revisions made to the financial statements are summarized below:

Consolidated statements of income:

	For the Year Ended December 31, 2010							For the Year Ended December 31, 2009
	Previously Reported		Revised		Effect Of Change			Previously Reported		Revised		Effect Of Change
Cost of products sold	$	4,544	$	4,544	$	—		$	4,485	$	4,488	$	3
Selling, general and administrative expenses		1,493		1,480		(13	)		1,508		1,517		9
Operating income		2,419		2,432		13			1,775		1,763		(12	)
Income from continuing operations before income taxes		2,192		2,205		13			1,534		1,522		(12	)
Provision for income taxes		863		868		5			572		567		(5	)
Income from continuing operations		1,329		1,337		8			962		955		(7	)
Net income		1,113		1,121		8			962		955		(7	)
Earnings per share — basic		1.91		1.92		0.01			1.65		1.64		(0.01	)
Earnings per share — diluted		1.90		1.92		0.02			1.65		1.64		(0.01	)

Consolidated balance sheet:

	December 31, 2010
	Previously Reported			Revised			Effect Of Change
Accumulated deficit	$	(547	)	$	(1,807	)	$	(1,260	)
Accumulated other comprehensive loss		(1,478	)		(218	)		1,260

Consolidated statements of cash flows:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Cash flows from operating activities:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Deferred income tax expense (benefit)		182			187			5			(154	)		(159	)		(5	)
Pension and postretirement		(702	)		(715	)		(13	)		(181	)		(169	)		12

Consolidated statements of shareholders’ equity and comprehensive income:

	For the Year Ended December 31, 2010									For the Year Ended December 31, 2009
	Previously Reported			Revised			Effect Of Change			Previously Reported			Revised			Effect Of Change
Accumulated deficit:
Beginning balance	$	(579	)	$	(1,847	)	$	(1,268	)	$	(531	)	$	(1,792	)	$	(1,261	)
Net income		1,113			1,121			8			962			955			(7	)
Ending balance		(547	)		(1,807	)		(1,260	)		(579	)		(1,847	)		(1,268	)
Accumulated other comprehensive income (loss):
Beginning balance	$	(1,421	)	$	(153	)	$	1,268		$	(1,695	)	$	(434	)	$	1,261
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7
Ending balance		(1,478	)		(218	)		1,260			(1,421	)		(153	)		1,268
Comprehensive income:
Net income	$	1,113		$	1,121		$	8		$	962		$	955		$	(7	)
Pension and other postretirement benefit adjustments		(70	)		(78	)		(8	)		267			274			7

Recently Issued Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board, referred to as FASB, amended certain accounting and disclosure requirements related to fair value measurements. For fair value measurements categorized as Level 1 and Level 2, requirements have been expanded to include disclosures of transfers between these levels. For fair value measurements categorized as Level 3, a reporting entity should disclose quantitative information of the unobservable inputs and assumptions, a description of the valuation processes and a qualitative discussion about the sensitivity of the fair value measurement to changes in unobservable inputs. The guidance is effective for RAI for interim and annual reporting periods beginning January 1, 2012, and is not expected to have a material impact on RAI’s results of operations, cash flows or financial position.

In June 2011, the FASB issued amended guidance which requires comprehensive income to be reported in either a single statement or in two consecutive statements reporting net income and other comprehensive income. The amendment eliminates the option to report other comprehensive income and its components in the statement of changes in shareholders’ equity. The guidance is effective for fiscal years, and interim periods within those years, beginning January 1, 2012. In December 2011, the FASB deferred the changes related to the presentation of reclassification adjustments. The adoption of the amendment will have no impact on RAI’s results of operations, cash flows or financial position.

In September 2011, the FASB issued amended guidance that permits an entity to make a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount before applying the current two-step goodwill impairment test. If an entity concludes that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, it would not be required to perform the two-step impairment test for that reporting unit. The guidance is effective for RAI for interim and annual reporting periods beginning January 1, 2012, and will not have a material impact on RAI’s results of operations, cash flows or financial position.

XML

Fair Value (Details 4) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Impact of Interest rate swaps on Income Statement
Interest and debt expense	$ (47)	$ (48)	$ (47)
Other expense, net	$ 4	$ (3)	$ (9)

XML

Shareholders' Equity (Details) (USD $)	3 Months Ended												12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 30, 2009	Jun. 30, 2009	Mar. 31, 2009	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Declared quarterly cash dividends per share of common stock
Dividends declared per share	$ 0.56	$ 0.53	$ 0.53	$ 0.53	$ 0.49	$ 0.45	$ 0.45	$ 0.45	$ 0.450	$ 0.425	$ 0.425	$ 0.425	$ 2.15	$ 1.84	$ 1.73

XML

Retirement Benefits (Details Textual) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Defined Benefit Plan Disclosure [Line Items]
Prior service cost that are expected to be amortized from accumulated other comprehensive loss	$ (25)	$ (20)
Retirement Benefits (Textual) [Abstract]
Accumulated benefit obligation for pension plans	5,660	5,410
Qualified defined contribution plans expense	37	39	40
Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Maximum percentage of fixed income assets can included in debt securities	0.15
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Prior service cost that are expected to be amortized from accumulated other comprehensive loss	4	4
Maximum Range of rebalancing of assets around target asset allocations	5.00%
Expected pension contributions	309
Defined Benefit Postretirement [Member]
Defined Benefit Plan Disclosure [Line Items]
Prior service cost that are expected to be amortized from accumulated other comprehensive loss	21
Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Prior service cost that are expected to be amortized from accumulated other comprehensive loss	(29)	(24)
Maximum Range of rebalancing of assets around target asset allocations	5.00%
Expected Postretirement Contributions	$ 70

XML

Discontinued Operations (Details) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 31, 2010 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2010 RJR Tobacco [Member] USD ($)	Dec. 31, 2010 Northern brands [Member] USD ($)	Dec. 31, 2011 Canada [Member] RJR Tobacco [Member] USD ($)	Apr. 13, 2010 Canada [Member] RJR Tobacco [Member] CAD	Apr. 13, 2010 Canada [Member] Northern brands [Member] CAD
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Payment for accrual adjustment from discontinued operations			$ 324	$ 74
Payment made by RJR Tobacco to the government						325
Fine required to be paid by Northern Brands							75
Previously accrued liability by RJR					91
Discontinued Operations (Textual) [Abstract]
Aggregate accrual adjustment included in losses from discontinued operations before tax	(307)
Aggregate accrual adjustment included in losses from discontinued operations after tax	(216)	(216)
Adjustment classified as a loss on discontinued operations		(303)
Adjustment classified as a loss on discontinued operations after tax		(213)
Loss on sale of discontinued operations		(4)
Loss on sale of discontinued operations after tax		(3)
Realized tax benefit		$ 91

XML

Related Party Transactions

12 Months Ended

Dec. 31, 2011

Related Party Transactions [Abstract]

Related Party Transactions

Note 18 — Related Party Transactions

RAI and its operating subsidiaries engage in transactions with affiliates of BAT, which owns approximately 42% of RAI’s outstanding common stock. The following is a summary of balances and transactions with such BAT affiliates as of and for the years ended December 31:

Balances:

	2011		2010
Accounts receivable	$	67	$	48
Accounts payable		2		4
Deferred revenue		42		53

Significant transactions:

	2011		2010		2009
Net sales	$	479	$	381	$	404
Purchases		11		12		16
RAI common stock purchases from B&W		114		—		—
Research and development services billings		5		4		2

RAI’s operating subsidiaries sell contract-manufactured cigarettes and processed strip leaf to BAT affiliates. Pricing for contract manufactured cigarettes is based on negotiated cost, plus 10%, adjusted for contract years 2011 through 2014 with prices increasing or decreasing by a multiple equal to changes in the Producer Price Index, reported by the U.S. Bureau of Labor Statistics. Net sales to BAT affiliates, primarily cigarettes, represented approximately 6.0%, 4.0% and 5.0% of RAI’s total net sales in 2011, 2010 and 2009, respectively.

RJR Tobacco recorded deferred sales revenue relating to leaf sold to BAT affiliates that had not been delivered as of December 31, in each of 2011, 2010 and 2009, given that RJR Tobacco has a legal right to bill the BAT affiliates. Leaf sales revenue to BAT affiliates is recognized when the product is shipped to the customer.

RJR Tobacco performs certain research and development for BAT affiliates pursuant to a joint technology sharing agreement entered into as a part of the B&W business combination. These services were accrued and billed to BAT affiliates and were recorded in RJR Tobacco’s selling, general and administrative expenses, net of associated costs.

RAI’s operating subsidiaries also purchase unprocessed leaf at market prices, and import cigarettes at prices not to exceed manufacturing costs plus 10%, from BAT affiliates.

In connection with RAI’s share repurchase program, RAI and B&W entered into an agreement on November 14, 2011, pursuant to which B&W agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI common stock. Under this agreement, RAI repurchased 2,806,637 shares of RAI common stock from B&W during 2011.

A member of the board of directors of RAI is also the president and chief executive officer of a company from which RJR Tobacco and American Snuff purchase certain raw materials. Such purchases during the year ended December 30, 2011, were approximately $1 million. Such purchases during the years ended December 30, 2010 and 2009, and related amounts due at December 30, 2011 and 2010, were less than $1 million. In addition to the purchases of raw materials, in July 2011, RJR Tobacco sold an airplane to this company for approximately $8 million.

XML

RJR Guaranteed, Unsecured Notes Condensed Consolidating Financial Statements (Details Textual) (Subsidiaries [Member], USD $) In Millions, unless otherwise specified	Dec. 31, 2011
Subsidiaries [Member]
RJR Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Numeric) [Abstract]
RAI's unsecured notes	$ 58

XML

Borrowing Arrangements (Details) (USD $)	12 Months Ended
	Dec. 31, 2011	Jul. 29, 2011
Borrowing Arrangements (Textual) [Abstract]
Credit facility under current borrowing capacity		$ 750,000,000
Credit facility under current maximum borrowing capacity		1,000,000,000
Credit facility sublimit on the aggregate amount of letters of credit	200,000,000
Borrowings outstanding	0
Amount outstanding for letters of credit	$ 7,000,000
Ratio of debt to EBITDA	not more than 3.00 to 1.00
Ratio of EBITDA to interest expense	not less than 4.00 to 1.00
Maximum [Member]
Line of Credit Facility [Line Items]
Pay rate of commitment fee	0.40%
Minimum [Member]
Line of Credit Facility [Line Items]
Pay rate of commitment fee	0.20%
Alternate Base Rate [Member]
Line of Credit Facility [Line Items]
Credit facility interest rate description	The alternate base rate, which is the higher of (1) the federal funds effective rate from time to time plus 0.5%, (2) the prime rate and (3) the reserve adjusted eurodollar rate for a one month interest period plus 1%
Overdue [Member]
Line of Credit Facility [Line Items]
Credit facility interest rate description	New Credit Agreement bear interest at a rate equal to the rate then in effect with respect to such borrowings, plus 2.0% per annum

XML

Inventories (Tables)

12 Months Ended

Dec. 31, 2011

Inventories [Abstract]

Components of inventories

	2011		2010
Leaf tobacco	$	885	$	997
Other raw materials		44		44
Work in process		60		64
Finished products		139		122
Other		24		25
Total		1,152		1,252
Less LIFO allowance		185		197
	$	967	$	1,055

XML

Borrowing Arrangements

12 Months Ended

Dec. 31, 2011

Borrowing Arrangements/Long-Term Debt [Abstract]

Borrowing Arrangements

Note 11 — Borrowing Arrangements

On July 29, 2011, RAI entered into a credit agreement, referred to as the Credit Agreement, with a syndicate of lenders, providing for a four-year $750 million senior unsecured revolving credit facility, which may be increased to $1 billion at the discretion of the lenders upon the request of RAI. This agreement replaces RAI’s Fifth Amended and Restated Credit Agreement, dated as of June 28, 2007, as amended.

The Credit Agreement contains restrictive covenants that (a) limit the ability of RAI and its subsidiaries to (i) pay dividends and repurchase stock, (ii) engage in transactions with affiliates, (iii) create liens, and (iv) engage in sale-leaseback transactions involving a Principal Property, as defined in the Credit Agreement, and (b) limit the ability of RAI and its Material Subsidiaries, as such term is defined in the Credit Agreement, to sell or dispose of all or substantially all of their assets and engage in specified mergers or consolidations. The Credit Agreement also contains a restrictive covenant that limits the amount of debt that may be incurred by non-guarantor subsidiaries, together with certain financial covenants. The restrictive covenants in the Credit Agreement are subject to a number of qualifications and exceptions. The financial covenant levels in the Credit Agreement are 3.00 to 1.00 for the consolidated leverage ratio and 4.00 to 1.00 for the consolidated interest coverage ratio. In addition, the maturity date of the Credit Agreement is July 29, 2015, which date may be extended, with the agreement of the requisite lenders, in two separate one-year increments. The Credit Agreement contains customary events of default, including upon a change in control, as defined therein, that could result in the acceleration of all amounts and cancellation of all commitments outstanding under the Credit Agreement.

RAI is able to use the revolving credit facility under the Credit Agreement for borrowings and issuances of letters of credit at its option, subject to a $200 million sublimit on the aggregate amount of letters of credit. Issuances of letters of credit reduce availability under such revolving credit facility. As of December 31, 2011, there were no borrowings, and $7 million of letters of credit outstanding, under the Credit Agreement.

Under the terms of the Credit Agreement, RAI is required to pay a facility fee of between 0.20% and 0.40% per annum, based on the facility’s credit ratings, on the lender commitments in respect of the revolving credit facility thereunder.

Borrowings under the Credit Agreement bear interest, at the option of RAI, at a rate equal to an applicable margin, based upon the credit ratings assigned to the Credit Agreement, plus:

• the alternate base rate, which is the higher of (1) the federal funds effective rate from time to time plus 0.5%, (2) the prime rate and (3) the reserve adjusted eurodollar rate for a one month interest period plus 1%; or

• the eurodollar rate, which is the reserve adjusted rate at which eurodollar deposits for one, two, three or six months are offered in the interbank eurodollar market.

Overdue principal and, to the extent permitted by law, overdue interest, outstanding under the revolving credit facility under the Credit Agreement bear interest at a rate equal to the rate then in effect with respect to such borrowings, plus 2.0% per annum.

The obligations of RAI under the Credit Agreement are unsecured. Certain of RAI’s subsidiaries, including its Material Subsidiaries, have guaranteed, on an unsecured basis, RAI’s obligations under the Credit Agreement.

XML

Retirement Benefits (Details 8) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	$ 5,110	$ 4,934	$ 4,054
Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	255	270	270
Domestic Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	1,012	1,027
Domestic Equities [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	54	115
International Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	519	594
International Equities [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	48	44
Global Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	322	352
Fixed Income [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	2,158	1,631
Fixed Income [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	144	96
High Yield Fixed Income [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	144	136
Hedge Funds [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	249	276
Hedge Funds [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		1
Private Equity [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	46	48
Real Estate [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	196	156
Real Estate [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		14
Global Tactical Asset Allocation [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	91	98
Real Estate and Other [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	6
Cash and Cash Equivalents [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	80	571
Fair Value, Inputs, Level 1 [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	1,281	1,342
Fair Value, Inputs, Level 1 [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	15	1
Fair Value, Inputs, Level 1 [Member] | Domestic Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	765	781
Fair Value, Inputs, Level 1 [Member] | International Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	118	126
Fair Value, Inputs, Level 1 [Member] | Global Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	322	351
Fair Value, Inputs, Level 1 [Member] | Fixed Income [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	40	34
Fair Value, Inputs, Level 1 [Member] | Fixed Income [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	15	1
Fair Value, Inputs, Level 1 [Member] | Real Estate [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	35	46
Fair Value, Inputs, Level 1 [Member] | Cash and Cash Equivalents [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	1	4
Fair Value, Inputs, Level 2 [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	3,042	3,080
Fair Value, Inputs, Level 2 [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	237	268
Fair Value, Inputs, Level 2 [Member] | Domestic Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	247	246
Fair Value, Inputs, Level 2 [Member] | Domestic Equities [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	54	115
Fair Value, Inputs, Level 2 [Member] | International Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	401	468
Fair Value, Inputs, Level 2 [Member] | International Equities [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	48	44
Fair Value, Inputs, Level 2 [Member] | Global Equities [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		1
Fair Value, Inputs, Level 2 [Member] | Fixed Income [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	2,082	1,542
Fair Value, Inputs, Level 2 [Member] | Fixed Income [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	129	95
Fair Value, Inputs, Level 2 [Member] | High Yield Fixed Income [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	144	136
Fair Value, Inputs, Level 2 [Member] | Hedge Funds [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		2
Fair Value, Inputs, Level 2 [Member] | Private Equity [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		3
Fair Value, Inputs, Level 2 [Member] | Real Estate [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		20
Fair Value, Inputs, Level 2 [Member] | Real Estate [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		14
Fair Value, Inputs, Level 2 [Member] | Global Tactical Asset Allocation [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	91	98
Fair Value, Inputs, Level 2 [Member] | Real Estate and Other [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	6
Fair Value, Inputs, Level 2 [Member] | Cash and Cash Equivalents [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	77	564
Fair Value, Inputs, Level 3 [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	494	468	464
Fair Value, Inputs, Level 3 [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	494	467
Fair Value, Inputs, Level 3 [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	0	1
Fair Value, Inputs, Level 3 [Member] | Domestic Equities [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	0
Fair Value, Inputs, Level 3 [Member] | International Equities [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	0
Fair Value, Inputs, Level 3 [Member] | Fixed Income [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	36	55	96
Fair Value, Inputs, Level 3 [Member] | Fixed Income [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	36	55
Fair Value, Inputs, Level 3 [Member] | Fixed Income [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	0
Fair Value, Inputs, Level 3 [Member] | Hedge Funds [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	249	275	291
Fair Value, Inputs, Level 3 [Member] | Hedge Funds [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	249	274
Fair Value, Inputs, Level 3 [Member] | Hedge Funds [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets		1
Fair Value, Inputs, Level 3 [Member] | Private Equity [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	46	45	43
Fair Value, Inputs, Level 3 [Member] | Private Equity [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	46	45
Fair Value, Inputs, Level 3 [Member] | Real Estate [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	161	90	31
Fair Value, Inputs, Level 3 [Member] | Real Estate [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	161	90
Fair Value, Inputs, Level 3 [Member] | Real Estate and Other [Member] | Postretirement Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	0
Fair Value, Inputs, Level 3 [Member] | Cash and Cash Equivalents [Member] | Pension Benefits [Member]
Pension and postretirement plan assets carried at fair value
Fair value of pension and postretirement plan assets	$ 2	$ 3